key: cord-0019067-s96n6k04 authors: nan title: SRI 2021: Scientific Abstracts date: 2021-07-14 journal: Reprod Sci DOI: 10.1007/s43032-021-00654-8 sha: 3121263ed5d9b2e2b93376d0122edfd17a5e149c doc_id: 19067 cord_uid: s96n6k04 nan The SRI President's Presenter's Award Originally established in 1996 as the Wyeth President's Presenter Award to recognize the 25 most meritorious oral abstracts submitted by individuals still in training. Fellows and those in both pre and post-doctoral training are eligible to receive the award. The 25 awardees will receive a certificate and a $1,000 award, and will be recognized during the meeting. The Society has always sought a means by which to encourage young investigators to present their research at our meeting. We anticipate the SRI President's Presenter's Award will encourage more abstract submissions and higher quality abstracts by the very people who need encouragement to consider a research career. The Early Career Investigator Travel Award, with support from the National Institutes of Health, was established to enhance the career development of early investigators by facilitating interaction with other scientists in the field, development of research collaborations, and exposure to the latest technologies and scientific developments in reproductive biology and medicine. Early career investigators are defined as individuals who have completed their terminal research degree or end of post-graduate clinical training, whichever date is later, within the past 10 years and who has not previously competed successfully as PD/PI for a substantial NIH independent research award. Up to four $1,000 travel awards and certificates will be given beginning in 2019 to awardees who will be selected by competitive review of abstracts submitted to each annual SRI meeting by the Program Committee, with special regard paid to representation of women and minorities. The Laxmi Baxi Award Established in 2013 and will be awarded to PhD individuals only, who are either graduate students still in training or postdoctoral fellows within five years of their PhD degree. Two $1,000 travel awards will be given to the top abstracts in basic reproductive science and in translational reproductive science. The awardees will receive a plaque, award and they will be honored at the SRI Annual Meeting Awards Ceremony. This award is made possible by a generous, long-standing member of SRI, Dr. Laxmi Baxi, and was created to encourage young PhD trainees to present their research at our meeting. Uterine fibroids or leiomyomas are the most common benign tumors in the female reproductive tract. Estrogen (E2), a steroidderived hormone, and its receptors (ER), ERα and ERβ, are known to be key modulators in the development of leiomyomas by their upregulation of growth factors and activation of signaling pathways. Multiple in vitro and in vivo studies have shown the beneficial effect of simvastatin, a hypolipidemic drug, on uterine leiomyomas. Here, we hypothesized that simvastatin would modulate estrogen-dependent proliferation, downstream signaling, transcriptional activity as well as ERα trafficking. Methods: The primary and immortalized leiomyoma cells were treated with simvastatin (0.001, 0.01, 0.1, and 1 µM) and E2 (10 nM), alone or in combination, for 48 h to examine cell viability by MTT assay, protein levels by western blotting, and cellular intensity by cytoimmunofluorescence. Estrogen response elements (ERE)-Luc activity was examined by luciferase assay. Palmitoylation and ubiquitination assay was performed by resin assisted capture and pull down assay. For the leiomyoma xenograft mouse model, one group was treated with the vehicle control (n = 10) and another group was treated with simvastatin (n = 10, 20 µg/gm body weight) subcutaneously for 28 days, and ER expression was assessed using immunohistochemistry (IHC). Human leiomyoma tissue samples were obtained from a double-blind, phase II, randomized control trial (NCT03400826) with simvastatin (40 mg daily) or a placebo (starch 1500 encapsulated) for a total of 12 weeks. At the end of the treatment, the samples were collected after surgery and IHC staining was performed. Results: Simvastatin treatment significantly decreased E2-induced cell proliferation and PCNA expression in leiomyoma cells. Simvastatin altered receptor trafficking by decreasing the localization of ER-α to the membrane and nucleus. The downstream targets of E2-ER signaling, ERK1/2 and AKT expression, and ERE-Luc activity were suppressed after simvastatin treatment. Notably, simvastatin inhibited ER-α palmitoylation, which links ER-α with the membrane and initiates ER signaling. Simvastatin increased ER-α degradation via ER-α ubiquitination. Finally, simvastatin treatment reduced ER-α expression in clinical fibroid tissue and xenograft animal model. The results of experiments on leiomyoma cells, animal models, and clinical tissue validated the effectiveness of simvastatin to treat uterine leiomyoma growth. Palmitoylation and ubiquitination modulate ER-α stability and trafficking, and simvastatin's effect on ER-α through blocking palmitoylation and enhancing its ubiquitination, results in ER-α degradation, which highlights the potential of altering these post-translational modifications as a strategy for therapeutic applications. O-002 J Lopez-Tello †, E Salazar, T Napso, HEJ Yong, ER Christoforou, I Sandovici, M Constancia, Amanda N Sferruzzi-Perri * . University of Cambridge, Cambridge, United Kingdom. Introduction: The placenta is an active organ that secretes hormones into the maternal circulation. In turn, the maternal liver is involved in regulating whole body glucose-lipid metabolism. However, the impact of placental hormone output on maternal hepatic function during gestation has yet to be explored. Previous work has shown that the Igf2-H19 locus is involved in controlling placental endocrine function in mice (Aykroyd et al., 2020) . This study used manipulations of the Igf2-H19 locus to induce placental endocrine malfunction and examine its consequences for hepatic metabolic function in pregnancy. Methods: Mice were crossed to produce entire litters with reduced levels of the H19 gene and activation of the normally silent maternal Igf2 gene in the placental endocrine junctional zone (Jz-ICR1Δ; A). On day 16 of gestation, maternal blood was collected for metabolite analysis, maternal liver for histology, biochemical, respirometry and RNAseq analyses, and placentas taken for qPCR, histology or for endocrine cell culture followed by LC-MS on the conditioned media. Results: Jz-ICR1Δ dams had litters with heavier placentas due to enlarged junctional zones (B). Additionally, Jz-ICR1Δ dams had elevated circulating glucose, insulin and LDL-cholesterol levels (C) and heavier livers with increased hepatocyte proliferation (D-E). There was no change in hepatic glycogen or fat content in Jz-ICR1Δ dams (F). However, genes involved in translation, mitochondrial homeostasis and response to oxidative stress, among others were affected in the maternal liver by Jz-ICR1Δ (G). No differences were observed in the expression of Igf2-H19 genes in the maternal liver (H). Mitochondrial proton leak and lipid peroxidation (TBARS) were reduced in the liver of Jz-ICR1Δ dams (I-J). Circulating AST, which indicates liver damage, was lower in dams with Jz-ICR1Δ (K). A total of 744 proteins were identified in the media from placental endocrine cell cultures, of which 92 were exclusively detected in the Jz-ICR1Δ group with 30 previously identified to be secreted (L). Gene ontology showed that these secreted hormones from the Jz-ICR1Δ group are involved in a variety of biological processes (L), including reproduction, metabolism and removal of superoxide radicals. Conclusion: Altered production of placental hormones due to conditional Igf2-H19 locus manipulation alters maternal hepatic and whole body metabolic function in pregnancy. Funding: Wellcome Trust, MRC. Introduction: IL-2 is a cytokine released from CD4+T cells that regulates many inflammatory responses depending on its circulating concentration. IL-2 potentiates anti-inflammatory actions in order to quell a chronic inflammatory response. IL-2 is elevated in many chronic inflammatory conditions and has been shown to be increased during preeclampsia (PE), and in Reduced Uterine Perfusion Pressure (RUPP) rats, a rat model of PE. PE is characterized by new onset hypertension during pregnancy and increasing evidence indicates that proinflammatory cytokines interact with blood pressure regulatory systems to cause hypertension in various animal models of PE. Our most recent studies indicate inflammatory mediators cause mitochondrial (mt) dysfunction which contributes to hypertension in response to placental ischemia. The objective of the study was to determine the effects of Low Dose IL-2 on blood pressure and mt function in the RUPP rat model of PE. Methods: We infused IL-2 (0.05 ng/ml) into RUPP rats on GD14 and examined hypertension and renal and placental and endothelial cell mt function compared to control RUPP. On GD19, mean arterial pressure (MAP) was analyzed and fetal, and placental weights were measured and blood, placentas, and kidneys were collected for analysis of mitochondrial function. Results: Mean arterial pressure was elevated 122 ± 5 mmHg in RUPP rats (n=6, p<0.05) versus NP controls (102 ± 3 mmHg, n=5), but was normalized with administration of RUPP + IL-2 (107 ± 1 mmHg, n=9, p<0.05) when compared to control RUPPs. Body, placental, and fetal weights were reduced in both RUPP and RUPP + IL-2 compared to NP controls. Placental mtROS, as measured by production of H 2 O 2 , was significantly elevated in RUPP rats (144.6 ± 14.18 % gated, n=5, p<0.05) compared to NP rats (100 ± 12.34 % gated, n=5), but was reduced in RUPP + IL-2 rats (108.7 ± 7.38 % gated, n=9, p<0.05). Renal mtROS was elevated in RUPP rats (127.1 ± 2.81 % gated, n=5, p<0.05) compared to NP rats (100 ± 5 % gated, n=5), but was improved with administration of RUPP+ IL-2 (63.26 ± 3.57 % gated, n=9 p<0.05). In HUVECS, mt ROS was significantly elevated in HUVECS treated with RUPP sera (6.38 ± 1.81 % gated, n=4, p<0.05) compared to NP control sera (1.86 ± 0.6 % gated, n=5), but endothelial cell mtROS was attenuated in HUVECS treated with RUPP + IL-2 rat sera (2.69 ± 0.53 % gated, n=7, p<0.05). Conclusion: These data indicate that Low Dose IL-2 normalized multiorgan mt function and hypertension in response to placental ischemia during pregnancy. Overall, our study indicates a role for the administration of IL-2 to improve mitochondrial dysfunction in the placenta and decrease blood pressure, which indicates its use as a potential therapeutic for PE. DHES0815A is a novel antibody-drug-conjugate (ADC) which binds specifically to HER2 overexpressing tumors at a distinct epitope from that bound by trastuzumab and pertuzumab after which it delivers the toxic payload, PBD-MA, a DNA mono-alkylating agent. The objective of this study was to evaluate the preclinical activity of DHES0815A against primary USC cell lines and xenografts. Methods: Twelve primary USC cell lines were assessed by immunohistochemistry (IHC) for HER2 protein expression and for C-erbB2 gene amplification using fluorescent in situ hybridization (FISH) analysis. Cell viability and bystander killing in USC cell lines after exposure to DHES0815A, the non-targeted ADC, and the unconjugated antibody (i.e. MHES0488A) were evaluated using flow cytometry-basedassays. In vivo activity of DHES0815A was tested against HER2/neu overexpressing USC xenografts. Results: High HER2/neu protein expression was seen in 25% (3/12) of the primary USC cell lines. USC cell lines overexpressing HER2/neu were significantly more sensitive to DHES0815A when compared to the non-targeted control ADC (p<0.001). DHES0815A did not induce significant bystander killing of HER2/neu negative tumors when admixed with HER2/neu positive tumors. DHES0815A caused growth-inhibition and increased survival in USC HER2/neu overexpressing xenografts when compared to controls (p<0.01). Conclusion: DHES0815A is both highly selective and toxic to USC tumors overexpressing HER2/neu both in vitro and in vivo. HER2directed ADCs, alone or in combination with other HER2/neu targeted agents may represent a novel treatment option for patients with tumors harboring HER2/neu overexpression refractory to trastuzumab and traditional chemotherapy. Diabetes Mellitus (GDM). Soumyalekshmi Nair †, 1 Andrew Lai, 1 Nanthini Jayabalan, 1 Dominic Guanzon, 1 Katherin Scholz-Romero, 1 David McIntyre, 2 Martha Lappas, 3,4 Carlos Salomon. Introduction: Gestational Diabetes Mellitus (GDM) is the glucose intolerance that develops during pregnancy, and has short and longterm effects on maternal and fetal heath. Extracellular vesicles (EVs)associated miRNAs are key regulators of gene expression in target cells. The aim of the present study is to identify the mechanism by which miRNAs are selectively packaged into EVs from placental cells, in normal pregnancy and GDM. Methods: Small EVs like exosomes were isolated from the cellconditioned media of Primary Human Trophoblast (PHT) cultures from normal glucose tolerant (NGT), and GDM patients. The miRNA and protein profile in PHT cells and EVs were analysed using next generation sequencing and high throughput mass spectrometry, respectively. The over-represented sequence motifs in the miRNAs were identified using the Motif Discovery on Short Sequence (MDS2) tool. To identify proteins associated with EVs miRNA sorting, trophoblast cellular extracts were incubated with biotin beads coated with candidate miRNAs, and pulled-down proteins were analysed by liquid chromatography mass spectrometry. Results: We identified a specific set of proteins and miRNAs that were differentially expressed in PHT cells in GDM compared to NGT. In EVs, miR-10a-5p was upregulated whereas miR-574-5p and miR-181-5p were downregulated in GDM compared to NGT (p value ≤ 0.05). A specific set of miRNAs were highly enriched in EVs compared to their cells of origin in NGT and GDM. Among these, 29 miRNAs were unique to NGT; 17 miRNAs were unique to GDM; and 26 miRNAs were upregulated in EVs in both NGT and GDM. We identified unique miRNA motifs in these three groups based on their coverage and p value. Candidate miRNAs were chosen for each group (miR-150-5p and miR-1246 for NGT; miR-1285-5p for GDM; and miR-486-5p for shared), based on their abundance and enrichment in EVs. Finally, we identified a repertoire of unique proteins that were interacting with miRNAs within each groups. Based on the peptide count and coverage, the top highly represented proteins were Nucleolin, Neuroblast differentiation-associated protein, Heterogeneous nuclear ribonucleoprotein, and RNA helicases. Conclusion: These findings provide insights into the differential mechanisms through which miRNAs are specifically sorted into EVs in normal pregnancy and GDM Introduction: In non-pregnant populations, adherence to diets with a lowglycemic index and low-glycemic load seems to lower blood pressure. We hypothesized that maternal adherence to a lower dietary glycemic index and load during pregnancy improves gestational hemodynamic adaptations and reduces the risk of gestational hypertensive disorders. We examined the associations of dietary glycemic index and load with maternal blood pressure, placental hemodynamic parameters and the risk of gestational hypertensive disorders. Methods: In a population-based cohort among 3378 pregnant Dutch women, dietary glycemic index and load were assessed from food frequency questionnaires at median 13.4 (95% range 9.9-22.9) weeks gestation. Blood pressure was measured in early, mid and late pregnancy. Placental hemodynamic parameters were measured in mid and late pregnancy by ultrasound. Data on gestational hypertensive disorders was acquired from medical records. Results: Mean dietary glycemic index (SD) was 58 (3) and mean dietary glycemic load (SD) was 155 (47). Dietary glycemic index was not associated with blood pressure, placental hemodynamic parameters and the risk of gestational hypertensive disorders. Higher dietary glycemic load SDS was associated with a higher diastolic blood pressure in early-pregnancy, remaining after adjustment for socio-demographic and lifestyle factors ((0.98 (95% CI 0.35-1.61) mmHg per SDS increase in glycemic load). No other associations of glycemic load with blood pressure or placental hemodynamic parameters and the risk of gestational hypertensive disorders were present. Conclusion: Within this low-risk pregnant population, we did not find consistent associations of dietary glycemic index and load with blood pressure, placental hemodynamic parameters and the risk of gestational hypertensive disorders. Further studies need to assess whether the effects on gestational hemodynamic adaptations are more pronounced among high-risk women with an impaired glucose metabolism. O-008 Introduction: Maternal obesity increases the risk of cardiovascular and metabolic disease in the offspring both during childhood and adult life. As compared to controls with normal body mass index, pregnant women and mice that are obese have lower circulating levels of adiponectin (ADN), an adipokine involved in regulating energy metabolism, vascular function and placental function. We hypothesized that offspring of obese mice have impaired resistance artery function, which is prevented by restoration of normal circulating ADN levels in obese dams during late pregnancy. Methods: Adult female mice were fed with either control (CON) or obesogenic (OB) diet until the OB group gained 25% of their initial body weight and mated with CON males. A mini-osmotic pump was subcutaneously implanted in all pregnant dams at late pregnancy (embryonic day 14.5). CON dams received a continuous infusion of phosphate saline buffer (PBS) whereas OB females received either PBS or ADN (0.62 µg g -1 day -1 ). Dams were maintained on their respective diets during pregnancy and throughout lactation. After weaning, offspring were fed CON diet. Between seven and nine months of age, adult offspring's resistance (mesenteric) and pulmonary arteries were dissected and mounted in a wire myograph. Contractile and dilator responses to phenylephrine or endothelin-1 and acetylcholine (ACh), bradykinin (BK) or an AMPK activator (A769662), respectively, were determined in the offspring of CON-PBS (n = 7), OB-PBS (n = 9) and OB-ADN (n = 5) dams. Concentration-response curves were compared by two-way ANOVA. Results: Mesenteric (MsA) and pulmonary artery (PA) vasoconstrictor responses to phenylephrine and endothelin-1 were similar among all groups. Likewise, MsA vasodilator responses to BK and A769662 were comparable among groups but offspring from OB-PBS and OB-ADN dams had 35% and 25% less ACh-evoked vasodilation (p<0.05 and p=0.07), respectively, compared to MsA from CON-PBS animals. PA vasodilator responses to ACh were not affected by any treatment. BK and A769662 did not evoke vasodilation in PA from any group. Conclusion: In mice, maternal obesity has a long-lasting impact on the cholinergic response of resistance vessels of the offspring. However, restoration of maternal ADN during pregnancy did not restore cholinergic responses in these vessels, suggesting they are independent of reduced ADN levels in pregnancy. The Impact of Pre-Pregnancy Maternal Lipid Metabolism on Neonatal Adiposity. Raziel Rojas-Rodriguez †, Patrick M Catalano * . Tufts Medical Center, Boston, MA, United States. Introduction: Changes in maternal glucose metabolism related to neonatal adiposity have been well-characterized. However, there are less data regarding the changes in maternal lipid metabolism and neonatal fat mass (FM). Since pregravid maternal BMI has as strong association with neonatal adiposity independent of gestational weight gain (GWG), it is necessary to examine maternal lipid metabolism longitudinally, beginning prior to conception. Aim: To investigate the longitudinal changes in maternal lipid metabolism in low (LA) and high (HA) adiposity women and their relationship with neonatal adiposity. Methods: Thirteen women were evaluated pregravid (P), 12-14 (E), and 34-36 weeks (L) gestation. Body composition was estimated utilizing hydrodensitometry. There were 6 LA and 7 HA subjects, based on P body fat percent (BF%). Basal endogenous glucose production and glycerol turnover (GLYTO) were measured for 2hr using 2 H 2 -glucose and 2 H 5 -glycerol. Following the basal measures, insulin sensitivity (IS) and GLYTO were measured using the hyperinsulinemic-euglycemic clamp with continued infusion of glucose and glycerol stable isotopes. Lipid oxidation (FATOX) was measured with indirect calorimetry. Neonatal body composition was performed using total body electrical conductivity. Results: At P, the HA group had higher weight (kg) (p≤0.01), fat free mass (FFM) (kg) (p≤0.05), FM (kg) (p≤0.001), and BF% (p≤0.01), compared to LA cohort. Both cohorts had similar GWG and accrual of FFM and FM during pregnancy. IS (umol/kgFFM/min)/(pmol/L insulin) decreased from P to L in both cohorts (p≤0.0001), with higher reductions in HA subjects (p≤0.01). GLYTO (mmol/hr) during the basal period and with insulin infusion (104 pmol/m 2 /min) increased with advancing gestation (p≤0.05, p≤0.01, respectively), indicating increased basal lipolysis and increased lipid insulin resistance with no signifi cant diff erences between groups. There was a longitudinal increase of clamp FATOX in both groups (p≤0.01). Neonates of HA mothers had higher FM (p≤0.01) and BF% (p≤0.01) compared to those from LA mothers. P FM was positively associated with L GLYTO at basal (r=0.67, p≤0.01) and insulin clamp (r=0.70, p≤0.01) conditions. There was a positive relationship between P and L GLYTO during both basal and insulin clamp (r=0.78, p≤0.01; r=0.82, p≤0.01, respectively) . L basal and clamp GLYTO were positively related to neonatal FM (r=0.65, p≤0.01; r=0.67; p≤0.01, respectively) . The % suppression of GLYTO at L was inversely associated with neonatal FM (r=-0.65, p≤0.05). Conclusion: P maternal adiposity and GLYTO are signifi cantly related to changes in lipid metabolism in L gestation. Maternal L basal and clamp GLYTO is signifi cantly related to neonatal FM and accounts for 45% variance in neonatal adiposity at birth. Future studies should consider pregravid lifestyle interventions to improve maternal metabolic state and prevent transgenerational obesity in off spring. Robert A. Wild, 1 Rodney K Edwards, 1 vs. exercise alone (E)] before OS-IUI can improve live birth rates in obese women with unexplained infertility. Our OBJECTIVE was to determine if there is a relationship between highly atherogenic very small ldl lipid particle concentrations and Pre-E in this cohort Methods: Frozen samples at each visit were blindly analyzed by ion mobility (Quest Diagnostics) at baseline (BL), after D+E or E (M4), and at 16, 24, and 36 weeks gestation. Mean values across the visits were analyzed using linear mixed models with repeated measures and 2 factor anova with repeated measures. Results: Pre-E developed in 11 of 76 (14.5%) patients who had a live birth. Triglycerides (TGs) and Chol/HDL ratios (not shown) were higher across the visits for those who developed Pre-E (p<0.001). Levels of highly atherogenic very small LDL cholesterol particles (a, b, c) were higher during but not before pregnancy in those who developed Pre-E (p<0.05) with or without gestational diabetes. Conclusion: Triglycerides are known to be elevated in preeclampsia; our data are consistent. This was found pre-pregnancy and throughout pregnancy in this cohort. Unlike the other lipids, highly atherogenic very small LDL cholesterol particles were elevated during, but not prepregnancy. Highly atherogenic dyslipidemia is a risk factor for short-(complications during) and long-term (cardiovascular complications later) maternal morbidity. The role of these very small LDL cholesterol particles in the pathogenesis of Pre-E (an acute vascular disease) deserves further investigation. Introduction: Mild CHTN aff ects 5-10% of reproductive age women, yet little data exist regarding the risks of progression from mild to severe CHTN or other cardiovascular diseases (CVDs). Our objective was to investigate the incidence of a composite of severe CHTN or other CVDs within 5 -7 years after an index pregnancy complicated by mild CHTN. Methods: This is a retrospective cohort of women with mild CHTN during an index pregnancy from 2012 -2014. Women were included if they received prenatal care at our center, had mild CHTN during pregnancy (defi ned by ACOG as elevated blood pressure (BP) prior to pregnancy or newly diagnosed in pregnancy < 20 weeks gestation (GA) with systolic BP (SBP) 140-159 mmHg and/or diastolic BP (DBP) 90 -109 mmHg). Women with Type 1 diabetes, SLE, cardiomyopathy, proteinuria (p/c ratio >0.3 or 24hr >300mg), severe CHTN, and creatinine levels > 1.1 mg/dL < 23 weeks GA were excluded. The primary outcome was a composite of severe CHTN (BP ≥160/110) more than 12 weeks after the index delivery or other CVDs (death, stroke, heart failure or cardiomyopathy, heart attack or angina, thromboembolism, renal failure (creatinine >1.1 mg/dL) unrelated to preeclampsia in a subsequent pregnancy. We estimated the cumulative incidence and 95%CI over the entire period from 2012-2019. We also examined differences in patient characteristics between those who progressed and those who do not. Other secondary CV outcomes (Table) were also collected. Results: A total of 459 women with mild hypertension in the index pregnancy met inclusion criteria. Of these, 160 (35%) women experienced the primary outcome composite of severe CHTN within 5 -7 years of the index pregnancy unrelated to a diagnosis of preeclampsia in a subsequent pregnancy. Race/ethnicity and smoking status differed between women with mild CHTN who progressed to severe CHTN versus those who did not, but notably, obesity was similar. The primary component of the composite outcome was severe HTN in 96.3% (Table) . Average time for progression from mild to severe CHTN was 2.4 ± 1.9 years after delivery (median [Q1-Q3] = 2.0 [0.7-3.6] years). There were 5 maternal deaths (3.1%). Secondary CV outcomes of interest were rare. Conclusion: In this cohort, one in three women with mild CHTN in an index pregnancy had progression to severe CHTN 5 -7 years later. Because CHTN is a major risk factor for heart disease (a leading cause of death among women in the US), opportunities to mitigate this disease are urgently needed. Amsterdam UMC -AMC, Amsterdam, Netherlands. Introduction: To develop a prognostic model for spontaneous preterm birth (SPTB) based on maternal characteristics, obstetric history and placental biomarkers. Methods: In this Dutch prospective multicenter cohort (RESPECT, ZonMw 50-50200-98-060) we recruited women <14 weeks of gestation at their initial prenatal visit. Maternal characteristics and obstetric history were collected from medical records and questionnaires. Pregnancyassociated Plasma Protein-A (PAPP-A) and Placental Growth Factor (PlGF) were collected between 9-14 weeks of gestation. The primary outcome was SPTB <37 weeks of gestation. Missing data were handled using multiple imputation and Rubin's Rules were used for pooled analyses. We used logistic regression with backward elimination to identify the most discriminative predictors. Internal validation was performed by bootstrapping. For clinical use, risk categories were calculated based on predicted probabilities: very low (<1%), low (1-5%), moderate (5-10%), and high risk (≥10%). We also evaluated the performance of the model for nulliparous women and multiparous women with and without a previous preterm birth. Results: A total of 3,695 women with singleton pregnancies were included for analysis of which 1,642 (44.4%) were nulliparous. SPTB occurred in 128 (3.5%) pregnancies. The most discriminative predictors for SPTB were nulliparity (OR 3.68, 95% CI 2. 33-5.84 ) and history of preterm birth <37 weeks (OR 6.90, . Other predictors in the model were maternal age, smoking, vaginal blood loss in the first trimester and PAPP-A. Model performance was fair (AUC 0.687) and a calibration plot showed that the model was well calibrated. The classification in risk categories and performance measures of are shown in Table 1 . Conclusion: This prognostic model including maternal characteristics, obstetric history and the biomarker PAPPA-A has a fair discriminative ability to predict the occurrence of SPTB. Perhaps this model could select women who may or may not benefit from follow-up management strategies such as cervical length screening. Loss of MIG-6 Results in Endometrial Progesterone Resistance and Endometriosis-Related Infertility through ERBB2 Overexpression. Tae Hoon Kim, 1 Jung-Yoon Yoo, 2 Jung-Ho Shin, 3 Ryan Marquardt, 1 Ulrich Müller, 4 Asgerally Fazleabas, 1 Steven Young, 5 Bruce Lessey, 6 Ho-Geun Yoon, 2 Jae-Wook Jeong * . 1 Introduction: Fertility problems are highly associated with endometriosis. Although the exact etiology of endometriosis-related infertility is unknown, endometrial progesterone resistance has recently been suggested as a crucial element in the development of endometrial diseases. MIG-6 acts as a key P4 signaling mediator in the endometrium of the human and mouse. Uterine-specific Mig-6 knock-out mice (Pgr cre/+ Mig-6 f/f ) are infertile due to non-receptive endometrium. We hypothesized that MIG-6 loss causes endometriosis-related infertility due to endometrial progesterone resistance. Methods: We examined MIG-6 levels in eutopic endometrium from infertile women with endometriosis. We utilized a non-human primate endometriosis model to track MIG-6 expression in eutopic endometrium through disease progression. To determine the effect of MIG-6 loss on endometriosis development, we surgically induced endometriosis with endometrium from control and Pgr cre/+ Mig-6 f/f mice. To investigate the effect of ERBB2 targeting on progesterone resistance and infertility, we introduced Erbb2 ablation in the Mig-6 knockout mice (Pgr cre/+ Mig-6 f/f Erbb2 f/f ). The expression of MIG-6 mRNA and proteins were significantly reduced in eutopic endometrium of early secretory phase infertile women with endometriosis. Induction of endometriosis in a non-human primate model of endometriosis progressively reduced the expression of MIG-6. Endometrial tissue from Pgr cre/+ Mig-6 f/f mice formed a significantly increased number of endometriotic lesions in the mouse compared to the control. ERBB2 overexpression was identified in non-receptive endometrium from Pgr cre/+ Mig-6 f/f mice. Pgr cre/+ Mig-6 f/f Erbb2 f/f double mutant mice reversed the endometrial progesterone resistance as well as all phenotypes including infertility and increased endometriosis development seen in Pgr cre/+ Mig-6 f/f mice. Remarkably, the transcriptomic analysis showed that altered genes in Mig-6 d/d mice reverted to their normal expression levels in Mig-6 d/d Erbb2 d/d mice. Conclusion: Together, our results demonstrate that MIG-6 loss causes progesterone resistance through ERBB2 overexpression in non-receptive endometrium of endometriosis-related infertility. Our results suggest that ERBB2 is a potential target for progesterone resistance and endometriosisrelated infertility. Subjects rated response to injection as percent (%) improvement and benefit duration. T-tests, non-parametric tests, Fisher's exact test, logistic regression, and survival analysis compared data. Results: Of 29 randomized women, all identified pelvic floor spasm as a major focus of endo-CPP. No subject dropped out before 1-year follow-up. At 1 month after masked injection, 11/15 (73%) who received BTX and 4/14 (29%) placebo reported benefit (p=.027). BTX reported a greater % improvement (p=.034) and longer-lasting benefit compared to placebo (p=.023). The number of pelvic floor muscles in spasm decreased in BTX only (p=.019). Adjusting for treatment and benefit, higher baseline disability predicted request for 2 nd injection at 1-month (p=.022) . Controlling for treatment, those without benefit more often requested open BTX at 1-month (p=.032). Prior to 2 nd injection, placebo group had more days with no benefit than BTX (p=.02). Women with focal pelvic pain at baseline exam had longer lasting benefit compared to those with diffuse (p=.02), especially in BTX group (p=.004). In all subjects, benefit was briefer with 1 st (masked) than 2 nd (open) injection (p=.02), particularly in placebo (p=.002). Over time, those receiving BTX used less pain medication than placebo (p=.037). VAS did not reflect benefit seen due to wide pain rating variability at baseline and after injection in both groups. Adverse events were mild and not serious, with no difference in incidence between groups (p=.11). Conclusion: We demonstrate pelvic floor muscle spasm as part of endo-CPP and relief of pain/spasm from BTX compared to placebo that persisted over time. BTX was well tolerated and not associated with more/worse adverse events than placebo. Those with focal pelvic pain were more likely to have longer benefit. Bleeding Patterns in Women with Endometriosis-Associated Pain Treated with Relugolix Combination Therapy: SPIRIT Program. Andrea S Lukes, 1 Sawsan As-Sanie, 2 Christian M Becker, 3 9 Myovant Sciences GmBH, Basel, Switzerland. Introduction: Relugolix combination therapy (Rel-CT: relugolix 40 mg, estradiol 1 mg, norethindrone acetate 0.5 mg) significantly improved endometriosis-associated pain vs placebo in the pivotal SPIRIT 1 and 2 studies. Clinical effect was maintained over 52 weeks (wks) in the long-term extension (LTE) study. Rel-CT has also been shown to inhibit ovulation and maintain estradiol concentrations as in the early follicular phase of the menstrual cycle. Here, we describe bleeding patterns in women with endometriosis treated up to 52 wks with Rel-CT. Methods: SPIRIT 1 and 2 were Phase 3, randomized, double-blind, 24-wk, placebo-controlled studies of Rel-CT, delayed Rel-CT (relugolix 40 mg monotherapy then Rel-CT, both for 12 wks), or placebo in premenopausal women (age 18-50 years) with surgically diagnosed endometriosis, moderate-to-severe dysmenorrhea and non-menstrual pelvic pain. Women completing SPIRIT 1 or 2 were eligible to enroll in the open-label LTE of once-daily Rel-CT. Bleeding patterns (no bleeding, spotting, light, moderate, heavy, extremely heavy) were based on women's daily eDiary records. Amenorrhea was defined as lack of bleeding for at least 56 consecutive days after starting treatment. Women who received Rel-CT in the pivotal studies and continued in the LTE were the focus of this analysis. Results: Of 1261 randomized women, 1044 completed the pivotal studies; 802 enrolled in the LTE. Baseline demographics/characteristics were balanced across treatment groups. Increasing proportions of women treated with Rel-CT experienced amenorrhea at Wk 24 and 52: 67.9% (95% CI: 62.0, 73.3) and 76. 6% (70.7, 81.9) , respectively. The average number of bleeding days per cycle (standard deviation) decreased from 5.8 (2.4) at baseline to 1.7 (3.6) and 1.4 (3.6) at Wk 24 and 52; days with heavy/extremely heavy bleeding reduced from 1.9 at baseline to 0.1 at Wk 24 and 52. Similar changes were observed in women initially receiving placebo after transitioning to Rel-CT at Wk 24. Conclusion: Most women with endometriosis-associated pain treated with Rel-CT over 52 wks achieved amenorrhea. There was a reduction of bleeding days per cycle, including days with heavy/extremely heavy bleeding. Findings are consistent with the mechanism of action of Rel-CT and may support patient counseling. Single-Cell Sequencing Reveals Novel Cell Type and Heterogeneous Non-Monoclonal Cell Populations in Human Leiomyomas. Jyoti Goad †, 1 Joshua Rudolph, 1 Jian- Jun Wei, 2 Serdar E Bulun, 2 Debabrata Chakravarti, 2 Aleksandar Rajkovic * . 1 We collected uterine leiomyomas (n=8) and matched normal myometrium (n=5) from eight patients undergoing hysterectomy. The tissue collected was dissociated to prepare a single-cell suspension. Single cells were processed through 10X Chromium system (10X Genomics). Part of tissue collected was used to perform genotyping and histology. Data analysis was performed using the Seurat pipeline. Data were validated using immunohistochemistry or in-situ hybridization. Results: We analyzed a total of 34,435 high-quality cells (11,235 cells from myometrium, 15,417 from MED12 positive, and 7,783 cells from MED12 negative leiomyoma). Our analysis revealed presence of 18 different clusters across lineages in myometrium and leiomyomas. These cell clusters were highly reproducible, as nearly all clusters were represented in all patient samples. We identified heterogeneity in smooth muscle (5 distinct populations) and fibroblasts populations (2 distinct populations) in myometrium. We identified transcriptional changes in smooth muscle and fibroblast cell clusters of both MED12 positive and MED12 negative leiomyomas compared to myometrium. Furthermore, we discovered novel lymphatic endothelial cell populations in both MED12 positive and MED12 negative leiomyomas. Our data shows that immune cell population infiltration in leiomyomas is genotype-dependent. We found increased infiltration of T-cells and NK cells in MED12 positive leiomyomas while B-cells and macrophages infiltrate MED12 negative leiomyomas. Moreover, our analysis revealed that MED12 positive leiomyomas are composed of cells carrying the MED12 mutant variant as well as cells carrying wild type MED12 allele, indicating that leiomyoma cellular moiety is not monoclonal. We generated a single cell atlas for myometrium and leiomyomas. Our data reveals previously unknown cellular heterogeneity in myometrium and leiomyomas. We discovered novel lymphatic endothelial cell populations in leiomyomas and found that immune cell infiltration in leiomyomas is genotype dependent. Furthermore, our data indicates that MED12 positive leiomyomas are not monoclonal. were collected for isolation of leiomyoma smooth muscle cells (LSMC) and gene analysis. The collected tissue specimens included Caucasians (N=12), African Americans (N=25), Hispanics (N=23) and Asians (N=7). The menstrual cycle phase was determined by histologic analysis with 32 specimens being identified as in the proliferative phase and 17 specimens in the secretory phase. The MED12 (Mediator of RNA polymerase II transcription, subunit 12 homolog) mutation status was determined by PCR amplification and Sanger sequencing. Of the specimens sequenced, 43 fibroids had the MED12 mutations (64.2%). MIAT and microRNA 29 family (miR-29a, -b and -c) were assessed by qRT-PCR. The direct interaction of MIAT and miR-29 family was determined by the luciferase activity assay and RNA immunoprecipitation (RIP). Using LSMC threedimensional spheroid culture system knockdown of MIAT was done by siRNA transfection and protein abundance of collagen type I (COL1A1) and collagen type III (COL3A1) was determined by western blot analysis. Results were analyzed by Student's t-tests and one-way ANOVA with Tukey's HSD for post hoc analysis. Results: Leiomyoma expressed significantly higher levels of MIAT which was independent of race/ethnicity and menstrual cycle phase. However, MIAT was more abundant, while miR-29 family was expressed significantly less in leiomyomas bearing the MED12 mutation as compared with wild type leiomyomas. Using luciferase reporter activity and RNA immunoprecipitation analysis we confirmed MIAT has sponge activity over miR-29 family. Transient transfection of MIAT siRNA in LSMC spheroids resulted in up-regulation of miR-29 family with an inverse relationship with expression of their targets COL1A1 and COL3A1. Treatment of LSMC spheroids with TGF-β3 (Transforming Growth Factor β-3) through TGF-β receptor signaling induced expression of COL1A1 and COL3A1, and MIAT levels, while repressed miR-29 family expression. Overall, knockdown of MIAT in LSMC spheroids partially blocked the effects of TGF-β3 on the induction of COL1A1 and COL3A1 expression. Conclusion: MIAT expression is induced in leiomyoma in a positive correlation with MED12 mutation status, resulting in a decrease in miR-29 family levels via sponging mechanism and accumulation of their targets COL1A1 and COL3A1. Collectively, these results indicate a significant role of MIAT in leiomyoma pathogenesis. Ayman Al-Hendy, 1 Introduction: Once-daily relugolix combination therapy (Rel-CT) reduced menstrual blood loss (MBL) in women with uterine fibroids (UF) and was well tolerated, through 24 weeks (wks) in LIBERTY 1 and 2. We report treatment effect on bleeding patterns in patients (pts) treated with Rel-CT for up to 52 wks or transitioning from placebo (PBO) to Rel-CT after 24 wks. Methods: Women with UF-associated heavy menstrual bleeding (HMB) who completed the 24-wk double-blind, PBO-controlled LIBERTY 1 and 2 trials were eligible to enroll in a 28-wk long-term extension (LTE) study. All received once-daily Rel-CT (40 mg relugolix, estradiol 1 mg, norethindrone acetate 0.5 mg). Primary efficacy endpoint: proportion of pts who achieved or maintained an MBL volume <80 mL and a ≥50% reduction from pivotal study baseline to the last 35 days of treatment. Secondary endpoints: mean % MBL reduction and amenorrhea rate. Outcomes were analyzed by baseline LIBERTY treatment assignment (Rel-CT and PBO) using descriptive statistics without statistical testing for treatment comparison. In LIBERTY, study drug was initiated within the first 7 days of menses onset. At time of rollover into the LTE, women in the PBO group started treatment later in the menstrual cycle because they were required to complete the Week (Wk)24 feminine product collection before transitioning to Rel-CT. Results: With Rel-CT (N=163), a rapid reduction in MBL was observed at Wk4 (least square (LS) mean % change from baseline: -52.8%), reaching -81.2% at Wk8, which was maintained through Wk52 (-89.9%). With PBO (N=164), there was no meaningful change in MBL during the first 24 wks (-17 .6%) nor decrease in MBL after the first 4 wks of the LTE, because Rel-CT was initiated later in the menstrual cycle. At Wk32, a rapid reduction in MBL (LS mean % change: -79.6%) was observed, progressing to -91.9% at Wk52, confirming the effect of Rel-CT on MBL shown in the pivotal studies. At Wk52, MBL <80 mL was observed in 87.1% and 75.6% pts in the Rel-CT and PBO→Rel-CT groups and, in 89.0% and 81.1% of pts, a ≥50% reduction of MBL was reported in the Rel-CT and PBO→Rel-CT groups, respectively. The proportion of pts achieving amenorrhea over the last 35 days of treatment was 70.6% (Rel-CT group) and 57.9% (PBO→Rel-CT group). Conclusion: Rel-CT had a rapid and clinically meaningful impact on MBL reduction in women with UF, which was maintained through Wk52. The onset of treatment effect was faster when Rel-CT was initiated at the start of menses. Introduction: MicroRNAs (miRNAs) are small non-coding RNAs that regulate gene expression by degrading target mRNAs and/or by suppressing translation. We previously showed increased FKBP51 and decreased progesterone receptor (PR) levels in decidual cells at the maternal-fetal interface of laboring vs. non-labor specimens. Several miRNAs are known to be involved in the pathogenesis of preterm birth (PTB). We hypothesize that idiopathic PTB is associated with dysregulation of specific miRNAs that target FKBP5 and PR transcripts. Methods: Global RNA sequencing (RNA-Seq) was used to detect differentially expressed miRNA profiles in placental specimens obtained from term labor (n=7) or idiopathic PTB (n=5) or gestational age (GA)matched controls obtained from pre-eclamptic patients (n=5) with indicated PTBs. Differentially expressed miRNAs with ≥ 2-fold changes among the groups were analyzed by TargetScan software to identify relevant miRNAs targeting FKBP5 or PR transcripts. Expression levels of these newly identified miRNAs were then assessed by miRNA-specific reverse transcription, followed by qPCR analysis and normalization to U6 snoRNA levels. Data were compared using One-Way ANOVA, P< 0.05 was considered statistically significant. Results: RNA-Seq analysis revealed that idiopathic PTB placentas exhibited 144 and 161 upregulated miRNAs and 342 and 299 downregulated miRNAs, compared to term or GA-matched control specimens, respectively. Among these differentially expressed miRNAs, TargetScan software identified 21 downregulated miRNAs targeting FKBP5 and 14 upregulated miRNAs targeting PR. Moreover, highest fold changes in miRNA-877 upregulation and miRNA-186 downregulation were found in idiopathic PTB vs. term or GA-matched controls. Thus, further analysis by qPCR confirmed that: 1) miRNA-877-3p was significantly upregulated in idiopathic PTB vs. term or GA-matched controls (Mean± SEM; 2.31± 0.3 vs. 1.29± 0.4 or 0.72± 0.1, respectively; P<0.05); and 2) miRNA-186-3p was significantly downregulated in idiopathic PTB vs. term or GA-matched controls (0.41± 0.04 vs. 1.28± 0.3 or 1.12± 0.2, respectively; P<0.05). Conclusion: These results identified several novel miRNAs expressed in the placenta linked to idiopathic PTB. Increased miRNA-877-3p and decreased miRNA-186-3p levels likely contribute to the induction of idiopathic PTB by down-regulating PR and up-regulating FKBP5 transcripts, respectively. Moreover, these miRNAs can be used as potential A Broad Spectrum Chemokine Inhibitor Prevents Infection-Induced Myometrial Inflammation and Activation. Adam Boros-Rausch †, 1, 2 Tsung-Yen Wu, 3 Kristina Adams Waldorf, 3 Oksana Shynlova * , 1, 2, 4 Stephen Lye * . 1 prevents contraction of uterine smooth muscle (myometrium) by inhibiting the expression of pro-inflammatory cytokines and contraction-associated proteins (CAPs). Methods: Human myometrial biopsies (N=4) were collected from women at term (not in labor), and primary myocytes were isolated by enzymatic digestion. Myometrial cells were treated with LPS (bacterial lipopolysaccharide, 100ng/mL), FSL-1 (bacterial lipopeptide, 100ng/mL), or vehicle for 8 or 24 hours to mimic the infectious process w/wo BSCI (250nM). Conditioned media was collected and secreted cytokines IL6, CCL2, and CXCL8 were analyzed by ELISA. For in vitro contraction assays, myometrial cells were embedded in collagen gels (1.5×10 5 per well in a 6-well plate) for 48 hours and stimulated with inflammatory mimics (LPS, FSL-1, or vehicle) w/wo BSCI (100nM) for 96 hours. Chronically catheterized NHP at 117-125 days gestation received choriodecidual inoculations of either (1) saline (N=7), (2) GBS (5x10 8 colony forming units (CFU)/mL; N=5), and (3) GBS with BSCI (10 mg/kg intravenous and intra-amniotic; N=4). Cesarean sections were performed at PTL or 4 days after inoculation, myometrial biopsies were collected, and total RNA was extracted for RT-qPCR. Results: 1) BSCI significantly decreased CCL2 and CXCL8 secretion (P<0.05) by LPS-induced primary human myocytes in vitro. 2) LPSinduced myocytes embedded in 3D collagen gel caused a significant (P<0.05) decrease of gel area (70%), while FSL-1 administration caused a significant (53%) decrease of gel area, as compared to vehicle-treated control. Pre-treatment of myocytes with BSCI significantly prevented collagen gel contraction induced by bacterial mimics. 3) Compared with saline controls, GBS induced PTL in 4 animals, but in only 1 of 4 receiving BSCI. CCL2, CXCL8, IL1B, IL1RN, IL10, and GJA1 transcript levels were significantly elevated in NHP myometrium during PTL. BSCI significantly (P< 0.05) inhibited GBS-induced expression of cytokines and CAP gene GJA1. Conclusion: BSCI can inhibit uterine smooth muscle cell contraction and cytokine expression in vivo and in vitro. BSCI could represent a novel therapeutic for reducing dysregulated myometrial inflammation and potentially suppressing preterm labour in women. Exposure Introduction: Fetal exposure to chorioamnionitis-driven fetal inflammatory response syndrome (FIRS) is a known risk factor for subsequent development of necrotizing enterocolitis (NEC). NEC remains a leading cause of mortality and morbidity in premature infants, however, mechanisms remain elusive. Our previous work has shown that murine fetal exposure to maternal inflammation (FEMI) decreases neonatal Paneth cell function and density. Paneth cells are key to intestinal innate immunity and disruption of their biology is associated with NEC. Thus, understanding how FEMI disrupts Paneth cell biology may have important implications in understanding chorioamnionitis-associated NEC. Interferon lambda (IFN-λ) has recently been found to induce Paneth cell necroptosis through STAT 1 signaling. As IL-6 can upregulate STAT-1, we hypothesized that fetal exposure to prenatal maternal inflammation decreases Paneth cell function through IL-6 dependent upregulation of IFN-λ expression. Methods: IL6 -/mice on a C57BL/6J background were given a single intraperitoneal injection of 100 ug/kg of Escherichia coli O55:B5derived LPS on day 15.5 of gestation and compared to wild type and sham controls. Neonatal small intestine was harvested on day P7 or P14 following spontaneous delivery. Tissue expression of the Paneth cellspecific antimicrobial peptide α-defensin-1 was quantified by real time rtPCR. IL-6 receptor (IL-6R) and IFN-λ expression was determined using in situ hybridization. Placental samples were harvested on day 19.5 for IL-6R evaluation. Statistical significance was determined using ANOVA. Results: FEMI significantly decreased α-defensin-1 expression compared to sham controls (0.6692 ±0.042 vs 1.03 ± 0.06, n≥5 per group, p<0.0001). However, this reduction was IL-6-dependent as IL6 -/mice had elevated levels compared to shams (1.55 ± 0.08 n≥5 per group, p<0.0001). IL-6R was visualized diffusely through the placenta and at the base of intestinal crypts where Paneth cells reside (N=3). Neonates exposed to FEMI had increased IFN-λ RNA staining at the base of intestinal crypts compared to controls at P7 and P14 (N=3). Conclusion: FEMI decreases neonatal Paneth cell function in an IL-6dependent manner, likely due to robust expression of IL6-R in placental tissue and at the base of intestinal crypts. Further, FEMI upregulates IFN-λ expression within intestinal crypts that persists for several weeks of life after birth. Given our laboratory's prior findings that FEMI induces IL-6 dependent intestinal injury, our novel findings that FEMI increases IFN-λ expression in intestinal crypts may help explain chorioamnionitisassociated development of NEC in preterm infants. Inflammatory-Related Mir-612 Is Increased in Circulating Exosome-Like Vesicles from Women Undergoing Preterm Birth. Bruna Ribeiro de Andrade Ramos * , 1 Júlia Abbade Tronco †, 1 Márcio de Carvalho * , 1 Patrícia Pintor dos Reis * , 1 Juliano Coelho da Silveira * , 2 Márcia Guimarães da Silva * . 1 1 Sao Paulo State University, Botucatu, Brazil; 2 Sao Paulo University, Pirassununga, Brazil. Introduction: Preterm Labor (PTL) and Preterm Premature Rupture of Membranes (PPROM) lead to severe perinatal morbidity/mortality worldwide. Exosomes act in cell communication and contain microRNAs (miRNAs) that are potential biomarkers for these complications. We aimed to compare the expression, in exosome-like vesicles (sEV) from peripheral blood, of miRNAs between term and preterm pregnancies. Methods: Case-control study with women with PTL, PPROM, term pregnancy with and without labor (TL and T) seen at the Botucatu Medical School Hospital, SP, Brazil. sEV were isolated from plasma using Total Exosome Isolation reagent (Invitrogen) and visualized by transmission electron microscopy (TEM). Western blot (WB) for detection of exosomal protein CD9 and Nanoparticle Tracking Analysis (NTA) were performed. Total RNA was extracted using DNA/RNA/Protein Purification kit (Norgen), quantified, then purified/concentrated using Amicon columns. The expression of over 800 miRNAs was performed by nCounter Human V3 miRNA Assay (NanoString). Clinical and sociodemographic data were compared by t-test and X 2 . miRNA counts were normalized by background threshold using miR-6721 as the endogenous control. A comparison of miRNAs expression and relative risk was performed by generalized linear model (Poisson or negative binomial distribution) and adjusted by Wald`s correction. Results: Samples from 31 pregnant women -15 preterm (8 PTL and 7 PPROM) and 16 term (9 T and 8 TL) were included in this study. Mean gestational age was 34w5d ± 2w3d and 39w2d ± 1w for preterm and term groups, respectively. TEM, WB, and NTA confirmed sEV isolation, the median size of the particles was 115.5 ± 4.5 nm. Expression of miR-612 was increased in preterm groups compared to term groups [PTL: 187.7 ±27.4 vs. TL: 155.7 ±29.9, p=0.003 RR=1.20 (1.06-1.36 ) and PPROM: 168.7 ±22.7 vs. T: 135.3 ±20.5, p<0.001 RR=1.25 (1.09-1.42) ]. miR-612 has been shown to increase apoptosis in tumor cells and to regulate NF-KB inflammatory pathway, processes involved in PTL/PPROM pathogenesis. miR-1253, miR-1283, miR378e and miR-579-3p were down-regulated in PPROM compared to term (T) pregnancies. miR-1283 is involved in trophoblast proliferation while there is limited data on miR-1253, miR-378e and miR-579-3p. Conclusion: miRNAs from circulating exosome-like vesicles are differently expressed between term and preterm pregnancies and have the potential to be used as non-invasive biomarkers for pregnancy complications and therapeutic purposes. Future in vitro studies will allow elucidating the exact role played by inflammatory-related and other microRNAs in the pathophysiology of PTL and PPROM. Dose-Response Profile of a Novel Anti-Interleukin-1 Therapeutic, Rytvela, for Prevention of Preterm Birth. Tiffany Habelrih †, 1,2 Sarah-Eve Loiselle †, 1,2 France Côté †, 1,2 Xin Hou * , 2 Christiane Quiniou * , 2 Sylvain Chemtob * . 1,2 1 Université de Montréal, Montreal, QC, Canada; 2 CHU Sainte-Justine, Montreal, QC, Canada. Introduction: Preterm birth (PTB) is the leading cause of neonatal morbidity and mortality. Studies have shown that interleukin-1 (IL-1) plays an important role in the pathophysiology of PTB as it participates in inducing the production of pro-inflammatory mediators and uterine activating proteins (UAPs [FP, CX43, COX2, OTR]) leading to labour. More importantly, uteroplacental inflammation, associated with PTB's parturition pathways, is detrimental to the fragile fetus and can lead to long term sequalae. Our group has developed an allosteric antagonist of the IL-1 receptor, namely Rytvela, found to be potent and safe in preventing PTB by inhibiting the MAP-Kinase pathway while preserving the NF-kB pathway (important in innate immunovigilance), as it suppresses inflammation. Rytvela has been shown to inhibit inflammatory upregulation and uterine activation. This study aims to further pre-clinical development of Rytvela by evaluating the optimal dose to inhibit the inflammatory cascade, prolong gestation and protect the fetus. Methods: Pregnant CD-1 mice were injected with LPS (10 ug intraperitoneal) or IL-1b (1 ug/kg intra-uterine) on gestational day (G) 16.5 to induce preterm labour. Rytvela was injected at different doses (0.1, 0.5, 1, 2, 4 mg/kg/day s.c.) from G16 to G19. Rate of prematurity (2SD above mean). Pregnancy + obesity resulted in marked IR, reflected by a lower steady state glucose infusion rate (GIR) during the clamp in the DIO group vs non-pregnant non-obese controls (13.3±1.33 vs 18.2±1.37mg/kg/ min, p=0.014). GIR was restored in DIO+ES vs (untreated) DIO groups (16.8±1.01 vs 13.3±1.33mg/kg/min, p=0.029), reflecting enhanced wholebody insulin sensitivity, and did not differ from non-pregnant non-obese controls (p>0.05). Corticosterone was increased in DIO+ES/DIO groups vs non-pregnant non-obese controls (122±10.5/132±11.8 vs 74±11.9ng/ ml, p=0.011/p<0.001) but not significantly impacted by ES. Conclusion: ES attenuated IR induced by pregnancy/obesity in rats without evoking a measurable stress response. If this can be replicated clinically, ES could have a role in the management of maternal obesity. Mechanisms of action and safety require further study. Seasonality and the Immune System during Pregnancy: Impact of Seasonal Affective Disorder. Cindy Xin Wen Zhang †, Robert Levitan, Stephen Matthews. University of Toronto, Toronto, ON, Canada. Introduction: The immunology of pregnancy is complex, requiring a balance between heightened and suppressed maternal immune responses throughout gestation. Aside from internal cues provided by the fetus and placenta, the immune system also responds to environmental cues, including the change in seasons. One extreme manifestation of seasonality in humans is Seasonal Affective Disorder (SAD), a form of depression characterized by overeating, hypersomnia, and weight gain in the fallwinter period. There is evidence for altered immune function in SAD patients which has implications for understanding seasonal influences on psychopathology risk in children. We hypothesized that high maternal seasonality, as in SAD, is associated with a unique pattern of immune activity during pregnancy, and that season of sample collection moderates this effect. Methods: All participants were enrolled in the Ontario Birth Study (OBS), the sample included 100 highly seasonal mothers with a lifetime history of SAD and 100 age-and BMI-matched control mothers. Maternal plasma c-reactive protein (CRP) was measured in the 1 st and 3 rd trimester using ELISAs. In a subsample (n=67), gene expression of pro-(IL1β, IL6, TNFα) and anti-inflammatory (IL4, IL10) cytokines were measured in peripheral leukocytes collected at the same times as plasma. Multiple regressions were conducted to predict CRP using the variables maternal seasonality group, gene expression of each cytokine, seasonality group by cytokine interaction, and BMI as a covariate. Results: In the 1 st trimester, there was a significant effect of maternal seasonality (p=0.044) but no effect of season (p=0.71), and no interaction effect (p=0.99). Highly seasonal women had significantly lower plasma CRP than controls at this time (p=0.041). There was no effect of maternal seasonality or season in the 3 rd trimester. There was no change in plasma CRP across pregnancy (p=0.56). There was a significant increase in antiinflammatory cytokine IL10 expression from trimester 1 to trimester 3 in all subjects (p=0.002). Upon further investigation, this difference was only present in highly seasonal subjects (p=0.001). In the 1 st trimester, multiple regression analyses revealed a significant interaction effect of IL1β gene expression and maternal seasonality group (p=0.028), and a main effect of IL10 gene expression (p=0.047). Conclusion: This is the first study to investigate effects of season and maternal SAD on immune function during pregnancy. The finding that highly seasonal women had lower levels of plasma CRP in trimester 1 has implications for understanding fetal neurodevelopment. Primary neurulation and neural proliferation occur during the first trimester and are susceptible to inflammatory insults that may lead to the aberrant cortical development associated with psychiatric disorders. Future studies will assess whether maternal prenatal data relate to offspring developmental outcomes. Upregulation of CBS Transcription. Jin Bai †, Thomas J Lechuga †, Qian-rong Qi †, Yi-hua Yang †, Quan-wei Zhang †, Yan Li †, Dong-bao Chen * . University of California, Irvine, CA, United States. Introduction: Normal pregnancy is featured by dramatic rises in uterine blood flow, providing the bidirectional maternal-fetal exchanges of nutrients and respiratory gases obligated for in utero fetal growth and survival. Pregnancy-associated uterine vasodilation is accompanied with dramatically elevated estrogens and augmented production of a newly recognized uterine artery (UA) vasodilator hydrogen sulfide (H 2 S) in UA endothelial cells (UAECs) and smooth muscle cells by selectively upregulating the expression of its producing enzyme cystathionine β-synthase (CBS) but not cystathionine γ-lyase (CSE) in vivo. However, whether estrogens stimulate pregnancy-dependent UA H 2 S biosynthesis is unknown. This study using fully validated primary human UAECs isolated from both non-pregnant (NP) and pregnant (P) women was to determine if estrogens stimulate pregnancy-dependent UAEC H 2 S biosynthesis via specific estrogen receptor, ERα and/or ERβ, mediated CBS transcription. Methods: Real-time PCR, Western blot and methylene blue assay were used to measure CBS/CSE mRNA expression, protein expression and H 2 S production in hUAECs, respectively. Putative estrogen-responsive elements (EREs) were identified by LASAGNA motif search tool. Luciferase reporter gene expression studies using human CBS promoter and its 5'-deletion constructs were used to locate α/βEREs in CBS proximal promoter and further verified by ChIP-qPCR using specific ERα and ERβ antibodies. Results: Baseline H 2 S production and CBS mRNA/protein were higher (p < 0.05) in P-vs. NP-hUAEC culture in vitro; all were stimulated by treatment with estradiol-17β (E 2 β, 10 nM, 24-48 h) by 2-3 fold (p < 0.01) in P-vs. NP-hUAECs and blocked by 1 μM ER antagonist ICI 182,780. Human proximal CBS promoter contains 2 αEREs and 4 βEREs, preferentially binding ERα and ERβ, respectively. Luciferase studies located ERα and ERβ interactions with specific αEREs and βEREs that mediate E 2 β-stimulated pregnancy-dependent trans-activation of CBS promoter; these results were further verified by ChIP-qPCR and sequencing analyses. In P-hUAECs, ERα or ERβ agonist alone transactivated CBS promoter and stimulated mRNA/protein expressions to levels similar to that of E 2 β, while ERα or ERβ antagonist alone abrogated E 2 β-stimulated responses. E 2 β did not stimulate either human CSE promoter trans-activation or mRNA/protein expressions in NP-and P-hUAECs. E 2 β also stimulated ER-dependent CBS but not CSE mRNA/ protein expressions in UA ex vivo explant ring cultures. Introduction: Development of insulin resistance (IR) in late pregnancy is important for fetal growth. This increase in IR is associated with impairments in post-receptor insulin signaling (IS) in skeletal muscle -specifically, a decrease in IRS1 expression and an excess of its inhibitory molecule p85α. The primary initiator of these changes is unknown. We hypothesized that placental miRNAs are associated with maternal IR in late pregnancy, based on their predicted targets within the IS pathway. Methods: 132 healthy women (70 lean (BMI<25); 62 obese (BMI>30)), were recruited at scheduled term C-section. TargetScan v.7 was used to predict 4 miRNAs targeting IRS1 and p85α. Expression of miR126-3p, miR128-3p, miR424-5p and miR144-3p was measured in placental tissue using qPCR. Maternal HOMA-IR was calculated as a measure of IR. Data were log normalized; group differences were assessed by t-test. Multi-linear regression models were generated to adjust for relevant clinical variables. p <0.05 was considered significant. MiRNet 2.0 tool was used for functional interpretation and network analysis by using hypergeometric test. Results: HOMA-IR was 62% higher in obese women at delivery (p<0.001). Placental expression of all selected miRNAs was higher in women with obesity (p<0.001). Placental miRNAs 126-3p, 128-3p and 424-5p were positively correlated with maternal HOMA-IR, conditional on fetal sex, gestational age and 4 other factors. After adjusting for prepregnancy BMI, none remained significant (Table) . Network enrichment analysis for the 4 miRNAs found the IS pathway highly significant (adj. P-value= 0.004). Functional analysis verified that IRS1 is targeted by miR144-3p and miR126-3p, and p85α is targeted by miR128-3p, miR424-5p, and miR126-3p. Conclusion: Placental expression of miRNAs targeting the IS pathway was higher in women with obesity than those without. Three of these miRNA correlated with maternal IR at time of delivery, but not independently of pre-gravid BMI. These findings suggest that maternal adiposity may be an epigenetic modifier in any potential effect of these placental miRNA on maternal IR. Introduction: Microvesicles (MV) are phospholipid bilayer enclosed structures that bud off from various cell types, retaining the membrane composition (lipid and protein) of their originating cell. Endothelial cells, platelets, leukocytes, erythrocytes, and placental trophoblasts have all been identified as sources of plasma MVs. Some MVs have been shown to express tissue factor, and thus can potentially initiate the process of thrombin generation and fibrin clot formation. Here we report on the potential contributions of MVs to clot formation potential in healthy women during the peripartum period. Methods: : Healthy women (N=20) were prospectively enrolled in a longitudinal study at an academic hospital in a protocol approved by the Institutional Review Board. Two blood collections were obtained: Visit 1 (V1) was in the late third trimester, and Visit 2 (V2) was 18-48 hours postpartum (10 cesarean deliveries and 10 vaginal deliveries). Blood was collected into citrate and platelet poor plasma was prepared and frozen (PPP). The Thrombodynamics T2F analyzer was used to measure plasma clot formation from two locations within the measurement cuvette: 1) at the site from exogenous immobilized tissue factor (TF) source (Clot TF ), and 2) at sites distant from the immobilized TF source (Clot Sp ). PPP was thawed in the presence of corn trypsin inhibitor to prevent contact pathway activation and either 1) immediately recalcified and assayed, or 2) centrifuged at 16,000x g for 45 minutes at 15°C to sediment potential MVs, the supernate was collected (PPP desMV ) and subsequently recalcified and assayed. Clot formation parameters describing onset time and rate were extracted, including: rate of Clot TF growth (V Tf ); onset time of Clot Sp (T Sp ), and the rate of Clot Sp growth (V Sp ). Comparisons were made across Visits using a paired Student's t-test. Data are presented as mean ± SD or Pearson correlation values. Results: Clot Sp parameters were more robust (p < 0.001) at V2 compared to V1 in PPP as characterized by onset time (T Sp , 14.6±4.3 vs. 22.1±6.5 min) and rate of formation (V Sp , 4.9±2.7 vs. 2.2±1.1 %/min). Route of delivery did not appear to affect ClotSp formation. No Clot Sp was observed in any PPP desMV preparations . The V Tf in PPP was significantly (p < 0.005) greater at V2 compared to V1, 59.1±7.9 vs. 51.5±2.5 μm/min. V Tf was significantly greater in PPP compared to PPP desMV at both visits (35.5±1.9 μm/min at V1, 38.1±3.2 μm/min at V2) . In PPP preparations, the V Tf correlated with V Sp across all visits (r=0.77). Conclusion: Compared to late pregnancy, the immediate postpartum period demonstrates an increase in endogenous clot potential that derives from sedimentable material. This material also potentiates faster clot formation from immobilized TF. Together these findings may implicate procoagulant MVs as contributors to the increased prothrombotic risk postpartum. Identification Introduction: During pregnancy cells are exchanged between the mother and fetus and may persist for many years in the recipient, a phenomenon known as microchimerism. In the mother, fetal Mc (FMc) can be detected many years after delivery and may contribute to future health and disease, including reproductive fitness. In the offspring, maternal Mc (MMc) can be detected in both immune and non-immune cells in peripheral blood and distributed throughout the body, however little is known about the functional and immunologic consequence of this maternal graft. The rare frequency of these microchimeric cells presents a challenge to their identification and isolation for down-stream studies. We have developed an approach to identify rare microchimeric cells using antibodies specific to non-shared HLA Class-I antigens as part of a broad flow cytometry immunophenotyping panel. In validation studies utilizing a dual antibody labeling strategy in which both donor and recipient cells may be uniquely labeled, we are able to reliably detect donor cells as low as 0.01%. By comparison, single labeling donor cells allows for enrichment of rare cells but requires further confirmation of cell origin. Sorting rare donor cells for downstream single cell RNA sequencing (scRNAseq) allows confirmation of cell origin using divergent single nucleotide polymorphisms and recovery of microchimeric T cell receptor (TCR) sequences. We have applied this technique to identify both FMc and MMc in a cohort of US maternal-fetal pairs. In an example maternal-fetal pair utilizing the dual antibody strategy, we identified FMc in maternal peripheral blood mononuclear cells collected prior to delivery at a level of 0.034%. Fetal origin cells were comprised of 77% T cells, the majority of which were naive, 14% monocytes, 11% dendritic cells, and rare B-cells and NK cells. In two cord bloods utilizing single antibody labeling of maternal cells, we were able to identify presumptive MMc at levels of 0.014% and 0.020%, including 39% and 22% T cells respectively. Confirmation of cell origin and distribution along with microchimeric TCR repertoire and predicted antigen specificity from our scRNAseq data is ongoing. We have developed a method to robustly phenotype and isolate rare microchimeric cells for downstream analysis and functional studies. We are now applying this technique to isolate rare microchimeric fetal and maternal cells in the setting of both normal and abnormal pregnancy to better understand the immunologic consequence of these grafts. Introduction: A history of adverse pregnancy outcomes (APO) has been associated with an increased risk of future cardiovascular disease, including stroke. Few large US population-based surveys included data on APO. Methods: The Population Assessment of Tobacco and Health (PATH) study is a nationally representative survey of 45,971 US respondents. Female respondents ≥ 50 years old who reported pregnancy history at the 2013-2014 baseline interview were included in this cross-sectional analysis (n= 3303; weighted n=37,312,466). The primary exposure was self-reported history of ≥ 1 APO, including preterm delivery, low birth weight, preeclampsia, placenta previa, placental abruption, and stillbirth. The primary outcomes were 1) self-reported stroke before age 60 and 2) any self-reported stroke. We used weighted logistic regression models to estimate odds ratios (OR) and 95% confidence intervals (95%CI) for the association between APO and stroke, adjusting for age, race/ethnicity, socioeconomic status, parity, and self-reported vascular risk factors. Results: Among stroke-free respondents, 16 % reported ≥1 APO. Among women who reported a stroke before age 60, 40% reported ≥1 APO (p < 0.001 compared to respondents who did not experience stroke < 60 years); among women reporting stroke at any age, 26 %reported ≥1 APO (p = 0.01 compared to stroke-free respondents). Controlling for covariates, women with APOs had increased odds of stroke before age 60 (adjusted OR 2.47, 95% CI 1.35, 4.51) . Addition of hypertension to the model did not significantly change the effect size (adjusted OR 2.43, 95%CI 1.34, 4.40) . The association of APOs with stroke at any age was not significant after controlling for covariates (adjusted OR 1.55, 95%CI 0.92, 2.62), with a similar relationship when including hypertension in the model. In this analysis of self-reported, US nationally representative survey data, APOs were independently associated with midlife stroke. Women with APOs are at higher risk for midlife stroke and should have targeted risk reduction interventions. (1):T-196, 2019). However, whether these ewes develop cardiovascular complications remains unknown. We have isolated the effects of hypoxic pregnancy in sheep on maternal cardiovascular function in late gestation. Methods: Pregnant ewes carrying a singleton were exposed to normoxia (N) or hypoxia (H: 10% O2 in maternal air) from 0.7 of gestation in isobaric chambers (Brain et al. PLoS Biol 17(1) :e2006552, 2019). At 138 days gestational age (dGA; term at 145 dGA), maternal blood samples were taken for plasma creatinine and calculation of estimated glomerular filtration rate (eGFR). Following euthanasia, the maternal heart was isolated and left ventricle (LV) function investigated (Langendorff preparation). Third-order maternal femoral arteries were isolated and vascular function established via wire myography. Statistical significance (p<0.05) was determined with the Student's t test and two-way ANOVA + Sidak post-hoc test. Results: Hypoxic pregnancy resulted in fetal growth restriction (A), and reduced LV developed pressure (LVDP; B) but enhanced LV end-diastolic pressure (LVEDP; C) in the maternal heart. Maternal femoral arteries from hypoxic pregnancy showed enhanced constriction in response to endothelin (ET-1; D) and phenylephrine (PE; E), but impaired endothelial-dependent dilatation to acetylcholine (ACh; F). This endothelial dysfunction was due to the absence of NO-dependent relaxation, as inhibition with the NO synthase blocker L-NAME reversed the ACh response to constriction (G). These vasoreactive changes were associated with increased maternal plasma levels of creatinine, and decreased estimated GFR (H and I), in keeping with systemic endothelial dysfunction and impaired glomerular ultrafiltration. Conclusion: The data support that mothers from complicated pregnancy are at greater risk of cardio-renal dysfunction because of lasting adverse effects originating during the sub-optimal pregnancy rather than a genetic predisposition. Small NonCoding RNA Biotypes in the Human Preimplantation Embryo. Sophie Petropoulos * , 1 Introduction: Human embryonic development during the first week is a critical window of development. During this time, the first lineages are established: 1) trophectoderm (TE; prospective placenta), 2) primitive endoderm (PE; prospective yolk sac), and 3) pluripotent epiblast cells (EPI; prospective embryo proper). We have previously determined that lineage specification in human embryos occurs during late embryonic day (E) 5. Mechanism(s) underlying lineage segregation in the human remain unknown. To date, a comprehensive profile of all small ncRNAs during preimplantation development is lacking. With recent advancements in singlecell genomics, we can now measure the sncRNA content in an individual cell. We now hypothesize that 1) sncRNA biotypes are detected throughout development and increase with time. 2) sncRNAs, particularly the miRNA biotype, restrict expression of totipotency genes during late E5, ultimately causing a cascade of differentiation required for lineage specification. Methods: Human embryos (E3E8, N=36 embryo, 601 cells) were dissociated into singlecells and libraries were prepared using smallseq. Data was processed using an in house pipeline that is an improvement on the established pipeline (https://github.com/eyay/smallseq). Results: SncRNA biotypes are detected throughout preimplantation in human embryo (E3-E7). Expression of miRNAs, tRNAs and snRNAs increase with development. In contrast, the number of snoRNA molecules present decrease with developmental time. tRNA represents the most abundant biotype (15-20% of all biotypes). Further, 244 significantly differentially expressed miRNAs are detected between the TE and ICM lineage. These lineage specific signatures emerge at E5 and become progressively more pronounced with time. Candidate miRNAs (including miR-200c-3p and miR-24-3p) potentially responsible for driving lineage segregation have been identified. These miRNAs target pluripotency and known lineage genes, SOX2 and CDX2, respectively; suggesting that miRNAs may be an upstream regulator of lineage specification. Conclusion: This comprehensive characterization of small ncRNA at single-cell and lineage specific resolution could aid in our understanding of what constitutes human preimplantation development and shed light on underlying mechanism(s) of cell fate specification. Understanding the biological processes during human preimplantation development is not only important for acquiring fundamental knowledge pertaining to human embryogenesis, but also for clinical application given the increased use of ART, stem cell biology and regenerative medicine. Introduction: It is estimated that up to 3,000 human genes cannot tolerate loss-of-function (LoF) of one alleles (haploinsufficient) and that single-copy LoF of many of these genes is incompatible with life (haplo-essential). Thus, de novo LoF of haplo-essential genes in humans likely contributes to early reproductive failure. We hypothesized that targeted genome editing in mouse embryos followed by in vitro culture to blastocyst and embryo genotyping for LoF allele dosage could be used to experimentally assess genes for haplo-essentiality at early stages of development. Methods: Putative haplo-essential genes were identified using DOMINO dominance predictions and data from the Genome Aggregation Database, Cancer Dependency Map Project, and the International Mouse Phenotyping Consortium. Included in the search were mouse genes that have a 1:1 human ortholog. Genecodis was used to assess the gene list for enrichment of biological processes. CRISPR-Cas9 was used to induce putative LoF frameshift mutations in 1-cell-stage mouse embryos. Embryos were cultured to blastocyst stage (120 hours), time-lapsed imaged on an Embryoscope+, and assessed for LoF allele dosage by Sanger sequencing. Fisher's exact tests were used to test for abnormal development and genotype-phenotype associations. Results: Genes predicted to be haplo-essential enriched for ribosomal and mRNA translation initiation proteins. Given their critical role to basic cellular function, we predicted LoF of these genes would cause early lethality at, or before, the blastocyst stage. CRISPR-Cas9 editing resulted in a statistically significant enrichment of early embryonic lethality for Rpl5, Rpl7a, Rpl31, Eif3d, and Eif4a3 when compared to control culture embryos. Although not significant, CRISPR-Cas9 editing of Eif4a1 resulted in similar gross morphologic abnormalities in 56% of experimental embryos vs 25% control embryos. Preliminary data revealed an enrichment of early embryonic lethality for Rpl5, Rpl7a and Eif3d when ≥25% of the alleles detected in the embryo were predicted to be LoF frameshift mutations. Conclusion: This pilot suggests that LoF mutations of genes predicted to be cell-essential enrich for early embryonic lethality phenotype. De novo mutations of these genes may explain early pregnancy failure. We have demonstrated this pipeline as a successful screen. To circumvent issues with mosaic embryos, further studies can be performed using cell permeable Cre to conditionally knockout genes at the 1-cell stage as a high standard confirmatory process. Elucidating the Role of FOXO3 in Regulating Ovarian Reserve and Function in Humans. Caterina Clementi, Karen Hunter Cohn, Genevieve Galarneau, Piraye Yurttas Beim * . Celmatix Inc., New York, NY, United States. Introduction: FOXO3 belongs to the forkhead family of transcription factors and has been implicated in regulating ovarian reserve in mice. Disruption of this gene in mice results in premature depletion of the follicular precursor pool, while a constitutively active transgene results in the maintenance of a larger follicle pool. In humans, FOXO3 has been linked to human longevity, but its role in reproductive longevity or ovarian function has not yet been elucidated. Methods: Our Personalized Reproductive Medicine (PReM) Initiative cohort consists of a centralized repository of biological samples derived from patients undergoing treatment at multiple fertility centers in the United States, linked to detailed reproductive phenotype data. Samples underwent whole genome or exome sequencing. We used Ensembl Variant Effect Predictor to perform the functional annotation of variants with a minor allele frequency < 1% in gnomAD located within gene boundaries. For a subset of genes known to regulate ovarian function, we evaluated variants predicted to have high impact effects on protein function. Results: We identified 14 fertility patients with different combinations of 7 unique, rare functional variants (RFV) in FOXO3. Two of these RFVs were within the forkhead domain and were predicted to have a negative impact on protein function by disrupting DNA binding and protein stability. Patients carrying both RFVs in the forkhead domain showed diminished ovarian reserve (DOR) and multiple IVF failures, indicative of severe folliculogenesis defects. Patients carrying only 1 RFV in the forkhead domain had increased miscarriage rates but showed normal ovarian reserve. Patients with RFVs outside of the forkhead domain of the protein were characterized by normal ovarian reserve and successful IVF on the first cycle. Interestingly, a rare variant predicted to impact a regulatory region of the protein was found in a patient with polycystic ovary syndrome (PCOS) with high ovarian reserve. We identified a group of infertility patients carrying rare functional variants in FOXO3, a gene linked to longevity in humans and regulation of ovarian reserve in mice. When we evaluated the patient phenotypes and predicted functional impact of these variants, we identified a series of functional alleles with associated ovarian reserve phenotypes that are suggestive of a function-phenotype dose-response relationship. Mutations with a negative impact on protein function were found in DOR patients, while a predicted activating mutation was found in a patient with PCOS. These opposite effects on ovarian reserve observed in patients are consistent with phenotypes observed in Foxo3 KO and transgenic mouse models. Loss Introduction: Ovarian DNA damage occurs naturally with age and is accelerated by exposure to gonadotoxic agents such as chemotherapy. Emerging evidence suggests that noncoding RNAs (ncRNAs) may play important roles in regulating the ovarian DNA damage response to gonadotoxins. The ncRNA H19 plays essential roles in mammalian development, but little is known about its role in ovarian biology. We have previously shown that H19 null mice are more susceptible than their wild type (WT) counterparts to chemotherapy-induced ovarian DNA damage. Specifically, H19 null mice exhibit increased ovarian DNA damage and apoptosis, as well as complete fertility loss (while WT mice recover fertility), after treatment with doxorubicin (DXR), a chemotherapeutic agent used for cancer treatment in women. In this work, we sought to evaluate whether loss of H19 directly impacts oocyte and embryo development at baseline and after gonadotoxin exposure. Methods: We first induced DNA damage with doxorubicin (DXR). 5wk H19 knockout (H19 KO) and wild type (WT) mice (n=5) were injected with DXR or saline. 48 hours later, GV oocytes were collected for immunofluorescence to evaluate ψH2AX, a marker of DNA breaks. Additional GV oocytes were cultured to evaluate in vitro maturation. For in vivo-matured MII oocyte retrieval, DXR-treated mice were superovulated, followed by hCG injection and collection of cumulus-oocyte complexes (COCs). Collected oocytes were subjected to in vitro fertilization in order to evaluate oocyte maturation, fertilization and embryo development after DXR. Stain positive follicles in H19 KO and WT mouse ovaries, and fertilization and embryo development, were analyzed using one-way ANOVA. We observed decreased in vitro maturation and increased evidence of DNA breaks in H19 KO mice as compared to WT. After DXR, H19 KO oocytes exhibited reduced fertilization as compared to WT. This may represent a "two-hit" mechanism by which loss of H19 reduces oocyte competence and increases oocyte DNA damage, and renders oocytes more susceptible to gonadotoxin-induced injury. Further mechanistic studies will determine the mechanism by which differential H19 expression in the follicle microenvironment regulates oocyte sensitivity to gonadotoxins. Novel Anti-Mullerian Hormone Receptor 2 Binding Peptide (AMHR2BP) Modulates Oocyte Function In Vivo. Laura Detti * , 1 Ghassan M Saed * . 2 1 Cleveland Clinic, Cleveland, OH, United States; 2 Wayne State University, Detroit, MI, United States. Introduction: Anti-Müllerian hormone (AMH) inhibits hormone production, and ovarian cortex follicle development in in vitro, and in vivo, ovarian cortex, and in luteinized granulosa cells (GCs). We showed a novel binding peptide to AMH receptor 2 (AMHR2BP) to inhibit GCs replication and function, and to preserve the ovarian follicle number by minimizing the progression of follicular development, in addition to decreasing hormone production, cell replication and apoptosis, in a mouse model. We now sought to investigate whether AMHR2BP can modulate oocyte function by assessing the two oocyte-derived hormones that stimulate mitotic proliferation in granulosa cells, BMP15 and GDF9. Both, BMP15 and GDF9 act in an additive manner and have a critical role in granulosa cell and theca cell growth, as well as in differentiation and maturation of the oocyte. Methods: This was a translational study where 24 18-weeks old C57BL female mice were equally divided and assigned to four treatments: Baseline (euthanized just prior to the experiment), AMHR2BP (AMHR2-BP, 50 µg /day), rAMH (recombinant AMH, 1.8 µg /day), and placebo group (normal saline), via intraperitoneal pumps. Mice were euthanized 3 weeks after pump placement and the ovaries were explanted for realtime RT-PCR analysis. BMP15 and GDF9expression was measured. We used Kruskall-Wallis's test for comparison of medians between groups (SPSS; p<0.05). Results: Compared with Placebo, AMHR2BP and rAMH administration caused stalling of BMP15 and GDF9 expression and maintained baseline levels. The table reports the individual groups' data. Conclusion: Oocyte-derived BMP15 and GDF9 stimulate granulosa cell replication and with this experiment we showed that AMHR2BP, as well as rAMH, could stall oocyte function for as long as they are administered. Although a direct effect on the oocyte could not be assessed with this experiment, we confirmed an overall inhibitory effect on follicular function. Combined with our previous findings of direct inhibition of granulosa cells replication and in vitro and in vivofollicular development, we conclude that AMHR2BP could be used to inhibit time-linked loss of ovarian follicle reserve. Ovarian cortex concentration of BMP15 and GDF9 in the mice groups, Baseline, Placebo, rAMH, AMHR2BP. Introduction: Aneuploidy is among the major contributors to human infertility. However, the mechanisms by which aneuploid embryos fail to develop remain unclear. After implantation, morphogenetic remodeling leads to trophoblast differentiation and segregation of lineages within the inner cell mass (ICM) into the epiblast (EPI) and the primitive endoderm (PrE). Aneuploidy-induced overexpression of E-cadherin (E-cad) leads to premature differentiation of trophoblast cells. However, studies manipulating E-cad have failed to demonstrate a similar role in the EPI/ PrE segregation. Here, we studied the transcriptional consequences of aneuploidy in the ICM of human blastocysts, and uncover manifestations of a premature state of lineage differentiation. Methods: Prospective study comparing RNA-seq data of the ICM from day 5/6 blastocysts classified as euploid (n=5) and aneuploid (n=6) by preimplantation genetic testing for aneuploidy. Participants were recruited between October 2018 and November 2019 at IVI RMA Valencia. ICM fractions were separately collected and processed for RNA-seq. Differentially expressed genes (DEGs) were calculated with DESeq2 package [Benjamini-Hochberg (BH)-adjusted p<0.01 & abs(log2FoldChange)>2 significant]. Fgsea algorithm was used for enrichment analysis on Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways and Gene Ontology (GO) terms (BH-adjusted p<0.01 significant). Results: 27 DEGs were identified. To address the functional implications of these differences, significantly deregulated pathways according to KEGG and GO categories were analyzed. ICM from aneuploid blastocysts displayed significant downregulation in 9 KEGG and GO processes involved in RNA metabolism, ribosomal biogenesis and mitochondrial function, which are known transcriptional hallmarks of aneuploidy. Moreover, the aneuploid group displayed a transcriptional phenotype reminiscent of a premature differentiation. This phenotype was characterized by significant upregulation of 27 GO processes including mesenchymal cell differentiation, axis specification, cell migration, and development of nervous and urogenital systems. Vimentin (VIM), a key marker of the epithelial to mesenchymal transition (EMT), was among the top upregulated DEGs. The GO term intercellular adhesion via plasma membrane was significantly upregulated, yet other members of the cadherin family rather than E-cad contributed significantly to enrichment. Conclusion: EMT and regulation of cell adhesion may direct the segregation of human EPI and PrE lineages. An increase of cell adhesion properties in the ICM of aneuploid embryos may lead to premature differentiation. However, unlike in trophoblast cells, an E-cad-independent response may shape ICM identity and alter embryo developmental fate. Keerthana Karunakar Poojary †, Sandhya Kumari †, Satish K Adiga, Guruprasad Kalthur * . Kasturba Medical College, Udupi, India. Introduction: JQ1 is a cell permeable potent inhibitor of Bromodomain and extraterminal (BET) proteins. It is used in the treating neurodegenerative diseases and cancer. JQ1 inhibits BET by competitively binding to the acetyl lysine pockets in the bromodomain protein resulting in the dissociation of the BET protein from the chromatin and inhibiting the cellular signalling pathways associated with it. Since BET proteins are necessary for the completion of oogenesis and play a significant role in oocyte maturation as well as embryo development, the present study was designed to understand the impact of JQ1 on the oocyte maturation and its cytoplasmic organization. Methods: Germinal vesicle (GV) stage oocytes collected from 8-week old Swiss albino mice were randomly segregated into control, vehicle control (0.01% DMSO) and JQ1 groups (25, 50 and 100 μM). The oocytes were subjected to in vitro maturation to assess the nuclear maturation. The MII oocytes were assessed for actin and spindle organization, chromosome alignment, acetylation level and intracellular reactive oxygen species (ROS). To understand the effect of JQ1 on embryo development, OCCs collected from superovulated mice were transferred to insemination droplet containing JQ1 (0 and 25 μM in M16 media). Fertilization was checked after 12h of insemination and embryo development was monitored until the blastocyst stage. The maturation (MII) rate in JQ1 group was significantly (p<0.001) lower compared to control. In addition, non-significant increase in the fragmentation and degeneration of oocytes was observed in JQ1 group. MII oocytes from JQ1 group had higher percentage of aggregated F-actin distribution compared to control. Oocytes with abnormal spindle (25 μM: 85.71% and 50 μM: 100%) and misaligned chromosomes (25 μM: 78.57 and 50 μM: 83.33%) were significantly higher. JQ1 exposed oocytes had lower lysine acetylation and elevated intracellular ROS level. Further, to assess its effect on fertilization and embryo development, only lower concentration of JQ1 (25 μM) was used for IVF experiment, since at 50 and 100 μM concentrations oocytes had lower nuclear maturation rate. The fertilization rate in control and VC groups was 73.94±4.01and 75.34±5.92% respectively, which was significantly lower in JQ1 group (p<0.001). Presence of JQ1 in the insemination droplet not only reduced the sperm motility, it decreased the lysine acetylation and increased the DNA damage in spermatozoa. There was 3-fold increase in the percentage of oocytes with abnormal fertilization (parthenogenic and triploid embryos) in JQ1 exposed oocytes (p<0.05) and lower blastocyst rate (37.55%) compared to control (51.35%). Conclusion: BRDT inhibitor JQ1 significantly inhibits the oocyte maturation, affects the cytoplasmic organization of the oocyte and compromises the preimplantation embryo development. Opposite Effects of LH/PKA/MTOR and AMPK Signaling on Induction of Autophagy in Luteal Cells. Emilia Przygrodzka †, Michele R Plewes †, Guojuan Li, John S Davis * . University of Nebraska Medical Center, Omaha, NE, United States. Introduction: Autophagy is a self-degradative process important for balancing sources of cellular energy at critical times in development and in response to nutrient stress and can also lead to apoptosis. Several markers of autophagy increase in the corpus luteum (CL) during luteolysis. Mammalian target of rapamycin (MTOR) and 5' AMP-activated protein kinase (AMPK), key players in autophagy, are known to inhibit or activate autophagy, respectively. AMPK increases autophagy by inhibition of MTOR via phosphorylation of regulatory-associated protein of MTOR (RPTOR) at Ser792 and direct phosphorylation of ULK1 (Ser317) and Beclin (Ser93). MTOR inhibits autophagy by phosphorylation of ULK1 at Ser757, which disrupts the interaction between ULK1 and AMPK. Herein, we hypothesize that LH/protein kinase A (PKA)/MTOR signaling and AMPK signaling exert opposite effects on autophagy by modulating the activity of proteins involved in autophagy induction (MTOR, RPTOR, ULK1) and autophagosome formation (ATG16L1; Beclin and LC3B). Methods: To test this hypothesis, small luteal cells (SLC) isolated from the mature bovine CL (n=3-5) were incubated with LH (1-100 ng/ml), AICAR (AMPK activator; 1 mM) or AICAR + LH (10 ng/ml). Additionally, SLC were incubated with forskolin (FSK; PKA activator; 10 μM), H89 (PKA inhibitor; 30 μM), rapamycin (MTOR inhibitor; 20 nM), chloroquine (autophagy activator; 10 μg/ml), compound C (AMPK inhibitor; 50 μM), or transfected with dominant negative AMPKα1 (dn.AMPKα1). Data were analyzed using one-way ANOVA. Results: Treatment with LH or FSK decreased (p<0.01) phosphorylation of RPTOR (Ser792) and AMPKα (Thr172), and increased (p<0.01) phosphorylation of MTOR (Ser2448) and its substrates p70S6K (Thr389) and ULK1 (Ser757). Incubation in the presence of LH up to 4h decreased basal and chloroquine-stimulated content of LC3B, a marker of autophagy, by 46% and 52%, respectively. Pre-treatment with H89 or rapamycin abolished (p<0.05) LH-mediated effects on AMPKα, RPTOR, MTOR, p70S6K, ULK (Ser757) and ULK substrate ATG16L (Ser278). In contrast, the AMPK activator AICAR induced (p<0.01) phosphorylation of AMPKα (Thr172), RPTOR (Ser792), Beclin (Ser93), ULK1 (Ser317) and ATG16L1 (Ser278). The effects of AICAR on RAPTOR, ULK1 (Ser317) and Beclin were abrogated after pretreatment with compound C or transfection with dn.AMPKα1. Pretreatment with AICAR inhibited (75%, p<0.01) LH-stimulated progesterone production and inhibited LH-mediated effects on RPTOR. Confocal microscopy revealed that AICAR, but not LH, enhanced colocalization of autophagosomes and lysosomes in SLC. The search for therapy against cardiovascular dysfunction programmed developmentally is ongoing, as interventional mechanisms of human translational relevance remain uncertain. Chronic fetal hypoxia is a common outcome of complicated pregnancy in humans. Adopting a two-pronged approach by combining studies in humans and in the chicken embryo, we show that chronic hypoxia increases the vascular expression of the hydrogen suphide (H2S) gene, cystathionine gamma-lyase (CTH) in both species. Further, the H2S precursor, N-acetylcysteine (NAC) protects against vascular dysfunction in hypoxic chicken embryos via epigenetic changes in the promoter region of CTH, enhancing H2Sdependent vascular relaxation. Methods: Fertilized Bovans Brown eggs were incubated in normoxia or hypoxia (14% O2) from day 1 of incubation, term is 21 days). Half of the eggs were randomly assigned to daily NAC treatment (33 μg/kg) starting at day 13 of incubation. At day 19, ex vivo femoral artery vascular responses were established by wire-myography and the aorta isolated to determine the expression of CTH by qPCR. The CTH gene promoter was analysed in silico with MathInspector and DNA methylation determined by Pyrosequencing. Human umbilical artery endothelial cells (HUAEC) from healthy pregnancies were exposed in vitro to hypoxia (48 h, 2% O2) and CTH expression evaluated. Results: Hypoxic chicken embryos showed endothelial dysfunction, rescued by NAC via enhanced NO-independent mechanisms ( Fig.1 A,B ). Embryos treated with NAC showed enhanced vascular relaxation to H2S (Fig.1C) . The vascular CTH expression was increased in hypoxic embryos and enhanced further by NAC treatment (Fig. 1D ). The increased CTH transcript was associated with decreased CpG methylation in a sense hypoxia-response element (HRE), along with increased CpG methylation in an antisense HRE (Fig. 1E ). Sustained hypoxia in vitro induced CTH expression in HUAEC (Fig. 1F ). The gasomtrasmitter H2S appears an excellent candidate of human translational relevance for intervention against programmed cardiovascular disease. Little is known about the endocrine placenta in offspring programming. Recently we have shown placental endocrine malfunction in mice (induced by placental endocrine zone mis-expression of Igf2-H19 genes; Jz-ICR1Δ) programmes sex-dependent changes in adult offspring insulin sensitivity and pancreatic insulin production, with only males being insulin resistant (J DOHAD 2019, 10:S109). However, the molecular and morphological changes underlying the sexually divergent outcomes remain unknown. Here, we show sex-specific alterations in the fetal and adult hepatic transcriptome, and adult pancreas morphology, in response to Jz-ICR1Δ. Methods: Jz-ICR1Δ litters were generated by mating female H19ICR1flox and male TpbpaCre mice. The reverse parental cross was used to generate control litters. At gestational day 19, liver transcriptomes of male and female fetuses were assessed by RNAseq. Separate litters that delivered and were standardized to 3 pups per sex, were fed either a chow or high sugar high fat (HSHF) diet from weaning. At 17 weeks, liver and pancreas were collected for hepatic gene expression analysis by qPCR and pancreas islet morphology by stereology. Data from 1-2 fetuses/offspring per litter (3-6 litters per group) were analyzed by two-way ANOVA (genotype, diet) or t-test (genotype), p<0.05. RNAseq, q<0.05. Differentially expressed genes (DEG) in response to Jz-ICR1Δ were sexually dimorphic with only 25% of DEG shared between male and female fetuses (Fig1A). In Jz-ICR1Δ females, G6pc and Rgs16 decreased and Serpina7 increased in the fetal liver, effects that tended to remain in adulthood (Fig1B, C, D) . Other fetal DEG analyzed were unaltered in Jz-ICR1Δ adults (not shown). Jz-ICR1Δ adult males and females had increased islet density (Fig1H,L). Jz-ICR1Δ males also displayed reduced pancreas islet area (Fig1E) . Chow Jz-ICR1Δ males, but not females, had a greater proportion of small islets versus their diet controls (Fig1F,G,J,K). Conclusion: Placental endocrine malfunction induces sexually dimorphic changes in offspring hepatic transcriptome beginning in utero and adult pancreas morphology. These changes may explain the varied metabolic outcomes between male and female Jz-ICR1Δ offspring. Introduction: Obesity in pregnant women causes fetal cardiac dysfunction and offspring cardiovascular disease risk. The mechanisms are poorly understood. Using a mouse model of maternal obesity with fetal overgrowth and increased placental glucose and fatty acid transport, we determined the role of myocardial metabolism in offspring cardiac dysfunction. We hypothesized that maternal obesity enhances offspring cardiac fatty acid metabolism. Methods: Pregnant female C57 mice with pre-gestational, diet-induced obesity (Ob, n=15), or non-obese controls (Con, n=31), were euthanized on embryonic day (E) 18.5 or allowed to deliver (term~E20.5). E18.5 fetal hearts were dissected, weighed and analyzed by RNA-Seq. Offspring were weaned onto chow and, 6 months postnatally, cardiac diastolic function (echocardiography), glucose uptake ( 18 F positron emission tomography) and fatty acid uptake ( 14 C-oleic acid tracing) were assessed. Following necropsy, cardiac mitochondrial substrate respiration and fatty acid content were determined using respirometry and mass spectrometry. Gene expression and glucose transporter abundance were quantified by qPCR and western blot. Differences between Con and Ob offspring were determined by t-test, separately in males and females. Results: Before birth, maternal obesity increased heart weight and expression of the master regulator of lipid metabolism, peroxisome proliferator activated receptor γ (Pparg), in female and male fetuses (n=5 per sex, per group, P<0.05). Six months postnatally, cardiac Pparg expression remained higher in Ob than Con offspring (females +34% n=9-10; males +91% n=10-11, P<0.05). Diastolic function, assessed by the ratio of mitral inflow/wall displacement (E/E'), was lower in Ob than Con offspring and inversely correlated with cardiac Pparg expression in males (R=-0.82, P<0.01), but not females (P=0.61). Maternal obesity increased cardiac uncoupled fatty acid respiration in male offspring (+42%, P<0.05; females P>0.05) and decreased cardiac glucose uptake in female offspring (-23%, P<0.05; males P>0.05). Maternal obesity did not alter offspring cardiac fatty acid uptake or content, carbohydrate respiration, or glucose transporter abundance (P>0.05). Conclusion: Increased cardiac fatty acid respiration is consistent with Pparg upregulation in male offspring of obese dams and may underpin the developmental programming of diastolic dysfunction. Decreased cardiac glucose uptake in female offspring of obese dams reflects the reported phenotype of people with diabetes. We speculate that impaired cardiac metabolic flexibility, driven by increased substrate availability in utero, contributes to long term cardiovascular risk in children of obese women. Gene Expression in the Fetal Liver during Hypoglycemia. Priya Mukherjee †, 1 Amanda Jones, 1 Paul Rozance, 1 Brown Laura, 1 Sean Limesand, 2 Stephanie Wesolowski. 1 1 University of Colorado, Aurora, CO, United States; 2 University of Arizona, Tuscon, AZ, United States. Introduction: Placental insufficiency produces growth restricted (PI-IUGR) fetuses that are hypoxemic and hypoglycemic. These fetuses have increased gluconeogenic gene expression (PCK1 and G6PC) and hepatic glucose production (HGP), which are absent in normal fetuses. Further, both of these features are resistant to suppression with insulin in PI-IUGR fetuses. Previous research has demonstrated that fetuses with experimental hypoglycemia (HG) have increased HGP and expression of PCK1 and G6PC that is suppressible with insulin. In contrast, fetuses with experimental hypoxemia (HOX) have increased PCK1 and G6PC expression without associated HGP. The objective of this study was to determine their combined effects and test the hypothesis that hypoxemia induces insulin resistance on suppression of gluconeogenic gene expression and HGP activated by hypoglycemia. Methods: Late gestation sheep were made hypoglycemic (HG, n=11) via maternal insulin infusion or hypoglycemic and hypoxemic (HG+HOX, n=12) via nitrogen insufflation by tracheotomy. Fetal arterial blood samples were collected before (PRE) and after 4-6 days of treatment (POST). To measure HGP and test insulin sensitivity post treatment, metabolic studies were performed with U 13 C-glucose tracer to measure rates of glucose production (HGP) during basal (BASAL) and hyperinsulinemic-euglycemic clamp (HEC) periods. Fetal data were analyzed by 2-way ANOVA with main effects of treatment (TRT: HG, HG+HOX) and period (PRE vs POST; or BASAL vs HEC) and interaction (INT: treatment x period). Liver tissue samples were collected under HEC conditions to measure gene expression (PCK1, G6PC) and analyzed by MW-test. Results: HG and HG+HOX fetuses had a 51% decrease in plasma glucose concentrations. HG+HOX fetuses had 25% lower arterial blood pO2 compared to HG fetuses (INT: P<0.05), with no difference in fetal weight. During the BASAL period, HGP rates were active (P<0.05 vs zero, onesided t-test) in HG (6.2 umol/min/kg) and HG+HOX (9.7 umol/min/kg) fetuses. HGP was higher in HG+HOX compared to HG fetuses regardless of period (TRT: P=0.07). In liver tissue collected under HEC conditions, expression of PCK1 and G6PC was 13-fold and 5-fold higher, respectively, in HG+HOX group compared to HG fetuses (P<0.05). Conclusion: In response to HEC conditions expression of the two main gluconeogenic genes was higher in the livers of HG+HOX compared to HG fetuses, while HGP remained 65% higher in HG+HOX compared to HG fetuses. Thus, hypoxemia may underlie molecular mechanisms that prevent insulin mediated suppression of PCK1 and G6PC. These results provide new insight regarding the causative roles of reduced glucose and oxygen supply on the early activation of HGP and insulin resistance in fetuses with PI-IUGR. Overweight prevalence among women of reproductive age is rising, leading to a pregnancy obesity phenotype. Maternal Obesity (MO) increases both fetal and maternal risk of pregnancy-associated adverse outcomes. Offspring can be programmed for metabolic diseases. MO can affect development of the fetal liver, an organ crucial for metabolic homeostasis. The fetal liver receives different quality blood in the right and left lobes, potentially altering programming. We investigated liver lobe-dependency of MO on oxidative stress (OS). Methods: At 60 days before conception and throughout gestation, ewes consumed 150% (MO, n=8) or 100% (Control, C, n=10) of recommended global nutrient intake. At 90% of gestation, we euthanized ewes under general anesthesia and fetal liver lobes were collected. Enzymatic activities, total antioxidant capacity (TAC) and protein carbonylation were measured spectrophotometrically. Data were compared between groups using an unpaired t-test, with p<0.05 considered statistically significant. Results: MO decreased ewes fetal total (13.7%) and liver (22.4%) weight. MO increased fetal liver mitochondrial protein carbonylation (p=0.04), with more significant impact in the right lobe. Mitochondrial TAC was reduced in MO (-18 .9%), consistent with lower mitochondrial free thiols concentration (-14 .6%) and mitochondrial catalase activity (25.8%). Interestingly, hepatic superoxide dismutase and total catalase activities were unaffected. MO did not change fumarase activity; however, it decreased aconitase activity (-48 .6%), a TCA cycle enzyme susceptible to oxidative stress. After chemical aconitase reactivation, a greater inhibition was observed due to MO (91%) compared with C (83.8%), again exacerbated in the right lobe. Conclusion: MO affects prenatal hepatic function by inducing mitochondrial OS with potential modulation of fetal liver metabolism. All effects were exacerbated in the right lobe. These alterations likely represent fetal hepatic metabolic programming due to MO, with the potential of later-life compromise of hepatic mitochondrial function, predisposing offspring to metabolic disease. Impaired Autonomic Control of Heart Rate Variability during Acute Stress in the Chronically Hypoxic Fetus. N. Hafiz †, 1 B. J Allison, 2 N. Itani, 2 K. J Botting, 2 Y. Niu, 2 C. C Lees, 1 C. J Shaw * , 1 D. A. Giussani * . 2 1 Imperial College London, London, United Kingdom; 2 University of Cambridge, Cambridge, United Kingdom. Introduction: Fetal heart rate variability (FHRV) is an excellent example of translating reproductive science to the bedside, as it is an established and powerful predictor of fetal wellbeing. The chronically hypoxic fetus is at a seven-fold risk of stillbirth or birth asphyxia (Gardosi et al. BMJ 346:f108, 2013), however underlying mechanisms remain unclear. Progress in this field has been hampered in part by the inability to record cardiovascular data from the chronically hypoxic fetus. We designed isolators able to maintain chronically instrumented pregnant sheep under controlled and significant hypoxic conditions for prolonged periods of gestation, coupled with a bespoke wireless data acquisition system (CamDAS) to record continuous in vivo fetal cardiovascular function. Here, we provide evidence of significant impairment in the autonomic control of FHRV during an episode of acute hypoxic stress in the chronically hypoxic fetus. Methods: Eight pregnant sheep were anaesthetised at 117±2d gestational age (term ~147d) and the fetus surgically instrumented with vascular catheters. Five days postoperatively, the animals were subjected to acute hypoxia (fetal PaO2 from 20±0.5 to 10±1 mmHg) followed by a 10-day exposure to normoxia (n=4) or chronic hypoxia (fetal PaO2 21±1 to 12±1 mmHg, n=4). Two days later, the pregnancy was exposed to second acute hypoxia of the same magnitude as the previous. FHR was sampled in 1-min blocks for 45 min prior to (baseline), during (30 min), and for 60 min after (recovery) the hypoxic episodes and power spectral indices calculated. Fetal blood was collected during all acute hypoxic episodes and processed for plasma catecholamines (ELISA). Data were analysed by Two-Way RM ANOVA. Significance was accepted when P<0.05. Results: There were no differences between groups prior to chronic hypoxia (Fig 1) . However, the chronically hypoxic fetus showed markedly blunted values for rebound tachycardia (A), LF power (B, an index of sympathetic control), HF power (C, an index of parasympathetic control) and increments in plasma catecholamines (D and E) during subsequent acute hypoxia. The chronically hypoxic fetus shows markedly impaired autonomic control of FHRV during acute stress, which may explain its much-increased vulnerability to stillbirth and birth asphyxia. RNAseq of Amniotic Fluid Reveals Activation of the Innate Immune Response and Differential Expression of Brain Transcripts in Fetuses with Cytomegalovirus Infection. Lisa Hui * , 1, 2, 3, 4 Luc de Catte, 5 Neeta Vora, 6 Sally Beard, 1 Jovana Maksimovic, 7 Alicia Oshlack, 7 Susan P Walker, 1,2 Natalie Hannan * . 1 Introduction: Cell-free RNA in amniotic fluid is derived from multiple fetal organs and produces characteristic gene expression profiles during specific physiological states. Cytomegalovirus (CMV) is the most common congenital infection and is associated with neurological morbidity and perinatal mortality. We performed the first RNAseq study of live human fetuses with CMV to identify differentially-expressed genes (DEGs) associated with infection. Methods: Amniotic fluid was collected from women at 18-22 weeks gestation undergoing amniocentesis for suspected CMV infection due to maternal seroconversion or ultrasound abnormality. CMV infection was diagnosed via viral PCR of amniotic fluid. Thirteen infected fetuses were paired to 13 non-infected controls, matched for gestational age (+/-1 week) and fetal sex. Paired-end RNA sequencing was performed on cell-free amniotic fluid RNA using the Novaseq 6000 at 30 million reads/ sample. Following adapter trimming, reads were mapped using Star. Read counts were summarised across genes using featureCounts. Generalized linear models were fitted for each gene using edgeR, accounting for unwanted variation using RUVseq. DEGs were identified using quasilikelihood tests. Genes with a false discovery rate <0.05 were considered statistically significant. Results: There were 309 up-regulated and 32 down-regulated genes in the CMV-positive group, compared with the CMV negative group. Gene set enrichment analysis showed significant enrichment of multiple Gene Ontology categories involving the innate immune response to viral infection and interferon signaling. There were 32 down-regulated genes, including 8 neurodevelopmental genes known to be preferentially expressed by brain. The fetal innate immune response to congenital CMV infection is detectable in second trimester amniotic fluid. We identified neurodevelopmental genes that are differentially expressed in infected fetuses. These mRNA transcripts have potential applications as biomarkers of neurodevelopmental outcome in congenital CMV. Introduction: Early-onset preeclampsia is a multisystemic disease of pregnancy characterised by elevated blood pressure and end-organ dysfunction and diagnosed between 20 to 34 weeks gestation. Its exact mechanism remains elusive, but several competing pathological theories exist such as the role of a substance 'X' and the release of syncytiotrophoblast membrane extracellular vesicles (STBEV); small and medium/large STBEVs. Recently, STBEV's are being explored as carriers of this potential substance X(s) in their cargo.We hypothesise that the mRNA content of medium/large STBEVs differs substantially between EOPE and normal pregnancy (NP). The differentially expressed transcripts detected would highlight pathways that may be functionally important in EOPE. Methods: STBMV's were generated by ex-vivo dual lobe placenta perfusion followed by proteomic analysis to identify DEPs between EOPE and NP STBMV. DEGs obtained were bioinformatically analysed to identify functionally enriched pathways in R with Cluster Profiler and SPIA. Enriched pathways were analysed in four categories GO: BP (biological process) GO: MF (molecular function) GO: CC ( cellular component) and KEGG pathways while topographical analysis was done for KEGG. Results: Two pathways were perturbed with topological analysis and activated: Focal adhesion, cytokine-cytokine receptor interaction. Eight B.P's were found to be perturbed, such as platelet degranulation and epithelial cell differentiation. Ten molecular functions were perturbed such as phosphatase regulator activity, phosphatidylcholine binding and quaternary ammonium group binding. Focal adhesion was the only overexpressed KEGG pathway. Conclusion: A known complication of Preeclampsia is Eclampsia, a state of convulsion and coma in a woman diagnosed with preeclampsia. The finding of an activated neuroactive ligand-receptor pathway may explain the link between EOPE and neurological manifestations in the mother. The activated cytokine-cytokine receptor pathway may be the driver for the endothelial dysfunction and platelet activation characteristic of EOPE.In conclusion, EOPE is a disease with a complicated interacting mechanism, some of which may propagate disease or serve a self-protective role. Our analysis has bioinformatically teased out some of these pathways that may help identify mechanistic and therapeutic targets. Decidua iTreg and nTreg suppress anti-fetal immune responses by inhibiting effector T cells (Teff) proliferation. iTreg produce anti-or proinflammatory cytokines and also induce cytokine production by Teff. We hypothesize that disruption in iTreg function is associated with preeclampsia (PE). Our objective is to compare the cytokine production by decidua T cells in PE to healthy pregnancies. Methods: Maternal peripheral blood (PB) and decidua blood (from the surgical sponge at cesarean delivery) were collected from PE cases and controls. Isolated lymphocytes were stimulated in vitro, and stained with immunofluorescence antibodies for identification of FoxP3 + nTreg, PD-1 hi iTreg, CD4 + , and CD8 + effector T cell (Teff) subsets by flow cytometry. Production of anti-inflammatory IL-10, and proinflammatory cytokines IL-17, and IFN-g were detected using intracellular staining ( Figure 1 ). Proportions were compared using two-sided tests with p<0.05. Results: 61 participants were enrolled. The proportion of decidua Teff was similar to PB; however, decidua CD8 + Teff expressed higher levels of activation marker CD69 and produced more IFN-g compared to PB (Fig. 1, left) . Decidua contained greater iTreg and lower nTreg proportions compared to PB. Additionally, decidua iTreg exhibited more CD69 expression and IL-10 production ( Fig. 1 , right). Decidua iTreg exhibited higher IL-17 production in PE. iTreg and memory CD8 + Teff from decidua displayed lower IL-10 production in PE compared to controls but was not statistically significant ( Fig. 2) . Conclusion: Human decidua harbors activated and cytokine-producing regulatory and effector T cells. Our data provide evidence for the maternalfetal rejection phenotype in PE with an imbalance of proinflammatory cytokine production in PE due to enhanced IL-17 production by iTreg and decreased IL-10 production by decidua iTreg and CD8 + Teff cells. Further elucidation of the immune mechanisms of PE will inform new therapeutic strategies. Phagocytosis was determined with FACS and high content imaging. mRNA expression of metalloproteinase 9 (MMP9), TIMP1 and TIMP2 was detected with RT-qPCR. Activity of MMP-9 was determined with immunoblots and gelatine zymography. After normality testing, statistical significance was determined using t-test. Results: Expression of M1 markers namely CD86, CD80 and CD40 (p=0,07) is increased in PE HBCs, but only by trend. The M2 marker CD206 was increased in PE HBCs (p=0,01). Both groups of HBCs were positive for CD68 (CTR 84, 7 ± 8, 4 ; PE 84,6 ± 9,4%) and CD163 (CTR 91,3 ± 7,7%; PE 90,8 ± 10,5%), respectively. PE HBCs secrete higher levels of pro-inflammatory cytokines such as IL-6 (p ≤ 0,05), IL-8 (p ≤ 0,01), IL-12p70 (p ≤ 0,05), IL1α (p=0,06) and TNFα (p=0,06). In the same samples also anti-inflammatory cytokines as IL-13 (p ≤ 0,05), IL-4 (p ≤ 0,05) and TGFβ (p ≤ 0,05) were elevated. Phagocytic activity was higher in PE HBCs (p ≤ 0,05). PE HBCs express higher MMP-9 levels (p ≤ 0,05) as CTR HBCs. Additionally, levels of IL-17 (p=0,06), one of the regulators of MMPs were elevated. In line, release of TIMP1 was significantly decreased but secretion of TIMP2 was not affected by PE. The risk of postpartum (PP) stroke is increased in pregnancies complicated by hypertension or preeclampsia. Deficiency in regulatory T cells, a subset of CD4 T cells, is associated with vascular disease and may contribute to PP health complications. Internal carotid artery (ICA) stenosis due to vasoconstriction or arterial dissection may lead to maternal ischemic stroke. In this study we (1) characterized function, mechanical behavior and structure of ICAs from C57BL/6 (WT) and CD4 deficient (CD4 -/-) virgin and PP mice; (2) assessed the role of nitric oxide (NO) in the control of ICA function at pre-conception and PP. Methods: WT and CD4 -/mice were housed under pathogen-free conditions, mated to same-strain males and allowed to litter. At 3 days or 4 wks PP, mothers or virgin controls were euthanized. Vasoconstriction to phenylephrine (PE, 0.01 -30 µM) or to high K + (20 -100 mM) and vasodilation to ACh (0.001 -10 µM) were assessed in pressurized at 80 mmHg ICAs. To evaluate the role of NO, PE, high K + and ACh were tested after NOS inhibition with L-NNA. To characterize ICA distensibility, passive lumen diameters were measured at 3-140 mmHg. The expression of eNOS in ICAs was evaluated by immunohistochemistry. Differences between sets of data were determined by t-tests or two-way RM ANOVA and were considered significant at P <0.05. Results: Constriction of WT ICAs to PE was not modified at any PP periods. In contrast, responses to PE were significantly increased in ICAs from 3 days and 4 wks PP CD4 -/mice (52.4 ± 4.7%, n=5 and 52.3 ± 4.5% n=9) vs. CD4 -/virgins (38.4 ± 4.7%, n=10 at 10 µM PE). Constriction to high K + was not enhanced. ICAs from WT and CD4 -/mice were highly sensitive to ACh with no significant difference in EC 50 values. L-NNA treatment resulted in a rightward shift of dose-response curves to ACh. NOS inhibition enhanced PE constriction of ICAs from WT virgin and PP mice. Although a similar effect was detected in ICAs of virgin CD4 -/mice (62.9 ± 5.6%, n=5 at 10 µM PE), no such changes were observed in CD4 -/at 3 days (60.4 ± 4.2%, n=5) and 4 wks (55.6 ± 3.9%, n=6) PP. Passive distensibility was not modified at PP. ICA diameters increased from 306±4 µm (WT, n=30) and 305±3 µm (CD4 -/-, n=24) at pre-conception to 323±5 µm (n=24, P=0.008) and 318±3 µm (n=20, P=0.007) at 4 wks PP, respectively. eNOS expression was significantly reduced in vessels from 4 wks PP CD4 -/mice but it was not different in ICAs from virgin vs. PP WT mice. Conclusion: The PP in CD4 -/mice is characterized by decreased NOdependent control of ICA constriction in part due to reduced expression of eNOS. CD4 immune deficiency in pregnancy may predispose the ICAs to vasospasm and increase the risk of maternal PP stroke. (1) . Quantifying composition in 3-D as opposed to traditional 2-D histologic analysis may reveal new information on vaginal microstructure to inform diagnostics and design criteria to improve interventions. Dual-view inverted selective plane illumination microscopy (diSPIM) images a tissue in 3-D using fluorescent stains (3). The fluorescent stain TO-PRO-3 Iodide and Eosin (T&E) is a potential analog to Hematoxylin and Eosin (H&E) that can be used to acquire 3-D images (2). Therefore, the objective of this study was to validate T&E as an H&E fluorescent analog and then to acquire 3-D images of the murine vagina. Methods: To validate T&E, vaginas (fibulin-5 +/+, fibulin-5 +/-, and fibulin 5 -/-, n=3/genotype) were extracted from C57BL6 X 129 SvEv female mice at 3-6 months at estrus and snap frozen (IACUC approved). Samples were formalin-fixed, sectioned and randomly allocated for either H&E or T&E staining. Sections stained with H&E were imaged using bright-field optical microscopy at 10X objective magnification, and T&E imaged using a fluorescent slide scanner at 20X objective magnification and then pseudo-colored to resemble H&E (4). The epithelial layer and extracellular matrix area fractions were quantified and evaluated for equivalence between stains using Bland-Altman.For the diSPIM imaging of murine vaginas, vaginas were extracted from CD1 mice (nonparous, day 18 pregnant, and postpartum (n=1/timepoint)) (IACUC approved). Samples were formalin-fixed, stained with TO-PRO-3, dehydrated, stained with eosin, and optically cleared with Ethyl Cinnamate. Next, samples were imaged with diSPIM reconstructed with MATLAB and visualized using Amira (3). Results: Bland-Altman analysis showed similarity between the T&E and H&E stains, validating T&E as an analog to H&E in the murine vagina. 3-D images of the pregnancy samples demonstrated the capability of diSPIM to acquire images across the entire vaginal volume (Fig 1) . Introduction: Emerging evidence supports the role of the vaginal microbiota in adverse pregnancy outcome, but the underlying mechanisms are poorly understood. We have previously shown that miscarriage is associated with vaginal dysbiosis but without knowledge of the cytogenetic status of those miscarriages. We aim to investigate the vaginal microbial composition and the local immune response in chromosomally normal and abnormal miscarriages and compare this to uncomplicated pregnancies delivering at term. Methods: We used 16S rRNA gene based metataxonomics to interrogate the vaginal microbiota in a cohort of 167 women, 93 miscarriage patients (54 euploid and 39 aneuploid using molecular cytogenetics) and 74 women who delivered at term and correlate this with the aneuploidy status of the miscarriages. We also measured the concentrations of IL-2, IL-4, IL-6, IL-8, TNF-α, IFN-γ, IL-1β, IL-18 and IL-10 in cervical vaginal fluid. Results: We show that euploid miscarriage is associated with a significantly higher prevalence of Lactobacillus spp. deplete vaginal microbial communities compared to aneuploid miscarriage (P=0.008). In women having Lactobacillus spp. deplete vaginal microbial communities, euploid miscarriage associates with higher concentrations of pro-inflammatory cytokines IL-1β, IL-8, IL-6 (P<0.001, P=0.01 and P<0.001 respectively) and lower concentrations of anti-inflammatory cytokines IL10 (P<0.001) when compared to viable term pregnancy. We identified Prevotella bivia and Streptococcus as particularly common in euploid miscarriage and as drivers of pro-inflammatory cytokines (IL-1β, IL-6 and TNF-α). Co-occurrence network analyses revealed low levels of co-occurrence between Lactobacillus crispatus and all other organisms and strong co-occurrence between Streptococcal species. Our data show that an adverse vaginal microbiota combined with a heightened cytokine response influences early pregnancy outcome. Although this may be a reflection of intrinsic maternal immune response, it appears that the cytokine response is largely driven by the bacterial taxa present in the vagina, which presents an opportunity for specific, directed intervention. The negative co-occurrence between L.crispatus and all other organisms suggests a possible therapeutic role for probiotics containing this organism. The influence of Streptococci also suggests a potential benefit of targeted antibiotics with probiotics for some patients. Conclusion: These findings support the hypothesis that the vaginal microbiota plays an important aetiological role in euploid miscarriage and may represent a target to modify the risk of pregnancy loss. Increasing age and food insecurity were associated with anemia (p=0.04 and p=0.02 respectively). Conclusion: We found that anemia was highly prevalent in this population -significantly higher than previously reported in a large national study. Many women who perceived their bleeding as heavy were subsequently found to have anemia. Given the high prevalence of anemia in this population, there may be a role for community level education to increase awareness of what constitutes normal menses and of HMB as a cause of anemia. Introduction: Preterm birth, defined as birth prior to 37 weeks of gestation, is a major contributor to neonatal mortality and increased morbidity, worldwide. There is a lack of effective preventative treatments due to the understudied molecular mechanisms causing the myometrium to switch from a quiescent to a contractile phenotype at labour. Previous research has identified transcription factors such as activator protein-1 and progesterone receptors that regulate the expression of contractionassociated genes such as Gja1 during active labour. We investigated the differentially expressed transcription factors, using RNA-seq, during mouse gestation to better understand how gene expression is activated in the labouring myometrium. This revealed the SOX family of transcription factors are differentially regulated during pregnancy in the myometrium. To further investigate the role of these SOX factors in mouse gestation, their expression was investigated by RT-qPCR during normal gestation, RU486-induced preterm labour, and an LPS inflammation model of preterm labour. Additionally, chromatin accessibility was assessed at various timepoints throughout normal mouse gestation using an Assay for Transposase Accessible Chromatin paired with Sequencing (ATAC-seq). These data were subjected to differential peak analysis and subsequently used for motif analysis to uncover the transcription factor binding sequences. Results: RNA-Seq analysis revealed upregulation of Sox4, Sox7, and Sox9 during labour. Conversely, Sox8 was expressed at Day 15 and downregulated during active labour (p<0.01). RT-qPCR confirmed the expression level changes for all transcription factors during normal gestation. Interestingly Sox4 was also confirmed to increase in both pre-term labor models whereas Sox7 and Sox8 were only differentially regulated in RU486-induced preterm labor . Accessible chromatin regions identified by ATAC-seq were evaluated revealing an enrichment of SOX factor binding motifs (SOX4, SOX7, and SOX9) at term-not-in-labour and term labour compared to Day 15 of gestation. Conclusion: As Sox4 was expressed in term and both pre-term labour models this transcription factor may be critical in modulating gene expression changes required for labour onset. Results from RU486induced pre-term labour suggest that Sox7 and Sox8 might be inhibited or activated, respectively, by progesterone signaling but are less responsive to infection induced signals. Together these data suggest that the SOX factors expressed at term in the myometrium cause changes in the accessible chromatin landscape, consistent with their roles as regulatory transcription factors in the pregnant myometrium. In this study, we hypothesized that factors associated with CC could play a role in determining the implantation potential of euploid embryos. We used in-depth transcriptomic analysis to compare CC from euploid embryos that resulted in a live birth to CC from euploid embryos that failed to implant. Methods: Written consent was obtained from patients undergoing IVF treatment. CC associated with individual oocytes were collected and stored. Following IVF and ICSI, embryos were individually cultured, blastocysts were biopsied for preimplantation genetic testing for aneuploidy (PGT-A) and cryopreserved. Frozen embryo transfer was performed in a subsequent cycle. CC were processed (n=20;10 implanted and delivered, 10 non-implanted) for RNA sequencing and then for pathway analysis. Real-time PCR analysis was performed in independent samples (n=10;5 implanted and delivered, 5 non-implanted) to verify the gene expression levels in both sets. Results: All samples subjected to RNA-seq showed homology (70-80%) to the human reference genome. Approximately 15,000 genes showed diff erential expression between the two groups. Using Gene Ontology Enrichment analysis, it was observed that approximately 60 diff erentially expressed genes were involved in the biological function of fertilization (p<0.05), and about 120 genes were involved in the molecular function of guanyl nucleotide exchange factor activity (p<0.05). KEGG enrichment pathway analysis showed that about 100 diff erentially expressed genes were involved in the calcium signaling pathway and about 50 genes were a part of the cell adhesion molecules (p<0.05). Real-time PCR for few genes from the top 20 genes viz. SLC30A2 and SLC6A19 were performed with CC from the two groups to validate RNA sequencing data. PCR results were consistent with RNA sequencing analysis, demonstrating a signifi cant increase in the expression of SLC30 A2 (p=0.003) and increased expression approaching signifi cance in SLC6A19 (p=0.17). Conclusion: Our study reveals signifi cant diff erences in CC transcriptome associated with embryos that result in a live birth compared to those that fail to implant. We also identify SLC30 A2 and SLC6A19 as potential biomarkers. The clinical relevance of our fi ndings will need to be validated in future studies. Rapid Aneuploidy Testing in Reproduction Using Nanopore-Based Sequencing. Shan Wei, 1 Conclusion: Sequential IV boluses of rFSH, after GnRH suppression, mimic endogenous FSH secretion but yield significantly lower serum FSH levels in women with obesity. FSH pharmacokinetics and serum cetrorelix levels were similar in both groups, indicating that another factor underlies the observed significant reduction in serum FSH in obese subjects. This model of pulsatile, IV rFSH reveals a novel and clinically relevant difference in pharmacodynamics between NW and obese women, which has not been previously observed. Different Immunoregulatory Components at the Decidua Basalis of Oocyte Donation Pregnancies. Kim Introduction: Regulatory T cells (Tregs) and related immunoregulatory cytokines, such as interleukins (IL), transforming growth factor-β (TGF-β) and galectin-1 (gal-1), play a key role in maintaining tolerance at the decidua basalis in human pregnancy. Previous studies observed decreased numbers of decidual Tregs in miscarriage and preeclamptic pregnancies. These complications occur in higher frequencies in oocyte donation (OD) pregnancies, characterized by more fetal-maternal human leukocyte antigen (HLA) mismatches compared with naturally conceived (NC) and non-donor in vitro fertilization (IVF) pregnancies, as the fetus obtains paternal and donor-derived HLA genes. Consequently, the maternal immune system has to cope with greater immunogenetic dissimilarity. Involved immunoregulatory mechanisms however remain poorly understood. Therefore, we examined whether the number of Tregs and immunoregulatory cytokines in decidua basalis of OD pregnancies differs from NC and IVF pregnancies. Methods: This case-control study included 27 OD, 11 IVF and 16 NC placentas of uncomplicated pregnancies, collected after delivery at term between 2005 and 2013. Clinical data, maternal peripheral blood and umbilical cord blood were collected. Decidua basalis was dissected from the placentas and processed to formalin-fixed, paraffin-embedded slices (4 µm). Immunohistochemical staining for FOXP3, IL-10, IL-6, gal-1, TGF-β and Flt-1 was performed. Semi-quantitative (FOXP3+ Tregs) and computerized analysis (cytokines), using Image-J software, were executed. Maternal peripheral blood and fetal umbilical cord blood were typed for HLA class I and II, using Sequence Specific Oligonucleotides PCR, to calculate the number of fetal-maternal HLA mismatches. Results: No significant differences were found when comparing the three groups for the mean number of FOXP3+ Tregs. However, when the amount of fetal-maternal HLA mismatches was related to the percentage of Tregs, the Tregs were significantly higher in pregnancies with 4-6 HLA class I mismatches (n = 16), than in those with 0-3 HLA class I mismatches (n = 38; p = 0.029). Furthermore, OD pregnancies express less IL-10, IL-6, gal-1 and Flt-1 in decidua basalis compared to NC pregnancies. Moreover, the amount of IL-10 was significantly lower with 3-4 fetal-maternal HLA class II mismatches (p = 0.032). This study suggests that the immunoregulation at the fetalmaternal interface in OD pregnancies with a higher amount of fetalmaternal HLA mismatches appears to be altered. Unravelling mechanisms of immunomodulation during OD pregnancy, reflected by high level of fetal-maternal dissimilarity, could help to reach the ultimate goal in transplantation; induction of donor-specific tolerance. In addition, it might help to understand the development of complications in OD pregnancy. Associations of Maternal Urinary Bisphenol and Phthalate Urine Concentrations in Pregnancy with Offspring Pubertal Development. Sophia Blaauwendraad †, Romy Gaillard * , Vincent Jaddoe * . Erasmus Medical Center Rotterdam, Rotterdam, Netherlands. Introduction: Fetal exposure to bisphenols and phthalates influences the steroid-dependent development and maturation of the reproductive system and might subsequently influence pubertal development. We examined the associations of maternal urinary bisphenols and phthalates concentrations in pregnancy with offspring pubertal development. In a population-based, prospective cohort study among 1059 mother-child pairs, we measured maternal urinary bisphenol and phthalate concentrations in first, second and third trimester. We measured child's Tanner stage and age of first menstruation at the mean age of 13.5 years by questionnaire and ovarian and testicular volume at the mean age of 9.7 years using MRI. Analyses were performed for boys and girls separately. Introduction: Platelet activation may affect fecundability via inflammation and decreased perfusion of reproductive organs. We aimed to determine: 1) whether women with high plasma platelet factor 4 (PF4) concentrations, a biomarker of platelet activation, are less likely to conceive and have a live birth; 2) whether treatment with low-dose aspirin (LDA) mitigates these risks. This was an ancillary analysis of the Effects of Aspirin in Gestation and Reproduction trial, which randomized women with a history of pregnancy loss who were attempting conception to LDA or placebo. We included 1,185 women with available pre-pregnancy plasma PF4 concentrations. Outcomes of interest were fecundability, pregnancy loss, and live birth. We used discrete-time Cox proportional hazards models to estimate fecundability odds ratios, and we used log-binomial regression to estimate relative risks for pregnancy loss and live birth by PF4 tertile. Multivariable models included age, BMI, smoking, education, income, and previous live birth. Analyses were conducted for the overall population and stratified by treatment group. Results: During follow up, 775 (65.4%) women had a positive pregnancy test within 6 menstrual cycles. High pre-pregnancy PF4 was associated with improved fecundability overall, especially among women randomized to LDA ( Table 1) . There was no association between prepregnancy PF4 and fecundability among women randomized to placebo. Pre-pregnancy PF4 was not associated with pregnancy loss or live birth, overall or stratified by treatment group (Table 2) . Conclusion: High pre-pregnancy plasma PF4 concentration was positively associated with fecundability, especially among participants randomized to treatment with LDA. Inhibition of platelet activation via LDA may be beneficial to achieving pregnancy among women with a history of pregnancy loss. The Multivariable analyses were performed to evaluate the impact of nutrition on the relationship between polygenic score and adverse adult health outcomes. The reference for comparisons was polygenic score between the 20th and 80th percentile. Results: During the first year of life, healthy nutrition profiles were associated with reduced risk of obesity, reduced levels of fasting insulin, reduced systolic BP and increased HDL, independent of the polygenic score. By the third year of life, the only association that remained significant was with the risk of adult obesity. Significant interactions were identified between polygenic score, duration of breastfeeding and cardiometabolic outcomes which persisted after adjustment for diet quality during years 1 and 3. Breastfeeding reduced the relative risk of obesity and high fasting insulin (to reference levels) in those with high (80-100th percentile) and low (0-20th percentile) polygenic scores. For high systolic BP and low HDL, these results were only replicated for those with high polygenic scores. Conclusion: Good nutrition in the first year of life offers the greatest potential to reduce the risk of adverse adult health outcomes in those at increased genetic risk. Clinical studies suggest that cannabis use in pregnancy leads to impaired fetal growth, but the longterm effects on cardiac function in the offspring are unknown despite the fact that fetal growth deficits are associated with an increased risk of developing cardiovascular disease in postnatal life. While animal studies have shown that maternal exposure to Δ9-tetrahydrocannabinol (Δ9-THC, the major psychoactive ingredient in cannabis) can decrease fetal growth, to date little is known about its eff ects on cardiac function in the off spring. Therefore, we hypothesize that maternal exposure to Δ9-THC during pregnancy will impair fetal development resulting in cardiac dysfunction in postnatal life. Methods: Pregnant Wistar rats were exposed to 3 mg/kg Δ9-THC i.p. daily during gestation (gd 6-22) followed by echocardiogram analysis of cardiac function at postnatal day 1 and 21. Heart tissue was collected at both time points for molecular assessment of cardiac remodelling. Results: Exposure to Δ9-THC during pregnancy led to fetal growth restriction with a signifi cant (p<0.05) decrease in heart:body weight ratios. This was accompanied by signifi cantly higher neonatal heart rate and lower stroke volume at birth. By three weeks, pups exhibited catchup growth along with signifi cantly greater left ventricle anterior wall (LVAW) thickness (at systole) with decreased fractional shortening, stroke volume, and cardiac output. Moreover, these Δ9-THC exposed off spring exhibited increased expression of collagen type I and III, along with β-MHC, associated with cardiac remodelling. Conclusion: These data suggests that maternal exposure to Δ9-THC during pregnancy impedes fetal growth resulting in impaired postnatal heart function in early life. Furthermore, the increased thickness in the left ventricle along with an increase in markers of cardiac hypertrophy and fi brosis may underlie the adverse physiological changes observed in the heart at 3 weeks. Further studies are warranted to address whether the cardiac defi cits in these Δ9-THC exposed off spring persist into adulthood. Given the high rate of maternal cannabis consumption coupled with its legalization in North America, understanding the long-term detrimental eff ects of Δ9-THC on off spring health is of great importance. This is especially concerning given the concentration of Δ9-THC has drastically increased over the past two decades. The role of the placenta in developmental programming has been comparatively ignored. We have previously induced placental endocrine-specifi c malfunction in mice by placental endocrine zone deletion of the paternally-expressed imprinted Igf2 gene (UE). While off spring exposed to UE are growth-restricted in utero (Placenta 2018; 69:e60-61), the impact of UE on the cardiovascular physiology of the off spring is completely unknown. Here, we show that adult male off spring exposed to UE have an increased programmed risk of cardiovascular dysfunction. Methods: UE litters were generated by crossing TpbpaCre females with Igf2-fl oxed males. Off spring of the reverse genetic cross, with normal placental endocrine function, served as controls. After natural delivery, litters were standardised to 3 female and 3 male pups. At 12-13 weeks of age, 1-2 males per litter (from 5-6 litters per group) were killed and hearts and second-order femoral arteries were isolated and mounted on a Langendorff and wire myography preparation, respectively. Signifi cance was set at p<0.05 and determined by Two-way ANOVA followed by Tukey test or the Student's t test for unpaired data, as appropriate. Results: Compared with controls, male UE off spring showed cardiac systolic ( Fig. A and B) and diastolic (C and D) dysfunction, increased cardiac sympathetic dominance (E), without a change in coronary fl ow rate (F). Moreover, isolated femoral arteries from male UE off spring showed a blunted contractile response to phenylephrine (G and H) and a greater relaxant response to acetylcholine (I and J). Conclusion: Placental Igf2 endocrine-specifi c loss programmes defects in the cardiovascular function of adult male off spring. The increased dilator while reduced constrictor phenotype of femoral arteries may refl ect compensation in the peripheral circulation to off set cardiac load in these off spring. Introduction: Suboptimal periconceptional social, lifestyle and medical exposures, defi ned as vulnerability markers, are associated with poor maternal health and pregnancy outcomes. Evidence is rising that a smaller embryo is associated with impaired fetal growth, adverse birth outcomes and increased risks of non-communicable diseases later in life. So far, it is unknown whether an accumulation of vulnerability markers has a detrimental eff ect on embryonic growth. The aim of this study is to investigate the association between the degree of the maternal vulnerable condition, determined by an accumulation of vulnerability markers, and embryonic growth depicted by longitudinal crown-rump length (CRL) and embryonic volume (EV) measurements. We included 555 ongoing singleton pregnancies from The Rotterdam Periconceptional Cohort (Predict Study), comprising 324 natural and 231 in vitro fertilization/intra-cytoplasmic sperm injection (IVF/ICSI) pregnancies. Data on vulnerability markers were collected through questionnaires. Researchers performed standardized CRL and EV measurements at 7, 9 and 11 weeks of gestation using three-dimensional ultrasound scans and virtual reality techniques. We used linear mixed models to investigate the associations in natural and IVF/ICSI pregnancies. Results: Exposure to two or more vulnerability markers was associated with a smaller embryo in natural pregnancies ( Figure I ). For example, the CRL and EV of embryos of women exposed to fi ve or more vulnerability markers were 1.44 mm (13.4%) and 0.06 cm 3 (45.8%) smaller at 7 weeks of gestation than those of embryos of women exposed to zero or one vulnerability marker. At 11 weeks of gestation, the CRL and EV of these embryos were 3.07 mm (6.5%) and 1.16 cm 3 (12.6%) smaller than those of embryos of women exposed to zero or one vulnerability marker. In IVF/ICSI pregnancies, no associations between the degree of the maternal vulnerable condition and embryonic growth emerged. A higher degree of the maternal vulnerable condition is associated with reduced embryonic growth in natural pregnancies. This finding highlights the importance of identifying vulnerable women as early as possible to optimize modifiable periconceptional social, lifestyle and medical conditions, and subsequent embryonic growth. 6, 19] ). PreE newborns were comparatively hypoxemic as indicated by lower umbilical venous pO 2 (P = 0.028), trends toward higher pCO 2 (P = 0.069) and lower pH (P = 0.087), as well as elevated Epo (P < 0.01) and Hb (P < 0.05). While elevated RVSP:SYS ratios at 1-week of age were modestly associated with PreE (P = 0.06), when PreE cases were complicated by SGA, 40% of newborns had elevated RVSP:SYS ratios compared to 0% of normotensive AGA controls (P = 0.019). By 6-months of age, no infants had an elevated RVSP but 43% of PreE infants showed evidence of septal flattening compared to only 8% of controls (P < 0.05). Septal flattening at 6 months of age also tended to be associated with lower umbilical venous pH and elevated Hb (P = 0.053 and P = 0.067, respectively). Conclusion: PreE, particularly when accompanied by SGA, is associated with abnormalities in the pulmonary circulation during the neonatal period that extend into infancy at high altitude. Consideration of such developmental effects of PreE and SGA can aid in the identification of at-risk individuals and important maturational windows for the prevention of pulmonary vascular disease among babies born to highland residents or those with exaggerated hypoxia in utero or newborn life. The decidual stroma is generated from the endometrium upon embryo implantation and provides support for the developing fetus. Recent work from our lab has uncovered that decidualization triggers an epigenetic silencing program within decidual stromal cells (DSCs) that transcriptionally silences a diverse set of ~800 genes, including genes associated with type 1 immunity, as well as fibroblast activation and wound healing. This program is generated by PRC2 (Polycomb Repressive Complex 2), whose primary catalytic subunit is the histone methyltransferase EZH2. Given its vast scope, we elected to explore how this program affects decidual biology and impacts pregnancy. Methods: Employing Ezh2 conditional uterine knockout (cKO) mice (Pgr cre/+ Ezh2 fl/fl ), we performed immunohistochemistry, transcriptional analyses (RNA-seq, qRT-PCR), and western blotting on whole tissues and isolated DSCs of early pregnancy to identify altered biological pathways. To assess leukocyte responses, we treated mice with anti-CD40 and Poly(I:C) on E6.5 followed by flow cytometric analysis. To determine whether Ezh2 cKO decidua was more sensitive wounding signals, we performed RNA-seq on TGF-β1-treated wild type (WT) and Ezh2 cKO DSCs, and performed surgical wounding of implantation sites in vivo. To determine whether Ezh2 cKO decidual abnormalities mediated by TGF-β in vivo, we treated Ezh2 cKO mice with TGFβR-I inhibitor LY364947. Results: The decidua of Ezh2 cKO mice were smaller compared to wild type and showed accumulations of myofibroblasts, deposition of type I collagen around the embryo, and fewer uterine NK cells (p<0.05). After inflammatory stimulation, antigen presenting leukocytes could traffic out of Ezh2 cKO but not WT decidua. Transcriptomic analyses of Ezh2 cKO decidua and DSCs revealed increased expression of numerous genes associated with wound healing and the TGF-β pathway, and Ezh2 cKO DSCs significantly induced ~3-fold more genes than WT DSCs after culture with TGF-β1. In vivo inhibition of the TGF-β signaling pathway in Ezh2 cKO mice significantly (p<0.05) increased decidual size and reduced myofibroblast formation and collagen levels. Direct surgical wounding induced myofibroblasts and TGF-β target proteins in Ezh2 cKO but not wild type decidua. The decidua employs PRC2-mediated gene silencing to tightly control local immune regulation and pro-fibrotic signals. This may serve to prevent the decidua from assuming a chronically wounded state in response to invasion and growth of fetal tissues. TGF-β signaling was central to the observed defects, and in-vivo blockade of TGF-β signaling partially rescued the dysregulation caused by PRC2 deficiency. Introduction: Human endometrium is only receptive to an implanting blastocyst within a narrow window of 2-4 days in the mid-secretory phase. Recent single cell sequencing of human endometrium across the menstrual cycle has identified an abrupt and discontinuous transcriptomic activation in the epithelia in the mid-secretory phase. Such transcriptomic and accordingly functional changes require delicate interplay between a diversity of factors including cytokines and signaling pathways. The Notch signaling pathway members are expressed in human endometrium. The Notch ligand Jagged1 (JAG1) localizes in the endometrial luminal epithelium (LE) and is abnormally reduced in infertile women. However, the functional consequences of reduced JAG1 production on endometrial receptivity and embryo implantation is unknown. This study aimed to determine the role of JAG1 in regulating endometrial receptivity in humans and mice. Methods: Primary human endometrial epithelial cells (HEECs) and Ishikawa cells were used to determine the effect of JAG1 knockdown on cell adhesion (via a spheroid adhesion assay and xCELLigence). In mice AgoJag1 siRNA or scrambled control was injected into each uterine horn. Uteri were collected at E4 and E4.5 (day of plug=E0) and implantation sites counted and fixed. LE was isolated enzymatically for E4 uteri. Jag1 knockdown in human cells and mouse LE was measured by qPCR and immunoblotting. Changes in genes and proteins in response to JAG1 knockdown were assessed via a customized RT 2 Profiler PCR array, qPCR, immunoblotting and immunohistochemistry. Paired student's t-test or repeated measures ANOVA were used as appropriate for statistical analysis with a significance threshold of P < 0.05. Results: Knockdown of JAG1 in both HEECs and Ishikawa cells significantly reduced their adhesive capacity (P < 0.05), compared to control. We confirmed that in human endometrial epithelial cells, JAG1 interacted with NOTCH3 and knockdown of JAG1 significantly reduced the expression of Notch signaling downstream target HEY1 and classical receptivity markers (LIFR, SPP1, ITGB3, MAOA and IGFBP1). Knockdown of Jag1 in mouse LE significantly impaired embryo implantation compared to control (P < 0.05). We identified ten genes (related to tight junction, infertility and cell adhesion) that were differentially expressed by Jag1 knockdown in the LE in mice. Further analysis of the tight junction family members in both human and mouse models revealed that JAG1 altered the expression of tight junction components Cldn4, Cldn11 and Ocln in mice. Conclusion: Our data demonstrate that JAG1 alters endometrial epithelial cell adhesive capacity and regulates endometrial receptivity in both humans and mice. In contrast, inhibition of active αvβ3 diminished control EC migration (p<0.0001) but had no effect on FGRadv ECs (p= 0.92), indicating integrin αvβ3 as a mechanistic candidate contributing to reduced migration in FGRadv. To understand cellular processes causing aberrant αvβ3 function, we first assessed expression and found no significant differences in αvβ3 transcript or protein between control and FGRadv ECs. However, as integrin signaling also requires dynamic activation and recruitment to focal adhesion complexes (FACs), we investigated αvβ3 in FACs and unexpectedly found that αvβ3 was significantly increased in FGRadv EC complexes (p=0.022). Conclusion: FN-αvβ3 and α5β1 interactions regulate fetoplacental EC migration overall, but integrin αvβ3 is dysregulated in FGRadv. This dysregulation is not caused by differences in expression but rather, recruitment to focal adhesion complexes. These findings suggest impaired focal adhesion dynamics and represent a previously unidentified mechanism contributing to deficient angiogenesis in FGRadv. Characterization . Inflammasome NLRP3 is a key pathway in innate immunity, however, regulation of its activity in HBCs during normal pregnancy and pregnancy-related complications remain largely unelucidated due to limited tissue access and complex isolation procedure. The objectives of the study are to investigate the regulation of NLRP3 inflammasome activation in placental HBCs, and to characterize key components in Signal 1 and Signal 2 pathways as compared to the established roles in other tissue-resident macrophages. Methods: HBCs were freshly isolated from human placenta, and LPS and ATP were utilized to activate Signal 1 and Signal 2 of NLRP3 inflammasome, respectively. HBCs were pre-treated with caspase-1 inhibitors WEHD and VX765, P2RX7 receptor antagonist KN-62, or NLRP3-specific siRNA separately before treatment with LPS and ATP. ELISA was used to measure secreted IL-1β levels in culture media. For Western blotting, RIPA buffer was used to extract protein from HBCs, and proteins were separated via gel electrophoresis. Total cellular protein levels were quantified using DC protein assay. Membrane was incubated with multiple primary followed by secondary antibodies. In Signal 1 pathway, IL-1β was found to be a weak agonist that can stimulate its own production in an autocrine fashion; ROS was found to be indispensable to mediate downstream signaling events. In contrast to its established role in other tissue-resident macrophages, MEK was identified to mediate the Signal 2 pathway without any impact on Signal 1, underscoring unique aspects of NLRP3 regulation in HBCs. P2X7R, NLRP3 and caspase-1 demonstrated positive regulatory roles in the Signal 2 pathway, consistent with their roles in other tissue-resident macrophages. Conclusion: Unique aspects in Signal 1 and Signal 2 regulation of NLRP3 inflammasome activity were revealed in this comprehensive study of placental HBCs in comparison to their established roles in other tissueresident macrophages, presenting HBC as a potential therapeutic target for the treatment of pregnancy-associated complications. Figure 1 . Regression analysis revealed a statistically significant positive relationship between perfusion and BMI at 20 weeks (R 2 =0.099, p=0.014). Other relationships were not statistically significant. Comparisons between median perfusion of adverse and normal pregnancies were not statistically significant. Conclusion: To our knowledge, this is the earliest measurement of perfusion in the human placenta using VS-ASL. Our analysis showed positive correlation with BMI and perfusion at 20 weeks, but no significant change in median perfusion pregnancies with adverse outcomes in early pregnancy. Possible explanations include perfusion compensation later in gestation in response to other placental restrictions (e.g. oxygen exchange). Further analysis is needed in larger and more uniform subjects with adverse outcomes. Analysis is ongoing to compare perfusion data with placental histopathology from delivery. Placental NRF2 Introduction: A fundamental unanswered question in reproductive biology is: What protects the hemi-allogeneic fetus from rejection by the maternal immune system? We are testing the hypothesis that the multinucleated syncytiotrophoblast (SynT), formed by fusion of proliferative cytotrophoblasts (CytT) and covering the chorionic villi, may serve a critical role through production of immune modulators that act on the maternal decidua to protect the hemi-allogeneic fetus from rejection by the maternal immune system. Methods: Human primary CytT and human trophoblast stem cells (hTSCs; provided by Drs. Okae and Arima, Sendai, Japan) cultured under conditions to promote CytT to SynT differentiation, or in a hypoxic environment, were analyzed at different times using RT-qPCR and Western blot. We also analyzed placentae of global Nrf2 knockout (KO) vs. wildtype (WT) mice at 12.5 days post-coitum (dpc) for effects on immune modulator expression. Results: We observed that genes involved in the induction and maintenance of immune tolerance were markedly upregulated upon CytT to SynT differentiation. These immune modulators include HMOX1, PD-L1, GDF15, and kynurenine pathway components, IDO1 and AhR. Intriguingly, we discovered that the redox-regulated transcription factor NRF2 and co-regulated C/EBPβ and PPARγ, which serve critical roles in mouse labyrinthine trophoblast development, were also markedly induced during SynT differentiation. Notably, NRF2 knockdown prevented induction of C/EBPβ, PPARγ and the immune modulators, as well as induction of aromatase (CYP19A1), a key marker of SynT differentiation. ChIP-qPCR revealed that temporal induction of aromatase and the immune modulators was associated with increased binding of endogenous NRF2 to putative response elements within their promoters, indicating that these transcription factors and immune modulators are direct downstream targets of NRF2. Consistent with our cell culture studies, placentas of global Nrf2 KO mice at 12.5 dpc manifested a significant decrease in C/EBPβ, PPARγ, HMOX1 and Ahr mRNA, compared to those of WT mice. Importantly, NRF2 deficiency has been implicated in preeclampsia, a hypertensive disorder of pregnancy, associated with shallow implantation, inflammation and placental hypoxia. Notably, when hTSCs were cultured in a hypoxic (2% O 2 ) environment, the differentiation-associated induction of NRF2, C/EBPβ, aromatase and immune modulators was prevented. Introduction: Infertility in the US is a public health concern aff ecting millions of women across diverse backgrounds. Despite a National Public Health Action Plan that includes improving access to and eliminating disparities in infertility care, inequities persist. This study examined how race, education, and insurance contribute to diff erences in infertility care. Methods: We used data from the 2017-2019 National Survey of Family Growth Female Questionnaire (N=6141). We further analyzed those who reported speaking to a medical provider about help getting pregnant (N=478) and those who underwent infertility testing/treatment (N=139). Frequencies, Mann-Whitney tests, and multiple logistic regression models were utilized, with a p<0.05 signifi cance cutoff . Results: Of the 6141 respondents, within each race 10% White, 6.8% Hispanic, 6.7% Black, and 8.5% other race (N=478) reported speaking to a medical provider about help getting pregnant. Black and Hispanic women were less likely to speak to a provider about help getting pregnant compared to White women (OR 0.64, p=.001 and OR 0.65, p=.0004, respectively) . Logistic regression models showed race to be a signifi cant predictor of speaking to a provider, even when controlling for age (p=.016) and insurance status (p<.0001). Those with non-private insurance were less likely to speak to a provider than those with private insurance (p<.0001), even when controlling for age and race. In women over 30 years, those with 5+ years of higher education were more likely to talk to a provider than those with a bachelor degree (p<.05 Introduction: Over 2.5 million newborns die yearly and more than 80% of them are of low birthweight (LBW). LBW is a complex clinical entity composed of fetal growth restriction (FGR) and preterm birth (PTB). Surviving newborns face a higher risk of perinatal morbidities (such as bronchopulmonary dysplasia, necrotizing enterocolitis, cerebral palsy) due to the devastating effects of utero-fetal inflammation on vulnerable fetal organs. There is currently no efficient treatment for antenatal fetal protection. Among many proinflammatory mediators, IL-1β stands significantly in causing detrimental effects. The host lab has recently designed an IL-1 receptor antagonist, Rytvela, found to be effective against PTB when given as a prophylaxis. The study objective is to further characterize Rytvela by evaluating its efficiency in preventing PTB and FGR when administered after inflammatory insult, thereby evaluating the optimal treatment timing and duration. Introduction: Potential adverse side-effects of antenatal therapy with synthetic glucocorticoids (sGC) in threatened preterm birth have raised concern. Often different sGC with varying formulations are used. Here, we investigated whether different sGC formulations have differential effects on the developing cardiovascular system. We stripped as many confounding factors as possible to isolate direct mechanisms by using the chicken embryo. This model system permits investigation of the direct effects of therapy on the developing heart and vasculature, independent of effects on the mother and the placenta. Methods: Fertilised eggs were dosed at day 14 (term is 21 days; ~ 0.67 of gestation) with 0.1 mg/kg of sGC or water vehicle. There were 4 groups: Dexamethasone-phosphate (Dex), Betamethasone (Beta) acetate/ phosphate (Celestone), Beta-phosphate (B-Phos) or Beta-acetate (B-Ace) (See Table 1 ). At day 19, cardiac and peripheral vascular function were determined (Langendorff and myography). In different cohorts, hearts were perfusion fixed for stereological analysis or frozen for molecular analysis. Cardiomyocytes were also isolated and studied. Data were compared via Two-WAY ANOVA+Tukey. P<0.05 was considered significant. Results: Treatment with any sGC promoted growth restriction, which was more severe following Beta treatment due to the acetate formulation (Table 1) . Cardiac function was impaired by all sGC, again with Beta being more severe. Dex treatment resulted in enhanced peripheral constrictor reactivity, cardiomyocyte hypertrophy and induced oxidative stress, caspase 3-mediated apoptosis, with p38-mediated reduced proliferation. In contrast, Beta treatments impaired peripheral vasodilator reactivity, reduced total cardiomyocyte number, promoted excessive GR activation due to loss of negative feedback, and led to p53-mediated apoptosis with reduced cardiomyocyte proliferation. Beta acetate shared the loss of GR negative feedback and enhanced p53 expression, whereas Beta phosphate did not. The data support direct and divergent adverse effects of sGC used in human clinical practise on the developing cardiovascular system. The work offers insight into mechanisms underlying detrimental effects, providing a platform to modify current clinical antenatal glucocorticoid therapy and make it safer for the treatment of the preterm baby. Methods: Timed-pregnant, CD1 mice were inoculated with either mCMV in doses ranging from 5 x 10 5 to 1 x 10 7 or vehicle (mock injection of phosphate buff ered saline) by IU inoculation at embryonic day (E)10. Dams were euthanized at 96 or 120 hours post-infection (hpi) for quantifi cation of fetal viability and tissue harvest. Immunocards for 96 immunomarkers were run on placentas. mCMV viral titers were conducted on uterine, placental, and fetal brain tissue. Placental and fetal brain tissue was evaluated for local mCMV antigens with immunohistochemistry (IHC) staining for pp65. Results: A signifi cant decrease in fetal viability was noted at 120 hpi after IU inoculation of mCMV compared with mock inoculation (p<0.05; Fig) . These fetal miscarriages occurred without notable proinfl ammatory changes in placenta at 96 hpi. Viral specifi c antigens were observed in placental and fetal periventricular brain areas by IHC analysis. Placental and fetal CMV infections occur following IU inoculation of mCMV in immunocompetent, outbred mice. We created a novel model which demonstrates CMV passage through placenta leading to fetal death, consistent with eff ects in humans. This model provides a platform for studying CMV vertical transmission as well as possible interventions to prevent fetal sequelae. Introduction: Having a low socioeconomic status (SES) may amplify the negative impact of psychological distress on maternal and perinatal health. We have therefore investigated the association between SES (conceptualised by educational level) and psychological distress during pregnancy. And, we examined the association between psychological distress and maternal and perinatal health among diff erent SES groups. Methods: This study was embedded in the Generation R study. The primary outcome was the prevalence of psychopathology and stress, measured with self-reported questionnaires. Diff erences between SES groups were tested with the chi-square test. Secondary outcomes were preterm delivery, small for gestational age, birth weight, gestational age, foetal growth restriction, pregnancy-induced hypertension, preeclampsia, and mode of delivery. Linear and logistic regression analyses were used to examine the associations between psychopathology/stress and the secondary outcomes. A principal component analysis was performed to reduce the number of predicting variables tested. A statistically signifi cant association (p-value<0.05) between the principal component (PC) and one of the secondary outcomes was used as a benchmark to perform additional analyses for individual psychopathology and stress measures. Results: 7,228 women were included in this study. Compared to women with a high SES, we found that women with a low SES experience symptoms of psychopathology or stress twice as often. We found no associations between psychopathology or stress and any of the secondary outcomes among women with a low SES. Among women with a high SES, the psychopathology PC was positively associated with preterm birth (OR 1.07, 95%-CI 1.03;1.12, p-value <0.01) and negatively with birth weight (β -18, 95%-CI -24;-12, p-value <0.01). The stress PC showed a positive association with preterm birth (OR 1.14, 95%-CI 1.04;1.25, p-value 0.01) and negative associations with birth weight (β -48, 95%-CI -59;-37, p-value <0.01) and gestational age (β -0.07, 95%-CI -0.10;-0.04, p-value <0.01). Conclusion: In this study, psychological distress during pregnancy was associated with perinatal health outcomes among women with a high SES, but not among those with a low SES. To clarify the complex associations between SES, psychological distress, and maternal and perinatal health, information regarding mental health should be included in standard national data. is an activator of the JNK pathway, which controls vital cellular processes, including embryonic development, proliferation, and apoptosis. In 2017, our group reported a de novo nonsense variant in MAP4K4 in a fetus with hypoplastic left heart and fused kidneys that was identifi ed as part of our ongoing trio-based exome sequencing study. Query of MAP4K4 in the data sharing platform, Gene Matcher TM , identifi ed another seven individuals from four families who harbor variants in MAP4K4. These individuals display dysmorphic facial features, neurologic dysfunction, cardiac anomalies and all survived past the neonatal period. Methods: To test the functional relevance of MAP4K4 to patient phenotypes, we suppressed the zebrafi sh ortholog of MAP4K4 using morpholino antisense oligonucleotides. We examined renal, cardiac, and craniofacial abnormalities in zebrafi sh larvae, all of which have anatomical surrogates. We performed phenotyping during the fi rst fi ve days of development. We established knockdown effi ciency of MAP4K4 morpholino and tested whether we could detect a dose-dependent phenotypic response. Depletion of MAP4K4 and assessment or renal tubule integrity using NaK-ATPase immunostaining did not produce a signifi cant phenotype. However, evaluation of zebrafi sh larvae expressing a cartilage-specifi c transgene (-1.4col1a1:egfp) displayed a dose-dependent increase in the angle of the ceratohyal cartilage, suggestive of altered craniofacial patterning. Cardiac structure was also signifi cantly altered with atrial but not ventricular size signifi cantly enlarged in larvae with depleted MAP4K4. Heart beat per minute was also signifi cantly lower in the morpholino-injected batches compared to controls. Conclusion: Our functional data, combined with a small cohort of individuals harboring rare MAP4K4 variants, support the candidacy of this signaling eff ector as a contributor to early developmental processes impacting the heart and craniofacial cartilage morphogenesis. Our ongoing work to test variant eff ect will elucidate the pathomechanism of this rare syndrome. Methods: Under general anaesthesia, 10 fetal sheep were instrumented with flow probes and catheters in the carotid and femoral arteries at 116±2 days of gestation (dGA; term ~145 days). Following recovery, at 123±2, pregnancies were randomly exposed to normoxia (n=5) or hypoxia (10%O 2 , n=5) using isobaric chambers for 10 days. Carotid to femoral foot-to-foot transit times were obtained from 3 consecutive days of flow recordings before and at the end of treatment using the maximum point of the second derivative (Chiu et al. Am Heart J 121:1460 , 1991 . Waveforms were analysed from 10 cardiac cycles every 5 min for 1 morning hour. Crown rump length (CRL) data from the same sheep breed (Fowden et al. Q J Exp Physiol 74: 703, 1989) were divided by transit times to yield fetal cfPWV. Simultaneous pressure and flow traces were analysed to calculate the pressure and flow augmentation index (AIx) independent of CRL, as described (Kelly et al. Circ 80:1652 , 1989 , Hirata et al. Stroke 37:2552 , 2006 . Flow AIx was divided by pressure AIx to index vascular conductance. Results: Chronic hypoxia decreased the fetal PaO 2 from 20.8±0.7 to 12.3±1.0 mmHg (mean±SEM, P<0.05). Neither gestation or hypoxia affected fetal cfPWV (Fig.1A) . However, a fall in the carotid pressure AIx occurred in hypoxic relative to normoxic fetuses (Fig.1B) . Further, the ontogenic fall in femoral pressure AIx and the ontogenic increase in femoral conductance in normoxic fetuses did not occur in hypoxic fetuses (Fig.1C,D) . Conclusion: We show that it is possible to measure in vivo arterial stiffness in fetal life. Chronic hypoxia has significant effects on regional arterial stiffness in fetal life. These changes favour an increase in peripheral relative to central stiffness, supporting fetal brain sparing during chronic hypoxia. Analysis of cfPWV and of AIx in pressure and flow waveforms in fetal life provides a useful tool to diagnose fetal origins of vascular disease in adverse pregnancy. In Utero e-Cigarettes Exposure Enhances Neonatal Brain Ischemic Damage: Role of the miRNA-30c. Andrew Walayat †, Yanyan Zhang, Yong Li, Asanjan Hosseini Maryam, Daliao Xiao * . Loma Linda University, Loma Linda, CA, United States. Introduction: Electronic-cigarettes (E-cigs) have rapidly become one of the most common tobacco products, a great concern for public health. Studies on the prevalence of E-cig use during pregnancy report higher rates of exclusive prenatal e-cigarette use than conventional cigarette use. To date, the safety of E-cigs to maternal and fetal development remains largely unknown. This study seeks to investigate how E-cig exposure in utero causes gender-dependent alterations of transcriptomic patterns, consequent development of brain hypoxic-ischemic (HI) sensitive phenotype in neonates, and the attenuation of the hypoxic-ischemic phenotype via miRNA inhibition. Methods: Time-dated pregnant rats were exposed to chronic intermittent E-cig vaporing in a chamber from gestational day 4 to 20 and control pregnant rats were kept in similar chambers. In the 1st set of experiments, brain tissues from exposed and control pups at postnatal day 9 (P9) were isolated to perform miRNA expression profile analysis and mRNA transcriptomic patterns by next-generation seq analysis and integrated with bulk RNA-seq to identify prospective miRNA targets. In the 2nd set of experiments, neonatal offspring (P7) underwent HI procedures. In the 3rd set of experiments, neonatal offspring (P5) underwent ICV injections of LNA-antagomir-30c and then underwent HI protocols at P7. Results: There were 26 miRs/piRs in male and 11 miRs/piRs in female offspring that were significantly altered by e-cig exposure as compared with the controls. MicroRNA-30c was one of the differentially expressed miRNAs that was significantly up-regulated by e-cig exposure in male offspring. Similar to the miRNA-seq analysis, our RNA-seq analysis indicated gender-dependent alterations of gene expression patterns following E-cig exposure: 91 genes (55 up, 36 down) in males and 244 (120 up, 124 down) in females, with 8 common (Lsm6, Parp2, Megf8, Gm23134 down; Gnb1, Stmn1, Tubb5, Psme1 up). Prenatal E-cig exposure enhanced HI-induced brain infarct size in male but not in female offspring as compared with the controls. However, the administration of LNA-antagomiR-30c in male offspring demonstrated no significant differences of HI-induced infarct sizes in both e-cig exposed and control groups. Conclusion: These findings provide novel evidence that E-cig exposure in utero is associated with gender-dependent alterations of epigenetic and transcriptomic patterns resulting in development of neonatal brain HI-sensitive phenotype in offspring. E-cig exposure-mediated changes of miR-30c may plays a key role in the phenotype development. Introduction: Early to mid-gestation (G) ZIKV infection in women is associated with the highest rate of birth defects due to congenital zika syndrome (CZS) including a wide range of neurological and neurodevelopmental anomalies. We reported vertical transfer and notable disruption in fetal frontal cortex development including loss of radial glial fibers, astrogliosis and oligodendrocyte damage at 21 days post ZIKV infection (dpi) at mid-G in the olive baboon (PMID: 30657788) predicting significant neuropathology by term gestation. In the present study we examined the fetal brain outcome at term following ZIKV infection during early or mid-G in baboons. We hypothesized that ZIKV infection would result in significant fetal brain defects by term gestation. Methods: Timed-pregnant baboons were inoculated subcutaneously with ZIKV (PRVABC59; 10 4 ffu) during early (n=4;55-58 dG) or mid-G (n=3; 92-97 dG). Dams were euthanized and tissues collected at 167-172 dG; term ~183 dG). Control fetal brains (n=3) were obtained at 167-172 dG. Immunostaining for inflammation (Iba-1), oligodendrocyte precursor cells (Olig-2), glia (GFAP) and neural progenitor cells (NPCs) (Nestin) were performed on the fetal cortex, cerebellar and hippocampal sections. Results: Viremia was observed in 6/7 dams between 4-7 dpi, resolving by 14 dpi. ZIKV RNA was not detected in any fetal tissues sampled. Neuroinflammation (Iba-1) was significant in the frontal cortices of early-G but not mid-G fetuses compared to the control while both gestation ages had significant neuroinflammation in the cerebellum. Oligodendrocyte precursor cells (olig-2) were significantly reduced in cerebellum of early-G but not mid-G but not in the frontal cortex compared to the control. Significant increase in glial cells (GFAP) was observed in the cortex of both gestation groups compared to the control, a hallmark of astrogliosis. NPCs (Nestin) in the dentate gyrus (DG) of the hippocampus were significantly reduced with disorganized NPCs and loss or stunted neurites in the ZIKV fetuses compared to the control (p value 0.05). Conclusion: We observed significant gestational age dependent neuropathology in fetal brains consistent with early to mid-G being the most vulnerable to ZIKV. Although, ZIKV RNA was not observed at term in any fetal tissues, neuropathology observed in the affected fetal brains suggests vertical transfer occurred at some point during gestation, consistent with our earlier report demonstrating vertical transfer occurred within 14-21 dpi in baboons infected mid-gestation. The fetal brain injury resulting from early and mid-gestation ZIKV infection is comparable to neuropathology observed in human fetuses leading to the development of microcephaly and/or several neurodevelopmental abnormalities postbirth. (NIH: NS103772, OD010988). Thyroid Hormone Dominates IGF1 Expression and Actions in Fetal Cardiomyocytes. Natasha N Chattergoon, 1 Samantha Louey, 1 Sonnet Jonker, 1 George Giraud, 2,1 Kent L Thornburg * . 1 Results: Fetal aortic pressure did not change in the experimental period but fetal heart rate increased in IGF1 groups. Circulating glucose levels were reduced 50% in fetuses that received IGF1 alone but maintained at normal control levels in the T3+IGF1 group. • Gene expression of IGF-R1 was reduced by 30% in IGF1 fetuses and by 50% in T3+IGF1 fetuses compared to control. • Thyroid receptor alpha1 (TRα1) was reduced by 50% in the T3+IGF1 group. • Cardiac IGF1 expression in T3 fetuses was twice that of hearts in the IGF1 and T3+IGF1 groups. • Cell cycle inhibitor, p21, more than doubled by T3 treatment and significantly increased in T3+IGF1 compared to IGF1 alone. • Cell cycle promoter, cyclin D1, was reduced by 20% in T3 and T3+IGF1 compared to Vehicle and IGF1 groups. Conclusion: Our data suggest that while both T3 and IGF1 increase with gestation, T3 dominates IGF1's effects and regulates the expression of IGF1 related genes and their actions at the myocyte level. Reductions in IGFR1 expression likely impede IGF1-stimulated cardiomyocyte proliferation. As term approaches, elevations in T3 concentration ensure that IGF-1 stimulated proliferation is mollified in favor of maturation of the myocyte in preparation for dramatic increases in workload after birth. The overall preeclampsia prevalence discovered in our datasets is in the higher ranges from what is reported (often between ~3-12%). Surprisingly, we fi nd no diff erence of preeclampsia prevalence or CVD prevalence after preeclampsia between Whites, Asians, and Blacks despite the fact that these are large numbers of patients in our study; numerous previous studies have reported higher risks for preeclampsia in African Americans and also higher risks for CVD overall and after preeclampsia specifi cally. This raises the interesting question whether the lack of diff erence we observed is due to equal access to care and more similar lifestyles and employment situations within the Armed Forces versus in civilian populations. -19) . It is documented that SARS-CoV2 infection occurs by binding of viral spike (S) proteins to cellular receptor ACE2 and S protein priming by host cell protease TMPRSS2, localized on the cell surface of multiple organs, including heart, lungs, kidneys, testes, and intestine. However, data on ACE2 and TMPRSS2 expression in placenta, particularly in early gestation, are not well documented and the eff ect of viral exposure and potential vertical transmission during fi rst trimester are unknown. Therefore, we aimed to study the potential for SARS-CoV2 infection of human placenta, specifi cally in early trophoblast cells, using the novel trophoblast stem cells (TSC) model. We fi rst performed ISH staining for ACE2 and TMPRSS2 on formalin-fixed paraffin sections of first trimester(n=6), second trimester(n=5) and term(n=5) human placentas. Then, we derived TSC from fi rst trimester human placenta and diff erentiated into extravillous trophoblast cells (EVT) and syncytiotrophoblast cells (STB), as reported by Okae et al. Gene (qRT-PCR) and protein expression (western blotting) of ACE2 and TMPRSS2 were analyzed in TSC, EVT and STB. Furthermore, all three trophoblast cell types were infected with SARS-CoV2, with/without Remdesivir, which inhibits viral replication, and samples collected up to 48h post-infection. SARS-CoV2 titer was measured by plaque assay on cell culture supernatant and SARS-CoV2 replication was measured by qRT-PCR on cell lysates. Results: ISH staining revealed that ACE2 and TMPRSS2 were absent from cytotrophoblast at all gestational ages. ACE2 was moderately expressed in fi rst trimester STB, decreasing in this compartment at term; it was also highly expressed in term EVT. TMPRSS2 showed moderate expression in EVT, but less expression in STB, across gestation. In vitro, ACE2 and TMPRSS2 were predominantly expressed in the differentiated trophoblast cells, with higher expression in EVT than STB, while no/ low expression was detected in undifferentiated TSC, both at mRNA and protein levels. Moreover, infected EVT and STB showed higher viral titer and mRNA levels compared to undifferentiated TSC. In this context, treatment with the inhibitor of viral replication, Remdesivir, reduced viral load in both assays. The higher levels of ACE2 and TMPRSS2 in differentiated trophoblast, compared to cytotrophoblast/trophoblast progenitor cells, suggest that SARS-CoV2 can infect placental tissues through either STB or EVT, both of which are adjacent to maternal blood. The higher expression of these receptors in first trimester STB suggests that SARS-CoV2 infection during early gestation might present a higher risk to an ongoing pregnancy. pandemic has been associated with increased stress, anxiety, and feelings of depression across almost all populations. For those already experiencing heightened levels of stress and anxiety prior to COVID-19, the effect of increased stress and worry may have detrimental effects on health outcomes. While the cause-and-effect relationship between stress and infertility is still unclear, it is important to consider how COVID-19 leads to increased distress among infertility patients and how this may impact perceived treatment outcomes. Thus, we sought to better understand how various stressors related to COVID-19 impacted the patient experience during fertility treatment. Methods: An anonymous survey was distributed to patients at a private fertility clinic via the patient portal. Survey questions investigated patient demographics and feelings of anxiety regarding specific COVID-19 related stressors. Baseline levels of anxiety were measured by GAD-7, a standardized 7-question generalized anxiety disorder scale. Patient confidence in their fertility treatment and potential changes to their treatment plan due to COVID-19 were also assessed. Responses ranged from "not at all" to "all of the time". Survey responses were analyzed to determine average response and response frequencies. Results: Of the 290 participants, 89% were women with an average age of 33.8, and of whom 58.9% have been pursuing fertility treatment for at least a year. The average GAD-7 Anxiety Severity Score was 5.79, indicating an overall feeling of mild anxiety among respondents. 31% reported financial concerns related to the COVID-19 pandemic as at least one of the causes of their anxiety and worry. Of those that reported financial concerns, 64% came from patients who made less than $100,000 per year. 59% of respondents reported COVID-19 health concerns as one cause of stress, but only 29% reported delaying treatment or considering delaying treatment due to the pandemic. Fortunately, 54% of respondents indicated that seeking treatment has improved the way they feel about their fertility. Conclusion: According to our results, patients seeking fertility treatment report a mild level of anxiety and are impacted by many stressors such as financial concerns and the ongoing uncertainty of COVID-19. While these stressors may impact patients differently, providers should provide increased consideration for the psychological impact of infertility during COVID-19 via regular check-ins and resources to improve mental health. Further studies should focus on the impact of infertility and COVID-19related stressors among minority communities. Introduction: Severe acute respiratory syndrome coronavirus 2 (SARS CoV-2) is responsible for the pandemic of COVID-19, it infects cells via binding to angiotensin converting enzyme 2 (ACE2), subsequent entry cells through transmembrane protease serine type 2 (TMPRSS2). Evidence showed that SARS CoV-2 was detected in placenta in infected pregnant women, which indicating it might be responsible for the pregnancy complications such as preterm birth, abruption, fetal growth restriction and/or preeclampsia. Therefore, we hypothesize that SARS CoV-2 infection of placental microvascular endothelial cells (PMVECs) induces proinflammatory cytokines release to contribute to placental dysfunction, which impairs pregnancy outcomes. Methods: ACE2 and TMPRSS2 expression were measured by qPCR in human primary cultured term cytotrophoblasts (CTBs), syncytiotrophoblast (STBs), term and first trimester decidual cells (TDCs and FTDCs, respectively) as well as PMVECs (n=4/each cell type). Cultured PMVECs were treated with 10, 100, 1000 ng/ml of recombinant SARS CoV-2 S-protein ± 10 ng/ml IFNγ. Expression levels of proinflammatory cytokines IL1β, IL6 and IL8, chemokines CCL2, CCL5, CXCL9 and CXCL10, and coagulation factor III (F3) that is the prime initiator of the extrinsic coagulation cascade were measured by qPCR. Results: Weak ACE2 and TMPRSS2 levels were detected in CTBs and STBs as well as PMVECs. ACE2 levels were significantly higher in CTBs and STBs vs.TDCs or FTDCs, while TMPRSS2 levels were not detected in TDCs, FTDCs or PMVECs. qPCR analysis revealed that S-protein in all concentrations that used significantly increased IL1β, IL6,IL8, CCL2, and CCL5 levels, whereas only higher concentration S-protein significantly induced F3 levels in PMVECs compared to mock treated control. However, any concentration of S-protein did not alter CXCL9, and CXCL10 levels in PMVECs. Previous studies showed increased IFNγ levels in serum samples of COVID-19 patients as well as at the maternalfetal interface during early pregnancy and in preeclampsia. Therefore, we treated PMVECs with IFNγ alone or in combination with 10 ng/ml S-protein. IFNγ alone significantly increases proinflammatory cytokines and chemokines as well as F3 levels, however, in combination of S-protein further increase all inflammatory markers and F3 levels in PMVECs. Conclusion: These findings indicated that SARS CoV-2 infection in placental microvasculature: 1) induces proinflammatory cytokine and chemokine release, which contributes to cytokine storms in pregnant women and causes placental dysfunction; and 2) elevates F3 expression that may trigger vascular thrombosis in placenta. In the present study, CSH RNAi reduced umbilical blood flow and global nutrient uptake which ultimately led to reduced fetal and uterine weights. These data suggest that CSH is not only important for uterine blood flow and uteroplacental glucose uptake, but it also facilitates adequate umbilical blood flow necessary for the uptakes of oxygen, oxidative substrates, and hormones necessary to support fetal growth. Additionally, these data suggest that CSH may have uterotrophic actions. Supported by NIH HD093701. Their activity in the human placenta is associated with birth weight. Placental System A activity is reduced in pregnancies complicated by fetal growth restriction but the mechanistic importance of individual placental SNAT isoforms for intrauterine growth is unknown. We hypothesized that trophoblastspecific SNAT2/Slc38a2 knockdown, using lentiviral small-hairpin (sh) RNA delivery to the blastocyst trophectoderm, reduces placental growth, transplacental amino acid transfer and fetal weight in late gestation mice. Methods: Embryonic day (E) 3.5 mouse blastocysts were transduced with 5 x 10 5 transforming units of a lentiviral vector containing either a U6 promoter-driven, Slc38a2 targeting shRNA (Slc38a2KD), or a non-targeting control shRNA (SCR), both with green fluorescent protein (GFP). After 4hr, SCR and Slc38a2KD blastocysts were transferred to contralateral uterine horns of pseudopregnant CD-1 female recipients (n=29). On E18.5, recipients were euthanized and fetuses and placentae collected and weighed. Slc38a2 expression was determined by qPCR. Trophoblast plasma membrane SNAT2 abundance and in vivo System A transport capacity were determined by western blot and maternal-placental 14 C-methylaminoisobutyric acid clearance per gram placenta, respectively. Litter mean outcome measures were calculated for SCR and Slc38a2KD conceptuses and differences determined by paired Student's t-test. Results: Both SCR and Slc38a2KD transduced conceptuses exhibited trophoblast-specific GFP fluorescence. Placental, but not fetal, Slc38a2 expression was 59% lower in Slc38a2KD compared to SCR conceptuses (P<0.001, n=6 litters). Placenta-specific Slc38a2 knockdown reduced both fetal weight (-11%) and placental weight (-18%) compared to SCR controls (P<0.01, n=29 litters). Trophoblast plasma membrane SNAT2 abundance and in vivo System A amino acid transport capacity were also 20-30% lower in Slc38a2KD than SCR placentas (P<0.05, n=9-13 litters). Slc38a2 knockdown did not alter embryo implantation rate but diminished fetal viability, as measured by the proportion of transferred blastocysts surviving to term. Conclusion: This study demonstrates, for the first time, a cause-andeffect relationship between reduced placental expression of the System A amino acid transporter Slc38a2/SNAT2 and fetal growth restriction in mice. We speculate that Slc38a2/SNAT2 deficiency mechanistically contributes to placental insufficiency in human pregnancies complicated by fetal growth restriction. An In Vitro Placenta Model with a Native Stroma for Mechanistic Transport Studies. Katherine M. Nelson †, Sarah A. Geissler, Jason P. Gleghorn * . University of Delaware, Newark, DE, United States. Introduction: Transplacental transport of many medications is poorly understood, leaving pregnant women vulnerable to the unknown risks of many therapeutics that may be necessary during pregnancy. The ability to study placental drug transport is severely limited due to ethical concerns and technical challenges. Our objective was to develop an in vitro microfl uidic placental model incorporating multiple cell types and placenta derived extracellular matrix (pECM). This model can be used to delineate mechanisms of transplacental drug transport and perform drug screening. Methods: BeWo cells and HUVECs were purchased from ATCC or Lonza. Human primary trophoblast and placental endothelial cells were isolated from healthy term placenta. Placenta were decellularized using alternating hypo-and hypertonic washes with water and 10% NaCl, digested with pepsin, and gelled via neutralization with 1M NaOH. pECM was used to create thin membranes by drying gelation solution on silicon channel inserts at 37°C. The pECM was also used to create a stromal layer capable of housing stromal cells, such as fi broblasts. These pECM structures were incorporated into a microfl uidic device by clamping the silicon insert between two acrylic pieces containing microfl uidic channels (Fig. 1A) . Results: Confl uent trophoblast and endothelial cell layers were formed on the obverse and reverse of the pECM membrane forming maternal and fetal fl uidic channels. Fibroblasts were cultured within a hydrated stromal layer in addition to the epithelial and endothelial monolayers ( Fig. 1 B & C) . Barrier formation was confi rmed with transepithelial electrical resistance (TEER). Culture was maintained over 7 days. Antipyrine, sodium-fl uorescein, and glucose were used to validate transport dynamics in static and dynamic conditions. We have successfully created a placenta-on-a-chip device using multiple cell types and pECM that enable the investigation of passive and active mechanisms of transplacental transport and the impacts of fl uid fl ow on these processes. Additionally, the incorporation of pECM allows for mechanistic studies of cell-ECM interactions and the use of potentially pathological ECM to study cellular interactions in the context of preeclampsia or preterm birth. Obesity Downregulates Lipid Metabolism Genes in First Trimester Placenta. Aisha Rasool †, 1 Begum Aydogan Mathyk, 2 Danielle Roncari, 1 Perrie O'Tierney-Ginn * . 1 1 Tufts Medical Center, Boston, MA, United States; 2 Brandon Regional Hospital, Brandon, FL, United States. Introduction: Maternal obesogenic environment aff ects placental fatty acid (FA) metabolism and shapes fetal growth trajectory. Placentas of obese women have low mitochondrial beta-oxidation of FA and accumulate lipids in late pregnancy. This reduces ATP production and creates a lipotoxic environment, impairing placental effi ciency. The chronology of these changes during gestation are poorly understood. We hypothesize that placental fatty acid metabolism is impaired in women with obesity from early pregnancy. Methods: RNA was extracted from placentas of 27 healthy women (13 obese [body mass index (BMI)>35]; 14 lean [BMI<25]) collected in early pregnancy (gestational age (GA): 7.2-13.4 weeks). Maternal fasting triglycerides were measured in plasma collected at the time of procedure. Placental expression of 35 fatty acid metabolism genes was analyzed using multiplex nCounter assay (Nanostring). Expression was normalized to stable housekeeping genes (L19, YWHAZ and beta-actin), log transformed, and analyzed using nSolver Software (4.0.70). Analysis covariates included gestational age, race, smoking and fetal sex. False discovery rate (Q) was calculated by Benjamini Krieger Yekutieli test. Q values <0.05 were signifi cant. Spearman rank testing was used for correlations. Results: Expression of genes associated with FA oxidation (ACOX1; Q=0.00008, CPT2; Q=0.0009, AMPKα; Q=0.004), FA uptake (LPL; Q=0.001, LIPG; Q=0.008, MFSD2A; Q=0.002), FA synthesis (ACC; Q=0.004) and storage (PLIN2; Q=0.002) were signifi cantly reduced in placentas of obese (BMI: 35.8 ± 6.5 kg/m2) compared to lean (BMI: 21.2 ± 1.9) women. Maternal age, race, GA and smoking were not diff erent between BMI groups. Maternal circulating triglyceride levels were positively correlated with BMI (r=0.55, p=0.02), and negatively correlated with lipid synthesis genes ACSS2 (r= -0.64, p=0.005), ACSL5 (r= -0.50, p=0.03) and SREBP1 (r= -0.61, p=0.007). Conclusion: We demonstrate that obesity and hyperlipidemia impact placental FA metabolism from the first trimester of pregnancy. As hypothesized, markers of FA oxidation were decreased in placentas of obese women suggesting impairments in mitochondrial (CPT2) and peroxisomal (ACOX1) function. Markers associated with FA synthesis and uptake were downregulated in placentas of obese women, contrary to what is seen at term. FA synthesis genes were also negatively correlated with high maternal triglycerides. In early pregnancy, lipid uptake and synthesis pathways are critical for phospholipid production and growth, and disruption of these pathways may aff ect placental effi ciency later in pregnancy. As these changes begin as early as 7 weeks, interventions designed to improve outcomes in pregnancies complicated by obesity must start prior to conception or from fi rst trimester for maximal eff ectiveness. Thymic Involution in Murine Pregnancy. Soo Hyun Ahn †, 1 Sean L Nguyen, 1 Tae-Hoon Kim, 2 Jae-Wook Jeong, 2 Ripla Arora, 1 Margaret G Petroff * . 1 1 Michigan State University, East Lansing, MI, United States; 2 Michigan State University, Grand Rapids, MI, United States. Introduction: The thymus, a lymphoid organ that is instrumental for the maturation of self-tolerant T cells, undergoes temporary involution in both weight and cellularity during pregnancy. This phenomenon can be recapitulated by injecting non-pregnant (NP) female mice with ovarian hormones, estrogen and progesterone. However, the mechanism of how these hormones aff ect thymic involution is unknown. Here, we examine the role of the thymic nuclear progesterone receptor (PGR) receptor in pregnancy-induced thymic involution and thymocyte development. Methods: Using RT-qPCR, we measured transcript expression of Pgr and other steroid hormone receptors in the thymus throughout pregnancy in WT mice. We determined the cellular localization of PGR using immunofl uorescence microscopy. To study the role of PGR in thymocyte maturation and thymic involution, we generated a thymic epithelial cell (TEC)-specific Pgr knockout mouse model (TEC PRKO ) by crossing mice harboring Cre driven by the TEC-specific Foxn1 promoter with Pgr fl/fl mice. Thymic weights, cellularity, and T cell development were evaluated in NP and pregnant mice using multi-parameter flow cytometry in both WT and TEC PRKO mice. Results: Pregnancy induced a 4-7 fold upregulation of Pgr mRNA in WT females, while transcript levels for Esr1, Esr2, Pgrmc1, and Pgrmc2 remained similar between NP and pregnant mice. PGR protein expression increased by 2-4 fold across gestation, and localized almost exclusively to cortical TECs in the thymus. In WT, both the thymic weight and cellularity decreased with advancing gestation; they remained unchanged in TEC PRKO females. Flow cytometric analysis showed significant increase in the proportions of the most immature thymocyte population (CD44+CD25-; DN1) in comparison with thymocytes of later maturation stages across gestation; this remained similar in TEC PRKO females. Finally, we examined the role of thymocyte death in thymic involution using Cleaved Caspase 3 (C-casp3) expression in thymocytes to signify cells either undergoing death by neglect (C-casp3+ CD5+TCRβ lo ) or clonal deletion (C-casp3+ CD5+TCRβ+). In the WT thymus, pregnancy induced increased proportion of thymocytes undergoing death by neglect and decreased proportion of thymocytes undergoing clonal deletion. On the other hand, both selection processes were reduced in NP thymus of TEC PRKO mice. Conclusion: Using a combination of molecular, flow cytometric, imaging, and novel mouse model approaches, we show that PGR expression by TECs is responsible for thymic involution during pregnancy. Further, our results indicate that PGR plays a fundamental role in both positive and negative selection during pregnancy and in normal T development in the thymus. A Role for the IL-33-ILC2 Axis in Driving Uterus-Intrinsic Parturition Pathways in Mice. Johan Siewiera †, Madelene Dahlgren, Kelly Cautivo, Damon Rideaux, Ari Molofsky, Adrian Erlebacher. UCSF, San Francisco, CA, United States. Introduction: The pathways that initiate parturition remain largely undefined. One critical step is thought to be "decidual activation," the process whereby the decidua increases its expression of COX-2 and produces prostaglandins that stimulate myometrial contraction. Functionally dissecting the upstream triggers for decidual activation has been difficult, however, since model organisms such as mice normally initiate parturition via luteolysis, the process through which the ovary stops producing progesterone. Methods: Wild-type and mutant mice were treated with a single subcutaneous injection of depot medroxyprogesterone acetate (DMPA; also known as Depo-Provera) on E12.5 to sideline luteolysis-induced parturition and instead assay uterus-intrinsic parturition pathways. We measured parturition timing and analyzed late gestation uteri by flow cytometry, immunofluorescence, RNA-Seq and prostaglandin ELISA. Results: We find that mice deficient in the alarmin IL-33 show a severe parturition delay when we experimentally force circulating progestin levels to remain high, thus ensuring that parturition will occur through uterus-intrinsic pathways. Strikingly, IL-33 expression in late gestation and consequent activation of the key IL-33 target cell type, the Group 2 Innate Lymphoid Cells (ILC2), are confined to the myometrium and more specifically to the mesometrial triangle, the histologically-distinct segment of myometrial tissue that remains in contact with the decidua throughout the entirety of gestation. We also find that IL-33 is required for optimal uterine contraction in a model of inflammation-induced preterm labor. Surprisingly, disruption of the IL-33-ILC2 axis decreases COX-2 expression by the decidua and its production of PGE 2 . Conclusion: These results reveal a contribution from IL-33, acting through ILC2s, in driving the uterus-intrinsic parturition pathway in mice, as well as a previously unappreciated upstream role for the myometrium in controlling decidual activation and the timing of labor induction. Supported by NIH grant R01AI150191 to A.E. Single-Cell RNA Sequencing Identifies Novel Uterine Macrophage Population Increased by Regulatory T Cells and Associated with Decreased Fetal Loss. Emma L Lewis †, 1 Paige M Porrett, 2 Michal A Elovitz * . 1 1 University of Pennsylvania, Philadelphia, PA, United States; 2 University of Alabama, Birmingham, AL, United States. Introduction: Intrauterine fetal demise (IUFD) -fetal loss after 20 weeks -affects 6 pregnancies per 1,000 live births in the United States. At least one-third of IUFDs are of unknown etiology and mechanistic studies of IUFD are rare. Therefore, we investigated immunologic mechanisms of IUFD using the CBA mouse model of mid-late gestation fetal loss. Methods: CBA and C3H/HeN (C3H, control) female mice were mated to DBA/2 males and sacrificed at multiple gestational ages (E8-E18) for immune phenotyping of the maternal-fetal interface by flow cytometry (N=4/strain/age). We also performed an adoptive transfer of 2x10 5 regulatory T cells (Tregs) or PBS to CBA dams at E2. Treg and PBS treated CBA mice were sacrificed at E14 and E18 to determine rates of fetal loss and immune compositional changes by flow cytometry (N=7-9 dams/group). To further elucidate uterine immunologic shifts, we performed single cell RNA-sequencing (scRNA-Seq) on CD11b+ cells sorted from the uterus of Treg and PBS treated CBA mice (N=3/group). Repeat experiments comparing CBA and C3H mice were used to confirm cell types identified by scRNA-Seq by flow cytometry (N=6-8/group). Results: Compared to C3H dams, CBA dams have 3.5-fold higher rates of fetal loss (p=0.0001). Mid-gestation CBA dams also have 4.2-fold fewer uterine Tregs (p=0.001) and 3-fold fewer decidual macrophages (p=0.0004) than C3H dams. Treg transfer restores CBA pregnancy to be more similar to a C3H pregnancy phenotype by decreasing fetal loss 2.7-fold (p=0.04), increasing pup viability (Fig A) , and increasing uterine Tregs 2.3-fold (p=0.05) as assessed by flow cytometry. scRNA-Seq identified 15 uterine CD11b+ populations, with Trem2+ Apoe+ macrophages increased by Treg transfer (p=2.2e-12). These uterine Trem2+ Apoe+ macrophages are enriched for gene sets from macrophages subsets found in other tissues, including those in atherosclerotic plaques (p<0.0001). We then identified this Trem2 macrophage by flow cytometry and found that pregnant CBA mice had 2-fold fewer of this macrophage subtype than C3H mice (p=0.004). Conclusion: These data identify a novel uterine macrophage population that may be critical for healthy pregnancy and demonstrate that systemic Treg transfer alters tissue immune populations, which has broad implications for immunotherapy. scRNA-Seq also reveals specific uterine cells and gene pathways that suggest potential mechanisms of and therapeutic targets for IUFD. The human endometrium is a highly dynamic organcyclically proliferating, differentiating, and shedding in response to ovarian hormones. Defects in this organ could result in endometrial, pregnancy, and birth related diseases. Mouse models have fundamental differences that make it a poor model for the human endometrium. Current in vitro models using human biopsied cells only represent the adult endometrium and have not been used to study interactions between the different cell-types of the endometrium. We developed a model of the human endometrium combining human pluripotent stem cell-derived endometrial stromal fibroblasts (PSC-ESF) and endometrial epithelial organoids (EEO) in a 3-dimensional (3D) organoid system. Methods: PSCs were differentiated into ESF were able to decidualize in vitro. The protocol guided the cells through developmental stages: differentiating to intermediate mesoderm (IM), endometrial stromal progenitors (ESP), and finally ESF. Differentiation was characterized by qRT-PCR and ICC. EEO were isolated from term placenta and expanded in culture as organoids following a published protocol. PSC-ESF and EEO were independently dissociated and combined to allow self-assembly in 3D. The two-cell organoids were then exposed to two 16-day periods of decidualization cues, separated by a period of hormone withdrawal and were maintained up to 52 days. Results: Differentiating cells at the IM stage upregulate T, LHX1, and PAX2 as measured by qRT-PCR. The PSC-ESP have increased expression and cell surface localization of AMHR2 as well as region specificity characterized by expression of HOXA10 and HOXA11, but not HOXA9 or HOXA13. PSC-ESF lost expression of AMHR2 while upregulating expression of hormone receptors. PSC-ESF also expressed receptors for ligands expressed by EEO, such as LIFR, SMO, and NOTCH1/2/3 and were able to co-culture with primary EEO. The PSC-ESF organized in a layer surrounding the EEO and cell type specific expression of stromal (HOXA11, PDGFRβ, VIM) and epithelial (KRT7, EpCAM, acetylatedα-Tubulin) markers. Conclusion: We have generated a two-cell, 3D model of the endometrium that will enable the study of how these two human cell types interact in vitro. Using induced PSC from patients with known disease outcomes, our model can investigate these cell types and how their interaction is affected in diseases such as endometriosis and endometrial cancer. Furthermore, this model will be a valuable platform for the addition of other cell types, such as vascular endothelial cells or fetal trophoblasts, to enable more complex and more representative modeling of the human endometrium in vitro. The Vertical Transfer of Maternal Immune Cells during Pregnancy Promotes Neonatal Immunity against Viral Infections in Mice. Ina Stelzer, 1,2 Christopher Urbschat, 1 Kristin Thiele, 1 Ioanna Triviai, 1 Julian Kottlau, 1 Felix Stahl, 1 Maria Emilia Solano * , 1 Petra Arck * . Hamburg, Germany; 2 Stanford University, Stanford, CA, United States. Introduction: The function of vertically transferred immune cells from mother to fetus and their long-term retention in offspring's organs remains poorly defined. We previously detected maternal microchimeric (MMc) cells with an adaptive immune cell phenotype in fetal bone marrow at late murine gestation (E18.5). We here aimed to elucidate a potential functional contribution of MMc to fetal immune development and early life immunity. Methods: F1 offspring were generated from an allogeneic mating model (female (F) C57Bl/6J CD45.2 H-2 b x male (M) Balb/c CD45.1 H-2 d ), allowing to detect and sort maternal CD45.2 H-2 b cells from fetal CD45.1/2 H-2 d/b cells by flow cytometry. For functional tests, we established a reductionist approach by generating allogeneic pregnancies (F Rag2 -/yc -/ x M WT) that lack the vertical transfer of adaptive-immune MMc cells (MMc low ). Offspring from reciprocal matings (F WT x M Rag2 -/yc -/ ) served as controls (MMc pos ). Neonates were inoculated with murine cytomegalovirus (MCMV) on their first day of life, and viral load determined on neonatal day 7. Results: The presence of MMc promoted the preferential differentiation of sorted fetal hematopoietic stem and progenitor cells (HSPC, E18.5) towards myelopoiesis in comparison to HSPC cultured alone, as observed in an in vitro co-culture system. Consistently in vivo, MMc low fetuses with significantly reduced levels of MMc showed decreased monocyte frequencies among myeloid cells in the bone marrow (E18.5). Strikingly, MMc low neonates showed a higher viral load after neonatal MCMV infection in comparison to MMc pos controls, which could be rescued by replenishing MMc in dams during pregnancy via adoptive transfer of peripheral adaptive immune cells. The direct involvement of neonatal bone-marrow derived monocytes in reducing MCMV viral load was confirmed in vitro, as evident in a significant reduction of MCMV plaque sizes in presence of monocytes. Conclusion: The functional capacity of MMc cells to support stem cell differentiation, monocyte development, and subsequently neonatal immunity establishes that 'cellular parenting' mediated by MMc cells during pregnancy ultimately reduces the severity of early life infections. Introduction: Premature ovarian failure (POF) can be genetic or treatment-related as seen with reproductive age women exposed to chemotherapy. POF results in the loss of endocrine function and fertility with limited treatment options. In this mouse study, we present a novel concept for fertility and endocrine function restoration using mouse Thursday Orals granulosa cell-derived induced pluripotent stem cells (mGriPSCs) to generate functional oocytes, augment endocrine function, and restore fertility. Methods: mGriPSCs were labeled with the green fluorescent protein (GFP) reporter gene and differentiated in three-dimensional suspension culture into steroidogenic ovarian cells and presumptive oocytes. These differentiated cells were then isolated by fluorescence activated cell sorting (FACS) for the ovarian surface antigen, anti-Mullerian hormone receptor 2 (AMHR2), which by RT-PCR analysis is also expressed in mouse oocytes. Following FACS, 17,000 AMHR2 positive cells were then injected into each ovary of five subfertile, immunodeficient mice. Mice were hyperstimulated and underwent either oocyte retrieval or mating with wild type males to assess neogametogenesis and fecundity. Results: FACS revealed 0.4% of differentiated stem cells were AMHR2 positive. These sorted cells continued to produce estrogen, progesterone, and AMH in vitro. One month after injection of sorted cells into mouse ovaries, 44% of oocytes obtained from these mice expressed the GFP reporter, confirming their stem cell origin. Further, these stem cellderived oocytes were calcium activated or fertilized in vitro. When stem cell-injected mice were mated with wild type mice, we obtained three litters, the first of which was sacrificed at embryonic day 18, the second at embryonic day 20, and the third delivered live pups. Overall, 33% of the offspring showed GFP reporter expression by immunohistochemistry (IHC). Additionally, IHC analysis of host mouse ovaries and embryos displayed contribution of the GFP cells to various cell types, confirming the chimeric composition of these tissue. Conclusion: We believe that these exciting results provide translational opportunities to further explore this experimental paradigm using human iPSCs. Patients could potentially be treated with autologous stem cells to restore endocrine function and fertility, therefore providing additional novel options for women with POF. Introduction: Hypertensive disorders in pregnancy (HDP) are a leading cause of maternal and fetal morbidity and mortality worldwide. Racial diversity exists for HDP with African women having higher risk while Asian women having overall decreased risk than White women. Genetic polymorphisms in the heme oxygenase-1 (HO-1) regulatory region have been linked to cardiovascular and metabolic diseases. HO-1 is the rate-limiting enzyme that catalyzes the degradation of heme to produce carbon monoxide (CO) and bilirubin, which have both anti-inflammatory and cytoprotective properties. HO-1 polymorphisms at rs3074372 (GTn repeat, S/M/L) and rs2071746 (A/T SNP) can affect HO levels, with shorter GTn repeats and A allele associated with higher HO-1 expression. To explore whether HO-1 genetic variants can predispose women to HDP, we first determined the frequencies of HO-1 variants (GTn repeat length, A/T SNP) among 5 different racial populations [African, American (Hispanic), European (White), East Asian, and South Asian] from the 1000 genome project. We then compared the White HO-1 variant frequencies to an available White HDP cohort. Methods: Sequences of GTn repeats and data on A/T SNP of female individuals were extracted from the 1000 genome phase 3 database using HipSTR v0.6.2 and from ensembl.org, respectively. Genotypes of GTn repeats and A/T SNP of HDP patients were determined using DNA fragmentation analysis and Taqman SNP genotyping, respectively. GTn repeat lengths were defined as short (S, ≤27), medium (M, >27 and ≤35), or long (L, >35). Chi-square test was used for statistical analysis (p<0.05 was considered statistically significant). Results: Both HO-1 genetic variants showed significant racial differences (GTn repeats, p<0.00001; A/T SNP, p<0.00001). The S allele frequency was highest in East and South Asian women; M and A alleles were highest in Hispanic and White women; and L and T alleles were highest in African women. Of note, the highest risk genotype LL-TT was most common in African women compared to others. The HDP cohort had a higher ratio of the L allele (p=0.02) than White controls while no difference in A/T allele ratios was observed. Conclusion: The two genetic variants of HO-1 show different distributions across racial populations. African women more often had alleles associated with low HO-1 expression in contrast to Asian women who had alleles with highest HO-1 expression. We speculate that these genetic variants may contribute to the racial diversity in HDP. Of the two HO-1 variants, GTn repeat length more likely plays a role in any genetic predisposition to HDP as there was no difference in the A/T SNP ratios between the HDP and control populations. Introduction: Maternal uterine vascular adaptations are important for maintaining normal uteroplacental (UP) perfusion and preventing pregnancy complications such as preeclampsia (PE) and intrauterine growth restriction. The venous compartment is the major blood reserve of the body. Inadequate venous reserve or compliance, and venous insufficiency during pregnancy are linked to poor reproductive outcome in women. Yet, little is known about the contribution of venous hemodynamics to gestational uterine vascular remodeling. We hypothesized that (1) increasing UP venous impedance leads to slower upstream arterial blood flow (hence less shear stress) and less arterial remodeling; and (2) the placenta alters its secretion of signaling molecules to compensate for, or as a consequence of its underperfusion. Methods: (1) We developed a surgical model of increased uteroplacental impedance (IUPI) in pregnant Sprague-Dawley rats (IUPI; n=10) that involved ligating the main uterine artery and vein (MUA+MUV) at the cervical end to allow single blood inflow/outflow from the ovarian end and putting a silver clip on the MUV at the ovarian end to partially restrict venous outflow. The sham-operated contralateral horn served as control. (2) To analyze the secreted placental proteins using a proteomics approach (secretomics), two placentas from each ligated vs. control horn were collected (n=4 animals) for ex vivo culture for 20 hrs. Proteins in the conditioned media were concentrated by acetone precipitation, then analyzed by WB and liquid chromatography mass spectrometry (LCMS) using isobaric tandem mass tag (TMT). Results: (1) Compared to the control horn, pup weight in the IUPI horn decreased 5 ± 1% and placental efficiency (pup/placental weight ratio) was significantly lower (6.0 ± 0.2 vs 6.7 ± 0.2; p = 0.02). The anticipated expansive MUA and MUV remodeling was completely abolished with venous flow restriction. (2) Proteomics analysis detected 2305 proteins and 92 of which were differentially regulated (p < 0.05). Some upregulated proteins (e.g. fibrinogen β and hemoglobin zeta chain) and down-regulated proteins (e.g. ribosomal proteins, asparagine synthetase and heat shock protein 90) are related to PE. WB analysis verified the upregulation of fibrinogen β subunit in the ligated samples. Conclusion: Increased uteroplacental impedance due to reduced venous outflow decreases maternal uterine vascular remodeling and alters some placental secretory proteins in a way similar to PE, suggesting a significant role of venous hemodynamics in assuring healthy pregnancy outcome. Our novel rat surgical IUPI model may prove useful in identifying some of the underlying mechanisms. The New Generation Antiplatelet Agent Prasugrel Represents an Exciting Novel Candidate Therapy for Preeclampsia. Natalie Hannan * , 1 Natasha De Alwis †, 2 Natalie Binder, 1 Sally Beard, 1 Vi Nguyen, 1 Kaitu'u-Lino Tu'uhevaha, 1 Stephen Tong. 1 1 University of Melbourne, Parkville, Australia; 2 University of Melbourne, Heidelberg, Australia. Introduction: Preeclampsia (PE) is a serious complication of pregnancy, claiming over 60,000 mothers worldwide and far more neonatal loss. Central to the pathophysiology is the systemic maternal endothelial dysfunction; culminating in hypertension and major end organ damage. Prasugrel, a new generation antiplatelet drug used clinically to prevent in cardiovascular events and stroke, demonstrates key anti-thrombotic, anti-inflammatory properties and thus may be effective in preventing the development of PE. Objective: To examine whether prasugrel can mitigate the pathophysiology in human and mouse models of preeclampsia, and compare the effects of prasugrel directly to the antiplatelet aspirin, the current most widely prescribed drug to prevent PE. Methods: Functional studies were performed on human primary: 1) cytotrophoblast 2) endothelial cells 3) and PE placental explants. We tested the effects of prasugrel and aspirin on human tissues at increasing doses (0-100μM) to determine effects on oxidative stress, mitochondrial function, sFlt1 production, endothelial dysfunction (in multiple in vitro models) and vascular reactivity wire myograph studies using pregnant arteries from both women and mice. Importantly we tested the effects of prasugrel in two mouse models of PE. Results: Prasugrel reduced reactive oxygen species (ROS) production and induced nuclear translocation of the transcription factor, Nrf2, as well as enhancing Nrf2 target gene expression. Prasugrel potently reduced sFlt1 secretion from preeclamptic placental explants and reduced proinflammatory cytokine production from preeclamptic placental explants and endothelial dysfunction models. Prasugrel reduced markers of dysfunction (VCAM1 and ET-1) and models of dysfunction (monocyteendothelial adhesion) and enhanced phosphorylation of endothelial nitric oxide synthase (eNOS). Strikingly, administration of prasugrel significantly reduced blood pressure (hallmark characteristic), as well as redcuing circulating markers associated with PE in two mouse models. Conclusion: Prasugrel potently enhances placental cryoprotection, decreases sFlt1 and pro-inflammatory mediator release, reduced both endothelial dysfunction and blood pressure mouse models of disease. Given they are classified as category B/C drugs and used in the newborn, they represent exciting candidate therapies to prevent and/or treat PE. Sildenafil Improves Placental Function and Remodeling in Preeclamptic Rats. Dylan J Lawrence †, Carolyn L Bayer * . Tulane University, New Orleans, LA, United States. Introduction: Preeclampsia is a pregnancy-induced hypertensive disorder that results from abnormal vascular remodeling and placental ischemia during early development. Tempol, a superoxide dismutase mimetic, and the phosphodiesterase inhibitor sildenafil are two potential treatments for preeclampsia that target different mechanistic pathways. While both therapies been shown to improve the maternal symptoms of preeclampsia in preclinical models, the effects on in vivo placental function have not been demonstrated. Our aim was to use spectral photoacoustic (sPA) imaging to monitor the longitudinal placental response to tempol or sildenafil treatment in the reduced uterine perfusion pressure (RUPP) rat model of preeclampsia. Methods: Sprague Dawley rats (n=8) were administered tempol or sildenafil via drinking water beginning on gestational day (GD) 12. Highresolution ultrasound (US) and sPA images of the placental environment were acquired on GD14, 16, and 18 with the RUPP surgical procedure implemented immediately after the first imaging session. All sPA images were exported for processing and a linear spectral unmixing algorithm was performed to estimate the concentration of oxyhemoglobin and deoxyhemoglobin. The placenta was then manually segmented using the co-registered B-mode US images of anatomy and the average placental oxygenation and total hemoglobin concentration, a measure of vascular remodeling, were calculated. Results: Placental oxygenation in the RUPP was decreased after the surgical intervention, as compared to normal pregnant (p<0.05). Vascular remodeling was also found to be impaired in RUPP animals. Administration of sildenafil, but not tempol, significantly improved placental oxygenation (p<0.05) and increased vascular remodeling in the RUPP in comparison to untreated RUPP animals. Conclusion: Using ultrasound-guided sPA imaging, we have shown that sildenafil treatment restores placental function in the RUPP rat model of preeclampsia. Our work demonstrates that sPA imaging could be used to monitor differential longitudinal effects of therapeutic intervention on placental growth, independent from maternal symptom management. Introduction: Preeclampsia (PE) is a leading cause of maternal and fetal morbidity and mortality during pregnancy. L-Tryptophan (Trp) can be metabolized into various biologically active metabolites, including aryl hydrocarbon receptor (AhR; a transcription factor) ligands. These Trpmetabolites regulate many critical biological processes (e.g., vascular and immune responses). However, the concentrations of most Trp-metabolites are unknown in maternal and fetal circulations, particularly in PE. Methods: 25 Trp-metabolites were measured in paired maternal (Mat) and umbilical cord vein (UCV) sera from women with normotensive (NT) pregnancy and PE using LC-MS/MS. 20 women with singleton pregnancies were included in each group (10 with male and 10 with female fetuses). Results: 20 Trp-metabolites were detected in Mat and UCV sera, among which 9 are AhR ligands. The concentrations of 9 Trp-metabolites including 4 AhR ligands (L-Kynurenine, Cinnavalininate, Indole-3-lactic acid [ILA] , and Indoleacetate [IAA]) were higher (P < 0.05) in UCV vs. Mat, whereas 2 (5-hydroxy-L-Tryptophan [L-5-HTP] and Serotonin, an AhR ligand) were lower (P < 0.05) in UCV vs. Mat. Only ILA was elevated (P < 0.05) in PE-Mat (45% above NT-Mat) and PE-UCV (27% above NT-UCV). The concentration of IAA in UCV was 30% higher (P < 0.05) in NT with male vs. female fetuses. Positive correlations between Trp-metabolites (Trp and 3-Indoxyl sulfate in Mat, and ILA in UCV) and maternal mean artery pressure were identified in NT-, but not PE-Mat and UCV. Trp-metabolites in Mat (Kynurenic acid, Picolinic acid, L-5-HTP, and Indoxyl-b-D-glucuronide) and UCV (ILA and Indole-3-propionic acid) were also positively correlated with maternal proteinuria in PE patients. Conclusion: These data indicate that the placenta is a major source of Trp-metabolites and fetal sex does not significantly affect levels of most Trp-metabolites in maternal and fetal circulations during NT and PE. In addition, Trp-metabolites are associated with blood pressure regulation in normal pregnancy; however, PE uncouples these associations. Thus, Trp-metabolites may regulate maternal and fetal endothelial/vascular function during pregnancy. The PE-induced ILA elevation suggests that dysregulation of endogenous AhR ligands may contribute to PE-associated endothelial/vascular dysfunction. Can WS1442 Ameliorate Maternal Vascular Dysfunction in Preeclampsia? Stephanie A Worton †, Yasmin Mills †, Susan L Greenwood * , Jenny E Myers * . University of Manchester, Manchester, United Kingdom. Introduction: In pre-eclampsia (PE), dysfunction of maternal resistance arteries, which contributes to vasospasm, hypertension and organ hypoperfusion, is characterised by increased sensitivity to vasoconstrictors and impaired endothelium-dependent vasorelaxation. The Crataegus (hawthorn) extract WS1442, which is licensed for treatment of heart failure, relaxes resistance arteries via both nitric oxide (NO) and endothelium-derived hyperpolarising factor (EDHF) pathways, but its effects have not been assessed in pregnancy. Hypothesis: WS1442 will reduce vasoconstrictor sensitivity and cause endothelium-dependent relaxation in arteries from women with normal pregnancy and PE. Methods: (i) Using wire myography, vasoconstrictor responses to U46619 (thromboxane mimetic) were assessed in omental arteries (<400um) from normal pregnancy (NP; N=6) and PE (N=3) before and after treatment with WS1442 (100μg/ml; 1hr). (ii) In pre-constricted omental arteries (U46619 EC 80 ), relaxation in response to increasing WS1442 concentrations (1-1000μg/ml) was assessed (NP N=8, PE N=5). (iii) To investigate the mechanism of WS1442 activity, concentration-response experiments were repeated in endothelium-denuded omental arteries (N=6), and mouse mesenteric arteries obtained from wild type (WT; N=4) and endothelium-derived NO synthase deficient (eNOS -/-; N=4) pregnant animals. Data were compared by 2-way ANOVA. Results: (i) WS1442 treatment reduced U46619-induced constriction in omental arteries from women with NP (post-treatment constriction WS1442 36.8±11.3% vs. vehicle control 77.8±6.9%; p<0.0001), and women with PE (52.5±19.0% vs. 87.4±8.8%; p=0.006). (ii) WS1442 relaxed pre-constricted arteries from NP (remaining constriction WS1442 10.5±1.73% vs. control 36.1±8.8%, p=0.0001), but not PE (32.6±9.4% vs. 47.8±12.8%). (iii) Endothelium removal prevented WS1442-induced relaxation (39.5±11.1% vs. 60.1±10.1%). WS1442-induced relaxation occurred in mesenteric arteries from WT mice (41.0±4.1% vs. 67.5±5.0%; p<0.001), and persisted in eNOS -/mice (34.2±12.3% vs. 70.2±3.5%; p<0.0001). Conclusion: WS1442 substantially reduced agonist-induced constriction of omental arteries from NP and PE, and relaxed pre-constricted arteries from NP but not PE. WS1442-induced relaxation was endotheliumdependent, but independent of eNOS, implicating an EDHF contribution to vasorelaxation. WS1442 merits further investigation as a potential treatment for PE. Evaluation of ATR Inhibitors for Targeted Therapy of Ovarian Clear Cell Carcinoma. Jing Ji, 1 Zhigui Li †, 1 Emily Sherman †, 1 Oloruntoba Osagie †, 1 Shijun Mi, 3 Whitney Soble, 1 Jessie Li †, 1 Gloria Huang * . 1 1 Yale School of Medicine, New Haven, CT, United States; 2 Xi'an Jiaotong University, Xi'an, China; 3 Albert Einstein College of Medicine, Bronx, NY, United States. Introduction: ARID1A mutations occur in approximately 50% of ovarian clear cell carcinomas (OCCC) and result in deficient ARID1A protein expression. ARID1A deficiency impairs the DNA damage response that maintains genome integrity. We therefore hypothesized that ARID1Amutated OCCC may be vulnerable to further inhibition of the DNA damage response using ATR inhibitors. The objective of this study was to evaluate the usefulness of ATR inhibitors in OCCC and to determine the relationship between ATR sensitivity and ARID1A status using isogenic cell line and xenograft models. Methods: Using stable lentiviral transfection, we generated paired isogenic human OCCC cell lines (ES2 and OVISE) with or without ARID1A expression. ARID1A wildtype ES2 cells were transfected with short hairpin RNA targeting ARID1A, or non-targeting shRNA control. ARID1A mutant OVISE cells were transfected with doxycycline (Dox)inducible full-length ARID1A cDNA or doxycycline-inducible control cDNA (LacZ). Cells were treated with two different ATR inhibitors (AZD6738 or VX-970), and their effects on cell growth quantified using the Sulforhodamine B (SRB) assay. Immunoblotting and immunofluorescence (IF) were done to evaluate ARID1A knockdown and restoration, and to detect γ-H2AX (a DNA damage marker). For the in vivo evaluation of ATR inhibitor therapy, ES2-shARID1A xenografts were grown in athymic nude mice. After randomization, xenograft-bearing mice were treated with an ATR inhibitor (AZD6738) or vehicle control. Comparisons were performed using two-tailed t-tests or One-way ANOVA, as appropriate, and a P-value <0.05 was deemed statistically significant. Results: Immunoblotting and IF showed efficient ARID1A knockdown and restoration compared to isogenic controls. ES2-shARID1A cells (ARID1A knockdown) were more sensitive to ATR inhibitors compared to ES2-shCon cells (control); P<0.01 for AZD6738, P<0.01 for VX-970). OVISE-ARID1A+Dox cells (ARID1A restoration) were more resistant to ATR inhibitors than OVISE-ARID1A (no Dox) or OVISE-LacZ+Dox cells (control); P<0.001 for AZD6738, P<0.01 for VX-970. Following ATR inhibitor treatment, increased expression of γ-H2AX by immunoblotting and IF was observed in ARID1A-deficient cancer cells compared to ARID1A-expressing cells. In vivo, AZD6738 treatment effectively suppressed tumor growth of ARID1A deficient OCCC; mean tumor volume of treatment group vs vehicle control, P<0.001. Conclusion: ARID1A deficient OCCC is sensitive to ATR inhibition in vitro and in vivo. These data support clinical evaluation of ATR inhibitors in OCCC and consideration of ARID1A mutational status as a potential predictive biomarker of response to ATR inhibitors. Endoplasmic Reticulum Stress Response to Hyperinsulinemia in Endometrial Epithelial Cells Depends on PIK3CA Mutation. Mike R Wilson †, Ronald L Chandler * . Michigan State University, Grand Rapids, MI, United States. Introduction: Endometrial cancer (EC) was the first cancer identified with an increased risk among obese populations. Obesity is associated with over 60% of EC occurring in the United States and incidence of EC is rising steadily due to the obesity epidemic. Hyperinsulinemia is also known to contribute to EC independent of obesity. However, obesity or hyperinsulinemia alone do not result in EC. Genetic mutations driving EC are well characterized, but these mutations alone are not sufficient for EC pathogenesis as they exist in uteri without cancer. While the PI3K pathway gene PIK3CA is highly mutated EC, recent studies have identified that PIK3CA mutations also occur at a high rates in the endometrial epithelium of women without EC. In normal cells, the PI3K pathway maintains metabolic homeostasis, but in cancer the PI3K pathway is activated to promote cell survival. There is an urgent need to understand the mechanisms by which obesity and genetic mutation interact to promote EC. Metabolic signaling influences protein production and folding. The unfolded protein response pathway maintains protein quality control, and is activated upon endoplasmic reticulum stress. During endoplasmic reticulum stress, if proteostasis cannot be achieved, the unfolded protein response is activated, resulting in cell death. Obesity results in systemic endoplasmic reticulum stress, with hyperinsulinemia as a contributing factor. Our hypothesis is that endoplasmic reticulum stress induced by hyperinsulinemia contributes to the development of EC, and that the effect of hyperinsulinemia depends on endometrial mutation. Methods: We performed in vitro studies using immortalized endometrial epithelial cells. Cells were transfected with siRNAs and plasmids and treated with insulin over 3 days. RNA and metabolites were isolated from the cells for RNA-seq and mass spectrometry, respectively. Statistical tests were performed on all experiments. Results: We identified a unique role for mutant PIK3CA in regulating endoplasmic reticulum stress in response to insulin treatment, an effect which was not observed following loss of EC tumor suppressors PTEN, PIK3R1 or ARID1A. Mutant PIK3CA antagonizes endoplasmic reticulum stress induced by insulin, promoting survival through resistance to unfolded protein response-mediated cell death mechanisms. Using RNAseq and metabolomics approaches in tandem, we have identified a role for nucleotide metabolism in regulating this process. Conclusion: PIK3CA-mutant endometrial epithelia may be better suited to survival in a hyperinsulinemic environment, and as such, hyperinsulinemia may promote the spread of PIK3CA-mutants throughout endometrial glands. Through understanding endoplasmic reticulum stress resistance in the endometrium, we hope to develop preventative interventions for obese women at risk for EC. Complications in Gynaeoncology Surgery? Lusine Sevinyan †, 1 Sadie Jones †, 2 Jonathan Horne †, 3 Rasiah Bharathan, 3 Anil Tailor, 1 Simon Butler-Manuel, 1 Peter Williams, 4 Introduction: Despite the informed consent process, patients' understanding of potential post-operative complications is often limited, making it difficult to call the decision an informed one, so estimating the risk of postoperative complications is important for shared decision making and to help multidisciplinary teams plan postoperative care. Increased incidence of gynaecological cancers and operations, especially technically challenging minimally invasive surgery (MIS) in older, obese and patients with multiple comorbidities, requires accurate prediction of the likelihood of mortality and morbidity and patient involvement in joint decision making about the management. ACS-NSQIP (American College of Surgeons National Surgical Quality Improvement Program) risk calculator is a validated web-based tool based on 21 preoperative risk factors to predict 8 post-operative outcomes. The objective of our study was to explore the validity of ACS NSQIP in gynaeoncology for perioperative prediction of postoperative complications. Methods: A retrospective multicentre cohort study evaluated 1552 patients who underwent surgery at a tertiary oncology centre. Data collection undertaken through dedicated database. Data collated on 764 patients undergoing robotic, 248 laparoscopic and 540 open surgery for suspected or confirmed gynaecological malignancy. All missing data collated from patient notes. Following data lock with the actual post-op event/complication that occurred in this retrospective cohort, ACS NSQIP used to count predictive scores for each patient. Data analysis evaluating ACS-NSQIP validity and relevance in gynaecological oncology patients and its ability to predict postoperative complications performed. Results: ACS-NSQIP was found to best predict mortality (AUC -0.900), it was most accurate for prediction of complications as follows: discharge to rehabilitation (AUC-0.866), cardiac complications (AUC-0.844), sepsis (AUC-0.795), pneumonia (AUC-0.779), VTE (AUC-0.715), return to theatre (AUC-0.715), surgical site infection (AUC-0.684), readmission (AUC-0.680), renal failure (AUC-0.665). Poor result in the prediction of UTI (AUC-0.561) was noted. Conclusion: ACS-NSQIP risk calculator appears to predict major complications and post-operative mortality making it useful as an informed consent tool. Preliminary data suggests that further validation is required to fully evaluate if the risk scores may be used to inform patients pre-operatively of their risk of complications and is currently being undertaken. The inflammatory gene NLRP7 is the major gene responsible for recurrent complete hydatidiform moles (CHM), a benign abnormal pregnancy that develops in 5-20% of cases into the most malignant form of trophoblastic disease, the gestational choriocarcinoma (CC). Yet, the role of NLRP7 in the development of CC has not been investigated. Methods: Three approaches were employed to define the role of NLRP7 in CC development, i) a clinical study that analyzed a distinctive collection of human placenta and sera collected from uncomplicated control (n=29), HM (n=26), and CC (n=11) patients ii) an in vitro study investigating the impact of NLRP7 knockdown on the proliferation, migration and invasion of the CC cell line, JEG3, using novel 2D and 3D cultures systems, and iii) an in vivo study using three CC mouse models, including the newly developed CC orthotopic model. Immunohistochemistry, Western blotting, Antibody-array and RT-qPCR analyses were used to characterize the impact of NLRP7 invalidation on the maternal tumor-associated microenvironment. Results: We demonstrated that placental NLRP7 is highly expressed in CC patients and in JEG3 cells and functions in an inflammasome-independent manner. NLRP7 knockdown decreased JEG3 proliferation and tumor organization. In vivo models substantiated the direct involvement of NLRP7 in CC aggressiveness by creating an immunosuppressive microenvironment that fosters the growth and dissemination of tumor cells. The study characterized the critical role of NLRP7 in CC and proposes that it plays a significant role in CC growth and dissemination. This finding highlights NLRP7 therapeutic promise as a molecular target. Kingdom; 3 UCL, London, United Kingdom; 4 Edinburgh University, Edinburgh, United Kingdom; 5 University of Bristol, Bristol, United Kingdom. Introduction: The vaginal microbiota has a key role in the pathogenesis of spontaneous preterm birth (sPTB). Whilst Lactobacillus crispatus has been demonstrated to be protective against cervical shortening and sPTB, depletion of Lactobacillus species and high-diversity vaginal microbiota are associated with increased risk of preterm prelabour rupture of membranes and sPTB. Interactions between the host innate and adaptive immune response and vaginal microbiota are not well understood. In this study, we investigate the vaginal microbiota and cervicovaginal fluid immunophenotype of women at high risk of sPTB. Methods: Women at high risk of preterm birth were recruited from preterm birth surveillance clinics at five UK hospitals (n=133). Cervicovaginal fluid (CVF) was collected at three points during pregnancy, 12-16, 20-24 and 30-34 weeks. Bacterial DNA was extracted from CVF and the composition assessed using MiSeq-based 16S rRNA gene sequencing surveying the V1-V2 region and cytokine, complement and immunoglobulin immunoassays were performed on the matched CVF supernatant. Results: Lactobacillus species depleted, high-diversity vaginal microbiota were associated with increased mannose binding lectin (MBL), IgM, IgG1-4, and C3b (all p<0.0001), C5 (p<0.001), IL-8 (p<0.01), IL-6 (p<0.001) and IL-1β (p<0.0001). Women with these microbial compositions who subsequently delivered preterm had significantly higher concentrations of MBL, IgM, C3b, C5 and IL-8, IL-6 and IL-1β compared to those who Thursday Orals delivered at term. Cervical shortening was associated with increased relative abundance of Lactobacillus iners (p<0.05) and elevated IgM (p<0.01), IgG2 (p<0.05), C3b (p<0.01), C5a, IL-6 and IL-1β (all p<0.05). Vaginal progesterone had no effect on the local immune milieu. In contrast, insertion of a braided cervical cerclage resulted in an augmented immune response and increased risk of sPTB compared to monofilament cervical cerclage (57% vs 20%, p=0.02). Conclusion: We propose that a dysregulated innate and adaptive immune response, bridged by the complement system, can play a role in the mechanism of microbial driven PTB, and provide support for exploring live biotherapeutics and complement therapeutics for preventing sPTB. Introduction: Complement activation is increased in patients with severe coronavirus disease 2019 . Eculizumab, an inhibitor of complement protein C5, may aid in the treatment of severe COVID-19, but published reports are limited to non-pregnant adults. We sought to determine if eculizumab is safe and effective for treatment of pregnant or postpartum women with severe COVID-19. Methods: Open label, multicenter, Expanded Access Program (EAP), evaluating eculizumab for treatment of severe COVID-19, beginning August 2020 at Cedars-Sinai Medical Center. Hospitalized patients, including pregnant and postpartum women, were eligible if they had severe COVID-19 with bilateral pulmonary infiltrates and supplemental oxygen requirement. Those with mild to moderate disease were excluded. Eculizumab was given on day 1 (1200mg IV) with additional doses if still hospitalized (Day 4, 8, 15, 22; Day 12, 18 optional) . The primary outcome was survival at Day 15. Secondary outcomes were number of days alive and free of mechanical ventilation at Day 15 and 29, improvement of oxygenation, and duration of ICU and hospital stay. We assessed safety and adverse maternal and neonatal outcomes, and pharmacokinetic, pharmacodynamic and complement biomarker studies. Results: The trial is ongoing at time of submission. We present data from eight pregnant or postpartum women enrolled from August 2020 to February 2021; six enrolled during pregnancy (mean 30±4.0 weeks gestation; range 25-35 weeks) and two enrolled postpartum. Baseline oxygen requirement ranged from 2L/min nasal cannula to 12L by nonrebreather mask. The median number of doses of eculizumab was 2 (range 1-3), and median time to discharge was 5.5 days (range 3-12). All participants met the primary outcome of survival at Day 15, and all were alive and free of mechanical ventilation at Day 15 and 29. None required ICU admission, and all were free of supplemental oxygen by Day 29. Free C5 levels were <0.5 μg/ml after eculizumab treatment (free C5: 296±84 vs. 0.04±0.01 µg/ml), consistent with complete terminal complement inhibition. Soluble C5b-9 levels also decreased after treatment (sC5b-9: 1254±441 vs. 400±179 ng/ml). None of the pregnant participants required preterm delivery due to COVID-19. One delivered at 36w3d for placenta previa; the rest had term deliveries. There were no serious maternal or neonatal adverse events at 3 months of follow up. Conclusion: In this series of pregnant and postpartum women with severe COVID-19, treatment with eculizumab was safe and effective. A larger, controlled study in pregnant women is indicated. Introduction: In utero, Zika virus (ZIKV) exposure is associated with fetal brain and visual system defects, along with fetal demise and pregnancy loss. Human placental studies show evidence of ZIKV infection; however, little is known about the time course of vertical transmission or maternalfetal interface (MFI) responses during acute stages of infection. We used pregnant rhesus macaques to determine the trajectory and cellular pathways of vertical ZIKV transmission, hypothesizing that earlier maternal inoculation would increase fetal infection risk. Methods: To evaluate the timing of vertical transmission, we challenged pregnant rhesus macaques with ZIKV and terminated the pregnancy 7, 14, or 30 days post-infection (dpi). MFI and fetal tissues were examined for histopathology, and tissue viral load was measured by qRT-PCR. To test the effect of gestational timing, we infected pregnant macaques at two different times during early pregnancy. Macaques were infected with a Puerto Rican isolate ZIKV-PRVABC59 (ZIKV-PR), or a Senegal isolate ZIKV-DAK AR 41524 (ZIKV-Dak) to compare the vertical transmission of Asian or African lineage viruses. A total of 19 pregnant macaques were inoculated with ZIKV and compared to 10 control pregnancies. Results: We challenged 11 pregnant macaques with ZIKV-PR at gestational day (gd) 45; with pregnancy terminated at 7 dpi (n=2), 14 dpi (n=4) and 30 dpi (n=5). At 7 dpi, 1/2 had virus only in the MFI, at 14 dpi 2/4 had virus detected in the MFI and 1/4 had virus detected in cord blood, and at 30 dpi 3/5 had virus detected in the MFI and 1/5 pregnancies had virus detected in the fetus. We challenged 4 additional pregnant macaques at gd 30 with ZIKV-PR with termination at 14 dpi; 1/4 resulted in fetal demise with no virus in the fetus. 1/4 had virus detected in cord blood and amniotic fluid, and 4/4 had virus detected in the MFI. We then sought to compare the results of ZIKV-PR to ZIKV-Dak. Four pregnant macaques were challenged with ZIKV-Dak at gd 45 and terminated 14 dpi, and virus was detected in 1/4 of the fetuses and 4/4 in MFI tissue. Conclusion: Although vertical ZIKV transmission is well-documented, the window for vertical transmission timeline and mechanism of fetal infection are unknown. Our results suggest a permissive window for ZIKV vertical transmission 1-2 weeks after maternal infection. The fetal demise that occurred, ZIKV-PR at gd 30, suggests that infection during very early pregnancy may be more susceptible to adverse pregnancy outcomes. Additionally, our results suggest that ZIKV-Dak, an African lineage virus, compared to ZIKV-PR, an Asian lineage virus, may lead to more productive infection in the MFI. Future studies will continue to evaluate the effects of genetically diverse viral isolates and gestational timing of infection on ZIKV vertical transmission. Introduction: Cytomegalovirus (CMV) is a ubiquitous bloodborne virus that can cross the placenta and cause devastating effects in pregnancy, such as miscarriage or permanent neurological/neurocognitive effects on the human fetus. Our group recently developed a novel mouse model of congenital CMV infection, allowing for an enriched understanding of the underlying pathophysiology of this disease. Whether this mouse model recapitulates neurodevelopmental behavioral features of human CMV infection remains unknown. Such knowledge would add to the validity of this model and would serve as a springboard for further work into the underlying neural disruptions that results from in utero infection with CMV. Methods: Timed-pregnant, CD1 mice were inoculated with 5 x 10^5 m murine (m)CMV or vehicle (mock) by intrauterine (IU) inoculation at embryonic day (E)10 (n=5 dams/group). We tested newborn pups on postnatal day (PND) 5 and 9 on three assays that require integration of multiple sensory systems and gross motor coordination: cliff aversion, negative geotaxis, and surface righting. Standard statistics were employed. Results: Plaque assays of placenta and fetal brain at 120 hours postinoculation confirmed vertical transmission of the virus. mCMV-infected dams gave birth to significantly fewer viable pups (86.0% vs. 69.1%, p<0.001). At PND5, mCMV-infected pups performed significantly poorer than controls on cliff aversion and negative geotaxis tasks, with no difference on surface righting (p<0.01, p<0.05, p>0.05, respectively). We found no differences between groups on any of the tasks on PND9. Conclusion: These findings suggest that our model recapitulates elements of congenital CMV infection by demonstrating the impairment in early postnatal neurologic function. Our data raise interesting questions regarding the underlying neurodevelopmental programs and network connectivity that may be disturbed by CMV-induced neural injury/ inflammation, and compensatory mechanisms that the plastic, neonatal brain is able to enact to counteract such perturbations.. Adopting 3D Introduction: Endometrial stromal cells (ESCs) are hormone responsive, fibroblast-like cells which undergo decidualization upon exposure to progesterone. The mechanisms driving decidualization remain poorly characterized despite the importance of the process in both healthy and diseased endometrial states. Traditionally, ESCs are cultured and expanded on polystyrene, which gives cells non-physiological cues and leads to loss of hormone responsiveness with increasing passages. We hypothesized that adopting 3D synthetic hydrogels to ESC culture would provide an environment more representative of tissue, allowing for an enhanced hormone response over a greater number of passages. Methods: Primary samples of healthy endometrial stromal cells were isolated from tissue biopsies collected from patients at Newton Wellesley Hospital under informed consent (n=3). 3D cultures involved encapsulating cells in 3uL, fully defined hydrogel droplets, while 2.5D samples were plated on top of flat layers of gel (30,000 cells / sample for all groups). Within each group, cells were treated with either estrogen (E2) or E2 with Medroxyprogesterone acetate (MPA). Cultures were maintained for 15 days, and prolactin (PRL) secretion (ELISA) was measured as a marker of decidualization and analyzed using a t-test. Cells were phenotypically characterized by immunostaining and confocal microscopy to assess morphological state and relevant protein expression. Results: Compared to 2D cultures, ESC cultured in 3D hydrogels had an enhanced progestin-induced decidualization response (8.3 vs 65.7-fold change from E to EP, respectively; p < 0.05). ESCs remained significantly hormone responsive in 3D cultures through at least passage 7 while 2D cultures were largely unresponsive by passage 5. Adjusting gel stiffness led to changes in ESC remodeling but not PRL secretion, emphasizing how different environmental contexts can induce difference ESC morphologies while suggesting that the decidualization response is not tied to a single visual morphology in 3D. Culturing ESCs in 2.5D did not induce the enhanced PRL secretion seen in 3D (p < 0.05). This suggests that the dimensionality of 3D cultures more so than the softness allows for an enhanced decidualization response. The enhanced response in 3D was seen in both traditional and fully defined media formulations. Conclusion: Culturing ESCs in 3D hydrogels allows for a more robust progestin-induced decidualization response than traditional 2D cultures. Furthermore, this responsiveness is maintained over a greater number of passages and does not depend on a particular media context. 3D culturing methods therefore extend the application of primary ESCs and provide a means to investigate the role of the extracellular matrix in decidualization. Introduction: Classical Galactosemia (CG) arises from loss of function of galactose-1-phosphate uridylyltransferase (GALT). CG is often characterized by early primary ovarian insufficiency (POI) despite maintenance of a lifelong galactose-restricted diet. Some information is available about toxic metabolites produced in the absence of GALT, but mechanistic understanding of CG-POI is lacking. We generated mouse granulosa cells (GC) null for GalT to test how CG specifically impacts GCs. We compared GalTKO:GC versus parent OV3121 cell growth, and their expression of regulators of primordial follicle growth activation (PFGA) Tumor necrosis factor alpha receptor 2 (Tnfr2), and Antimüllerian hormone receptor 2 (Amhr2). Last, we assessed cisplatin (CIS) sensitivity to test if loss of GalT renders cells defective in their response to genotoxic insult. Methods: CRISPR:Cas9 was used to generate GalTKO:GC cells. Comparison of cell growth was performed by direct cell counts and also CellTag fluorescence. qRT-PCR was performed on replicates of parent or GalTKO:GC cells treated as follows. Cells were cultured in DMEM:F12 media (5% FBS + Pen/Strep), treated with vehicle(s) PBS or EtOH, or, with 10 ng/ml Tnfα, 10 ng/ml Amh, combined Tnfα + Amh, or, 20 uM CIS. Statistical tests used were Welch's two sample t-test or ANOVA with Bonferroni post-hoc test. P-values <0.05 were considered statistically significant. Results: GalTKO:GC cells grow significantly slower than parents, doubling every 27.6 hours versus 21.2 hours, respectively. qRT-PCR revealed altered Amhr2 and Tnfr2 expression. GalTKO:GC express significantly lower levels of Amhr2 (47% of control) and Tnfr2 (77% of control) transcripts. Treatment with Amh, Tnfα, or both agents resulted in a distinct response in GalTKO:GC where both Amhr2 and Tnfr2 were upregulated approximately two-fold versus vehicle controls. Parent cells treated identically did not upregulate Amhr2 or Tnfr2. No difference was detected in the fraction of cells killed by CIS after 24 hours. Despite this, CIS treatment resulted in a 50% decrease in Amhr2 expression in surviving parent cells, but no such decrease occurred in GalTKO:GC. Conclusion: GaltKO:GC cells appear to be a robust tool suitable to probe the consequences of the loss of GALT function in CG-POI. Combined with prior published work, these preliminary studies suggest that key positive (Tnfr2:Tnfα) and negative (Amhr2:Amh) regulators of PFGA are aberrantly regulated in the absence of GalT. In addition, the lack of enhanced sensitivity to CIS-induced death does not favor compromised response to genotoxic insult as contributing to follicle loss in CG. Introduction: Despite its high prevalence, the pathogenesis of human placental dysfunction (PD) and its related clinical complications remains unknown. We used a high throughput multiomics approach to better define the molecular phenotypes of conditions related to PD, including preeclampsia (PE), fetal growth restriction (FGR), and spontaneous preterm delivery (sPTD). Methods: Using our comprehensive Magee Obstetrical Maternal Infant (MOMI) Database and Biobank, we identified women with the following conditions: severe PE (n=75), FGR (birthweight<3rd centile; n=37), FGR with a hypertensive disorder (FGR+HDP; n=29), sPTD (n=72), and two control groups: 1) uncomplicated, term pregnancy with birthweight >10th centile (n=113) 2) Induced PTD or elective cesarean section without PE, FGR or preterm labor (n=16). Placental biopsies, snap-frozen in liquid Thursday Orals nitrogen, were used for targeted proteomics (453 proteins), untargeted metabolomics, and transcriptomics (processing underway). We deployed unsupervised dimensionality reduction algorithm, partial least squaresdiscriminant analysis (PLS-DA), and hierarchical clustering to evaluate differences between cohorts. We executed differential analysis among the cohorts to identify misregulated proteins and metabolites. Finally, we performed n-of-1 analysis in which outlier analytes (not in the normal baseline [1, 99] ) represent biomolecular signatures indicative of the disease state. Results: While there were no clear clusters between cohorts and the controls using the unsupervised algorithms, applying PLS-DA supervised learning to the metabolomics data displayed clear separation of the cohorts from the controls. This was driven by a higher expression of lipid and vitamin metabolism pathways in the FGR/FGR+HDP groups. We also identified analytes that were differentially expressed between each disease group and the controls. We validated our approach using known differentially expressed analytes, such as sFLT-1 and PlGF. Finally, individual women had a significantly higher number of outlier protein values across the pathological cohorts, compared to the control. Transcriptomics analysis as well as hierarchical clustering to reveal placental disorder subgroups is currently underway. Conclusion: Multiomics analyses of the placental tissue provide new insights into the biological pathways underlying PD and identify potential biomarkers and biosignatures indicative of a disease state. Future integration of this multiomics approach with clinical and histopathological data may improve our ability to define and treat clinical syndromes that emanate from PD. Determining the Impact of Environmental Toxin Cadmium at the Feto-Maternal Interface Using an Organ-on-Chip (FMi-OOC) Device. Sungjin Kim †, 1 Lauren Richardson †, 2 Enkhtuya Radnaa †, 2 Zunwei Chen †, 1 Ivan Rusyn, 1 Ramkumar Menon * , 2 Arum Han * . 1 1 TAMU, College Station, TX, United States; 2 UTMB, Galveston, TX, United States. Introduction: At term, labor is associated with multiple fetal-and maternal-derived signals that coordinate to initiate delivery of the fetus. Exposure to toxic environmental chemicals may prematurely trigger labor-associated inflammation at the feto-maternal interface (FMi: decidual-fetal membrane interface), leading to preterm birth (PTB). However, cell-specific response leading to FMi cell inflammation that contributes to PTB onset remains unclear. Using a recently developed and characterized microfluidic organ-on-a-chip system for FMi (FMi-OOC) that mimics the physiological functions and responses of in vivo FMi, this study tested the effect of maternal exposure to cadmium (Cd), a well-reported environmental toxin associated with PTB. Methods: The FMi-OOC contains four concentric circular chambers designed to culture immortalized and well-characterized fetal membrane cells (decidua, chorion trophoblasts, and amnion [mesenchyme and epithelium]) and collagen matrix. Decidual cells were treated with CdCl 2 (1 and 10 μM) mimicking maternal exposure, and its effects across the FMi towards the fetal cell compartments. Effects on cell cycle (flow cytometry), cell death (apoptosis/necrosis staining), and inflammation (Luminex assay) were analyzed; along with concentrations of CdCl2 across FMi. Results: Within the FMi-OOC, CdCl 2 propagated to the chorion within 48h. CdCl 2 induced cell death (p=0.02) and a pro-inflammatory environment in the decidua (low IL-10 and high TNF-α secretion) (p=0.02), but had minimal effect on the fetal chorion cells with no effect on the amnion. The effect was dose dependent. Conclusion: FMi-OOC maintained intercellular interactions as seen in vivo and allowed us to determine the response from a specific compartment. CdCl 2 produced a maternal, but not fetal, response within the FMi-OOC. This observation is in line with in vivo patient data which has shown that Cd-mediated adverse effects are mediated by maternal pathophysiological response rather than fetal-derived triggers of preterm labor. We postulate that intact chorion layer functions as a barrier for various substances and its compromise is essential for propagation of toxic substances. Introduction: Ovarian cancer is the deadliest gynecologic malignancy. Approximately 50% of high grade serous ovarian cancers are homologousrecombination (HR) proficient and relatively resistant to poly (ADPribose) polymerase inhibitors (PARPi). We have shown that combining the histone deacetylase inhibitor entinostat with the PARPi olaparib has preclinical efficacy in human xenograft immunocompromised models of ovarian cancer. Here, we determine the effects of entinostat plus olaparib in an immunocompetent syngeneic mouse model. Methods: We treated HR proficient ID8 mouse ovarian cancer cells with entinostat, olaparib, or both. We performed cell viability, clonogenicity, and DNA damage assays. Cell viability was replicated in genetically defined ID8-P53 -/-(HR proficient) and ID8-P53 -/-BRCA2 -/-(HR deficient) cells. We injected ID8 cells intraperitoneally into syngeneic mice, which were treated with entinostat, olaparib, or both for 21 days. We performed immunohistochemistry staining for markers of: proliferation (Ki67), antitumorigenic M2 macrophages (mannose receptor), pro-tumorigenic M1 macrophages (CCL3), and an immune checkpoint (PD-L1). Results: Compared to olaparib, entinostat plus olaparib significantly decreased ID8 cell viability (P<0.0009), had no effect on clonogenicity (P<0.2), and significantly increased DNA damage (P<0.0001). Entinostat plus olaparib was no more effective than olaparib alone in inhibiting viability in ID8-P53 -/-(P<0.67) or ID8-P53 -/-BRCA2 -/-(P<0.06) cells. Compared to olaparib, ID8 tumors from mice treated with entinostat plus olaparib showed significantly decreased Ki67 (P<0.0006), and mannose receptor (P<0.0001), whereas increased CCL3 (P<0.0001) and PD-L1 (P<0.0001). Conclusion: Entinostat plus olaparib reduced HR proficient ID8 mouse ovarian cancer cell growth in vitro and in vivo. ID8 tumors from mice treated with the combination showed more anti-tumorigenic M1-like macrophages and fewer pro-tumorigenic M2-like macrophages, along with increased PD-L1 expression. This suggests that entinostat plus olaparib in HR proficient ovarian cancer not only has direct effects on tumor cells but also modulates the tumor immune microenvironment. Future studies will investigate the possibility that entinostat sensitizes tumors to a PD-L1 inhibitor. Introduction: For reproductive age women diagnosed with pre-invasive or invasive gynecologic malignancies (GM), access to reproductive endocrinologists and infertility (REI) specialists is key to understanding fertility preserving options prior to gonadotoxic cancer treatment. We examined patient factors associated with successful completion of fertility consultation after referral to REI in this population. Methods: We performed a retrospective cohort study of women ages 18-45 seen and referred for newly diagnosed cervical cancer (CC), endometrial intraepithelial neoplasia (EIN) or endometrial cancer (EC), and borderline ovarian tumor (BOT) or ovarian cancer (OC) at a single academic center between 2015-2019. ANOVA and Kruskal-Wallis test were performed to compare differences between disease type. We then examined patient factors associated with our primary outcome, completed REI consultation, using univariate log binomial regression. Due to small sample size, Firth's logistic regression was used to analyze factors with p-value <0.1 in a multivariable model. Results: Of 92 total patients with documented fertility referral, 65 patients (71%) completed REI consultation. Of those referred, 87% of women with CC (n=13) consulted REI, compared to 74% with BOT/OC (n=29) and 61% with EIN/EC (n=23). Age, BMI, race, income, relationship status, having ≥1 child, and known metastasis were not significantly associated with REI consultation after referral. Groups by disease type did not differ significantly by age or parity. In the multivariable model, women with government-sponsored insurance were 73% less likely to complete REI consultation compared to those with private insurance ( The ability to identify women at high risk of preterm birth (PTB) remains limited. One risk factor for PTB is shift work (1), suggesting that altered circadian rhythms may play an important role. Two convenient circadian markers are the hormones melatonin and cortisol, which peak at night and in the morning, respectively. Here, we asked whether alterations in melatonin and cortisol rhythms are associated with length of gestation and risk of preterm birth. Methods: Pregnant volunteers wore wrist actigraphy devices (MotionWatch8, CamNtech, Cambridge, UK), completed sleep surveys (Munich Chronotype Questionnaire), and provided saliva every four hours for a 24-hour period each trimester. Melatonin and cortisol were measured by ELISA (Salimetrics, USA). Cosinor analysis was used to define hormone profiles as having strong rhythms (sinusoidal with high peak-to-trough amplitude) or low amplitude (not sinusoidal). We analyzed the time of peak hormone concentration and daily mean, maximum, and minimum concentrations. We compared length of gestation and the risk of PTB between patients with strong and low amplitude cortisol and melatonin rhythms. Introduction: Neurosteroids such as allopregnanolone (ALLO) play important roles in stress pathophysiology. Low stress-responsive ALLO is associated with perinatal depression, but preterm birth is also associated with maternal stress. Animal models show associations between low ALLO and reduced gestational length, and neurosteroids may directly inhibit uterine contractility via myometrial γ-aminobutyric acid receptor activation. We hypothesized that women who deliver preterm have lower maternal ALLO compared with women who deliver at full term. We evaluated maternal serum ALLO and other steroid hormones at two points in gestation and investigated a preterm birth prediction model using clinical and maternal demographic factors. We performed a nested case-control study using banked serum samples. We included healthy women with singleton pregnancy and excluded mothers with major medical illness, preeclampsia, or chronic hypertension. We matched preterm cases with term controls (1:1) by gestational age (GA) at first blood sample and the least difference in time between samples (N=27 per group). We used a novel, validated high-performance liquid chromatography tandem mass spectrometry assay for ALLO and five other steroids. We used ANOVA, T-test, linear regression and AUROC for statistical analyses and predictive modelling. Results: We found no significant difference in maternal preterm or term ALLO at the examined timepoints (sample 1 at 16.9 weeks mean GA: 4.46±1.71 ng/mL vs 4.38±1.70 ng/mL, p=0.87; sample 2 at 26.5 weeks mean GA: 7.44±3.01 vs 7.84±3.77, p=0.67). However, we found that preterm cases had higher cortisol levels for sample 1 (325 ± 120 ng/mL vs. 253 ± 107 ng/mL, p=.024) and lower percent change between samples (53 ± 63% vs. 103 ± 96%, p=.029). We created a model for preterm birth with cortisol and demographics (AUROC 0.64). We improved the model slightly by adding ALLO and five other clinical and demographic characteristics (AUROC = 0.69). We found no significant difference in ALLO levels during gestation between pregnancies ending with pre-or full-term delivery. Further evaluation in larger cohorts with additional gestational timepoints may be informative. Cortisol showed some utility as an early pregnancy biomarker for preterm birth prediction. Our models suggest future studies using maternal clinical and demographic factors and steroid hormone serum concentrations for preterm birth risk assessment. Adverse Introduction: Preterm birth (PTB) is one of the main causes of neonatal mortality and morbidity. Current studies showed that neonate morbidity in PTB is linked to increased levels of IL-6 in amniotic fluid, fetal blood and gestational tissues (GT) and that IL-6 increases uterine activation proteins (UAP) leading to PTB. A small peptide, labelled HSJ633, developed by our lab inhibits selectively IL-6-induced STAT3 phosphorylation and LPS-induced PTB in mice. We hypothesize that IL-6 can induce damages to fetal tissues, and that inhibiting IL-6 receptor using our nanopeptide HSJ633 will improve birth outcome and maintain the integrity of the fetal tissue. Methods: An established LPS-induced PTB model on timed pregnant mice was used to evaluate the degree of inflammation in GT, maternal plasma and amniotic fluid as well as fetal lungs and intestines. Pregnant mice were injected with LPS (10μg/kg i.p.) at gestational day 16 in presence or absence of HSJ633 (1mg/kg/12h), Tocilizumab (TOC; 10mg/ kg/12h), or vehicle. All experiments were compared with TOC, an anti-IL6R antibody commercially available. Results: Concomitant treatment with HSJ633, and to a lesser extent TOC, reduced the gene expression of pro-inflammatory cytokines and UAP (IL-1β, IL-6, TNFα, CCL2, Casp1, OXTR, IL-12 and PGES) and expression of pro-inflammatory proteins (IL-1β, IL-6 and TNFα) in GT, maternal plasma and amniotic fluid. Furthermore, HSJ633 reduced abnormal morphologies in the offspring induced by inflammation (number and level of atrophy of the intestinal villi as well as the number and size of the pulmonary alveoli). Immuno-histological analysis of HSJ633-FITC revealed presence in the placenta but not in the fetus. Conclusion: Collectively, our data show that HSJ633 antagonized the activity of IL-6R in a LPS-induced PTB model, and improved birth outcome by increasing survival and preserving fetal organ integrity. These findings highlight the importance of IL-6 and uncover in vivo pharmacological efficacy of a novel IL-6R modulator. HSJ633 is a promising new therapeutic prototype in prevention of PTB. Progesterone In mammals before term, the cervix ripens with loss of response to progesterone (P4) as characterized by degradation of cross-linked extracellular collagen, reduced density of cell nuclei in the stroma, and increased density of resident macrophages (Mφs). In vitro, Mφ morphology distinguishes anti-inflammatory (elongated M2, eM) from inflammatory (round M1, rM) phenotypes. Thus, the objective of this in vivo study was to determine whether premature cervix ripening before preterm birth (PTB) reflects a shift to an inflammatory-like Mφ morphology. Methods: Pregnant CD1 mice were given the P4 receptor (PR) antagonist RU486 or were ovariectomized (Ovx) on pregnancy day 16 to induce PTB within 24h. Other Ovx mice were given the PR agonist R5020 to block PTB. Cervix sections were obtained from prepartum mice 6h after treatment (day 16.5). Cervix sections from vehicle-treated and shamoperated (days 15, 16.5 and 18) served as controls. The density and shape of F4/80-stained Mφs were evaluated in the cervix stroma. Results: In the cervix stroma from controls, total Mφs, as well as the major rM and eM subtypes increased by the day before birth (day 18 vs 15 or 16.5). A novel, though minor polymorphic subset (pM) also increased by day 18 vs 16.5 of pregnancy. Within 6h of RU486 treatment, the density of all Mφ subtypes increased vs controls, ~15h before PTB (day 17), a >2 day advance before term birth. Moreover within 6h of Ovx and before PTB, resident rM increased, but neither eM nor pM density changed. Importantly, PR agonist treatment of Ovx mice not only prevented PTB, but blocked the rise in rM and increased the presence of eM without an affect on pM density. Thus, the density of the rM phenotype was temporally related to loss of P4 efficacy (PR antagonist or Ovx-reduced systemic concentrations) that advanced cervix ripening and induced PTB. By contrast, the purported anti-inflammatory eM phenotype correlated with PR agonist-forestalled cervix remodeling and blocked PTB in R5020-treated Ovx mice. Conclusion: Findings support the hypothesis that the balance of Mφ phenotypes tips towards a pro-inflammatory subtype which may promote cervix stroma remodeling in these models for PTB. Efficacy of a PR agonist to block preterm parturition following loss of systemic P4 appears to promote an anti-over pro-inflammatory Mφ phenotype. These models for the mechanism of parturition before labor advance the possibility that biomarkers for Mφ polarization in the prepartum cervix may forecast PTB risk. In conjunction with previous findings that inflammatory changes related to reduced CN density and a decline in cross-linked collagen in the cervix stroma of mice days before birth, the results may lead to innovative local immunotherapeutic approaches that block or promote inflammatory-mediated ripening before or at term. The Introduction: Excessive retinal inflammation is a hallmark in the progression of the retinopathy of prematurity (ROP), and is strongly associated to retinal vasoobliteration. Dysregulation of microRNAs (miRs), key negative regulators of genes expression, has been implicated in the ocular inflammation. However, the role of miRs in inflammatory process during ROP pathogenesis, and especially on activated-microglial cells, remains to explore. This study aimed to investigate the potential anti-inflammatory role of miR-125 in a rat model of Oxygen-Induced Retinopathy (OIR). Methods: qRT-PCR and western blot were performed respectively to evaluate the expression of miR-125 and inflammatory cytokines in retinal tissues of OIR rats compared to normoxic healthy rats and also in activated microglial cells (SIM-A9) subjected or not to hyperoxia and LPS. In vitro: miR-125 function on inflammation on SIM-A9 by LPS or hyperoxia was performed using a miR-125 mimic. The angiogenic properties of Human Retinal Microvascular Endothelial Cells (HRMEC) treated with the culture medium of SIM-A9 pre-subjected to hyperoxia and transfected or not with miR-125 mimic, were analyzed by a matrigel assay. In vivo: OIR rat pups were intravitreally supplemented with miR-125 mimic (10 nmol/kg) or a control-miR at P5 during the vasoobliteration phase of the cycling OIR model (50/10% O2 from P1 to P14). Retinal tissues were collected at P10 to analyze the inflammatory markers and the vascular density by retinal lectin-immunostaining. Results: We found that miR-125 expression is significantly reduced in the retina and choroid of OIR rats compared to control rats, and in SIM-A9, correlated with an upregulation of key proinflammatory cytokines including TNF-a, IL-6 and IL-16. Interestingly, we found a significant decrease of TNF-a, IL-6 and IL-16 expression in SIM-A9 transfected with miR-125. HRMECs exposed with the culture medium of SIM-A9 pre-subjected to hyperoxia showed a decrease in their angiogenic capacity, which is recovered by the overexpression of miR-125. In vivo, OIR rat pups intravitreally supplemented with miR-125 mimic displayed a significantly decrease of TNF-a, IL-6 and IL-16 in the retina, associated with lower vasoobliteration area compared to the control at P10. This study suggests that miR-125 acts as an inflammatory suppressor of activated-microglial cells protecting microvascular density during OIR. miR-125-based therapy could potentially constitute a novel anti-inflammatory therapeutic strategy to limit vascular degeneration in ischemic retinopathy and notably, during ROP. Mid-Trimester Changes in Cervicovaginal Metabolites Are Distinct in Women with and without Preterm Birth. Megan Cavanagh †, Emmanuel Amabebe †, Neha Kulkarni †, Dilly Anumba * . University of Sheffield, Sheffield, United Kingdom. Introduction: The interaction between host cells and microbes in the vagina leave metabolic fingerprints that may be associated with infection and spontaneous preterm birth (sPTB, <37 weeks' gestation). In order to unravel the pathomechanism of sPTB and improve risk stratification and prediction, we investigated metabolite changes in cervicovaginal fluid (CVF) across mid-trimester in asymptomatic high risk pregnant women that deliver preterm compared to term metabolite profiles. Methods: Cervicovaginal fluid was obtained from asymptomatic high risk women at gestational time point (GTP)1 (20-22 weeks , n=50) and GTP2 (26-28 weeks, n=46). Metabolomic analysis was performed using Waters Acquity UPLC coupled to a Waters Synapt G2-Si Time of Flight mass spectrometer with electrospray sample introduction. Samples were introduced directly into the mass spectrometer using the UPLC only as an automated injector without the use of chromatography. Extraction was performed and the aqueous fraction was analysed in both positive and negative modes. Differences in normalised metabolite % total ion count between term and preterm women were determined by OPLS-DA and Students' t-test. Results: There were no significant differences in metabolites between term and preterm women at either GTPs. However, the changes in metabolites from GTP1 to GTP2 expressed as GTP2/GTP1 ratio differed between the groups. Carbohydrate derivatives (p=0.007), aminosugars and nucleotides (p=0.008), lipids, flavonoids and amines (p=0.004), fatty acids (p=0.01), steroids and vitamins (p=0.01) were altered between GTPs in different directions in preterm vs term women. We have observed distinct metabolic changes between women with and without preterm birth from mid to late second trimester. These findings could provide predictive biomarkers for spontaneous preterm birth before symptoms of labour appear and could reveal new preterm birth associated pathways. University of Chicago, Chicago, IL, United States. Introduction: PGF2α is thought to participate in labor by inducing uterine smooth muscle contraction. Inflammation has been implicated in the onset of labor both at term and preterm. We investigated the role of PGF2α in generating inflammation in 3 pregnancy-relevant tissues cultured ex vivo: a) RAW-Blue TM cells (modified from the immortalized mouse macrophage cell line RAW 264.7 to express a colorimetric reporter under the control of NF-κB and AP1); b) peritoneal macrophages (PMs) freshly extracted from non-pregnant mice; and c) pregnant mouse uterine explants. Methods: RAW-Blue TM cells were cultured (10 5 cells/well) with or without PGF2α (1-125 µM) or LPS (0.2 ng/ml, a positive control) in duplicate for 5h. Resident PMs obtained by lavage from virgin CD1 mice (8-16 weeks old) were cultured in triplicate with or without PGF2α (5 µM, 5h). Day 14.5 pregnant uterine explants were stimulated with or without PGF2α (5 µM) or LPS (10 ng/mL) in duplicate for 4h. To test whether estradiol (E2) influences expression of contraction-associated proteins (CAPs), uterine explants were treated with E2 at 0 pM, 10 pM (equivalent to non-pregnant serum levels), 100 pM (physiologic pregnancy levels near term), or 1000 pM (supraphysiologic) for 8 or 24h in triplicate. The expression of interleukin (Il)-1β, Il-6, tumor necrosis factor (Tnf), oxytocin receptor (Oxtr), and prostaglandin F receptor (Ptgfr) were analyzed by qPCR. Western blot was performed for PTGFR, OXTR, connexin 43 (Cx43), and pERK1/2. Statistical differences were assessed by ANOVA or Kruskal-Wallis and post hoc t-test or Dunn's test for parametric and non-parametric data, respectively. Results: As expected, LPS induced markers of inflammation in each cell type: NF-κB/AP1 (RAW-Blue TM ), Il-6 (PMs), Il-1β, and Tnfα (explants). In contrast, PGF2α did not activate NF-κB/AP1 in RAW-Blue TM or Il-6 in PMs. PTGFR protein was not detected in RAW 264.7 macrophages, but was present in pregnant mouse uterus, both before and during tissue culture. Stimulation with 100 pM E2 for 24h decreased Ptgfr mRNA 2-fold compared to control, but E2 treatment did not alter PTGFR, OXTR, Cx43, or pERK1/2 protein levels compared to baseline. Despite the presence of PTGFR in uterine tissues, PGF2α did not induce Il-1β, Tnfα, or Oxtr mRNA. Conclusion: PGF2α does not generate an inflammatory response in murine macrophages and pregnant uterine explants cultured ex vivo. In macrophages, this may be explained by absence of the prostaglandin F receptor, but this does not account for results seen in uterine tissues. In contrast to other studies, E2 failed to increase CAP expression in uterine explants. The pro-labor and uterine contractile actions of PGF2α during pregnancy may not be mediated through inflammatory pathways. The objective of this is systematic review is to summarise treatments for infection/inflammation-induced PTB applied in preclinical models of PTB. Methods: Searches using medical subject headings (MeSH) and keywords were performed in PubMed, EMBASE and Web of Science, in accordance with PRISMA guidance. MeSH and keyword themes included "animal models", "preterm birth", "inflammation" and "therapeutics". Two independent researchers screened studies and extracted data. The inclusion criteria were formulated using the PICOS framework. Participants: animals with infection/inflammation-induced PTB. Intervention: prenatal interventions to prevent PTB. Comparison: an appropriate vehicle control for the intervention. Outcome: effect of the intervention on gestational length and maternal inflammation. Study type: Original quantitative, peerreviewed, and controlled studies. The presence of bias in methodological design was also determined. Results: Our searches identified 3,916 studies. Twenty-three studies met our inclusion criteria. All studies utilised mouse models and PTB was most commonly induced by lipopolysaccharide (LPS) or Escherichia coli (E. coli). However, the doses, serotypes and routes of delivery varied. No two interventions were the same. Gestational length was significantly prolonged in 19 of the 23 studies and markers of maternal inflammation were significantly reduced in 20 studies. All studies were assigned an unclear risk of bias. We identified several treatments that successfully target maternal inflammation and hold promise as therapeutic agents of PTB. However, we were unable to perform a meta-analysis due to the heterogeneous nature of the data. Importantly, this systematic review highlights the poor methodological reporting of preclinical studies. Better standardisation of animal models of PTB is urgently required to improve the reproducibility of preclinical studies, to allow for meaningful comparison of the intervention efficacy and aid clinical translation. Introduction: Immune responses are known to be dictated in part by hormonal milieu. In the mouse, circulating estrogen levels peak prior to ovulation, which occurs during estrus, while progesterone levels rise during metestrus and diestrus. We sought to characterize the inflammatory profiles of mouse resident peritoneal macrophages (RPMs) across the estrous cycle both at baseline and after a low dose inflammatory stimulus. Methods: Vaginal smears were obtained from virgin CD1 female mice (8-16 weeks) and stained with 0.1% w/v crystal violet solution to identify estrous cycle stage. Peritoneal cells were harvested by lavage with ice-cold PBS from euthanized mice in estrus, metestrus, and diestrus (n=3 each). Cells were plated 10 5 cells/well in 96-well plates in DMEM complete medium and incubated for 2h. To characterize basal cytokine expression, cells in triplicate wells were immediately lysed and frozen at -80 o C. Adherent macrophages were cultured overnight (~18h) before stimulation with LPS (0.2 ng/ml) or control for 6h. Total RNA was extracted. qPCR was performed to quantify the expression of interleukin (Il)-6, Il-1β, Il-10, nitric oxide synthase 2 (Nos2), and 18S rRNA (housekeeping gene). Statistical differences were assessed by Kruskal-Wallis followed by Dunn's post hoc test. Results: Diestrus phase was characterized by high basal levels of Il-6 (30X) over estrus, but low Nos2 (undetectable). No significant differences were found in expression of Il-1β and Il-10 between estrus, metestrus and diestrus. LPS induced Il-6, Nos2, Il-1β, and Il-10 at all stages of the estrous cycle, with no differences between stages except for LPSinduced Nos2, whose expression was lower in estrus than in metestrus and diestrus. After 24h of culture in the absence of LPS exposure, Il-6 levels in diestrus macrophages decreased to match those of estrus and metestrus. In contrast, in estrus macrophages, expression of Nos2 and Il-1β increased significantly over 24h of culture (5X and 125X over diestrus). Culture-associated changes were minimal for Il-10 at all estrous stages. Conclusion: Macrophages play roles in homeostasis, antimicrobial defense, and tissue repair. Here we show that the baseline and LPSinduced inflammatory state (Il-6, Il-β and Nos2 expression) of peritoneal macrophages is lowest in estrus. Lower inflammatory responses to LPS during estrus suggest an overall blunted inflammatory milieu at this ovarian cycle stage. Prolonged (24h) culture of peritoneal macrophages significantly alters their expression profiles for inflammatory mediators. The (Fig 1) . When comparing the different Lactobacillus species, the risk of preterm birth was lowest among women presenting with L. crispatus, but none of these associations reached statistical significance. Conclusion: Our results, in combination with future larger studies, could potentially help early diagnosis and detection of women with a higher risk of preterm birth and hopefully help reduce the risk. p305A] that epigenetic chemical probes that disrupt the binding of BET proteins to their acetylated histone recognition sites block the expression of pro-and antiinflammatory genes in decidual stromal cells. This suggests that BET-mediated epigenetic mechanisms are involved in the control of the pro-and anti-inflammatory activities of the decidua, which is critical for pregnancy maintenance and labor induction at term. Here we continued exploring the system by determining (i) the expression of BET family members in decidual stromal cells and (ii) BET protein binding and acetyl histone-3 (aH3) and -4 (aH4) levels at the promoters of the prototypical anti-inflammatory and proinflammatory genes IDO1 and IL6, respectively, in decidual stromal cells treated with lipopolysaccharide (LPS) and the BET-disrupting epigenetic probe (+)-JQ1. Methods: Stromal cells were isolated from decidua tissue at term, immunopurified and cultured in medium supplemented with estradiol and medroxyprogesterone acetate. Sub-confluent cultures were treated with 0.5 µM (+)-JQ1 for 72h. LPS (1µM) or vehicle was added for the last 24h. Total RNA was isolated and mRNA levels encoding BET family proteins were determined by real-time quantitative RT-PCR. Formaldehyde-fixed cells were processed for chromatin immunoprecipitation to determine BET protein binding and aH3 and aH4 levels at the IDO1 and IL6 promoters. Results: Messenger RNAs encoding the BET family members BRD2, -3 and -4 were detected in decidual stromal cells. BRD2 and -4 mRNA abundance were 9-fold higher than that of BRD3, indicating that BRD2 and -4 were dominant. LPS had no effect on BRD mRNA levels, but (+)-JQ1 treatment caused a 4.2-fold increase (P<0.05, N=5) of BRD2 mRNA abundance suggestive of negative autoregulation. LPS treatment formerly shown to stimulate IDO1 and IL6 expression increased histone-3 and -4 acetylation and BRD4 binding at the IDO1 and IL6 promoters, while pre-treatment with (+)-JQ1, which blocked expression, reduced acH3, acH4 and BRD4 levels at the promoters of both genes (P<0.05 n=3-4). Conclusion: BRD4, and possibly BRD2, have critical importance in the control of pro-and anti-inflammatory gene expression in decidua cells by interacting with acH3 and/or acH4 at the promoter regions. Notably, BRD binding and histone acetylation are co-regulated at the target promoters. Genome wide studies are warranted to assess the overall importance of this epigenetic mechanism in maintaining the pregnancy-protective antiinflammatory properties of the decidua and in promoting the switch to an inflammatory phenotype at labour. Introduction: Significant racial disparities persist in sPTB. Non-optimal cervicovaginal (CV) microbiota have been linked to spontaneous preterm birth (sPTB). Select CV immune responses appear to mitigate this microbiota-associated risk in a racially dependent manner. The prevalence of a non-optimal microbiota is higher in Black women, yet how the CV immune response might alter sPTB risk among Black women with the same non-optimal CV microbiota has not been studied. Methods: This was a secondary analysis of a prospective pregnancy cohort. Term births and sPTB were selected 2:1 among Black women. Term births were included if delivered between 38-40 weeks without chorioamnionitis. CV microbiota was analyzed with 16S rRNA gene sequencing and microbial communities classified into community state types (CST) from swabs at 16-20 weeks. CST I, II, III, and V are predominated by Lactobacillus, while CST IV is a non-optimal community enriched in anaerobes with a relative lack of Lactobacillus. Cytokines were measured by Luminex, and antimicrobial peptide beta-defensin (βD) was measured by ELISA. Cytokine detection was stratified into high, medium and low groups. βD was dichotomized at the median into high and low groups. A sensitivity analysis assessed differences in the proportion of detectable samples between sPTB and term. Wilcoxon rank-sum and ANOVA tests compared cytokine abundances, and multivariate logistic regression assessed associations between significant cytokines and sPTB. Results: Among the 248 Black women studied, IL-6 was increased in sPTB, while IL-2 was decreased in sPTB (p=0.014 and p<0.001, respectively). Eleven of 14 cytokines were higher in CST IV vs non-CST IV (p<0.05 for all). After stratifying by CST and birth outcome, median cytokine abundance was higher in CST IV/sPTB and CST IV/term vs non-CST IV/sPTB and non-CST IV/term birth. Median βD was lower in sPTB vs term birth (p<0.001). There were no interactions between cytokines and CST IV, or between cytokines and βD, on the outcome of sPTB. In sensitivity analyses, the proportion of detectable samples differed significantly between sPTB and term births for IL-6, GM-CSF, IL-15, IL-5, and TNF-a (p<0.05 for all). Conclusion: Detection of immune mediators in the CV space in pregnancy appears distinct from profiles outside of pregnancy. Immune response differs by optimal versus non-optimal CST. Among Black women with non-optimal CST, immune mediators may identify those at greater risk for sPTB. R01NR01478 (ME) The presence of funisitis is particularly associated with adverse neonatal outcomes such as neonatal sepsis, cerebral palsy and chronic lung disease. Local neutrophil infiltration of the chorioamnion is the hallmark of histological chorioamnionitis, and hence this study set out to determine whether maternal peripheral neutrophil counts could be predictive of chorioamnionitis and funisitis at the time of delivery and/or at the time of PPROM. Methods: A retrospective study was performed on 122 women who presented with PPROM between 2012-2019. Cerner© patient electronic records were used to collect maternal blood neutrophil counts, C-reactive protein (CRP) values and placental histology results both at the time of presentation following PPROM (maternal only) and at the time of delivery. Statistical analyses were carried out using the GraphPad Prism 8 software. Results: Of the 122 women studied; 54 women had normal histology, 8 women had histological evidence of chorioamnionitis, and 60 women had funisitis. The median gestation of PPROM was 33 +2 (31 +0 -34 +5 ), 24 +6 (23 +7 -31 +0 ) and 25 +5 (24 +1 -28 +0 ), and the median gestation of delivery was 34 +2 (32 +6 -35 +1 ), 24 +4 (24+1-31 +2 ) and 26 +5 (25 +0 -29 +2 ) in women with normal histology, chorioamnionitis and funisitis respectively. A significant increase in neutrophil counts were seen in women who had funisitis at the time of delivery (14.45 x 10 9 /L compared with 10.03 x 10 9 /L, p < 0.0001) and at the time of PPROM (11.12 x 10 9 /L compared with 8.248 x 10 9 /L, p <0.01). A significant increase was also seen in the CRP in women who had funisitis at the time of delivery (66.74 mg/L compared with 7.881 mg/L, p < 0.001), and at the time of PPROM (26.61 mg/L compared with 5.668 mg/L, p< 0.001). Using a neutrophil count of ≥ 14.45 x 10 9 /L and a CRP count of ≥ 43 mg/L at the time of PPROM, the false positive rate was 5% and the positive predictive value was 85% for both parameters to predict the presence of funisitis. Conclusion: This study highlights the potential benefits of using maternal peripheral neutrophil counts, in combination with CRP, to aid clinical decisions on the timing of delivery in women with PPROM. Macrophages are thought to play important roles in establishing, maintaining, and completing healthy pregnancies. We used mouse resident peritoneal macrophages (RPMs) to study different functions of this cell population before and during pregnancy at baseline and in response to simulated infection using bacterial lipopolysaccharide (LPS) in vitro. Methods: Peritoneal cells were isolated by lavage with ice-cold PBS from euthanized virgin female CD1 mice (8-16 weeks old) in diestrus and from pregnant mice at gestation days (GD) 4.5, 14.5, and 18.5 (n=3 each). Cells were plated 10 5 cells/well in a 96-well plate in DMEM medium and incubated for 2h to allow macrophages to adhere. Medium was changed, and adherent cells in triplicate wells were immediately harvested to characterize basal cytokine expression. Remaining RPMs were cultured overnight (~18h) before stimulation with LPS (0.2 ng/ml) or control for 6h. Total RNA was extracted. qPCR was performed for interleukin (Il)-6, Il-1β, Il-10, nitric oxide synthase 2 (Nos2), and 18S rRNA (a housekeeping gene). Data were analyzed using the ddCt method. Statistical diff erences were assessed by Kruskal-Wallis followed by Dunn's post hoc test. Results: Basal Il-6 levels in RPMs did not vary signifi cantly between diff erent gestation days, but all were signifi cantly (p < 0.05) lower in pregnancy than in diestrus. In contrast, Nos2 was undetectable in diestrus, but increased during pregnancy, reaching significance on GD18.5. Collectively, Il-1β and Il-10 expression were signifi cantly lower at GD4.5 compared to E14.5 (Il-1β and Il-10, 4-fold) and E18.5 (Il-10, 2-fold). After 24h of culture, Il-1β and Nos2 increased, while IL-6 and Il-10 expression decreased in all samples, with highest values for all four of these transcripts found in GD 18.5 macrophages. LPS markedly enhanced the expression of Il-6, Nos2, Il-1β, and Il-10 in all samples. However, LPS-induced Il-6 expression was consistently lower in pregnancy than in diestrus. Across gestation, the magnitude of Il-10 induction following LPS-exposure decreased, with a signifi cant reduction observed on GD18.5 compared to diestrus. Conclusion: In this study, we characterized infl ammatory responses of mouse peritoneal macrophages in the non-pregnant and pregnant states. Macrophages undergo a shift toward a diminished proinfl ammatory profi le during pregnancy, both in the absence and the presence of an infl ammatory stimulus. Prolonged (24h) culture alters the infl ammatory profi le of peritoneal macrophages. Introduction: Leukocytes invade the uterus at every delivery, term or preterm, to release infl ammatory mediators to accelerate labor. We developed a leukocyte migration assay (LMA) that assesses changes in leukocyte migration in response to chemoattractants from the human fetal membranes (hFM). We hypothesized that leukocytes express diff erent chemokine receptors at term and preterm. Methods: hFM were collected at preterm labor (PL; n=3) and term labor (TL; n=6) and used to prepare whole tissue extracts at 100 mg/ mL in DMEM-F12. In addition, whole blood was collected at preterm not-in-labor (PNL; n=9), PL (n=5), term not-in-labor (TNL; n=8) and TL (n=6), and leukocytes were isolated then assessed for migration in response to hFM extracts using a modifi ed Boyden Chamber. RNA from whole blood was used to assess the mRNA abundance of CXCR1-5, CCR1-8, CX3CR1, PIK3CA/B/D/G, Rac1, RhoA, CDC42, Vav1, Arp2 and Arp3 relative to Actb in leukocytes. The migration of TL leukocytes towards TL hFM extracts was assessed in the presence of SB225002 or J113863, antagonists for CXCR2 and CCR1, respectively, and PL leukocyte migration towards PL hFM extracts was assessed in the presence of JMS17-HCl, an antagonist for CX3CR1. Correlations were tested by Pearson's correlation test and statistical diff erences were determined by ANOVA (p<0.05). The migration of TL leukocytes towards TL hFM extracts was positively correlated with the expression of CXCR2, CXCR3, CXCR5, CCR1, CCR3, CCR5, CCR7, PI3KCB, PI3KCD, Rac1, Vav1, Arp2 and Arp3 (p<0.05-0.0001) and negatively correlated with CCR4 expression (p<0.05). Treatment with either SB225002 or J113863 resulted in a dose-dependent reduction in the chemotaxis of TL leukocytes towards TL extracts (p<0.05-0.001). The expression of CX3CR1 in leukocytes was signifi cantly higher at PL than at PNL (p<0.01), and JMS17-HCl inhibited migration (p<0.05). Conclusion: Fourteen chemokine receptors in TL leukocytes and one in PL were associated with leukocyte migration. This key distinction may guide both the diagnosis and treatment of preterm birth. Supported by CIHR and NSFC. Model. Ethelin Cammock †, Jennifer J Barr †, Abigail Combs †, Mauro Schenone * , Giancarlo Mari * . University of Tennessee Health Sciences Center, Memphis, TN, United States. Preterm birth is one of the leading causes of infant mortality in the United States. Maternal stress has been correlated with preterm birth in several population studies. However, the mechanism is poorly understood. Multiple studies have demonstrated that maternal stress leads to an increase in intrauterine infl ammation which has been associated with changes in placental pathology (Chen et al., 2020) . Investigation of pathological changes in the placenta may increase understanding of the link between maternal stress and preterm birth. Our objective is thus to assess the impact of 1 hour of daily antepartum restraint stress on placental stress in the murine model. Nulliparous mice (n=16) underwent timed breeding at 8-10 weeks of age. Dams were then randomly assigned to either stress or control groups. The mice assigned to stress underwent daily 1-hour periods of restraint in a ventilated clear 50-mL conical centrifuge tube from E1-E15. Mice were sacrifi ced on day E17. Uteri were immediately harvested and fi xed in 10% formalin. Histopathology was examined for 4 placentas from each specimen and graded in a semi-quantitative fashion using a scale from 0-4 for each outcome. The primary outcome was the fraction of placentas scoring greater than 2/4 on the vacuolation scale (corresponding to moderate vacuolation). The secondary outcome was the fraction of placentas scoring greater than 2/4 on the necrosis scale (corresponding to coalescing foci of necrosis). Diff erence in vacuolation and in necrosis, considered separately, were evaluated with Fisher's exact test with a signifi cant p-value of .05. Distribution of pathology scores in shown in Figure 1 . There was no statistically signifi cant diff erence between the degree of placental vacuolar degeneration (p=0.22) or necrosis (p=0.22) between controls and mice exposed to restraint stress. One hour of daily restraint stress does not produce signifi cant changes in placental vacuolar degeneration or necrosis in murine model. Further study is needed to determine if more severe stress stimuli will induce these changes in placental pathology. Phenotypic Analysis of Human Choriodecidua in Relation with Parturition. Léa Chicoisne †, Vaarany Karunanithy * , Céline Bertholle * , Brigitte Izac * , Franck Letourneur * , Daniel Vaiman * , Francisco Miralles * , Muriel Andrieu * , Céline Mehats * . Institut Cochin, Paris, France. Introduction: The timely onset of labor and birth is a critical determinant of perinatal outcome. Both preterm birth (before 37 weeks of gestation) and postterm pregnancy (after 40 weeks) are associated with an increased risk of adverse pregnancy events. A better understanding of the mechanisms involved in the onset of labor may enable to predict, even control, preterm and/or term delivery. The choriodecidua is a maternal-fetal interface constituted of the maternal decidual stromal and immune cells -mostly T cells and antigen-presenting cells (APC) in late pregnancy-directly in contact with the fetal chorionic trophoblasts of the fetal membranes. This choriodecidual interface shows the highest gene expression variability in labor among gestational tissues. To examine cell state changes, single nucleus RNA-sequencing (snRNA-seq) approach was performed as it achieves comparable gene detection to single cell RNAseq, with reduction of cell dissociation bias and stress response. Our aim is to gain knowledge in the cell populations present in the choriodecidua at term pregnancy before and after the onset of labor. Methods: Choriodecidua samples were obtained at term pregnancy from 7 non-laboring women delivered by caesarean section and from 7 women who delivered spontaneously after labor. Nuclei are isolated from frozen tissues using dounce homogenization in lysis buffer and sorted by flow cytometry using a pan-nuclear pore antibody. Further encapsulation and snRNA-seq were performed using the 10X Genomics technology. Data computational analyses were processed using 10X Cell Ranger software and Seurat v.4 pipelines. Results: Transcriptomic profiles of 62,752 nuclei were obtained. We identified the expected cell populations, ranked from the most to the less abundant: trophoblasts, stromal cells, immune cells -myeloid and lymphoid subtypes-, endothelial cells -lymphatic and vascular-and epithelial endometrial cells. We could also identify a small population of proliferative cells. For the first time, we are able to define five distinct subsets of trophoblasts in chorion. Mesenchymal cells comprise decidual stromal cells and a new population of fibroblasts, yet uncharacterized. The largest number of deregulated genes with labor was observed in these fibroblasts, followed in a less extent by lymphoid cells and then trophoblasts. As expected, an upregulation of inflammatory genes was associated with labor, and this, in all the different cell populations. Conclusion: Our preliminary results suggest a broader degree of cellular heterogeneity in trophoblasts and stromal cells than reported before. Our unbiased snRNA-seq approach holds the promise of a detailed molecular characterization of the distinct cell types and their changes with labor. The biological trigger that initiates normal parturition remains unclear, although it is thought that inflammation plays a role in fetal membrane weakening. Our lack of knowledge is in part due to the unique nature of some of these processes in humans, and the logistical and ethical issues of studying human pregnancy. We recently demonstrated that all ten of the innate immune system Toll-like Receptors (TLR) are expressed in the amnion, with TLR9 at high levels. TLR9 detects both viral and bacterial CpG rich DNA fragments, eliciting an inflammatory response. However, its endogenous ligand is unknown. Cell-free fetal DNA (cffDNA) in the mom's circulation that originates from the placenta activates TLRs. As cffDNA is also found in the amniotic fluid, we hypothesized that it would activate TLR9 in the amnion causing the secretion of pro-inflammatory cytokines. Methods: Fetal membranes were collected from repeat cesarean sections at Kapi'olani Medical Center for Women and Children with IRB approval. Amnion epithelial cells (AECs) were isolated by consecutive trypsin (0.2%) digestion. Cultured AECs were treated with 5µM of TLR9 ODNs (2006, 2395, 2216) and their respective controls (Invivogen, CA) for 6 hours. Cytokine secretion (IL-1α, IL-1β, IL-2, IL-4, IL-6, IL-8, IL-10, 1L-12, IL-14, IL-17A, IFNγ, TNFα, and GM-CSF) was measured by MultiAnalyte ELISArray (Qiagen, CA), and the data normalized to total protein. Fetal membrane explants were cut and secured to a modified transwell insert. These were treated with cffDNA on the amnion side. Conditioned media was collected from both sides of the explant. IL6 (R&D Systems, MN) secretion measured by ELISA. Data were normalized to the weight of the explant and total protein secretion into the media. Results: The three ODNs increased different cytokines. ODN 2006 increased cytokine secretion for IL-6 and GM-CSF (6.48 and 0.75 fold respectively). ODN 2216 increased IL-1α, IL-6, IL-8, and IL-10 (0.52, 1.90, 2.56, and 1.37 fold respectively). ODN 2395 increased IL-2 and IL-17A (0.58 and 0.98 fold respectively) (n=3). cffDNA caused significantly (p=0.0324) more secretion of IL-6 apically (6.27 fold, p=0.0142) compared to basally (1.86 fold, p=0.0081) (n=5). The ODN data shows that TLR9 is functional and able to increase cytokine secretion in AECs, although each tested elicited a different response. cffDNA evoked both an autocrine apical increase in IL-6 secretion, as well as a signal to the basal side of the explant. This suggests that cffDNA may be an endogenous ligand that can initiate inflammation in the fetal membranes, adding to the inflammatory load in this tissue at term. TLR9 knockdown experiments are ongoing to confirm cffDNA action through this receptor. Progesterone ( We use an in-vitro human fetal membrane (FM) explant model system to study the human FM weakening pathway, a prerequisite for FM rupture and pPROM. In this model both TNFα, modeling inflammation/infection, and thrombin, modeling decidual bleeding/ abruption (the leading associations with pPROM), cause dose dependent FM weakening and concomitant tissue changes that mimic the natural weak zone seen in fresh FM at term. The choriodecidua (CD) is the primary target for both TNFα and thrombin induced weakening in this model. Also, GM-CSF is a critical intermediate in the pathway, its induction being both necessary and sufficient for TNFα and for thrombin induced FM weakening. GM-CSF ultimately induces many MMPs and other proteases, and suppresses many TIMPs and other protease inhibitors in FM. As the fetal-maternal interface is barraged with inflammatory and bleeding challenges, FM integrity would be threatened unless an inhibitory system was also in play. We have previously shown exogenous P4 inhibits inflammation induced weakening due to TNF, thrombin and even GM-CSF in our system. We hypothesized P4 produced within FM might inhibit inflammation induced FM weakening. We found evidence that P4 is part of a previously undescribed, inducible negative feedback system at the fetalmaternal interface, which inhibits inflammation induced FM weakening. Methods: FM fragments from term uncomplicated repeat CS deliveries were mounted in Transwell inserts and cultured with control media and increasing GM-CSF (0-200 ng/ml), 10nM RU486 (to block P4 action), or 1μM trilostane +/-10 -7 M P4 (to block P4 production). P4 and rupture strength were determined. Also immortalized trophoblast cells (BeWo) were cultured with control media or increasing concentrations of GM-CSF. P4 production was determined by ELISA and 3βHSD by Western Blot. Results: GM-CSF induced P4 production in both FM explant cultures and BeWo cells in a concentration dependent manner (p < .001). GM-CSF also increased 3βHSD protein in BeWo cells in a concentration dependent manner (p<.05). Incubation of FM explants with RU486, blocking P4 action, or trilostane, blocking P4 production, each caused FM weakening. Exogenous P4 with Trilostane restored FM strength. Conclusion: In addition to its role in inflammation induced FM weakening, GM-CSF induces P4 production in FM and trophoblastic cells. Blockade of P4 action with RU486 or inhibition of P4 production with Trilostane cause FM weakening. The weakening due to inhibition of P4 production with Trilostane is reversed by exogenous P4. These data are are consistent with the existence of a tissue level negative feedback system whereby P4 is induced by GM-CSF generated as a critical part of inflammation induced FM weakening. The P4 then functions to inhibit both GM-CSF production and its downstream action with resultant preservation of FM integrity. Cigarette Introduction: Maternal tabagism is a well-known risk factor of preterm prelabor rupture of the fetal membranes (pPROM), an obstetrical complication responsible for one third of preterm births. Cigarette consumption during pregnancy is described for inducing inflammation or oxidative stress, mechanisms both implicated in fetal membranes weakening. Nevertheless, data about cell signaling cascades implied in such mechanisms are still poorly understood. Our proposed hypothesis is that the Receptor for Advanced Glycation End-products (RAGE) and its ligands are ones of the important actors of the cigarette-dependent inflammation associated with extracellular matrix degradation in fetal membranes. Methods: Human fetal membranes explants and primary amniotic epithelial cells (pAECs) were treated with Cigarette Smoke Condensate (CSC) combined or not with RAP, a competitive inhibitor of RAGE (n=5). Cell suffering was evaluated by lactate dehydrogenase release. HMGB1 (a RAGE ligand) cellular media secretion by amnion and choriodecidua explants was determined using Western-Blot. Inflammation status was evaluated by checking transcription and release of inflammatory cytokines (IL6, IL8, TNFα, IL1β) by RT-qPCR and protein quantification. Induction of NFκB pathway, a cellular effector of the RAGE activation was determined using a luciferase reporter assay. Finally, gelatinase (MMP2 and 9) activity was assessed using zymography assay. Statistical analysis were performed by non parametric tests using GraphPad PRISM software. Results: CSC induced cell suffering and HMGB1 media release only for amnion explants and those are directly associated to a RAGE-dependent inflammatory response (as attested by the use of RAP inhibitor). Thus, pAECs, derived from amnion, are also sensible to CSC treatment regarding the induction of inflammation (cytokines release, NFκB pathway activation) through RAGE engagement. In addition, CSC activated metalloproteases activity, reflecting an increase of extracellular matrix (ECM) degradation. Conclusion: For human amnion, RAGE-NFκB axis appears implicated in inflammatory response induced by CSC exposure in explants and pAECs. This inflammation associated with an increase of gelatinase activity could explain a pathological earlier fetal membranes weakening possibly implied in pPROM. Our work establishes a new molecular pathway to understand negative effects of maternal smoking on amniotic membranes integrity leading to potential advances in terms of diagnosis and prevention of pPROM. . We employed high-resolution ex vivo MRI of human cervical tissue to test the hypothesis that the CMI-derived cellularity and fiber density correlates with quantitative histology. Methods: A 15 × 20 × 3 mm section of cervix was dissected from the posterior midline of a fresh total hysterectomy specimen and imaged with a Varian 11.7T MRI, using spin-echo sequence with 20-direction diffusion encoding (max b = 3900 s/mm 2 , voxel = 0.25 × 0.25 × 1 mm). It was later fixed in 10% neutral-buffered formalin and embedded in paraffin. Sections (5 µm) were stained with H&E ( Fig. 1A) and Masson's trichrome (Fig. 1E ). Whole slide images of both were digitized at 20× magnification. A positive nuclear density map ( Fig.1B) was obtained by calculating the density of hematoxylin-stained nuclei. A positive cervical fiber density map ( Fig. 1F ) was obtained by segmenting cervical fibers on the trichrome stained slide and calculating their density. The H&E and trichrome images were registered to the MR images by initial manual alignment and nonrigid registration with their delineated contours. The registration was then applied to all histology maps. We used in-house CMI software to generate a cellularity map (Fig. 1C ) from MR images by computing the fraction of restricted isotropic diffusion (≤ 3×10 -4 mm 2 /s) in each image voxel and a fiber density map (Fig. 1G ) by computing the fraction of anisotropic diffusion (radial diffusivity 1 -5 ×10 -4 mm 2 /s), which could model the water diffusion near and between collagen and muscle fiber. In the center region (bolded box), 80 evenly spaced regions of interest (ROIs, 1.25 × 1.25 mm) were drawn in the H&E-, Trichrome-, and CMI-derived maps. Correlation plots revealed that CMI-derived cellularity correlates with positive nuclei density (R = 0.71, P < 0.001), and CMI-derived fiber density correlates with positive cervical fiber density (R = 0.64, P < 0.001) in each ROI. The CMI-derived cellularity and fiber density significantly correlate with histological quantifications. Our findings support CMI's validity of quantifying cervical microstructure properties in future human studies. Introduction: Non-optimal cervicovaginal (CV) microbiota, including Gardnerella vaginalis (GV), are associated with spontaneous preterm birth (sPTB). Lactobacillus crispatus (LC) constitutes a component of a healthy CV ecosystem and has been shown to mitigate sPTB risk associated with non-optimal microbiota. We recently determined that metabolomic output differs among Black women with non-optimal microbiota who have sPTB, noting an increase in tryptophan (Trp) metabolites. This study sought to determine associations between relative abundances of select microbial species and Trp metabolites with birth outcome. Methods: This is a nested case-control study of 40 Black women. CV microbiota was characterized by 16S rRNA gene sequencing and classified into community state types (CSTs) from swabs at 20-24 weeks. Four groups (n=10/group) were compared: 1) women in CST IV, a non-optimal community characterized by anaerobes such as GV, who delivered at term; 2) women in CST IV who had sPTB; 3) women in CST I, a healthy ecosystem dominated by LC, who delivered at term; and 4) women in CST IV who had sPTB. We dichotomized GV and LC relative abundances at the median into high and low groups. Metabolomic analyses generated relative abundances of Trp metabolites, kynurenate (KY) and tryptamine (TY). Kruskal-Wallis tests and Wilcoxon rank-sum tests were used to establish significance (p<0.05). Results: Trp metabolite detection differs by GV abundance and birth outcome as shown in Table 1 . Among women with high GV, median KY is higher in those with sPTB, while lowest levels of KY are noted among women with low GV regardless of birth outcome (p=0.035). TY is highest among women with high GV and term birth (p<0.001). Among women with sPTB, KY and TY are greater in those with high GV (p=0.015 and p=0.007, respectively). As shown in Table 2 , KY and TY are higher among women with low vs high LC (p=0.048 and p=0.007, respectively). Conclusion: Relative GV and LC abundances are associated with differential Trp metabolism and birth outcome. KY and TY have been implicated in the regulation of epithelial and mucosal barrier integrity in other biologic systems, suggesting that these microbial metabolites may play a similar role in the CV space. Incorporation of relative bacterial and microbial metabolite abundances into future studies examining hostmicrobe interactions in sPTB is warranted. R01NR01478 (ME) Colon-Caraballo †, Mala Mahendroo. UT Southwestern Medical Center, Dallas, TX, United States. Introduction: During pregnancy, the structure and mechanical function of the cervix is regulated by precise changes in processing, assembly, and composition of the extracellular matrix (ECM). Recent transcriptomic studies demonstrate a constant expression of genes encoding fibrillar collagens and ECM molecules required for collagen assembly. In contrast, expression of collagen-degrading proteases was reduced in pregnancy time points, with a few notable exceptions -MMP14 (constant expression at all time points) and fibroblast activation protein (FAP-induced expression on gestation days 15 and 18). Recent proteomics studies demonstrate a remarkably high turnover rate for fibrillar collagens in the cervix of both nonpregnant (NP) and pregnant mice. These findings suggest continuous collagen degradative pathways must be in place to ensure cervical ECM homeostasis. Therefore, we hypothesize that previously unrecognized extracellular and intracellular collagen degradative pathways are required to ensure collagen homeostasis in the cervix. Understanding ECM remodeling processes that determine a successful pregnancy is essential to understand how this process can go awry and lead to a premature birth. Methods: Studies were carried out in the mouse cervix. Immunohistochemistry (IHC) was used to evaluate the cell-specific expression of the proteases MMP14 and FAP in the non-pregnant (NP) and pregnant (d6-d18) mice cervix. MMP14 collagenolytic activity was determined by in situ-zymography (ISZ). UPARAP-Endo180 receptor protein levels were assessed by Western blot in the NP and pregnant cervix. Results: IHC revealed cell-type specific expression of MMP14 in the cervix. Strong immunostaining for MMP14 was observed in the epithelial compartment in the NP and D6 pregnant cervix with a decline in late pregnancy. However, strong immunostaining of MMP14 in the stromal compartment was observed in the D15 and D18 pregnant cervix compared to early gestational time points. ISZ experiments demonstrate MMP14dependent collagenolytic activity that can be pharmacologically inhibited with a MMP14 inhibitor. Consistent with its gene expression, FAP1 protein expression was increased in the stromal ECM in the late pregnant cervix (d15 and d18). UPARAP-Endo 180 receptor protein expression was highly expressed in the NP and pregnant (days 6-18) cervix. Our results suggest that constant collagen turnover in the cervical ECM is critical to sustain the structural and mechanical changes that occur during pregnancy under physiological conditions. Importantly, the expression and activation of MMP14, FAP, and UPARAP observed during pregnancy support the involvement of both extracellular and intracellular collagen degradative pathways to facilitate cervical ECM remodeling in preparation for parturition. Introduction: Preconditioning refers to sub-lethal insults which induce tolerance to subsequent more damaging stressors. We've previously demonstrated preconditioning promotes uterine quiescence in an antiapoptotic, anti-inflammatory manner in the pregnant mouse and is regulated at the level of the cellular unfolded protein response (UPR). Utilizing an in-vivo uterine stretch model of preconditioning in the pregnant pig-tailed macaque, we examined the levels and action of serum GRP78, a component of the uterine secretome released during preconditioning, its relationship to circulating cytokine and prostaglandin levels, uterine contractility and the timing of labor. Methods: Chronically catherized pregnant pigtail macaques at 118-125 days of gestation received either chorio-decidual and intra-amniotic saline infusion (n=7) or varying protocols of intra-amniotic balloon infusion with saline (n=5). Maternal blood was sampled frequently before and after balloon inflation. Intra-amniotic balloon inflation rates varied to produce a slow (preconditioning) or rapid (non-preconditioning) rise in biomechanical uterine stretch. Amniotic cavity pressure was measured to quantitate contraction frequency and intensity. GRP78, cytokine and prostaglandins were examined by ELIZA. In vitro siRNA and lentiviral analysis in the HTERT-HM and THP-1 cell line examined the action of GRP78. Results: Pregnant uterine stretch preconditioning generated a temporal, robust and recurring increase in circulating GRP78 levels, which was associated with suppressed cytokine and prostaglandin responses and prolonged gestation. Non-preconditioned animals, failed to generate a surge in GRP78 and consequently demonstrated increased cytokine, prostaglandin levels and preterm labor.The anti-inflammatory action of GRP78 in the context of the uterine myocyte and macrophage cell was confirmed in vitro. Conclusion: Uterine UPR preconditioning acts as a signaling mechanism whereby normal stressors experienced across gestation, act to promote uterine quiescence through the generation of a specific preconditioned secretome. Components of which may serve as non-invasive biomarkers for preterm birth. A Role for Mirabegron in the Management of Uterine Contraction. Hazik Asif †, Scott Barnett †, Buxton Iain * . University of Nevada, Reno, Reno, NV, United States. Introduction: Preterm labor (PTL) is the leading cause of infant morbidity and mortality. The β3 adrenergic receptor (β3AR) is present in the myometrium making it a potential therapeutic target in PTL. Although downstream effects of the β3AR are known in some cell types, there is still much that is unknown. We hypothesized that mirabegron, a selective β3AR agonist FDA approved for overactive bladder, can be used to mediate relaxation in contracting human myometrial tissue, and that β3AR expression in human myometrium varies in disparate states of pregnancy. We hypothesized that the β3AR is present in both smooth muscle and endothelial cell compartments of the myometrium. Methods: Myometrial tissue from term nonlaboring (TNL) patients (n=4) were dissected into strips (5 x 2 x 1-2 mm (l.w.d). The strips were secured in a horizontal tissue bath system (Danish Myo Technology) suspended in oxygenated Krebs buffer (NaCl 118 mM, KCl 4.75 mM, KH2PO4 1.2 mM, Na2HCO3 25 mM, glucose 20 mM, MgCl2 1.2 mM, CaCl2 1.8 mM, at a pH of 7.4) at 37 o C. Strips were exposed to 60 mM KCl (3min) followed by washout and oxytocin (8 nM, 30 min). Tissues were then exposed to mirabegron (1, 3, 10, 30, or 100uM drug or DMSO control for 60 min), followed by washout. Analysis was performed via LabChart (ADInstruments). Western blot was performed to determine the relative expression of the β3AR in non-pregnant (NP, n=13), TNL (n=12), term labor (n=12), preterm nonlabor (PTNL, n=6), and preterm laboring (PTL, n=6) tissue samples prepared in MAPK lysis buffer including protease and phosphatase inhibitors. β3AR expression was normalized to GAPDH. Human myometrial cells were derived by enzymatic expression and grown in primary culture. The primary cells were resuspended with CD31(+) conjugated microbeads and magnetically separated and then cultured into CD31 -(myocyte) and CD31+ (endothelial) cell populations. Cells were stained with anti-β3AR, wheat germ agglutinin (WGA), and DAPI antibodies and imaged via immunofluorescence. DAPI and WGA established cellular membranes and nuclei. Results: Mirabegron relaxed contracting human myometrium tissue strip with an EC 50 of 32.5uM, with contractions returning after washout. Western blot analysis showed that the β3AR was found to increase in all states of pregnancy when compared to the NP state (p<0.0001). There was no difference in the β3AR concentration throughout pregnancy (p>0.05). Imaging revealed that the β3AR is present in both myocyte and endothelial cells of the human myometrium. The upregulation of the β3AR during disparate states of pregnancy further support the significance of the role it may play in mediating uterine quiescence in pregnancy. The presence of the β3AR in both myocyte and endothelial cells suggest that it has specific functions in each cellular compartment that contribute to the agonist response. Mirabegron shows promise as a tocolytic strategy for PTL patients. Oxytocin is administered to ~50% of laboring patients for induction and augmentation, and to almost all patients for prevention of post-partum hemorrhage. However, response to oxytocin varies widely between patients. Inadequate oxytocin response can result in cesarean delivery, uterine atony, and post-partum hemorrhage. Thus, identifying patients at risk for poor oxytocin response, and developing strategies to enhance oxytocin response, could have clinical utility. We hypothesized that genetic variants in the oxytocin receptor (OXTR) impair trafficking of the receptor to the cell surface, thus decreasing oxytocin response. Further, we investigated whether pharmacological chaperones could mobilize OXTR to the cell membrane and enhance cellular response to oxytocin. Methods: Experiments were performed in HEK293T cells transfected with wild type (WT) and variant OXTR and in hTERT-immortalized human myometrial (hTERT-HM) cells. Missense genetic variants for study were selected from the gnomAD database based on prevalence and a functional screen. OXTR was tagged with an N-terminal HA tag to enable detection of cell surface and total OXTR by quantitative flow cytometry. Oxytocin response was measured by using fluorescence-based calcium flux assays and inositol monophosphate (IP1) accumulation assays. Results: We found that two of the four variants analyzed, V281M and E339K, impaired receptor trafficking from the endoplasmic reticulum and Golgi body to the cell surface. V281M and E339K decreased cell surface OXTR localization by 49% and 36%, respectively, compared to WT OXTR. Accordingly, these variants reduced maximal oxytocin signaling by 23% and 22%. Next, we investigated whether small molecule modulators of OXTR could act as pharmacological chaperones, increasing the trafficking of OXTR from intracellular stores to the cell membrane. Overnight (16 hour) treatment with three different modulators increased the cell surface localization of transfected V281M OXTR to above WT levels. These same modulators increased cell surface localization of the endogenous (WT) OXTR in hTERT-HM cells by three-fold. Finally, pre-treatment with one modulator increased oxytocin-induced IP1 accumulation in hTERT-HM cells by 12%. Conclusion: Genetic variants present in the human population impair trafficking of OXTR, which can decrease oxytocin response. Pharmacological chaperones may be a useful treatment strategy for patients predicted to have poor oxytocin response due to genetic or other factors. (1) most are 'generalized' smooth muscle modifiers not designed to target myometrial-specific pathways, and (2) conservative dosing schedules must be employed to avoid adverse effects on the fetus. We seek to develop novel therapeutic approaches that leverage pathways specific to the myometrium through 'combination tocolysis' to delay birth. We have recently determined that by targeting two dysregulated proteins in the myometrium, connexin-43 (Cx43) and the β3 adrenergic receptor (β3AR), with low doses of 18β-glycyrrhetinic acid and nebivolol, respectively, their tocolytic effects are additive, all but eliminating uterine contractions. Here we expand upon that finding and hypothesize that 'combination tocolysis' using the Cx43 gap junction channel (GJC) specific inhibitor, 18α-glycyrrhetinic acid (18α-GA), and atosiban, an oxytocin receptor (OXTR) antagonist which is not an effective tocolytic when used alone, will produce an additive effect when co-administered. Methods: Myometrial strips (n=3 term non-laboring) were attached to a force transducer and isometrically stretched in an organ bath containing Krebs buffer. Tissues were maintained at 37°C with balanced oxygen (95% O 2 , 5% CO 2 ). Tissues were then sequentially challenged with KCl (60 mM) and oxytocin (8 nM) then treated with either 18α-GA (100-300 µM), atosiban (10-300 nM), or both, as accumulative doses in 15-minute intervals. Data were analyzed with LabChart®. Results: 18α-GA decreased 'area under the curve' (AUC) (10µM n.s., 30µM n.s., 100µM 17.5%, 300µM 59.8%) and 'contractions per unit time' (CPUT) (23.9% decrease over control at max dose), but not peak tension. Similarly, the atosiban decreased AUC (10nM n.s., 30nM 3.3%., 100nM 45.3%, 300nM 49.5%) and CPUT (33.3% decrease over control at max dose over control. When co-administered, the negative inotropic effects were amplified over individual dosing schedules for both AUC (18α-GA:atosiban -10µM:nM 5.9%, 30µM:nM 38.1%., 100µM:nM 61.5, 300µM:nM 92.9%) and CPUT (73.4% decrease over control at max dose over control). These data indicate that 'combination tocolysis' using the Cx43 GJC inhibitor, 18α-GA, and the OXTR antagonist, atosiban, produce additive negative inotropic effects over the use of individual drugs, which may allow for effective tocolysis at reduced concentrations. These findings, in concert our recent work which confirmed a similar trend using a non-specific Cx43 inhibitor (GJC/hemichannel) with a β3AR (eNOS) agonist, highlight the robust potential for 'combination tocolysis' of dysregulated and myometrial-specific contractile pathways to treat preterm labor. We have previously shown that alternative spliced estrogen receptor α (ESR1) isoforms and endoplasmic reticulum stress (ERSR) were implicated in the control of contractility of the myometrium. We further believe that the ERSR is crucial to regulating an alternate proteome necessary for stage related gestational functions. In this study we link the aforesaid phenomena to m 6 A methylation of mRNA. M 6 A methylation is the most frequently used epitranscriptomic modification and is performed by Metll3, a methyl transferase that is part of the m 6 A writer complex. We believe that m 6 A posttranscriptional modification of pre-mRNA and mRNA, controls alternative splicing and stress induced cap-independent translation during gestation allowing for an elastic proteome that is reactive to changes in the developing uterus. We hypothesized that the generation of ERSR will induce stress-dependent m 6 A activity by upregulating MettL3 (m 6 A writer) and will regulate hnRNPs and YTH proteins (m 6 A readers) levels. The levels of m 6 A readers, hnRNPG and hnRNPC, and the m 6 A writer, MettL3, were measured using western blotting techniques after a tunicamycin (TM, an ER stress inducer) treatment in a myometrial cell line (hTERT HM ). Mettl3, hnRNPC, hnRNPG, YTHDC1 and ALKBH5 protein expression levels and m 6 A methylation of RNA were analyzed using western blot and EpiQuik TM m6A RNA Methylation Quantification Kit in a mouse uterine gestational series. Results: Proteins HnRNPC1/C2 and MettL3 were significantly upregulated with 0.1 µg/mL TM ERSR induction at both the 12 and 48-hour intervals when compared to the control. HnRNPG was also significantly upregulated after induction with 0.1 µg/mL TM ERSR at 12, 48 and 72-hour intervals when compared to control. The strong correlation between ERSR and the increase in MettL3, HnRNPG and hnRNPC1/C2, signify not only an increase in m 6 A methylation associated with ERSR but a reader associated change in the functional proteome. Mettl3 was gestationally regulated with levels peaking at mid gestation and decreasing with the onset of labor. A similar expression pattern was seen in the reader proteins hnRNPG, hnRNPC, YTHDC1 and m 6 A labeled RNA. In contrast the eraser protein ALKBH5 was upregulated with the onset of labor. Conclusion: Our current data together with our previously published changes in alternative splicing and the up regulation of ERSR during pregnancy support a role for m 6 A methylation in the generation of a gestationally regulated myometrial proteome. Overall, as we understand the progression of alternative splicing, ERSR and m 6 A methylation of the myometrium during normal gestation, we can therapeutically target specific molecular pathways in order to prevent preterm birth. Uterine We identified novel uterine electromyography (uEMG) signals named uterine oscillatory signals (uOS); uOS are intermittently expressed between contractions and are characterized by regular periods and amplitudes. Frequency and duration of uOS are longer during oxytocin exposure and may be an indicator of the degree of uterine stimulation. Distribution and duration of uOS can be combined to calculate a "uterine stimulation index" (uSI). Our objective is to evaluate the relationship between uSI and oxytocin dosing. Methods: 4 term subjects receiving oxytocin were studied at a single academic center. Oxytocin doses were increased by 2 mU/min every 20 min per institutional protocol. 6-channel uEMG recordings were acquired using directional sensors. Presence of uOS was assessed by computer for each channel. uSI was calculated as the fraction of time uOS was observed within a 10-min moving window, averaged over all channels. If all 6 channels expressed uOS continuously throughout the window, the uSI would be maximal at 1; if no channel displayed any uOS, uSI would be 0. Results: All subjects showed cervical change after initiation of oxytocin, with doses ranging from 4-12 mU/min. When observed, peak uSI values occurred following a rise in uSI and successively increased to a max of 0.48. Following each peak, uSI decreased; however, mean inter-peak uSI successively increased ( Figure) . Peak uSI at each dose of oxytocin per patient are reported (Table) . uSI did not exceed 0.15 at oxytocin doses < 6mU/min. Oxytocin > 6mU/min was required to achieve uSI values above 0.2. Conclusion: Transient rises in uSI, observed with each incremental increase in oxytocin dose, suggest that uSI reflects the degree of uterine stimulation by oxytocin. uSI may offer a personalized approach to oxytocin titration rather than reliance on generic protocols using contraction frequency and/or cervical change. This tool has the potential to optimize oxytocin efficiency and shorten the duration of time to delivery. Identification Currently, there are no FDA-approved tocolytics for the management of preterm labor due to the off-target side effects and short duration of benefit of current off-label drugs. High-throughput screening of oxytocin induced Ca 2+ mobilization in uterine myometrial cells identified mundulone and mundulone acetate (MA) as hit antagonists. The aim of this work was to 1) examine the uterine selectivity of mundulone and MA by counterscreening vascular smooth muscle cells (VSMC)-the major off-target limiting the use of current tocolytics, 2) determine cytotoxic effects, 3) identify synergistic combinations of mundulone (and MA) with current tocolytics to increase efficacy and/or potency to decrease off-target side effects and 4) examine ex vivo tocolytic effects and confirm uterine selectivity at the tissue level by evaluating their effect on constriction of fetal ductus arteriosus (DA), a major off-target of known tocolytics Methods: Primary human myometrial cells were isolated from tissue collected at the time of cesarean delivery from women at term (≥39 weeks) pregnancy. A phenotypic high-throughput Ca 2+ mobilization assay was used to compare concentration-response curves (CRC; 10 point, 3 fold dilutions) between myometrial and aorta VSMC. The above assay was adapted for combination screening with current tocolytics (atosiban, indomethacin and nifedipine) in 8x8 concentration-response matrix format. Bliss, HSA and Loewe models were used to determine synergy using Combenefit software. Cytotoxicity was determined using WST1 cell viability assay on myometrial cells and to calculate a safety index (SI; ratio of IC 50 in cell viability assay to IC 50 in Ca 2+ assay). Ex vivo organ bath studies using day 19 mouse myometrial tissue and fetal DA vessels were performed to examine CRC on contractility and vessel diameter, respectively Results: MA was found to display selectivity towards myometrial cells compared to aorta VSMCs. Fold change (FC) in efficacy and potency was 13.5 and >4.5 for MA, respectively, while FC in potency for mundulone was >2.3. Mundulone displayed synergism with atosiban and nifedipine, while MA displayed synergistic efficacy with only nifedipine. Mundulone affected the viability of myometrial cells while MA and the mundulone+atosiban combination demonstrated a SI >10. Mundulone, MA and the combination of mundulone + atosiban showed concentration dependent inhibition of uterine contractions but did not affect fetal DA vasoreactivity Conclusion: Based on differences in uterine-selectivity and tocolytic efficacy between mundulone and MA, this natural product could benefit from medicinal chemistry efforts to study structural activity relationship (uEMG) is an emerging technology for non-invasively assessing uterine activity. Standard uEMG area sensors contain silver tape and adhesive hydrogel, which limits their application for long-term monitoring because of gel drying and associated altered signal acquisition. We have developed a novel gold uEMG area sensor with no adhesive hydrogel that may allow continuous monitoring for days or weeks. Here, we seek to compare the bioelectrical signal quality observed using gold and standard sensors. Methods: Observational cohort study of 6 subjects at >37 weeks with uncomplicated, singleton pregnancies in active labor. Two gold and 2 standard uEMG sensors were applied in varying configurations over the gravid abdomen. Multichannel uEMG was performed for 60 minutes. Uterine frequencies were assessed between 0.005-1.0 Hz. Primary outcome was the difference in bioelectrical signal quality, defined as signal-noise ratio, between gold and standard sensors. A signal-noise ratio >2.5 was considered acceptable for reliable signal detection. The bioelectric signals assessed were as follows: contraction-associated signals (CAS), fasciculation-like signals (FLS), oxytocin-associated signals (OAS), and low frequency oscillations (slow waves). Results: Both gold and standard sensors were able to detect all four signal types (CAS, FLS, OAS, and slow waves; Figure) . There was no significant difference in CAS or slow wave signal-noise ratios between gold and standard sensors (CAS: gold=3.8±2.1 vs standard=7.2±3.3, P=.058; slow waves: gold=6.3±3.1 vs standard=7.9±2.7, P=.369). OAS and FLS were too infrequent to assess differences in signal-noise ratio; however, only 3 subjects received oxytocin, and FLS are uncommonly observed during labor. Motion artifacts were more common in gold sensors. We demonstrate that our novel gold sensors can be used for uEMG analysis. Gold sensors have the ability to detect bioelectrical signals with signal-noise ratios equivalent to standard hydrogel-silver sensors. While gold sensors can remain applied to the skin for long periods of time, motion artifacts limit their application to periodic, short recordings; alternative technologies will need to be evaluated to accomplish the goal of long-term, continuous monitoring. Effects Introduction: Uterine muscle is smooth muscle and has the common characteristics --contractile function of vascular smooth muscle and other visceral smooth muscle. Contractile function is one of the most important functions of pregnancy uterus, uterine contraction is the core factor that determines delivery.Abnormal uterine contraction during labor can lead to prolonged labor, fetal distress, postpartum uterine inertia.At present, it is considered that normal pregnancy is a low-grade "inflammatory response" process, and the inflammatory response during delivery is enhanced, but the regulatory mechanism of inflammatory response during delivery is not clear. The expression of chemokines and cell adhesion factors in the myometrium of late pregnancy was upregulated, a large amount of leukocyte infiltration was recruited, abundant inflammatory mediators were released into local tissues, and signaling pathways such as prostaglandin synthesis or activation of nuclear factor κB were promoted. Positive feedback recruited more white blood cells, further released inflammatory mediators, enlarged inflammatory responses , increased prostaglandin synthesis and increased uterine contraction. The study shows that the human uterus is in the environment of 3%-5% oxygen volume fraction. Hypoxia can also stimulate oxidative stress in cells. Culture in vitro hypoxic environment more in line with the body environment. The primary human uterine smooth muscle cell culture system and the primary human peripheral blood monocyte culture system will be established, and the co-culture system of the two cells will be established; The activity of UtSM cells under hypoxic co-culture system will be analyzed by CCK8, the gel contraction test will detect the effect of hypoxic cells on UtSM cells contractile function; Western Blot the effect of hypoxic cells on the expression of UtSM cellscontractile related proteins will be detected; The effects of hypoxic monocytes on the secretion of UtSM cells inflammatory factors were detected by ELISA, and the related signaling pathway of hypoxic monocytes on the inflammatory response of UtSM cells was detected. Results: Under hypoxia, the activity of UtSM cells increased, the secretion of inflammatory factors increased, and the expression of contractile related proteins increased. Under the treatment of hypoxia and monocytes, the activity of UtSM cells increased significantly, the secretion of inflammatory factors proteins increased. Leveraging Human Genomics to Accelerate Next-Generation Female Contraceptive Drug Discovery. Karen Hunter Cohn, Caterina Clementi, Genevieve Galarneau, Piraye Yurttas Beim * . Celmatix Inc, New York, NY, United States. Introduction: Unwanted side effects, including heavy and irregular menstrual bleeding, are a barrier for hormonal contraceptive drug utilization by many women. Though dozens of products and formulations are available, they all rely on common mechanisms of action (MoA) through estrogen and/or progesterone. There is, therefore, an unmet need for next-generation female contraceptive drugs that unlock novel MoAs. Here, we report our efforts to identify novel contraceptive drug targets through genomic analyses aimed at surfacing molecular pathways and genes associated with ovulatory function in humans. We began by structuring multiple data streams for identification and algorithmic ranking of putative drug targets. These included Literature Mined Genetic Evidence (literature-based association with an ovulatory phenotype, scored on the quantity and strength of evidence with guidelines adapted from ClinGen), Animal Genetic Evidence (genotype-phenotype data from the Mouse Genetic Informatics database, curated for relevance to ovulation/reproduction), and Tissue Expression Specificity (expression in ovary/reproductive tissues using GTEx project data). Genetic analyses were completed using genomic and deep phenotypic data from our Personalized Reproductive Medicine (PReM) cohort of infertility clinic patients. These included GWAS in patients of European ancestry for phenotypes such as basal antral follicle count and anti-Mullerian hormone levels, controlling for patient age. We also identified rare functional variant carriers using Ensembl Variant Effect Predictor on variants with a minor allele frequency < 1% in gnomAD and located within RefSeq gene boundaries. Results: Algorithmic ranking of these data streams allowed us to prioritize putative contraceptive drug targets with multiple lines of evidence associating them with ovulatory function in humans. Notably, genes encoding receptors for estrogen and progesterone (ESR1, ESR2, and PGR) were among the most highly ranked genes using the approach. Further analysis of the most highly ranked putative targets also allowed us to identify rare, highly penetrant genetic variants in women who have failed multiple rounds of fertility treatments. We have demonstrated that genomic analysis can reveal and help prioritize putative contraceptive drug targets. Furthermore, identification of rare, highly penetrant genetic variants in otherwise healthy women who have been unable to conceive spontaneously and/ or who have failed multiple rounds of fertility treatments simultaneously reveal targets that are promising from an efficacy and safety perspective. Mass Cytometry Reveals Unique Clusters of Monocytes in Blood and Decreased Phagocytic Capacity of Eutopic Endometrial Macrophages in Women with Endometriosis. Júlia Vallvé-Juanico †, Sushmita Sen †, Ashley F George †, Kim Chi Vo * , Juan C Irwin * , Alexis Combes * , Nadia Roan * , Linda C Giudice * . University of California San Francisco, San Francisco, CA, United States. Introduction: We previously described that eutopic endometrial macrophages of women with endometriosis display a pro-inflammatory phenotype by RNASeq. Thus, our objective was to deep phenotype and identify differences in myeloid populations in eutopic endometrium and blood in women with endometriosis. Methods: A total of 31 endometrial biopsies and 26 blood samples in proliferative and secretory phases of the menstrual cycle from women with (Endo, n=35) and without endometriosis (Ctrl, n=22) were obtained from the UCSF/NIH Human Endometrial TissueBank under IRB approval (IRB#10-02786). Written informed consent was obtained from all participants. A 40-marker panel for mass cytometry (CyTOF) was designed. Samples were processed, barcoded, stained, and run on CyTOF®2 instrument. The obtained fcs. files were normalized, debarcoded and imported into FlowJo, for manual gating. Supervised analyses were done using the manually gated populations. Differential abundance (2-way ANOVA) and expression analyses (t-test (pVal<0.05) and Benjamini-Hochberg (FDR<0.05)) were performed. As we found significant differences between markers in myeloid populations, unsupervised clustering analyses were performed only on these populations. Association between cluster identity and associations with markers, disease status and cycle phase are currently underway. In the supervised analyses pipeline, no significant differences in abundance of populations were found between Endo and Ctrl at any phase of the cycle. However, markers were differentially expressed. Endometriosis eutopic endometrial macrophages overexpressed SIRPα, a phagocytosis inhibitor. Endometriosis is hypothesized to be the ectopic growth of endometrial tissue, with retrograde menstruation as the most likely etiology. Frustratingly, there is a reported average of an 8-year diagnostic delay from symptom onset (pain and infertility), which is further compounded by the lack of treatment options and palliation of symptoms with treatment. New insights into the characteristic differences between healthy and diseased tissue and new models for in vitro research and development are needed. We present a whole-transcriptome sequencing dataset from 20-patient diseased and 5-patient control cohorts with accompanying surgical and phenotypic metadata. Notably, 10 patients out of the diseased cohort had high-quality tissue sequenced from three different sites: eutopic endometrium, peritoneal membrane, and endometriosis lesions allowing for intra-patient transcriptional comparison. Additionally, we present recent efforts to generate endometrial and decidual-like cells from human induced pluripotent stem cells though transcription-factor overexpression. Results: We examine differential gene expression in sequenced tissues such as inflammatory-related genes, CXCL2, CCL18 and CCL19 in red versus clear lesions, or cancer-related genes DCSTAMP, ASCL2, and TRPM1 in red lesions versus peritoneum and discuss potential implications for disease classification and treatment. Transcriptional profiling of the candidate synthetic cell lines suggest similarity with in vivo patient tissues and existing endometrial single-cell RNA sequencing datasets. Comparative gene expression analysis of endometriosis patient tissues reveals new markers and drug targets for endometriotic lesions. Synthetic endometrial-like cells may enable high-throughput in vitro drug screening future patient-specific treatment options through personalized omics. The Resistance and Disease Progression in Endometriosis. Valerie A. Flores †, Tran Dang, Joshua Huttler, Hugh S Taylor * . Yale School of Medicine, New Haven, CT, United States. Introduction: Endometriosis is a chronic, gynecologic disease affecting 1 in 10 reproductive-aged women. It is an estrogen and progestin responsive disorder, however some endometriosis is resistant to progestin-based therapies. We have previously demonstrated that progesterone receptor (PR) levels are low in progestin-resistant disease. However, the role of estrogens acting through estrogen receptor alpha (ERα) in modulating PR expression and response to progestin-based therapy has not been fully characterized. Here we aimed to determine if aberrant ERα expression correlates with response to progestin based therapy and regulates disease progression. Methods: Endometriotic lesions were obtained from 48 subjects undergoing surgical evaluation in this retrospective cohort study. Matched eutopic endometrium was obtained from 11 subjects. Immunohistochemistry (IHC) was performed using a rabbit polyclonal IgG for detection of ERα, and the H-score was used to quantify ERα expression. Two investigators blinded to patient response independently scored IHC specimens. Data regarding hormonal therapy status, PR status in eutopic and matched ectopic lesions, and response to progestin-based therapy were determine from review of the electronic medical record. A Mann-Whitney U and Spearman's rank correlation were used for statistical analysis. Results: ERα levels were significantly lower in non-responders compared to those who responded to progestin-based therapy (4 vs 13, respectively; p = 0.02). There was a correlation between ERa levels and PR levels in ectopic lesions (p=0.001, r=0.68). There was no correlation between ERα levels in matched ectopic and eutopic lesions (n=11). ERα expression did not correlate with stage of disease, or medication use. Conclusion: ERα expression was lower in women with progestinresistant compared to progestin responsive endometriosis. As low ERα correlated with low PR expression, ERα is likely required to induce PR and allow progestin sensitivity. Existing medical therapies rely on lowering estradiol levels or inducing decidualization of lesions, yet each has associated failure rates. Maintenance of ER in endometriosis therapy may allow adequate PR to allow for progestin based therapies. Tofacitinib Alters STAT3 Signaling and Leads to Endometriosis Lesion Regression. Alexander Kotlyar †, Ramanaiah Mamillapalli, Valerie Flores, Hugh Taylor. Yale University, New Haven, CT, United States. Introduction: Endometriosis is a wide-spread gynecologic condition affecting up to 15% of reproductive age women. The JAK/STAT3 pathway is upregulated in endometriosis and a therapeutic target. Here we sought to determine the effect of Tofacitinib, a Janus kinase-inhibitor in widespread clinical-use, on JAK/STAT signaling in endometriosis and lesion growth. Methods: Cells were cultured with Tofacitinib at a therapeutic and subtherapeutic dosage. Mice with surgically-induced endometriosis were treated with Tofacitinib versus vehicle. Endometriosis lesion size and adhesion burden were assessed in mice treated with Tofacitinib versus vehicle. HIF1α and VEGF expression levels in human cells were assessed by qPCR. STAT3 and phospho-STAT3 expression from Tofacitinib-treated and untreated cells was performed via western blotting and densitometry. Results: Using a mouse model of surgically-induced endometriosis (n=20), daily Tofacitinib treatment led to lesion regression (p<0.01) and reduced adhesion burden (p<0.001). STAT3 phosphorylation was significantly decreased in both lesions and uteri of mice treated with Tofacitinib versus vehicle (p<0.05). In cell-culture, Tofacitinib reduced HIF1α and VEGF mRNA levels at 12 and 24hrs of treatment. Following 24 hrs of exposure, Tofacitinib effectively reduced STAT3 phosphorylation in Ishikawa cells (p<0.05), and patient-derived stromal (p<0.01) and epithelial cells (p<0.01) from eutopic endometrium. Expression of HIF1α was significantly reduced with Tofacitinib treatment of control endometrial stromal and epithelial cells, but not in patients with endometriosis. This study suggests that inhibition of JAK/STAT signaling using Tofacitinib may be a viable method for the treatment of endometriosis. By reducing STAT3 phosphorylation, lesion size and adhesive disease are both reduced. Introduction: Adenomyosis is a gynecological disorder characterized by the histologic presence of endometrial glands and stroma within the myometrium of the uterus and is associated with subinfertility, pelvic pain and abnormal uterine bleeding. However, its etiology is poorly understood due to a lack of phenotypic models. Recent advancements in 3 dimensional (3D) imaging and organoid cell cultures derived from primary human tissues provide an avenue to investigate endometriotic disease in vitro. Herein, we developed a fully defined and tunable synthetic polyethylene glycol (PEG) hydrogel to culture human endometrial epithelial organoids (EEOs). and investigate the role of extracellular matrix (ECM) in promoting disease pathogenesis. Methods: PEG hydrogels were prepared by reacting a multi-arm PEGvinyl sulfone macromer with specific peptides designed to promote cell adhesion by targeting integrins expressed by endometrial cells. ECM stiffness was tuned to mimic the bulk stiffness of the native endometrium (~300 Pa) and the myometrium (>2 kPa) by increasing macromer concentration. EEO morphology, efficiency and hormonal response was characterized using immunofluorescent imaging compared to Matrigel. The contribution of stromal cell was assessed as a co-culture aggregate spheroid. Transcriptomic analysis was performed using qPCR. Cytokines and matrix proteinase (MMPs) profiles were quantified using multiplexing Luminex assays. Results: Direct encapsulation singe cell EEOs in the PEG-based hydrogels resulted in formation of organoids in stiff and soft PEG hydrogels with no evident difference in efficiency or size. However, the EEO morphology was drastically altered in stiffer ECMs that mimicked the myometrial stiffness and mimicked ectopic lesion morphology as demonstrated by in situ tissue clearing and light-sheet imaging. Specifically, the organoids lost their architecture and demonstrated an invasive phenotype. We demonstrated these EEOs demonstrated many of the hallmarks of endometriotic disease which included reduced hormone expression, increased inflammatory cytokine expression, and invasive behavior mediated by epithelial-mesenchymal transition (EMT). A common feature of endometriotic (endometriosis and adenomyosis) disease is a stiff environment. We utilized an innovative synthetic hydrogel platform and identified that increased extracellular stiffness promotes an EMT-driven invasive endometriotic phenotype in vitro. This model provides an avenue to understand the biophysical origins of adenomyotic disease and drug screening. Next generation models will introduce additional cellular and molecular components of the lesion microenvironment. Introduction: Uterine adenomyosis is a condition in which endometrial glands and stroma break through the myometrium, causing dysmenorrhea, pelvic pressure, heavy menses, abnormal uterine bleeding and dyspareunia with a prevalence of 2% in women aged 15-50 years. Uterine fibroids can also cause similar symptoms, however the symptom profile of having both pathologies present has not been well documented in the literature. Methods: An IRB-approved retrospective chart review was conducted using the electronic medical records of 375 women aged 18 years and older seen between 2011 and 2019 at SUNY Downstate's Outpatient OB/ GYN Suite. Women were excluded if they were pregnant as well as those who were diagnosed with malignancy, HIV, renal failure, psychiatric illness and those using hormone therapy or history of steroid medication use. Diagnosis of adenomyosis and uterine fibroids were determined by a gynecologist. Data collected included demographics, BMI, menstrual and obstetric history as well as ultrasound findings and laboratory parameters including CBC, CMP, HbA1C and lipid profile. Women were categorized as adenomyosis alone (AA), adenomyosis concurrent with uterine fibroids (AF) and controls without either adenomyosis or uterine fibroids. Data were then analyzed for group differences between AA vs controls and AA vs AF using Wilcoxon Rank Sum and Fisher's exact test. Results: Women were mostly Black (64.8%) with median BMI of 27.0 kg/m 2 . AA women were significantly older than controls (42 vs 36 years, respectively; p= 0.01). AA women had a significantly higher prevalence of dysmenorrhea compared to controls (70.6 vs 29.2%, respectively, p= 0.002), endometriosis (17.2 vs 6.2% respectively; p= 0.045) and heart disease (13.3 vs 4.1%, respectively; p= 0.05). AA women were also more likely to have had a myomectomy than controls (20.7 vs 2.9%, respectively, p< 0.001). There were no clinically significant differences in laboratory values between the two groups. The subset of women with adenomyosis (AA & AF) were similar in age (p= 0.9577) and BMI (p= 0.1353). AF women were significantly less likely to have PCOS compared to AA women (2.8 vs 50.0%, respectively; p <0.0001). AF women compared to AA women were noted to have significantly thicker endometrium on ultrasound (7.6 vs 2.9 mm, respectively; p= 0.005) as well as significantly lower levels of hemoglobin (11.9 vs 12.8 g/dL, respectively; p= 0.03) and HbA1C (5.5 vs 5.7%, respectively; p= 0.04). Conclusion: Women with adenomyosis reported having dysmenorrhea at a higher rate than controls. They were also more likely to have a history of endometriosis, heart disease and previous myomectomy. Women with concurrent fibroids and adenomyosis were more likely to have thickened endometrium as well as lower levels of hemoglobin and HbA1C. A history of myomectomy was associated with the presence of adenomyosis. The Introduction: Impaired decidualization of eutopic endometrium is a key contributor to infertility in women with endometriosis. Our previous work identified a series of transcriptional factors, which might contribute to the development of endometriosis. Tfap2c was possible one of them. However, and its mechanism is still unknown. Methods: Eutopic endometrial samples were collected from 14 endometriosis patients with infertility and 16 healthy who underwent tubal sterilization were confirmed to be free of endometriosis laparoscopically. Endometrial tissues were digested for cell culture. PCR and western blot were used to verify Tfap2c expression. The expression of Tfap2c in primary ESCs was depleted by transfection with Tfap2c siRNA. Then, MTT assay, Flow cytometry, and wound healing assay were used to identify the effect of down-regulated Tfap2c on proliferation, apoptosis, and migration in ESCs. The expression of Tfap2c was reduced in eutopic endometrium from patients with endometriosis compared to control (p<0.05). Tfap2c siRNA transfected in ESCs successfully confirmed by Western blot. Cell viability of ESCs with transfected Tfap2c siRNA increased significantly, whereas the apoptosis rate decreased (both p <0.05). Transfection of Tfap2c siRNA promoted ESCs migration (p <0.05). Conclusion: Our results suggested Tcfap2 deficiency promotes cell proliferation and suppresses apoptosis in eutopic endometrium in patients with endometriosis, which might contribute to infertility. Additionally, cell migration enhancement of eutopic endometrium may be responsible for the formation of ectopic endometriosis sites. Introduction: Endometriosis is one of the most common reproductive disorders among women. Up to 44% suffer from ovarian endometriomas, which are often asymptomatic but can be large enough to cause pain, discomfort, and inhibit normal ovarian function. The standard surgical management for endometriomas is an ovarian cystectomy, however, for those seeking to conceive this has been associated with upwards of a 50% decrease in ovarian function, lower Anti-Müllerian hormone (AMH) levels, and difficulty achieving pregnancy. For those already experiencing infertility, this compounding effect can be devastating. While this data is well recognized, there is little data showing the implications of endometriomas on fertility prior to cystectomy. Thus, we sought to better understand how the presence and size of endometriomas may impact ovarian reserve in women that have not yet had surgical intervention, and their effects on controlled ovarian hyperstimulation for in-vitro fertilization (IVF) treatment. Retrospective chart review at a private fertility clinic. All patients 46 yo and younger undergoing IVF between Aug 2016 and Nov 2020 with a history of endometriosis were included. Baseline characteristics, including estradiol (E2) and AMH levels at time of menses, and endometrioma sizes were measured and IVF cycle statistics recorded. IVF outcomes were characterized as the number of oocytes retrieved, oocyte maturation and fertilization rate, and blastocyst utilization rate. Blastocyst utilization was defined as any embryo suitable for transfer or cryopreservation. Linear regression, T-tests, and chi-square analysis were used to analyze the data using SPSS (SPSS Inc., Chicago, IL, USA). Results: 75 patients were identified to have at least one endometrioma present on ultrasound at baseline, cycle day 2-5. Baseline characteristics were noted, with an average age being 37 years, average antral follicle count (AFC) of 8.98, and average AMH of 1.78. 72% of the cohort analyzed were noted to have more than one endometriomas. The presence and size of endometriomas did not significantly affect AMH or AFC, with R2 = 0.14 and 0.01 respectively. Cycle outcomes including average oocyte maturation rate, fertilization rate, and blastocyst utilization rate were 78%, 95%, and 38% respectively, similar to national data for this age group. Our results indicate that the size and presence of ovarian endometriomas prior to cystectomy do not have a significant negative effect on ovarian reserve and IVF outcomes. These results are encouraging for physicians and patients, as those struggling to conceive or suffering from painful ovarian endometriomas can now be recommended for oocyte or embryo cryopreservation prior to endometrioma removal without fear of further implications on their reproductive health. ). Additionally, in women diagnosed with endometriosis, the prevalence of CUA is 12.9% (95% CI 5.6 to 20.2, I 2 =97%). Conclusion: Our systematic review suggested that the pooled prevalence of endometriosis in women with CUA and distinct subtypes are between 25-40% based on available published data. Despite the previous report of the coexistence of endometriosis and CUA, the risk of endometriosis does not differ between women with or without CUA, however, heterogeneity between studies is significant. Nevertheless, our study may provide clinicians a current understanding of the epidemiology of endometriosis in women with CUA. Future studies with larger sample sizes and controls may assist us to elicit the association between these conditions. Simvastatin Inhibits Progesterone Receptor Signaling in Uterine Leiomyoma Cells. Sadia Afrin †, Malak El Sabeh, Mariko Miyashita-Ishiwata, Mostafa Borahay * . Johns Hopkins University School of Medicine, Baltimore, MD, United States. Introduction: Uterine leiomyoma is the most common benign tumors in the female reproductive tract and its growth is partly mediated by steroid hormones. Several progesterone (P4)-related aberrations have been identified in leiomyomas, including extensive extracellular matrix (ECM) deposition, upregulation of growth factors and their signaling pathways, epigenetic alterations, as well as the overexpression of the progesterone receptors (PRs). Thus, due to the involvement of P4 and PR in leiomyoma pathobiology, the objective of this study was to test the hypothesis that simvastatin, an anti-hyperlipidemic drug, would alter the P4-induced proliferation and PR signaling pathways in leiomyoma cells. Methods: Primary leiomyoma cells were treated with simvastatin (0.001-1 µM) and P4 (100 nM), alone or in combination, for 48 h to examine cell viability by MTT assay. The expression of PR-A/B was examined using western blot and immunofluorescence assay after simvastatin treatment. Next, we quantified the protein expression levels of ECM (collagen 1, fibronectin, versican), MAPK (ERK1/2 and JNK), mTOR, and PGMRC1 in response to simvastatin treatment. To investigate the role of simvastatin in PR transcriptional activities, we measured PRE-Luc activity through luciferase assay. The student's t-test was used to determine statistically significant differences (p<0.05). Introduction: Uterine fibroids (UFs) are benign monoclonal neoplasms of the myometrium (MM) and represent the most common tumors in women worldwide. So far, no long-term, non-invasive treatment option currently exists for UFs, and deeper mechanistic insight into tumor etiology is key to develop newer targeted therapies. The epitranscriptome is an emerging frontier in molecular medicine owing to its vast potential as an additional highly dynamic layer of gene regulation above and beyond the epigenome. Among >160 different chemical modifications in RNA, N6methyladenosine (m 6 A) is the most pervasive, abundant, and conserved modification within eukaryotic mRNAs. However, the role of m 6 A and its regulation have not been identified in UFs. In this study, we characterize the role of the key m 6 A writer METTL3 in UFs. Methods: MED12 mutation-positive and -negative UFs (n=12 each) along with matching MM (n=12) from the same patient uteri were collected at The University of Texas. Immunoblots were used to measure the METTL3 levels in tissues as well as in UF and MM cell lines. METTL3-specific shRNAs were introduced into a UF cell line to determine the role of METTL3 in cell growth (MTT assay), survival (apoptotic markers), and epigenomic changes (active or repressive Histone marks). The Student's t-test was used to determine the significant difference. Results: Quantitative immunoblot analysis revealed a significant upregulation of the m 6 A writer METTL3 (~3-fold, p<0.001) in UFs (independent of MED12 mutation status) compared to MM, which is consistent with upregulation of METTL3 in UF cells compared to uterine smooth muscle cells. Knockdown of METTL3 in UF cells exhibited altered morphological features, reduced proliferation and enhanced sensitivity to the apoptosis-inducing agent Staurosporine, concomitantly with upregulation of the pro-apoptotic BAX and downregulation of the anti-apoptotic BCL2 proteins (p<0.05). Unexpectedly, we also observed that METTL3 knockdown led to global upregulation of transcriptionally repressive histone methylation (H3K9me2, H3K9me3, and H3K27me3), suggesting that METTL3-depdendent RNA methylation may promote a transcriptionally permissive chromatin environment in UF cells. Conclusion: Together, these data suggested that m 6 A writer METTL3 is aberrantly upregulated in UFs, representing an initial paradigm for pathological dysregulation of the m 6 A machinery in UFs. METTL3 depletion in UF cells triggers global alterations in the m 6 A modification landscape along with reduced cell proliferation, increased death and upregulation of repressive histone methylation marks. These studies establish the RNA methylation machinery to be a viable target for therapeutic intervention in UFs. Tryptophan Catabolism Is Dysregulated in Leiomyomas. Tsai-Der Chuang, Derek Quintanilla, Drake Boos, Omid Khorram * . The Lundquist Institute at UCLA Medical Center, Torrance, CA, United States. Introduction: To determine the expression and functional roles of indoleamine 2,3-dioxygenase (IDO1) and tryptophan 2,3-dioxygenase (TDO2) in leiomyoma and the effects of their inhibitors on extracellular matrix (ECM). Methods: Leiomyoma and matched myometrial tissue samples were collected from patients (N=58) including Caucasians (N=12), African Americans (N=25) and Hispanics (N=21). The menstrual cycle phase was determined by histologic analysis with 27 specimens being identified as in the proliferative phase and 14 specimens in the secretory phase. The MED12 (Mediator of RNA polymerase II transcription, subunit 12 homolog) mutation status was determined by PCR amplification and Sanger sequencing. Of the specimens sequenced, 40 fibroids had the MED12 mutations (68.9%). Kynurenine concentration in paired leiomyoma and myometrium homogenates was measured using the Human Kynurenine ELISA kit. MSMC (myometrium smooth muscle cells) and LSMC (leiomyoma smooth muscle cells) were isolated for culture and the cell proliferation and the gene expression analysis were using three-dimensional spheroid culture system determined by CellTiter-Glo 3D Cell Viability Assay and western blotting analysis. Results were analyzed by Student's t-tests and one-way ANOVA with Tukey's HSD for post hoc analysis. Results: Leiomyoma as compared with matched myometrium expressed significantly higher levels of IDO1 and TDO2 mRNA and protein, and kyneurenine, a marker of enzyme activity. The expression of TDO2 but not IDO1 mRNA was significantly higher in fibroids from African American as compared with Caucasian and Hispanic patients. TDO2 but not IDO1 protein and mRNA levels were more abundant in fibroids bearing the MED12 mutation as compared with wild type leiomyomas. Treatment of LSMC and MSMC spheroids with the TDO2 inhibitor, 680C91 but not the IDO1 inhibitor, Epacodostat significantly repressed cell proliferation and the expression of collagen type I (COL1A1) and type III (COL3A1) in a dose-dependent manner; these effects were more pronounced in LSMC as compared with MSMC spheroids. Conclusion: These results underscore the physiological significance of tryptophan degradation pathway in the pathogenesis of leiomyomas and the potential utility of anti-TDO2 drugs for treatment of leiomyomas. Simvastatin Induces the Expression of Matrix Metalloproteinase in Human Leiomyoma Cells. Malak El Sabeh †, Sadia Afrin †, Mostafa Borahay * . Johns Hopkins University, Baltimore, MD, United States. Introduction: Uterine leiomyoma (UL) is the most common begin tumor in the female reproductive tract. UL arises from cellular proliferation and aberrant extracellular matrix deposition. One of the key proteins involved in regulating extracellular matrix is matrix metalloproteinases (MMPs) that are responsible for extracellular matrix degradation, among other functions. MMP levels are elevated after ulipristal acetate treatment, and high MMP activity correlated with reduced leiomyoma size. Simvastatin is a 3-hydroxy-3-methyl-glutaryl-CoA (HMG-CoA) reductase inhibitor and is commonly used for the treatment of hypercholesterolemia. In vivo and in vitro studies have shown promising effects of simvastatin as a treatment for uterine leiomyomas by inducing apoptosis, reducing proliferation, and altering extracellular matrix deposition. The aim of this study was to test the hypothesis that simvastatin increases the expression of MMPs in UL tissue. Methods: Primary and immortalized leiomyoma cells were treated with simvastatin concentration (0.001, 0.01, 0.1, and 1 µM) for 48 hours. The effect of simvastatin on the mRNA and protein expression of several MMPs was examined after 48 hours treatment by using RT-qPCR and western blot, respectively. To confirm this effect, primary leiomyoma cells were stained with anti-MMP2 and anti-MMP9 for immunofluorescence. The student's t-test was used to determine statistically significant differences (P<0.05). Results: Simvastatin significantly increased the mRNA expression of MMP-2, MMP-7, and MMP-14 in a dose-dependent manner, with the highest increase seen with MMP-9 with a 9.2-fold increase at the highest concentration (1 µM). Simvastatin also significantly induced the protein expression of MMP-2 in a dose-dependent manner with a 6.1-fold increase at the highest concentration (1µM). These results were also confirmed through immunocytochemistry using anti-MMP-2 and anti-MMP-9 antibodies. Conclusion: Simvastatin induces the expression of MMPs in human leiomyoma cells, altering the sensitive balance of extracellular protein degradation, the main component in uterine leiomyoma development. Recently, we reported that the Hippo signaling effector YAP was overexpressed in fibroids, possibly contributing to cell growth, fibrosis, inflammation and angiogenesis. Epigallocatechin gallate (EGCG) is a natural compound isolated from green tea that reduced fibroid growth in vitro and in a randomized clinical trial. Here, we tested the hypothesis that the reduction in cell growth, fibrosis, inflammation, and angiogenesis caused by EGCG would involve Hippo signaling. Methods: To assess cell viability, human myometrial (P51M) and fibroid (P51F) cells were treated with EGCG at different doses (1, 10, 50, 100 and 200 µM) for 24 hrs. To measure mRNA and protein expression, cells were treated with EGCG at 100 µM for 24 hrs. Several genes or proteins were evaluated. For cell growth: cyclin D1 (CCND1); for fibrosis: versican (VCAN), fibronectin (FN1), activin-A (INHBA), transforming growth factor β1 (TGFB1), TGFB2, and plasminogen activator inhibitor-1 (PAI-1); for inflammation: interleukin-11 (IL-11), IL-1B, and high mobility group box 1 (HMGB1); for angiogenesis: endothelin 1 (EDN1), vascular endothelial growth factor C (VEGFC), and platelet-derived growth factor C (PDGFC), and for Hippo signaling: non-phospho-YAP, baculoviral IAP repeat containing 5 (BIRC5), and connective tissue growth factor (CTGF). T-test was used for data analysis and p<0.05 was considered significant. Results: We found that viability of fibroid cells was slightly (5%) reduced by EGCG treatment at 100 µM, while myometrial cells growth increased (18%). In fibroid cells, the mRNA and protein levels of proliferative gene, cyclin D1, were reduced by EGCG treatment at 100 µM. Several fibrotic factors including VCAN, FN1, INHBA, TGFB1, TGFB2, and PAI-1 were found to be highly expressed at mRNA in fibroid cells which were downregulated by EGCG treatment. Notably, the protein expression of FN1 and PAI-1 was also reduced by EGCG treatment. We noticed that EGCG treatment significantly decreased mRNA levels of inflammatory mediators, IL-11, IL-1B, and HMGB1. The gene expressions of key mediators of angiogenesis such as EDN1, VEGFC, and PDGFC were also reduced by EGCG treatment. Mechanistically, EGCG treatment reduced protein expression of a transcriptional effector of Hippo signaling, YAP. We also found reduced transcript or protein levels of YAP-responsive genes, BIRC5 and CTGF. Conclusion: EGCG treatment altered Hippo signaling and was associated with reduced levels of genes involved in cell proliferation, fibrosis, inflammation, and angiogenesis in uterine fibroid cells. These results support the beneficial effect of green tea for human health and can be a useful natural compound for fibroid treatment. Evidence Introduction: A novel paradigm of uterine fibroid (UF) development was recently reported that UFs undergo homeotic transformation by suppressing rostral and overexpressing caudal HOXA genes in UF subtypes with high HMGA2 expression, but not in those with high HMGA1 expression. HOXA13 gene expression, which is normal in the cervix and vagina, was reported to be increased in UFs compared to myometrium (M) in UFs with HMGA2 upregulation. Even so, it is not known if this transformation translates into altered HOXA13 protein expression. We hypothesize that UFs will have increased HOXA13 protein when compared to myometrium. Design: Laboratory study. Methods: RNASeq was performed on patient matched M and UF tissue samples to assess a homeotic transformation gene expression pattern. Gene expression was confirmed with quantitative polymerase chain reaction (qPCR) and western blot analyses. Results are shown as mean ± standard error of the mean. Results: Using RNAseq, we found HMGA2 upregulation in all 4 patients. We confirmed a pattern of decreased HOXA1-HOXA7 expression and increased HOXA10-HOXA13 expression, with HOXA13 highest in UF compared to patient matched M in 3 out of 4 patients (Fig 1) . At the protein level, HOXA13 was upregulated in 4 out of 9 patients in a confirmatory cohort (Fig 2) . The HOXA13 protein expression data exhibited significant variation (UF 0.19 ± 0.06, M 0.14 ± 0.05, p = 0.6 for the difference UF -M). Conclusion: Many UFs with HMGA2 upregulation exhibit a pattern of homeotic transformation at the RNA level. In a confirmatory cohort, HOXA13 protein expression was increased in some, but not all UF. Cell culture studies are underway to address the variability between patient samples as are studies to further characterize the relation between HOXA13 protein expression and HMGA1/2 changes. Using Mendelian Randomization to Understand Uterine Leiomyomata and Its Associated Clinical Phenome. Jacqueline A Piekos †, 1 Jacklyn N. Hellwege * , 2 Nikhil K. KhanKari, 2 Samantha Greenblatt †, 1 Introduction: Uterine leiomyomata (UL) are the most common pelvic tumor in women affecting around 70% of European ancestry (EA) women and 80% of African ancestry (AA) women. ULs are highly heritable with genetic inheritance as high as 33%. We previously developed and validated an EA race specific polygenic risk score (PRS) for UL. Our objective in this study is to use the PRS in Mendelian Randomization (MR) analyses to better understand the causal relationships between ULs and other health conditions. Methods: Using our previously constructed and validated EA PRS developed within Vanderbilt's Biorepository (BioVU) and the Electronic Medical Records and Genomics (eMERGE) Network we conducted MR analyses evaluating the relationship between our UL PRSs and candidate novel clinical phenotypes and known risk factors from the literature. Phenotypes evaluated included endometriosis, ovarian cysts, uterine polyps, dysmenorrhea, and optic atrophy identified in our prior phenome-wide analyses of UL PRS and body mass index (BMI), type 2 diabetes, and blood pressure traits from published literature. To conduct analyses, we used a two-sample MR approach that used our previously developed genome-wide association study (GWAS) data to build our PRSs as the instrument for UL and race-specific GWAS summary statistics for candidate novel and known clinical phenotypes from the UK BioBank (UKBB). Results: The MR Egger model was significant (p=0.018) for the EA PRS and endometriosis. The intercept of the model was significant (p=5.4x10 -3 ) indicating some of the variants in the EA PRS directly influence endometriosis risk, independently of UL risk. MR analyses between the EA PRS and the phenotypes ovarian cysts, BMI, and systolic blood pressure revealed no horizontal pleiotropy between the phenotypes. Conclusion: MR analysis identified potential horizontal pleiotropy between the EA PRS and endometriosis. Horizontal pleiotropy between the two phenotypes suggests there are shared pathways involved in their etiology. Through this study, we will gain insights into the genetic origin of UL. Future MR analyses will be conducted on the remaining phenotypes to understand their relationships with UL. Recent studies have indicated an association between uterine fibroids and several cardiovascular disease (CVD) risk factors such as hypertension, obesity and abnormal serum lipids. It has also been reported that estrogen levels are inversely related to cholesterol levels. As fibroids are estrogen-related tumors, an inverse association between hyperlipidemia and the risk for fibroids should be observed. Methods: An IRB-approved retrospective chart review was conducted using the electronic medical records of 888 women aged 18 years and above seen at the State University of New York (SUNY) Downstate Health Sciences University's Outpatient OB/GYN Suite. Women who were pregnant were excluded as well as those who were diagnosed with HIV or renal failure, had history of psychiatric illness, and were on hormone therapy for reasons other than UL. Data extracted included demographics, social history, medical history, BMI as well as laboratory parameters specifically glucose, Hemoglobin A1C (HbA1C), total cholesterol, triglycerides, HDL cholesterol, and LDL cholesterol. Initial analysis revealed a group difference in age. Age matching was completed using a propensity score analysis to match on exact age, using a greedy algorithm. The matched data were then analyzed for group differences using t-tests, Chi-square and Fisher's exact test. Results: A total of 444 women were included in the age-matched analysis: 222 women with UL and 222 without UL as controls. Women were predominantly Black (86%) with mean age of 42.1 ± 11.3 years and BMI of 31.2 ± 7.6 kg/m 2 . Majority of the women were currently non-smokers (89%) who denied current alcohol use (81%). There was no difference between the groups in terms of BMI (p= 0.7908), current smoking (p= 0.0589) and current alcohol use (p= 0.2956). Women with UL were more likely to have a history of hypertension than controls (UL= 33.6 % vs. controls= 23.6%; p = 0.0213). There was no difference between the groups in history of diabetes mellitus (p= 0.4798), heart disease (p= 0.9835) and dyslipidemia (p= 0.2326). There was no difference between the groups in mean glucose levels (p= 0.3127) and mean HbA1C levels (p= 0.0995). Mean lipid profile parameters were all within normal range and there was no difference noted between the groups for any those parameters. Conclusion: In our population of predominantly Black women assessed for cardiovascular risk factors, women with UL were more likely to have a history of hypertension than those without UL. There was no association between presence of UL and other risk factors such as history of diabetes mellitus, heart disease and dyslipidemia. Introduction: Background/Objective: Submucous uterine myomas can be reliably and effectively treated by microwave endometrial ablation (MEA), yet additional treatment is often required due to postoperative recurrence. This study investigated the therapeutic efficacy of MEA when combined with transcervical resection (TCR). Methods: This retrospective study analyzed 32 women who had been treated for submucous uterine myoma(s) by MEA in combination with TCR ("MEA+TCR") at the International University of Medicine and Welfare Hospital between January 2016 and June 2020, and had been followed up for a minimum of six months after the procedure. Their medical records were retrospectively reviewed for information on the procedure's effectiveness in reducing heavy menstrual flow (menorrhagia/ hypermenorrhea), secondary effects in reducing menstrual cramps (dysmenorrhea), and complications. Efficacy was assessed in terms of pre-and post-treatment hemoglobin (Hb) levels and patients' visual analog scale (VAS) ratings of hypermenorrhea and dysmenorrhea severities as well as treatment satisfaction (maximum: 10 pts). Results are reported as mean±SD (range). The study population consisted of 32 women (6 nulliparous, 26 multiparous) of mean age 45.2±4.3 (36-52). Fibroids were single and multiple in 10 and 22 cases, respectively, with a major diameter of 26.3±12.3 mm and protrusion rate of 51.3±11.3%. The procedure lasted 45.5±21.0 (19-110) min and involved 7.0±1.3 (5-11) ablation cycles on average; patients stayed in hospital for 2.5±0.5 (2-3) d. Patients regarded their hyper-and dysmenorrhea as very severe at 10 months before the procedure, uniformly giving VAS scores of 10/10 pts for both items. Their ratings of menorrhagia severity had significantly improved by 3 and 6months post-surgery, dropping to 1.2±1.3 (0-5) and 0.9±1.3 (0-5) pts, respectively (both p<0.001). Similarly, VAS scores for dysmenorrhea severity markedly improved over the same time frames, falling to 1.3±1.8 (0-7) and 1.3±1.8 (0-5) pts, respectively (both p<0.001). Circulating Hb significantly improved from 8.7±1.9 (5.1-12.5) g/dl before the procedure to 13.5±1.1 (11.3-15.2) g/dl after it (p<0.001). No surgical complications were observed. The mean follow-up length was 33.8±16.8 (6-60) months: while 10 women (31.3%) developed amenorrhea during this period, no one experienced recurrence of hypermenorrhea. Patients were highly satisfied with MEA+TCR's ability to relieve menorrhagia (mean VAS score: 9.5±0.8 (7-10) pts). Conclusion: MEA+TCR can reliably and effectively treat hypermenorrhea resulting from submucous myomas by reducing the size of uterine fibroids. The procedure's effectiveness is further supported by patients' high levels of satisfaction with it. The Introduction: Uterine fibroids feature dysregulation of major physiological events leading to fibrosis, inflammation, and neoangiogenesis. These processes are regulated by growth factors, including PDGF, FGF, VEGF, and activin A. Nintedanib is an FDA-approved receptor tyrosine kinase inhibitor used for the treatment of idiopathic pulmonary fibrosis. Here, we tested the hypothesis that nintedanib would alter expression of genes involved in fibrosis, inflammation, and angiogenesis in uterine fibroid cells. Methods: Human myometrial (P51M) and fibroid (P51F) cells were treated with nintedanib at different concentrations (0.1, 0.5, 1, 5, and 10 µM) for 24hrs to examine cell viability. After 24hrs serum starvation, both cell types were treated with nintedanib at 5 µM for 24hrs with media supplemented with 10% serum. Then we measured mRNA and/or protein expression of fibronectin (FN1), versican (VCAN), plasminogen activator inhibitor-1 (PAI-1), and activin A (INHBA) (fibrosis), interleukin 8 (IL-8; inflammation), and endothelin 1 (EDN1; angiogenesis). Differences were considered significant at p ≤ 0.05. Results: Myometrial and fibroid cells proliferated at lower concentrations (0.1-1 µM) of nintedanib, and viability of fibroid cells exceeded ≥ 80% at 5 µM concentration. As expected, mRNA levels of the major extracellular matrix components FN1 and VCAN were elevated 1.84 fold ± 0.07 and 2.80 fold ± 0.24, respectively in fibroid cells vs myometrial cells. Nintedanib treatment significantly reduced levels of both transcripts in both cell types. Western blots confirmed the reduction in FN1 protein levels in fibroid cells after nintedanib exposure. The profibrotic growth factor INHBA was found to be higher (3.07 fold ± 0.15) in fibroid cells at baseline and nintedanib treatment significantly reduced mRNA levels of INHBA. Nintedanib treatment greatly reduced both mRNA and protein levels of PAI-1, a downstream target of activin A-mediated signaling in both cell types. The basal mRNA levels of the inflammatory molecule IL-8 were significantly higher (4.60 fold ± 0.33) in fibroid cells, as compared to myometrial cells while nintedanib treatment significantly reduced IL-8 levels in both cell types. Furthermore, basal levels of angiogenic factor EDN1 were found to be higher (3.22 fold ± 0.32) in fibroid cells vs myometrial cells, whereas nintedanib significantly reduced EDN1 levels. Conclusion: Treatment of uterine fibroid cells with nintedanib reduced expression of transcripts and proteins of key genes involved in fibrosis, inflammation, and angiogenesis. These results support further research efforts to examine the effect of nintedanib on growth factor-mediated signaling pathways for in vitro and in vivo models of uterine fibroid development. They are the most common reproductive tract tumors in women with an incidence up to 80% by age 50. Common symptoms are heavy menstrual bleeding, pelvic pain, and dysmenorrhea. Currently, hysterectomy is the only cure for these symptoms, and accounts for about 50% of all hysterectomies performed in the US. Understanding the disease etiology will lead to alternative and less invasive therapies. Uterine myometrium has the unique property to significantly enlarge in size during pregnancy to accommodate the developing fetus, suggesting the existence of myometrial stem cells, which we predict will have a mesenchymal stem cell (MSC) phenotype. Moreover, uterine fibroids are almost always clonal, strongly suggesting a single, dysregulated cell origin that we hypothesize is the MSC. We have used next generation sequencing, such as 1) standard RNAseq and 2) single cell RNAseq (scRNAseq) to identify markers capable of significantly enriching MSCs for experimentation in order to better understand the disrupted mechanisms that lead to fibroid development. Methods: Uterine myometrial samples were collected (n=5) and digested. Live cells were separated by flow cytometry using a MSC surface marker, SUSD2. Total RNA from SUSD2+/-cells was submitted for RNA-seq. Cells (n=7,000) from each patient were submitted for scRNA-seq on the 10X Genomics Chromium platform. A Uniform Manifold Approximation and Projection plot was generated from the scRNA-seq and combined with the RNA-seq signatures from SUSD2+/-cells. Results: 2,531 genes were enriched in the SUSD2+ cell population, including known MSCs markers such as MCAM, PDGFRB and CSPG4. Seven cell clusters were found within the myometrium and the vascular myocyte cluster (a common niche for MSCs) was enriched for MSC markers (MCAM, PDGFRB, CSPG4 and SUSD2). We delimited the MSCs within the vascular myocyte cluster (Fig 1, red circle) by using stem cell characteristics, such as the quiescent cell cycle state (G0) and the transcriptional dynamics of individual cells (velocity). Indeed, a smaller cell population expressed gene markers for the quiescent G0/G1 phase ( Fig 1A) and have low RNA velocity ( Fig 1B) . We are using these markers to enrich for these myometrial cells and confirm stemness using assaying typical stem cell activities. We have found a population of myometrial cells with characteristic MSC markers that can be used to enrich for myometrial stem cells for continued studies and better understand the etiology of uterine fibroids. Our objective is to conduct a comprehensive review and analysis of published cases of female genital MCD to investigate the demographic data, signs and symptoms, and treatment to educate providers and prevent misdiagnosis. Methods: Literature searches were conducted using the search terms: "vulvar Crohn's disease", "vaginal Crohn's disease", "genital Crohn's disease" and "genital granulomatosis". Case reports and case series from journal inception date to November 20th, 2020 in PubMed, CINAHL, Web of Science, and OVID databases were retrieved. Results: A total of 89 articles reporting 105 female cases of genital MCD were included. The median ages of admission, CD diagnosis, and onset of genital symptoms were 31, 20, and 29 years, respectively. About 26.2% of the women presented with genital symptoms before diagnosis of CD. The common genital symptoms of MCD were vulvar edema, pain, ulcers, fi stulas, masses, and infections, see Table 1 . The majority of the cases (n=93) were diagnosed by the presence of non-caseating granuloma via genital biopsy. Around 83.8% of women received medical and surgical management as listed in Table 2 . About 71.4% of women included achieved partial improvement (n=34) or complete resolution (n=41). Conclusion: Genital metastasis is a rare and commonly misdiagnosed complication of CD in women. The presentations of vulva edema, pain, and ulcers warrant investigation and careful management of genital MCD via medical and surgical intervention. To our knowledge, our study is by far the most thorough review of published cases, which may increase provider awareness, improve patient outcomes, and off er preventative measures. Pregnancy. Yuanlin Dong * , Ancizar Betancourt, Michael Belfort, Chandra Yallampalli. Balor College of Medicine, Houston, TX, United States. Introduction: Gestational diabetes mellitus (GDM) is one of the most common complications of pregnancy whose pathophysiology to date has not been completely clarified. Emerging evidence suggest an important involvement of adipose tissues (AT) in insulin resistance (IR), but the profile of adipokines involved in inflammation and lipid metabolism in GDM remain obscure. Present study was designed to investigate if omental AT (OMAT) from GDM women express greater levels of proinflammatory and lipolytic molecules compared to subcutaneous AT (SCAT), and if so, whether the regional differences in AT have implications for lipid homeostasis. Methods: Paired samples of OMAT and SCAT were excised from women during scheduled Cesarean sections at term in pregnant women with normal glucose tolerance (NGT) with either normal weight NW, BMI<25 kg/m 2 ) or obese (OBS, BMI>30 kg/m 2 ) and GDM ( BMI>30 kg/m 2 ) (n=4 in each group). The mRNA expressions for proinflammatory and lipid metabolic molecules were determined by quantitative RT-PCR, and their cellular localizations in AT were visualized by immunofluorescent staining. Human adipocyte cell line and human AT were cultured and glycerol release was measured to assess the lipolytic status. Results: : (1) Human AT express mRNA for proinflammatory molecules of RBP4 and TLR-4, and adipogenic molecules of ChREBP and CEL, but the differences between OMAT and SCAT and among NW, OBS, and GDM groups were not significant (P>0.05). (2) The mRNA of monocyte chemoattractant protein, MCP-1, macrophage marker CD68, and IL-6, IL-8, and TNF-α were significantly increased in OMAT from GDM women compared to OMAT and SCAT in NW and OBS women (P<0.05). (3) Immunostaining intensity per adipocyte show that ADM and its receptor components CRLR, RAMP2 and RAMP3, were significantly higher in OMAT compared to SCAT in all segments tested (P<0.05). (4) Glucose stimulates adipocyte MCP-1 mRNA expression, and TNF-α enhances ADM and its receptor component mRNA in adipocytes in culture in a dose-dependent manner. (5) In both OBS and GDM women basal glycerol release was higher in OMAT compared to SCAT (P<0.01), and OMAT from GDM releases more glycerol than OMAT from NW and OBS subjects (P<0.01), and (5) ADM dose-dependently stimulates glycerol release by OMAT, but not by SCAT, in women with NW, and ADM-induced increases in glycerol were reduced by pre-incubation of AT with ADM receptor blocker, ADM22-52. Conclusion: Excessive ADM and its receptor expressions by OMAT, but not by SCAT appear to contribute substantially to the lipid dysregulation in GDM women, and the increased proinflammatory molecules in OMAT may play a major role in stimulating ADM and its receptor expressions. Therefore, detailed understanding of the role of ADM in AT may provide new insights into GDM pathophysiology and open new possibilities for its prevention and treatment. Table 1 ). This diff erence was observed for singletons (12.5% vs 26.8%) but not for twins (12.5% vs 7.1%).At 7 days after randomisation, no diff erences were observed, except for singletons, ≤ 30 weeks GA ( Table 1 ). The incidence of maternal, fetal and neonatal adverse events were comparable between the treatment groups (Table 1) . The PROLONG trial provides initial evidence that ebopiprant, when administered with atosiban infusion to women with preterm labour, reduces the probability of delivering within 48 h. Anne-Marie Aubin †, 1 Compared to cerclage only, combined therapy was associated with reduced risk of PTB <32-weeks, reduced risk of PTB <34-weeks, increased birthweight, increased GA and a longer interval between intervention and delivery. Compared to progesterone alone, combined therapy was associated with reduced risk of PTB <32-weeks, reduced risk of PTB <28-weeks and increased GA. There were no diff erences in any other secondary outcomes. Conclusion: Combined treatment of cervical cerclage and vaginal progesterone achieves a greater reduction in PTB compared to single therapy. Further well-conducted and adequately powered randomized controlled trials are needed to assess these promising fi ndings. Enhancing is usually used to process raw recordings to obtain desired frequency band but it cannot reject interfering noises with overlapping spectra. In addition to a BBF, we propose to use a wavelet-based algorithm, Sureshrink, to further remove background noises. We validate the eff ectiveness in the state-of-the-art electromyometrium imaging (EMMI) technology, where we denoise EMGs recorded on body surface and derive EMGs on entire uterine surface (uEMG) with EMMI software. We show that Sureshrink signifi cantly increases the SNR of uEMG and thus improves EMMI. Methods: Data from EMMI human studies are used. We applied <192 BioSemi electrodes to abdomen and lower back encasing the uterus and collected data on body surface at a 2048 Hz sampling rate. Data collection is done in a delivery room a few hours before labor, along with the pressure recording from a Tocodynamometer (TOCO) contraction monitor. After a BBF of (0.34-1Hz), we perform SureShrink in Matlab to further exclude interfering noises. It involves a discrete wavelet transform to decompose signals to wavelet coeffi cients (WC) and the inverse transform to synthesize WCs back to signals. In between, WCs are shrank by an optimized soft threshold rule, which is nonlinear, adapted and level/timedependent. We then obtain 320-channel uEMGs by EMMI software and compare Signal-to-noise ratio (SNR) with/without SureShrink. For each channel, we defi ne SNR=20 log 10 (A con /A base ), where A con and A base denote the root mean square of segments of contraction and baseline confi rmed by TOCO respectively. Introduction: The incidence of preterm labor is about 12% world-wide, and remains the leading cause of neonatal mortality and morbidity, bringing heavy emotional and fi nancial burdens to both family and society. Parturition is a complicated maternal-fetal interactive process, coordinately regulated by hormones, nutrition, metabolites and the immune system. Our previous studies revealed the signaling mechanisms and regulation of maternal-fetal endocrine factors in the initiation of labor. However, the maternal-fetal interface, i.e. decidua, is a heterogeneous composite of multiple cell types. Although several studies have examined the human placental transcriptome of trophoblasts and stromal cells from later stages at the single-cell level, the subtypes of decidual T cells that play key roles in maternal-fetal immune tolerance during pregnancy, and their distribution in term labor vs. preterm labor remain largely elusive. Methods: In the present study, a total of 8 single-cell RNA-seq libraries were prepared from T cells enriched by CD3 + magnetic beads in two decidual compartments: decidua basalis (DB) and decidua parietalis (DP) from four women either at term in labor (TIL) or in preterm labor (PTL). ScRNA-seq libraries were prepared with the 10X Chromium system and were processed using the 10X Cell Ranger software, resulting in 64,249 cells being captured and profi led across all samples. We used Seurat to normalize expression profi les and identifi ed 12 distinct T cell clusters in both DB and DP. Using Logistics regression analysis, we found that 4 of the 12 clusters were correlated with preterm labor, either in DB or in DP samples. Using previously reported marker genes, we identifi ed a TIGIT high CTLA4 high IL10RA high Treg cell cluster, which manifested a much higher distribution in TIL T cells compared to PTL T cells, both in DB and DP samples. In vitro experiments showed that ORM1, a glycoprotein we recently found to be elevated in the plasma of patients undergoing PTL, could signifi cantly inhibit Treg cell diff erentiation and increase its apoptosis. Interestingly, we also defi ned two new subtypes of CD8 + T cells characterized by NKG7 high PRF high GZMK high and NKG7 high GZMK high TIGIT high IL10RA high in DB T cells, which manifested predominant distribution in PTL samples and TIL samples, respectively. Although these two types of T cells both express active and cytotoxic T cell markers, the latter subtype also highly expresses inhibitory T cell markers such as TIGIT and IL10RA. The aim of this systematic review and meta-analysis was to compare gestational latency between those who did and did not receive adjunct antibiotic or tocolytic therapy at the time of exam-indicated cerclage. Methods: We searched electronic databases from 1966 to 2020 for randomized controlled trials (RCT) and cohort studies comparing adjunct antibiotic or tocolytic use versus non-use at time of exam-indicated cerclage. No language restrictions were applied. Exam-indicated cerclage was defi ned as placement for cervical dilation ≥ 1 cm between 16 0/7 and 24 0/7 weeks' gestation in a singleton pregnancy. Studies including individuals with intra-amniotic infection, cerclage already present, nonviable gestation, or ruptured membranes were excluded. The primary outcome was latency from cerclage placement to delivery. Secondary outcomes included preterm birth <28 weeks and neonatal survival. We used the Cochrane Risk of Bias tools to assess study quality. Heterogeneity was assessed using the χ 2 and I 2 tests. Results were pooled and analyzed using a random-eff ects model. Results: Of 923 unique records identifi ed, 163 were reviewed in full. Three met inclusion criteria: one RCT and two retrospective cohort studies. The RCT was nested within one of the cohort studies, and therefore only one of these two studies was utilized for any given outcome to eliminate counting individuals twice. Risk of bias was "critical" for one cohort, "moderate" for one cohort, and "some concerns" for the RCT. Gestational age latency was reported by only one study and could not be pooled. Adjunct tocolytic-antibiotic therapy with exam-indicated cerclage was not associated with a decrease in risk of preterm delivery <28 weeks (RR 0.90, 95% CI 0.65-1.26; χ 2 =0, I 2 =0%) or neonatal survival (RR 1.11, 95% CI 0.91-1.35; χ 2 =0.05, I 2 =0%). Only three studies of adjunct antibiotic-tocolytic therapy at the time of exam-indicated cerclage were identifi ed. The available studies were insuffi cient to draw any conclusions regarding the eff ect of these therapies on meaningful outcomes. Preterm The aim of the study is to determine the incidence of prelabor preterm rupture of membranes (PPROM) after cerclage placement and to determine the predictors of PPROM after cerclage. Methods: This is a retrospective cohort study of women with singleton gestations who underwent history-, ultrasound-or examination-indicated cerclage over a 3-year period, excluding those without outcome data and pregnancies complicated with structural or genetic anomalies. Within this cohort we assessed the incidence of PPROM <37 weeks gestation. We then performed a nested case-control study to assess variables associated with PPROM. Cases included those with PPROM <37 weeks, and controls were those without preterm rupture at any time after cerclage placement. Participants had ultrasound prior to cerclage placement and sludge was noted if present. Sludge was defi ned as free-fl oating echogenic material at the internal os by review of transvaginal sonographic images during ultrasound. Demographics and clinical characteristic were compared between cases and controls using t-test, Kruskal-Wallis test, chi-square test, or Fisher's exact test as appropriate. We fi t a logistic regression model to assess the contribution of each baseline variable to PPROM. Results: Of 293 women receiving a cerclage in our study period, 243 were included. A total of 14 women (5.8%) delivered before 24 weeks. 60 women (24.6%) had PPROM after cerclage placement, of whom 12 (20%) had PPROM before 24 weeks of gestation. Specifi cally, among women with examination indicated, ultrasound indicated and history indicated cerclage, 35.7%, 26.4% and 18.8% had PPROM respectively. The mean gestational age of PPROM for examination indicated, ultrasound indicated and history indicated cerclage was 27 weeks, 26 weeks and 31 weeks respectively. Bivariable analyses showed that women who had PPROM after cerclage placement were more likely to be younger, have government insurance, have greater cervical dilation prior to cerclage placement, have an examination indicated cerclage, or have the cerclage placed at a later gestational age. However, after adjusting for confounders, no clinical variables, including maternal age, race, BMI, insurance, alcohol, tobacco, or drug use, cervical dilation prior to cerclage placement, gestational age of cerclage placement, indication for cerclage, the presence of sludge, or amniocentesis prior to cerclage placement were predictive of PPROM. Conclusion: Approximately 1/4 of women who receive a cerclage will experience PPROM before 37 weeks, with 5.6% delivering prior to 24 weeks. Even though, relatively common, it can be challenging to predict the cohort of women who will PPROM after cerclage placement. Methods: This retrospective study was conducted on 18 women who underwent caesarean section and whose fetuses were affected by diaphragmatic hernia between 2015 and 2020. Out of these 18 patients, 13 gave birth between 2015 and 2018 and followed a standard procedure involving intubation of the fetus immediately after delivery. The remaining 5 patients followed the EXIT protocol, adopted in 2019, which consists in intubating the fetus after extraction of the head, neck and upper trunk, while keeping the rest of the fetal body inside the maternal uterus. Results: 100% of fetuses born by EXIT procedure (n=5) survived and underwent hernia correction surgery. Of those born by standard procedure (n=13) , only 25% survived (n=3) and underwent surgery. The EXIT protocol has been adopted by the Obstetrics and Placental gene expression was assessed by Real-time PCR. Parametric or non-parametric tests were applied for statistical analysis depending on data distribution. Results: Placental efficiency resulted progressively lower from NW to OB GDM (-) and OB GDM (+). Antioxidant gene expression (CAT, GPX1, GSS) significantly decreased in OB GDM(-) compared to NW. In OB GDM(-) the pro-autophagic gene ULK1 significantly increased its expression respect to NW, whereas the expression of the main chaperone involved in CMA (HSC70) decreased in both OB GDM(-) and OB GDM(+) compared to NW. The expression of the CMA regulator PHLPP1 decreased in OB GDM (-) vs NW but its expression increased in OB GDM(+) vs OB GDM(-). When analyzing results in relation to fetal sex, we found sexual dimorphism for both antioxidant and CMArelated gene expression. Conclusion: There are few reports correlating autophagy to obesity, suggesting autophagy deregulation in the obese omental and subcutaneous adipose tissues. However, the role of autophagy in human placentas remains controversial. In particular, only few contrasting studies in OB/ GDM placentas reported alterations of macroautophagy, but to date placental CMA activity has never been specifically investigated. Moreover here we report for the first time an increase in PHLPP1 expression in the OB GDM(+) group supporting a correlative hypothesis between PHLPP1 activity and GDM. The sexual dimorphism might suggest different molecular mechanisms involved in GDM, with possible different resulting outcomes.These preliminary results can pave the way for further analyses aimed at elucidating the placental autophagy role in metabolic pregnancy disorders and its potential targetability for the treatment of diabetes outcomes. Introduction: Maternal underweight and obesity are prevalent conditions associated with chronic, low-grade inflammation, poor fetal development, and long-term adverse outcomes for the child. The placenta adapts in response to challenges in the pregnancy environment, such as suboptimal maternal body mass index (BMI), to support optimal fetal development. However, the mechanisms driving these adaptations, and the resulting placental phenotypes are poorly understood. We hypothesised that suboptimal maternal BMI would be associated with increased prevalence of placental pathologies related to inflammation and maturation in term (T) and preterm (PT) pregnancies. Methods: A retrospective cohort study was conducted using data from 12,154 pregnancies with placental assessments from the Collaborative Perinatal Project. The associations between maternal BMI (primary exposure) and placental pathologies (primary outcomes) were assessed by unadjusted and adjusted linear or nominal logistic regression models (adjusted for fetal sex, maternal race, maternal age, maximum gestational weight gain, smoking history, maternal education, and diabetes status). We also explored the effect of fetal sex on placental pathologies. Data are adjusted β (95% CI Opioid abuse has reached epidemic levels in the United States prompting further characterization of vulnerable populations. Use of opioids is common after bariatric surgery and greater risk of chronic opioid use may be associated with this type of surgery. The objective of our study is to evaluate postpartum opiate use by type of bariatric surgery. Methods: This is a retrospective cohort study in subjects with a history of bariatric surgery who delivered from 2009 to 2019 in a single academic center. Subjects were stratifi ed by surgery type into those with a history of a primarily restrictive surgery type (gastric band or gastric sleeve) or a primarily malabsorptive type (Roux-en-Y gastric bypass or duodenal switch). Univariable and multivariable analyses were performed. Opiate use postpartum was quantifi ed by total morphine millequivalents (MME) and top quartile opiate use during inpatient postpartum stay. Linear regression was performed with possible confounders included in the adjusted model. Results: A total of 190 subjects met inclusion criteria. Of those, 45 had a history of primarily restrictive surgery type and 145 primarily malabsorptive. Women with prior malabsorptive surgery had lower body mass index (BMI), were further out from surgery in the current pregnancy, and more like to be anemic than women with primarily restrictive surgery type (Table 1) . Total ibuprofen use and MME use during admission were higher in women with malabsorptive procedure type (2400 mg vs 200 mg and 61.6 MME vs 22.5 MME, respectively). MME use was not statistically signifi cantly diff erent between groups after controlling for confounders (aLRC 42.31, 95%CI -3.42 to 88.03) and both groups were similarly likely to be in the top quartile of opioid users (aOR 2.05, 95% CI 0.65 to 6.47). Conclusion: Subjects with primarily malabsorptive surgery used less ibuprofen than those with prior restrictive surgery. The type of bariatric surgery did not impact amount of opioid use postpartum. , and physical activity. Key words in our search strategy related to psychological therapies were psychotherapy, behavior therapy, cognitive behavioral therapy (CBT), motivational interviewing (MI), motivational enhancement therapy, mindfulness, hypnotherapy and incentives. We included studies that used a control group receiving usual care or an alternative version of a psychological intervention. Methodological quality was scored using the ErasmusAGE tool. A protocol of this systematic review has been registered in PROSPERO International prospective register of systematic reviews (PROSPERO 2020: CRD42020201172). Results: Of 5760 unique citations found, 40 studies were included. The mean quality score was 6.8 (range: 0-10). MI (n=21), CBT (n=8), incentive-based contingency management (IBCM) (n=9), mindfulness (n=1) and hypnosis (n=1) were investigated in combination with lifestyle behaviors. The fi ndings revealed that MI was eff ective in reducing (selfreported) smoking and alcohol consumption and restricting gestational weight gain (GWG). CBT was only studied as an intervention to restrict GWG and results predominantly confi rmed its eff ectiveness. IBCM was the most eff ective intervention for reducing smoking and substance use. The studies using hypnosis or mindfulness to reduce smoking or restrict GWG, respectively, showed no associations. The use of psychological therapies to improve lifestyle behaviors among (pre)pregnant women is relatively new and the emerging scientifi c proof is promising. Before wide implementation is legitimated, more evidence should become available on specifi c lifestyle factors, and on the subsequent consequences of lifestyle change on pregnancy outcomes. Numeracy Scores and Perinatal Outcomes among Women with Gestational and Pregestational Diabetes. Jennifer Jacobson †, 1 Amy Godecker, 1 Jennifer Janik, 1 April Eddy, 2 Jacquelyn Adams * . 1 (PC06) has been added as a quality measure to balance NTSV cesarean delivery rate. The goal of this project is to assess the relationship between maternal quality metrics (severe maternal morbidity (SMM)) and neonatal counterbalance measures (PC06 criteria) in an institution with a low NTSV cesarean delivery rate. Methods: Deliveries occurring between 1/2016-6/2019 were identifi ed using the pre-defi ned ICD-10 codes for PCO6 inclusions and exclusions. Term, appropriately grown, singleton infants without preexisting congenital or metabolic abnormalities, or evidence of maternal drug use in pregnancy were included. Maternal medical records of these infants were reviewed for parity, and nulliparous women were selected in order to evaluate NTSV qualifying women against both the PC06 and SMM complications of delivery (n=2543). SMM was similarly identifi ed using pre-defi ned ICD-10 codes. Results: The NTSV cesarean delivery (CD) rate was stable at 20%, the PC06 rate was stable at 3.7%, and the SMM rate was stable at 1.6% over the study period. Of all patients that met NTSV criteria, 6.6% (n=167) had SMM and/or PC06; 1.6% (n=40) had SMM, 5.0% (n=127) Conclusion: Overall, we found that low risk NTSV women at our institution experienced maternal or neonatal morbidity in 6.6% of deliveries. While we observed a marked increase in both PC06 and SMM risk in CD, the co-occurrence of these morbidities did not seem to be related. These data suggest that while we strive to reduce NTSV CD, we must monitor unexpected maternal and neonatal morbidities to ensure that our attempts to minimize CS do not result in negative consequences within our low-risk patient population. Introduction: Anemia in pregnancy has been linked with signifi cant maternal morbidity including maternal blood transfusion and cesarean delivery. We sought to investigate whether women with iron defi ciency anemia who receive intravenous (IV) iron infusion therapy have decreased risk for maternal morbidity compared to those who do not. Methods: This is a retrospective cohort study of women with a diagnosis of iron defi ciency anemia who delivered at term at a tertiary hospital from October 2013 to August 2020. Data were extracted from the hospital electronic medical record data warehouse using standardized defi nitions and billing and diagnosis codes. Women with iron defi ciency anemia who received IV iron infusion therapy during the prenatal period were compared to women who did not. The primary outcome was a composite maternal morbidity outcome that included receipt of blood transfusion, hysterectomy, and/or admission to the intensive care unit. Bivariate analyses and multivariable logistic regression modeling were performed. Results: Of a total of 35,265 deliveries, 6351 (18%) had a diagnosis of iron defi ciency anemia. Among this sample, 731 (11.5%) received IV iron during their pregnancy. Women who received IV iron were more likely to be of Hispanic or Black race, have Medicare/Medicaid insurance, be single/divorced/widowed, or multiparous compared to women who did not receive IV iron (Table 1 ). There was an increased risk of the composite maternal morbidity outcome in the group who received IV iron therapy (n=43, 5.9%) compared with the group who did not (n=186, 3.3%), (OR 1.83, 95% CI 1.30-2.57). After adjusting for potential confounders, including mode of delivery, race-ethnicity, parity, insurance type, and marital status, this association persisted (aOR 1.80, 95% CI 1.27-2.55). Conclusion: In contrast to our study hypothesis, composite maternal morbidity was increased among women who received IV iron. These fi ndings, however, are not felt to suggest a lack of effi cacy of IV iron. Instead, fi ndings suggest that women at higher risk of maternal morbidity are more likely to receive IV iron therapy. Further investigation is warranted to determine why this study population had worse maternal outcomes. The renin-angiotensin system (RAS) contributes to the physiological changes of pregnancy and angiotensin converting enzyme 2 (ACE2) is a key RAS regulator. Emerging evidence suggests circulating ACE2 is an indicator of cardiovascular stress outside of pregnancy. However, the signifi cance of elevated ACE2 during pregnancy requires further study. Methods: Data were derived from an observational cohort study of women at low risk for pre-eclampsia by USPSTF criteria and a trial of patients defi ned as high-risk for pre-eclampsia randomized to 81mg vs 162 mg of aspirin. Serum samples were obtained at two time points: 11-16 weeks (prior to aspirin) and 28-32 weeks gestation. Serum ACE2 activity was assessed by a natural substrate conversion assay where the product was quantifi ed by liquid chromatography with tandem mass spectrometry (LC-MS/MS), considered to be the gold standard for quantifi cation of angiotensin peptides. Serum concentrations of AngII and Ang-(1-7) (the substrate and product of ACE2, respectively), were also determined by LC-MS/MS. Analyses were completed with paired t-tests, RM 2-way ANOVA, and chi-square tests. Results: 78 low-and high-risk women were included. 7 women developed preterm pre-eclampsia. Across all groups, serum ACE2 activity was increased in the third vs fi rst trimester: in patients who did not develop pre-eclampsia (n=71; 1.81 +/-0.07 vs 1.37 +/-0.05 ng/mL, P<0.0001) and patients who did develop pre-eclampsia (n=7; 2.21 +/-0.23 vs 1.25 +/-ng/mL, P<0.0001). Moreover, the change in serum ACE2 activity was signifi cantly greater (1.2 fold) in patients who developed pre-eclampsia vs those who did not (P<0.01). Serum ACE2 activity was not diff erent at either time point in between low-risk patients (n=35) and the high-risk cohort treated with aspirin (combined data 81 mg + 162 mg, n=36), see Figure. ACE2 activity was not correlated with serum AngII concentrations at either time point. Serum Ang-(1-7) concentrations were detectable in only 4/7 and 1/7 women who developed pre-eclampsia in the fi rst and third trimester, respectively (vs 21/71 and 29/71 in those who did not, P=0.14 and P=0.17), and these peptides did not signifi cantly change over time. Conclusion: ACE2 increases during pregnancy and this change is signifi cantly greater in women who developed preterm pre-eclampsia. However, the increased ACE2 concentrations do not appear to infl uence systemic angiotensin peptide levels. Introduction: It is known that amniotic fl uid comes in contact with the maternal blood during childbirth and fl ows into the maternal circulation. In our previous study, we have reported that amniotic fl uid promotes blood coagulation and platelet aggregation through activated tissue factor pathway. Although amniotic fl uid contains some coagulation factors related to tissue factor-and contact activation pathways, it is not wellknown which mechanisms work towards blood coagulation with amniotic fl uid contamination. Protein C is an anticoagulant, which inactivates factor Va and VIIIa with its cofactor protein S. Pregnancy is a hypercoagulable state due to increased coagulation factors and decreased potential of anticoagulation system, therefore; we hypothesized that on contamination of pregnant maternal plasma with amniotic fl uid, the susceptibility to Activated protein C (APC) is decreased. The purpose of this study is to examine the eff ect on anticoagulation pathway when amniotic fl uid is mixed with pregnant women's plasma. Methods: Plasma collected from 51 healthy pregnant Japanese women in the 3rd trimester was mixed with increasing concentrations of amniotic fl uid. Activated Protein C-sensitivity ratio (APC-sr) was calculated using an endogenous thrombin potential (ETP) based assay where thrombin production was measured by calibrated automated thrombography. Results: APC-sr of maternal plasma signifi cantly increased in an amniotic fl uid volume-dependent manner indicating reduced sensitivity to APC. The diff erence in the ratio was approximately by 1 (p<0.0001) between without (0 µL) and with 8 µL of amniotic fl uid addition. The ETP in the presence of APC was signifi cantly elevated even with addition of 1 µL of amniotic fl uid (p<0.05). Conclusion: Our results demonstrate that addition of amniotic fl uid to pregnant women's plasma causes inhibition of anticoagulation pathway which may promote hypercoagulation and partly contribute to pregnancy disorders like pulmonary thromboembolism, which sometimes occurs during the early postpartum period. Further research is needed to identify the corresponding inhibitory mechanisms or factors in the amniotic fl uid involved in coagulation in the maternal system. Longitudinal (Table) . Interestingly, these metabolic differences between cases with and without diabetes were not present in the T1 plasma and there were no significant differences in the urine at either T1 or T2. Conclusion: These results reveal a unique metabolic signature in women with DM versus non-diabetics who later develop PE. As elevated BCAA and long-chain fatty acids are hallmark metabolic changes in non-pregnant diabetics associated with insulin resistance, future work aims to investigate the contributions of these metabolites to underlying PE pathophysiology. (Table 2) . Conclusion: An algorithm-driven review of P-SMM revealed differences in baseline characteristics between those with and without preventable events. This may help target intervention strategies to those at highest risk. More than 30% of P-SMM was associated with provider treatment choices. However, the majority of P-SMM had >1 category identified as an opportunity for improvement, suggesting that multifactorial approaches are needed. Introduction: Thrombocytopenia in pregnancy is defined as a platelet count less than 150,000/mL. Severe thrombocytopenia with platelet count <50,000/mL is a risk factor for procedural bleeding. However, the platelet count at which bleeding risk increases is unknown, especially relating to risk for postpartum hemorrhage (PPH). We hypothesized that women with any thrombocytopenia are at higher risk for PPH. Methods: This was a retrospective cohort analysis of women ages 14-55 delivering at a single center from 7/2013 -10/2018. Women at ≥ 28 weeks gestation with documented platelet count on admission to labor and delivery and quantitative blood loss (QBL) were included. The primary outcome was PPH, defined as QBL >1000cc. Secondary outcomes were median QBL, blood transfusion, administration of uterotonics (methylergonovine, carboprost, misoprostol, or tranexamic acid), and hemorrhagic shock. Subgroup analyses were then performed by platelet count in increments of 50,000/mL. Continuous variables were compared with Mann-Whitney or Kruskal-Wallis tests and categorical variables with chi-square or Fisher's exact tests with p<0.05 as significant. Results: 29,348 women were included, 4402 of whom had thrombocytopenia. Women with thrombocytopenia were more likely to have PPH. They also had a higher median QBL and were more likely to require transfusion or uterotonics (Table 1 ). There was no difference in shock. When women with thrombocytopenia were stratified by platelet count in increments of 50,000/mL, women with platelet counts <50,000/ mL were at the highest risk for PPH. As platelet count increased, risk for PPH, median QBL, and rates of transfusion and uterotonic use decreased, demonstrating a negative linear relationship (Table 2) . Women with mild thrombocytopenia, platelet count from 100,000-149,000/mL, remained at higher risk for PPH than women with normal platelets (OR 1.57, 95% CI 1.42-1.74, p<0.001). Conclusion: In our cohort, thrombocytopenia of any degree was associated with PPH. Women with the lowest platelet counts had the highest risk for PPH but even women with mild thrombocytopenia remained at increased risk compared to women with normal platelet counts. Methods: Retrospective cohort study of women with A2GDM who underwent antenatal surveillance at our institution between 9/1/2019-8/31/2020. During the peak of the COVID19 pandemic, AFT for women with A2GDM was reduced from twice weekly to once weekly, starting on 3/23/2020. Patients who received both testing frequencies were excluded. AFT consisted of a modified biophysical profile. We compared the incidence of pregnancy-induced hypertension (gestational hypertension, preeclampsia with or without severe features, or HELLP syndrome), primary cesarean delivery rate, macrosomia (neonatal weight >4000 grams), neonatal hypoglycemia (glucose < 35 mg/dL in the first 48 hours of life), and NICU admission between women who had once weekly versus twice weekly AFT. Wilcoxon rank-sum test, chi-squared, and Fisher's exact test were used for statistical comparison with p<0.05 considered statistically significant. Continuous data are expressed as median [interquartile range]. Results: 156 women had one AFT frequency for A2GDM during the specified time periods; 62 underwent once weekly testing and 94 had twice weekly testing. There were no significant differences in baseline demographics between groups (Table 1 ). There were no significant differences in perinatal outcomes between women who had once versus twice weekly AFT (Table 2) . The frequency of AFT in pregnancies complicated by A2GDM was not related to differences in perinatal outcomes. There may be an opportunity to individualize antepartum surveillance in this population with consideration of other risk factors. This could have particular relevance during a pandemic when weighing risks and benefits of frequent outpatient visits. Uterine Conservation with Placenta Accreta Spectrum. Table 1 . Of the 61% who had a previous cesarean delivery (CD) the majority had only one prior. Only two had concern for placental invasion (increta), and 83% had a previa at the time of delivery. Morbidly adherent placenta was confirmed for 78% at delivery, and outcomes for these patients are shown in Table 2 . 89% of the patients had the placenta completely removed and 83% had successful uterine conservation. These patients had lower estimated blood loss than those with hysterectomy (p=0.04), and had fewer units of blood cells transfused (p=0.03). Of the three unsuccessful conservation cases, one had increta and one had percreta on final pathology. There were no postpartum readmissions in the cohort, and only two postpartum complications -one wound breakdown and one smooth muscle infarct on postpartum hysteroscopic biopsy. Conclusion: Of our 18 confirmed cases of PAS at CD, 83% underwent successful uterine conservation with planned intraoperative UAE. While none had a delayed hemorrhage, infection, or readmission, the majority of patients had a significant postpartum hemorrhage. Patients should be selected for less invasive pathology to the degree possible, and should be delivered at a specialized center for PAS care. increasing preterm birth risk. While the mechanism for this relationship is unknown, uterine evacuation whereby the cervix is mechanically or osmotically dilated has been hypothesized to mediate risk for preterm birth due to the potential for cervical damage. Considering the known relationship between prior cervical surgery and an increased risk for preterm birth, an examination of procedures that result in cervical trauma can shed light on mechanistic reasons why cervical integrity in the midtrimester is a strong predictor of preterm birth. The aim of this systematic review was to evaluate studies that examine the relationship between prior TOP and spontaneous abortion (SAB) on measures of cervical health in subsequent pregnancies. Methods: This systematic review was conducted in line with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA). Research published over the last 60 years was assessed to capture the span of time whereby both surgical and medical TOP procedures were widely adopted. Studies that were included investigated the relationship between cervical health as the primary outcome and previous TOP/SAB status as the exposure. Research in which cervical health is a secondary focus was included if prior history of TOP/SAB was also reported. A systematic search for peer-reviewed literature was conducted in Medline (Ovid) and Embase (Ovid) in September, 2020 using a combination of keywords and controlled vocabulary for the concepts of TOP/SAB and cervical health. Risk of bias assessment was conducted using the Newcastle-Ottawa Scale. We assessed if a fetus with an AC > 95th %tile in the setting of an EFW ≤ 90th %tile develops an EFW > 90th %tile on follow-up ultrasound imaging and are LGA at birth. Methods: We identified singleton, non-anomalous fetuses at ≥ 24 weeks gestational age (GA) with an AC > 95th %tile and EFW ≤ 90th %tile over 5 years. Subsequent fetal growth scans were reviewed and categorized as 1) persistence of a dichotomy between AC (> 95th %tile) and EFW (≤ 90th %tile); 2) an EFW > 90th %tile; or 3) appropriate growth (AGA) (EFW ≤ 90th %tile and AC ≤ 95th %tile). Delivery records were extracted; birth weights (BW) were classified as LGA if they were > 90 th %tile for GA. Results: 280 subjects were identified as having dichotomous biometry at a mean (SD) GA of 34.3 (2.6) weeks. Of these, 61 had at least one subsequent scan ≥ 3 weeks later with 46% AGA, 18% LGA, and 36% remaining dichotomous. Of those who had more than one subsequent scan (n=9), 67% switched to another category. Based on last scan before delivery there were 43% AGA, 18% LGA, and 39% dichotomous fetuses. At birth, of these fetuses, 9%, 82%, and 10% were LGA newborns, respectively. Conclusion: Approximately 1 in 5 fetuses with dichotomous biometry will have an LGA fetus on subsequent scanning. This supports the use of follow up scanning for suspected impending LGA. However, these ultrasound findings may again become discrepant later in pregnancy. Based on last scan before birth, ultrasound based LGA is a relatively accurate predictor of birth weight, with few cases in the other categories resulting in an LGA newborn. (n=6) were culture positive at one hour, 60 percent (n=6) were culture positive at four hours and 60 percent (n=6) were culture positive at six hours after initiation of ampicillin. There were no significant differences in patient demographics. Conclusion: GBS culture results within one and six hours after initiation of ampicillin may not accurately reflect initial maternal colonization status prior to antibiotic administration. Positive results should be considered true positives but negative results may be falsely negative. These data point toward treatment of fetal exposure over eradication of maternal colonization as a possible mechanism of action. (ADN) are lower in pregnancies of obese mothers and are associated with increased placental nutrient transport and fetal overgrowth. We have previously shown that normalizing maternal ADN in late gestation in obese mice reverses placental dysfunction and fetal overgrowth and prevents cardiac dysfunction in adult offspring. We hypothesized that maternal obesity decreases cardiac mitochondrial respiratory function in adult offspring and that normalization of circulating adiponectin levels in obese pregnant mice prevents these changes. Methods: C57BL/6J female mice were fed either a control (CON) or obesogenic diet (OB). Pregnant females received a continuous infusion of sterile PBS or mouse recombinant full-length ADN from E14.5 until delivery resulting in the following groups CON-PBS, OB-PBS, and OB-ADN. At weaning, male and female offspring (n= 8-13/group) were fed a control diet until 7-9 months of age. Functional studies of high-resolution respiration on left ventricle samples used a lipid substrate-uncouplerinhibitor titration (SUIT) protocol with the Oroboros Oxygraph-2K. Respiratory rates were measured following the stepwise addition of palmitolycarnitine and malate (ADP independent), ADP (oxidative phosphorylation capacity), glutamate and succinate (Complex-I, II linked), oligomycin (leak state respiration following ATP synthase inhibition (L(Omy)), and carbonyl cyanide 4-(trifluoromethoxy)phenylhydrazone (FCCP) until maximal uncoupling (electron transport system capacity). One-way ANOVA followed by Tukey's multiple comparison post hoc tests was used to analyze results. Results: ADP independent and oxidative phosphorylation capacity were similar in all groups. Offspring from OB-PBS dams had reduced Complex-I, II linked respiration (-32%, p<0.05) compared to CON-PBS and OB-ADN. Similarly, OB-PBS offspring had lower rates of L(Omy) (-30%, p<0.05) and maximal uncoupled electron transport system capacity (-27%, p<0.05) compared to CON-PBS offspring. Restoring maternal ADN in obese pregnancies prevented left ventricle mitochondrial dysfunction in adult offspring. Conclusion: Exposure to maternal obesity led to decreased cardiac mitochondrial respiratory function in adult offspring and normalization of circulating ADN levels in obese pregnant mice prevented this cardiac mitochondrial dysfunction. We speculate that impaired mitochondrial respiratory function contributes to programming of cardiac dysfunction in offspring of obese mothers, and low maternal adiponectin in pregnancy may be an important programming factor. ) . Significant associations were limited to obesity, hypertension and lipid profile; none were evident with fasting glucose or fasting insulin. Conclusion: Genetic variants associated with HPA-A function (TSST) were associated with adult cardiometabolic outcomes independent of birthweight. These associations may explain, in part, the residual confounding seen in analyses evaluating the role of HPA-A function in moderating the relationship between birthweight and markers of adult disease. Introduction: Gestational hypertensive disorders and a higher maternal blood pressure across the full range during pregnancy are associated with higher offspring blood pressure. Animal studies suggest that early gestational exposure to an adverse in utero environment is related to vascular remodeling in the offspring of affected pregnancies. Therefore, we hypothesized that gestational hypertensive disorders and maternal blood pressure across the full range are not only associated with higher blood pressure, but also with early atherosclerotic changes in the offspring. Methods: Among 4777 mother-offspring pairs, we examined the associations of gestational hypertensive disorders and maternal blood pressure with offspring blood pressure, carotid intima media thickness and distensibility at the age of 10. We examined the effect of mediation by gestational age and weight at birth, breastfeeding status and child adiposity. We also explored critical periods for fetal exposure to a higher maternal blood pressure, as we expected the strongest effect in early pregnancy. Results: Compared to normotensive pregnancies, offspring of mothers with gestational hypertension had higher systolic and diastolic blood pressure (difference: 0.17 (95% CI 0.02,0.31) and 0.23 (95% CI 0.08, 0.38) SDS in offspring systolic and diastolic blood pressure, respectively), which was not explained by birth and child factors. Offspring of mothers with preeclampsia had higher systolic blood pressure, but this association attenuated after correction for birth and child factors. No associations were found for offspring carotid IMT and distensibility with any gestational hypertensive disorder. Higher maternal systolic and diastolic blood pressure in early, mid and late pregnancy were associated with higher offspring systolic and diastolic blood pressure and lower carotid distensibility (all p-values <0.05), but not with IMT. These associations persisted after correction for birth and child factors. We found the strongest effects for higher maternal blood pressure in early pregnancy. Conclusion: Gestational hypertension and already a higher maternal blood pressure across the full range during pregnancy are associated with higher blood pressure in the offspring. Higher maternal blood pressure is also associated with decreased offspring carotid distensibility. These findings suggest that higher maternal blood pressure influences blood pressure and arterial stiffness in the offspring. Further studies need to assess whether these associations reflect intrauterine mechanisms, or family-based shared lifestyle and genetic factors. Introduction: Gestational hyperandrogenism predisposes offspring to intrauterine growth retardation (IUGR) and cardiometabolic dysfunction in postnatal life. IUGR is associated with left ventricular (LV) hypertrophy and increases the risk for cardiovascular disease. In this regard, prenatal testosterone (T) excess induces IUGR and programs LV myocardial disarray and hypertension in adult female offspring. However, the early impact of prenatal T excess in programming cardiovascular dysfunctions and if it is female-specific is not known. We have previously shown prenatal T excess 1) increases fetal T levels in female fetuses to control male fetal levels while also increasing estradiol and 2) induces a transient increase in insulin-like growth factor 1 (IGF1). Because IGF-1 plays a key role in cardiac hypertrophy, metabolism and function, steroids are major programming agents, and males are exposed to higher levels of T during fetal life we hypothesized that the impact of prenatal T excess on LV remodeling involved early changes in expression of AR, ESR1, ESR2, and IGF-1R in the female fetuses but not in male fetuses. We further hypothesize early molecular changes adversely alter myocardial morphology (fibrosis and increased left ventricular mass). Methods: Pregnant ewes were injected with testosterone propionate (T), or oil-vehicle (CON), 100 mg i.m. twice weekly from gestational day 30 to 90; term: 147 days. At 90 days of gestation, fetal and heart weights were recorded, and LV tissues (n=6/sex/group) were collected, and snapfrozen or fixed in formaldehyde in PBS pH 7.4 and paraffin-embedded for molecular and histological analyses. Steroid and IGF-1R expression were measured by RT-PCR and collagen content using Masson trichrome staining. Data were analyzed by one-way ANOVA. Results: Heart/body weight ratios did not differ between the groups. While LV AR mRNA gene expression did not differ between T and CON fetuses, LV ESR2 was upregulated (P=0.027) in T treated females but not in males compared to their CON fetuses (11.1±3.3 vs. 1.8±0.7 and 6.2±2.5 vs. 1.6±0.7 respectively). No significant differences were observed in LV ESR1 in both female and male T fetuses. IGF1R was significantly increased (P=0.007) in T treated females but not T males compared to their CON fetuses (4.1±0.99 vs. 1.23±0.3 and 2.1±0.3 vs. 1.14±0.25 respectively). Histological analysis of LV showed no difference in collagen content among the groups. Conclusion: These data suggest that maternal exposure to excess T during pregnancy alters myocardial signaling pathways involved in programming cardiomyocyte structure and metabolism. Furthermore, the influence of gestational T excess on cardiac reprogramming may be mediated via estrogenic rather than androgenic programming. Supported by NIH R01HL139639. (1): [73] [74] [75] [76] [77] [78] [79] [80] [81] [82] [83] [84] [85] 2017) . Therefore, chronobiological processes may be linked to the programming of cardiovascular dysfunction by developmental hypoxia, which is one of the most common complications of human pregnancy, however this idea has never been tested. Here, in a study using mice, we provide the first evidence that gestational hypoxia influences clock gene expression in the placenta, the key interface between the maternal 24h rhythm and the fetus, and induces long-lasting effects on the cardiac clock of the adult offspring. Methods: Pregnant BALB/c mice were exposed to control (21% O 2 ) or hypoxic (10.5% O 2 ) conditions from embryonic day (E)11-E17.5 (term is E21). Placental tissue was sampled at 10 am on E17.5 in a cohort of animals. Another cohort delivered, and offspring were raised under normoxic conditions. Offspring hearts were then collected at the juvenile (2 week) and adult (8 week) stages. Clock gene expression was measured in tissues via RT-qPCR. Results: While there was no effect in females, hypoxic male placentas had greater expression of Hif1α (25%, P=0.02) and the core clock genes: Clock (39%, P=0.046), Per2 (44%, P=0.027) and Cry1 (55%, P=0.009), but reduced expression of Rev-erbα (-32%, P<0.05) compared to controls ( Fig. 1 A-E). Disruptions induced by gestational hypoxia also extended to postnatal life; cardiac clock gene expression was unaffected in juveniles, however adult male offspring of hypoxic pregnancy showed a substantial reduction in cardiac Per2 expression (-67%, P<0.05; Fig.1 Methods: Female C57BL6/J mice were fed chow (11% fat) or an obesogenic high-calorie diet (41% fat + 20% sucrose) before mating and throughout pregnancy and lactation. The liver and gastrocnemius muscle were snap frozen following collection from fetuses on E18.5 from obese (OB-fetus) and control dams (CON-fetus) and from 3 month old offspring from obese (OB-offspring) and control dams (CON-offspring). Each group (n=10) consisted of 5 males and 5 females. RNAseq determined differentially expressed transcripts in the liver and muscle. Significant genes (DEG; P<0.01) were generated for each sex independently using edgeR. DEG were queried for enrichment and modeled to functional pathways. Results: OB-male and female E18.5 fetuses were heavier (P<0.05) than controls. There was minimal overlap (<3%) between male and female DEG. In liver, male OB-fetuses had 399 DEG, female OB-fetuses had 173 DEG. Male DEG were significantly enriched for broad metabolic and protein processing pathways; however, female DEG were enriched for fatty acid metabolism and PPAR signaling. In muscle, male OB-fetuses had 211 DEG and female OB-fetuses had 289 DEG compared to controls. Female DEG were enriched for RNA transport yet mTOR signaling was enriched in both sexes. Only male OB-offspring gained more weight (P<0.05) than CON-offspring. In liver, male OB-offspring had 571 DEG and female OB-offspring had 273 DEG compared to controls. DEG seen in both sexes were enriched for steatosis including increased apolipoproteins and perilipins. The muscle of female offspring showed greater response than that of males (females 580 DEG and males 275) and female muscle DEG support greater glucose uptake and metabolism in response to maternal obesity. In both tissues, less than 3% of fetal DEG were also identified as DEG in the offspring. Conclusion: Transcriptomic data support that fetuses of obese mothers modulate metabolism in both muscle and liver and that adult metabolic processes continue to be impacted as overt disease develops. These changes were strikingly sexually dimorphic in agreement with published findings that male offspring of obese dams exhibit more pronounced metabolic disease. In both males and females, the transcriptomic responses in the fetus were different than those at 3 months, implicating adaptive mechanisms throughout adulthood. In . We hypothesized that Δ9-THC-exposed offspring would undergo catch-up growth, leading to compromised mitochondrial and hepatic function. Methods: Pregnant rat dams received daily dose of vehicle or Δ9-THC (3 mg/kg i.p.) from embryonic day (E) 6.5 through E22. At birth, body weight (BW) and organ to BW ratios were recorded. Hepatic and mitochondrial outcomes were assessed via immunohistochemistry (IHC), lipid analysis, and western immunoblotting at three weeks and six months. IHC images were subject to blinded pathological analysis, while immunoblot data were analyzed via an unpaired Students' t-test. Results: Δ9-THC offspring had reduced BW and liver to BW ratio, followed by whole body and hepatic catch-up growth by three weeks. At six months, Δ9-THC offspring exhibited increased adipose to BW ratio, suggestive of dyslipidemia. Male Δ9-THC offspring displayed increased hepatic triglycerides (p<0.05) at six months, concomitant with increased hepatic diglyceride acyltransferase 1 (DGAT1) and DGAT2 protein (p<0.05). Furthermore, male and female Δ9-THC offspring demonstrated decreased hepatic PAS staining at six months, indicating reduced glycogen stores. Male Δ9-THC offspring also exhibited increased protein abundance of p66Shc (p<0.05) and mitochondrial complexes I, III, and V (p<0.05), along with decreased SOD1 (p<0.05), suggesting mitochondrial dysfunction. At three weeks, male Δ9-THC offspring had increased DGAT2 (p<0.001) and fatty acid binding protein 1 (FABP1; p<0.01) protein, while there were no differences in markers of oxidative stress or mitochondrial dysfunction. Conclusion: Overall, our data indicate that catch-up growth may disrupt hepatic metabolism and mitochondrial function independent of gestational insult. It also suggests that Δ9-THC-exposed offspring may be vulnerable to development of the metabolic syndrome later in life, and that early elevation of FABP1 and DGAT may serve as a potential mechanism to explain mitochondrial dysfunction in adulthood. We have previously shown sex-specific effects of placental gross features on birth weight in the Collaborative Perinatal Project, a cohort of university-based births >50 years ago. We search to confirm these findings in a modern community-based cohort of low-risk term births. Methods: A community hospital based sample with universal placental examination was searched for those births followed to at least age 2 years at our institution. Gross placental examination was performed according to a protocol that recorded trimmed placental weight (PW), major and minor disk axes, minimum and maximum disk thickness and cord eccentricity. Infant sex, and centiles for weight and length/height at birth and ages 1 and 2 years were extracted from medical records. Gross measures and centiles of growth were both analyzed with nonparametric tests due to non-normal distributions. Results: 1631 infants met inclusion criteria. Placental measures of disk thickness (minimum and variance), chorionic disk ellipsivity, and eccentricity of cord insertion relative to the mean chorionic surface radius were significantly reduced in males (p=0.02, p=0.003, p=0.01. p=0.02, respectively) compared to females. While PW and chorionic plate area (CPA) were significantly related to birth weight and length centiles in both sexes, disk thickness was related to birth centiles in females only (e.g., p=0.01 v. p=0.10). PW and CPA) showed effects on growth centiles at years 1 and 2 in both sexes (each p<0.01), while the effects of disk thickness in females did not persist to years 1 and 2. Conclusion: Placental measures show significant relationships to weight and length centiles at birth, with disk thickness associated with growth only in female infants. The unique effect of disk thickness on female birth centiles was lost by age 1. Disk thickness represents the placental villous arborization and parallels the nutrient exchange surface area available to the fetus. The different impacts of such villous branching on male and female fetal growth may contribute to differential fetal programming and account for divergent lifelong health risks. Animal studies have reported significant modification to brain DNA methylation patterns following ACS, but the changes in humans have yet to be investigated. Here, we have examined the neonatal blood as a surrogate tissue since human brain samples are not accessible. We hypothesized that a differential methylation signature will be identified in peripheral blood following ACS treatment in neonates born at term. Methods: ACS-treated women and their neonates (born at term) were retrospectively identified through the Ontario Birth Study at the Sinai Health System and matched (for maternal age, BMI, parity, and fetal sex) to untreated control women (n=14/gp). Genomic DNA was extracted from neonatal blood spot cards and differentially methylated CpG sites (DMS) were identified using bioinformatic approaches (MethPipe) following reduced representation bisulfite sequencing (RRBS). Reads with >30x coverage were evaluated, and significance was defined as FDR<0.05. Comparison of DNA methylation between ACS-treated and untreated subjects was performed through regression analysis. Gene set enrichment analysis was performed through the STRING database. Results: A total of 1815 DMS were identified, of which 843 were hypermethylated and 972 were hypomethylated. Applying a filter to highlight DMS that were >10% different in effect size, 98 DMS were hypermethylated and mapped to 64 genes, while 140 DMS were hypomethylated and mapped to 46 genes. Gene set enrichment analysis of all hypermethylated genes identified pathways of cell proliferation and the hypomethylated gene set identified the ubiquitin-proteasome system (UPS) and intracellular protein trafficking pathways following ACS exposure. Conclusion: Through this study, we have identified genome-wide changes in DNA methylation patterns and their associated gene networks in term-born neonates following ACS treatment. The UPS regulates antigen degradation and presentation in immune cells, while regulating synaptic function and neurotransmitter transport from cell body to synapse in neurons. We are currently conducting animal studies to investigate methylation changes in the neonatal brain. These studies will elucidate the direct impact of ACS on target brain methylation patterns and identify correlations in blood-brain signatures. Determining a brain-specific signature of ACS and their surrogate biomarkers in peripheral blood will create a powerful clinical tool to improve quality of care for the early identification of neonates who may develop later adversities. Enrichment We generated two distinct sequences for each parameter combination, one in-vitro methylated using CpG methyltransferase (M.SssI) and one left unmethylated to assess non-specific antibody binding. As picomoles of spike-in control put into the experiment is known, we used generalized linear models to quantify methylated DNA captured. We performed cfMeDIP-seq on maternal plasma drawn at 17wks (N=3). Samples were sequenced on Illumina Nova-seq (paired-end 100bp). We calculated picomoles of DNA present in the original sample. We used publicly available DNA methylation microarray data from placenta and cfDNA from non-pregnant females to assess placental DNA enrichment. Introduction: Women with pre-gestational diabetes are five times more likely to deliver an infant with a heart defect yet the underlying mechanisms of hyperglycemia-induced embryopathy are incompletely understood. Genome-wide mRNA expression is an unbiased way to investigate how maternal hyperglycemia affects gene expression of the developing heart. Our hypothesis is that maternal diabetes will cause changes in gene expression in the developing embryonic heart throughout development. Methods: Hyperglycemia, defined as ≥250 mg/dL was induced in eightweek-old female CD1 mice by injecting a one-time intraperitoneal dose of 150mg/kg streptozotocin. Control mice received an equal volume of normal saline. Hyperglycemic and control females were mated with CD-1 males. At Embryonic Day(E) 14, 17, and Post-natal day (P) 0 pregnant mice were euthanized, and the embryonic and neonatal hearts were harvested. RNA was extracted from homogenized pooled cardiac tissue (N=2 litters/group/timepoint). Total RNA was prepared using the Illumina Tru-Seq RNA sample prep kit (Illumina, San Diego, USA), and sequencing was conducted on the Illumina HiSeq 2500. RNA was extracted from the pooled pup hearts in both groups at the timepoints described above. RNA sequencing was then used to compare genomewide differential expression throughout development within control mice, diabetic mice, and within diabetic and control pup hearts. This differential expression of genes was assessed within each group and across disease (diabetic) and normal (control) maternal conditions across various stages of development. Two-way ANOVA and Post Hoc Tukey statistical tests were employed to examine the effect of stage of development and disease state on number of DEG's. P-values of ≤ 0.05 were considered significant. Results: The average maternal blood glucose concentration between control and diabetic dams was 112+/-24 and 473+/-47 respectively (p≤0.0001). Control embryonic hearts exhibited differential expression in 2450 genes from E14-P0. Diabetic hearts exhibited differential expression of 2104 from E14-P0. However, this contrasts with the number of DEG ranged from 65, 95, and 210 with each timepoint E14, E17 and P0 respectively between diabetes and control. Conclusion: Results from this study suggest that the number of differentially expressed genes within the developing embryonic heart are more greatly impacted by advancing stages of development over maternal diabetes. In a mouse model of pregestational type 1 diabetes, whole transcriptome sequencing can illuminate mechanisms diabetes induced cardiac embryopathy. These genetic insights can identify potential genetic pathway targets for therapy or prevention. Introduction: Fetal glucagon concentrations are elevated in intrauterine growth restriction. Glucagon receptors are expressed in the placenta, with prior data suggesting that glucagon may inhibit umbilical uptake of certain amino acids. We hypothesized that chronic fetal hyperglucagonemia would result in decreased amino acid transfer to the fetus and decreased growth. Methods: Late gestation fetal sheep received a direct intravenous infusion of glucagon (5 or 50ng/kg/min; n=7 and 5, respectively) or a vehicle control (n=10). After 8-10 days, uterine and umbilical blood flows were measured using the 3 H 2 O transplacental diffusion technique. Uteroplacental and umbilical (fetal) uptake rates of oxygen, glucose, lactate, and amino acids were calculated using the Fick principle. Total RNA was isolated from cotyledons, and gene expression analysis was performed using qPCR. All glucagon-exposed fetuses were grouped and compared to controls using the unpaired Student's t-test to evaluate global trends related to experimental hyperglucagonemia. Results: Fetuses receiving glucagon had 13% lower fetal weight compared to controls (p<0.05). Fetal hyperglucagonemia resulted in 30% higher fetal oxygen concentrations (p<0.05), 42% lower lactate (p<0.01), and significantly lower concentrations of nearly all amino acids. Glucose concentrations were not different. Uterine blood flow was 33% lower in hyperglucagonemic fetuses (p<0.05), while umbilical blood flow was similar between groups. Fetal hyperglucagonemia resulted in lower uteroplacental uptake of oxygen by 32% (p<0.001), glucose by 34% (p<0.01), and several amino acids by 53-79% (valine, isoleucine, leucine, arginine, serine, proline, methionine, tryptophan; p<0.05). Placental lactate production was 33% lower than controls (p<0.05). Fetal uptake rates of valine, isoleucine, leucine, phenylalanine, proline, and tyrosine were 36-51% lower than controls (p<0.05), while fetal glucose and oxygen uptake were not different. Cotyledons from hyperglucagonemic fetuses had 40% lower mRNA expression of both placental lactogen and vascular endothelial growth factor A compared to controls (p<0.01). Conclusion: These results demonstrate that fetal hyperglucagonemia significantly lowers uteroplacental blood flow, as well as uteroplacental oxygen and nutrient uptake. As glucagon does not cross the placenta, we speculate this effect is mediated by glucagon-activated signaling through the placenta via receptors localized on the fetal-facing basal membrane. This leads to reduction in fetal nutrient supply, particularly of the branched chain amino acids, and lower fetal weight. The link between metabolic disorders during pregnancy and an increased risk of developing chronic non-communicable diseases in later life has been well established. However, the mechanisms underlying this link, whereby fetuses exposed to gestational diabetes mellitus (GDM) have a higher risk of abnormal glucose homeostasis in later life, is poorly understood. Extracellular vesicles (EVs) have been well characterized in the maternal circulation in GDM and normal and pregnancies; however, little is known about EVs' profile in the fetal circulation. Methods: A retrospective, case-control study design was used to identify EV-associated proteins that vary in fetal circulation from normal (n=35) and GDM (n=40) pregnancies. EVs were isolated from plasma by differential centrifugation and size exclusion chromatography and characterised by enrichment of protein associated with EVs, morphology, and size distribution using Western blot, electron microscopy, and nanoparticle tracking analysis, respectively. Quantitative proteomic (Sequential Windowed Acquisition of All Theoretical Mass Spectra [SWATH] ) and bioinformatic analysis by Ingenuity Pathway Analysis (IPA) was performed. Results: A total of 1431 proteins in circulating EVs in fetal plasma were identified. A total of 117 proteins (56 upregulated and 61 downregulated in GDM compared to normal) were significantly different (p<0.05, False discovery rate 1%) between normal and GDM EVs. Interestingly, Fructose-1,6-bisphosphatase isozyme 2, Pyruvate kinase PKM, Hexokinase-1, Phosphoglycerate kinase 1, Superoxide dismutase were the proteins with the more significant changes in GDM compared to controls. Bioinformatics analysis showed that the proteins identified in EVs regulate insulin secretion genes in response to a glucose stimulus, insulin receptor signaling, and glucose homeostasis. Conclusion: Overall, our data proposed the modified protein cargo of EVs present in the fetal circulation in GDM might be associated with the changes in cell metabolism and fetal growth observed in GDM. We suggest that EVs may alter the metabolic function and the gene expression, and ultimately the cell phenotype, by transferring specific proteins to target cells. Introduction: Metformin reduces hepatic glucose production in adult humans with diabetes and is used by some women during pregnancy. Importantly, metformin crosses the placenta, yet little is known about its tissue specific effects in the fetus. We hypothesized that metformin would have direct signaling and metabolic effects in the fetal hepatocyte. This has important implications for understanding the potential direct effects that may develop in the liver of fetuses exposed to metformin. Methods: Primary hepatocytes from late gestation fetal sheep were isolated (n=4-6), incubated overnight, and treated with 0, 250, or 1000 μM metformin for 24 h. Phosphorylated (P-) and total protein expression for AMPK, ACC, mTOR, and S6 was measured by western blotting. Gene expression was measured by RNA-sequencing (Illumina NovaSEQ6000). Paired end reads were mapped (Oar_v3.1 genome) and filtered data were analyzed by paired t-test. Genes with an FDR adjusted q-value <0.05 and absolute fold change >1.5 were used for KEGG pathway enrichment (DAVID 6.8) and discovery of putative upstream regulators (Ingenuity Pathway Analysis). Hepatocytes also were stimulated (500 nM dexamethasone + 100 μM cAMP) in glucose-free media with lactate plus pyruvate and glucose production was measured. Expression of OCT1, metformin transporter, was measured by qPCR in fetal tissues. Results: In fetal hepatocytes, metformin increased P-AMPK and P-ACC and decreased P-mTOR and P-S6, classic metformin targets. We identified 954 upregulated and 929 downregulated genes in response to metformin. These genes were enriched in pathways for glucose and lipid metabolism, DNA replication, and signaling via MAPK, FOXO, ERBB2, and glucagon. The stress inducible protein, NUPR1, was the top predicted upstream activator. Expression of HNF4A, a transcription factor for hepatocyte differentiation and metabolism, was decreased 4.7 fold and top predicted upstream regulator inhibited by metformin. Metformin decreased stimulated glucose production by 75%. Of the genes specific to glucose production, metformin decreased G6PC and FBP1, yet PCK1, PCK2, and PC were unchanged. Expression of OCT1 was greatest in fetal liver compared to other tissues (muscle, pancreas, adipose, heart, lung). We show that the fetal liver has abundant OCT1 expression, the major metformin transporter, and that metformin has signaling and metabolic effects in fetal hepatocytes. While metformin decreased glucose production and expression of genes in the latter steps of gluconeogenesis, this was not the most impacted pathway in the fetal hepatocyte, as it is in the adult. Rather, we identified novel effects of metformin on activation of stress pathways via NUPR1 and impaired metabolic genes via decreased HNF4A. Thus, fetuses exposed to metformin may have previously unrecognized effects that disrupt normal hepatic metabolism. Introduction: Intrauterine growth restriction (IUGR) may result from gene-environmental interaction is hypothesized. We aim to investigate the epigenetic involvement of long non-coding RNA (lncRNA) in IUGR. Methods: Quantitative measurement was applied for the gene expression of lncRNA-XIST (lncXIST), and lncXIST-targeted molecules including miRNA, mRNA, and proteins. A transgenic trophoblast culture model and an over-expression mouse model were developed to demonstrate the epigenetic regulatory function of lncXIST-miRNA-targets. Results: We firstly documented that lncXIST is significantly up-regulated. The lncXIST expression is increased (p=0.01) in the placentas of IUGR. Through bioinformatic prediction with programs mv22v2 and bibiserv, we identified a microRNA, the miR-424, as a candidate target of lncXIST and determined that the gene expression of miR-424 in IUGR was increased (p=0.002). Further prediction with programs Target Scan, PicTar, and DIANA LAB, genes FGFR1 and MEK1 were identified as the potential downstream targets of miR-424. In vivo measurement of FGRF1 and MEK1 in IUGR placentas showed that the mRNAs of FGRF1 and MEK1 were down-regulated significantly (p=0.021 and p=0.001, respectively), and both of proteins were decreased (p<0.05). To assess the association among the up-regulated lncXIST and miR-424 with the down-regulated FGRF1 and MEK1, a statistical toll Spearman was applied with the CRISPR-cas9 gene editing system. A statistically positive correlation was documented between lncXIST and miR-424 (p<0.001), and between MEK1 and FGRF1 (p<0.05). However, a negative correlation was shown between lncXIST and FGRF1 (R 2 =0.0035), lncXIST and MEK1 (R 2 =0.0433), miR-424 and FGRF1 (R 2 =0.0084), and miR-424 and MEK1 (R 2 =0.0593). In phase II, a plasmid containing miR-424 was transfected into cultured human trophoblast HTR8/SVneo cells, in which the endogenous mRNAs of FGRF1 and MEK1 were documented to be down-regulated (p<0.05 in both). A retroviral CRISPR-Cas9 system was used to over-express exogenous lncRNA-XIST in a stabilized human trophoblast HTR8/SVneo cell line, in which miR-4244 was co-transfected. Our results showed that there was no significant change on cell apoptosis and cell cycles, however, lncXIST may significantly inhibit cell mobility through miR-424. Conclusion: Identification of a single gene mutation that may associate with IUGR has not been success. However, many epigenetic factors such as methylation and lncRNA have been identified and characterized. In this study, we reported lncXIST and miR-424 as the epigenetic regulators involved in MEK1-FGRF1 pathway in IUGR, which has opened a novel avenue for further exploration of pathogenic mechanism and designing a rational intervention strategy. Chronic Intrauterine Hypoxia Alters Mitochondrial Dynamics in the Fetal Guinea Pig Heart in a Sex Dependent Manner. Loren P. Thompson, Hong Song. University of Maryland SOM, Baltimore, MD, United States. Introduction: Chronic gestational hypoxia imposes a metabolic stress to fetal organ growth and contributes to developmental programming of organ dysfunction in the offspring. The fetal heart responds to hypoxic stress by undergoing concomitant changes in cell proliferation/ differentiation and mitochondrial biogenesis, which impacts respiratory function Mitochondrial number or content is regulated by formation of networks via fusion of outer (OMM) and inner (IMM) mitochondrial membranes and removing defective mitochondria via fission. We hypothesize that chronic hypoxia alters mitochondrial function of fetal hearts by altering its mitochondrial dynamics (i.e. the balance between fusion and fission). This may contribute as an underlying mechanism in contractile dysfunction, as well as, in developmental programming in offspring hearts. Methods: Pregnant guinea pigs were exposed to either normoxia (NMX, N=7) or hypoxia (HPX, 10.5%O 2 ) starting at 25d (early-onset, N=7) and 50d gestation (late-onset, N=7) until term (~65d) . On day 19 of incubation (term is 21 days), the heart was excised following cervical transection and mounted on a Langendorff preparation. Following measurement of basal cardiac function, hearts were randomly treated with a bolus of water vehicle (Control), a H 2 S donor (NaHS) or a CO donor (CORM-3), with or without the non-selective K ATP channel inhibitor Glibenclamide (Glib) or the mitochondrial K ATP channel inhibitor 5-hydroxydecanoate (5-HD). An I/R challenge was induced 10 min after treatment for 30 min, followed by 2h of reperfusion. Myocardial infarct size was determined by tetrazolium staining. Results: Treatment with either H 2 S and CO donors improved cardiac function and reduced cardiac infarct size after I/R in the chicken embryo. However, H 2 S improved cardiac function earlier while CO did so later after I/R. While the cardioprotective effects of H 2 S were blocked by Glib but not 5-HD, the cardioprotectve effects of CO were blocked by both Glib and 5-HD (Fig. 1) . Introduction: Placental insufficiency results in an adverse in-utero hypoxic environment for the developing fetus, resulting in intrauterine growth restriction (IUGR) associated with oxidative stress and muscle mitochondrial dysfunction. Oxidative stress, the imbalance between free radicals and antioxidants, is believed to be a significant driving force underlying IUGR skeletal muscle mitochondrial dysfunction. PQQ, a novel antioxidant-like compound, shows promise in rescuing postnatal oxidative stress situations, but the mechanisms underlying its antioxidant and positive mitochondrial effects have not been examined in an in-utero environment setting. It is postulated that PQQ will prevent oxidative stress and restore muscle mitochondrial function. Methods: Model 1: Immortalized mouse myoblasts (C2C12) were differentiated for 7 days to form myotubes. PQQ (1uM and 10uM) was administered either every other day for 7 days, or for the last 48 hours, or for the last 5 hours of differentiation. 750uM H 2 O 2 was administered for 24 hours on day 6 of differentiation to induce oxidative stress. qPCR was performed to examine relative mRNA expression of genes of interest. Data were analyzed by one-way ANOVA and Dunnett's multiple comparisons test. Model 2: PQQ was administered to guinea pig dams in drinking water (1mg/L) from mid-gestation until 65d (term ~69d). Fetuses with brain-to-liver ratio >0.65 and body weight <80g were classified as spontaneous IUGR and those outside both thresholds classified as normal intrauterine growth (NG). Male fetal gastrocnemius muscle was collected and qPCR was performed to examine relative mRNA expression of genes of interest. Data were analyzed by one-way ANOVA and Dunnett's multiple comparisons test. Genetic adaptation in long ancestry populations may explain the relative birth weight sparing effect seen. Leh in India is located at 3,500m within the Himalayan plateau. Many families have resided at this altitude for thousands of years, making the population a unique group to study potential genetic influences on birth weight. Methods: Over 2 years, 300 pregnant women were recruited from Sonam Norboo Memorial Hospital, Leh Ladakh to the HAPS (hypoxia and pregnancy) study. Collection of umbilical cord blood and placenta was done after birth. Birth details (gestation-with accurate ultrasound dating confirmed, fetal sex, weight and length) were recorded. Samples were processed at the Institute for Genomics, Delhi using the Illumina Global Screening Array. Genetic associations were tested through principal component analysis based on fine structure analysis data and an admixture test and selection analysis testing to investigate birth weight associations. Results: Admixture analysis suggests a considerable component of the contemporary Ladakhi genome descends from ancestral highlander populations residing on the Tibetan plateau for < 35,000 years, with subsequent admixture with neighbouring Indo-European populations. Although no gene variants reached genome wide significance in relation to birth weight analysis this was to be somewhat expected with n=300. However, the top 60 variants reached p value of (1 x10 -4 to 1 x 10 -7 ) with enrichment of SNPs previously associated with birth weight (HMGA2), along with LING02 (SNP associated with body mass index) and PPP2R2C (body weight gene). This study supports evidence of enrichment in high altitude populations of SNPs in key metabolic genes involved in body mass/ weight and height. Strengthening our findings, a key replication was found in the gene HMGA2 that has been previously reported by the EGG birth weight consortium. The Cardiac Adenosinergic System Is Developmentally Regulated. Lowell Davis, Samantha Louey, Sonnet S Jonker * . Oregon Health & Science University, Portland, OR, United States. Introduction: Adenosine is a metabolic by-product and paracrine factor released by cardiomyocytes. Adenosine acutely improves local oxygen delivery by increasing blood flow, while longer-term effects on myocardial function are mediated by changed mRNA and protein levels. In addition to acute production of adenosine, the adenosinergic system is transcriptionally regulated by hypoxia. The purpose of this study was to determine how the cardiac adenosinergic system is regulated developmentally, including the transition from relatively hypoxic fetal environment to postnatal life. Methods: PCR was performed on left ventricular myocardium from 65% (94 days) and 93% (136 days) gestation, 4 days postnatal, and adult sheep. Expression of genes involved in adenosine signaling were normalized to 18s ribosomal RNA, and analyzed by ANOVA followed by Tukey's test with significance at P<0.05. Results: Neonatal levels of ecto-5'-nucleotidase (NT5E) are lower than adult levels. Levels of equilibrative nucleoside transporters (ENT) 1 and 2 were not significantly different. Adenosine receptor (AR) levels were different by developmental age. A1 levels were lower in the late-term fetus and adult compared to the neonate. A2a levels were higher in the mid-gestation fetus compared to the adult. A3 levels were lower in fetuses and neonates compared to the adult. Conclusion: Together, these data suggest increasing capacity for adenosine production after the neonatal period by the extracellular NT5E, decreasing reliance on the A2a receptor and increasing reliance on the A3 receptor. The importance of the A1 receptor appears to increase transiently in the neonate. These findings indicate developmental differences may be important for acute coronary vasoregulation and for the chronic preconditioning, contractile and growth effects of the cardiac adenosinergic system. Antenatal Introduction: Antenatal synthetic glucocorticoids (sGCs) are a lifesaving treatment in managing pre-term birth. However, the off-target effects of sGCs can lead to acute changes in P-glycoprotein (P-gp; encoded by Abcb1) levels in the fetal blood-brain barrier (BBB). Breast cancer resistance protein (BCRP; Abcg2) is another key BBB transporter that is modified by sGCs. sGCs regulate P-gp and BCRP in part via the glucocorticoid receptor (GR). There are known sex differences in GR isoform expression, and therefore signaling. Additionally, studies in young animals exposed to multiple courses of prenatal sGCs found increased HPA axis sensitivity in males compared with females. Drug transporters are essential for fetal brain protection. Whether there are longer-term effects of antenatal sGCs on BBB drug transporters after birth, and whether these are sex-specific are not known. We hypothesized that antenatal sGC treatment will increase P-gp and BCRP expression and function at the BBB of juvenile offspring in a sex-dependent manner. Methods: Pregnant guinea pigs were treated with a single course (gestation day (GD) 50) or 3 courses (GD 40, 50 & 60) of betamethasone (1mg/kg) or vehicle (n=10). Cerebral microvessels were collected from post-natal day (PND) 14 male and female offspring to measure gene and protein expression of drug transporters (Abcb1, Abcg2). Brain endothelial cells were further isolated from microvessels and cultured to identify differences in P-gp and BCRP function, through accumulation of the fluorescent substrates calcein-AM, and chlorin-e6, respectively. Results: Data were analyzed by student's t-test unless indicated otherwise. Multiple courses of sGC treatment resulted in a significant decrease in P-gp function in endothelial cells derived from male (P<0.05), but not female offspring. P-gp protein expression was also decreased (P<0.05) in microvessels derived from male offspring that had been exposed to sGC, in utero. There was no effect of a single course of sGC on function or expression of P-gp. BCRP was not affected by antenatal sGC. When comparing drug transporter function between sexes, males had significantly higher P-gp function compared to females (P<0.05, 2-way ANOVA). Conclusion: Our discovery of sex differences in drug transporter function in the BBB is novel, and may underlie sex differences in drug sensitivity. Further, reduced P-gp function at the BBB of young male offspring following prenatal sGC exposure, could result in increased transfer of P-gp substrates into the brain. This is clinically relevant as many of the drugs given in the NICU are actively transported by P-gp. Importantly, single course exposure, the current gold-standard treatment in humans, had no effect on drug transport function after birth. Introduction: Acute perinatal white matter injury (WMI) is the most common form of perinatal brain injury in preterm infants resulting from insults to the developing brain during a peak period of oligodendrocyte vulerability. WMI is characterized by reactive microgliosis, reactive astrocytosis and failed myelination. Recent studies in the injured mature brain show the formation of diverse reactive astrocyte subtypes, some supporting brain repair and other «inflammatory» reactive astrocytes driving neurodegeneration. The specific nature of astrocyte reactivity after WMI remains obscure. We report progress on a basic research project aimed to investigate the formation, function and therapeutic modulation of inflammatory astrocytes in WMI. We tested the formation of inflammatory astrocytes across multiple rodent WMI models. Inflammatory astrocytes were identified using in situ Hybridization (ISH). Microfluidic qRT-PCR of mRNA isolated from immunopanned primary astrocytes evaluated the expression of a panel of reactive astrocyte subtype-specific genes. Purified astrocytes were also analyzed through scRNA seq. C1q/Il1-a/TNF mutant mice were used to investigate the necessity of inflammatory astrocytes for WMI outcomes. Finally, exosomes purified from mesenchymal stem cells were added to inflammatory astrocytes in vitro to evaluate influence on astrocyte polarization. (uLMS) is a rare and aggressive tumor. Signal transducer and activator of transcription 3 (STAT3) is a transcription factor that plays a key role in cell proliferation and survival. It has been previously reported that the JAK/STAT pathway is constitutively active in many cancers and diseases including uterine leiomyosarcoma. We investigated the hypothesis that direct inhibition of STAT3 decreases cell proliferation of uLMS. Methods: Leiomyosarcoma cells (SK-UT-1) were exposed to Stattic, a small molecule inhibitor of STAT3 activation and nuclear translocation. Cell proliferation was measured using a 3-(4, 5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium (MTS) assay. Western blotting was used to analyze expression of cyclin D1, beta-catenin, active Y705-phosphorylated STAT3 (p-STAT3), Bcl-2, and Caspase-3. Immunohistochemistry was used to detect p-STAT3 in 3D cell cultures of SK-UT-1 and in normal myometrium and leiomyoma tissue specimens. The decidua, situated at the maternal fetal interface, is hypothesized to play a role in the onset of labor, and this process may be mediated by the prostaglandin (PG) synthesis pathway (an important clinical target for labor induction and augmentation). Most studies, however, rely solely on tissue drawn from fetal membranes and adherent scrapes of decidua, which is likely not reflective of the entire decidual interface. PG synthesis is highly complex with at least three rate-limiting steps, i) the release of arachidonic acid (AA) by phospholipase A2 (PLA2) ii) conversion of AA to PG intermediates by PTGS1/2, and iii) isomerization by select PG synthases. We hypothesize that the decidua 1) exhibits a distinct expression profile of genes in the PG pathway with the onset of labor, and 2) these genes exhibit differential expression in preterm labor (PTL) compared to term labor (TL). The aim of this study is to conduct a complete expression profile of the PG pathway in a unique set of decidua biopsy samples. Methods: Decidual samples dissected from the myometrium at cesarean section were used to assess PG gene expression by RNAseq and qRT-PCR (n=7 preterm non-labor (PTNL), n=11 preterm labor (PTL), n=31 term non-labor (TNL), n=31 term labor patients (TL)). Expression analyses were conducted using student's t-test, one-way ANOVA, and adjusted for multiple testing using the Benjamini-Hochberg method. Results: RNAseq analysis identified 30 of the 53 unique PG genes to be highly expressed in decidua. We observe increased expression in PTGS2 (p=0.011) and PTGES (p=0.003) and decreased expression of PG-D synthases (p<0.05) with labor (term or preterm). In contrast, the expression of upstream enzymes is differentially expressed with pregnancy outcome. At term, we observe a decrease in PLA2 subtypes 2D, 4B and 6 while preterm labor is associated with lower expression of PLA2G16 and PLAA (p<0.05). We observe that downstream PG synthases are differentially expressed with labor irrespective of gestational age at delivery. However, cases of preterm labor exhibit differential expression profiles when compared to term births at the level of upstream PG enzymes (PLA2). The presence of multiple PLA2 subtypes within the decidua suggests the potential for fine tuning the release of AA during PG synthesis during labor. Further investigation of upstream activity of PG synthesis may provide insight on the mechanism of PTL. Attenuated Briefly, the abdominal aorta (below the renal arteries and above the aortic bifurcation) and the uterine arteries of both uterine horns were partially occluded with silver clips to reduce blood flow into the uterine circulation. Pregnant rats with sham surgery (without clips) were served as controls (Sham, n=4). To determine the effect of NOS on Piezo1 functionality in pregnancy, rats (n=6) were given L-NAME in drinking water (0.5 g/L) to inhibit NOS from Day 10 of gestation until euthanasia, with age-matched, normal pregnant rats as control (LP, n=4). Animals were euthanized at late pregnancy (day 20). Main uterine arteries (MUAs) were isolated, pressurized and assessed in physiological conditions by pressure myography. The functionality of Piezo1 channels was evaluated by Yoda1 (10 and 20 µM), a chemical Piezo1 activator that mimics the effect of fluid shear stress on endothelial cells and induces vasodilation. Results: The RUPP surgery was performed in early-pregnancy before prominent uterine vascular remodeling. In RUPP, unstressed cervicalend MUAs tended to have smaller lumen diameter (p=0.12) while the pressurized MUA diameter and distensibility were significantly increased. Surprisingly, there was no significant difference in pup or placental weights. Yoda1-induced vasodilation (20 µM) was inhibited by ~45% in RUPP vs. Sham MUAs (27±4% vs. 49±8%, p=0.016). With in vivo NOS inhibition, MUA diameter and distensibility were significantly decreased as expected. At 20 µM of Yoda1, vasodilation was reduced ~68% in the L-NAME group (20±5% vs. 62±7%, p<0.0001). Conclusion: Yoda1-induced MUA vasodilation was reduced in the RUPP and L-NAME treated groups, indicating that Piezo1 functionality and/ or its signaling were impaired by reduced UPBF in PE. These findings suggest that therapeutic interventions targeting Piezo1 signaling may be beneficial for treating pregnancy complications such as PE. Introduction: Engagement in physical activity (PA) during pregnancy mediates numerous health benefits for both the mother and fetus. The physiological mechanisms contributing to these benefits are unclear but are thought to act upon the placenta. In men, acute PA results in the release of small extracellular vesicles (EVs) into circulation which may be important for tissue cross-talk during exercise. It is unknown whether small EVs are released in women after an acute bout of PA, and whether pregnancy impacts this response. The objective of this study was to define the circulating small EV profile after a single bout of moderate-intensity PA by size and concentration in healthy pregnant and non-pregnant women. Methods: Pregnant (13-28 weeks gestation, N=10) women and nonpregnant controls (N=9) performed a single session of moderate-intensity treadmill walking for 30min. Plasma was collected immediately preand post-PA, and small EVs (<200 nm) were isolated by differential ultracentrifugation. The presence of EVs was confirmed by western blotting for the small EV markers TSG-101 and Flottilin-1. EVs were quantified by size and concentration using nanoparticle tracking analysis. Percent change post-PA was compared between groups for mean vesicle size with an unpaired t-test and ANCOVA was used to compare the percent change between groups post-PA for concentration adjusting for baseline as a covariate. Significance was set at p<0.05. Results: At baseline, pregnant women had higher levels of small EVs compared to non-pregnant women (1.83×10 10 ±1.25×10 10 particles/mL and 8.11×10 9 ±4.04×10 9 particles/mL, p=0.03).Mean vesicle size was not different between groups. After an acute bout of moderate-intensity PA, the mean difference for the percent change of small EVs was 88 between pregnant versus non-pregnant women (CI 95%=7-169, p=0.04, η p 2 =0.25). Percent change of mean vesicle size showed no differences pre-versus post-PA. All isolated EV fractions were positive for TSG-101 and Flotilin-1. Conclusion: On average, pregnant women had a greater release of small EVs after a single bout of moderate-intensity PA when compared to nonpregnant women. Placental Proteins. Veena Sangkhae, 1 Yoel Sadovsky, 2 Tomas Ganz, 1 Elizabeta Nemeth * . 1 1 UCLA, Los Angeles, CA, United States; 2 Magee-Womens Research Institute, Pittsburgh, PA, United States. Introduction: Iron is essential for maternal and fetal health but the molecular mechanisms ensuring increased iron availability during pregnancy are not well understood. Hepcidin is the key iron-regulatory hormone and functions by blocking iron absorption, recycling and mobilization from stores, effectively decreasing plasma iron levels. In healthy human and rodent pregnancies, maternal hepcidin decreases starting in the second trimester and is nearly undetectable by late pregnancy, and it is hypothesized that this allows for greater iron availability for transfer to the fetus. However, fetal hepcidin may also regulate iron transfer across the placenta. We explored the regulation of maternal and fetal hepcidin during pregnancy, and their effect on iron homeostasis. Methods: 1) To determine if maternal or embryo hepcidin regulates iron homeostasis, we used mouse models and generated combinations of dams and embryos lacking hepcidin or not and quantified embryo iron endowment. 2) To determine consequences of elevated maternal hepcidin on pregnancy, pregnant mice received daily injections of a hepcidin mimetic starting in the second trimester and we assessed pregnancy outcomes and iron parameters. 3) We also developed a bioassay to identify pregnancy-associated hepcidin regulators. Results: 1) Maternal but not fetal hepcidin determines embryo iron endowment in a healthy pregnancy. Maternal hepcidin was inversely related to embryo iron stores: embryos from hepcidin-deficient dams had higher hepatic iron stores (P<0.001 Two-way ANOVA), regardless of embryo hepcidin genotype. 2) Augmented maternal hepcidin during the second half of pregnancy in mice led to dose-dependent embryo iron deficiency, anemia, and even death. Even with mild maternal hepcidin elevation, where maternal hematological parameters were unaffected, embryos developed systemic iron deficiency which even led to decreased brain iron content (0.7±0.2 to 0.3±0.1 µg/g, P=0.002), indicating that embryos are remarkably sensitive to maternal iron restriction. 3) Despite the critical role of maternal hepcidin suppression for heathy pregnancy, the physiological mechanism of suppression remains unknown. Using our in vitro bioassay with primary mouse hepatocytes or human hepatocytes, we determined that the placental trophoblast is the source of a hepcidinsuppressing factor. Treatment with trophoblast supernatants suppressed hepcidin mRNA more than 10-fold (P<0.001) for up to 48hr. Studies to determine the identity of the placenta-derived hepcidin suppressor(s) are ongoing. Conclusion: Suppression of maternal hepcidin is essential to ensure adequate iron supply for transfer to the fetus and for the increase in maternal red blood cell mass. A placenta-derived hepcidin suppressor likely plays an important role in this adaptation. (MVM) is associated with adverse pregnancy outcomes, including preeclampsia and gestational hypertension (PAH). We sought to examine whether women who develop MVM have increased coagulation potential, which may influence early placentation. Methods: Platelet-poor plasma from 29 women was collected prepregnancy (PP) in the follicular phase, and early pregnancy ([EP], 12-13 weeks). Outcome data and placentas were collected at delivery, with placental histopathologic features of MVM characterized, including decidual arteriopathy (DA) and infarcts or agglutination (INAG). Plasma was analyzed for levels of factors II, V, VII, VIII, IX, X, antithrombin (AT), and Protein C, reported as % of mean physiological. Thrombin generation (TG) parameters (lagtime, peak level, rate, and endogenous thrombin potential [ETP] ) were assessed at each study visit, using tissue factor (TF) initiation +/-soluble thrombomodulin (TM). Comparisons were made between PP, EP and changes from PP to EP within each parameter in the context of MVM. Mean ± standard deviation are presented. Results: Women were 30 ± 4 years of age, body mass index of 25.9 ± 5.6 kg/m 2 , 90% white race, and 69% nulliparous. DA was identified in 13 placentas, 7 from pregnancies complicated by PAH. INAG was identified in 13 placentas, 9 with PAH. DA and INAG were identified in 7 placentas, 5 from pregnancies with PAH. While there were no PP differences between women +/-placental DA, those who developed DA showed a greater increase in TG parameters between PP and EP (Δlagtime DA = -0. Introduction: Preeclampsia is clinically defined by new onset hypertension and proteinuria, and affects 3-5% of pregnancies worldwide. Preeclampsia is associated with an increased risk of later-life cardiovascular disease. However, it remains difficult to interpret whether adverse outcomes and mechanisms of preeclampsia differ between healthy women and women predisposed to poor vascular health. To address these questions, relevant animal models are needed. Previous work demonstrates that breeding complement component C1q knockout (C1q -/-) males to wildtype female mice results in preeclampsia-like phenotypes. The current aim was to determine whether C1q -/male mice induce preeclampsia-like vascular dysfunction in apolipoprotein-E knockout (ApoE -/-) females who are predisposed to poor vascular health. Methods: ApoE -/female mice were time mated either to male C1q -/-(ApoE -/x C1q -/-) or wildtype C57BL/6 mice (ApoE -/x C57). Blood pressure was measured at the end of pregnancy from gestation day (GD) 14.5-17.5. Body weight, heart weight, heart/body weight ratio and ex-vivo vascular function data were collected at GD 17.5. Results: Preliminary data indicate that high-risk ApoE female mice bred to C1q -/male mice (ApoE -/x C1q -/-) exhibit elevated systolic blood pressure (p<0.01), diastolic blood pressure (p<0.01), and mean arterial pressure (p<0.01) when compared to ApoE -/x C57 controls. Preeclampsia-like ApoE -/females had larger heart weights (p=0.03) and heart to body weight ratios (p=0.01) compared to ApoE -/controls. Further, preeclampsia-like ApoE -/females exhibited vascular dysfunction evidenced by increased sensitivity to phenylephrine (p<0.03) and blunted endothelial-dependent relaxation (p<0.01). Conclusion: Breeding hypercholesterolemic ApoE -/female mice to C1q -/male mice induces preeclampsia-like vascular dysfunction during pregnancy. This model provides a novel method to investigate preeclampsia in individuals with a predisposition toward poor cardiovascular health and may improve our understanding of preeclampsia subtypes.This project was supported by the American Heart Association Go Red for Women 16SFRN27810001. Hypertension 64:36-44, 2014) . Here, we aimed to systematically assess the impact of altitude on maternal blood pressure at term and on the prevalence of hypertensive disorders of pregnancy. Methods: PubMed, Ovid EMBASE, Cochrane Library, Medline, Web of Science and clinicaltrials.gov were searched (inception to 11/11/2020). Observational, cohort, or case-control studies were included if they reported a high-altitude and appropriate control pregnant population. Studies published >50 years ago were excluded. Two reviewers independently assessed articles for eligibility and risk of bias. Results: At high altitude, maternal systolic and diastolic blood pressure at term was higher than at low altitude (4.4±2.2mmHg, p<0.05, 3.8±1.0mmHg, p<0.001 respectively, n = 4140, 11 studies, Figure 1 ). Hypertensive disorders of pregnancy were more common at high altitude (Odds Ratio ( Conclusion: Maternal blood pressure is higher at term in pregnancies at high compared to low altitudes, accompanied with increased risk of gestational hypertension but not pre-eclampsia. Risk of stillbirth at high altitude is also increased. With a growing population residing at high altitude worldwide, it is essential to clearly define the associated risk of adverse pregnancy outcomes. Introduction: In individuals with metabolic risk factors, extra virgin olive oil (EVOO) intake has been associated with reduced risk of cardiovascular morbidity by improving lipoprotein profile, increasing insulin sensitivity and decreasing blood pressure, inflammation and oxidative stress. Studies in pregnant women show reduced risks of gestational diabetes, preeclampsia and fetal growth restriction in those who adhere to Mediterranean-based diets high in EVOO. We aimed to investigate the effects of EVOO consumption on cardiovascular function and laboratory markers of metabolic dysfunction in healthy reproductive-aged women. Methods: Healthy nulliparous women were randomized to receive 45 ml (40 g) of EVOO high in oleic acid and phenolic content daily for 8 weeks or an identical dose of a control sunflower seed oil. Participants and study personnel were blinded to group assignment. Women underwent detailed cardiovascular assessment at baseline and following treatment, including assessment of blood pressure, cardiac output, pulse-wave velocity (PWV), calculation of arterial distensibility and beta stiffness, and response to volume challenge. Lipid profiles and markers of insulin sensitivity were assessed at both study visits. Group differences at baseline were assessed by Student's t-test and Fisher's exact test for continuous and dichotomous variables, respectively. Repeated measures ANOVA was used to assess the group by time interaction. Results: 12 women were randomized to EVOO and 15 to the control oil. Women were similar at baseline, although women in the EVOO group were more likely to report a family history of hypertension (90%, 40%, p = .03), had faster brachial PWV (8.8 ± 1.4 m/s, 7.5 ± 1.4 m/s, p = .03), greater blood pressure response to volume challenge (160.6 ± 82.5, 49.2 ± 115.5, p = .01) and had lower HDL (53.2 ± 10.3 mg/dL, 64.3 ± 12.9 mg/dL, p = .02). Compliance with the prescribed volume of oil was high in both groups (EVOO 97.8%, control 99.5%). Following the 8 week intervention, women randomized to EVOO had relatively reduced fasting insulin (-0.31 ± 0.52 uU/mL, p = .03), reduced HOMA-IR (-0.054 ± 0.12, p = .046), but increased LDL cholesterol (+5.1 ± 4.0 mg/dL, p = .047). Blood pressure was not different between groups, but there was a tendency toward slower PWV, lower blood pressure response to volume challenge and lower hemoglobin A1c in the women randomized to EVOO. Conclusion: Dietary supplementation with EVOO high in oleic acid and phenols was well tolerated and resulted in improved insulin sensitivity, but higher LDL in our pilot study in healthy nulliparous women. A larger trial in pregnant women will determine whether this improved insulin sensitivity is associated with lower risks of pregnancy morbidity. Continuous Core Body Temperature and the Onset of Parturition in Humans. Elise N Erickson, Kierstyn Tuel, Leslie Myatt, Leonardo Pereira. Oregon Health and Science University, Portland, OR, United States. Introduction: Clinicians have no reliable method for determining future onset of labor in term or preterm pregnancies with precision. The purpose of this study was to use continuous body temperature measurement in healthy pregnancies to determine if a temperature decrease occurs in the days prior to the onset of labor as is observed in other mammals. This method of labor prediction has been used for veterinary care (e.g. horse, sheep, dog); however, this has not been evaluated in human pregnancy. Methods: Multiparous pregnant individuals at 36-38 weeks of gestation carrying a singleton pregnancy were included. We excluded individuals who have HTN, GDM, BMI >30.0, work night or rotating shifts. The thermometer was an axillary device worn in the inner aspect of the upper arm, held in place with adhesive patches, monitors were worn continuously for 24 hours and changed to the alternate side daily. Temperatures were recorded every 4 seconds, synced on a smartphone application and stored in cloud-based platform. Data averaged over one-minute intervals was downloaded and used as the unit of analysis. Temperatures were then standardized within each individual (calculated z-score for each temperature). A total of 685,198 temperatures were analyzed using mixed effects regression within each 24 hour period of time prior to the participant's report of when labor symptoms were noted (participant as the random effect). Data were further considered by day/night periods (6am-10pm/ 10pm-6am). The models were adjusted by the gestational age at which the measurement of temperature occurred across the study period and by night/day period. Comparisons of temperature across the study period were also made between participants who began laboring spontaneously and those who did not. Results: Twenty-eight participants enrolled in the study and 25 completed data collection. Mean participant age was 29.3 (4.2) years and mean prepregnancy body mass index was 23.5 (3.2) kg/m 2 . Vaginal birth occurred in 23 participants. Nine participants underwent a labor induction at a mean (SD) gestational age of 40.6 (0.72) weeks. The remainder of the sample began laboring spontaneously at a mean (SD) of 40.1(0.89) weeks. Models adjusted for gestational age and day/night measurement revealed that individuals had a significant decrease in body temperature in the 7 days prior to spontaneous labor onset with a nadir of day 3 before labor symptoms (-1.27 o F, 95%CI -1.37--1.11). Conclusion: This pilot data demonstrate that human female body temperature decreases in the days preceding the onset of a physiologic labor similar to what is documented in various mammalian species. This pattern did not emerge from within the sample of individuals prior to perception of labor symptoms during induction of labor. Further study will determine if real-time temperature measurement and changes in temperature may be useful for prediction of future labor onset. The Sodium-Dependent Phosphate Transporter Slc20a2 Protects the Placenta from Ectopic Calcification. Ana Correia-Branco †, 1 Ciara Benson, 2 Nirmala Jayaraman †, 1 Olga Kashpur †, 1 Mary C. Wallingford * . 1 1 Tufts Medical Center, Boston, MA, United States; 2 University of Washington, Seattle, WA, United States. Introduction: Mechanisms of maternal-fetal phosphate transport flux and the biomedical relevance of placental vascular calcification (calciumphosphate mineral deposition) remain largely unknown. Expression of the placental phosphate transporter Slc20a2 is decreased in early preeclampsia (PE) while adenosine and expression of the adenosine receptor are both increased. Both Slc20a2 and adenosine signaling are described to mediate processes promoting vascular calcification. Furthermore, Slc20a2 knockout (KO) mice have been described as a model of placental calcification, thus providing a genetic link and preclinical model. We propose that Slc20a2 protects the placenta from ectopic calcification by maintaining homeostatic phosphate levels in balance with ATP metabolism and adenosine signaling and hypothesize that Slc20a2 loss will upregulate extracellular phosphate levels and adenosine signaling in placenta. Methods: Phosphate P 33 uptake and extracellular calcium deposition were assessed on BeWo cells after cGMP induction by forskolin as a model of human syncytiotrophoblast. Placental gene expression was examined in human (n=200) and mouse (n=15) by microarray and RNAseq. The molecular requirement for placental Slc20a2 was assessed with the Slc20a2 KO mouse line by protein analyses after Slc20a2 loss was confirmed by in situ hybridization. The relationship between fetal skeletal ossification and ectopic placental calcification (E17.5) was evaluated by novel tissue clearing and Alizarin Red (AR) staining methods. Cell-type specific calcium deposition and immunohistochemistry patterns were evaluated in human placenta. Results: P 33 uptake by BeWo cells was sodium-dependent and 2.4mM phosphoric acid induced extracellular calcium deposition. The sodiumdependent phosphate transporters Slc20a1 and Slc20a2 are the most highly expressed in mouse and human placenta. Increased placental calcification was observed and initiates in the chorionic plate and labyrinth; ongoing fetal ossification studies compare whole tissue AR findings to microCTbased quantitative analysis. Human placentae presented diverse microcalcification patterns. Conclusion: We conclude that Slc20a2 is abundant in mouse and human placenta and presents a protective effect upon the chorionic plate and basal labyrinth from calcification in mouse. Ongoing work investigates the interaction of Slc20a2 with the adenosine pathway through proteomic approaches. We present the argument that this research will advance our understanding of the link between maternal phosphate homeostasis and placental calcification, improving clinical assessment of early onset placental disease. Prolonged Hypoxia Inhibits HMSMC HIF1a-Related Contractility Expressions but Not Apoptosis, Possible Leading to Uterine Atony at Labor. Yunshan Chen. Guangzhou Women and Children's Medical Center, Guangzhou, China. Introduction: Uterine atony is often accompanied with labor arrest. Transient hypoxic state was considered to be one of the mechanisms ensuring myometrium contraction.And in prolonged labor, a long-term repeated hypoxic state might have some effct on myometrium and HMSMCS leading to uterine atony. Methods: Expressions of hypoxia and contraction-related markers of clinical myometrium biopsy specimens in two groups(In-labor group and long-labor group) will be compared in vivo, and long-term hypoxia in vitro experiments,in which myometrium tension and HMSMCs changes, will be all observed at different levels. Results: HIF-1α expressions in Long-labor group were obviously decreased compared to In-labor group(p<0.05) in vivo, and OTR(Oxytocin receptor) and Cx43 expressions in myometrium both had a decreased trend in vivo.While in vitro experiment,as the duration of hypoxia time increased from 2h to 12h, the expressions of HIF-1α,OTR and Cx43 all keep decreasing(P < 0.05) similar to myometrium sample of Long-labor group. Also,in myometrium strips tension experiment, with the prolongation of hypoxia time, the uterine muscle contraction amplitude, contraction frequency and area under curve all continued to decrease, and HMSMCs contraction state showed a gradual decline from 2-4hours to 12 hours with hypoxia period prolonged, all with a significant statistically difference(p<0.01). While the autophagic level(number of autophagosomes,LC3B and Beclin-1 expressions) in the Long-labor group were all down-regulated, but apoptosis markers(Caspase-3, Caspase-9) and TUNEL Assay all showed no statistically difference(P>0.05).In vitro experiment, the prolongation of hypoxia did not cause changes in the expressions of apoptosis-related proteins (caspase3, 9) and Flow cytometry results on hMSMCs (P>0.05), which was also consistent with the trend of myometrium samples from Long-labor group. Conclusion: Prolonged hypoxia in HMSMCs might inhibit HIF1a-related contractility and self autophagy protection mechanism, but not enhanced apoptosis, this could be one of the internal mechanisms of uterine atony in long labor. Impaired Endothelium-Dependent Vascular Function in Female Mice with a History of a Pregnancy Complicated by Dyslipidemia. Tamara Sáez †, 1,2 Abbey Pagée †, 1,2 Raven Kirschenman, 1,2 Floor Spaans, 1,2 Sandra T Davidge * . 1,2 1 University of Alberta, Edmonton, AB, Canada; 2 Women and Children's Health Research Institute, Edmonton, AB, Canada. Introduction: Women that experienced dyslipidemia during pregnancy are at risk for developing cardiovascular complications later in life. High circulating levels of oxidized low-density-lipoproteins (oxLDL) are associated with vascular dysfunction via oxidative stress, contributing to the pathophysiology of cardiovascular diseases. It has been shown that gestational dyslipidemia concomitants with maternal vascular dysfunction; however, whether this vascular dysfunction may persist postpartum is unclear. Therefore, we hypothesized that gestational dyslipidemia leads to later-life vascular dysfunction. Methods: Pregnant C57BL/6 mice were fed a high-cholesterol diet (HCD) between gestational day (GD) 13.5 and term (GD19.5). Control pregnant mice were fed a standard chow diet (CD). After delivery, all females were on a CD for 3 months (3 months postpartum), after which aortas were isolated to assess ex vivo vascular function by wire myography (n=7-11). Vascular responses to methacholine (MCh) were evaluated in the presence or absence of oxLDL (50 µg/mL) or L-NAME (nitric oxide synthase inhibitor; 100 µM), as well as vascular responses to sodium nitroprusside (SNP). Reactive oxygen species (ROS, oxidative stress marker) were evaluated in aortic sections by dihydroethidium staining (n=3-5). Results: Three months postpartum, a HCD during late pregnancy reduced maximal MCh-induced vasodilation (72.5±5.1 vs 90.7±2.1%; p=0.001) and reduced nitric oxide contribution (177.1±24.7 vs 239.2±16.4 AU; p=0.036) versus females that were fed on a CD in pregnancy. In females that were on a HCD in late pregnancy, pre-incubation with oxLDL decreased maximal vasodilation to MCh compared to vessels without oxLDL (54.6±9.9 vs 72.5±5.1%; p=0.04), while no effects of oxLDL were found in CD females. No differences between groups were found in the maximal SNP-induced vasodilation. Finally, HCD during late pregnancy tended to increase aortic superoxide levels 3 months postpartum compared to females on a CD during gestation (4.5±2.1 vs 3.6±1.1 AU, p=0.06). Conclusion: A high-cholesterol diet during late pregnancy impairs maternal vascular function long-term, potentially via increased vascular responsiveness to oxLDL and oxidative stress formation, and lower nitric oxide contribution to vasodilation. Our study suggests that vascular dysfunction during gestational dyslipidemia persists after pregnancy, which could play a key role in developing long-term cardiovascular complications. Remodeling Postpartum in Mice. Kirtika Prakash, Rebecca I Fairchild, Nicole M DeLance, Natalia I Gokina, Elizabeth A Bonney * . University of Vermont, Larner College of Medicine, Burlington, VT, United States. Introduction: Pregnancy-induced vascular remodeling occurs postpartum (PP) and is regulated by maternal immunity and breastfeeding. In mesenteric vessels this begins in late pregnancy, peaks 2 to 4 weeks (wks) PP then resolves. Macrophages regulate vascular biology. Tissue macrophage presence is regulated by Monocyte chemoattractant protein 1 (MCP-1, CCL2 ). Blood levels of MCP-1 increase 3d and peak 2 wks PP. Vessels from MCP1 -/mice show impaired PP remodeling. We altered PP MCP-1 levels to determine the effect on vascular parameters Methods: Adult (~4 months) C57BL/6 (WT) and MCP-1 -/females were mated with same-strain males or left virgin. WT mice were injected with 0.5µg MCP-1 or PBS (control) i.p. every 4 days from 2 to 4 wks PP. MCP-1 -/mice were similarly treated from 3d to 2 wks PP. WT mice were given 50 µg MCP-1 blocking antibody every 4 days from 3d to 2 wks PP or from 2 to 4 wks PP. Serum from nursing and non-nursing females was assayed for MCP-1 by ELISA. Passive distensibility was assessed from arterial diameters measured post pressure increase from 3 to 120 mmHg. Here we report % increase in diameters at 80 mmHg relative to 3 mmHg. Passive arterial diameters or wall thickness (um) were measured at 50 mmHg. Statistical analysis of distensibility used two-way RM ANOVA. Analysis of structural data and MCP-1 levels used the t-test. Significance was set at p<.05. Results: Serum MCP-1 levels were similar in nursing vs. non-nursing mice at 3d (p=0.13) and 2wks (p=0.9) PP. Vessels from WT virgins given MCP-1 (n=6) vs. PBS (n=4) for 2 wks exhibited similar distensibility (p=0.51), passive lumen diameters (p=0.96), and arterial wall thickness (p=0.36). Similarly, vessels of WT mice given MCP-1 from 2 to 4 wks PP (n=8) vs PBS (n=4) did not show changes in these parameters (p=0.74, 0.44, 0.12, respectively). However, vessels from MCP1 -/mice given MCP-1 from 3d to 2 wks PP (n=12) showed an increase in distensibility compared to vessels (n=12) from control mice (90.1 ± 2.7% vs. 78.2 ± 1.9% , p < 0.001). No significant difference in passive lumen diameters (um) (232.5 ± 8.9 vs. 215.3 ± 8.0, p=0.17) or arterial wall thickness (12.5 ± 0.8 vs. 11.6 ± 0.5, p=0.24) was found. Vessels from WT mice given anti-MCP-1 3d to 2 wks PP had similar distensibility (94.1±3 vs. 90.2±4.3, p=0.43) and passive lumen diameters (218.2±9.3 vs. 217.7±7.7, p=0.97) compared to controls. However, these vessels had increased wall thickness (12.7±0.6 vs. 10.5±0.3, p=0.003). Administration of anti-MCP-1 to WT mice 2 to 4 wks PP did not change these parameters. Conclusion: Although MCP-1 is not modified by nursing, it likely plays a role in early PP vascular remodeling. However, MCP-1 probably does not play a critical role in this process late PP.Supported by NIH RO1HL141747 Relationship between Low-Dose Epidural Analgesia and Obstetric Laceration Location and Severity. Gillian Horwitz †, Megan Trostle †, Iffath Hoskins * , Ashley S. Roman * . NYU Langone Health, New York, NY, United States. Introduction: While previous studies have characterized the relationship between epidural analgesia and severe perineal lacerations, the relationship between epidural analgesia, specifically low-dose epidural analgesia (LDEA) and all other obstetric lacerations has not been well studied. The objective of this study was to determine the association of LDEA with any perineal laceration. We hypothesized that women with LDEA would be less likely to have any perineal laceration. Methods: This was a single-center, retrospective, cohort study of all vaginal deliveries of vertex, singleton gestations at 34 weeks or beyond in women with no prior vaginal deliveries from 7/2013 to 10/2018. We compared obstetric laceration location and severity between women with and without LDEA. The primary outcome was the rate of any perineal laceration. The secondary outcomes included rates of anterior vulvar, 1 st -degree, 2 nd -degree, severe perineal, sulcal, or cervical lacerations. Fischer's exact test, Chi-square test, Mann Whitney U test, and multivariate regression were performed with p<0.05 considered statistically significant. Results: Among 8,544 women meeting inclusion criteria, 7,316 had LDEA. Women with LDEA were at increased risk of perineal lacerations (p<0.001), and in particular 2 nd -degree perineal lacerations (p=0.001). Multivariate analysis was performed to adjust for demographic and labor differences between the groups, and women with LDEA remained at increased risk of perineal lacerations (OR 1.40, ). In the multivariate analysis, other significant factors associated with perineal laceration included birth weight, race and ethnicity. LDEA was associated with a lower risk of anterior vulvar laceration (OR 0.83, CI 0.71-0.96). There was no difference between groups in the rates of 1 st degree, severe perineal, sulcal or cervical lacerations. Conclusion: Women with LDEA were at increased risk of perineal lacerations, particularly 2 nd -degree lacerations. LDEA was not associated with an increased risk of severe perineal laceration. Introduction: Maintenance of immunological tolerance towards the semiallogeneic fetus is important for successful pregnancy outcome. However, some couples experience unexplained recurrent pregnancy losses (uRPL). It has been described that regulatory T-cell (Treg) percentages are decreased at the maternal-fetal interface (decidua) after miscarriage compared to elective termination of pregnancie. We hypothesized that in women with uncomplicated term pregnancy after a history of uRPL a higher level of immune regulation is required at the fetal-maternal interface compared to women with uncomplicated pregnancy without any miscarriage in history. We developed two heavy metal-labelled antibody panels for in-depth immune profiling by mass cytometry using a total of 59 unique immune markers. The first panel focused on all immune lineages while the second had a focus on T cells, including intracellular markers. Immune cells from both the decidua basalis and the decidua parietalis were isolated shortly after delivery, and directly stained with the two antibody panels together with a reference control for data normalization. We analyzed decidua of 6 women with historic uRPL (case group) and 3 women without miscarriage in history (control group). Results: Analysis and visualization of the high-dimensional data was performed by applying HSNE and t-SNE for the case and control groups combined. For this first analysis, we focused on Tregs. In clustering analysis based on marker expression, FoxP3 + and FoxP3 -Treg-like cells (CD25 + CD127 -CTLA-4 + ) clustered together. We observed a significantly higher Treg-like cell percentage in the decidua parietalis of cases compared to controls (2.35% vs. 0.18% within CD45 + cells, P=0.024). For both the decidua basalis and parietalis, 50% of cases had an increased Treg-like cell percentage compared to controls. Conclusion: A proportion of women with a history of uRPL display increased Treg-like cell levels at the fetal-maternal interface, suggesting a possible compensatory role allowing a successful pregnancy. We aim to further elucidate the immunological context of this potential regulatory compensation mechanism by analyzing the other immune cell types in the decidua. Preterm Birth in Chronic Toxoplasma Gondii Infection. Maureen Edith Groer * , 1 Adetola Louis-Jacques * , 1 Samia Dutra †, 1,2 Ming Ji. Introduction: Toxoplasma gondii is a l apicomplexan unicellular parasite that infects most warm-blooded animals with more than 40 million infected people in the U.S. Chronic infection is marked by quiescent tissue cysts containing bradyzoites which are suppressed by adaptive and innate immune responses. Th1 immunity (IFN-γ and IL-12) keeps the organisms confined in cysts as bradyzoites, but NK cells. The humoral immune system responds by producing immunoglobulins. Expert opinion and clinical practice guidelines are that women with chronic T. gondii infection are not at risk for reactivation. In pregnant women with there is potential for reactivation due to the immune changes in pregnancy. The goal of the study is to measure immune changes and pregnancy outcome in chronically infected women. Methods: During prenatal visits 578 Hispanic women completed questionnaires, blood was drawn, and clinical data were obtained. All women were screened for T.gondii IgG titers. While a cohort is being followed through pregnancy, data presented here is about the women initially screened at the first prenatal visit and birth outcomes data were collected from the electronic health record. The T.gondii positive and negative groups were compared on gestational age (GA), preterm birth, miscarriage and small for gestational age (SGA). Results: T.gondii chronic infection was much higher in this population than is typical in the U.S.. The mean gestational age at delivery was 36.5 +-6.4 for the T. gondii negative women and 34.1+-9. The placenta is a highly vascularized organ that supports maternal and fetal health during pregnancy. Placental dysfunction is associated with adverse clinical outcomes, such as preeclampsia, fetal growth restriction, and preterm birth. Herein, we employed tandem mass spectrometry proteomic analyses of mouse placenta collected between embryonic day (E) 8.5-E17.5. We hypothesized that proteins and pathways that regulate crucial processes such as specifi cation of placental progenitors, or regulation of placental morphogenesis, maturation and aging would 1) be overrepresented at corresponding time points and 2) display common temporal abundance patterns. Methods: To test this idea, we analyzed mouse allantois, chorion and placenta samples collected at 12h intervals between E8.5-E12.5 and 24h intervals between E12.5-E17.5 (n=3/independent liters per stage, N=45). Decidua was removed to enrich for placental progenitors and the developing maternal-fetal interface (MFI). Matched paraffi n embedded placenta tissue sections were used to conduct a corresponding histological examination of major morphological features and cell types of interest. In total, 3792 distinct proteins were detected. Results: Proteomes diff ered principally in accordance with gestational age. Protein abundance kinetics (Xina) identifi ed groups of co-occurring proteins over the course of development. The complex abundance pattern of prolactins in the mouse placenta proteome were evaluated in order to compare the proteome to published literature. Functional enrichment analysis (GO and GSEA) identifi ed biological processes, molecular functions and pathways that change during development of the placental labyrinth. Abundance patterns that fl uctuated during the initial diff erentiation of placental structures (E8.5-E9.0), placental morphogenesis (E9.5-E13.5), and/or placental maturation (E13.5-E17.5) were identifi ed. GSEA using Reactome pathway database identifi ed that FGF singling was enriched early in MFI development, while VEGF, EPH/EPHRIN, and signaling by RHO GTPases was enriched late in MFI development. Finally, co-occurring temporal abundance patterns and kinetics of proteins associated with blood vessel formation and blood pressure were identifi ed, such as cell-matrix adhesion, cell-cell junctions, cellular adhesion, and extracellular matrix constituents. The presented study has defi ned novel developmental stagespecifi c protein networks that characterize mouse placentation. Future work will evaluate conserved targets which can be manipulated to alter placental vascular structure or function in new strategies for preventing or treating human placental dysfunction. We previously used detailed placental pathologic data to further subclassify PE: EO-PE was further subdivided into "classic" (small placentas, with 2 of these 3 lesions: decidual vasculopathy, infarcts, and hypermaturity) +/-fetal thrombotic vasculopathy (FTV). LO-PE was further subdivided into "normal" (no fi ndings) and "villitis" (mostly chronic villitis). Here, we combined RNA sequencing data with the above pathologic fi ndings to identify markers specifi c to each subtype. Methods: 47 PE and superimposed PE placentas (9 cases of classic+FTV, 10 classic-FTV, 16 normal, and 12 villitis), all with severe features, were used for this study. Clinical diagnosis was based on current ACOG criteria, and adjudicated by two maternal fetal medicine specialists; all placentas had gross and histologic examination performed by a single perinatal pathologist. RNAseq was performed using Illumina HS4000. Data was processed using our standard RNAseq pipeline; diff erential expression analysis (DEA) was done by DESeq2 (using Log2FC>1.5, padj<0.005 as cut-off ) to detect markers of each pathological subclass. We fi rst performed DEA of PE vs superimposed PE cases and noted similar gene expression patterns. Therefore, we combined PE and superimposed PE for further analysis. Six combinations of DEA from the pathology category were performed, and the EO-classic-FTV category was noted to have the highest number of diff erentially expressed genes (77-120 DEGs). Normal vs. villitis showed only 6 DEGs, consistent with the mostly focal nature of villitis in these placentas. Functional enrichment analysis of the unique genes among these DEGs identifi ed altered Apelin pathway in EO-classic+FTV, and altered immune response pathways in LO-villitis. Conclusion: Our fi ndings suggest that severe PE can be characterized by combination of pathological fi ndings and molecular profi les. Further detailed pathological subclassifi cation will improve the identifi cation of subclasses and molecular biomarkers. Introduction: Fetal sex is a key biological variable to include in omicsbased analyses of the placenta. DNase-seq data is a type of epigenomic data that profi les the accessible chromatin landscape of the genome by detecting regions digested by DNase-I. Compared to other chromatin accessibility assays, such as ATAC-seq, it is more sensitive and its cleavage bias is better characterized. The purpose of this study was to analyze the sex-specifi c diff erences of placenta DNase-seq data to better understand the potential sex diff erence in placental epigenetic regulatory mechanisms. Methods: Six female and six male placental samples from term, nonpathological pregnancies were collected from the OHSU Placental biorepository. DNase-seq data of these samples were generated at the Altius Institute for Biomedical Sciences. We identifi ed overlapping peak sets present in both sexes using Diff Bind, and identifi ed statistically diff erent peaks using EdgeR (FDR q < 0.05). Results: Female samples have signifi cantly more DNase-I Hypersensitive sites (DHSs) at the fi rst exon than males (p= 2.95x10 -4 , t-test). We identifi ed 27,745 peak sets unique to female samples and 16,972 unique to male samples. 90,655 overlapping peak sets appeared in both female and male samples. Out of 90,655 peak sets, 181 peaks (0.002%) were statistically diff erent. A total of 105 peaks had stronger peak signals in female samples; 81 peaks at chromosome X and 24 peaks at autosomal chromosomes. The ten most DNase-I hypersensitive peaks in female samples were in the X chromosome. To our knowledge, this is the fi rst genome-scale assessment of sexual dimorphisms in the placental epigenome characterized using DNase-seq data of placenta tissue. We identifi ed diff erential DHSs depending on the fetal sex qualitatively and quantitatively. The next steps include the integration of ChIP-seq data from matched samples. These additional data will further provide a clearer description of the sex-specifi c epigenetic regulation of gene expression. Introduction: Atypical protein kinase Cs (aPKCs) are a family of kinases important for the regulation of cell polarity. The two major forms of aPKC present in humans are aPKC-ι and aPKC-ζ. Very recently, aPKCs have been found to initiate trophectoderm polarization and establishment, and thus, placental formation in humans. Additionally, aPKC-ι specific knockdown in human trophoblast stem cells (TSCs) fail to form syncytiotrophoblast (ST), emphasizing its critical role in trophoblast differentiation. Compensation for aPKC-ι by aPKC-ζ isoforms has been described, yet, the expression and function of aPKC-ζ isoforms in trophoblasts and the placenta remains unknown. Thus, we examined the expression and localization of aPKC-ι and aPKC-ζ isoforms in human placenta and trophoblasts. Further, we assessed syncytialization of primary human trophoblasts in the presence of total aPKC inhibitors to address the importance of all aPKCs in trophoblast differentiation. Methods: Placental tissue (1 st and 3 rd trimester) was stained using immunofluorescence (IF) for aPKC-ι and aPKC-ζ. Isolated primary trophoblasts and total placental lysate protein and mRNA were collected for western blotting and RT-PCR analysis of aPKC isoforms. Primary first trimester and term CT were stimulated to differentiate into ST with Br-cAMP +/-aPKC inhibitors (pseudosubstrate and aurothioglucose [ATG] ) and fusion assessed with IF using anti-E-cadherin and nuclear stains. Results: APKC-ι and aPKC-ζ specific antibodies revealed largely overlapping expression patterns in CT and ST, and low expression in extravillous trophoblasts, in first trimester and term placentas.Surprisingly, aPKC-ζ western blots of placental lysates and trophoblasts displayed two bands; one corresponding to full length aPKC-ζ and a ~55kDa band. Using RT-PCR and isoform specific primers aPKC-ζ isoform 1 (full length) and isoform 3, which has a predicted molecular weight of ~55kDa, could be amplified. Thus, there are 3 isoforms of aPKC expressed in the human placenta, and specifically, the trophoblasts. Pseudosubstrate and ATG inhibitors did not prevent syncytialization of both primary first trimester and term CTs to ST. We have shown for the first time that aPKC-ζ isoforms 1 and 3 are present in human placenta, specifically, the trophoblasts. Thus, placental trophoblasts express 3 isoforms of aPKCs that must be addressed when assessing placental function. Published aPKC-ι phenotypes do not address aPKC-ζ isoforms, however, their distinct and overlapping expression with aPKC-ι suggest both isoform specific functions and redundant roles. Unlike the published data that show inhibition of aPKC-ι prevents syncytialization in TSCs, inhibition of total aPKCs did not prevent syncytialization in primary CTs of the first trimester and term. Thus, aPKC isoform specific roles will be important to understand as their functions regulate pivotal trophoblast features. Differential DNA Methylation between Infection Associated and Idiopathic Spontaneous Preterm Birth. Heather M Brockway * , Jones N Helen * . University of Florida, Gainesville, FL, United States. Introduction: Preterm birth (PTB), birth before 37 weeks gestation, is a global public health concern with 70% of these PTB categorized as idiopathic spontaneous (isPTB). Yet little is known regarding the molecular mechanisms of isPTB. We previously identified transcriptomic signatures of placental maturation in a highly phenotyped cohorts. Introduction: Increasing numbers of women consume a 'Western diet' (WD), high in fats and sugars, which has been associated with maternal obesity and adverse pregnancy outcomes such as fetal growth restriction. However, WD alone, independent of maternal obesity, negatively impacts maternal metabolic health and is associated with adverse term placental and fetal outcomes, although impacts upon the placenta, especially earlier in pregnancy, are ill-defined. We postulated that WD exposure during pregnancy, in conjunction with markers of poor maternal metabolic health, impacts the vasculature of the placental labyrinth, independent of maternal obesity. Methods: Female guinea pigs were weaned onto a Control or WD and mated to control males at six months (~25-30 human years) of age, then necropsied at 40 days gestation (term ~69 days) for gross and histologic examination (CD: n=9 (6 pregnancies), WD: n=12(7 pregnancies)). Placental histopathology was assessed using H&E and IHC. The fetal capillary area was detected by vimentin staining, and the maternal lacunae with pan-cytokeratin staining. Results: While maternal and placental weights were unchanged between the two groups, WD fetal weights were 23% lighter (p=0.08) and fetal/ placental weight ratio was significantly smaller than CD (p=0.02). In histologic assessment, 2 out of 12 WD placentae displayed large necrotic areas, comprising ~50% of the tissue area, compared to CD placentae which showed only small necrotic areas. Although the ratio of labyrinth/ Interlobium area was unchanged between the two groups, the fetal capillary area in the labyrinth was significantly decreased (p<0.001) and the maternal sinus area in the labyrinth was significantly increased (p=0.02) in WD placentae. Conclusion: Lifelong WD exposure, independent of maternal body weight, results in distinct abnormalities of late 2nd third placental architecture and decreased fetal capillary area. This study supports the concept that life-long maternal diet alone plays a significant role upon placental vascularization in association with markers of poor maternal metabolic health, independent of obesity. These resulting alterations may negatively impact later pregnancy placental hemodynamics and contribute to poor birth outcomes including growth restriction and stillbirth associated with a dysfunctional placenta. The key role of placental dysfunction in the aetiology of numerous pregnancy pathologies, such as preeclampsia (PE) and intrauterine growth restriction (IUGR) is now well established. Nonetheless, molecular mechanisms that orchestrate placental function and that are behind disease development are still incompletely understood. In this study, we seek to identify expression Quantitative Trait Loci (eQTLs) in healthy and pathological placentas. An eQTL describes the correlation between a change in sequence of a specific locus on the genome (eSNP) and levels of expression of a target gene (eGene). Therefore, these results can give insights into the regulation of the eGene in question, identifying potential key elements (e.g. transcription factor binding sites, enhancer regions). eQTL mapping will therefore help to clarify the functional landscape of the human placenta. Introduction: Cannabis use during pregnancy is associated with a variety of obstetrical outcomes, including preeclampsia, preterm labour and low birth weight. The molecular mechanisms underpinning these outcomes are not well understood but may be attributed, in part, to the actions of the psychoactive cannabinoid, Δ-9-tetrahydrocannabinol (THC). In the placenta, mononucleated cytotrophoblasts (CT) syncytialize/fuse to form the multinucleated syncytiotrophoblast (ST) layer at the maternofetal interface. Furthermore, the placenta is rich in mitochondria and these organelles are known to play an important an important role in the development and function of this tissue. We hypothesized that THC would compromise the process of trophoblast syncytialization and alter trophoblast function, in part, as a result of mitochondrial dysfunction. Methods: BeWo cells, as CTs or STs, were treated with 20 µM THC for 48 hours. We quantified markers of trophoblast fusion (GCM1, ERVW-1, ERVFRD-1, CG), and function (placental lactogen (PL), insulin like growth factor 2 (IGF2) and progesterone (P4)) using RT-PCR and ELISA. We quantified mitochondrial stress (HSP60, HSP70), mitochondrial ETC function (respirometry), cellular ROS (DCFDA assay) and mitochondrial membrane potential (JC-1 fluorescence). We also evaluated the contribution of cannabinoid receptor 1(CB1R) or cannabinoid receptor 2 (CB2R) on mitochondrial fragmentation (OPA1, MFN1, MFN2, DRP1) using inhibitors specific to each of these receptors (AM281 and AM630, respectively). Results: Treatment with 20 µM THC caused a significant elevation of cellular ROS (80% increase), reduction in ATP production (by 50%) as well as an attenuation of the mitochondrial membrane potential along with a, more than 2-fold, increase in the expression of (HSP60, HSP70). These changes were paralleled with an observed reduction in trophoblast fusion (reduced mRNA levels of GCM1, ERVW-1, ERVFRD-1, CG). We also observed reduced hCG and P4 (3-fold reduction) secretion, reduced expression of PL and IGF2 transcripts concomitant with a significant increase in mitochondrial fission (decreased OPA1 and MFN2, increased DRP1 transcripts). These markers of mitochondrial fission, resulting from THC treatment, were reversed when cultures were pretreated with 1μM AM281 and not with 1 μM AM630. Conclusion: Taken together, our data suggest THC evokes mitochondrial dysfunction in syncytiotrophoblasts and impacts mitochondrial dynamics, a process known to be linked to cellular health. These changes appear to be mediated, in part, through CB1R. Importantly, these changes in mitochondrial function are associated with the reduced production of hormones which are important for fetal growth and may support a plausible mechanism by which THC exposure during pregnancy leads to adverse fetal outcomes. In the dispersal type, the chorionic blood vessels undergo successive divisions with gradually diminishing caliber as the vessels traverse towards the placental margins. In the magistral type, the blood vessels traverse towards the placental margins without appreciable decrease in vessel diameter. Since extracellular matrix needs to be continually degraded to modify the structural scaffold as these chorionic blood vessels evolve, we hypothesize, that matrix degrading enzymes secreted by cytotrophoblasts may dictate the branching patterns of the chorionic vessels. We, therefore, investigated if placental expression of matrix metalloproteinase-9 (MMP-9) protein would differ between the two vascular patterns of chorionic blood vessels of human placenta. Methods: In this IRB approved study, full-term placentas were obtained from women with uncomplicated pregnancy. All placentas were photographed, the vascular patterns were determined and chorionic villi were isolated. Chorionic villi MMP-9 protein expression was analyzed using human MMP-9 monoclonal antibody based ELISA kit from R&D Systems, MN. Independent t test was used for statistical analysis. P< 0.05 was considered significant. Results: 26 full term placentas were collected. All women delivered normal healthy newborns. The branching pattern of the chorionic vessels was 54% of the dispersal type, and 46% magistral. In placentas with dispersal type of branching pattern, MMP-9 protein expression was significantly higher (p=0.006). Women who delivered placentas with magistral type of branching pattern, the mean newborn weight was found to be significantly higher (p=0.039). Conclusion: Our findings underscore the importance of chorionic villi MMP-9 protein expression in molding the branching architecture of chorionic blood vessels of human placenta. In the magistral type, the calibers of the chorionic blood vessels from the point of insertion of the umbilical cord to the placental margin, remain unchanged. We suggest, that this unchanged caliber of blood vessels in the magistral type, may have allowed better nourishment and oxygen to be catered to the fetus; thereby resulting in fetal weight gain. to pregnancy complications such as preeclampsia. Vascular endothelial growth factor-A (VEGFA) and fibroblast growth factor-2 (FGF2) regulate endothelial functions primarily via inducing phosphorylation of their receptors and downstream proteins. Thereby, determining the VEGFA-and FGF2-induced protein phosphorylation profile changes in fetoplacental endothelial cells will advance our understanding of signaling mechanisms regulating fetoplacental endothelial functions. Methods: Human umbilical cord vein endothelial cells (HUVECs) isolated from healthy pregnant women at term and cultured till passages 4-5. After serum starvation, cells were treated with 10 ng/ml VEGFA, FGF2, or ECM-b (control) for 10 min. Cell lysates were prepared using a lysis buffer containing protein phosphatase inhibitors, followed by chemical cleavage. After determination of protein concentrations, the cell lysates were subjected to antibody-based protein phosphorylation array analysis (Kinexus Bioinformatics). Western blotting was used to confirm phosphorylation of proteins of interest. Results: Compared with the control, 10 min of VEGFA treatment elevated (≥ 2 fold) the phosphorylation of 48 proteins including many proteins that are important to endothelial functions (e.g., STAT2, AKT1, and ERK1/2), and suppressed (≥ 2 fold) phosphorylation of 88 proteins including many proteins in the VEGFA signaling pathway (e.g., MEK1, VEGFR1, and VEGFR2). FGF2 increased phosphorylation of 18 proteins including STAT4 and Src, while it decreased phosphorylation of 19 proteins including RSK1 and SIK3. VEGFA-induced AKT1 and ERK1/2 phosphorylation was confirmed by Western blotting. Conclusion: This is the first report of the VEGFA-and FGF2-induced protein phosphorylation profile changes in HUVECs. These data indicate that VEGFA and FGF2 rapidly and dramatically alter the signaling cascades in fetal endothelial cells, which is much more complicated than we expected before. More importantly, these signaling molecules could be potential therapeutic targets for VEGFA-and FGF2-regulation associated endothelial dysfunction in pregnancy complications such as preeclampsia. NIH PO1 HD38843 (JZ). Is Extracellular Outflow of Transcription-Related Factor High-Mobility Group A1 Protein Involved in the Pathogenesis of Preeclampsia? Yuka Uchikura, Keiichi Matsubara, Yuko Matsubara, Takashi Sugiyama. Ehime University, Toon, Japan. Introduction: High-mobility group A1 (HMGA1) protein, a transcriptionrelated factor, generally fulfill its function in nuclei of cells. It is known that HMGA1 is highly expressed in cancer cells and undifferentiated cells early in pregnancy, and is lowly expressed in differentiated cells. Although we have reported the involvement of HMGA1 in the pathogenesis of preeclampsia (PE), there are few reports on its function so far. We investigated the role of HMGA1 in terms of the pathogenesis of PE. The expression of HMGA1 on the maternal side of preeclamptic placenta and in the uterus 3 days after fertilization in PE model mice was observed by immunohistochemistry. In order to study the effects of extracellular HMGA1, extravillous trophoblast cells (EVTs; HTR8 / SVneo) was cultivated with deoxycholic acid (DCA) and we performed wound healing assay / Matrigel transwell migration assay. HMGA1 concentration in the culture supernatant was measured by ELSA under low oxygen or with DCA. Exosomes in the culture supernatant were collected and HMGA1 expression in exosomes was analyzed using western blotting method and DIA proteome analysis. Results: HMGA1 was translocated outside the nuclei of EVTs in preeclamptic placenta and a part of it was found extracellularly early in pregnancy. HMGA1 was also expressed around zygote in PE model mice. The migration and invasion ability of EVTs was suppressed by promoting nuclear export of HMGA1 caused by DCA. The exosomal HMGA1 released from EVTs was induced by DCA. Conclusion: HMGA1 generally exists in the nuclei of EVTs in normal pregnancy and promotes the proliferation, invasion, and migration. However, HMGA1 is translocated from the nuclei into the cytoplasm and a part of it is released extracellularly in the form of exosomes resulted in reduced EVTs' invasion and migration in PE. The LGA infants and disproportionally large placentas consistent with enhancement of nutrient supply to the placenta leading to up-regulation in nutrient transport and thereby placental and fetal growth. While little changed in the GDs, umbilical vein and artery PO 2 were decreased in DM infants, likely involving aberrant placental development with diffusional impairment of oxygen and increased utilization with the larger size in these infants, respectively. Accordingly, oxygen is unlikely to be a primary promotor for fetal growth in these pregnancies as it is in ND pregnancies, with a change in the balance of nutritional cues whereby oxygenation is lower, with implications for longer term development. and respirometry were carried out in placentomes, and uterine artery reactivity was assessed by myography. A separate cohort of pregnant ewes was surgically instrumented at 120 dGA with Transonic flow probes and catheters to record cardiovascular function via wireless data acquisition. Five days later, ewes were exposed to N (n=5) or H (n=5) for 10 days. Data were compared statistically via Two-way RM ANOVA or the Student's t test. Results: Hypoxic pregnancy led to fetal growth restriction (FGR), increasing placental protein carbonylation and maternal serum sFlt-1 ( Figure, A-C) . The fall in maternal blood pressure and uterine vascular resistance measured in control ewes with advancing gestation did not occur in hypoxic ewes, and this was associated with increased uterine PI and enhanced vasoconstrictor reactivity to serotonin (5-HT; Figure, D-G). Hypoxic pregnancy decreased placental mitochondrial complex I-dependent respiration (OXPHOS) with no effect on total OXPHOS, but increased placental transcription of glucose transporter 3 (GLUT3) and carnitine palmitoyl transferase 1 (CPT1; Figure, H . Placental microstructure is known to be disrupted in pregnancies complicated by congenital heart disease (CHD), but studies using accepted classification systems of placental histopathology in LVOTO and non-LVOTO CHD are lacking. In this study, we sought to test the hypothesis that fetuses with LVOTO have higher rates of placental pathology and lower placenta-to-birth weight ratios compared to fetuses with non-LVOTO CHD. Methods: In this single-center cohort study of neonates with CHD, we determined the prevalence of pathologic lesions of the placenta in those with LVOTO and non-LVOTO CHD. We used the Redline classification system to characterize placental lesions into four main categories: 1) maternal stromal-vascular lesions, 2) fetal stromal-vascular lesions, 3) acute inflammatory/ immune processes, and 4) chronic inflammatory/ immune processes. Additionally, we quantified placentas with umbilical cord abnormalities, large for gestational age (>90 th percentile), and small for gestational age (<10 th percentile). Placentas in each group with any pathology and those with multiple pathologies were also determined. Prevalence of each lesion type, presence of any pathology, and presence of multiple pathologies were compared using Chi square analysis. We determined differences in placental weight to birth weight ratios between the two groups using linear regression analysis. Results: A total of 272 pregnancies complicated by CHD were assessed for inclusion and 196 had placental pathologic examination performed (LVOTO n=60, non-LVOTO n=136). Pathologic lesions were present in 82% of placentas from fetuses with CHD (LVOTO 88% vs. non-LVOTO 79%; p=0.13) and multiple pathologies were present in 55% (LVOTO 52% vs. non-LVOTO 56%; p=0.58). No specific pathology was significantly more common in LVOTO compared to non-LVOTO fetal CHD. Specifically of interest were fetal stromal-vascular lesions which were found in 30% and 19% of fetuses with LVOTO and non-LVOTO CHD, respectively (p=0.09) and umbilical cord abnormalities (LVOTO 22% vs. non-LVOTO 17%; p= 0.43). There was no significant difference in placenta-to-birth weight ratios between groups (p=0.99). Conclusion: Pathologic lesions of the placenta are highly prevalent in fetal CHD irrespective of type of structural heart disease and no specific category of placental pathology predominates. Pathologic examination of the placenta should be considered in all pregnancies complicated by fetal CHD. The critical role of the placenta is to deliver adequate oxygen and nutrition to support fetal development. Despite its importance, we know little about it. Due to the heterogeneous nature of the placenta, the organ-level average measurements, as commonly performed in most placental magnetic resonance imaging (MRI) analysis, are not regionspecific and often fail to represent the regional variation. To address this challenge, we developed an automatic intra-placenta segmentation technique using multi-contrast MRI. Methods: A fuzzy clustering algorithm based on a Gaussian mixture model was employed. While the number of clusters equal to three as estimated by Calinski-Harabasz criterion, there are a total of four groups, as a built-in outlier detection session sorted voxels similar to neither of the clusters into the abnormal group. The parameters needed for the fuzzy clustering algorithm were extracted fromT2* and diffusion MRI by mono-exponential fitting and DTI fitting, representing the features of each voxel. The MRI data was collected from 22 patients with normal pregnancy, and 5 patients with confirmed placental pathologies. Elastix was employed to conduct image registration. The three separated compartments were automatically identified as intervillous space (IVS), placental vessel (PV), and placental tissue (PT). The spatial distribution of each compartment closely matches the biology of the placenta. We found that the placenta can be reliably segmented into intra-placental compartments, and we found a remarkable difference in the volumes of abnormal placental regions in normal and abnormal pregnancies (p=0.003). Percentages of abnormal region (the 4 th group) volume against total placental volume in normal patients was lower than 3%, while the percentage in five abnormal patients are 14%, 16%,17%, 23%, and 38% respectively. The automatic intra-placental segmentation achieved by our method allows detailed spatial evaluations of three placental compartments, enhancing invivo visualization and compartment-specific quantifications of the heterogeneous organ as well as providing an early marker of placental dysfunction. Asymmetric FGR was classified as fetal wt <25% and brain:liver wt ratio >0.66. Effects of HPX and sex differences were evaluated by Western immunoblot on separate gels. IGFII band densities were normalized to ß-actin, and groups (NMX/ HPX and males/females) were compared using Student's t-tests (p < 0.05). Results: Gestational ages were similar between the NMX and HPX cohorts of both males and females (Table 1) . Fetal body, brain, and liver wts were less (p<0.05) in HPX vs. NMX controls for both sexes. HPX increased (p<0.05) relative placenta wt (placental wt/fetal body wt ratio) by ~30% and brain:liver wt ratios by ~40% (Table 1) . HPX had no effect on IGFII protein levels in males but increased (p=0.047) in females (Figure 1, top) . With NMX, females had lower IGFII levels than males (0.39 ± .07 vs 0.20 ±.05, p=0.029). With HPX, females had higher IGFII levels than males (1.86 ± .48 vs 3.9 ± .59, p=0.049) (Figure 1, bottom) . Conclusion: This study identified two specific effects of IGFII expression in GP placenta, contrary to our hypothesis. HPX female placentas exhibit an enhanced response in IGFII expression compared to males. This may be a compensatory mechanism for protecting against further placental dysfunction. Moreover, there is an inherent sex difference in the expression of IGFII, which may indicate a reserve capacity for IGFII synthesis in females. Thus, male placentas may be more vulnerable to worsening placental function under conditions of hypoxia due to their limited capacity to generate IGFII. (NIH HL 126859) We recently reported on placenta-specific cell-free-(cf) DNA methylation and cell-free transcriptomics during early gestation, providing predictive possibilities for pregnancies with adverse outcomes, even prior to the emergence of characteristic clinical and laboratory features. We next extended our early gestation detection capabilities towards exploring maternal urine cell-free (cf) RNA signatures along with the electric field-induced release and measurement -liquid biopsy (eLB-EFIRM) technology with a rapid turnaround time, for non-invasive detection of adverse pregnancy outcomes (APOs), such as preeclampsia (PreX), gestational diabetes mellitus (GDM) and fetal growth restriction (FGR). Methods: We analyzed cfRNA content of 192 maternal urine samples collected prospectively and temporally for each subject from the first trimester until delivery. We examined urine cfRNA by RNA-seq analysis using SaVanT, a web-based signature visualization tool, in order to assess the tissues/cells-of-origin for the detected cfRNAs. Our focus was on the first and second trimesters of pregnancy, and detection of differentially expressed transcripts/genes (DEGs), along with validation of these DEGs by the eLB-EFIRM technology. Results: Using the RNA-seq analysis at all trimesters of pregnancy and at delivery, and SaVanT, urine cfRNA was deconstructed to arise from sixteen different tissues-of-origin. Placenta-specific cfRNA signature increased with advancing gestation while trending lower than normal in pregnancies with adverse outcomes. Moreover, using cfRNA sequencing, we were able to detect 3710 differentially expressed genes (DEG) in the first trimester of pregnancy, 472 of them GDM-specific, 410 Preeclampsia-specific and 90 for FGR. Using elastic regularization and prediction modeling with eLB-EFIRM technology we plan on a panel of 3-5 reproducible DEGs in early gestation that are specific for PreX, GDM and FGR, prior to the emergence of classical clinical features. We tested and validated the ability of the eLB-EFIRM technology to detect one placenta-specific DEG, namely the human placental alkaline phosphatase in urine samples from subjects in our cohort. Our preliminary studies support the possibility of employing urinary cell-free transcriptomics for the potential prediction of APOs that develop subsequently. This non-invasive approach coupled with the eLB-EFIRM technology of detection will pave the way for accessible and convenient diagnostic testing during pregnancies.Supported by NICHD. Conclusion: XRF is a unique tool in the field of placental physiology, and has opened avenues for nucleic and protein-based research. In this study, significant differences were observed in essential elements between pathological conditions. It is as yet unclear whether this represents differences in the uptake of metals from the maternal circulation or differences in the transport of metals to the fetus or a combination of these mechanisms. However, it is established that molybdoenzymes remove sulphites from the body, while iron is involved in catalasemediated radical scavenging, and manganese is a cofactor of radicalscavenging family superoxide dismutase. We therefore postulate these results indicate dysregulation of the antioxidant response to oxidative stress in the placenta. We have recently demonstrated that EG-VEGF is highly expressed in the human placenta; contributes to placental vascularization and growth and that its aberrant expression is associated with pregnancy pathologies including preeclampsia and fetal growth restriction. These fi ndings strongly suggested that antagonization of its receptors may constitute a potential therapy for the pregnancy pathologies. Methods: Two specifi c antagonists of PROKR1 (PC7) and for PROKR2 (PKRA) were reported to reverse PROKs adverse eff ects in other systems. In the view of using these antagonists to treat pregnancy pathologies, a proof of concept study was designed to determine the biological signifi cances of PC7 and PKRA in normal pregnancy outcome. PC7 and PKRA were tested independently or in combination in trophoblast cells and during early gestation in the gravid mouse. Results: Both independent and combined treatments uncovered endogenous functions of EG-VEGF. The independent use of antagonists distinctively identifi ed PROKR1 and PROKR2-mediated EG-VEGF signaling on trophoblast diff erentiation and invasion; thereby enhancing feto-placental growth and pregnancy outcome. Our study provides evidence for the potential safe use of PC7 or PKRA to improve pregnancy outcome. Introduction: Maternal COVID-19 infections are common in pregnancy, yet rates of infant SARS-CoV-2 transmission are low. As the interface between mother and fetus during pregnancy, the placenta may form a protective barrier against vertical transmission of COVID-19. Major immune populations at the maternal-fetal interface include macrophages and natural killer (NK) cells which can mount cellular and infl ammatory cytokine responses against viral infections. Understanding whether these cells respond to COVID-19 in the placenta may help understand intrauterine mechanisms preventing fetal transmission of SARS-CoV-2 in pregnancy. Methods: Placental biopsies (including decidual tissue) were obtained from 8 SARS-CoV-2 positive pregnancies (COVID) and 5 contemporary SARS-CoV-2 negative pregnancies (Control) during a peak period of COVID-19 admissions at Boston Medical Center. Formalin-fi xed cryosections were stained with primary antibodies (CD14 or CD56) and fl uorescently labeled secondary antibodies. Immunofl uorescence images of decidual tissue were obtained by automated acquisition and used to calculate a fl uorescence ratio (FR) of corrected total cell fl uorescence (CTCF) of target antigens over secondary-only negative background. FR of COVID and Control specimens were compared using independent t-tests. Results: CD14+ macrophages and CD56+ NK cells were observed in all decidual tissues examined. Quantitative microscopy revealed signifi cantly greater macrophage infi ltrates in COVID samples compared to Control samples (p< 0.01, Figure 1 ). There were also signifi cantly greater NK cell infi ltrates in COVID samples compared to Controls (p< 0.05, Figure 2 ). Conclusion: Our data demonstrate that NK cells and macrophages accumulate at the maternal-fetal interface in pregnancies complicated by COVID-19, suggesting these leukocyte populations may be of interest for ongoing studies examining intrauterine responses to SARS-CoV-2 during pregnancy. The LPS had the tendency to increase the macrophages at 6hpi and have no diff erences at 24hpi compared to PBS, while PD-L1 expression in placenta macrophages was increased at 6hpi (p<0.05) and 24hpi (p<0.05, Figure 1B ). T cells in placenta were decreased at 24hpi (p<0.05) compare with PBS, but the PD-1 expression in placenta T cells was signifi cant increased at 24hpi (p<0.05, Figure 1 C) . In the cMI model, the placenta leukocyte numbers signifi cantly increased at 3hpi (p<0.01) and 24hpi (p<0.05), and the PD-1(p<0.01) and PD-L1 (p<0.01) expression increased in the leukocyte at 24hpi (Figure 2A The fetal membrane acts as an important immunologically protective barrier between the mother and fetus. We have previously demonstrated that innate immune mechanisms exist in placental villi to resist infection and select viruses preferentially infect the fetal membrane. Our prior work has also demonstrated that chorionic villi (CV) and fetal membrane (FM) explants have distinct cytokine/chemokine profi les. We identifi ed interleukin-11 (IL-11) as a cytokine predominantly secreted by fetal membrane. IL-11 is in the IL-6 family and is required for successful embryo implantation. IL-11 regulation in non-reproductive tissues has been demonstrated to be tissue specifi c. In this study, we investigated the tissue specifi city of IL-11 production by the fetal membrane and the induction of IL-11 in response to various infectious stimuli. Methods: Fetal membranes were collected at cesarean section in the absence of labor or infection. Intact fetal membrane or separated amnion and chorion were incubated overnight in DMEM F12 supplemented with 10% FBS and penicillin-streptomycin. Primary amniotic epithelial cells (AEC) and immortalized amniotic epithelial cells were also used and cultured as previously described. TGF-β, Lipopolysaccharide (LPS), poly-I:C, cyclic GAMP, R848, herpes simplex virus (HSV)-1, Listeria monocytogenes, Streptococcus agalactiae, Zika (ZIKV) virus, and Rubella virus were used to infect or expose explants and primary cells. Culture supernatants were harvested and cytokine responses were measured by ELISA and Luminex profi ling. Cells or tissues were lysed and RNA was isolated. IL11 transcription was measured by qPCR. Results: IL-11 is constitutively secreted by intact fetal membrane, amnion and chorion explants. TGF-β controls IL-11 secretion in the amnion. In amniotic epithelial cells inhibition of this signaling reduces IL-11 levels. Moreover, addition of TGFβ enhances IL-11 secretion in amnion and cells. IL-11 is not induced by synthetic ligands of antiviral pattern recognition receptor signaling, infection with HSV-1, LPS, or infection of L. monocytogenes or S. agalactiae. However, IL-11 is robustly induced by ZIKV virus and Rubella virus infections, which occurs early during replication. Conclusion: IL-11 secretion is regulated by TGF-β in the amnion layer of the fetal membrane and is produced at high amounts in comparison chorionic villi. IL-11 is secreted in response to teratogenic viruses and may be important in the response to vertical infections in the fetal membrane . Chorioamnionitis is associated with an increased risk of autism spectrum disorders (ASD), a neurobehavioral disability that is more prominent in males than females. Although pre-clinical findings show that GBS-induced maternal immune activation occurs with more prominent inflammation and ASD-like behaviours in males than females, the mechanism underlying this sex difference is not understood. This knowledge gap raises the question of the role of sex steroids in the immune response. Our hypothesis is that testosterone up-regulates the placental innate immune response. Our objective is to test the effect of the androgen blockade in alleviating the molecular (pro-inflammatory cytokines) and cellular (PMN) responses in GBS-induced placental injury and subsequent neurobehavioral impairment of males. Methods: Lewis dams were injected every 24 h from gestational day (G) 18 to G21 with corn oil (vehicle) or flutamide (anti-androgen) administered at a dose of 50 mg/kg body weight. On G19, dams were injected with saline or GBS serotype Ia suspended in saline. The four experimental groups were: (1) vehicle/saline, (2) flutamide/saline, (3) vehicle/GBS, (4) flutamide/GBS. Dams underwent C sections on G22, with respect to their injection time. Maternal, fetal sera and placentas were collected for protein assays and in-situ analyses. Specifically, ELISA to measure key placental and fetal blood inflammatory mediators and immunohistochemistry to specify the distribution and quantify the amount of these inflammatory molecules. Our preliminary results showed that the dose of flutamide we used counteracted the androgen effect as shown by a significant decrease in anogenital distance of male pups from flutamide compared to vehicle dams. An expected trend of decreased maternal weight gain was associated with maternal GBS infection. A significant decrease in IL-1β, IL-6 and TNF-α concentration was observed in placentas of the GBS/flutamide group compared to the GBS group only. Conclusion: Flutamide is effective in inducing the androgen blockade. Furthermore, our results indicate that the androgen blockade results in a reduced GBS-induced placental innate immune response. placental macrophages or macrophage-like monocyte cell line THP.1), and incubated with the obesity-related saturated fatty acid palmitic acid (PA, 200 uM) and GBS for 24 h, then assayed for proinflammatory cytokine and MMP production by ELISA. Full thickness human gestational membrane punches were similarly exposed to PA or GBS. Cell death was assayed by lactate dehydrogenase assay. Results: PA induced cell death in MO cultured alone, which was ameliorated by co-culture of MO with DSC or CTB. PA did not kill DSC or CTB cultured alone. Without GBS, PA significantly induced GM-CSF, TNFα, MMP9, IL-1β, and IL-6 by DSC and CTB individually or in co-culture with MO, while PA did not significantly induce MO proinflammatory responses. Co-cultures treated with GBS alone induced GM-CSF, TNFα, MMP9, IL-1β, and IL-6. Co-cultures of MO with CTB or DSC induced the greatest inflammatory response when exposed to both GBS + PA. MO-DSC co-cultures induced a greater magnitude of proinflammatory cytokines than MO-CTB co-cultures. There was high variability in primary human gestational membranes, but synergistic induction of MMP9 during PA + GBS exposure was observed. The saturated fat PA induced a proinflammatory response from DSCs, CTBs, and MO, both alone and in co-culture. Induction of proinflammatory cytokines during co-culture was often synergistic. A greater magnitude proinflammatory response from DSC-MO cocultures suggests that DSCs are the structural cell type of the gestational membranes driving the proinflammatory response to PA. PA + GBS induced additive or synergistic increases in proinflammatory mediators. This study may explain why GBS-related complications are more common among pregnancies complicated by PPO. have been shown to possess the ability to differentiate into multiple cell types. These MSCs can be obtained from umbilical cord blood (UC). This is especially important for potential treatment in hypoxic-ischemic brain injury, which is shown to have significant morbidity and mortality. MSCs have a promising role in the treatment of hypoxic ischemic encephalopathy. Methods: 3 mL of umbilical cord blood were obtained at various gestational ages after delayed cord clamping. Peripheral blood mononuclear cells (PBMCs) separated by gradient centrifugation within 4 hours of delivery were passed through magnetic bead micro-columns to exclude the CD34 positive hematopoietic stem cells. The CD34 negative populations were cryopreserved for later processing. The samples were incubated with fluorescent-tagged mesenchymal cell marker antibodies CD 29, CD44, CD73, CD105, and hematopoietic cell marker CD45. Live cells were assessed with 7-Aminoactinomycin-D (7-AAD). The cell populations were analyzed by fluorescence-activated cell sorting (FACS). Descriptive statistics were used with results of the overall samples to test the hypothesis that stem cell number would be higher in the preterm group. <0.05. Methods: Using the ruptured whole-cell patch clamp technique, BK Ca currents were assessed in VSMCs from women with normal pregnancy following treatment with Kyn 1 mmol/L or vehicle. STOCs were recorded in the absence or presence of Kyn (1 mmol/L) via a whole-cell perforated patch clamp approach. Intact resistance arteries (<400 um) were mounted on the pressure myograph and loaded with Fluo-4-AM to image Ca 2+ sparks pre-and post-treatment with Kyn (1 mmol/L) or mounted on the wire myograph to assess the vasorelaxant effects of Kyn (0.05-3 mmol/L) in preconstricted arteries ± inhibition of Ca 2+ sparks (ryanodine). Introduction: Normal pregnancy is associated with dramatic rise in serum aldosterone, while pre-eclampsia has been associated with a much lower increase. Our objective was to associate serum aldosterone levels with blood pressure profiles in pregnancy and determine aldosterone variation over gestation in high and low risk women. Methods: Our data was derived from a cohort study and randomized trial. The cohort study recruited women at low risk for pre-eclampsia by USPSTF criteria. In the randomized trial, patients defined as high risk for pre-eclampsia were randomized to 81mg versus 162mg of aspirin for prophylaxis prior to 16 weeks gestation. Serum samples were obtained at two time points: 11-16 weeks (prior to aspirin) and 28-32 weeks gestation. In a convenience subgroup, serum aldosterone levels were assessed by liquid chromatography with tandem mass spectrometry. Analyses were completed with 2-way ANOVA with pairwise analysis. Results: 78 low and high risk women were included. 7 women developed preterm pre-eclampsia. Serum aldosterone was significantly increased (2.5 fold) in the third vs first trimester in low risk patients who did not develop disease (n=35, P<0.0001). In the high-risk cohort treated with aspirin, a significant, (reduced compared to control) (1.69 fold) increase in serum aldosterone concentrations between trimesters was noted (Combined data 81+162, n=36, P<0.05). Across all groups, the change in aldosterone (delta, Late-Early) was negatively correlated with third trimester systolic blood pressure (p=0.007, r= -.305) and diastolic blood pressure (p=0.013, r= -.287). Serum aldosterone was not increased in patients who developed preterm preeclampsia (n=7, P=0.393). Our data indicate the relevance of the rise in aldosterone for blood pressure regulation in pregnancy and a potential alteration in a subset of high-risk and pre-eclamptic patients. More study is needed to determine if aspirin alters this pathway in high risk women. The effect of aspirin on important physiologic pathways such as the renin-aldosterone system to prevent pre-eclampsia has not been sufficiently studied. Our objective was to compare serum aldosterone concentration in patients undergoing aspirin prophylaxis. Methods: This is a secondary analysis from a randomized trial which recruited women indicated for aspirin prophylaxis by USPSTF criteria. Subjects were randomized to 81mg versus 162mg of aspirin starting prior to 16 weeks gestation. Serum samples were obtained at 11-16 weeks (prior to aspirin initiation) and 28-32 weeks. In a convenience subgroup, serum aldosterone levels were assessed by liquid chromatography with tandem mass spectrometry. Analyses were completed with 2-way ANOVA with pairwise analysis and sample t-tests. Results: 42 women were included (n=20, 81 mg), (n=22, 162 mg). Common indications for enrollment were pre-existing DM (n=13) and chronic hypertension (n=19). 6 women (14%) developed preterm pre-eclampsia. The baseline aldosterone was not different based on dosing group. For women on 81mg, third trimester aldosterone was not significantly increased; however, women who received 162mg aspirin had a statistically significant increase in aldosterone in third trimester versus baseline (p=0.01) ( Figure 1 ). For our subgroup analyses, women with pregestational diabetes had no difference in their change in aldosterone (delta, late-early) but in the non-diabetics, the aldosterone significantly changed (p=0.04). In women with chronic hypertension, no differences were observed in their third trimester values or change related to aspirin dose. In obese women (n=27), regardless of risk profile, the late aldosterone was significantly higher in women on 162mg versus 81mg (p=0.011), while early aldosterone levels were similar (Figure 2 ). Conclusion: Higher aspirin dose was associated with an increase in serum aldosterone in the third trimester in high risk women. This association was stronger in obese women but the clinical risk profile also influenced serum aldosterone. Watanabe, Akihiko Wakatsuki. Aichi Medical University School of Medicine, Nagakute, Japan. Introduction: Hypertensive disorders of pregnancy (HDP) is classified into preeclampsia (PE), gestational hypertension (GH). Although endothelial dysfunction is a basic pathologic event that occurs in pregnant women with HDP, it is believed that PE and GH are differ in etiology and pathology. We hypothesize that the etiology and pathology of PE is the two-stage disorder from uteroplacental dysfunction by abnormal implantation and placentation and those one of GH is inherent in organic vascular disorder. This study aimed to investigate these differences between PE and GH. Methods: We examined serum parameters of oxygen free radicals (d-ROMs), maternal angiogenic factor (PlGF) and antiangiogenic factor (sFlt-1), placental hypoxic change and oxidative DNA damage, and maternal organic vascular disorder in 23 women with PE (PE group), 13 with GH (GH group), and 16 with uncomplicated pregnancies (control group). Initima-media thickness (IMT) of the carotid artery was assessed as a marker for maternal organ vascular disorder. Immunohistochemical analysis was performed to measure the proportion of placental trophoblast cell nuclei staining positive for hypoxia-inducible factor-1α (HIF-1α), which is a marker of hypoxic change and 8-hydroxy-2'-deoxyguanosine (8-OHdG), which is a marker of oxidative DNA damage. Results: Maternal serum d-ROM concentrations were significantly increased in both PE and GH groups relative to the control group. Maternal serum sFlt-1 concentrations, ratio of sFlt-1/PlGF, and proportions of HIF-1α-positive nuclei and 8-OHdG-positive nuclei were significantly higher in the PE group compared to GH and control groups. IMT was significantly greater in PE and GH groups compared to the control group and was higher in the GH group compared to the PE group. Conclusion: Our findings demonstrate that placental hypoxic changes and oxidative DNA damage are severe in patients with PE and accompanied by an increase in antiangiogenic factors. Moreover, maternal organ vascular disorder was more severe in patients with GH compared to those with PE, as assessed by IMT. 2) To identify the role of p38MAPK in TNFα effects on monolayer integrity to better understand potential therapeutic targets for those effected by preeclampsia. Methods: Uterine Artery Endothelial cells from late pregnant sheep (Ovine P-UAEC) were grown to confluence in 96-well ECIS impedance sensing plates which measures monolayer resistance. The higher the resistance, the better the monolayer integrity. Cells were serum starved and treated alone with different doses (0.1, 1, and 10uM) of (SB203580 (SB), BIRB0796 (BB), PP2, U0126, PD98059 (PD98), and PD0325901 (PD03)) and then +/-TNFα (10ng/mL) for 20 hours. We then followed with combinations of SB with either PP2, U0126, or PD98 to see if their rescue effects could be improved. Results: While PP2, SB (at high doses), and U0126, alone had positive effects on the monolayer, PD98 and PD03 were only effective at very low doses and were toxic at 10 uM. With TNFα, PP2 alone showed monolayer rescue. Combination of p38 and Src inhibition (SB and PP2) did not provide added rescue to PP2 alone. For MEK/ERK inhibitors, 10uM U0126 showed the greatest rescuing ability. To mimic the known cross specificity effect of U0126 on the M/E and p38 pathways, PD98 and SB were used in combination (neither one with cross specificity for the other). PD98/SB combinations at submaximal doses did indeed provide rescue although, not improved over PD98 alone at the higher doses. SB was also able to alleviate some of the basal high dose PD98 toxicity. Conclusion: In addition to Src and MEK/ERK, p38MAPK appears to also regulate monolayer integrity in P-UAEC in both the basal and TNFα driven state. Further, the U0126 unique rescuing ability over PD98, PD03, and the improved action of lower PD98/SB dose combinations, suggesting U0126 is effective due to its cross reactivity with both MEK/ERK and p38MAPK. Together our data reveals the complexity of kinase signaling that controls both basal and TNFα impaired monolayer integrity and suggests multiple drug targets may exist which could be used alone or in combination to treat vasodilation dysfunction observed in PE. Funded by T32 HD041921. Finding the Missing Connection to Preeclampsia GWAS. Introduction: Preeclampsia (PE) is one of the major complications during pregnancy, and defective placental development has been suggested as the key triggering factor in the pathophysiology of PE. Studies on expression quantitative trait loci (eQTLs) has been evaluated in various human tissues, but eQTL research in placenta has been relatively lacking. To determine the gene regulatory mechanism in preeclamptic placenta, we conducted the eQTL analysis in placentas. The mRNA extracted from 83 placentas obtained from cesarean section performed in Seoul National University Hospital during Nov. 2018 to March 2020 were sequenced with NGS. Matching maternal and fetal DNA were analyzed with Korean Biobank array. Linear regression model was applied using matrix eQTL. Cell type proportions using single cell transcriptome was used as covariate to identify cell type specific eQTL. Results: We found 4542 genes that contain at least one eQTL with statistical significance (FDR < 0.01). 40% of genes had eQTL located in placental regulatory element annotated by ENCODE, and another 10% were in coding region. 34% (1560) of eQTL had matching result with GTEx database in variant level. We found 14 novel genes that did not have any eQTL reported in multi-tissue analysis data from GTEx or all previously published placenta eQTL studies. Among these, 9 novel genes were annotated as highly placenta specific. No result was significant for FLT1 or rs4749613, which were reported to be highly associated with preeclampsia in previous GWAS studies. We expanded the knowledge base for regulatory elements of placenta, and found 14 novel eQTL regulated genes. We suggest a more advanced technology which can target extra-villous trophoblast to further reveal cell specific regulation. Ovine uterine artery endothelial cells of pregnancy (P-UAECs) express β-adrenergic receptors (ARs). The structural catechol 3,4 di-OH-A ring of catecholestrogens stimulate P-UAEC proliferation via β-ARs. Hypothesis: β-AR proliferative P-UAEC angiogenesis responses are stimulated by both exogenous and endogenous stimulation, the latter via autocrine catecholamine-induced signaling mechanisms. Methods: Evaluated in P-UAECs: 1) expression of catecholamine biosynthetic enzymes, tyrosine hydroxylase (TH), DOPA decarboxylase (DDC), dopamine β-hydroxylase (DβH), and phenylethalomine N-methyltransferase (PNMT) by Western Blotting; 2) β-AR Norepinephrine (NE) and Epinephrine (Epi) stimulation (0.1-100nM) of proliferation; 3) angiogenesis in P-UAECs is stimulated by the catecholamine substrate L-Tyrosine via β-ARs indicating de novo catecholamine biosynthesis, comparing to physiologic doses (100nM-10mM) of L-Tyrosine, L-Arginine, L-Leucine, and L-Threonine. Inhibition of β-ARs was performed using Propranolol (10μM; pretreatment 1h), then treatment with optimized concentrations of NE, Epi [0. 1-1nM] , or L-Tyrosine, L-Arginine, L-Threonine, and L-Leucine [1-10mM.] Proliferation was evaluated using direct cell counting and BrdU incorporation. Results: P-UAECs express all catecholamine biosynthetic enzymes including TH, DDC, DβH, and PNMT. NE and Epi dose dependently increased (P<0.01) P-UAEC proliferation (0.1nM, 1.78±0.028-and 1.0nM, 1.89±0.035-fold, respectively) which was abrogated (99.8%; P<0.01) by Propranolol. Catecholamine substrate L-Tyrosine dose dependently increased (P<0.05) P-UAEC proliferation with maximum proliferation (2.6±0.13-fold) at 10mM. Nitric Oxide Substrate L-Arginine did not induce proliferation. By contrast, "nutritive" amino acids (L-Threonine and L-Leucine) responses were not dose dependent and these responses (1.9±0.13-and 2.1±0.13-fold, respectively) were less (P<0.05) than L-Tyrosine responses. Propranolol inhibited L-Tyrosine proliferation by 65.6%, but had no effect on L-Arginine, L-Threonine, or L-Leucine responses. Therefore 34.4% of L-Tyrosine-induced proliferation was non-β-AR and likely was the tropic nutrient effect of amino acid supplementation. We demonstrate for the first time that P-UAECs express functional biosynthetic catecholamine enzymes (TH, DDC, DβH, and PNMT) and catecholamine-induced P-UAEC proliferation can occur via de novo endothelial synthesis via an autocrine intramural signaling mechanism regulating P-UAEC proliferation during pregnancy that may be dysfunctional in preeclampsia. , proteinuria, placental formation and fetal/pup growth. Galectin-7 production by human 1 st trimester chorionic villous samples (CVS) from pregnancies which were uncomplicated vs those which had PE was compared (n=3-6). The effect of recombinant human galectin-7 (1µg/ml) and ADAM12S (2µg/ml) on 1 st trimester placental villous gene expression (n=3-5) and outgrowth (n=3-5) was determined. In vivo, galectin-7 treatment induced the classic features of PE in pregnant mice: elevated sBP (E14-17) and proteinuria (E12-15). There was no effect in non-pregnant mice. Galectin-7 treatment decreased E13 placental weight (p<0.05), labyrinth vascular branching (p<0.05), and spiral artery remodeling (p<0.05) and altered E13 and E17 placental gene expression (↑IL6, ↓IL10, ↓ADAM12). Galectin-7 also dysregulated reninangiotensin system components in the E13 and E17 placenta, decidua and kidney (angiotensinogen, prorenin and angiotensin II type 1 receptor). Pups from galectin-7 treated pregnancies were significantly smaller from post-natal day (P)1 to P21 (p<0.05). In women, galectin-7 mRNA and immunostaining was increased in 1 st trimester CVS from pregnancies that went on to have preterm PE compared to uncomplicated pregnancies (p<0.05). In vitro, treatment of 1st trimester human placental villous with galectin-7 impaired placental villous outgrowth (p<0.05), induced sFlt-1-e15a production (p<0.05) and inhibited ADAM12 production (p<0.05) and ADAM12S and angiotensinogen secretion (p<0.05). Conclusion: Galectin-7 is a placental-produced factor which plays a significant role in the initiation of PE, via its actions which impair placental formation, cause placental inflammation, and alters placental production of sFlt-1 and renin-angiotensin system components. Therapeutics to target galectin-7 may be useful to prevent placental damage leading to PE. Figure) . T1 PEC screen stratified 67.2% of ACOG high-risk women as low risk. ACOG and T1 PEC screen strata had differences in maternal BMI, mean arterial pressure, UAP and biomarkers (Table) . 37 (82.2%) T1 PEC screen +ve women took 162mg ASA while 67 (69.1%) low risk women continued 81mg ASA (p=< .001). ASA dosages across ACOG risk categories were similar (p=0.177). Women downgraded in ACOG risk by the T1 PEC screen did not have a higher rate of PEC< 37 weeks. The focused use of 162 mg ASA in a small group of T1 PEC screen +ve women did not increase the rate of PEC requiring preterm delivery compared to risk stratification that casts a wider net using ACOG criteria (p=0.22). Conclusion: T1 PEC screening effectively stratifies women at risk for preterm PEC and refines target population that may benefit from higher dose ASA. Two thirds of women considered high risk by ACOG criteria can be appropriately reassured. Introduction: Placental ageing is a normal physiological response in progressing pregnancy with the organ exhibiting extreme morphological and physiological senescence at term. Pre-eclampsia and intra-uterine growth restriction can cause premature placental ageing, resulting in maternal and foetal morbidity and mortality worldwide. Aim: To investigate senescence-associated secretory phenotype (SASP) in maternal blood and markers of cellular senescence in the placenta in pre-eclampsia and intra-uterine growth restriction. Methods: Maternal plasma samples were taken at term gestation from nulliparous women with pre-eclampsia (n=9), intra-uterine growth restriction (n=10), and age-matched control uncomplicated pregnancies (n=15). SASP panel of cytokines was evaluated using a multiplex Mesoscale ELISA assay in all groups. Statistical analysis was performed using GraphPad Prism 8®. Placental samples were collected after cesarean sections from pre-eclampsia (n=6), intra-uterine growth restriction (n=11) and control uncomplicated pregnancies (n=16) for absolute telomere length analysis by RTqPCR. Multiple regression and statistical analysis was performed using IBM SPSS v26. Results: SASP consists of both inflammatory cytokines and mediators including, Interferon-γ (INF-γ), Interleukins (IL-13, IL-6, IL-8), Monocyte chemoattractant protein-1 (MCP-1) and Macrophage Inflammatory Protein 1 alpha (MIP-1α) and Matrix Metalloproteinase-3 (MMP-3). There was a significant increase in IL-6 in pre-eclampsia when compared to healthy controls (0.54 pg/ml ± 0.271 v 0.3 pg/ml ± 0.102; P=0.017). In addition, there was a non-significant increase in MMP3 in both pre-eclampsia (15.049 ng/ml ± 4.98 v 8.005 ng/ml ± 1.078; P=0.095) and intra-uterine growth restriction (16.12 ng/ml ± 5.40 v 8.005 ng/ml ± 1.078; P=0.088) when compared to controls. No significant differences were seen between study groups for other cytokines in the SASP panel. The calculated absolute telomere length of the placenta showed no significant difference between controls (4.87 ± 3.74 kbp) compared to pre-eclampsia (7.45 ± 3.17 kbp) and IUGR (4.87 ± 4.07 kbp). Correlation analysis shows an inverse association between BMI in controls and intra-uterine growth restriction and a positive correlation between gestational age and preeclampsia (p=0.058). Conclusion: Our data show increased inflammatory markers such as IL-6 in maternal plasma in pre-eclampsia only suggesting altered inflammatory signaling, which may modulate senescence. Absolute telomere length of the placenta at term may be dependent on other variable factors such as BMI and gestational age. Our results indicate that improper placentation may be associated with maternal physiologic factors, leading to advanced placental ageing and playing a pathophysiologic role in pregnancy disorders such as pre-eclampsia and IUGR. Introduction: In Europe, the incidence of eclampsia is estimated at 2-6 cases per 10,000 deliveries: antepartum (45%), postpartum (36%) and during labor (19%).Given the speed and unpredictability of the eclamptic event, which strikes even in the absence of premonitory signs and symptoms, it would be useful to have a portable and always available rapid assistance kit equipped in the stretchers and wheelchairs of the maternity department. This kit is an inexpensive and useful solution, especially in facilities that provide care for many pregnant women with hypertensive conditions during pregnancy. In our facility, we recorded 60 cases of preeclampsia during the year 2019. Of these, 10% developed eclampsia. In two cases, the eclamptic attack occurred outside the inpatient ward. In these two cases, the presence of the Fast-Kit in the patient's stretcher allowed prompt assistance and prevented a worsening of the clinical condition. Methods: Pregnant woman PARA 0000 at 40 weeks gestation, polydramnios. During outpatient control she has blood pressure of 170/103 mmHg, so she started antihypertensive therapy with nifedipine orally. The cardiotocographic recording from American College of Obstetricians and Gynecologists was TYPE I. Gradually appeared neurological signs: visual disturbances, headache and mental confusion. Given the worsening of the neurological symptoms, a consultation was requested, with the result of suspected Posterior Reversible Encefalopathy Syndrome with visual disturbances. CTG gets worse. Continued antihypertensive therapy and MgSO4 for neuroprotection. Given the persistence of symptoms, the delivery was performed by Caesarean section and a CT scan of the brain was performed, which did not reveal any changes. On returning to the ward, during the lift ride, the woman suffered an eclamptic attack. The presence of the Fast Kit allowed the airway to be kept clear and the bolus of MgSO4 to be administered promptly. Once the eclamptic attack had been resolved and the patient returned to the operating theatre, she continued her therapy and monitoring until she was stabilized. The patient was transferred to the inpatient ward and the Fast Kit was reinstated. Results: Creation of a fast kit for the management of the eclamptic emergency. Conclusion: In our experience, such an inexpensive and easy-to-generate fast-track kit can be of great help in unpredictable situations that could cause harm to patients. .032), no significant differences were observed in serum levels of any of the inflammatory cytokines, chemokine or ER stress markers tested. Conclusion: Acute infusion of lipid and insulin, to mimic the metabolic syndrome of obesity and induce a decrease in LH and FSH, was not associated with a significant increase in levels of a comprehensive panel of mediators and markers of inflammation. These results imply that the endocrine dysfunction and adverse reproductive outcomes in women with obesity are not a consequence of the ambient inflammatory environment but may be mediated by direct lipotoxic effects on the hypothalamicpituitary-ovarian axis. Introduction: Ovarian hyperstimulation syndrome (OHSS) is dramatically reduced when using antagonist cycle with GnRH agonist trigger before ovum pick up. This trigger induces short luteinizing hormone (LH) and follicle stimulating hormone (FSH) peaks, which are associated with reduced progesterone and estrogen levels during the luteal phase resulting in an inadequate luteal phase and a significantly reduced implantation rate. We aimed to evaluate if luteal oral Dydrogesterone (Duphaston) supplementation in an antagonist cycle after a lone GnRH agonist trigger rescue the luteal phase, allowing the possibility to peruse with fresh embryo transfer. Methods: A retrospective cohort study. The study group (n=123) included antagonist cycle triggered with lone GnRH-agonist trigger due to imminent ovarian hyperstimulation syndrome (OHSS). The control group (n=374) included patients under 35 years old, who underwent an antagonist protocol with a dual trigger of a GnRH-agonist and hCG (hCG group). In the study group (Duphaston group) patients were given Duphaston in addition to standard luteal support. The outcomes were pregnancy rate and OHSS events. Results: The mean number of oocytes retrieved and estradiol plasma levels were significantly higher in the Duphaston group (16.9 ±7.7 vs. 10.8 ± 5.3 and 11658 ± 5280 pmol/L vs. 6048 ± 3059 pmol/L, respectively). Fertilization rate, the mean number of embryos transferred and the clinical pregnancy rate were comparable between groups (65.4% vs 66.3%, 1.5 ± 0.6 vs 1.5 ± 0.5 and 46.3% vs 40.9%, respectively). No OHSS was reported. Conclusion: This study was the first to evaluate outcomes of Duphaston supplementation for luteal support in an antagonist cycle with lone GnRH agonist trigger and a fresh embryo transfer. We showed that the functionality of the luteal phase in those cycle could be restored resulting in a pregnancy rate comparable to that obtained in an antagonist cycle with dual trigger. This approach was safe, and prevented the need to postpone embryo transfer in case of pending OHSS. The is present in 10-13% of sexually active men (with non-symptomatic antibodies detected in some 70-80%), it was proposed that as an active infection this might have major consequences for male fertility. However, infection with any of the several types of human papilloma virus seems considered almost exclusively as a prelude to cervical cancer in females. There are no enough studies and research on the correlation between HPV, therefore, this study was conducted to investigate the presence of human papillomavirus (HPV) in human sperm cells and to evaluate potential effects of HPV on the motility and morphology sperm functions, specially motility and morphology sperm of infertile men in patients referring at infertility clinics of Jahrom University of Medical Sciences in 2017-2019. Methods: In this double-blind placebo-controlled clinical trial, Specimens of semen were collected from 176 randomly selected men patients who attended the fertility clinics at infertility clinic in Jahrom University of Medical Sciences. The presence of HPV DNA and RNA were examined by polymerase chain reaction. Semen quality and sperm cell function (motility and morphology sperm) were analyzed by computer-aided autoanalyzer. Results: There was significant difference among the studied variables in terms of confounding variables. Human papillomavirus type 16 DNA and RNA were found in 30% of the sperm cells specimens, respectively. Human papillomavirus type 18 DNA and RNA were present in 22% of the same sperm cells specimens, respectively. Incidence of asthenozoospermia among patients infected with either HPV was significantly higher than in those without HPV in their sperm cells (70% versus 19%). The data were analyzed using descriptive and inferential statistics (P < 0.0001). Conclusion: These results suggest that human papillomavirus can be found in human sperm cells and that certain HPV-specific genes are actively transcribed. Sperm motility and morphology parameters seem to be affected by the presence of HPV in the sperm cells, and also the incidence of asthenozoospermia may be associated with HPV infection. Introduction: AMH inhibits primordial follicle recruitment and reduces responsiveness of early antral follicles to FSH in mice 1 . In humans, AMH level predicts response to ovarian stimulation for IVF. Recently, high AMH levels (>8ng/mL) were found to be associated with longer follicular phase length among regularly cycling, fertile women attempting to conceive naturally 2 . Our question was whether AMH level is associated with length of time to development of a dominant follicle in ovulatory women undergoing gonadotropin stimulation for ovulation induction and intrauterine insemination. Methods: Retrospective cohort study of 2,340 gonadotropin/IUI cycles performed at Massachusetts General Hospital between 11/2007 and 09/2020 were evaluated. Cycles in women with a diagnosis of PCOS or anovulation were excluded. Serum AMH levels obtained within a year of cycle start were recorded. Univariate and linear regression analysis were performed in Stata. included univariate analysis and linear regression adjusting for patient age, BMI and multiple cycles per patient. Results: The most common diagnosis was idiopathic infertility (38%) followed by diminished ovarian reserve (22%) and male factor infertility (13%). Mean age was 36.8 (SD 4.0) years, median AMH was 1.5 (IQR 0.6, 3.01) ng/mL and mean time to trigger was 10.5 (SD 2.4) days.When analyzed by AMH (ng/mL) quartiles (Q1-Q4), the mean time from baseline US until trigger was 11.2 days (SD 2.3) among individuals in the highest AMH quartile (Q4: 3.05-14) compared to 10.5 (SD: 2.9), 10.0 (SD: 1.9), and 10.5 days (SD: 2.18) in AMH quartiles Q1 (0.03-0.6), Q2 (0.61-1.5), and Q3 (1.5-3.01), respectively.Higher AMH levels were significantly associated with longer length of stimulation in the unadjusted model and when adjusted for patient age, BMI, and multiple cycles per patient (p<0.001 for all comparisons). In the adjusted model, an increase of 1 ng/ mL in serum AMH level was associated with a 0.21 (95% CI: 0.145,0.271) day increase in time from baseline ultrasound to administration of HCG. The role of AMH in the follicular phase of human folliculogenesis is difficult to characterize in vitro. These results suggest that there is an association between pre-treatment serum AMH levels and time to development of a dominant follicle in gonadotropin/IUI cycles with higher serum AMH level associated with longer duration of stimulation. Therefore, AMH may decrease follicle responsiveness to gonadotropins in regularly cycling infertile women. While the impact may not be clinically significant, this has implications for characterizing the physiologic role of AMH. The Introduction: Recent interim analysis from a randomized controlled trial demonstrated that intramuscular (IM) progesterone for luteal phase support during FET cycles leads to higher ongoing pregnancy rates compared to vaginal (PV) progesterone. We hypothesized that there may be certain patient characteristics that convey a greater benefit of IM progesterone compared to PV progesterone. Methods: The Current Procedural Terminology code 89352, which represents frozen embryo thaw, was used to identify all patients undergoing FET from a single infertility clinic from 1/2015-7/2019 (n=865). Retrospective data on patient demographics, comorbidities, baseline laboratory parameters, route of progesterone supplementation, and pregnancy outcomes were collected in a RedCap database using chart review. Bivariate analysis was used to compare pregnancy outcomes between FET cycles that received IM progesterone versus FET cycles that received PV progesterone supplementation alone. After controlling for age, race, body mass index, insurance status, gravidity, and parity, multivariable logistic regression was used to produce adjusted odds ratios (aOR) of live birth stratified by route of progesterone supplementation. Results: 428 patients (49.5%) received IM progesterone compared to 437 (51.5%) that received PV progesterone. The total live birth rate (LBR) was 41.6%; however, the LBR amongst patients that received IM progesterone was 47.6% compared to 35.5% for those who received PV (p=0.0003). Patients that received PV progesterone had a biochemical pregnancy rate of 19.6% compared to 10.5% (p=0.0002) amongst those that received IM, whereas the rate of no documented pregnancy, pregnancy of unknown location, ectopic pregnancy, and miscarriage were similar between the two groups. Among patients with a diagnosis of PCOS, PV progesterone was associated with an increased odds of live birth (aOR=1.89, p=0.02) as opposed to a decreased odds of live birth (aOR=0.52, p=0.005) when they received IM progesterone. The following factors were not found to be statistically different between patients receiving PV versus IM progesterone and had a live birth: age at oocyte retrieval, BMI, or embryo grade. Conclusion: As expected, we found a significantly higher LBR when analyzing all patients that received IM compared to PV progesterone for luteal support during FET cycles, which seems to be driven by a lower biochemical pregnancy rate. Conversely, patients with PCOS may actually have better outcomes with PV progesterone following FET, and prospective studies are warranted to determine the best route of progesterone for luteal support in this population Introduction: Uterine Peristalsis Imaging (UPI) is a three-dimensional electrophysiology imaging system to noninvasively image and quantify nonpregnant uterine peristalsis during the menstrual cycle. We developed UPI by integrating novel magnetic resonance imaging (MRI) and body surface electrical mapping. We validated the accuracy and resolution of this advanced imaging system by comparing the UPI-derived uterine propagation patterns with transvaginal ultrasound (US) measurements. Methods: UPI system consists of two major components: MRI scan of patient-specifi c uterus-abdomen geometry and body surface electrical imaging (Fig. 1) . Firstly, patients underwent an MRI scan to generate accurate uterus geometry. Body surface electrodes' locations were also imaged using MRI markers. Secondly, electrodes were applied to abdomen surface to record the electrical peristalsis signals. Thirdly, a transvaginal ultrasound was conducted during the electrical measurements to record the peristalsis in two dimensional B-mode. Finally, UPI integrated patient's geometry to image the uterine peristalsis waves (red bands) on the uterus (blue). We tracked the real-time endometrium movements of uterine peristalsis from the ultrasound video and compared with the UPI fi ndings of uterine peristalsis for validation. Seven independent UPI validation sessions were conducted in this pilot study. Results: A representative UPI result from a 26 year old, G0 female during the ovulatory phase (Day 13) is shown in Fig. 2 . Two complete uterine peristalsis cycles are shown: (A) a cycle initiating at the cervix and propagating to the fundus over 18 secs, and (B) a subsequent cycle initiating at the fundus and propagating to the cervix over 19 secs. Blue regions represent inactive areas, and red regions represent the areas experiencing peristalsis. In the corresponding transvaginal ultrasound videos, the same directional uterine peristalsis patterns were visualized by observing the contour of the endometrial canal, which confi rmed the UPI fi ndings. Conclusion: The developed UPI system provides rich spatial-temporal information of uterine peristalsis in a noninvasive and quantitative way. The initiation and propagation patterns can be imaged and quantifi ed. Future work will compare uterine peristalsis patterns between patients with normal and abnormal menstrual cycles, with the goal of aiding in clinical diagnosis and treatment of female infertility. Outcome. Erika P New †, 1 Shayne Plosker * , 2,1 Kate Devine, 3 Samad Jahandideh, 3 Anthony N Imudia. , ideally prior to conception. However, these guidances are vague and only mention a small number of tests on the market. Current panel discrepancies among genetic testing companies, allelic variations screened, and large expanded screening panels make clinical application of such recommendations burdensome on both the patient and practice. This is especially true for couples seeking assisted reproductive technology (ART) therapy, as reciprocal positive couples have the option of preimplantation genetic testing of their embryos. No streamlined recommendations currently exist to guide both genetic testing companies and clinicians on best practices regarding expanded screening and subsequent genetic counseling. Thus, we wanted to understand the clinical impact of GCS prior to the use of ART therapy. Methods: A retrospective chart review was performed on couples who were offered GCS over the last 6 months. Patients were divided into groups: those who accepted and those who declined screening. If testing was accepted and patient and/or partner results were positive, genetic counseling was required. If testing was accepted and both partners were negative, or testing was denied, genetic counseling was optional; if couples declined genetic counseling, a declination waiver was required. Patients who used donor gametes, gestational carriers, or underwent egg freezing were excluded. Results were analyzed using SPSS (SPSS Inc., Chicago, IL, USA). Results: 674 couples were offered GCS over the last 6 months with 577 couples accepting and 97 declining (85.6% vs 14.4%). 5 different GCS labs were used with test panels, screening from 18 to 283 diseases. 47 couples out of the 577 that accepted had originally declined testing. 375 females of the 577 couples tested positive as a carrier for at least 1 disease. Of the 202 females who tested negative, 77 of them had partners test positive for at least 1 disease. 241 couples had both the patient and partner test positive for at least 1 disease. 125 couples had both the patient and partner test negative. Almost 20% of couples who had at least 1 spouse test positive declined to receive counseling with a signed waiver. Conclusion: Given these results, there is variation in screening outcomes between the patient and partner that make specific GCS guidelines necessary. As GCS continues to evolve, expanded carrier screening will inevitably become more complicated, raising confusion and increasing the burden on clinicians to reevaluate patient and practice protocols. Thus, more comprehensive clinical guidelines are necessary to limit practice liability and increase the number of informed patients regarding their genetic health. Comparing the therapeutic effect of intravenous injection using hBM-MSC with several different dosage in POI mouse model will reveal the optimal treatment protocol. Methods: In this study, we induced POI in C57/BL6 mice by chemotherapy (CXT) using a standard protocol. We then injected four different dose levels of hBM-MSCs by retro-orbital injection (6 mice/ group) at day 7 and day 14 post CXT. After hBM-MSC treatment, we performed breeding experiment to screening optimal dosage of hBM-MSC for intravenous injection to restore fertility in this preclinical POI model. Mice in separate parallel experiments were sacrificed without breeding 2 weeks after MSC treatment and we collected serum, ovary, and other major organs (5 animals/group). We also analyzed the transmission of human DNA with fetus genomic DNA (8 fetuses/ group) to confirm safety of intravenous injection. Results: The experimental group receiving 2,000,000 cells injection were all dead immediatly likely due to embolic accident secondary to high viscosity of the inoclum. The pregnancy rate in the three other treated groups were significantly higher (70±23% to 90±10%) that untreated negative control (25±21%). We noticed that a single time injection was sufficient to restore fertility (88±13%) in POI mouse model. human genes representing engrafted hBM-MSC were not detected in mouse blood nor in neonatal pup livers. We also found that pups delivered by the hBM-MSC treated mice had normal morphology and has similar weight gain to healthy controls. Conclusion: Our data confirm the feasibility of delivering mesenchymal stem cell treatment through Intravenous injection to restore fertility in chemotherapy induced POI mouse model. Our study support the feasibility of hBM-MSC as potentially effective therapy for POI. Pilot clinical trials are warranted to validate the utility of such approach in POI patients. Introduction: Up to 75% of women with polycystic ovary syndrome (PCOS) remain undiagnosed. PCOS is a highly heterogeneous endocrine disorder that is characterized by both reproductive and metabolic features. The symptom heterogeneity of PCOS is a leading cause of its lengthy and difficult diagnosis process, which typically requires a combination of clinical evaluation and biochemical assessment for diagnosis. This can include clinical tests for androgens, sex hormones, or other hormones to exclude the possibility of non-PCOS conditions. Methods: In this study, we utilized health data and laboratory measurements recorded in electronic health records (EHRs) to understand which frequently ordered laboratory measurements best explained PCOS disease risk. To do this, we evaluated the biomarker profiles of 8,292 PCOS cases and 34,771 controls identified from a validated EHR phenotyping algorithm in a multivariable logistic regression model. Results: In our combined multivariable logistic regression analysis using inversed normalized age-adjusted labs covaried for median age and race, free testosterone demonstrated the strongest association with PCOS (OR = 2.44, p = < 2.2e-16). This association was consistent among White (OR = 3.17, p = 1.35e-06) and Black (OR = 2.33, p = 1.05e-18) female patients in a race stratified analysis. Given the magnitude of the association with testosterone, we accounted for testosterone levels in the analysis of other biomarkers. After accounting for free testosterone, we observed that six labs remained associated (p < 0.05) with a PCOS diagnosis, including triglycerides (OR = 1.32, p = 7.35e-03) and sex hormone-binding globulin (OR = 1.37, p = 6.20 e-03). However, when total testosterone was accounted for, only four labs remained significant and progesterone explained the most variance in the model at 5% (OR = 1.98, p = 0.01). Conclusion: High testosterone is a salient feature of PCOS, but its strong effects may mask significant, but smaller effects of other biomarkers. These findings present insight into androgen-independent biomarkers for PCOS that may be useful in prediction models, which warrants further investigation. Introduction: Polycystic ovarian syndrome (PCOS) is the most common endocrine disease in women of reproductive age and is associated with a 40-80% obesity rate. PCOS is associated with an increased risk of pregnancy complications including gestational diabetes mellitus (GDM) and premature deliveries. While metformin has been shown to be beneficial in reducing early pregnancy loss and preterm delivery in PCOS, its impact on fetal growth is not clear. Since metformin can cross the placenta and expose the developing fetus to persistently high concentrations, we hypothesized that gestational metformin exposure would alter fetal anthropometric measures in PCOS pregnancies Methods: This retrospective study included 127 women with PCOS receiving prenatal care at Valley Children's Hospital in Madera, CA over the last 10 years. Past medical history, family history, current medications, BMI, age, gravity and parity, and fetal anthropometric measurement (CI, FL/BPD, FL/AC, estimated fetal weights at 20 weeks, and rate of weight gain) were retrieved from their medical charts. Fetal growth measures from obese and non-obese women were compared between metformin and no metformin groups. Data were analyzed using a 2-tailed independent t-test for parametric data and Wilcoxon signed-rank test for non-parametric data with significance set at alpha = 0.05. Results: 21 patients were excluded from data analysis as they presented for pre-pregnancy counseling. Of the remaining 106 patients, 27.4% were on metformin, 20.8% had GDM, 71.3% were obese, and 21.7% were advanced maternal age. Metformin had no impact on fetal morphometric measurements in the non-obese PCOS group. In contrast, FL/AC differed significantly (p= 0.02) between Obese PCOS-metformin and Obese PCOS-no metformin group (20.9 +/-0.15 n=15 vs 21.5 +/-0.13 n=54, respectively). The average FL/BPD also tended to be different (p=0.07) between the Obese PCOS-metformin and Obese PCOS-no metformin groups (71.5 +/-1.01 n=16 vs 73.8 +/-0.65 n=54, respectively). Sub analysis of Obese PCOS with GDM revealed no effect of metformin on fetal measures. There were no differences in rate of weight gain or estimated fetal weight around 20 weeks gestation in any of the groups. PCOS is also associated with physical disturbances and infertility, thus depression and anxiety are often overlooked and under-treated. Given these risks, early identification and treatment is crucial. This project investigates the differences in depression prevalence, as determined by the Edinburgh Postpartum Depression Scale (EPDS), among PCOS and non-PCOS patients presenting to a fertility clinic, as well as changes in prevalence of depression during the COVID19 pandemic. Methods: A retrospective case-control study was performed of all new patients seen during the period of March 2018 to December 2020 at a large, academic-affiliated, urban fertility clinic. Descriptive and demographic variables were gathered. Inclusion criteria was new patients aged greater than 18, who had completed the EPDS questionnaire. Patients who had refused completing the EPDS or had missing data were excluded. The pre-COVID period was defined as before March 2020. Operational definition for a positive depression screen was determined by either a previous diagnosis of depression, or by an EPDS greater than 8. Chi-square tests, t-tests, Wilcoxon ranked tests, and multivariate logistic regression were used for statistical analyses. Results: At our academic center, 785 new patients met criteria, of which 185 were diagnosed with PCOS (4.2%). The rate of positive screen for depression in the PCOS population was higher during the COVID pandemic (30.56%, n=22/72) compared to before (16.81% n=19/113) (p=.03) [OR= 2.18, (1.08, 4.40)]. After controlling for primary infertility status, recurrent pregnancy loss, and desire for procreative management, the difference in positivity rate of depression screen was still significant (p<.001). However, among the concurrent non-PCOS new patient population (n=600), the rate of positive depression screening did not increase during COVID pandemic compared to before (18.29% vs 19.69%), after controlling for desire for procreative management. There was no difference in positive depression screening between the PCOS and non-PCOS population, however, the PCOS population had higher rates of primary infertility and decreased rates of recurrent pregnancy loss compared to the non-PCOS new patient population. Conclusion: It is crucial that health care providers are aware of the possible increase in depression prevalence among PCOS patients, heightened in the context of COVID19. Utilizing an EPDS in clinic to screen for depression allows providers to quickly and efficiently identify patients who may require additional mental health care intervention. Introduction: Aging is a gradual process that affects to all individuals and it is associated with chronic degenerative diseases, cardiovascular diseases and a decrease in reproductive processes. It can be influenced by different factors like diets. Thus, the control of the diet can be an important factor over longevity and reproductive function, like the Male Sexual Behavior (MSB), the fertilizing capacity of the spermatozoa and metabolic health. Some studies shown the reduction of 10 to 40 % in the nutritional regimen (Caloric Restriction "CR") is the most effective physiological manipulation to extend the maximum life expectancy. In addition, the CR can maintain the MSB and can even achieve fertility in aged wistar rats. However, the sperm quality parameters as well as the MSB and metabolic parameters have not been detailed. OBJETIVE: Evaluate the effects of CR on the reproductive and metabolic parameters in the aged Wistar rats. Methods: Wistar male rats (12 months old) were housed individually into acrylic cages. The food intake, the MSB tests and quality sperm were evaluated for 15 days before at CR. After, the rats were separated in different groups accord its diets: 15, 35% of CR and a control group with ad libitum food. MSB, sperm quality and hormonal test were performed at 6 and 12 months of CR. Results: The CR after 6 an12 months in animals of 18 and 24 months age improve the sperm quality compared to control. A progressive decrease in sperm quality is observed for the control group, it was significative at 24 months of age, not there for the RC groups, the MSB decreased for the control group since the 18 months of age, while RC groups maintained the MSB at 24 months of age, thus, the metabolic parameters show homogeny for the groups CR while the control presented alterations in testosterone, Estradiol, Insulin and leptin. We can conclude that the CR improves the sperm quality, the MSB and metabolic parameters during aging. Outcomes of IVF Cycles Using Testicular and Zymot Obtained Sperm from Men with High Sperm DNA Fragmentation. Nicole D Ulrich †, Min Xu, James Dupree, Samantha Schon * . University of Michigan, Ann Arbor, MI, United States. Introduction: Elevated DNA fragmentation in sperm has been linked to poor IVF outcomes and miscarriage. Previous research recommended the use of testicular sperm for fertilization with ICSI (T-ICSI) to improve live birth rates. However, there are concerns associated with T-ICSI including decreased fertilization rates and increased embryo aneuploidy. Recently, the Zymot sperm sorting device has been approved to sort out sperm with low DNA damage, which may provide another treatment option for couples with elevated DNA fragmentation. Methods: We conducted a retrospective chart review of men who underwent DNA fragmentation testing and their partners from an academic fertility clinic from April 1, 2017 -January 31, 2021. All DNA fragmentation testing performed at a commercial company using SCSA. We included men with high-DNA fragmentation (>25%) who did either sequential IVF cycles first with T-ICSI then with ejaculated sperm prepared with Zymot sperm sporting device (Z-ICSI) or one cycle with split fertilization using both T-ICSI and Z-ICSI. Data abstracted included sperm retrieval method, sperm preparation, fertilization method, fertilization rate, embryo development, and pregnancy outcomes. Embryo morphology was evaluated using the Gardner grading system. Additional variables assessed included infertility diagnosis, number of oocytes retrieved, fertilization rate, rate of good quality day 3 embryos (A or B grade), pregnancy (serum hCG), ongoing pregnancy (fetal cardiac activity), and pregnancy outcome. Results: Five couples met our criteria with mean DNA fragmentation index (DFI) of 45%, (range 28 -70) and underwent 9 total IVF cycles. Four of these couples underwent 8 total cycles, using T-ICSI in the first cycle followed by Z-ICSI in the second. The fifth couple underwent one IVF cycle with split fertilization using both a frozen sample for T-ICSI and a fresh sample for Z-ICSI. The fertilization rate in the T-ICSI cycles was 48% vs 83% in Z-ICSI cycles. Rate of good quality day 3 embryos was 40% in T-ICSI cycles and 47% in Z-ICSI cycles. Of the 5 cycles with T-ICSI sperm, 4 did not achieve pregnancy and one resulted in frozen euploid embryo not yet transferred. Of the 5 cycles with Z-ICSI, 2 did not achieve pregnancy, one resulted in frozen euploid embryo not yet transferred, one resulted in pregnancy but has not yet had an OB ultrasound, and one resulted in live birth. We present a case series of 5 couples using both T-ICSI and Z-ICSI during their IVF cycles. The Z-ICSI cycles had higher fertilization rates and two positive pregnancies, one of which has resulted in a live birth. In comparison, the T-ICSI cycles from the same patients did not achieve pregnancy. Use of a device like the Zymot in patients with elevated DNA fragmentation may provide a less-invasive treatment option with higher fertilization rates. Larger studies are needed to further investigate these outcomes. The caloric restriction (CR) refers to the restricted intake of food from ad libitum feeding. CR has been proposed as increases longevity factor, It has been observed so conclusively in yeasts. However, CR in mammals can improve the state of health of many organisms also humans. Thus, it is know that the reduction in the diet that ranges from 10 to 40 % in young organisms can improve the quality of life (Health General) and can even improve neuroendocrine signals of the hypothalamic-pituitarygonadal axis (HHG) by modifying the hormonal reals patter that can be reflected in the alteration of metabolic homeostasis. On the other hand, it is known that as individual beings the aging, the ovarian function declines like the metabolic homeostasis. However, CR effets on female wistar rat during th adult-elderly step are unknown. The objetive of this work was to determine if CR improves the reproductive health parameters in the adult Wistar female rat. Methods: Eighteen female Wistar rats of 3 months of age were used and it was divided into three experimental groups: Control or Ad libitum food intake, CR 15% and CR 25%. All subjects were placed into individual cages and kept in inverted light cycles 12:12 hours, the total food intake was evaluated for 15 days before to CR. During CR, the body weight and the estrus cycle of the rats were monitored, after 3 months they were euthanized by decapitation for blood serum extraction; the metabolic and hormonal parameters were quantified. Results: The results obtained show that the CR keeps the females in constant cyclicity, which suggests normal ovarian physiology, but there is an increase in the concentrations of fatty acids in the metabolism of the subjects of the control group. The hormonal data with metabolic activity conclude that CR is a strategy that favors the health of experimental groups still in the young stage. We can conclude that the CR is a propitious rate to improve the health of the Wistar female rats. Introduction: 1-3% of the adult population use synthetic glucocorticoids (sGCs) for a variety of conditions, from autoimmune disorders to cancer. sGCs provide acute relief; however, chronic exposure has been shown to increase vulnerability to diabetes, hypertension and various neuropsychiatric disorders. Studies have shown that stress in males prior to conception can lead to abnormal neuroendocrine function and behaviours in offspring. Recent evidence indicates that epigenetic factors including microRNA (miRNA) within sperm may offer an explanation as to how the effects of paternal chronic stress are transferred intergenerationally. It remains unknown if chronic exposure to sGCs leads to changes in sperm that could result in intergenerational transmission. We hypothesized that sGC exposure in adult male guinea pigs will modify the miRNA profile in epididymal sperm. Methods: Adult male guinea pigs were exposed to the sGC dexamethasone (Dex) in drinking water (equating to a dose of 3mg/kg) or normal water (Ctrl) (N=6/group) every other day for 48 days. Water, food intake and weight were monitored. Sperm collected from epididymal seminal fluid in the caput and cauda regions were counted and visually assessed for motility, morphology and vitality. Sperm were isolated and total RNA extracted. miRNA was assessed by miRNA 4.0 microarray and data were processed by TAC 4.0.1. miRNA probes were selected from human, mouse and rat miRNA IDs. miRNA expression was evaluated using a one-way ANOVA and p-values were FDR adjusted by the Benjamini-Hochberg algorithm. Log2Fold-Change (FC) >+-1.5, and FDR corrected p-value < 0.05 was considered significant. Results: Dex-treatment did not affect water and food intake or weight. In addition, sperm did not differ in morphology, vitality, sperm count, or motility. miRNA expression analysis revealed 42 miRNA that were significantly down-regulated, and 45 up-regulated by sGC in the caput. In the cauda, 112 miRNA were down-regulated while 10 were up-regulated. Examples of miRNA that were significantly (FDR p-value<0.05) downregulated by Dex included miR-30a (FC= -8.25) and miR-30c (FC=-6.92). We have shown that chronic sGC exposure alters the miRNA profile of sperm in adult male guinea pigs. This is highly clinically relevant given the widespread usage of acute and chronic glucocorticoids treatment in humans. Importantly, the miR-30 family has been shown to be of central importance for embryo development. While the potential effects of dex-induced alterations in sperm miRNA in offspring remains to be determined, this study provides new insight into the possible molecular mechanisms underpinning transmission of paternal experiences. Developing The common marmoset (Callithrix jacchus) provides significant advantages over murine models to assess neurobiological mechanisms related to autism, intellectual disability, and schizophrenia. As a first step to establish a marmoset neurodevelopmental model by gene-editing, the present study sought to optimize ovarian stimulation and in vitro fertilization in marmosets. Methods: Several stimulation regimens were tested. After estrumate (0.1 ml of 8 µg/ml), ovarian stimulation started on day 1 with 25IU of follicle stimulating hormone (FSH). FSH was increased to 50IU on days 2 and 6 of stimulation to simulate the 2 FSH peaks of a marmoset ovarian cycle. Cetrotide (EMD Serono) (0.01mg/100g body weight) was administered on days 5 and 7 to prevent a premature LH surge. Ovarian follicles were monitored via ultrasound. hCG was administered on day 9 of stimulation and oocytes were surgically collected 30-32hr post hCG trigger. Mature eggs were inseminated with sperm and immature oocytes were incubated overnight at 38C (P-1 medium, Irvine Scientific, 5% CO2, 5% O2). Fertilization was assessed on Day 1 post oocyte retrieval, zonas were removed, and embryos were incubated with a lentiviral vector (LVV) with GFP driven by an EF1α or CAG promoter. Embryos were incubated for 2 days at 38C (MultiBlast medium, Irvine Scientific, 5% CO2, 5% O2). Fluorescence was evaluated on Day 4 using a THORLABS Quantalux sCMOS camera. Plasma progesterone was measured via ELISA kit (Cayman Chemical Company). Results: In a successful stimulation, progesterone levels of two females fell from 57.06 ng/ml to 3.37 ng/ml and from >100 ng/ml to 8.23 ng/ml, respectively after estrumate. Oocytes were collected from donors and inseminated on Day 0, or if immature, on Day 1. Embryos fertilized on Day 1 and all inseminated eggs were transferred to 30 µl droplets containing 1 µl LVV or PBS control. Three of five developing embryos in the EF1α-GFP treatment had evidence of expressed GFP on Day 4, while none of the CAG-GFP-treated embryos showed fluorescence greater than controls. Conclusion: This is the first reported use of Cetrotide in marmoset ovarian stimulation. Without Cetrotide and increased FSH doses, fewer oocytes were collected and all were immature. Compared to CAG, the EF1α promoter appeared to be a superior driver for GFP in marmoset embryos. These results represent the first step toward developing a genetically modified marmoset model accessible to the neuroscience community to study neurodevelopmental disease. Introduction: During winter, many roads have salt spread on them to prevent them from freezing. Salt can wash into adjacent ecosystems and increase salinity exposure in plants and animals. It has been shown that a drastic increase in salinity can be harmful for most types of plants that are not naturally found in saline environments. In this study, we aimed to investigate if added salinity can also be harmful for animals. The impact of salts on zebrafish development was investigated in two stages: 1) from the 2-cell embryo stage (0.5 h after fertilization) to the blastocyst stage (2.5 h after fertilization, containing 256 cells); 2) from the blastula stage to a larval stage (6-day-old, freely swimming fish The migratory and invasive properties of human endometrial stromal cells (HESC) are critical for cyclic endometrial regeneration, as well as embryo implantation and trophoblast invasion during conception cycles. Mesenchymal stem cells (MSC) in the endometrium have been implicated in facilitating endometrial regeneration and repair, but these cells can only be obtained from biopsy or surgical samples. Human umbilical cord is a rich and accessible source of MSC. The secretome of umbilical cord (UC)-MSC promotes cellular motility and wound healing in nonreproductive tissues, but its effect on HESC function is not well studied. We hypothesized that the UC-MSC secretome upregulates HESC migration and invasion. Methods: confirmed by flow cytometry and multilineage differentiation assays. A commercially available telomerase-immortalized HESC (T-HESC) line was used for motility assays. Transwell migration and invasion assays were performed to determine effect of the UC-MSC secretome on T-HESC motility. For invasion assays, transwell inserts were coated with 0.3 mg/ml Matrigel. T-HESC were seeded in the upper chamber and exposed to UC-MSC conditioned medium (or DMEM + 10% FBS as control) in the lower chamber for 24h. In co-culture experiments, UC-MSC were cultured in the lower chamber for 24 hours (or DMEM + 10% FBS as control), followed by seeding the upper chamber with T-HESC. After 24h, migrated or invaded T-HESC were H&E stained, imaged and quantitated using ImageJ software. Results: Flow cytometry demonstrated that UC-MSC express MSC markers CD44, CD90, CD73 and CD29 and lack expression of CD45 (a hematopoietic marker). UC-MSC exhibited multilineage differentiation into osteocytes and adipocytes. Exposure of T-HESC to the UC-MSC secretome for 24 hours, in both conditioned medium and co-culture experiments, significantly increased T-HESC transwell migration and invasion. Student t-test was used for statistical analysis with p < 0.05 considered significant. Our findings demonstrate that the UC-MSC secretome upregulates HESC migration and invasion, two cellular processes that are required for cyclic remodeling and repair of the endometrium. Given these findings, and the ability to access UC-MSC without invasive procedures, these studies raise the possibility of a therapeutic application for UC-MSC in disorders of endometrial regeneration. Introduction: Prioritized genes in endometrial receptivity are inconsistent between studies and their transcriptional regulators remain poorly known. Our aim was to discover consensus key regulators of endometrial receptivity from previous reported genes to understand its complexity from a systems biology perspective and to deepen in the hormonal and non-hormonal basis of implantation dysfunction. Methods: Endometrial receptivity gene lists were retrieved from transcriptomic datasets searched at Gene Expression Omnibus. Regulators for these gene lists -transcription factors (TFs), miRNAs and progesterone and/or estrogens -were consulted in KEGG, Gene Ontology, Tarbase and Dorothea databases. Relative contributions of each regulation type (Hormonal or non-hormonal, progesterone or estrogens, TFs or miRNAs) were evaluated with Fisher's exact tests for comparing proportions. Consensus TFs and miRNAs regulating most gene lists were validated in independent datasets of 109 and 20 healthy patients biopsied across the menstrual cycle, prioritizing those with significant endometrial gene expression changes in mid-secretory phase (ANOVA and post hoc test). Results: Nineteen gene lists from endometrial receptivity studies were collected including 3,608 unique genes (50-818 genes/list). Most of these gene lists (n=17) were regulated in a higher proportion by TFs and showed a high hormonal regulation, 8 of them being significantly more regulated by progesterone than estrogens (FDR < 0.05). The remaining 2 gene lists, previously associated to implantation failure dysfunction, exhibited a lower hormone-dependent behaviour and tended to be more regulated by estrogens and miRNAs (FDR < 0.05). Genes targeted by hormonal regulation were higher than non-hormonal (odds ratio = 91.94, FDR < 0.05). However, we identified a 43.96% of TFs and a 77.27% of miRNAs not associated to ovarian hormones showing a strong non-hormonal regulation in receptivity acquisition. Transcription factor CTCF and 10 miRNAs were validated in an independent patient cohort for regulating a higher proportion of gene lists and for showing a significant expression change in mid-secretory phase (FDR < 0.05). Conclusion: CTCF was newly proposed as the most consensus TF involved in endometrial receptivity. While menstrual cycle progression seemed to be triggered mainly by TFs, gene lists associated previously to implantation failure dysfunction showed less influenced by TFs and ovarian hormones. An appreciable proportion of hormone-independent TFs and miRNAs were identified revealing new ways in menstrual cycle regulation and disease. Early pregnancy maintenance relies on proper lipid regulation in the uterus for placental growth and differentiation, steroid hormone and prostaglandin production, and immune factors that contribute to local immunosuppression. We hypothesized that early pregnancy loss correlates with a dysregulated uterine lipidome. We utilized a mouse model to investigate viable pregnancy vs. spontaneous embryo resorption. Methods: Wild-type CF-1 mice were bred and embryonic day (E) 10.5 uterus samples were collected from implantation sites containing either viable embryos (n=5) or embryos that were in the early stage of resorption and not yet hemorrhagic (n=5). Serum samples were collected from E10.5 dams with 0-1 (n=5) or 5-7 resorptions (n=5). Untargeted lipid profiling was performed on methanol extracts using ultra-high performance liquid chromatography mass spectrometry (MS) in positive and negative ion modes with electrospray ionization. Raw MS data were mined using LipidSearch (Thermo). Significance was determined by Student's t-test and defined as P<0.05. Data are presented as fold change (FC) in resorption vs. control groups. Results: Palmitic acid (PA) was elevated in resorptive implantation sites (FC 1.28, P=0.023). Elevated PA could hinder pregnancy maintenance, as it induces ER stress in cultured blastocysts, inhibits in vitro trophoblast invasion, and activates placental inflammation. A low PA to oleic acid (OA) ratio is important for embryo development and preventing ER stress, but uterine OA levels were unchanged (FC 0.99, P=0.96) such that this ratio increased. The SM lipid class, which is pro-apoptotic in the endometrium, was elevated (FC 1.11, P=0.008). Serum PG lipids were lower in mice with a high number of resorptions (FC 0.52, P=0.008); low PG levels have been associated with repeat implantation failure. Serum bile acids taurocholic acid and taurochenodeoxycholic acid were also lower or trended lower in mice with a high number of resorptions (FC 0.46, P=0.030 and FC 0.35, P=0.061, respectively). Reduced serum bile acids could result in a loss of protection against detrimental processes that reduce embryo viability. Conclusion: Little is known regarding the molecular mechanisms leading to early pregnancy loss. Metabolomics revealed dysregulated uterine and serum lipidomes associated with spontaneous pregnancy loss in mice. The lipid molecules and classes identified suggest that ER stress, hindered cell-cell communication, and impaired placentation may contribute to early fetal loss in wild-type mice. Ongoing studies will identify changes in upstream lipid regulation and downstream lipid modifications and effectors associated with loss of early pregnancy maintenance. Anelli, Paola Panina-Bordignon. Vita-Salute San Raffaele University, Milano, Italy. Introduction: Protein secretion is a complex task for a cell: therefore, to be efficient, it requires adaptation of both the Endoplasmic Reticulum (ER) and downstream secretory organelles.This occurs in endometrial stromal cells (EnSC) that after decidualization become professional secretors: in the midluteal phase of the menstrual cycle, EnSC change their morphology and start secreting a wide array of proteins required for correct blastocyst implantation. Clarifying the mechanisms of decidualization is essential to get a better insight of human reproduction and associated diseases. Additionally, this inducible model of secretory differentiation offers the opportunity to study transcriptionally regulated and cargo-induced modifications of the secretory organelles. Methods: We studied in vitro decidualization of the cell line T-HESC (human endometrial stromal cells immortalized with telomerase) by high resolution microscopy to visualize the morphological changes of the organelles, and by proteomic and transcriptomic analysis. We also studied decidualization in a condition of para-physiological stress: accumulation of unfolded collagen in the ER due to ascorbic acid deprivation. Results: Our data show that decidualized T-HESC recapitulate well the secretory phase of primary EnSC in terms of morphological changes, secretion of soluble mediators and induction of ER chaperones and enzymes, and Golgi complex proteins. Interestingly -and differently from most secretory differentiation models -not only the ER but also the Golgi compartment is significantly enlarged. The transcriptomic analysis revealed distinct clusters of secretion-related genes with a similar expression pattern, likely representing a co-regulation. Decidualization requires a mild activation of the unfolded protein response (PERK pathway), likely to increase the capacity of the secretory organelles. Transcriptomic and proteomic analysis suggest that specific pathways besides the UPR are likely induced to control the enlargement of the Golgi compartment. Interestingly, ascorbic acid deprivation does not induce a further activation of UPR, suggesting that these cells are programmed to endure high ER stress. Our results indicate that proliferative endometrial stromal cells are already well equipped with folding enzymes and chaperones, likely anticipating their secretory differentiation. Decidualization entails a further upregulation of these proteins, and the massive expansion of secretory organelles, to achieve efficient secretion without full UPR induction. A full understanding of these molecular mechanisms, that regulate protein secretion in the decidualizing stroma will be clinically relevant to target spontaneous decidualization in a variety of reproductive disorders, including implantation defects, recurrent pregnancy loss, and pregnancy disorders. Introduction: Optimization of maternal factors to improve in-vitro fertilization (IVF) outcomes has been widely studied. Endometrial thickness has been implicated as a prognostic factor in IVF success, however this has largely been studied in the context of minimum endometrial thickness requirements. Whether there is a threshold at which a thick endometrium becomes detrimental to pregnancy rates has been unclear. Thin endometrium has been associated with lower pregnancy rates following IVF, however, data has been conflicting, and no clear guidelines exist on when embryo transfer may be futile due to thin endometrium. The impact of atypically thick endometrium is even less clear and results have been similarly conflicting. Methods: A retrospective review of IVF cycles performed at a single private institution between 2015-2017 was performed. Patients with normal uterine anatomy who underwent frozen eSET of a euploid embryo as determined by comprehensive chromosome screening were included. Endometrial thickness was measured by transvaginal ultrasound following 10-14 days of estradiol exposure. A total of 235 cycles met inclusion criteria. Pregnancy outcomes were summarized using frequencies and percentages, and compared using Chi-square or Fisher's Exact tests, when appropriate. These were done including and excluding patients with PCOS or endometriosis. Statistical analyses were performed using R 3.4.2. All reported p-values are two-sided and a significance level of 0.05 was used. Results: Specific infertility diagnoses did not significantly impact endometrial lining thickness. Endometrial thickness was grouped into four categories: <8mm, 8-10mm, 10-13mm, and >13mm. Clinical pregnancy rates were 71.4%, 75.3%, 73.2%, and 54.8%, respectively (p = 0.172). Patients with an endometrial lining >13mm had statistically higher rates of negative pregnancy tests, 38.7% for >13mm vs 28.6%, 17.6%, and 15.2% for <8mm, 8-10mm, 10-13mm, respectively (p=0.029). All four groups had similar biochemical pregnancy rates. In euploid embryos an endometrial lining >13mm negatively impacts rates of positive pregnancy tests. Given differences in patient population and protocols for individual practices, it is possible that a specific measurement (e.g. >13mm) may be less clinically useful than a percentile cutoff (e.g. 95th percentile). Future prospective studies and histological analysis are needed to better understand this association. Risk Introduction: Interstitial ectopic pregnancy comprises 5% of ectopic pregnancies but are dangerous given the risk of catastrophic hemorrhage compared to other ectopic pregnancies. The diagnosis of interstitial ectopic pregnancy is difficult and relies on radiological imaging. We aimed to identify factors associated with delayed or misdiagnosis of interstitial ectopic pregnancies. Methods: All patients who presented to Boston Medical Center (BMC) between January 1, 2012 and April 30, 2019 with an admission or intraoperative diagnosis of interstitial ectopic pregnancy were retrospectively identified by ICD-9/ICD-10 codes for "other ectopic pregnancy" and the BMC Clinical Data Warehouse using the keywords "interstitial ectopic pregnancy" and "cornual ectopic pregnancy." Data collected included age, gravidity, parity, BMI, last menstrual period (LMP), date of presentation, estimated gestational age (EGA), major medical conditions, history of sexually transmitted infection or pelvic inflammatory disease, prior pelvic surgery, presence of uterine structural abnormalities, adnexal lesions, and smoking status. Continuous variables were analyzed using analysis of variance with post hoc pairwise comparisons and unpaired t-tests, and discrete variables were analyzed using chi squared and Fisher's exact tests. We identified 53 patients with suspected or verified interstitial ectopic pregnancy. Of these, 15 (28%) were diagnosed correctly by initial ultrasound imaging, 20 (38%) were suspected to have an interstitial ectopic pregnancy on initial imaging but did not have it on final diagnosis, and 18 (34%) were not diagnosed by initial imaging and found to have an interstitial ectopic on subsequent imaging or at surgery. Patient variables that significantly impacted diagnosis accuracy were age and gravidity. The mean age of those with a correct diagnosis was 35 years, while the mean age of patients incorrectly diagnosed was 30 (p=0.0045, unpaired t-test). Additionally, those with lower gravidity were more likely to have an incorrect diagnosis. The mean gravidity of patients accurately diagnosed was 4.27, while those with an incorrect diagnosis had a mean gravidity of 2.62 (p=0.005, unpaired t-test). Parity demonstrated a trend similar to gravidity but did not reach significance. No other patient variables analyzed impacted the accuracy of diagnosis including ultrasonographer work shift (day or night). Conclusion: Younger women who have had fewer pregnancies are more likely to have an incorrect diagnosis of interstitial ectopic pregnancy. There may be lower tolerance and resultant lower accuracy of transvaginal ultrasound in those with less reproductive experience. Future studies should examine the level of patient discomfort during radiological imaging and its relation to the diagnostic accuracy of the transvaginal scan. Introduction: Tissue regeneration and repair in aged organisms have been described after the exogenous administration of platelet-rich plasma (PRP) and plasma-specific proteins. Adult stem cells produce and secrete a broad variety of growth factors that could have regenerative properties, acting in a paracrine manner. Thus, we aimed to analyze if the administration of plasma enriched in both stem cell secreted factors and platelet enclosed growth factors could improve the ovarian function in a mouse model of advanced maternal age (AMA). Methods: Young (8 weeks old, n=12) and AMA (28 weeks old, n=12) NOD/SCID females were randomized to receive intraovarian injection (10 µL/ovary) of: saline solution (control group, n=4), standard activated PRP (PRPa group, n=4), or activated plasma from aphaeresis previously enriched in bone marrow derived stem cell secreted factors by a granulocyte colony stimulating factor (G-CSF) mobilization treatment (G-CSFa group, n=4). Plasmas were obtained from poor responder women and activated with 5% calcium chloride 0.1M to release additional platelet enclosed factors. A week after treatment, animals underwent ovarian stimulation and mated with males. Mice were sacrificed 36h after mating, to collect Metaphase-II (MII) oocytes and embryos for further culture to the blastocyst stage. Results: G-CSFa increased the number of MII oocytes and 2-cell embryos in both young and AMA model (Fig. 1A-B ) when compared to controls. Moreover, G-CSFa injection was also able to reduce the percentage of oocyte fragmentation in the AMA model to those levels observed in the young control mice (Fig. 1C) , and increase the blastocyst formation rate to 94% compared to 66% in the AMA controls (Fig. 1D) Introduction: Folliculogenesis requires coordination of maturation between the oocyte and surrounding granulosa cells. We found that a homozygous deletion of A-kinase anchoring protein 13 (Akap13) resulted in an embryonic lethal phenotype, but female mice with a heterozygous deletion of the Akap13 gene had smaller sized litters, suggesting an impairment of fertility. Additionally, when siRNA directed against Akap13 was injected into oocytes, results suggested a release of meiotic arrest resulting in premature oocyte activation. Since Akap13 was expressed in both granulosa cells and oocytes, we sought to determine the mechanism of fertility impairment in the mice by creating a mouse model with conditional knockout of Akap13 solely in oocytes. A Cre-lox recombination strategy was utilized where LoxP sites were inserted into the Akap13 gene, flanking exons 24 and 25, to create Akap13 flox/flox mice in a C57BL/6J background. Mice with floxed alleles were mated with Gdf9-Cre-expressing mice. Genotypes were determined by sequencing ear or tail tissue samples. Female mice containing either Gdf9-Cre+/Akap13 flox/flox or Akap13 flox/flox were mated with wild-type male mice. Outcomes included litter sizes, sex of offspring, and time between litters. Up to six litters were analyzed in a minimum of five individual mating pairs. Cre excision of the Akap13 gene was confirmed by PCR. Statistical significance was determined by Mann-Whitney or two-tailed, unpaired t-test with p<0.05. Results: Analysis of offspring revealed that Cre excision of the Akap13 allele was 100% efficient and resulted in 157 offspring with an allele lacking exons 24 to 25 in the Akap13 gene, consistent with a maternal haploinsufficient allele. Litter sizes varied slightly among mating pairs but averaged 7-8 pups per litter. There were no differences in litter sizes between females with genotypes of Gdf9-Cre+/Akap13 flox/flox or Akap13 flox/ flox mice lacking Gdf9-Cre (n=5; p=0.973). Similarly, the sex of male and female offspring did not differ between the 21 Gdf9-Cre+/Akap13 flox/flox and 24 Akap13 flox/flox matings. Time between litters was slightly reduced (n=5; p=0.059) at the second litter in the Gdf9-Cre+/Akap13 flox/flox mice, suggesting a possible reduction in cycle length. Conclusion: In this murine model with oocyte-specific targeted mutation of the Akap13 gene, we observed no decrease in litter size indicating the excised GEF region of Akap13 may not be required for oocyte competence or fertility. We did observe a subtle reduction in times between litters, suggesting the possibility of altered follicle dynamics in these mice that begs further study. (Table) . No correlation was found between age and AMH within the cases (r=0.017 p=0.92); a weak negative correlation was found within the controls (r= -0.23 p=0.08). Maternal age, age at menarche, past CHC use or history of fertility concern were similar between the groups. Parity differed but showed no significant effect on AMH (linear model and it has been established that the mutated mtDNA is associated with abnormal metabolism. We speculate that MDR1 function is important for mitigating premature aging by efflux of toxic metabolites/ROS. These data show a role of MDR-1 in oocyte mitochondrial physiology and ovarian reserve maintenance. The future directions will be to analyze mtDNA in mutants and to assess metabolic dysfunction such as diabetes, dyslipidemia and cardiovascular disease via phenotype testing. The translational next step is to survey MDR1 mutation in a genomic database and associated fertility outcomes. In conclusion, our mouse model is well-suited for studying ovarian reserve in the context of chronic diseases due to aberrant metabolism. lymphocytes were further categorized into three (FGFBP2+, CD8+, IL7R+) and two (CD160+, COX6A2+) subtypes, each found in all samples with statistically significant markers. Two macrophage subtypes were observed: one (IL1B+) was present in all samples; whereas, the other (IL1B downregulated) had dropouts. Intriguingly, we identified two cell groups that were transcriptomically similar to macrophages but with upregulated immunoglobulin machinery -both found in multiple samples, yet with dropouts in at least one menstrual cycle phase. Withinsubtype analyses revealed notable across-cycle transcriptomic changes in CD3+ and NCAM1+CD160+ lymphocytes. Cell cycling activity was observed in CD3+CD8+ lymphocytes and AIFI+IL1B+ macrophages and demonstrated phase-dependent changes. Notably, cross-cycle changes were less pronounced in the previously unacknowledged lymphocytes expressing KIT, the receptor for stem cell factor SCF and whose interactions play essential roles in stem-cell maintenance. Conclusion: Our analyses reveal a more complex immune hierarchy in healthy and cycling human endometrium than previously described, including a previously unacknowledged KIT+ lymphocyte population. Across-cycle transcriptomic changes observed in immune subsets revealed additional contributors to cyclic endometrial transformation. Support: NIH P50HD055764 Cytokines. Corrine F Monaco †, John S. Davis * . University of Nebraska Medical Center, Omaha, NE, United States. Introduction: The ovarian corpus luteum (CL) is a transient endocrine gland that produces the progesterone required for embryo development, implantation, and maintenance of pregnancy. In the absence of an embryo, luteal progesterone secretion is disrupted and the CL regresses to form a fibrotic corpus albicans. Prostaglandin F2α (PGF2α) has been implicated as a major luteolytic hormone in many species, including domestic farm animals, primates, and humans. PGF2α-induced regression in cows rapidly elevates the expression of pro-inflammatory cytokines, such as tumor necrosis factor alpha (TNF) and interleukin 1β (IL1B). In addition to steroidogenic cells, the CL contains vascular endothelial cells, pericytes, and fibroblasts. While the exact role of luteal fibroblasts is unknown, previous studies show that luteal fibroblasts produce components of a fibrotic matrix. We hypothesize that luteal fibroblasts respond to proinflammatory cytokines and alter the microenvironment by producing additional luteolytic factors that contribute to successful luteal regression Methods: Fibroblasts were isolated from bovine CL tissue punches, passaged 2-3 times, and treated with 10 ng/mL of TNF or IL1B to examine early intracellular signaling responses and production of PGF2α. Results: Western blot analysis showed significant increases in NFκB (p65) (8-fold, p < 0.05, n = 6), and p38 MAPK (5.6-fold, p < 0.001, n = 6) phosphorylation by 10 minutes of TNF treatment. TNF increased phospholipase A2 phosphorylation nearly 2-fold (p < 0.05, n = 4) after 4 hours of treatment and prostaglandin-endoperoxide synthase 2 (PTGS2) protein expression 2-fold after 12 and 24 hours (p < 0.05, n = 4). TNFα also induced a 42-fold increase in PGF2α production (n = 2). Responses to IL1B were not as robust as TNF, but p65 phosphorylation was increased 2-fold after 10 minutes (n = 6, p < 0.05) and p38 phosphorylation increased 2.4-fold after 30 minutes (p < 0.05, n = 6). IL1B also increased PTGS2 expression (3-fold, p < 0.05, n = 4) and PGF2α production 9-fold by 4 hours and 28-fold by 24 hours (n = 2) of treatment. These results indicate that cytokines implicated in CL regression activate signaling pathways in fibroblasts to stimulate PGF2α release into the luteal microenvironment, potentially exacerbating regression of the CL. Physical Activity Throughout Gestation Differentially Regulates CD206 Expression in Term Placenta. Alexandra D Goudreau †, Catherine Everest †, Velislava Tzaneva * , Kristi B Adamo * . University of Ottawa, Ottawa, ON, Canada. Introduction: Physical activity (PA) during pregnancy is associated with health benefits for both mother and fetus, including healthy placental development and reduced risk of prenatal complications. However, the mechanisms through which these benefits arise are yet to be fully understood. In the non-pregnant population, habitual PA induces a phenotypic switch in a range of tissue-resident macrophages, from an M1 state (predominantly secretes pro-inflammatory cytokines) to an M2 state (predominantly secretes anti-inflammatory cytokines). Placentaresident macrophages, known as Hofbauer cells (HC), reflect the ability of other macrophage subtypes to polarize between M1 and M2 states. While HCs exist in a predominantly M2 state, dysregulations have been associated with adverse health outcomes such as pre-eclampsia, gestational diabetes, and pre-term birth. The effects of PA on HCs have not yet been investigated. This study aimed to examine the relationship between habitual PA throughout gestation and key protein markers of HCs polarization in term placenta. Methods: Pregnant individuals (n=22) were recruited through the PLACENTA study in Ottawa, ON, before 28 weeks gestation. Participants wore an accelerometer in both their second (24-28 weeks) and third (34-38 weeks) trimesters for a minimum of four days to objectively assess PA status. Placental tissue and full-thickness histology sections were taken within an hour of delivery from term placenta (>37 weeks gestation). The 11 most and least physically active participants were identified for further analysis. Western blotting was used to examine the protein expression of HC markers CD68, a pan-macrophage marker, and CD206, an M2 macrophage marker. Immunofluorescence was used to quantify the number of CD206+ cells, indicative of the number of M2 macrophages. Results: While CD68 protein levels (P = 0.401) and CD206+ cells (P = 0.521) were not significantly different between active and inactive participants, CD206 protein levels were significantly decreased in the physically active group (P = 0.0297). Additionally, CD206 levels were negatively correlated with second (R 2 = 0.272; P = 0.013) and third (R 2 = 0.247; P = 0.019) trimester moderate to vigorous PA (MVPA). Conclusion: Increased expression of CD206 has been associated with a wide range of detrimental conditions, including chronic obstructive pulmonary disease, myeloma, and cirrhosis, as well as exposure to pathogens and toxins. The results of this study suggests that although the number of M2 HCs remains consistent between physically active and inactive individuals, PA may initiate a mechanism downregulating CD206 expression within HCs while maintaining the number of M2 HCs present in term placenta. This mechanism and its significance in fetal outcomes should be investigated in future research. were performed (vaginal plug as gestational day ~ GD 0.5). Mice were tail-vein injected with 6.7 μg each of A488-conjugated (at 24h) and A647-conjugated anti-CD45 antibody (at 5 minutes) before sacrifice ( Figure 1 ). Virgin uteri and mouse decidua (GD 12-17) mononuclear cells (MCs) were isolated by mechanical (GentleMACS) and enzymatic (Collagenase, DNAse) disruption. MCs were labeled with fluorescent antibodies to CD3ε, 11c, 19, 45 (PE-Cy5), Ly6G, and TCRβ. Data was acquired using BD Fortessa flow cytometer and analysis was performed using FlowJo 10.2. Vascular status amongst all CD45-PE-Cy5+ ILCs was determined as: A488+A647+ (always vascular), A488+A647-(vascular only at 24-hours), A488-A647+ (vascular only at 5-min), and A488-A647-(non-vascular). Statistical significance was determined by Likelihood Ratio Chi-square testes followed by Wilcoxon multiple comparisons tests. Results: First, non-vascular ILCs decreased, while exclusively vascular ILCs proportionally increased with gestational age (p < 0.0001). ILCs that exited the tissue at or after the 5-min injection remained at a constant proportion, while cells that entered tissues after the 24-hour injection decreased upon pregnancy. Furthermore, a greater proportion of nonvascular ILCs were Tbet fate mapped in both the decidua and the virgin uterus. Conclusion: Assessing immune cell trafficking across gestation is an understudied area of decidual immunology. Our data indicates increasing vascular-tissue traffic of ILCs with advancing gestation. Furthermore, Tbet expression history is implicated in determination of tissue entry/ residency. Future studies will determine whether dynamic Tbet regulation is necessary for acquisition of permanent tissue residency. Introduction: Chronic intervillositis of unknown etiology (CIUE) is a rare, poorly understood, histopathological diagnosis of the placenta that is frequently accompanied by adverse pregnancy outcomes including miscarriage, fetal growth restriction and intrauterine fetal death. CIUE is thought to have an immunologically driven pathophysiology and may be related to human leukocyte antigen mismatches between the mother and the fetus. Dizygotic twins with one-sided CIUE provide an interesting context to study the influence of immunogenetic differences in such cases. Methods: Dizygotic twin cases were selected from the pathology registry between 2000 and 2015 of a tertiary hospital (University Medical Center Utrecht). CIUE was defined as an infiltrate occupying at least 5% of the intervillous space with approximately 80% of CD68-positive mononuclear cells, in the absence of infection. We identified 3 dizygotic twin pregnancies in which CIUE was present in only 1 of the 2 placentas. Two of the pregnancies ended in term delivery and 1 ended in preterm delivery. Presence of CIUE was correlated with lower placental weight and lower birthweight when compared with the co-twin whose placenta was unaffected by CIUE. The presence of one-sided CIUE in dizygotic twin pregnancy is associated with selective growth restriction in the affected twin. This suggests a unique fetal immunogenetic contribution to the pathogenesis of CIUE. Further study of dizygotic and monozygotic placentas affected by CIUE could identify new insights into its pathophysiology and into the field of reproductive immunology. Introduction: Inflammation is linked to development of many diseases including tumorigenesis. Previously, we showed that adverse developmental environmental exposures to endocrine disruptor diethylstilbesterol (DES) epigenetically program myometrial stem cell (MMSCs) towards a pro-inflammatory profile and thus create a chronic inflammatory milieu in myometrium (MM), eventually leading to uterine fibroid (UF) development. However, the mechanism responsible for initiation of this persistent (DES)-induced epigenetic alteration is unknown Methods: Female newborn Tsc2-mutant Eker rats were treated S.C. with vehicle (VEH) or 10 µg/kg of DES, on postnatal days 10-12(key period of uterine development). SCs were isolated from MM tissue (N=5/group) using Stro-1 and CD44 surface markers at adult age (5 months). Whole genome RNA-sequencing and ChIP-sequencing (with anti-H3K4me3 antibody) were performed in DES-and VEH-MMSCs. qRT-PCR was performed to confirm the differential gene expression. knockdown (KD) of Tasp1 enzyme responsible for activation of MLL1 and thus methylation of H3K4 was performed using 3 lentiviral particles. DES-MMSCs were treated with histone decetylase (HDAC) inhibitor HDACiVIII at 2.5-5 µg/ml for 24&48 hr. Differentiated MM cells were exposed to secretome from VEH/DES-MMSCs. Western blot analysis was performed Results: Our previous RNA-seq data showed that 28.3% of inflammatory responsive genes (IRGs) were upregulated in DES-vs VEH-MMSCs including key cytokine genes that contribute to recruitment of macrophage A means to test single and mixtures of many toxicants and to predict toxic levels is needed. We report here a high throughput screen (HTS) using transgenic embryonic stem cells (ESC) cultured in a live imager that records time lapse growth and cell cycle progression. These ESC predict future growth deficits as well as past decreased cell accumulation. Methods: Mouse fluorescence ubiquitinated cell cycle indicator (FUCCI) ESC were tested with zero stress in normal stemness (NS) media, or with increasing levels of two environmental toxicant families: PFAS (PFOA/ perfluorooctanoic acid) and phthalates (DEP/diethyl phthalate). ESC were cultured for 72hr with daily media change in a Sartorius Incucyte zoom or a Biotek Cytation 5 live imager and assayed in time lapse every 2hr for confluence and green fluorescence. Green fluorescence is an indicator that the cells are past G1 (red) and into S-G2-M-phase (green) parts of the cell cycle. Cyclicity of G1 delay before media change and release into S-G2-M-phase was established. The suppression of the rapid green peak after media change by stress was validated for quantitation of toxicant levels that suppress cell cycle progression. Results: It was observed that the fraction of FUCCI ESC in green decrease over time from 12-24hr after the previous feeding and then rapidly enter S-G2-Mphase of cell cycle after media change as a leading indicator that predicts future cell division. The fed/unfed fold change increase in green cell cycle advancement ranged from 4.5 on day 1 to 6.75 on day 2 during NS ESC culture. However, when ESC were cultured with NS media and 100uM PFOA these fold change green peaks were suppressed to 1.3 and 4.52, respectively. DEP also significantly decrease fed/unfed increase in green, but only on day 1 and only from 4.5 to 3.0. Conclusion: Suppression of entry into S-G2-M-phase strongly by PFOA and weakly by DEP after media change was a predictor of stressful levels of environmental toxicant that can be used to screen single and mixed environmental and hormonal stressors in high throughput. Human FUCCI pluripotent stem cells should be validated for HTS use. Methods: Ovarian cortex hydrogels made from acellular tissues previously characterized by our group (n=9) and obtained using three different detergents-based protocols (Sodium dodecyl sulfate (SDS), P1; Sodium deoxycholate (SDC), P2 and Tri-n-butyl phosphate (TnBP), P3) were subjected to a mass spectrometry analysis (LC-MS/MS). In a subsequent bioinformatics study, the protein profiles of these hydrogels were compared with each other, a non-decellularized hydrogel and with published data of the human ovarian proteome. Results: Data showed an important enrichment in extracellular proteins after P1 and P2 (83.3% and 76.6%, respectively), which was lower in P3 (56.97%) (P<0.05). When compared against the Matrisome Project database, we were able to identify 23, 17 and 37 matrisomal proteins after P1, P2 and P3, respectively, with 69.5%, 70.5% and 75% of them found in human ovaries. While P2 had a milder effect on basement membrane members COL4A1 and COL4A2, P1 maintained ECM glycoproteins with crucial roles in ovarian function (EMILIN-1, LAMA5, LAMB2) and ECM-Regulators (TGM2). The proteomic analysis of different ovarian extracellular matrix hydrogels places SDS and SDC-based protocols as good candidates to obtain functional supports that could be used for in vitro folliculogenesis. P3 was excluded, as it did not efficiently decellularize the ovarian cortex. Specifically, P1 seems to have a minor effect on ovarian matrisomal proteins, possibly providing the best native extracellular environment for future translational research. Interestingly, previous histological and molecular characterizations performed by our group support these findings. Therefore, we propose that buffered solutions with low concentrations of SDS as the best option to generate decellularized tissues and hydrogels to be used for follicle culture. The endometriosis (EMS) pathogenesis and its outcome appears to be associated with multiple factors, less attention was focused toward the extracellular matrix (ECM) of endometriosis lesions and their potential role in the progression of disease moreover, there are well-documented confirmations represent the key role menstrual blood stem cell (MenSCs) in the pathogenesis of endometriosis. Using the matrices of decellularized (DEC) lesion as a 3D-organotypic approach, from native human ECM source, with MenSCs transplantation, will provide new insights into the complex crosstalk established at the lesion microenvironment. Methods: Specimens were collected from the patients in the fertility age and DEC based on the established protocol. EMS model inducted by implantation of DEC scaffold of ectopic lesion and transplantation of MenSCs in the mouse model. H&E, Trichrome, and DAPI staining, as well as scanning electron microscopy (SEM), conducted to examine the preservation of ECM structure and the presence of a nucleus. Cell viability and scaffolds toxicity measured by MTT assay. The tensile strength conducted to measure the biomechanical properties of each group. Cell proliferation potential, immune regulation, MenSCs engraftment, and angiogenesis on the ECM of implanted scaffold determined by immunofluorescence staining. Results: Microscopic evaluation of specimens revealed that decellularization was successfully removed from the cells. SEM confirmed the ECM structure preservation following the decellularization process. MTT assay findings revealed that the percentage of cell survival was greater than 85%. It was presented that decellular lesions bio-scaffold is a collagen-rich matrix with significant mechanical properties. Among mice implanted with the DC-ECM EMS+ MenSCs versus DC-ECM of non -EMS+ MenSCs there was a significant difference in the amount of stem cell engraftment (p<0.004). There was no significant engraftment in animals with no stem cell treatment in both groups. Stem cell treatment with DC-ECM EMS+ MenSCs led to significant increases in angiogenesis markers CD31 and CD34 and proliferation factor (PCNA) compared to the DC-ECM of non -EMS+ MenSCs group (p<0.02 and p<0.003, respectively). This project is still ongoing and additional results will be updated in near future. Based on the findings of this study, we would be able to understand the crosstalk of ECM and stem cells in the trafficking toward the lesion and the role of matrix in the development of disease based on that we can improve the therapy to block those factors recruitment or at least a therapy that can cease the inflammation. Models. Angelos Youssef †. LUMC, Leiden, Netherlands. Introduction: RPL remains unexplained in 50-75% of couples. For these couples, there is no effective treatment option and clinical management rests on supportive care. Essential part of supportive care consists of counselling on the prognosis of subsequent pregnancies. Indeed, multiple prediction models exist, however the quality and validity of these models varies. In addition, the prediction model developed by Brigham et al. is the most widely used model, but has never been externally validated. The aim for this study is therefore to identify prediction models for pregnancy outcome in couples with unexplained RPL, to evaluate those prediction models and to identify the performance of the most used prediction model. We have shown subtle differences in gross placental pathology in children with an older sibling with autism (and at increased genetic risk of autism) compared to controls. We here explore whether placental gross features can distinguish the at-risk child in a low-risk community-based population. A community hospital based sample with universal placental examination was searched for those births followed to at least age 2 years at our institution. Billing codes were searched for diagnoses related to autism spectrum disorder (ASD) among the patient population of the Department of Pediatrics Developmental Pediatrics group. At least 2 diagnoses related to ASD as per Newschaffer et al were required to be considered an ASD case. Controls were selected from the next infant born of same gender, gestational age +/-2 weeks, and season of birth +/-2 weeks. Gross placental examination was performed according to a protocol that recorded trimmed placental weight (PW), major and minor disk axes, minimum and maximum disk thickness and cord eccentricity. 165 ASD and 617 controls were included in the current analysis. Due to nonnormal distribution of growth variables, non-parametric tests were used. Results: While placental weights did not differ between ASD cases and controls, ASD cases had significantly smaller major disk axis (p=0.011), reduced chorionic plate area (p=0.044), reduced average thickness (p<0.0001) and reduced thickness variability (p<0.0001). Both fetalplacental weight ratios and beta, the nonlinear representation of the fetal to placental relationship (p=0.034, p=0.011, respectively). The significant associations persisted after stratification for sex in males with only average disk thickness (p=0.05) and disk thickness variability (p=0.003) retaining significance in the small set of 10 ASD females and 40 matched controls. We have demonstrated significant differences in gross placental features in ASD cases in a population based sample with universal placental examination. This complements our previous reports of similar gross differences in ASD cases diagnosed in the 1990's in a British covenience sample, and also from a high-ASD risk cohort of infants with an older sibling with autism. The present sample represents sporadic ASD. Future studies should be directed to identify factors that can reduced placental expansion and arborization in fetuses without genetic predisposition. Epidemiologic studies have shown that GDM can negatively impact maternal health after pregnancy, but also influence offspring risk of metabolic disease later in life (fetal metabolic programming).The placenta is the crucial fetal organ linking the maternal-fetal unit; placental epigenetic marks, in particular DNA methylation, have been increasingly recognized as plausible molecular mediators of the maternal intrauterine environment effects (i.e. GDM-exposure) on metabolic programming. In this study, we aimed to investigate relationships between GDM and DNA methylation in placentas from term pregnancies. Methods: We profiled the placental DNA methylome using the Infinium MethylationEPIC BeadChip Array of 222 term newborns, 22 from GDMcomplicated pregnancies and 200 from pregnancies without complications, GDM status was obtained from medical chart review. DNA methylation array data was preprocessed using functional normalization. After quality control, we performed an epigenome-wide association study (EWAS) to assess possible effects of GDM on term placenta DNA methylation at more than 700,00 CpG sites. We used robust linear models adjusted for maternal and infant confounders including in-silico estimates of placenta cell subtypes. False discovery rate (FDR) used to adjust for multiple comparisons. RNAseq data was used to evaluate the relation between expression and DNA methylation in genes near to GDM-related CpG sites. Results: GDM status was significantly associated with placental DNA methylation at multiple CpG sites (n=15, FDR 5%). Some of these loci mapped to regions associated to GDM in previous placental EWAS (e.g., 6p21.33). Other GDM-linked CpGs mapped to novel genomics regions. One of these mapped to 12p22.11 near the TMTC1 gene, methylation at this site was also associated with gene expression. Genes near significant CpGs were enriched for carbohydrate and glycolipid related pathways. Introduction: Exposure to phthalates is ubiquitous. As phthalates are reproductive and developmental toxicants, perinatal exposure is of particular concern for parents and their offspring. Therefore, we aimed to assess associations of prenatal urinary phthalate metabolites with gestational age at birth and birth weight. We conducted a pilot study on associations of phthalate and DINCH (Di(isononyl) cyclohexane-1,2-dicarboxylate) metabolite concentrations during pregnancy with birth outcomes in 123 pregnant participants in Boston, Massachusetts. We measured 14 phthalate and 2 DINCH metabolite concentrations (ng/mL) in urine samples collected at a mean gestational age of 35 weeks. Gestational age at birth and birth weight were abstracted from medical records. We evaluated individual metabolites, the molar sum of di-(2-ethylhexyl) phthalate metabolites (ΣDEHP), and the sum of available butyl (Σbutyl) phthalate metabolites (mono-n-butyl phthalate, mono-isobutyl phthalate, monobenzyl phthalate). We estimated associations of tertiles for specific gravitycorrected metabolite concentrations with gestational age at birth and birth weight using individual linear regression models adjusted for maternal age. Results: Mean ± SD for gestational age at birth and birth weight was 39.4 ± 1.2 weeks and 3.3 ± 0.5 kg, respectively. Most urinary metabolites were detected for >90% of participants. In regression models, mean gestational age at birth was 4.3 days shorter (95% confidence interval (CI): -7.9, -0. Introduction: A smaller study in this unique population with universal placental examination suggested that specific patterns of placental acute and chronic inflammation carry significant odds of autism case status. We have tripled our autism case numbers and seek to confirm these findings. Methods: A community hospital based sample with universal placental examination was searched for those births followed to at least age 2 years at our institution. Billing codes were searched for diagnoses related to autism spectrum disorder (ASD) among the patient population of the Department of Pediatrics Developmental Pediatrics group. At least 2 diagnoses related to ASD as per Newschaffer et al were required to be considered an ASD case. Controls were selected from the next infant born of same gender, gestational age +/-2 weeks, and season of birth +/-2 weeks. Maternal and fetal acute inflammation (MAIR, FAIR) was scored as 0-4 based on the number of affected sites (membranes, chorionic plate-maternal and umbilical cord and chorionic plate vessels-fetal) and semi-quantitative estimation of neutrophil infiltrate density. Chronic placental inflammation (CPI) was scored as "confined to basal plate and maternal-placental interface", and "villous infiltrates/chronic villitis", and subjectively scored as to extent of mononuclear lymphocyte infiltrate. Contingency tables considered p<0.05 significant. Placental acute or chronic inflammation is very commonly identified as subclinical even in low risk newborns. We explore whether placental inflammation impacts early childhood growth of term well newborns via effects on placental efficiency. Methods: A university affiliated community hospital in an ethnically diverse urban setting instituted a protocol of universal placental examination between January 2010 and March 2015. Gross and histologic examinations were performed according to a standard protocol. Inclusion criteria were limited to term singleton liveborns who had follow up in resident or faculty pediatric practices to at least 2 years of age, and whose placentas had been fully evaluated. In 232 children, maternal and fetal acute inflammation was scored as 0-4 based on the number of affected sites (membranes, chorionic plate-maternal and umbilical cord and chorionic plate vessels-fetal) and semi-quantitative estimation of neutrophil infiltrate density. Chronic placental inflammation was scored as "confined to basal plate and maternal-placental interface", and "villous infiltrates/chronic villitis", and subjectively scored as to extent of mononuclear lymphocyte infiltrate. Analyses used nonparametric tests due to nonnormal distribution of growth variables. Results: In this term population, no acute of chronic inflammatory pathology was associated with altered placental efficiency, whether calculated as a linear fetal placental weight ratio or as the nonlinear "beta", that relates placental and birth weight by a power law. No differences were observed between sexes. Conclusion: We have previously found associations with fetal acute and chronic placental inflammation and conditions such as autism; prenatal inflammatory exposures have also been linked to increased risk of obesity. The current data do not support a strong relationship of placental acute or chronic inflammation with placental efficiency which might be a pathway for abnormal metabolism that could predispose to obesity. Negative results may reflect the current small sample size, which precluded analysis of sex-specific effects or more quantitative differentiation among acute and chronic inflammatory infiltrates. Introduction: Placental acute and or chronic inflammation and maternal and fetal vascular pathology have been shown to impact placental growth and, by extension, birthweight. We test whether these associations are mediated by effects of histopathology processes on the fetal placental weight ratio (FPR). Methods: In a community hospital in an ethnically diverse urban setting, a mandate for universal placental examination led to gross and histologic examinations performed according to a standard protocol. 232 term singleton liveborns followed to at least 2 years of age had pathology report data extracted for diagnoses made by a single observer at birth. Maternal and fetal acute inflammation (MAIR, FAIR) was scored as 0-4 based on number of affected sites (membranes, chorionic plate-maternal and umbilical cord and chorionic plate vessels-fetal) and semi-quantitative estimation of neutrophil infiltrate density. Chronic placental inflammation (CPI) was scored as "decidual-placental interface only", and "chronic villitis", and subjectively scored as to extent of mononuclear lymphocyte infiltrate. Maternal uteroplacental vascular pathology (UVP) considered both villous fibrosis and hypovascularity and lesions such as infarct and thrombosis; fetal vascular pathology (FVP) was coded to distinguish terminal villous lesions (avascular villi, stromal karyorrhexis and erythrocyte fragmentation) and mural thrombi embedded in the walls of muscular placental vessels. Analyses used nonparametric tests due to nonnormal distribution of FPR. Results: In this population of term newborns, rates of high grade histopathology lesions were low, with 11.8% of MAIR in both membranes or chorionic plate, 3% with FAIR in umbilical and chorionic vessels, 11.8% with CPI , and 13.7% with UVP. 10.8% of FVP confined to terminal villi only, and a 5.3% rate of mural thrombus in chorionic or fetal stem vessels (FVP). UVP demonstrated negative associations with birth weight centile and placental weight (r= -0.27, r=-0.24, respectively) but not FPR. A trend to lower birth weight centile (p=0.07) but no impact on FPR was found with FVP lesions. Conclusion: CPI and maternal UVP have been linked to fetal growth restriction. Lack of association in our population sample may reflect current sample size, but our data provide no support for an hypothesis that placental histopathology, apart from UVP with gross infarcts and/or thrombosis, has any fetal impact via effects on the FPR. The Association between Vitamin D Levels and Insulin Resistance. Based on Vit D, 73.5% (n= 674) of women were categorized as deficient and the remaining 26.5% (n= 243) were normal. Deficient women were found to be significantly older than those with normal levels (p <0.0001). They were also more likely to be morbidly obese when compared to the normal group (p= 0.0003). Women with a history of hypertension were more likely to have normal Vit D levels (p= 0.043), while women with a history of smoking were more likely to have low Vit D levels (p= 0.0191). No correlation was noted between Vit D levels and race (p= 0.1202), history of drinking (p= 0.529), history of diabetes (p= 0.6027), as well as hemoglobin A1C levels (p= 0.9063). Furthermore, women with acanthosis nigricans were more likely to have low Vit D levels than those without that finding on physical exam (p= 0.001). There was no correlation noted between Vit D levels and the other signs of insulin resistance such as acne (p= 0.1398), hirsutism (p= 0.5327) and skin tags (p= 0.3354). There was no association found between vitamin D 25-OH levels and hemoglobin A1c levels in our study population. However, there appears to be an association between low vitamin D levels and smoking as well as acanthosis nigricans, a physical sign of insulin resistance. Interpregnancy Inter-pregnancy interval (IPI) is defined as the spacing between live birth and the beginning of the next pregnancy. Past research has found that IPIs shorter than 18 months (M) are associated with adverse pregnancy outcomes. However, it is unclear whether IPI is an independent risk factor or a marker of other confounding risk factors, such as race, socioeconomic status, and age.This makes it difficult to accurately counsel patients as to their individual risk based on IPI, especially for the older patients whose fertility is in decline. Methods: CDC WONDER is a public access, open database which contains all US birth data. Using this database for 2016-2017 (the first years to contain more expanded information including IPI), we analyzed IPI in relation to adverse pregnancy outcomes-preterm birth(PTB), gestational hypertension (gHTN), low birth weight (LBW), and gestational diabetes (GDM)-accounting for race, pre-pregnancy BMI, education, marital status, and maternal age. We focused our analysis to singleton pregnancies. Results: Short IPI (less than 18M) increased the rates of PTB and LBW, with stronger association with PTB rates.The highest PTB risk was seen among patients with IPI less than 12 M, modest increase was seen between 12-17 M, and rates plateaued at 18-23 M. This pattern was consistent in subgroup analysis by risk factor, indicating that IPI is an independent risk factor for PTB. While short IPI increased the risk of PTB in all races, the highest rate of PTB was seen in the non-Hispanic African-American population with short IPI, likely due to a high background PTB rate and a higher rate of IPI less than 12 M. Short IPI was an independent risk factor for LBW in all ethnic groups, with non-Hispanic African-American patients having the highest rate of LBW, followed by Asians, and then Whites. Low BMI and unmarried status were positively correlated with both PTB and LBW, while higher education (bachelor's degree or higher) was negatively correlated. In all subgroups, short IPI increased the risk independently, with the exception of LBW in the higher education group where there was no association observed. IPI less than 12 M was associated with increased PTB risk in women aged 20 years or younger, but there was no association with age otherwise. IPI was not associated with gHTN or GDM. Non-Hispanic African-American race and high BMI were associated with higher rates of gHTN. Asian race was associated with a higher rate of GDM. In this analysis of a nationwide birth database, short IPI, particularly less than 12 M, is an independent risk factor for PTB and LBW, whereas no association was seen between IPI and gHTN or GDM. It is important to educate patients about this modifiable risk factor of pregnancy complications. It may also be reasonable for the older patients to consider pregnancy after 12M of IPI based on our observation. .01) WEMWBS score before and after exercise. It can also be noted that increasing the number of sessions, particularly more than 15 sessions, was associated with even greater scores in the well-being scale post-exercise (F [1, 267] : 5.18, p: 0.02). The study introduced a sustainable exercise program among low to middle income pregnant women. The most immediate benefi t was the improvement of blood sugar control in the chronic exercise group with no evident adverse eff ects of SZG to the mother or fetus. Also, SZG had positive emotional and mental well-being eff ects on pregnant women and with routine exercise, this further increased. For healthcare and social workers, SZG may be used in maintaining maternal health and its practice may serve as a well-rounded form of alternative therapy. In developing countries with limited tertiary center access, SZG is a preventive medicine tool already available to local community healthcare workers. We found T1DM significantly impacted birth outcomes where mean birth weight was 3182g for those who did not have diabetes, 3325.3g for women with GDM, 3325.29g for women with T2DM, and 3079g for those with T1DM (p<.05). We did not find a disproportionate impact of pregnancy complications of HTN, mental health and substance abuse, or DM on birth outcomes for non refugee women compared to refugee women. Conclusion: Women with mental illness, T1DM, and HTN had significantly lower birth weight than those who did not. Refugees status was associated with improvement of outcomes, despite the impact of language, social, and economic barriers faced by this vulnerable segment of the population. Refugee women in our cohort did not disproportionately experience worse birth outcomes when faced with medical comorbidities compared to the native population despite potential barriers to healthcare. These results suggest greater resiliency among refugee women with past literature identifying theories to explain this finding. The "healthy immigrant effect" is the phenomenon that first generation immigrants have significant health advantages relative to comparable native born populations due to a multitude of components. This study illustrates the potential transgenerational effect of this phenomenon, given the impact of birth weight on long term health outcomes. in women with a vulnerable health status, the preferences regarding a nudge, provided via a web application that aims to help them improve their lifestyle by offering rewards. Methods: We conducted semi-structured interviews of women with a low socioeconomic status, based upon their level of education and neighbourhood of residence. After transcription, a thematic content analysis was applied. Results: Twelve women were interviewed. We identified five themes : (I) "Usefulness of an app as integral information source", (II) "Permissibility and effects of offering rewards", (III) "Preferences regarding content", (IV) "Preferences regarding type of rewards and system of allocation", and (V) Barriers. None of the participants objected to being rewarded for healthy behaviour; they mentioned that being rewarded could tip the scales towards healthy behaviour. Furthermore, participants stated that the freedom to choose when and with what they would be rewarded, would increase the chance of behavioural change. The acquired insights into the preferences regarding a nudge of women with a vulnerable health status will support the design of an effective nudge to help them adequately prepare for pregnancy and ultimately prevent adverse pregnancy outcomes. Association To better understand the impact of this, we examined the association between prenatal SARS-CoV-2 infection and adverse pre-and postnatal outcomes. Methods: This retrospective cohort study utilized data extracted from the Kaiser Permanente Southern California electronic health records (EHR) of 29,323 singleton pregnancies between April 6, 2020 through December 31, 2020. Prenatal exposure to SARS-CoV-2 infection was ascertained from PCR-based test results. The test was universally offered to all pregnant women. Baseline characteristics and outcomes (using ICD-10-CM and procedure codes) were ascertained from the EHRs. Logistic regression was used to estimate the odds ratios (OR) and 95% confidence intervals (CI)s before and after adjustment for several potential confounders. The incidence of COVID-19 diagnosis during the study period was 4% (1,185/29,323 singleton pregnancies Vertical transmission was observed in 13 (1.1%) of exposed neonates. The findings suggest that prenatal SARS-CoV-2 infection increases the risk of preeclampsia and ICU admission and can put the mother and her neonate at increased risk. Further studies are needed to determine if the higher risk of preeclampsia associated with SARS-CoV-2 infection involves placental microvascular dysfunction. The rate of vertical transmission from the mother to the baby is low, suggesting that pregnancy complications resulting from maternal SARS-CoV-2 exposure may pose a greater risk to the baby than transplacental viral transmission. The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection causes COVID-19, a respiratory infection that induces lung inflammation and pathology that in the worst cases can be fatal. Although the number of cases do not differ between men and women, men have about twice the risk of mortality as women. The basis for this sex differential is unknown. Our research objective was to model the impact of sex steroids on innate immune and inflammatory responses induced by SARS-CoV-2infection in a highly permissible lung cell line. We specifically chose to investigate the effect of progesterone (P4) as it is elevated in the second half of the menstrual cycle, as well as in pregnancy. We infected a lung adenocarcinoma epithelial cell line (Calu-3) with SARS-CoV-2 USA-WA1/2020 with or without P4 (100 nM) at varying multiplicity of infection (MOI; 0, 0.5, 3). Cells were observed for cytopathic effect (CPE) and harvested at 24 or 48 hours (h) post-infection (p.i.) for evaluation of viral RNA replication (RT-qPCR), cell lysis (LDH assay) and activation of antiviral innate immunity (RT-qPCR) via measuring biomarker gene expression of innate immune activation (ifit1, ifnb), inflammation (il6) and interferon signaling (mxa). All experiments were performed four times and samples tested in triplicate. Statistical analyses were conducted using Wilcoxon rank sum. Results: Calu-3 cells are highly permissible to SARS-CoV-2 infection with active viral replication confirmed by viral RNA abundance and plaque assay. CPE was visible by 24 h.p.i. and cytotoxicity was significantly higher at 48h than in uninfected cells (MOI 3, p<0.03). P4 pre-treatment was associated with a significant decrease in SARS-CoV-2 viral load (3.3-7 ± 0.2-0.9 log2fold, p<0.03), cell lysis (53-60% ± 1-4%, p<0.03) and a concomitant decrease in ifnb and il6 expression (1.5-2.7 ± 0.5-0.7 log2fold, p<0.03). In contrast, P4 treatment was associated with a significant increase in the interferon stimulated gene, mxa, (1.7-2.4 ± 0.7 log2fold, p<0.03) versus untreated cells; ifit1 levels were not significantly different, but trended higher after P4 treatment. Conclusion: Collectively, these data provide the first evidence that P4 may impart regulation of innate immune and inflammatory induction programs in SARS-CoV-2 infected lung cells. P4 signaling downregulated virus-induced IFN-β and IL-6 expression. While induction of mxa may occur through the redundant actions of other Type I or III interferons, regulation of ifit1 may result from P4 regulation of interferon regulatory factor activation and/or interferon signaling programs. Additional studies are ongoing to determine how P4 alters the antiviral response, which may explain in part the differential mortality by sex associated with COVID-19. transfected with mammalian expression plasmids encoding SARS CoV2 non-structural proteins (NSPs), which are critical elements of the viral replication and transcription complex. The transfected cells were analyzed for autophagy flux markers by western blots and immunofluorescence. The expression levels of autophagy proteins were correlated with lipid droplet area and number. Results: We found that SARS CoV2 partially utilizes the autophagy pathway and blocks the process at fusion step with lysosomes. SARS CoV2 infection is associated with upregulation of lipid droplets in placental cells. The NSP6 protein is a multipass transmembranous protein which is located in the endoplasmic reticulum, where it can associate with ATG5 and other autophagy pathway proteins. We show that overexpression of SARS COV2 non-structural proteins, NSP6 and NSP8 modulates autophagic response and upregulates lipid droplet biogenesis. NSP6 in particular restricts the expansion of autophagosomes, thereby favoring the reduced ability of autophagosome to deliver viral proteins to lysosomes. These altered pathways may trigger inflammatory responses during pregnancy which could drive adverse outcomes Conclusion: Our findings suggest that SARS COV2 modulates autophagy machinery for its own replication and likely has an inhibitory effect on the autophagy process via blocking autophagosome/lysosome fusion and affecting lipid droplet biogenesis. Ongoing studies are investigating the mechanism of action of SARS COV2 including modulation of host processes via its nonstructural proteins. Studies of these NSPs will shed light on their specific role in COVID19 pathogenesis in the placenta and may also provide attractive drug targets for intervention. The A cross-sectional study was conducted to determine whether the measures implemented to mitigate COVID-19 infections had a substantial impact on risk behaviors, endometriosis symptoms, stress, and access to healthcare. Methods: Electronic questionnaires that measured COVID-19 impact and peri-traumatic stress were disseminated through social media over June-September 2020 and completed by 82 adult patients with endometriosis living in Puerto Rico, where strict lockdowns were implemented from March to May 2020. Descriptive data analysis and correlations were done in quantitative data using JMP Statistical Software, and systematic analysis of free text was done on qualitative responses using NVivo 10 Software. Results: Many participants (72%) reported that their work was affected due to the pandemic, and 17% lost their job. Participants self-reported worsening of endometriosis symptoms (77%) and high levels of peritraumatic stress (76%), as well as changes in risk behaviors such as less exercise (38%), eating less healthy (56%), increased sedentarism (65%), and sleeping less hours (65%) during the pandemic in comparison to the previous months. They also reported substantial barriers in access to medical appointments (44%), scheduled procedures (63%), and prescriptions (60%). Electronic health modalities (telemedicine, mobile apps) were considered acceptable alternatives for gynecologic care during natural disasters by 94% of the study participants. The COVID-19 pandemic negatively impacted the health and wellbeing of endometriosis patients while imposing substantial restrictions on access to health care. These timely insights will guide the development and implementation of plans to address barriers to health care and minimize long-term detrimental effects of natural disasters on the health of those living with stress-related disorders such as endometriosis. This study was supported by 1R21HD098481-01 . As a result, many countries entered harsh lockdowns in order to restrict the spread of the virus. Several studies were conducted to assess the implication of the lockdowns on the rates of preterm birth, stillbirths and other maternal and perinatal outcomes, with inconsistent results. We have conducted a systematic review to report the current evidence of the Indirect impacts of COVID-19 on the rates of preterm birth and perinatal mortality & morbidity. Methods: We conducted a systematic review following the PRISMA guidelines. We searched electronic databases MEDLINE, Embase, PubMed for potentially relevant published and preprint studies. Two independent reviewers conducted title/abstract screening, full text screening, and data extraction using a pre-specified form. Conflicts were resolved by consensus or consultation with a third reviewer. The primary outcome was the rate of preterm births following the introduction of the COVID-19 restrictions, compared to the rate before these restrictions. Secondary outcomes included stillbirth and neonatal death rates, neonatal birthweight, NICU admissions and rates of caesarean deliveries. We have excluded studies assessing the direct effect of COVID-19 (positive cases) on pregnancy and perinatal outcomes. Results: Our initial search has retrieved a total of 485 studies, of which 21 met inclusion criteria after screening. Studies from the Netherlands, Ireland, Japan, USA, Denmark, Italy and centres in USA and Israel demonstrated a reduction in preterm birth rates during "lockdown" periods compared to prior periods. Very (< 32 weeks) and extreme (<28) preterm birth rates were more affected than late preterm births. This did not appear to be at the expense of increased stillbirth or neonatal deaths. In contrast, studies from Uruguay, Nepal, the UK, Sweden, other centres in USA and Israel, and a 17 country international cohort study, found no difference in preterm birth rates. Stillbirth or neonatal death rates were increased in Italy, Nepal, UK, Israel and Kenya. Conclusion: COVID-19 mitigation policies vary between regions which may have led to the inconsistencies in the reported effects on preterm birth and perinatal mortality across studies. It is vital to interrogate these differences to identify risk factors for preterm birth that may be potentially modifiable at the patient (reduced exposure to infection/inflammation), clinician (decision making) and societal levels (public health measures) to enable new strategies to prevent preterm birth in non-pandemic times. Introduction: Although health organizations worldwide have promoted and recommended the use of e-health modalities for monitoring symptoms and facilitating access to care, there is limited data on the adoption of these approaches for women of reproductive age. This study aims to assess if it would be acceptable for women of reproductive age to use e-health modalities, including mobile apps and telemedicine, for gynecologic consultations. This is of particular relevance currently as the COVID-19 pandemic has caused severe measures to mitigate this infection, including lockdowns and curfews, which limit access to care including gynecological consultation. Methods: We conducted a cross-sectional study using an anonymous questionnaire to assess the perception of women of reproductive age regarding facilitators and barriers for using e-health modalities to monitor gynecologic health and book appointments with gynecologists. The questionnaire was sent electronically via social media (Facebook, Instagram, Whatsapp, Twitter). The duration to achieve pregnancy during infertility treatment has been associated with significant mental health burden. During the COVID-19 pandemic, restrictive clinic policies have forced delays in access to care. As a result, patients undergoing infertility treatment may be at risk of significant psychological impact. We aim to investigate changes in depression screens among infertility patients during the COVID pandemic and characterize risk and protective factors. Methods: Using an institutional database from an academic center in Houston, Texas, we performed a retrospective case-control study to evaluate the effect of the pandemic on depression screens in new patient visits. Women undergoing infertility treatment with completed Edinburgh Postnatal Depression Scale (EPDS) questionnaires during the pandemic (1/2020-9/2020) were compared with a pre-pandemic cohort (12/2018-3/2019). Patients seeking fertility preservation, endocrine management, and age less than 18 were excluded. Primary outcomes were positive screens (EPDS score ≥10). Secondary analysis was used to stratify positive screens by demographics (race, income, nulliparity, history or pregnancy loss, and history of live births), medical and psychiatric comorbidities. Chi-square, ANOVA, independent sample t Tests, and simple logistic regressions were calculated for EPDS scores and positive screens. Results: Of the 807 patients in our database, 666 (83%) met the inclusion criteria with 267 (40%) of patients evaluated during the COVID pandemic. Overall, the rate of positive depression screens was unchanged during the pandemic (15.5% vs 13.9%) compared to pre-pandemic, and was unaffected by patient race or income. In the secondary analysis, patients with living children had a lower odds of screening positive for depression OR 0.55 (p=0.03, CI0.32-0.95, n=181) but exhibited an absolute increase in EPDS scores by +1.18 points (0.02-2.34, p=0.047) during the pandemic. Having no living children in combination with a history of SAB or RPL increased the odds of positive screens (OR1.67, 1.02-2.74, n=130 and OR2.38, 1.02-5.57, n=28 respectively). Additionally, patients with no medical comorbidities were more likely to screen positive OR 1.88 (1.14-3.09, n=429) for depression. The prevalence of positive depression screens in our new patient population was unchanged during the COVID pandemic. Race or income did not affect the rate of positive screens. In our secondary analysis, having living children was identified as a potential protective factor for those with positive screens. Women with known risk factors of depression-particularly a history of spontaneous abortions or recurrent pregnancy loss-were at significant risk of screening positive for depression. Universal screening may help to identify psychological health needs, particularly when infertility treatment is delayed. Introduction: Neurosteroids play critical roles during pregnancy for both maternal and fetal health. Stress-reactive neurosteroids are reportedly low in women with perinatal depression and may be associated with poor pregnancy outcomes in animal models. Neurosteroids are present at low serum concentrations, and a major research obstacle has been reliable methods for quantification especially for clinical/translational investigation. A simple selective assay for neurosteroids would allow diagnostic studies in pregnancy. Here we present a high-performance liquid chromatography tandem mass spectrometry (HPLC-MS/MS) assay to quantify allopregnanolone (3α-hydroxy-5α-pregnan-20-one), pregnanolone (3α-hydroxy-5β-pregnan-20-one), epipregnanolone (3β-hydroxy-5β-pregnan-20-one), pregnenolone, progesterone, cortisol and cortisone in pregnancy. Methods: We extracted serum analytes by methanol precipitation and separated via HPLC (Agilent Poroschell 120, 50 x 4.6 mm, 2.7 µm particle size, EC-C18 analytical column) followed by identification and quantification using MS/MS. We used Clinical Laboratory Standards Institute and Food and Drug Administration (FDA) guidelines for bioanalytical assay validation to assess recovery, selectivity, lower limit of quantification, accuracy and precision (%CV), and to evaluate matrix effect and stability. Data analyses were performed using Analyst 1.6.2 and Sciex OS-MQ 1.6.1, with t-tests for log transformed patient data. We analyzed charcoal-stripped and regular human serum for assay development and quality controls (N=6). To test the assay in clinical samples we analyzed serum obtained from pregnant women (N=54). Results: Extraction recovery was >95% for all analytes and there was no significant ion interference, demonstrating adequate selectivity. Range of quantification for allopregnanolone, pregnanolone and epipregnanolone was 0.78 ng/mL to 100 ng/mL, and for pregnenolone, progesterone and cortisone it was 1.56 ng/mL to 400 ng/mL. For cortisol it was 3.91 ng/mL to 1,000 ng/mL. Accuracy was 101.6% ± 5.5% and 102.6% ± 6.5% for intraday and interday, respectively. Intraday %CV was 9.5% ± 3.0% and interday %CV 11.5% ± 4.1%. We evaluated matrix effects and accepted results which met FDA criteria. We demonstrated sample stability up to seven days at 4°C. We developed a fast selective HPLC-MS/MS assay for validated simultaneous quantification of serum neurosteroids and steroid hormones in pregnancy. This assay may be useful in clinical pregnancy research and investigations. While we have shown that GV microbial supernatant disrupts the cervical epithelial barrier, the mechanisms regulating the effects of live bacteria on CV epithelial cells remain unclear. The study objective was to elucidate the host-microbiota interactions between GV and cervical/vaginal epithelial cells by investigating the effect of 1) LC and GV on the CV epithelial barrier and host immune response and 2) the role of the TLR2 receptor in perpetuating these effects. Methods: Human ectocervical (Ect1/E6E7, Ecto), endocervical (End1/ E6E7, Endo), vaginal epithelial cells (VK2) and HEK TLR2 reporter cells were co-cultured with LC (ATCC 33197) or GV (ATCC 14019) (~1x10 6 -1x10 4 CFU/well) for 24 hours either alone or pre-treated with a monoclonal anti-TLR2 antibody (10 ug/ml). Bacterial abundance was quantified by CFU assays. Cell permeability assays (n=6) were performed following exposure to live bacteria with or without antibody. Media was used for LDH cytotoxicity assays (n=9) and measurement of cytokines/ MMPs by Luminex (n=3). NFkB activation (n=6-9) and IL-8 (n=6-9) up-regulation in HEK TLR2 cells was measured using QuantiLuc and QuantiBlue assays. Results: GV increased cell permeability in a dose-dependent manner in ecto (p<0.0001), endo (p<0.0001) and VK2 (p<0.0001) cells while LC had no effect. GV but not LC increased cytotoxicity (p<0.0001) in all three cell lines. Significant increases in 18 (out of 25 detectable) cytokines including IL-6, IL-8, IL-1a/b, IL-1RA, TNFa, MMP9 were observed after exposure to GV but were mostly unchanged with LC in ecto, endo and VK2 cells. LC and GV induced NFkB activation (p<0.0001) but only GV increased IL-8 (p<0.0001) in HEK TLR2 reporter cells. Pre-treatment with the anti-TLR2 antibody significantly mitigated: 1) GV-induced cytokine expression in ecto, endo and VK2 cells and 2) GV induced NFkB and IL-8 activation in HEK TLR2 cells. Conclusion: Live GV reduces CV epithelial barrier integrity, increases epithelial cell death and initiates immune activation in host CV epithelial cells through TLR2-dependent mechanisms. These results provide evidence of a regulated and complex host-microbe response in the CV space that is both bacteria and epithelial cell type specific. Further investigation into CV host-microbial interactions will undoubtedly lead to new therapeutic approaches for adverse reproductive outcomes. Is (Fig. 1) . RNASeq analysis revealed upregulation of specific pathways in the E. coli group compared to the LPS group (Fig. 2) . Additionally, comparison within IA E. coli animals with and without PTL showed significant increase in gene expression associated with inflammatory responses, specifically NF-κB signaling, IL-6 production and type I Interferon response. Conclusion: Induction of PTL was correlated with both quantitative and qualitative changes in the intensity of the immune response to IUI. These IUI macaque models with or without PTL offer unique opportunities to unravel the IUI-specific pathways responsible for induction of PTL. Immune The full length of bacterial 16S rRNA gene in cervicovaginal fluid samples of asymptomatic pregnant women (20-22 weeks' gestation) who delivered at term (n=16) and preterm (n=16) were sequenced using the Oxford nanopore MinION. The sequences were mapped and clustered into Operational Taxonomic Units (OTUs) using QIIME tool on Greengene, SILVA, RDP, EzBioCloud and NCBI databases individually. The relative abundance of bacterial species between the cohorts was compared by Wilcoxon rank sum test, and further expressed as a fold change (cut-off ± 2). Results: Only Lactobacillus vaginalis and Atopobium vaginae were identified by all 5 databases. Only SILVA (p<0.001) and Greengene (p=0.03) showed significant differences in relative abundance of bacterial species between term and preterm-delivered women. These databases showed that L. vaginalis, L. iners and L. jensenii were more abundant in the preterm group, while L. gasseri and L. acidophilus were more abundant in the term group. Preterm birth was associated with more abundance of bacterial vaginosis-associated (e.g. Inflammation is believed to be the primary driver of preterm birth and the associated neonatal complications, including neurological. Prevention of adverse neonatal outcomes remains a significant goal. Statins are known for their anti-inflammatory effects. We hypothesize that statins administered before lipopolysaccharide (LPS)-induced maternal inflammation will reduce pro-inflammatory (IL-6, IL-1β, TNF-α) and increase anti-inflammatory cytokines (IL-4, IL-10) in fetal brain in a mouse model. Methods: Day 15 pregnant CD-1 mice were randomly allocated for intraperitoneal injection with either simvastatin (SIM/LPS, n=9), pravastatin (PRAV/LPS, n=8) (both at 10 µg/g of body weight in saline), or saline (SAL/LPS, n=9, positive control) 2 hours prior to administration of LPS (250 µg in saline). Dams who received saline injections at both time points (SAL/SAL, n=9) served as negative controls. Six hours after the last injection, dams were euthanized, and fetal tissues collected. After determination of fetal gender, protein extraction was performed from the brains of 1 male and 1 female pup per dam. Concentrations for IL-6, IL-1β, TNF-α, IL-4 and IL-10 in maternal plasma and fetal brain were measured using MILLIPLEX multiplex immunoassays and analyzed by gender using One-Way or Kruskal-Wallis ANOVA followed by Dunn's multiple comparisons test (statistical significance: P<0.05). The concentrations of IL-6 (P=0.0005), IL-1β (P=0.01) and TNF-α (P=0.01) were significantly elevated in maternal plasma in SAL/ LPS group in comparison to SAL/SAL dams. with SAL/SAL controls, administration of LPS significantly increased concentrations of IL-6 (males P=0.04, females P=0.03), TNF-α (males P=0.02, females P=0.04) and decreased quantities of IL-4 (females P=0.02) and IL-10 (males P=0.02, females P=0.03) in fetal brain. Treatment with pravastatin significantly decreased the brain concentrations of IL-6 (P=0.02) and TNF-α (P<0.0001) in male pups, IL-6 (P=0.03) in female pups, and increased IL-4 (P=0.04) in female pups as compared to SAL/LPS control. There were no statistically significant differences in the cytokine levels with maternal exposure to simvastatin. IL-1β in fetal brains was not affected by any treatment. Conclusion: Administration of statins, especially pravastatin, before the exposure to maternal inflammation appears to suppress pro-inflammatory and increase anti-inflammatory cytokine quantities in the fetal brain. We propose a novel role for statins as prevention of fetal brain inflammation. Increased 16S rRNA sequencing confirmed the presence of gram-negative bacteria, Ralstonia insidiosa (R. i), within the basal plate. In this study, we sought to characterize the location and function of R. i at the maternal-fetal interface, to elucidate the effect of R. i on trophoblast cell viability and activity; and to assess whether R. i play has an adverse or beneficial role within the gravid intrauterine environment. Methods: R. i presence and abundance within term placenta was investigated using species-specific bacterial probes and fluorescent in situ hybridization. JEG-3 cells were challenged with R. i in a dose dependent manner to study the impact on cell survival, invasion and pro-inflammatory responses in the trophoblasts. Pregnant mice were challenged with R.i to determine whether R.i. home to the placenta and affect parturition. Potential cross talk between trophoblasts cells treated with R. i and decidual NK (dNK) cells was analyzed. Primary dNK cells were isolated from term basal plates and challenged with conditioned supernatant from primary extravillous trophoblast cells treated with R. i at differing multiplicities of infection. dNK cells HLA-G and KIR2DL4 expression was analyzed by flow cytometry and cytokine secretion (IL-8) measured using ELISA. Results: We identify R. i as a bona fide resident at the maternal-fetal interface by species-specific FISH probes in term basal plate tissue. Furthermore, our studies provide in vivo evidence that viable R. I colonize and replicate within the murine placenta following intrauterine administration but did not lead to preterm birth. R. i challenge of JEG-3 cells did not induce apoptosis or induce pro-inflammatory responses. Excitingly, primary dNK cells challenged with conditioned media from R. i treated trophoblasts demonstrated elevated HLA-G expression in EVTs as well as IL-8 in the dNK cells, both of which are associated with immunotolerance. Conclusion: Collectively, our findings demonstrate that R. insidiosa does not induce pro-inflammatory responses but may promote immune tolerance and support normal pregnancy outcomes. Our studies provide a foundation for understanding possible 'commensal' microbial-placental interactions and hint at the functional importance of R. insidiosa at the fetal-maternal interface in maintaining placental health and supporting fetal tolerance. Experiments were also carried using macrophages collected from the abdomen of pregnant mice on day15.5 using conditional medium collected from primary smooth muscle cell culture. Total RNA was extracted by Trizol reagent for gene expression analysis using qRT-PCR; protein levels were analyzed by ELISA, IHC and IF studies. Migration studies carried out using transwell plates and cell counts. Results: LPS induced both CXCL12 RNA and protein levels specifically in myometrium compared to controls (3-fold and 3.5-fold respectively, P<0.002). Highest levels were found just before the start of labor. LPS also enhanced the infiltration of neutrophils, macrophages and T cells at 6 h after LPS injection, and induced macrophage M1 polarization. In vitro studies showed that condition medium from LPS treated primary smooth muscle cells (SMC) induced macrophage migration, M1 polarization and upregulated inflammatory cytokines such as IL-1, IL-6 and IL-TNF-α. AMD3100 treatment in pregnant mice led to a significant decrease in the rate of preterm labor (70%), prolonged pregnancy duration (21 vs 20 days) and suppressed macrophage infiltration into gestation tissue by 2.5 fold. Further, in-vitro treatment of SMC by AMD3100 suppressed the macrophage migration, polarization and decreased expression of IL-1, IL-6 and IL-TNF-α. Conclusion: LPS treatment in pregnant mice induced preterm labor by increasing myometrial CXCL12 which recruits immune cells that in turn produce inflammatory cytokines. These effects stimulated by LPS were completely reversed by AMD3100 through blocking of CXCL12/CXCR4 signaling. Thus, the CXCL12/CXCR4 axis presents an excellent target for preventing infection and inflammation-related PTL. BV) and inflammation contributing substantially to its pathogenesis. Gardnerella vaginalis and its metabolites are increased in vaginal samples of patients with BV. Hence, we determined the metabolic profile of G. vaginalis by examining its metabolism of glucose, L-lactic acid (LAC), and D-lactic acid (DAC). Methods: G. vaginalis (n=6) was cultured under anaerobic conditions for 48 hours and then sub-cultured with combinations of 13 C u -glucose, 13 C 3 -LAC, and 13 C 3 -DAC. Following 48 hours in culture, 13 C-NMR spectra were acquired with Broth only and G. vaginalis cultured without 13 C-substrates as controls. Data was normalised to the lactate integral from the conversion of broth glucose after 48 hours of incubation. Results: Greater concentrations of 13 C u -acetate were produced from 13 C u -Glucose when in single substrate culture compared to that formed in joint culture with either enantiomer of 13 C 3 -lactic acid. Greater concentrations of 13 C-lactate were produced from 13 C u -glucose when in single substrate culture compared to that formed in joint culture with 13 C 3 -LAC only. No statistically significant difference was found between metabolites formed from 13 C 3 -LAC compared to 13 C 3 -DAC. Observations of raw spectra also indicated minimal production of formate, succinate and ethanol. Conclusion: The findings suggested preferential metabolism of 13 C uglucose over either enantiomer of 13 C 3 -lactic acid during the production of acetate. Acetate is a marker of vaginal dysbiosis (BV), infection and preterm birth. Further studies are required to determine whether G. vaginalis out-competes Lactobacillus species for glucose metabolism. The cervix serves as the gate at the external maternal fetal interface for the developing pregnancy and remodels into the gateway for birth. In studies of rodent models and biopsies of the human cervix, reduced cell nuclei (CN) density and degradation of cross-linked collagen in the stroma are indices of inflammatory processes before birth at term. The novel approach in this study addresses the hypothesis that histomorphological structure and inflammation across subregions of cervix stroma are similar in women who deliver at term and preterm. Methods: Hysterectomy specimens were obtained from multipara women with obstetrical complications at 32-34 weeks (Preterm not in labor, PT; n=4) or 37-39 weeks (Term, T; n=3, 2 post-induction and 1 not in labor). Blocks of tissue from the external cervical os to the lower uterus were processed and longitudinal sections were stained with methyl green for CN and picrosirius red (PSR) for collagen, and with antibodies to macrophages (M0s, CD68) and smooth muscle actin (SMAα). CN and M0s were counted to assess density/area in the ectocervix, endocervix, vicinity of the internal os, and lower uterus. Optical density of PSR birefringence for collagen cross-linking and area of SMA stain/section were also assessed. Results: CN and cross-linked collagen densities were similar in the stroma of the ectocervix, endocervix, and internal os subregions between PT versus T groups. However, in the T group, CN were less dense in the lower uterus versus ectocervix (P<.05 ANOVA). No difference was found in density of M0s in the cervix stroma among all 4 subregions in the PT group (P>.05 ANOVA). By contrast, M0s/area in the endocervix in the T group was increased compared to that in the ectocervix, internal os, and lower uterus subregions, as well as versus the endocervix in the PT group (P<.05 ANOVA). The percent area with SMA staining progressively increased from ectocervix to lower uterus in both groups. Moreover, the average SMA/area was the same in PT vs T groups (P>.05 Student's t-test). Conclusion: These findings support the hypothesis that inflammation within subregions of the cervix are similar at term and preterm. However, at term, reduced CN density in the lower uterus vs ectocervix and abundance of M0s in the endocervix relative to other subregions and to endocervix at preterm support an alternative hypothesis. The data reveal that specific morphologic changes may distinguish remodeling in subregions of the lower reproductive tract of women at term from those who deliver preterm. This novel finding indicates that structural changes in the cervix associated with ripening before term may prove useful to evaluate risk of prematurity and identify a potential locus for antiinflammatory therapeutic approaches to forestall preterm birth. Differential Vaginal Lactobacillus Species Metabolism of Glucose, L-and D-lactate by 13 C-Nuclear Magnetic Resonance Spectroscopy. Emmanuel Amabebe †, Dilly Anumba * , Steven Reynolds * . University of Sheffield, Sheffield, United Kingdom. Introduction: Cervicovaginal dysbiosis can lead to infection/ inflammation-associated spontaneous preterm birth. In conjunction with the host vaginal habitat, the vaginal bacteria produce unique metabolic by-products. In a healthy vagina, lactobacilli are the predominant species and have been linked to increased likelihood of term delivery. Although, lactobacilli are known to thrive by acidifying the vagina environment (pH < 4.5), the mechanism underpinning how lactobacilli, and other anaerobes, interact with each other through lactic acid metabolism remains unresolved.Objective To determine whether vaginal Lactobacillus species, L. crispatus and L. jensenii, differentially metabolise glucose, L-and/or D-lactic acid to propagate their survival/dominance, and prevent dysbiosis and infection-associated preterm birth. Methods: L. crispatus and L. jensenii were incubated anaerobically for 24h at 37°C, with 13 C u -glucose, 13 C 3 -D-lactate or 13 C 3 -L-lactate (singularly or combined) for 24h. 13 C-spectra were acquired using a 9.4T NMR spectrometer. Metabolite integrals were normalised by the concentration of live bacteria present in the incubated samples i.e. the lactate integral produced from the conversion of broth glucose after 48 hours of incubation (pre and post addition of 13 C substrates). Results: L. crispatus and L. jensenii (n=6 each) metabolised 13 C u -glucose to 13 C-lactate and 13 C-acetate. L. jensenii converted more 13 C 3 -D-or 13 C 3 -Llactate to 13 C-acetate than L. crispatus, p<0.001. There was no significant difference in the amount of 13 C-lactate produced by both species from 13 C u -glucose. Six of the L. jensenii 13 C spectra also showed succinate peaks at 32.4 and 180.6 ppm. Conclusion: The conversion of glucose, L-and D-lactate to more acetate by L. jensenii compared to L. crispatus, suggests a possibly important pathomechanism of female genital tract dysbiosis, altered vaginal pH, infection and infection-associated spontaneous preterm birth. Introduction: TLT-1 is a type 1 single Ig domain receptor that binds fibrinogen. Its long splice variant is specific to platelets and relocates to the cell surface from α-granules upon stimulation. In adults, TLT-1 dampens the inflammatory response and facilitates platelet aggregation at sites of vascular injury. Preterm birth is associated with both bleeding and infection. Hypothesis: relative TLT-1 deficiency is associated with prematurity and fetal inflammation. To test this we examined the levels of soluble TLT-1 (sTLT) in cord blood and compared the inflammatory response in C57BL/6 (WT) and TLT-1 -/-(KO) pups of mothers given LPS during pregnancy. Methods: Cord blood plasma samples from infants born 26-34 (n=7) or 38-42 (n=5) weeks of gestation to healthy mothers aged 17-38 were examined for sTLT. In mouse studies, WT or KO mothers were mated to same-strain males for 24 hours (day 0 gestation). On Day 15, females received ip injections of 10ug of LPS in PBS (control=PBS alone). Twelve to 16 hours later, we examined maternal and fetal tissues (blood, decidua basalis and amniotic fluid) for cytokine response by QT-PCR and multiplex assay. Hypothesis testing used ANOVA or Mann Whitney U as appropriate. We report median/ range or mean±SEM and p values. Results: sTLT in preterm cord blood (median 0.82, range 0.43 to 1.56 pg/ml) was lower than in term babies (median 1.97, range 1.41-2.41, p=0.005). In mice, the unexposed litter size in KO vs WT mice was similar (7.6, vs 8.2 ±0.6 pups, n~6 p=0.5). Maternal inflammatory response (LPS vs. PBS) and rate of delivery of at least one pup by 16 hours after LPS was similar. However, in decidua of pups whose mothers received LPS 12 hours before, relative RNA expression of CXCL1 (KC) tended to be higher in KO vs WT tissues (five-fold, n~6; p=0.16) while that of GMCSF tended to be 50% lower (n~5; p=0.07). In amniotic fluid, KO pups vs WT expressed higher levels of IL-6 (90.8 vs10.7 ng/ml n~6; p=0.05) and γ-IFN (3.3 vs 0.8 ng/ml n~6; p=0.04) but not TNF (p=0.72). This effect remained when controlling for the maternal response (p=0.03 and 0.04). Conclusion: The data suggest possible associations between lower TLT-1 and prematurity in infants and between TLT-1 deficiency and increased inflammation in fetal mice exposed to infectious stimuli. The data supports further investigation to probe mechanisms underlying the link(s) between bleeding, infection and subsequent preterm birth. However, EMT associated cell migration kinetics is not yet studied in fetal membranes. In this study, we tracked AEC migration through a nude (cell free) extracellular matrix under normal & oxidative stress conditions (inducer of EMT) using 3D imaging. Methods: To create a nude membrane, the amniochorionic membranes were collected from term cesarean deliveries. The amnion layer separated from the chorion was treated with 5M Urea to remove cells (nude membranes). To test AEC migration, we used immortalized AEC grown under normal & oxidative stress conditions (OS & EMT inducer cigarette smoke extract treated AEC). Green fluorescence probe Col-F labeled nude (cell free) membrane was attached to a trans-well system & red fluorescent protein (RFP)-expressing AECs (iAEC-RFP; normal or OS induced) were seeded on the top of the membrane. Antioxidant N-acetyl cysteine (NAC, 15 mM), or EMT inhibitors (A83-01, 0.5µM & SB431542, 1µM) treatments were used as controls. Time-lapse imaging with Z-stack using a Keyence microscope (BZ-X800E) captured cellular migration through membrane matrix. The images were analyzed with 3D measurement using BZ-X800 Analyzer. iAEC-RFP cells migration, morphology & the EMT marker vimentin were analyzed with IHC. Results: AECs maintained their epithelioid morphology when resting on nude membranes. Extracellular matrix of nude membrane permitted AEC migration as confirmed by image analysis of iAEC-RFP. CSE treated cells (OS & EMT) migrated ~2 times faster than normal AECs (Fig.1) , showed mesenchymal morphology & expressed vimentin (Fig.2) . CSEinduced migration was partially delayed with NAC treatment & EMT inhibitors-containing media treatment partially retained iAEC-RFP cells morphology as well as migration (Fig.2) . Using a live & cell free fetal membrane matrix in a transwell system, we determined epithelial cell transition, migration, & its kinetics under specific conditions. We report that OS can induce amnion epithelial cell EMT & increase their migratory potential leading to accumulation of proinflammatory mesenchymal cells in the matrix. Lack of transition of mesenchymal cells back to epithelial cells due to OS is a detrimental factor for membrane weakening. Microbiome. Jose Galaz †, 1 Roberto Romero * , 2 Andrew D Winters, 1 Kevin R Theis * , 1 Nardhy Gomez-Lopez * . 1 1 Wayne State University SOM, Detroit, MI, United States; 2 Perinatology Research Branch, NICHD/NIH/ DHHS, Detroit, MI, United States. Introduction: A mid-trimester sonographic short cervix is the strongest predictor for preterm birth, which is associated with intra-amniotic infection and/or inflammation, and disruption of the cervico-vaginal microbiome. While intra-amniotic infection is caused by microbes, sterile intra-amniotic inflammation (SIAI) is induced by alarmins. However, causal relationships between intra-amniotic inflammation, cervical shortening, and subsequent changes in the cervico-vaginal microbiome are lacking. Herein, we established a murine model to measure cervical length in vivo and studied the relationships between intra-amniotic inflammation, cervical shortening, and the cervico-vaginal microbiome. Methods: Cervical length was measured in C57BL/6 dams using highresolution ultrasound and compared with the excised cervix (n = 6). Dams received ultrasound-guided intra-amniotic injection of LPS on 16.5 days post coitum as a model of endotoxin-induced preterm birth (n = 6), IL-1α as a model of SIAI (n = 6), or PBS (n = 6). RU486 (n = 6) was subcutaneously injected as a model of non-inflammatory preterm birth, or DMSO (n = 6). Cervical length was measured at time of injection and 6 h after. Cervical length difference between time points was reported as percentage of cervical shortening. A second cohort of dams receiving the same treatments (n = 6 per group) was used to collect cervical/vaginal tissues 6 h after injection for evaluation of the cervical and vaginal microbiome using 16S rRNA gene sequencing. Results: First, we established a reliable in vivo method for measuring cervical length in mice. Dams that received intra-amniotic injection of LPS or IL-1α displayed significantly greater cervical shortening compared to controls. In contrast, the administration of RU486 did not alter the cervical length. Microbiome analyses revealed taxonomic differences in the bacterial profiles of cervical and vaginal samples; however, generalized linear models showed no differences in the cervical or vaginal bacterial profile richness or heterogeneity for LPS vs. PBS, IL-1α vs. PBS, or RU486 vs. DMSO. Similarly, PERMANOVA analyses revealed no differences in composition or structure of cervical or vaginal microbiomes between these three contrasts. Lastly, based on LEfSe and ANCOM-BC analyses, there were no differentially abundant bacterial taxa in the cervix or vagina for any comparison. Conclusion: Cervical length can be measured by ultrasound in mice. Alarmin-and endotoxin-induced intra-amniotic inflammation led to cervical shortening, which did not occur in a non-inflammatory model. Notably, cervical shortening was not associated with an altered cervicovaginal microbiome. Further research is needed to study microbiome perturbations closer to delivery. Branch at Galveston, Galveston, TX, United States; 3 The University of Texas Medical Branch, Galveston, Galveston, TX, United States. Introduction: Ureaplasma parvum (UP), an intracellular organism, is one of the most frequently isolated organisms from the cervicovaginal space of patients with preterm birth. The exact mechanisms by which Ureaplasma spp. infect the cells in the female genital tract and establish ascending infection are yet to be fully elucidated. We hypothesize that UP can promote inflammation in the cervical epithelial and stromal cells and be packaged inside cervical cell-derived exosomes for propagation and establishment of ascending infection. Methods: Human ectocervical and endocervical epithelial cells, and cervical stromal cells (Stroma) were exposed to 10 9 -10 10 CCU UP culture per milliliter of media for 24h and 48 h. Fluorescence microscopy was used to determine the entry of DiO-labeled UP and its co-localization with the endosome-specific tetraspanin CD9 in all cervical cells. The cytotoxicity of UP to cervical cells were assessed by LDH assay while inflammation was determined using ELISA for GM-CSF, IL6, and IL8. Exosomes were isolated from UP-infected Ecto cells using differential ultracentrifugation and size exclusion chromatography and characterized by determining U. parvum antigen and mba by western blot, a virulence factor in UP. LPS was used as a positive control. Statistical analyses using one-way ANOVA and posthoc test were performed to establish significance (p<0.05). Results: Regardless of exposure time, UP infection did not cause cytotoxicity in cervical epithelial or stromal cells. LPS did not induce inflammation in cervical epithelial cells, whereas UP infection caused a significant increase in GM-CSF (p < 0.0001), IL6 (p < 0.0001), and IL8 (p < 0.01) compared to the control. Gentamicin treatment dampened this inflammatory response in the epithelial cells. Conversely, LPS induced a significant increase in GM-CSF, IL6, and IL8 (p < 0.0001) in cervical stromal cells compared to UP infection. Fluorescence microscopy showed the intracellular colonization UP in both epithelial and stromal cells. UP was co-localized with the endosome-specific tetraspanin, CD9. Western blot analyses showed that exosomes isolated from UP-infected Ecto cells were positive for CD9, CD63, U. parvum, and mba. Conclusion: UP infection promotes cervical epithelial cell inflammation. This study also determined that UP can be packaged inside the exosomes released from cervical epithelial cells. This can be a mechanism used by UP to evade the immune system and establish ascending infection to the uterine and amniotic cavity during pregnancy. Quantification of Cervical Microstructure Change in Normal Pregnancies Using Diffusion Basis Spectrum Imaging. Hansong Gao, Wenjie Wu, Zhexian Sun, Sicheng Wang, Zichao Wen, Qing Wang, Pamela K Woodard, Yong Wang. Washington University School of Medicine, St. Louis, MO, United States. Introduction: Cervical remodeling is key to the timing of birth. The cervical collagen fiber and hydration change dramatically from early pregnancy to late pregnancy. We use diffusion basis spectrum imaging (DBSI) to quantitatively measure the microstructural components change in cervical remodeling by characterizing the water diffusion property. Temporal differences in cervical remodeling were compared between normal early and late pregnancies. Methods: In each normal early (12-14 weeks' gestation) and late pregnancy group (36-38 weeks' gestation), ten healthy women underwent imaging on a 3.0 Tesla MRI scanner using a spin-echo sequence with 23-direction b value encoding. To compare the temporal difference, DBSI was performed on both the early and late pregnancy patients in both the subglandular and outer stromal regions. Conclusion: Our DBSI findings suggest that the microstructural compartments are significantly different in early and late pregnancies in the subglandular region, but insignificantly different in the outer stroma zone. DBSI can non-invasively quantify the change in microstructural components, suggesting that cervical collagen fiber disorganization and hydration increase in the subglandular region from early to late pregnancy. Sulforaphane Abrogates ROS Mediated Nrf2 Decrease in Mechanically Stretched Primary Amnion Cells. Justin G Padron †, Chelsea Saito-Reis, Claire E Kendal-Wright * . Chaminade University of Honolulu, Honolulu, HI, United States. Introduction: Nuclear-factor-E2-related factor 2 (Nrf2) is a key transcription factor for the regulation of cellular responses to cellular stress and its expression is significantly lower after spontaneous term labor in human fetal membranes. As the fetal membranes are known to stretch in vivo, and we have previously shown that total Nrf2 decreases with in vitro stretch, we sought to abrogate stretch mediated Nrf2 downregulation associated with cellular stress using the phytochemical sulforaphane. Methods: Human fetal membranes were collected at term repeat Cesarean section (with IRB approval) and primary amnion epithelial cells (AEC) isolated. Expression of Nrf2 in isolated AECs was confirmed using immunocytochemistry. AECs were grown on distensible silicon plates coated with collagen IV and subjected to 4 hrs of 20% stretch using a Flexcell-FX500TM tension system. Cells were treated with 0, 1, and 2 uM of Nrf2 activator sulforaphane during stretch. Cytoplasmic ROS production was quantified by DCF formation using OxiselectTM Intracellular ROS Assay Kit (Cell Bio Labs). Cytotoxicity as a result of mechanical stretch was quantified using the Pierce LDH Cytotoxicity Assay Kit (Abcam; Cambridge, MA, USA). Results: Robust expression of Nrf2 in AECs was confirmed using immunocytochemistry (n=3). 4 hrs of 20% of stretch increased ROS by 41.7% (n=5, p=.047). LDH activity was increased with stretch by 34.7% (n=5, p < 0.05). Nuclear Nrf2 was decreased by 39.2% (n=4, p < 0.05) with mechanical stretch, however 1uM sulforaphane treatment increased nuclear Nrf2 by 33.1% (n=4, p < 0.05) in the stretch treatment condition. Conclusion: As stretch forces have been postulated to contribute to fetal membrane weakening and Nuclear Nrf2 decreases with in vitro mechanical stretch; phytochemicals like sulforaphane may provide potential dietary therapeutics, to rescue the effects of the loss of this transcription factor in vivo. Nrf2 is known to have anti-inflammatory effects in several cell types including primary amnion cells, thus the manipulation of the activity of this transcription factor may be key to controlling inflammation during parturition. Determining the Role of Elastic Fibers on Cervical Contractility In Vivo and In Vitro. Cassandra K. Conway †, Kristin S. Miller * . Tulane University, New Orleans, LA, United States. Introduction: Cervical smooth muscle cells (cSMCs) work in coordination with the extracellular matrix (ECM) to perform normal reproductive function. However, the relationship between cSMC function and ECM structure and function remains unclear. Specifically, elastic fibers may interact with SMCs to maintain contractility [1] . Additionally, elastic fiber degeneration is associated with cervical pathologies [2] . Therefore, this study seeks to utilize Fibulin-5 haploinsufficient mice to determine the role of elastic fibers in cSMC function. Methods: A total of n=16 Fibulin-5 +/+ wildtype (WT) and Fibulin-5 +/haploinsufficient (HET) female mice at estrus aged 4-6 months were utilized for this study (Tulane IACUC Approved). To determine an appropriate pressure loading environment and in vivo contractile behavior, WT and HET (n=5/group) mice were anesthetized with isoflurane, a catheter placed transcervically, and measurements of pressure and contraction frequency were recorded. A separate cohort of mice (n=3/ group) were euthanized, the cervix isolated and cannulated within an inflation-extension device while submerged within aerated Kreb's Ringer Buffer at 37°C. At the physiologic length and the in vivo (mean±SD) pressure, biaxial maximum contraction was induced with 20mM KCl [3] . T-tests compared in vivo pressure and frequency measurements between genotypes. A 2-way ANOVA (Genotype, Pressure) compared changes in outer diameter and force with maximum contraction. Posthoc t-tests with Bonferroni correction were utilized where appropriate. Results: In vivo frequency of contractions increased (p<0.05) in the WT compared to the HET, however, baseline and contractile pressure did not significantly change with genotype. Maximum axial (p<0.001) and circumferential contractility (p<0.01) increased in the HET compared to the WT for all pressures. Conclusion: Fibulin-5 haploinsufficiency increased in vivo frequency of contractions and in vitro maximum circumferential and axial contractile potential. Contrastingly, axial contraction decreased within vaginal samples when exposed to elastase [4] . This may suggest a compensatory mechanism for contractile potential in the HET mouse through cSMC and elastic fiber remodeling. Therefore, further understanding the interplay between elastic fiber remodeling and cSMC function may inform normal and pathological cervical function. [1] Karnik et al., Development, 2003 Polarized Light Imaging of the Pregnant Cervix. Jessica Ramella-Roman * , Ilyas Saytashev †, Sudipta Saha †. Florida International University, Miami, FL, United States. Introduction: The current global level of preterm infants born every year is 15 million. Of these, about 1 million will die before the age of five due to complications that result from premature birth prior to 37 weeks of gestation. Many survivors will face life-long challenges including neurological disorders, long-term cognitive impairment, defects in hearing, vision and digestion, as well as respiratory disease. There is an absence of clinical tools for early and accurate detection of spontaneous preterm birth risk which limits our understanding of the pregnant cervix. Modalities such as Second Harmonic Generation (SHG) can visualize the cervix ultra structure but are costly and not easily applicable in human studies. Here we propose the use of polarized light imaging to monitoring the pregnant cervix. The main advantage of this approach is in its ease of translation to clinical use. Methods: We have developed an instrument that combines two polarization imaging techniques, Muller Matrix microscopy and Muller Matrix confocal polarimetry, and integrated these modalities into a Nonlinear Microscope (NLM). We utilize a femtosecond laser with a home-built laser scanning microscope. Reflected light at fundamental wavelength (700-900 nm) is separated from epi-detected TPEF/SHG by a short-pass dichroic mirror and directed to an output port by a beam splitter. Mueller Matrix Polarimetry imaging is enabled by an addition of a polarization state generator at the microscope input, and a polarization state analyzer before the camera. Mice cervices at different gestational time were imaged with this system. MMI and SHG is ultimately compared. Results: Our results show that the mouse cervix collagen anisotropy and directionality can be captured through Mueller Matrix imaging. These results are validated by co-registered Second Harmonic data collected simultaneously. The SHG data provides direct visualization of the collagen fibers while the pregnant cervix ultra-structure is correctly reconstructed by utilizing Mueller Matrix decomposition. Mueller matrix decomposition extracts constituent polarization properties from a Mueller matrix of any unknown complex system. The decomposition of the sample's Mueller matrix, yields three canonical matrices accounting for material depolarization MΔ; retardance, optical activity MR, and diattenuation MD. In this study, retardation and depolarization were used to localize area of compact collagen from area of loosely connected fibers. Conclusion: Our imaging systems can relay information about the cervix mechanical properties and structure by measuring birefringence and the general anisotropy of the tissue ultrastructure. Preliminary data on pregnant mice demonstrate that Mueller Matrix polarimetry is an effective technique for imaging the cervix. This modality has the advantage of being easily translatable to the clinical setting and in-vivo pilot studies in humans are underway. Methods to Quantify the Genetic Architecture of Cervical Length. Hope M Wolf †, 1 Roberto Romero * , 2 Jerome F Strauss, III * , 1 Sonia S Hassan * , 3 Shawn J Latendresse * , 4 Bradley T Webb * , 1 Aaron R Wolen * , 5 Adi L Tarca * , 3 Timothy P York * . 1 1 Virginia Commonwealth University School of Medicine, Richmond, VA, United States; 2 Eunice Kennedy Shriver National Institute of Child Health and Human Development, NIH, Rockville, MD, United States; 3 Wayne State University School of Medicine, Detroit, MI, United States; 4 Baylor University, Waco, TX, United States; 5 The University of Tennessee Health Science Center, Memphis, TN, United States. Introduction: A short cervix (cervical length < 25 mm) in the midtrimester (18 to 24 weeks) of pregnancy is a powerful predictor of preterm birth. Although the biological mechanisms of cervical change over the course of pregnancy have been the subject of extensive investigation, very little is known about the genetic architecture of cervical length, or the extent to which genetic factors contribute to premature cervical shortening. We have developed longitudinal models of cervical length change across pregnancy that, when combined with genomic data, can be used to estimate the heritability of cervical length and its genetic covariance with gestational age at birth. Methods: Latent growth curves were established to model cervical change for a large cohort of women with longitudinal assessments of cervical length across pregnancy. Cervical length was measured in millimeters using transvaginal ultrasound. Baseline cervical length was measured between 18 and 24 weeks of gestation, and 1 to 15 additional measurements were collected for each subject during follow-up. Demographic characteristics, including relevant medical history and birth outcome data, were collected for each subject. Gestational age at birth was measured from the first day of the woman's last menstrual period and confirmed by obstetrical ultrasound. Results: The latent growth curve describes cervical change as a function of time using two classes of parameters: intercept terms, which account for inter-individual variability in the baseline value of cervical length, and polynomial terms, which capture individual departures in the rate of change from the population mean. We describe how the parameters of the model can be combined with genomic and birth outcome data to make predictions about the genetic architecture of cervical change across pregnancy and its genetic relationship to spontaneous preterm birth. Conclusion: An estimate for the genetic contribution to cervical length and its role in mediating the timing of birth is essential to understanding the pathophysiology of spontaneous preterm birth. The methods we have developed will allow us to estimate the heritability of cervical length and its bivariate genetic correlation with gestational age at birth. Extensions of this model can be used to develop a polygenic risk score which could be applied in clinical practice to rapidly assess a patient's genetic risk for developing a short cervix and delivering preterm. Introduction: Oxytocin (OT) administration during labor is clinically challenging due to the decreased response seen with continuous exposure. This attenuation may result from oxytocin receptor (OXTR) desensitization, a process common to most G-protein coupled receptors (GPCRs), where an agonist-occupied receptor undergoes phosphorylation and temporary internalization. Prior studies have shown that following endocytosis, the OXTR recycles back to the cell surface via the endosomal recycling pathway. However, other GPCRs, in response to prolonged agonist exposure, are targeted for degradation. The objective of this study was to determine whether prolonged agonist stimulation leads to OXTR degradation. Methods: HEK-293 cells stably transfected with OXTR_GFP were pretreated with cycloheximide (CHX) to stop de novo protein synthesis and then treated with OT at different concentrations (10 -9 -10 -6 M) and durations (2-8hrs). Cells were pretreated with MG132 and PP-I for 30 minutes prior to OT exposure to inhibit the ubiquitin-proteasome degradation pathway. Protein content was quantitated by immunoblot. Confocal microscopy was used to determine colocalization between OXTR and lysosomes labeled with a LysoTracker probe. To detect OT-stimulated OXTR ubiquitination, OXTR_GFP was immunoprecipitated and probed with antibody to ubiquitin using standard immunoblotting techniques. Sitedirected mutagenesis was used to generate lysine-deficient OXTR mutants to additionally determine the role of ubiquitination in receptor trafficking. Results: In HEK-293 cells stably expressing OXTR_GFP, OXTR protein levels decreased significantly following treatment with 100nM OT for 6hr or longer in the presence of CHX, consistent with protein degradation (n=6, p<0.001). OXTR_GFP did not colocalize with LysoTracker following exposure to OT for up to 4 hrs, suggesting that the receptor is not targeted to the lysosomal compartment for degradation. Proteasome inhibitors MG132 and PP-I reversed the oxytocin-induced OXTR degradation. Additionally, OXTR_GFP ubiquitination was detected following 4 hour treatment with OT. Unlike the WT, protein expression of the lysine-deficient OXTR mutants OXTR-4K_GFP and OXTR-0k_GFP was not decreased following prolonged treatment with OT, further implicating receptor ubiquitination in receptor trafficking and proteasomal degradation. Conclusion: Our data suggest that the OXTR is degraded following prolonged agonist exposure in vitro. Additionally, we show that the receptor is not targeted to the lysosome, but rather ubiquitinated and targeted to the proteasome for degradation following prolonged exposure to OT. These results present a novel target for improving OT response in labor management to improve uterine contractility. A Patient-Specific Multi-Scale, Multi-Physics Simulation of Whole Uterine Contraction. Yiqi Lin †, 1 Jazmin Aguado-Sierra, 2 Zhexian Sun, 1 Constantine Butakoff, 3 Sicheng Wang, 1 Mariano Vazquez, 2 Yong Wang. 1 1 Washington University, St. Louis, MO, United States; 2 Barcelona Supercomputing Center, Barcelona, Spain; 3 Elem Biotech, S.L., Barcelona, Spain. Introduction: We employed the patient-specific anatomical and diffusion MRI data together with the uterine surface pacing to conduct an electro-mechanical coupled whole uterine contraction simulation. Our simulation system was built using the Alya platform, a numerical solver for coupled systems of partial differential equations discretized on unstructured meshes. Methods: We generated the body-uterus geometry and detailed uterus segmentation using patient-specific MRI data. A tetrahedral mesh was created on myometrium from the segmented image using ANSA software with at least 4 transmural elements to apply boundary conditions onto the exterior muscles. We refined and interpolated DTI-derived myometrium fiber orientation data to the meshed uterus geometry. Then, we built a electrophysiology model as a non-linear reaction-diffusion system that generates transmembrane potential based on the modified Fitzhugh Nagumo model. We coupled the electrophysiology simulation with the electro-mechanical contraction using excitation-contraction coupling model by Hunter-McCulloch. The whole process was simulated on Alya based on an automatic mesh partition. Results: Based on patient's MRI data, meshed uterus geometry and interpolated fiber orientation data were derived and shown in Fig. 1A and 1B. After a single stimulus paced in the fundus region, Fig. 1C shows the mechanical deformation in the fundus view. Fig. 1D shows the transmembrane potential propagation and the mechanical deformation from fundus to cervix. The electrical wave travels 38 seconds in this simulation. Under the similar simulation environment, we paced a second stimulus on the uterus side 0.5 second after the first pacing. Fig. 1E shows the propagation and interaction of two transmembrane potential waves, which merge together starting from the thirteenth second. The simulation takes around 3 hours to finish on a 48-cores server. Conclusion: Our system can reproduce the electrical and mechanical activation patterns of the whole uterine contraction using patient-specific data. It helps us better understand the underlying biology of human uterine contraction and potentially provide more clinical insight about the labor progression. We aim to use this system to conduct patient-specific diagnosis of dysfunctional labor, and optimize treatment plan by predicting patient's responses to candidate intervention or drugs. Contraction Synchronization Predicts the Onset of "True" Labor. Ponnila S Marinescu †, 1 Roger C Young, 2 David Adair, 3 Braxton Hern, 3 Eva K Pressman, 1 Neil S Seligman * . 1 1 University of Rochester, Rochester, NY, United States; 2 PreTeL, Inc., Chattanooga, TN, United States; 3 University of Tennessee College of Medicine, Chattanooga, TN, United States. Introduction: Global synchronization of uterine activity is necessary for labor, but little is known about how often synchronized contractions are expressed in "true" vs "false" labor. Contraction synchronization can be assessed using multichannel uterine electromyography (uEMG). Here, we use uEMG to compare the frequency of synchronized contractions among women who presented for evaluation of "true" versus "false" labor. Methods: Multi-center observational cohort study of women from 2 academic medical centers. Women with uncomplicated singleton pregnancies between 30w0d -42w0d and chief complaint of contractions were included. Those with cervical dilation < 2 cm and no further cervical change were in the "false" labor (FL) group, which was divided into < 36w0d and > 36w0d sub-groups. The "true" labor (TL) group was a comparison cohort of 6 term women with cervical exams > 2 cm and subsequent dilation. Primary outcome was number of synchronized contractions within a 10-minute period. Contractions were reported by toco. A 6-channel uEMG was performed using directional sensors for > 60 minutes and filtered between 0.15 and 1.2 Hz to isolate uterine signals. A computer algorithm identified contractions by uEMG and then assessed each channel for uEMG activity through the first 5-15 seconds of each toco-positive contraction. A contraction was "synchronized" if EMG activity occurred in > 50% of the channels. Results: 19 women were included, 6 in the TL group and 13 in the FL group. There were 5 in FL subgroup < 36 weeks and 8 in FL subgroup > 36 weeks. Ratios of the number of synchronized contractions to total contractions for each group are presented in Table 1 . The FL subgroups did not differ from one another (P = .28) but a higher frequency of synchronized contractions was observed in the TL group compared to the collective FL group (P = .0005). Additionally, the FL subgroups were individually different from the TL group (P = .003 for < 36 weeks; P = .0003 for > 36 weeks). Conclusion: Contraction synchronization is more frequent in "true" labor than in "false" labor, even when gestational age is considered. We hypothesize that transition to more synchronized contractions may be necessary for the onset of "true" labor. Future work will be required to determine the value of synchronization analysis as a prospective predictor for "true" labor. Introduction: Uterine contractility is regulated by the interaction of myogenic, neurogenic, and hormonal mechanisms. Labour (both term and preterm) is an inflammatory process. Factors affecting contractility of the inflamed uterus are not fully understood. The hormonal peptide somatostatin (SST) is significantly increased in human plasma during late pregnancy. SST mediates its effects by family of G-protein coupled receptors (SSTR1-5). Activation of SSTR2 mediates contractility of smooth muscle of the human gut and the non-pregnant pig uterus. We studied the presence of SSTR2 during gestation and term labour (TL) using human, non-human primate (NHP), and mouse uterine tissues. We also assessed SSTR2 expression in preterm human myometrium, a NHP model of (Group B Streptococcus)-induced preterm labour (PTL) and murine models of infectious (LPS-induced) and sterile (RU486-induced) PTL. Methods: Myometrial biopsies were collected from term and preterm labouring women undergoing emergency caesarean section (TL/PTL), preterm and term not in labour women undergoing elective caesarean section (PTNL/TNL) following informed consent (N=2-4/group). Primary myocytes were isolated by enzymatic digestion from TNL tissues. Mouse TL model: myometrial tissues were collected at gestation day (GD) 15, 18, 19/TNL, TL (N=4; term GD19.5). PTL models: intraperitoneal injection of LPS (50µg/dam) or subcutaneous injection of RU486 on GD15, sterile saline or corn oil used as vehicle (N=4/ group). Myometrial tissues were collected on GD16 during PTL. NHP PTL model: on GD117-125 chronically catheterized pregnant Macaca nemestrina received choriodecidual inoculations of either vehicle (saline, N=7) or GBS (5x10 8 colony forming units/ml; N=5), cesarean section was performed at PTL or 4 days after inoculation. Tissues were fixed in formalin for immunohistochemistry, or flash frozen; total RNA was extracted for RT-qPCR. Results: Immunostaining of human myometrium revealed strong SSTR2 protein expression by smooth muscle cells and resident macrophages; the presence of SSTR2 protein was increased in both, term and preterm labour, as compared to tissues from not in labour patients. Similarly, murine gestational tissues showed an increase in myometrial SSTR2 expression at term (GD19 and TL) as compared to GD15, and during PTL (LPS-and RU486-induced) compared to control animals. SSTR2 transcripts were detected in pregnant non-labouring NHP myometrium and in primary human myometrial cells, however, SSTR2 mRNA expression was not affected by GBS infection (NHP), or treatment with Lipopolysaccharide (primary human myocytes). Conclusion: SSTR2 transcripts and protein was detected in human, NHP and mouse myometrium. Expression of SSTR2 protein was associated with the infl ammatory process of labour. Mice. Junjie Bao, 1,2 Xiaofeng Ma, 1 Monali Wakle-Prabagaran, 1 Ronald McCarthy, 1 Sarah K England * . 1 1 Washington University School of Medicine, St. Louis, MO, United States; 2 Guangzhou Women & Children's Medical Center, Guangzhou Medical University, Guangzhou, China. Introduction: Uterine activation arises in response to the electrical activity of the smooth muscle cells of the myometrium. BK Ca channels, as one of the most abundant potassium channels in the myometrium, are implicated to play an essential role in uterine contraction. However, it remains controversial and elusive if and how BK Ca channels are involved in basal versus infl ammatory states of the uterus. Here we investigated the role of the BK Ca channel in spontaneous and LPS-stimulated uterine contraction in vitro, to better understand the relationships between BK Ca channels and uterine contractile activity. Methods: Female C57BL/6J mice were paired with a male for 2 h, those that developed a copulatory plug were designated as gestation day (GD) 0 of pregnancy. Mice uterine samples were collected on GD18.5. A subset of samples were embedded in paraffi n and detected for the expression of BK Ca with immunofl uorescence microscopy. The others were dissected to obtain 4 x 8 mm strips of longitudinal muscle, and mounted onto force transducers in organ baths. Primary myocytes were also isolated and channel activity measured and analyzed for open-state probability (P o ) using pCLAMP software. All the data were normalized for comparison. Statistical comparisons were performed using Student's t test (two groups), or one-way ANOVA (three or more groups) with appropriate post hoc tests. Results: The BK Ca channel expressed in the myometrium of pregnant C57BL/6J mice at GD 18.5. Tension recording results showed that LPS increased the area under the curve (AUC) and the amplitude of contraction (p<0.05). While blocking BK Ca channels with paxilline decreased both spontaneous and LPS-stimulated uterine contractions (p<0.05). Patchclamp results showed that LPS markedly increased P o of mice MSMCs at a holding potential of 60 mV (0.00011±0.00006 vs 0.26570±0.05796, Baseline vs LPS, p<0.05), while paxilline decreased P o gradually and reached maximal eff ect in 15 min [0.26570±0.05796 vs 0.15210±0.08756 vs 0.02134 ± 0.01259 vs 0.00304 ± 0.00167, LPS vs LPS + Pax (0-1 min) vs LPS + Pax (4-5 min) vs LPS + Pax (14-15 min), p<0.05]. Furthermore, LPS could not increase P o with pre-treatment of paxilline as usual (LPS alone) (p>0.05). Conclusion: BK Ca channels are deeply involved in both basal and LPSstimulated uterine contraction in pregnant mice. Further elucidation of the mechanisms may provide new insights into potential strategies to regulate uterine contraction. The Anisotropic Mechanical Properties of Human Uterus. Shuyang Fang, 1 The mechanical function of the uterus is critical for a successful pregnancy. It is hypothesized the magnitude of uterine tissue stretch triggers the onset of contractions. Using imaging, mechanical test, and computational modeling, we investigate how the tissue's fi ber distribution and material properties impact its mechanical responses to loadings. Methods: We collected 27 specimens from a non-pregnant (NP) and a pregnant (PG) patient through the uterine wall thickness at 3 anatomical locations: anterior, fundus, and posterior (Fig.1ac) . We used optical coherence tomography and von Mises fi tting to characterize fi ber (collagen and SMC) distributions. We used spherical indentation and uniaxial tension to test its mechanical behavior under various loading conditions. We modeled the tissue as a fi brous network embedded in a compressive ground substance and fi tted this model to the experimental data using an iterative optimization to uncover the tissue's material properties. Results: Fiber distributions are signifi cantly diff erent between the NP and PG tissue, both are anisotropic (Fig.1a-d) . The best-fi t material parameters under indentation are averaged and listed in Table 1 and plotted in Fig.1e . Heterogeneous mechanical properties are seen in human uterine tissue at diff erent anatomical locations and across diff erent uterine wall layers (Fig.1fg) Conclusion: PG fi bers are more dispersed than NP fi bers (Fig.1d) . NP fi bers exhibit a circularly arranged, meanwhile, basket-interweaving architecture (Fig.1a) . PG fi bers exhibit a longitudinally or meridionally arranged architecture (Fig.1c) as the uterus undergoes a 6-fold increase in length during pregnancy. NP tissue, on average, is less compressible than PG tissue, but the diff erence is not signifi cant. The force response of the human uterus under all loading conditions is time-dependent and nonlinear, and uterine fi ber architecture dictates 2-D principal strain fi elds. Human uterine tissue also shows heterogeneous mechanical properties at diff erent locations. Critical Steroid-Target Genes. Ariel J Dotts †, Ping Yin * , William A Grobman * , Serdar E Bulun * . Northwestern University, Chicago, IL, United States. Introduction: Preterm birth is the leading cause of infant morbidity worldwide. Approximately 380,000 babies are born prematurely in the USA every year. Estrogen (E2) and progesterone (P4) play important roles during pregnancy and labor, but a clear understanding of the underlying mechanisms is lacking. E2 and P4 function by activating their cognate nuclear receptors ESR1 and PGR, respectively, to aff ect their binding to regulatory regions of target genes and control their transcription. Here, we sought to identify steroid hormone target genes and pathways critical for myometrial quiescence and contraction. Elucidating the molecular mechanisms whereby the myometrium transforms from a quiescent to a contractile state would fill an important evidence gap and be beneficial in advancing treatment for the prevention of preterm birth. Methods: We performed RNA-seq using human myometrial tissue biopsies obtained at cesarean delivery from pregnant women at term who were not in labor (TNIL; n=7) and women at term who were in labor (TIL; n=4). ChIP-seq for active histone modification marks (H3K27ac and H3K4me3) and ESR1 and PGR were conducted on myometrial tissues of TNIL and TIL (n=3 subjects for each factor). Results: Principal component assay of RNA-seq data distinguished the TNIL and TIL transcriptomes as two distinct clusters. Over 1600 genes were differentially expressed between TIL and TNIL tissues (FDR <0.05), with 799 (57%) upregulated and 610 (43%) downregulated in TIL tissues. Pathway analysis of these differentially expressed genes uncovered that genes and pathways key for labor were significantly enriched for those related to the acute inflammatory response and positive regulation of cytokine-mediated signaling pathway. ChIP-seq for ESR1 and PGR revealed common or unique genomic regions occupied by each transcription factor in TNIL and TIL myometrial samples. Genes associated with these regions were enriched in pathways similar to those identified in RNA-seq analysis, suggesting that ESR1 and PGR, via interaction with their target genomic loci, directly mediate the expression of genes associated with myometrial function. Integrative analysis of RNA-seq and ChIP-seq data of hormone receptors and histone marks uncovered ESR1/PGR downstream target genes potentially regulating myometrial contraction and labor. We are currently further characterizing the functions of these genes. Conclusion: ChIP-seq and RNA-seq data identified steroid hormone receptor target genes that are actively regulated during labor. These genes and pathways may serve as potential therapeutic targets to prevent preterm birth. Introduction: Uterine electromyography (uEMG) has been used in the assessment of myometrial contractile activity. Historical methods were based on propagation velocity or power spectrum amplitude and frequency analyses. Newly discovered uEMG signals, however, have enriched our understanding of the bioelectric relationship with myometrial activation. Here, we present these novel uEMG signals and their possible clinical correlates. Methods: Prospective observational study of women with singleton pregnancies between 16w0d-22w6d (mid-trimester analysis) and between 30w0d-42w0d (preterm-term analysis); women in the latter group were evaluated on Labor and Delivery for contractions. Four to seven-channel uEMG recordings were obtained using directional EMG sensors for > 30 minutes. Uterine signals were isolated using a bandpass filter between 0.15 and 1.2 Hz. Results: We identified four novel uterine EMG signals in addition to the previously identified "contraction associated signals"; criteria for each are shown in Table 1 . These new signaling patterns are independent of tocodynamometry (toco)-observed contractions and are distinct from one another, although some (e.g., spike-like signals) fall on a continuum with larger patterns (e.g., fasciculation-like signals). Each pattern is associated with a unique clinical implication. Spike-and burst-like signals were observed in mid-trimester patients; however, these women did not have recorded contractions, and therefore, the presence of other signals in the mid-trimester cannot be excluded. Conclusion: Discovery of novel uterine bioelectrical signaling patterns has enriched our understanding of uterine contractility and myometrial activation. Future work should focus on the overarching goal of correlating the relationships among these, and other undiscovered bio-signals, with specific clinical applications. Introduction: A fine uterine contraction can decide how successful a delivery goes. With every contraction narrowing the vessels that transport oxygen, the womb is challenged with hypoxia, leading to uterine hypoxic stress in which has been shown that hypoxia-induced factor (HIF) plays a crucial role. Our work aims at defining how HIF modulates the myometrial contractility so as to explore the potential targets for improving parturition. Methods: 6 pieces of myometrium tissues were collected from women undergoing caesarean section (3 of labor and 3 of non-labor). Western blot was performed to analyze the protein level of HIF-1α, HIF-2α and oxytocin receptor in myometrium. In addition, primary uterine smooth muscle cells were cultured and divided into 3 groups: C (control), H (hypoxia for 2h with 3%O 2 ) and I (HIF-1α inhibitor 2-MeOE2 treatment before and during hypoxia). Cells were harvested after hypoxia. Western blot was run for the expression of HIF-1α, HIF-2α and oxytocin receptor. Results: For laboring myometrial tissues, HIF-1α, and oxytocin receptor showed significantly higher expression than those in non-labor. And the expression of HIF-2α was opposite to the result of HIF-1α. Additionally in cellular experiment, group Η showed the highest expression of HIF-1α whereas it could barely be detected in either group C or group Ι. Meanwhile, the expression of oxytocin receptor was significantly higher in group H. However, the expression of HIF-2α in laboring myometrium was dramatically lower whereas it showed no differences among groups of cells. Conclusion: Hypoxic stress is one of the cause of triggering labor as HIF-1α may be the key factor in this process. Furthermore, HIF-1α is likely to strengthen the myometrial contractility via upregulating oxytocin receptor. Contractions are the decisive factor in childbirth, and energy is needed to maintain effective contractions, but the exact mechanism is unclear. In the exploration of the mechanism of contractions during labor, uterine smooth muscle HIF-1α is increased under postpartum hypoxia stress. There are indications that induction of HIFs could directly affect the EV biogenesis pathways involving RABs. Ras proteins are small GTPases of the Ras GTPase superfamily, which regulate vesicle transport pathways. Rab protein is involved in autophagy by controlling the fusion and transport of autophagosomes and is an important organizer of the membrane between autophagosomes and endosomal compartment. However, its effect on lipid metabolism in muscle cells is still unclear. Here, we investigate the promotive role of HIF-α in uterine smooth muscle autophagy and its basis. Methods: HIF-α activation promotes mitochondrial function by promoting autophagy in human uterine muscle or in vitro primary uterine smooth muscle cell models in labor and nonlabor.The uterine muscle transcriptome data enriched the gene set related to "autophagy". Autophagy flux was significantly increased in uterine myocytes with HIFα gene in labor. Mechanically, HIF-α inhibited RAB7B, which is responsible for the formation of autophagosomes and autosomes, by inducing miR-17-3P_R+1. Results: Chromatin immunoprecipitation assay enabled us to identify HIF-α as a transcription factor for miR-17-3P_R+1. In addition, the 3'UTR luciferase assay confirmed the direct inhibition of miR-17-3P_R+1 on RAB7B. Concordantly, HIF-α activation or miR-17-3P_R+1 transfection increased mitochondrial oxygen consumption and mitochondrial transmembrane potential and played a role in contractions energy support. In conclusion, we demonstrate for the first time that peripartum HIF-1α inhibits RAB7B via transcriptional induction of miR-17-3P_R+1. Depletion of RAB7B increases autophagic flux as indicated by the increased size of autophagic structures as well as the magnitude of macroautophagic sequestration and degradation. In addition, we found that regulation of lipid homeostasis during contractions and the molecular linkage between miRNAs and key molecules control autophagy and its coupled fuel oxidation in mitochondria. Therefore, this pathway provides a therapeutic target for contractions regulation and a theoretical basis for targeted energy supplementation during labor. Introduction: Endometriosis deleteriously impacts patients' quality of life with common symptoms being pain, abnormal uterine bleeding, and infertility. Given the wide range of surgical disease load that is poorly correlated to clinical pelvic pain symptoms, we hypothesize that the specific neurogenesis of pain neurons in endometriosis tissue correlates with phenotypic variability of pain. In this study, we aim to [1] investigate patient-specific neuronal growth in endometriotic tissue and [2] correlate these findings with self-reported preoperative quality of life (QOL) questionnaires. Methods: Patients with a clinical diagnosis of endometriosis were consented for this study and asked to complete the World-Endometriosis Research Foundation (WERF) Quality of Life (QOL) questionnaire. Patients underwent operative laparoscopy with excision of endometriosis and endometriomas as well as an endometrial biopsy for eutopic tissue. These samples were processed for immunohistochemistry (IHC), RT-PCR, and qPCR. Tissue from patients 30 years or older with the highest reported pain scores (greater than 7 out of a 10 point scale) were evaluated for varying expression levels of pain markers and nerve markers. Results: [1] A qualitative IHC analysis of neuronal markers reveals greater expression in eutopic endometrial tissue relative to endometriomas, whereas greater expression of pain-specific neuronal markers was observed in endometriomas compared to eutopic endometrial tissue. [2] The differential IHC expression of pain-specific neuronal markers between eutopic endometrium and endometriomas was further validated using Qt-PCR, which demonstrated an increased expression of the genes for the pain neuronal markers, Tyrosine hydroxylase (fold change=7), Tropomyosin receptor kinase A (fold change=4), and Neural cell adhesion molecule (fold change=4). Conclusion: These preliminary data suggest patient-and tissue-specific expression patterns for pain neurons, which may in part explain variability of pelvic pain symptoms. These findings provide exciting opportunities to establish patient-specific pelvic pain therapies. This translational approach offers insight into the development and progression of the disease, leading to advances in the field of Precision Medicine. Endometriosis. Valerie Flores †, Cagdas Sahin, Hugh S Taylor * . Yale School of Medicine, New Haven, CT, United States. Introduction: Endometriosis is a debilitating, gynecologic disease affecting 10% of reproductive-aged women. Response to medical therapy is variable as lesions do not consistently respond to first-line, progestinbased therapy. We showed in a retrospective study that progesterone receptor (PR) status in lesions can predict response to progestins. Low PR status was associated with a 6% chance of response, suggesting some women may benefit from alternative hormonal therapy as first-line. Here, we utilize patient-derived xenograft (PDX) murine models to test human endometriotic lesion response to GnRH antagonist, compared to endogenous progesterone (P4) exposure or medroxyprogesterone acetate (MPA). We aimed to test the ability of PR status to predict response to different hormonal therapies, as this could allow for individualized treatment of endometriosis. Methods: 8wk old NOD/SCID mice underwent transplantation of endometrioma lesions (5mm) collected from women undergoing surgery for endometriosis. Mice were not ovariectomized. IHC was performed to determine PR expression in lesions. The Histo-Score was used to quantify PR status as High or Low as previously described. Two wks following transplantation, mice underwent daily subq injections with vehicle (DMSO), MPA (50ug), or Cetrotide (100ug); n=6-9 lesions per group. After 1 month of treatment mice were sacrificed, lesions collected, and measured. Welch's t-test used for statistical analysis. Results: Lesions with high PR showed near-complete response to P4 or MPA compared to lesions with low PR (p= 0.01). Avg post-treatment size in high PR lesions was 4.7mm 3 compared to 35mm 3 in low PR lesions. High PR lesions responded completely to Cetrotide (i.e., 0 mm) (p= 0.009). Lesions with low PR responded poorly to P4 or MPA. The low PR lesions also had a lower response to Cetrotide when compared to high PR lesions, showing only a 50% decrease in size with Cetrotide compared to complete regression of high PR lesions. Overall, lesions with low PR showed more aggressive growth and resistance to multiple treatments compared to those with high PR. Conclusion: Use of PDX models to test clinical response is a novel approach to endometriosis. We have previously shown that women with low PR lesions respond poorly to progestins. Here we validate our prior work in a mouse xenograft model by prospectively showing that lesions with low PR expression do not respond to progestin-based therapy. We show that lesions with low PR have a better response to antagonist therapy, with a more than 2-fold decrease compared to treatment with P4 or MPA; we expect this response remains clinically meaningful for patients. However these results demonstrate a distinct behavior of lesions with low PR that extends beyond progesterone resistance. The use of murine avatars can allow clinicians to predict an individual's response to therapy, avoid trialing futile treatments, and allow a precision medicine approach to endometriosis. We set out to identify new treatment targets in endometriosis, and to test candidate targets in vitro and in vivo using suitable inhibitors. We have conducted genetic analyses in human family-and population-based studies complemented by a study of large-pedigree of rhesus macaque with endometriosis to identify novel rare and common associations in NPSR1. We investigated functional effects of NPSR1 in vitro and in vivo including laboratory inhibition experiments and endometriosis mouse models. Methods: Germ-line sequencing of 32-families with 3+ endometriosis cases was complemented by association analyses in 3194 cases and 7060 controls, and linkage/sequencing of 849 rhesus macaques with endometriosis. Laboratory analyses were conducted on relevant patient tissues. Target inhibition was performed in cell-based assays and in endometriosis mouse models including pain readouts. Results: Family-based sequencing revealed significant over-representation of predicted deleterious rare coding variants in NPSR1 in endometriosis cases vs. controls (P=7.8x10 -4 ), involving three missense variants: novel C7_34698148, rs34705969 and rs116825950. Association analysis also revealed a common insertion/deletion variant, rs142885915, associated with stage III/IV endometriosis (P=5.15x10 -5 , Odds Ratio=1.23, 95% Confidence Interval=1.09-1.39). NPSR1 was expressed in glandular epithelium from eutopic and ectopic endometrium, and on immune cells in peritoneal fluid, in particular monocytes from endometriosis cases. The NPSR1 inhibitor, SHA 68R reduced NPSR1 mediated Ca2 + and cAMP signalling, pro-inflammatory TNF-α release and monocyte chemotaxis in vitro (P<0.01), and in endometriosis models in vivo, with significant reductions of inflammatory cell infiltrate and abdominal pain observed (P<0.05). Conclusion: Genetic variants in NPSR1 are associated with endometriosis, and NPSR1 inhibition in relevant inflammatory pain models is consistent with a functional role of NPSR1 in endometriosis. The receptor presents a new non-hormonal target for the treatment of endometriosis. Immune While the pathogenesis of EMS remains unknown, the theory of retrograde menstruation is widely accepted. This theory suggests that menstrual effluent is refluxed into the peritoneal cavity where it adheres to peritoneal structures and develops into an endometriotic lesion. Therefore, the analysis of menstrual effluent (ME) can provide insights into the early time points of the pathogenesis of EMS. Here, we analyzed ME from EMS patients and healthy, fertile donors (HD) to further understand the role of immune dysfunction in the pathogenesis of EMS. Methods: ME was collected using a menstrual cup from HD (n=12) and from surgically confirmed EMS patients(n=12). Serum was extracted from ME. ME serum underwent multiplex cytokine analysis (Eve Technologies, Alberta, Canada). CD45 + cells were separated using cell sorting and underwent the EasySep dead cell remover (STEMCELL). CD45 + cells underwent flow cytometric analysis to identify T helper 17 cells (CD4 + CD3 + CCR6 + IL-17A + ), regulatory T cells (CD4 + CD3 + CCR6 -CD25 + Foxp3 + ), macrophages(CD11b + CD14 + CD68 + ), and neutrophils (CD11b + CD14 -CD16 + CD66b + ). Non-parametric student's t-test with Mann-Whitney correction was used to test for significance. With the remaining CD45 + cells, total RNA was extracted, and normalized to 20ng/ ul. The RNA was analyzed using Nanostring nCounter® and nCounter® Digital Analyzer by means of nCounter® Human PanCancer Immune Panel. Resultant RCC files were uploaded to the ROSALIND software and advanced analysis took place, as per manufacturer instructions. Results: ME serum from EMS had significantly elevated IL-1a compared to HD. EMS patients had significantly fewer T H 17 cells in the ME compared to HD and while not significant, T REG cells were increased in EMS patients compared to HD. Macrophages and neutrophils did not show significant differences between EMS and HD. Transcriptomic profiling revealed 20 differentially expressed (DE) genes in the ME CD45 + cells of EMS compared to HD. 19 DE genes were significantly decreased in EMS patients and many of these decreased DE genes were associated with the T H 17 axis including Rora, IL23A, and IL6. Conclusion: For the first time, we show that ME from EMS patients display drastic immune dysfunction compared to HD: specifically a decrease in the T H 17 axis. Therefore, this study highlights the T H 17 axis as an important area for future research in the pathogenesis and therapeutics of EMS. Introduction: Endometriosis is a gynecological inflammatory disease associated with severe pain and infertility. The most accepted theory for its pathophysiology is Sampson's theory of retrograde menstruation and subsequent lesion growth. Reports suggest that peritoneal mesothelial cells (PMCs) of the mesothelial lining have to be altered to enable lesion establishment, similar to PMCs in cancer metastasis. Peritoneal fluid (PF) from endometriosis patients has been shown to alter PMCs, but the active constituent remains unknown. We hypothesize the effect to be mediated by PF-derived exosomes and compared the effect of PF and PF-derived exosomes from endometriosis patients on PMCs in a pilot study. Methods: PF samples were obtained from Stage I/II endometriosis (n=3) and non-endometriosis (n=3) patients of varying menstrual phases undergoing surgery at the John Radcliffe Hospital, Oxford, United Kingdom and processed using size-exclusion chromatography. Exosomes from all samples were characterised by Nanoparticle-Tracking Analysis. Primary LP-9 and immortalised MeT-5A mesothelial cell lines were exposed to PF and exosomes from each patient. The effects were confirmed by bright-field microscopy and quantified using a FITC-dextran cell permeability assay. Results were compared using paired t-tests. Results: Exosomes were successfully isolated from PF from endometriosis and non-endometriosis patients. There were no significant differences (p > 0.05) in concentration and size of PF-derived exosomes from both groups. Following exposure to PF and isolated exosomes from endometriosis and non-endometriosis samples, it was observed by bright-field microscopy that isolated exosomes from both groups induced changes in LP-9 cell morphology, resembling retraction and gap formation, while PF with exosomes exhibited a stimulating effect on LP-9 growth. As quantified by the FITC-dextran cell permeability assay, PMCs exposed to samples from endometriosis patients experienced gap formation and an increase in permeability as judged by higher fluorescence levels, but these levels did not significantly differ (p > 0.05) from those induced by non-endometriosis samples. Conclusion: PF and PF-derived exosomes from endometriosis patients potentially have distinct functional effects on PMCs. Further investigation is needed to elucidate the roles of exosomes and other PF constituents in endometriosis. Collagen Little is known about its pathogenesis, which is partially due to a lack of suitable experimental models. Here, we use endometrial stromal (St-T1b), primary endometriotic stromal, epithelial endometriotic (12Z) and co-culture (1:1 St-T1b:12Z) spheroids to mimic the architecture of endometrium, and either collagen I or Matrigel to model ectopic locations. In vitro study on the immortalized epithelial endometriotic cell line 12Z, the immortalized stroma cell line ST-T1b and primary ectopic endometriotic stroma cells. Cells were cultured using the hanging drop method prior to 3D culture on collagen I or matrigel, and subjected to treatment with pharmacological inhibitors and microRNAs. Cells were observed by conventional and immunofluorescence microscopy. Results: Stromal spheroids, but not single cells, assumed coordinated directional migration followed by matrix remodeling of collagen I on day 5 or 7, resembling ectopic lesions. While generally higher area fold increase of spheroids occurred on collagen I compared to Matrigel, directional migration was not observed in co-culture or in 12Z cells. The fold increase in area on collagen I was significantly reduced by MMP inhibition in stromal but not 12Z cells. Inhibiting ROCK signalling responsible for actomyosin contraction increased the fold increase of area and metabolic activity compared to untreated controls on Matrigel. The number of protrusions emanating from 12Z spheroids on Matrigel was decreased by microRNA miR-200b and increased by miR-145. Conclusion: This study demonstrates that spheroid assay is a promising pre-clinical tool that can be used to evaluate small molecule drugs and microRNA-based therapeutics for endometriosis. Introduction: Adenomyosis is defined as the existence of endometrial tissue in myometrium and manifested by menorrhagia and dysmenorrhea with defective endometrial receptivity. Although various classifications are used to describe the extensiveness of adenomyosis, all are relatively subjective and inconsistent among different examiners. Thus, this study aimed to generate an algorithm for recognizing and quantifying the lesions that will provide more objective communication among examiners. Since TGF-β1 plays a crucial role in the pathogenesis of adenomyosis, the effects of anti-TGF-β1 on adenomyosis formation in a mouse model was used to validate the algorithm. Methods: Adenomyosis in mice was induced by injecting tamoxifen (1 μg/gm body weight) in the first four postnatal days (PNDs). At PND42, anti-TGF-β1 (10 μg) or ddH2O was injected into left or right uterine horn, respectively. Uteri were collected at PND64 for H & E staining. Deep computer learning using convolutional neural network (CNN), leaky rectified linear unit (ReLU) and dense atrous spatial pyramid pooling (DASPP) was used to establish the algorithm for identifying the lesions. The accuracy of the algorithm was tested by mean intersection over union (mIOU). The quantification of the lesions was established using four parameters, including distance ratio, area index, skeleton ratio and shape index ratio. Results: The computer successfully detected adenomyotic lesions and showed that anti-TGF-β1 significantly reduced their development. A software was generated for the quantification of adenomyotic lesions. Conclusion: Deep computer learning is proven feasible for the quantification of adenomyotic lesions. The information gathered in this study will be used to further develop an algorithm for human tissues. Currently, the number of models is limited and there are no murine cell lines available, although these cell lines would be of great value for endometriosis research, both in vitro and in vivo research. Therefore, we immortalized murine uterine stromal and epithelial cells in this study. Methods: Uteri from 9-week old C57Bl/6J mice were harvested and dissociated using the GentleMACS (Milteny Biotech). Murine uterine epithelial cells were selected using magnetically labelled EpCAM beads and stromal cells were collected in the flow-through. The isolated cells were cultured on Matrigel coated plates. After passaging, the cells were immortalized by transduction with retrovirus containing SV40/large T. Next, growth conditions were optimized, and the created cell lines validated by Western Blot, Immunofluorescence and RNA-sequencing. The cells have currently been in culture for 19 passages, and they have been keeping their respective stromal or epithelial appearance. Additionally, the cells have shown to be able to withstand the freezing and thawing process. Western blot and Immunofluorescence showed that the epithelial cells expressed E-cadherin, N-cadherin, Vimentin and Estrogenreceptor alpha. The stromal cells also showed expression of N-cadherin and Vimentin. RNA-sequencing indicated high expression of cytokeratins and cadherins in the epithelial cells. Additionally, these cells showed a high expression of genes in the PI3K-Akt signaling pathway. Pathway enrichment analysis indicated that the actin cytoskeleton-, extracellular matrix-, and regulation of cell adhesion-pathways were enriched in the epithelial cells. Conclusion: In this study, stromal and epithelial cell lines were successfully created from murine uterine tissue. The results of the Western blot, immunofluorescence and RNA-sequencing validated the epithelial characteristics of the created cell lines. In the future, these cell lines can be used for in vitro experiments, but also for inducing endometriosis in mice. These created cell lines have the advantage that it will be very easy to study the influence of certain genes on the development and progression of endometriosis in an animal model by using CRISPR techniques to knock out genes of interest in the cells before introducing endometriosis in the animals. The clinical diagnosis of endometriosis is often delayed 8 to 10 years after the onset of symptoms due to the lack of a reliable non-invasive diagnostic test. In recent years, a number of research studies have reported using microRNAs (miRNAs) as potential non-invasive biomarkers for diagnosing endometriosis. As miRNAs regulate gene expression, we hypothesized that a systematic review of differentially expressed miRNAs in endometriosis might identify candidate markers for further study. Methods: A systematic search of PubMed and EMBASE was conducted from January 2007 to July 2, 2019. Search keywords included "endometriosis", "microRNA", "miRNA", and "biomarkers". Using PRISMA guidelines, abstracts and later full-text articles were selected for review if they evaluated the roles of microRNAs in endometriosis. The differential expression of miRNAs in endometriosis and their potential as biomarkers of endometriosis from relevant published studies were synthesized and discussed. Results: Out of 210 studies identified, 28 met our inclusion criteria. The differential expression of miR-9, -34, -29c, -135, and let-7 were found to contribute to the pathogenesis of endometriosis through progesterone resistance and dysregulation of the cell cycle. Aberrant levels of miR-145, -141, -200b, -126-5p were found to be related to the proliferation, migration, and invasion of endometriotic cells. Dysregulation of miR-17-5p, -20a, -22, -449b-3p are hypothesized to affect the expression of angiogenic factors in endometriotic tissue. Furthermore, miRNAs let-7b and miR-342-3p were thought to contribute to the lipid dysfunction and thus lower BMI phenotype commonly observed in endometriosis patients. Several miRNAs in serum, including the let-7 family, miR-145, and miR-199a, emerged as potential diagnostic biomarkers for endometriosis. This study provides a foundation of candidate microRNAs that offer diagnostic utility. Additional functional and validation studies are needed to establish the external and internal validity of microRNAs as biomarkers and to better understand their role in pathoetiology of endometriosis. The G Protein-Coupled Receptor 55 (GPR55) as Putative Target for the Treatment of Endometriosis. Frank Sacher * , 1 Gernot Langer * , 1 Bernd Bojahr * , 2 Martin Fritsch * , 1 René Wenzl * , 3 Thomas M Zollner * , 1 Maik Obendorf * , 1 Jens Nagel * . 1 1 Bayer AG, Berlin, Germany; 2 MIC, Berlin, Germany; 3 Medical University of Vienna, Vienna, Austria. Introduction: The G-protein coupled receptor GPR55 binds and becomes activated by the phospholipid lysophosphatidylinositol (LPI), is expressed on pro-inflammatory macrophages and NK cells, endometrial cells and sensory neurons Methods: First, we study GPR55 expression in eutopic and ectopic endometrium as well as LPI levels in the peritoneal lavage of endometriosis patients and controls. Furthermore, we study the effect of the GPR55 agonist LPI in various in vitro and in vivo inflammatory models. Finally, we characterized the link between GRP55 and inflammatory pain in experimental models including an endometrial explant and an in vivo model of mechanical allodynia Results: Our results indicate that GPR55 is expressed in endometriosis lesions and that the endogenous agonist LPI is slightly increased within endometriosis patients. Furthermore, GPR55 agonist LPI induces the secretion of pro-inflammatory cytokines and ERK1/2 phosphorylation in human endometrial explants. Injection of LPI into the skin resulted in the formation of skin edema as sign of induced inflammation; this effect could be blocked by co-application of the anti-inflammatory drug dexamethasone. Finally, injection of LPI into the paw of mice induced mechanical allodynia as effective as the injection of Zymosan Conclusion: GPR55 is a pro-inflammatory receptor involved in inflammatory response to LPI. The results of the inflammatory in vitro and in vivo models suggesting therapeutic benefit of GPR55 antagonists in inflammatory conditions such as endometriosis Afrin †, Mostafa Borahay * . Johns Hopkins University, Baltimore, MD, United States. Introduction: Uterine leiomyomas (UL) are the most common tumors in the female reproductive tract. The Wnt/β-catenin pathway is a conserved pathway implicated in proliferation, differentiation and stem cell renewal. Wnt ligand binds to frizzled receptor (FZD) and its co-receptor, LRP5, resulting in the release of β-catenin from its destruction complex. β-catenin translocates to the nucleus where it alters gene expression. Several proteins in this pathway are upregulated in leiomyomas, and it was shown to be implicated in the paracrine signaling between UL stem cells and surrounding mature cells. Simvastatin is used to treat hypercholesterolemia but has promising effects as a treatment for UL as it was shown to induce apoptosis, reduce proliferation, and alter extracellular matrix deposition. The aim of this work is to check the effect of simvastatin on the Wnt/β-catenin pathway. Methods: Primary and immortalized leiomyoma (HuLM) cells were treated with simvastatin (1 µM) for 48 hours. The effect of simvastatin on the expression of several mRNA and proteins in the Wnt/β-catenin pathway was examined using RT-qPCR and western blot, respectively. Since β-catenin translocates to the nucleus, we performed subcellular fractionation to isolate nuclear protein. Leiomyoma cells were stained with anti-Wnt4, anti-total-β-catenin, and anti-non-phosphorylated-β-catenin for immunocytochemistry. Immunohistochemistry was done on human tissue collected from the clinical trial to test the effect of simvastatin on uterine leiomyoma (NCT03400826). The student's t-test was used to determine statistically significant differences (P<0.05). Results: Simvastatin significantly reduced the mRNA expression of Wnt5a in primary leiomyoma tissue by 47% and the protein expression of Wnt4 by 57% in HuLM cells. Simvastatin also reduced the protein expression of the co-receptor LRP5 by 78%. Total and nuclear β-catenin were reduced after simvastatin treatment by 49% and 43%, respectively. These results were also confirmed through immunocytochemistry with a decrease in the expression of Wnt4, total β-catenin, and non-phosphorylated-β-catenin, the active form of β-catenin, in both HuLM and primary cells. Moreover, simvastatin reduced the estrogen and progesterone's induced increase in protein expression of Wnt4, total β-catenin, and non-phosphorylated-βcatenin seen with immunocytochemistry. c-Myc, a downstream target of the Wnt/β-catenin pathway, was also affected by simvastatin treatment with a 51% decrease in its mRNA expression in HuLM cells. The effect of simvastatin on the Wnt/β-catenin pathway was confirmed using human tissue a decrease in non-phosphorylated-β-catenin after simvastatin treatment for 12 weeks. Conclusion: We conclude that simvastatin may have a therapeutic impact on UL through suppression of the Wnt/β-catenin pathway. Integrative Cistrome and Transcriptome Analysis Identifies Tryptophan-Kynurenine-AHR Pathway as a Novel Regulator of Leiomyoma Growth. Azna Zuberi †. Northwestern University, Feinberg School of Medicine, Chicago, IL, United States. Introduction: Uterine leiomyoma (LM) is the most common tumor in reproductive age women. Two distinct subtypes, one with MED12 mutation (mut-MED12) and the other with HMGA2 rearrangement (re-HMGA2), comprise 85% of all LM. Estrogen and progesterone, via their receptors ESR1 and PGR, play key roles in LM growth. Here, we aimed to identify hormone-dependent genes and pathways dysregulated by distinct driver mutations in the hope of finding druggable targets for LM treatment. Methods: ChIP-seq for ESR1, PGR, and MED12 was performed using fresh-frozen tissues of G44D (the most frequent MED12 mutation) mut-MED12 LM (n=3); re-HMGA2 LM (n=2); LM without these two mutations (designated as WT LM, n=3), and their matched normal myometrium (MM) (n=8). RNA-seq was performed using the same samples. Hydrophilic metabolites were quantified using LC-MS. CCK-8 kit was used to measure cell proliferation. Results: RNA-seq identified 2568 genes significantly differentially expressed only in G44D LM vs MM. Adjacent to these genes, we uncovered 785 sites that were co-bound by PGR, ESR1, and MED12 with their strongest occupancy in G44D LM. The genes associated with these sites were enriched with pathways key for LM pathogenesis. Specifically, Tryptophan (TRP) 2,3-Dioxygenase (TDO2) was only significantly upregulated in mut-MED12 LM. TDO2 protein catalyzes the first and rate-limiting step of kynurenine (KYN) production, which activates aryl hydrocarbon receptor (AHR) and plays important roles in tumorigenesis in general. Consistent with TDO2 transcript level, LC-MS assay revealed lower TRP level in G44D LM vs MM. Interestingly, KYN level was increased not only in G44D (90% of cases) but also in WT LM (71% of cases) compared with MM. KYN (25, 50, 75, 100, 150, and 200 uM) treatment of primary LM cells for 24h dose-dependently induced CYP1B1 (known AHR target gene) expression with the highest induction at 200 uM (n=3), indicating that it can activate AHR in LM cells. KYN (200 uM) treatment for 48h significantly increased LM cell proliferation (n=5). TDO2 specific inhibitor 680C91 (5, 10, and 15 uM) treatment for 48h dose-dependently decreased LM cell proliferation, reaching statistical significance at 10 uM; whereas KYN only significantly inhibited MM cell proliferation at the highest dose (n=5). Similar treatment with AHR specific inhibitor CH223191 also significantly inhibited LM cell proliferation at 10 and 15 uM; in contrast, MM cell proliferation was not altered by any of the doses used (n=5). These findings indicate that TDO2 and AHR inhibitors affect the function of LM cells more robustly than that of MM cells. Conclusion: Our data suggest that TRP-KYN-AHR pathway was dysregulated and may play key roles in LM growth. The observed differential effect of AHR and TDO2 inhibitors on LM vs MM cells sheds light on the anti-tumorigenic roles of the compounds, which may serve as novel therapeutics for the disease. Tissue Factor Pathway Inhibitor 2 Expression in Uterine Fibroids. Papri Sarkar †, Xiaofang Guo, Ozlem Guzeloglu-Kayisli, Asli Ozmen, Alexa Taylor, Erika New, Anthony Imudia, Charles Lockwood, Umit Kayisli * . University of South Florida, Tampa, FL, United States. Introduction: Tissue Factor Pathway Inhibitor-2 (TFPI2), a member of the Kunitz-type serine proteinase inhibitor family, acts as an anti-coagulant by inhibiting factor VIIa/tissue factor, factor Xa, plasmin, trypsin, and plasma kallikrein. TFPI2 is also reported to block extracellular matrix degradation (ECM) by inhibiting matrix metalloproteinase (MMP)-1, 2, 9 and 13 activity in human atheroma. TFPI2 is secreted predominantly by syncytiotrophoblasts and weakly by endothelial and smooth muscle cells. Abnormal uterine bleeding occurs in women with uterine fibroids, which also have increased ECM production and deposition. We recently found that uterine fibroid vs. their paired myometrial tissues show elevated levels of FK506-binding protein 51 (FKBP51), a co-chaperone that inhibits progesterone receptor transcriptional activity. Our global RNA-seq analysis revealed that FKBP5-silencing inhibits TFPI2 levels in fibroid cultures. Thus, we hypothesized that increased TFPI2 expression in fibroids promotes both abnormal bleeding via its anti-coagulant effects and excess ECM deposition via its anti-MMP effects. Methods: Primary cultures of smooth muscle cells (n=4) isolated from uterine fibroid tissues were transfected with either scrambled or FKBP5-siRNA. Cells were then treated with 10 -8 M estradiol (E 2 ) or 10 -7 M medroxyprogesterone acetate (MPA) and then TFPI2 levels measured by qPCR. Total RNAs from paired uterine fibroid vs. myometrial tissues from proliferative (n=8) and secretory (n=6) phases were isolated and TFPI2 levels using TaqMan Gene Expression Assay. Data were compared by a paired t-test or One-Way ANOVA with P<0.05 considered statistically significant. Results: Significantly lower TFPI2 levels were detected in FKBP5silenced vs. control siRNA treatment (Mean± SEM: 0.66±0.1 vs. 1.0± 0.01; P<0.05), consistent with our RNA-seq results. Moreover, both E 2 and MPA treatment significantly reduced TFPI2 levels (P<0.05) in fibroid cultures. TFPI2 levels did not differ significantly in uterine fibroid vs. their paired myometrial tissue (1.32± 0.6 vs . 3.16± 1.3; P=0.26). Comparison of TFPI2 levels in proliferative vs. secretory phase were also not different in uterine fibroids (P=0.7) vs. myometrial tissues (P=0.1). These results demonstrate FKBP5-mediated upregulation of TFPI2 levels, as well as E2 and MPA-mediated inhibition of TFPI2 mRNA, suggesting that sex steroid withdrawal during menstruation together with enhanced FKBP51-medicated inhibition of progesterone receptor activity in fibroids increases TFPI2, which may contribute to fibroid associated abnormal uterine bleeding. Introduction: Uterine fibroids are a significant burden for reproductive aged women. Yet, effective medical treatments suitable for long-term use remain limited. There is an urgent need to better understand the signaling pathways involved in uterine fibroid pathogenesis and how these pathways could be exploited for targeted therapeutics. Glucocorticoids are emerging transcriptional regulators in uterine fibroid cells and have been shown to promote fibroid cell proliferation. We hypothesize that glucocorticoid signaling in uterine fibroids regulates the expression of genes critical to fibroid pathogenesis. Methods: A bioinformatics analysis of COREMINE Medical, MetaCore, Ingenuity Pathway Analysis, and the Comparative Toxicogenomics Database was performed to identify novel glucocorticoid-associated genes that are linked to uterine fibroids. Immortalized human uterine fibroid cells (UtLM) and primary fibroid cells were treated with the glucocorticoids cortisol and dexamethasone (10 or 100nM) for RNA and protein measurements. Parallel experiments were performed in immortalized uterine smooth muscle cells (UtSMC). The mechanism of glucocorticoid regulation was explored via siRNA knockdown, and actinomycin D treatment was employed to evaluate the effect on RNA stability. For all experiments, biological replicates n>3. Results: We identified four genes that were associated with the search term "glucocorticoid receptor" and key uterine fibroid features. Glucocorticoid treatment significantly repressed the expression of all four genes in UtLM cells (p<0.05-0.0001). Notable among the repressed genes was the vitamin D receptor (VDR), which inhibits fibroid proliferation upon activation with vitamin D. Repression of VDR mRNA was specific to fibroid cells, as glucocorticoid exposure enhanced VDR expression in UtSMCs, and was validated in primary human uterine fibroid cells. By knocking down the glucocorticoid receptor (GR) gene, we determined that repression of VDR requires GR. Co-treatment of glucocorticoids and actinomyocin D demonstrated that glucocorticoids do not significantly alter the stability of VDR mRNA. In addition, glucocorticoid-mediated repression occurred within hours and was significant for nascent VDR transcripts, supporting a potential direct transcriptional regulation by GR. Interestingly, cotreatment of glucocorticoids with the active form of vitamin D, calcitriol, blunted expression of VDR-responsive genes. Conclusion: These studies are the first to demonstrate that glucocorticoids may interfere with vitamin D signaling in uterine fibroid cells by repressing the expression of VDR. Thus, glucocorticoids may promote fibroid growth by inhibiting the actions of vitamin D. The Effect of Isolation Method on the Phenotype of Uterine Fibroid Cells in Culture. Tanya L Glenn †, Erin Silva †, Pablo Suarez, Clare Flannery, Shannon Whirledge * . Yale University, New Haven, CT, United States. Introduction: Despite the prevalence and severity of uterine fibroids, their pathogenesis is poorly understood. This lack of insight regarding the mechanisms leading to uterine fibroid formation and growth has impeded the development of long-lasting, effective, non-surgical alternatives for the treatment of uterine fibroids. In vitro studies with primary patient cells are a fundamental aspect to identifying the uterine fibroid signaling pathways driving pathogenesis. Yet, we have found over 30 different published methods for isolating primary uterine fibroid cells from patient tissue. As such, no standardized protocol has been established, and potential variations among protocols may influence the reproducibility of outcomes. The objective of this study was to determine whether variables in cell isolation methods result in differences in fibroid cell proliferation or the expression of uterine fibroid markers. Methods: We performed fibroid cell isolation from patient-derived tissue, comparing primary variables among digestion protocols: timing of digestion (day of tissue procurement versus the next day), type of collagenase used for digestion (Type II versus Type IV) , and base media for digestion (DMEM/F-12 versus Hanks' Balanced Salt Solution-HBSS). We assessed the different methods by plating an equivalent volume of digested cells and measuring cell viability with an MTT assay, cell death by LDH release, and the transcript levels of the sex steroid receptors, estrogen receptor alpha (ESR1) and progesterone receptor (PGR), as well as uterine fibroid marker genes dermatopontin (DPT), versican (VCAN), transforming growth factor beta 3 (TGFβ3), and cytochrome P450 26A1 (CYP26A1) by qRT-PCR. Results: Compared to HBSS, cells from tissue digested in DMEM/F-12 media released less of the cell death marker LDH 24hr after plating. Correspondingly, cells digested in DMEM/F-12 media demonstrated the greatest rate of proliferation. While waiting to digest tissue until the next day did not result in increased release of LDH, proliferation rates were lower when compared to tissue processed the same day, and tissue digested next day in HBSS with collagenase IV demonstrated the slowest rate of cell proliferation. We found no statistical difference in the expression of ESR1, PGR, VCAN, TGFβ3, or CYP26A1 mRNA between cells digested the same day versus those digested the next day, although transcript levels of DPT were significantly lower (p< 0.033) in the next day digested cells. Conclusion: These data are the first to demonstrate that the method by which uterine fibroid cells are isolated from patient tissue can alter the cellular phenotype. This discovery suggests that efforts to standardize uterine fibroid cell isolation may greatly improve the reproducibility and rigor of uterine fibroid research. Growth. Lauren Reschke †, Sadia Afrin †, Malak El Sabeh †. Johns Hopkins University, School of Medicine, Baltimore, MD, United States. Introduction: Uterine leiomyomas or fibroids, are the most common benign smooth muscle tumors of the female reproductive system, with an estimated lifetime incidence of 70-80%. 1 Obesity is a chronic disease that represents a global health burden and major public health concern. Recent evidence suggests a positive association between body mass index (BMI) and uterine leiomyomas, with a two-threefold increased risk of uterine leiomyomas in obese women. 2,3 Leptin and ghrelin are key hormones involved in energy homeostasis, with leptin elevated in obese individuals, while ghrelin is decreased. We hypothesized that adipose tissue dysfunction-associated alterations in leptin and ghrelin influence leiomyoma proliferation in vitro. Methods: Human immortalized uterine leiomyoma (HuLM) cells were treated with leptin (100ng/mL) and ghrelin (10nM) for 8 days. Proliferative effects were examined using western blotting for cellular proliferation marker, PCNA, and collagen I, a marker of extracellular matrix (ECM) deposition. Student's t-test was used to determine statistically significant differences (p<0.05). Results: Compared to controls, the levels of PCNA significantly increased in cells treated with leptin by 62% (p=0.04), and trended to have more ECM deposition noted by an increase in collagen I (p=0.20). Cells treated with ghrelin had the opposite effect, with a significant 83% reduction in PCNA (p=0.001), and trended to have less ECM deposition with lower levels of collagen I compared to controls (p=0.84). Conclusion: Treatment of HuLM cells with leptin suggests increased leiomyoma proliferation and ECM deposition, while treatment with ghrelin demonstrates decreased proliferation and ECM deposition. Further experimentation is warranted to determine the underlying mechanisms of these changes. Obesity and obesity related alterations in leptin and ghrelin may be a potential target for conservative therapeutic interventions for women with uterine leiomyomas. References: Collectively, GnRH antagonists pose as treatment options for various gynecologic conditions including uterine leiomyoma through suppression of estradiol and progesterone, hormones that contribute to the morphogenesis of leiomyoma through increased expression of proteins that make up its extracellular matrix (ECM). Elagolix and relugolix are both orally administered GnRH antagonists that provide a new and innovative way to treat uterine leiomyoma. The half-life of elagolix is 4-6 hours with an IC50 of 1.5 nM, while the half-life of relugolix is 49.4 hours with an IC50 of 0.33 nM. Given the differing pharmacological properties of these two drugs, the objective of this study is to determine the direct effect elagolix and relugolix have on the extracellular matrix of human leiomyoma. Methods: Leiomyoma cells were exposed to elagolix and relugolix for 24 and 48 hours. Expression of leiomyoma extracellular matrix proteins (collagen, fibronectin, and versican) were analyzed using western blot analysis. Results: Suppression of ECM proteins was not sustained at 48 hours in leiomyoma cells treated with Elagolix, suggesting that leiomyoma cells directly metabolize elagolix to an inactive metabolite. Leiomyoma cells treated with Relugolix for 24 hours showed maximal, decreased expression of collagen (0.59 +/-0.16-fold, p=0.000032) and fibronectin (1.09 +/-0.88-fold, p=0.0000074) at 100 nM. For versican maximal, decreased expression was achieved at 10 nM (0.99 +/-0.19-fold, p=0.000015); at 100 nM protein expression increased perhaps due to a cytotoxic effect noted at this concentration. At 48 hours, a concentration dependent suppression was seen in collagen (0.59 ± 0.16-fold, p=0.0005) and fibronectin (1.09 ± 0.88-fold, p=0.000026) up to 100 nM. For versican, a concentration dependent suppression was achieved up to 10 nM (0.55 ± 0.00); at 100 nM protein expression, again, increased. Finally, when comparing performance of elagolix and relugolix, relugolix maintained suppression of our proteins' expression at 48 hours. Conclusion: Our findings suggest that treatment with relugolix directly regulated collagen, fibronectin and versican production in our 2D human leiomyoma cell culture model. The reduction in protein expression caused by relugolix treatment provides a direct mechanism whereby leiomyoma size may be decreased by disrupting the aberrant fibrosis that characterizes the leiomyoma phenotype. Introduction: Uterine fibroids represent the most common benign tumors in women in reproductive age. It has been reported that they arise from a single dysregulated myometrial smooth muscle cell. However, the underlying tumorigenic mechanism remains unclear and surgery has been the gold standard for treatment. Our primary motivation stems from the need to better understand the cellular hierarchy of uterine fibroids and myometrium, leveraging the high resolution of single cell RNAseq. We aim to identify cell types and states that are unique to the fibroids, based on their molecular signatures. This may point towards more targeted and less invasive treatment strategies for the disease, and better elucidate the mechanism of myometrial tumorigenesis. Methods: After tissue dissociation, single cell RNA-seq analysis was performed to profile a total of 5432 single cells from uterine fibroids (F), fibroid-free matched myometrium (M) and healthy myometrium (hM) from 7 patients. Full length cDNA libraries of individual cells were prepared using an adapted SmartSeq2 protocol. Nextera XT DNA Sample Preparation kit was used for library preparation. Each cell was sequenced on a Novaseq to ~1e 06 reads/cell. Quality control and bioinformatic analyses were performed using custom R scripts. Introduction: Recent studies showed that uterine fibroids exhibit dysregulation of the Hippo signaling pathway, a key signaling pathway regulating cell proliferation and apoptosis. Hippo cytoplasmic modules include MST1/2 kinases and SAV1 that form a complex to phosphorylate and activate LATS1/2, which then phosphorylates YAP/TAZ resulting in 14-3-3-mediated cytoplasmic retention and degradation of YAP/TAZ. Conversely, dephosphorylated YAP/TAZ translocates to the nucleus to induce expression of genes promoting cell proliferation, such as CTGF and cyclin D1 (CCND1). Nintedanib is a multi-target tyrosine kinase inhibitor that is FDA-approved for treatment of idiopathic pulmonary fibrosis. Here, we tested the hypothesis that nintedanib treatment of uterine fibroid cells would alter Hippo signaling to influence cell proliferation. Methods: To assess cell viability, human myometrial (P51M) and fibroid (P51F) cells were treated with nintedanib at different concentrations (0.1, 0.5, 1, 5 and 10 µM) for 24 or 48hrs. Next, following 24hrs of serum starvation, we treated both myometrial and fibroid cells with nintedanib at 5 µM for 24hrs or 48hrs in media supplemented with 10% serum. Then we measured mRNA and/or protein expression of PCNA, LC3B, SAV1, MST1, LATS1, YAP, p-YAP, CTGF and CCND1. ImageJ was used to quantify protein expression and differences in mRNA levels were assessed using the 2^delta-deltaCT method with an alpha of p<0.05. Results: We found a differential effect of nintedanib treatment at 5 µM for 24 or 48 hrs with a ≥ 20% reduction of fibroid cell growth, and no effect on myometrial cells. In addition, protein levels of the proliferation marker, PCNA, were decreased after 48hrs of nintedanib treatment in fibroid cells. Nintedanib treatment also significantly elevated protein expression of the autophagy marker LC3B in fibroid cells. The Hippo pathway kinases MST1 and LATS1 were not affected by nintedanib treatment while SAV1 mRNA was significantly induced in fibroid cells. The protein levels of YAP were significantly reduced after 24hrs of nintedanib treatment in fibroid cells. As expected, p-YAP protein expression levels were slightly increased by nintedanib treatment. Of note, the YAP-responsive genes, CTGF and CCND1, were decreased by nintedanib treatment in fibroid cells. We found that nintedanib treatment had a differential effect on fibroid cell growth compared to myometrial cells. Hippo signaling was altered, resulting in reduced levels of genes involved in cell proliferation. Nintedanib promoted fibroid cell death, at least in part, through autophagy. These results provide evidence to support additional evaluation of nintedanib using in vivo models of uterine fibroid growth. Besides the heavy bleeding during menstruation, dysmenorrhea, generally known as painful periods, is a common symptom of the disease. Vilaprisan is selective progesterone receptor modulator currently in development for the treatment of uterine fibroids and endometriosis. Available clinical data demonstrate good efficacy of vilaprisan in controlling uterine bleeding in uterine fibroid patients. Back-translation of clinical data into preclinical settings is critical advance preclinical research in the field. Here, we used an established murine model to study menstrual bleeding in rodents. In this murine model hormone substitution and induced decidualisation of the uterus are used to simulates menses in rodents. This experimental set up is combined with a behavioral analysis of the animals to assess overall well-being depending on vilaprisan treatment. Methods: Artificial menstrual cycle phases of ovariectomized mice were induced by E2 and P4 supplementation/ withdraw schedule including the induction of decidualisation with intra-uterine oil application. Concomitantly, animals were treated with vehicle or vilaprisan at doses of 0.3, 1 and 3 mg/kg. To study the well-being, animals were subjected after P4 withdraw to an open field test, which is generally used to assess locomotion and exploratory behaviors. Results: Treatment of mice with vilaprisan significantly reduced blood loss of the simulated menses in a dose-dependent manner compared to vehicle-treated animals and in line with the observed efficacy in clinical trials. Interestingly, while simulated menses result in a strong reduction of locomotor activity (Nagel et al, SRI 2019) , treatment with vilaprisan significantly improved activity behavior of the animals which is associated with an improved overall well-being of the animals. In clinical trials an improvement in quality-of-life related endpoints has been reported. Conclusion: Taken together we conclude that the murine heavy menstrual bleeding model translates well into the clinical setting as demonstrated by the observed efficacy of vilaprisan on both endpoints, blood loss as well as locomotor activity which mirror the results observed in clinical trials. Complementary and Alternative Medicine Use among Women with Symptomatic Uterine Fibroids. Elia Marina Rubio †, Joan Hilton, Vanessa Jacoby * . University of California San Francisco, San Francisco, CA, United States. Introduction: Uterine fibroids represent a significant health burden among reproductive-aged women. Fibroids can cause heavy menstrual bleeding, urinary incontinence, pelvic pain, emotional distress, and fertility problems. Minimally invasive surgeries and pharmaceutical therapies exist to provide temporary symptom relief. The use of complementary and alternative medicine (CAM) for a wide range of medical conditions is well documented, but CAM use specifically for fibroid-associated symptomology has not been adequately described. This study aims to examine CAM use among women with image-confirmed, symptomatic uterine fibroids in the United States. Methods: We conducted a cross-sectional analysis of baseline data from a multi-center, prospective cohort study of premenopausal women with symptomatic fibroids enrolled in the Uterine Leiomyoma Treatment with Radio Frequency Ablation (ULTRA) study from 2017-2019. Participants were queried about CAM use in the prior six months. Women were asked to indicate any use of 10 CAM modalities (acupuncture, massage, exercise, diet, herbs, tea, yoga, chiropractor, physical therapy, other) specifically for fibroid symptoms, or for other reasons. A multivariate logistic regression model was performed to identify the independent factors associated with CAM-use among those who used CAM to treat fibroid symptoms and those who did not use CAM for fibroids. Results: Among 204 women, 55% were Black/African American with a mean age of 42 (SD 6.6) years. CAM use was common with 42% (95% CI 35-49%) reporting use of CAM modalities specifically to treat fibroid symptoms. Popular CAM treatments used were diet (65%), herbs (52%), tea (48%), and exercise (35%); massage (29%), yoga (13%), acupuncture (17%), and chiropractor (8%) were also readily used. On average, each individual utilized 3 different types of CAM regardless of its use for fibroids symptoms only, other reasons only, or both. In our multivariable model, there were no differences in age or race/ethnicity among CAM users versus non-users. CAM users were 3 times more likely to report pelvic pressure or pain as a primary fibroid symptom than those who did not use CAM (OR 3.1 95% CI: 1.2-8.3). We also found that women with a body max index above average were less likely to use CAM for fibroids (OR: .94 95% CI .88-.98). Other notable but non-significant associations were CAM-users being almost twice more likely to desire future pregnancy (OR: 1.95 95% CI .91-4.18) and report experiencing urinary frequency or nighttime urination as a primary fibroid symptom (OR 1.49 .73-3.0). Conclusion: In a racially, ethnically, and geographically diverse sample of women seeking surgical intervention for uterine fibroids, CAM use was highly prevalent. Our findings highlight the use of CAM to mitigate the severity of symptoms. Clinical trials are needed to understand the effectiveness of CAM for fibroids symptoms. Introduction: Uterine fibroids are benign growths that arise in the myometrium, causing significant morbidity. Fibroids are associated with enhanced extracellular matrix (ECM) production and composed of clonally derived smooth muscle cells, as well as heterogenous cell types including fibroblasts, blood vessels, nerves, inflammatory cells, mesenchymal cells, and stem cells. Our prior research demonstrated that fibroids compared to matched myometrial tissues express significantly higher levels of FK506-binding protein 51 (FKBP51), an immunophilin protein that inhibits transcriptional activity of the progesterone receptor. The clinical significance of increased expression of FKBP51 in fibroid vs. myometrial tissues however is unknown. Thus, our aim is to determine the impact of increased FKBP51 levels in uterine fibroid pathogenesis by measuring global transcriptional changes in uterine fibroid cells. Methods: Human primary smooth muscle cells isolated from fibroid tissues obtained from patients with uterine leiomyoma were cultured to 70% confluence. Cultures (n=4) were transfected with either scrambled siRNA as control or FKBP5-specific siRNAs to silence FKBP5 expression. After 72 h, RNAs were isolated and processed for global RNA-Seq analysis to obtain differentially regulated genes. Ingenuity Pathway Analysis (IPA) software was used as a bioinformatic tool to describe dynamic molecular changes between groups. Results were confirmed by qPCR using TaqMan Gene Expression assays. Data were compared by a paired t-test and p<0.05 was considered statistically significant. Results: A 25-fold decrease in FKBP5 levels was detected in fibroid cultures after FKBP5 siRNA vs. scrambled siRNA transfection for 72 h. Bioinformatic analysis of global RNA-seq results revealed that FKBP5silencing was associated with downregulation of several ECM genes, including collagen type1 A1 (COL1A1), COL4A5, COL7A1, COL10A1, fibronectin (FN1), and laminin c1 (LAMC1). Analysis of qPCR revealed a 1.68-fold reduction in COL4A5, 1.76-fold reduction in COL7A1, 1.54-fold reduction in FN1, and 1.49-fold reduction in LAMC1 levels in FKBP5silenced vs. control transfected uterine fibroid cells (P<0.05). These results indicate that FKBP51 expression is involved in collagen, fibronectin, and laminin over-production in uterine fibroid cells. Compared to myometrial tissue, increased FKBP51 in fibroids promotes cell differentiation toward a secretory smooth muscle cell type leading to increased ECM deposition. Silencing FKBP51 reduces expression of these proteins, suggesting a novel therapy targeting cellular differentiation. Effect Introduction: Heavy Menstrual Bleeding (HMB) adversely effects the quality of life of one in four women of reproductive age and represents a substantial burden and cost to society. The aim of the present study was to determine whether the Selective Progesterone Receptor Modulator (SPRM) Ulipristal Acetate (UPA) is effective in reducing the volume of the uterus in women with HMB, and if this is influenced by whether fibroids are present. Methods: Nineteen women with HMB (with and without uterine fibroids) were recruited (informed written consent) for the embedded mechanism of action study in the UCON clinical trial (EUDRACT 2014-003408-65, REC -14/LO/1602). Women were treated with three 12 week cycles of 5 mg daily UPA with 4 weeks off medication between each cycle. Structural T2-weighted Magnetic Resonance Imaging (MRI) was performed at baseline (pre-treatment) and after six, and twelve, months and which corresponds to after 2.00 (SD = 0.16), and 2.96 (SD=0.09), cycles, respectively. The volume of the body of the uterus excluding cervix, and of uterine fibroids when present, was estimated from the MR images using the Cavalieri method of modern design stereology in combination with point counting. Results: The measurements, which were shown to have excellent intra-rater repeatability (Pearson's r 0.997 p<0.001 for uterus and 0.982 for fibroids p<0.001) and inter-rater reproducibility (Pearson's r 0.994 p<0.001 for uterus and 0.984 for fibroids p<0.001), were performed blind to whether the MR images had been acquired at baseline of after 6 or 12 months. For the total group of 19 patients, 8 of whom had fibroids, a significant reduction in the volume of the body of the uterus was observed after three, but not two, cycles of UPA (p = 0.02). Conclusion: SPRM UPA treatment for 12 months produced a significant reduction in the volume of the uterus. Further analysis is in progress to assess whether the response may be different depending upon whether fibroids are present in the uterus. Introduction: Uterine leiomyomas are one of common tumor of the female reproductive tract. Angiogenesis is the physiological process that forms new blood vessels from pre-existing vessels, and is a crucial step for tumor growth and development. Multiple angiogenic growth factors are differentially expressed in leiomyoma compared with myometrium, but the mechanism about leiomyoma angiogenesis remains still unclear. Some angiogenic factors are induced under hypoxia chiefly and oxygen concentration in uterine leiomyoma was reported significantly lower than in the surrounding myometrium. The mechanism of leiomyoma pathogenesis and physiology under hypoxic condition is unknown. The aim of this study was to assess the differential expressions of angiogenic, fibrosis and proliferative factors under hypoxic condition between uterine leiomyoma cells and myometrial cells. Methods: Primary leiomyoma cells and myometrial cells were isolated from leiomyoma and the surrounding myometrium. Cells were cultured in a hypoxic chamber (2% O2) or stimulated with cobalt chloride (CoCl2) to mimic hypoxic condition. The protein expressions of angiogenic factors (vascular endothelial growth factor: VEGF, endothelin-1: ET-1 and adrenomedullin: ADM) and hypoxia inducible factor-1α (HIF-1α) were measured by western blotting (WB). The expressions of transforming growth factor (TGF)-β3 and its downstream (SMAD signaling pathway) were evaluated by WB. Proliferation was valued by using proliferating cell nuclear antigen (PCNA) and extracellular matrix (ECM) production was valued by using fibronectin. The results indicate that angiogenesis, ECM production and proliferation are induced in uterine leiomyoma more under hypoxic condition than normal condition and suggest that leiomyoma is more capable to grow under low oxygen concentration than normal oxygen concentration. Further studies are warranted to show the association between tumor growth and hypoxia in uterine leiomyoma. Insights Into Primary Ovarian Insufficiency Through Clinical and Biochemical Data at the NIH. Jamie Merkison, Ninet Sinaii, Veronica Gomez-Lobo, Jacqueline Maher * . National Institutes of Health, Bethesda, MD, United States. Introduction: Primary ovarian insufficiency (POI) is a heterogenous condition causing progressive hypergonadotropic hypogonadism in women prior to age 40. POI has significant health and reproductive consequences for patients. The aim of this analysis was to provide a descriptive summary of clinical/biochemical information collected from patients to detail their presentation and fertility outcomes. Conclusion: This descriptive analysis of 530 women with POI showed the variability of clinical presentation and outcomes. Pregnancy rates were 2.6% following POI diagnosis. Compared to postmenopausal women in the general population, the incidence of hot flashes in POI appears to be similar (79 vs 76%) and vaginal dryness is higher (20 vs 58%). A Fragile X premutation as a cause was consistent with the literature at 4.3%. Advancing Equity and Diversity in Gynecologic Biobanking. Pablo Suarez, Shannon Whirledge * . Yale University, New Haven, CT, United States. Introduction: Race is the strongest risk factor for the development of uterine fibroids, the most common gynecologic tumor affecting women. Racial inequities are also reflected in disease severity and medical treatment, as Black women develop more severe symptoms and undergo hysterectomies at higher rates than white women. Yet, the factors driving racial disparities in uterine fibroids are unclear. Few studies have been designed to identify racially-linked factors, and in-vitro models infrequently report the race/ethnicity of the studied fibroid cell lines. The lack of representation in research impedes progress towards the development of effective therapies that will benefit all women with uterine fibroids. Achieving representation in fibroid research relies on the equitable inclusion of all races in clinical studies and biospecimen collection. The objective of this study was to determine demographic data for university-affiliated OB/GYN biobanks in the U.S. and to develop a targeted strategy to address barriers in participation of Black women in biospecimen collection. We performed a literature search in PubMed with the search terms: "biobank and gynecology," "biobank and gynecology," "gynecologic biorepository," "biobank and uterine fibroids," "biobank and leiomyomas," "biobank and race," "participation barriers and biobank," and "biobank and underrepresented groups." We also independently searched for university-affiliated OB/GYN biobanks. We then conducted a qualitative review of reported barriers and strategies to participation in biospecimen research among racial/ethnic minorities. Results: Our literature search identified only 6 relevant publications describing OB/GYN biobanking. We independently identified 19 university-affi liated OB/GYN biobanks, with only 1 reporting the racial/ ethnic composition of their participating subjects and 4 including a statement addressing diversity. The most common barriers to participation among racial/ethnic minorities identified are: misinformation and misconceptions about biobanking, mistrust, and confi dentiality concerns. To account for these barriers, tools assessing biobanking literacy, medical trust, and perceptions of justice in research have been validated. Key strategies identifi ed to improve participation of underrepresented groups in biobanking are community-based partnerships, educational structured interviews, multi-layer privacy protections, and accessible research records. We identifi ed a signifi cant defi cit in publicly available data on the racial/ethnic demographics of banked OB/GYN biospecimens, a barrier to translational research in uterine fi broids. Considering historic underrepresentation in biospecimen donation and participation barriers, we designed a recruitment model implementing tools and strategies that foster equity in biobanking, ultimately supporting the development of targeted therapeutics for uterine fi broids. Introduction: Currently, cervical length (CL) is the gold standard for prediction of spontaneous preterm birth (sPTB). The anterior UCA, a measurement of the angle between the cervix and the anterior lower uterine segment, has been investigated as an alternative predictor for sPTB, but, results have been inconsistent. A patient-level meta-analysis was performed to evaluate the ability of anterior UCA measurement to predict sPTB. Methods: Literature review of search terms "uterocervical angle" and "preterm birth" initially identifi ed 494 studies. A total of 3 studies with available patient level data met inclusion criteria. These were combined with data from a retrospective cohort from 2013-2020 at our hospital. Patients were included if they had a transvaginal ultrasound measurement of CL and UCA between 16+0 to 23+6 weeks. The primary outcome was sPTB < 37 weeks. Secondary outcome was sPTB < 34 weeks. The overall and individual study mean UCA was calculated. A receiver-operator curve (ROC) was created and the UCA and CL most predictive of sPTB were determined by maximizing the Youden's index. Results: A total of 2,016 women were included in the analysis. The overall mean UCA was 99.5 degrees. Individual study-specifi c mean UCA ranged from 94.9°-106.1° (p < .001). The mean UCA was wider in patients with sPTB < 37 weeks (109.6°) than term (97.9°; p < .001) and sPTB < 34 weeks (109.8°) than term (98.6°; p < .001). Based on the ROC, a cut point for UCA of 107° was most predictive of sPTB with sensitivity of 57% and specifi city of 64%. In this population, the predictive value of UCA was similar to that of CL, which had an area under the curve AUC = 0.62 compared to 0.63 for the anterior UCA. Conclusion: Larger UCA measurement was associated with an increased risk of sPTB < 37 and < 34 weeks. An anterior UCA of 107° had an increased sensitivity for sPTB < 37 weeks. In this population, UCA can be as valuable as CL for prediction of sPTB. Further investigation may identify situations in which UCA and CL together are better predictors than CL alone. Introduction: Current conception-based approaches to estimate the due date do not allow to integrate real-time pregnancy progression and thus, remain inaccurate. However, estimating the time of delivery is of high clinical importance as pre-and post-term deviations are associated with complications for the mother and her baby. With approaching labor, major transitions occur in fetomaternal systems that culminate in the delivery of the fetus. We aimed to comprehensively characterize the metabolic, proteomic and immune cell events that precede the spontaneous onset of labor, in order to understand these physiological transitions and identify predictive biomarkers of parturition. In blood collected during the last 100 days of pregnancy from 63 women, over 7,000 circulating plasma analytes and peripheral immune cell responses were analyzed by mass cytometry, high-throughput mass spectrometry, and an aptamer-based protein assay. Results: An integrated, multi-omic model accurately predicted the time to spontaneous onset of labor (R = 0.85, pvalue = 1.2e-40, training set; R = 0.81, pvalue = 3.9e-7, validation set). The most informative features of the multi-variate model included STAT1 signaling responses in CD56 lo CD16 + NK cells, IL-33-receptor IL1R4, Cystatin C, Angiopoietin-2, Cortisol, and Progesterone. Strikingly, analyte trajectories revealed precisely-timed fluctuations that marked a transition from pregnancy progression to pre-labor biology which occurred 2-4 weeks before delivery. The multi-omic assessment of maternal blood across different biological systems revealed a multivariate model of cellular and molecular events that accurately predicted the time to delivery. Our modeling approach is key to developing blood-based methods for accurately predicting the due date based on common pathways in term, pre-and post-term pregnancies. were studied. Nulliparas required significantly more pushing contractions to deliver than multiparas (20.3±1.8 vs 7.8±1.0 pushes, p<0.01). Cesarean deliveries were associated with significantly more pushing contractions than SVDs among both nullipara and multipara cohorts (40.1±10.1 vs 17.9±1.9, 32.1±23.4 vs 6.9±0.8, respectively; p<0.01). After the 70th percentile of pushing contractions, the probabilities of Cesarean deliveries are at their highest (nulliparas 33%, multiparas 50%) and SVD rates are at their lowest (nulliparas 33%, multiparas 0%) ( Figure 1 ). After the 80th percentile of pushing contractions, the probabilities of OVDs are at their highest (nulliparas 33%, multiparas 100%). There was no significant difference in maternal or neonatal composite morbidities as number of pushing contractions increased (p>0.32). Conclusion: These results establish a normative pattern of number of pushing contractions for nulliparous and multiparous patients. Providing patients a goal for expected number of pushing contractions may be of motivational benefit. We recommend that patients be counseled of an increased probability of Cesarean and OVD if SVD does not occur within the 70th to 80th percentile of pushing contractions. Investigating Introduction: Preterm birth (PTB) is the leading cause of death in children under the age of five. In 2014, there were approximately 15 million preterm births and of these around 12 million occur in Africa and Asia. A short interpregnancy interval (IPI) is well recognised as a risk factor for PTB, low birth weight (LBW) and small for gestational age babies (SGA). The aim of this study was to examine the association of these adverse birth outcomes with the country of birth economic status and IPI. Methods: A systematic review and meta-analyses were performed. EMBASE and Medline were searched to identify studies assessing IPI and its impact on PTB, LBW and SGA. Studies were included if they had an observational design. Systematic reviews with no new data were excluded. All studies were screened, data extracted, and bias assessed by two independent authors. Discrepancies were resolved by consensus. Studies were stratified by developmental status of the study country as described by the World Economic Situation and Prospects 2019 report. The co-primary outcomes were PTB, LBW and SGA. The Joanna Briggs critical appraisal tool was used to assess methodological quality. Overall summary estimates and 95% CIs with inverse variance weighted randomeffects meta-analyses were performed because heterogeneity was high. Pre-Labor Rupture of Membranes. Carmen Maria Avram †, Alice Darling †, Melissa Montoya †, Jennifer Gilner * , Sarahn Wheeler * , Sarah Dotters-Katz * . Duke University, Durham, NC, United States. Introduction: Initiation of breastmilk feeding (BF) among preterm and low birth weight infants occurs at lower rates compared to term infants, despite clear benefits to breastmilk in this population. Women admitted with preterm pre-labor rupture of membranes (PPROM) are at high risk for preterm delivery and may have limited access to prenatal BF education. We aimed to describe rates of BF initiation and cessation, and to identify risk factors for BF non-initiation among women with PPROM. Methods: Nested case-control study of women with PPROM admitted to a single tertiary center (2013-2019). Women without BF data and deliveries complicated by intrauterine or neonatal demise within 48 hours were excluded in primary analysis. Neonatal demise and those missing postpartum (PP) data excluded from secondary analysis. Demographic, antepartum, and delivery characteristics were evaluated. Primary analysis included rate of any BF initiation (BFI) at maternal discharge, and factors associated with (a/w) non-initiation. Secondary analysis performed for rates of BF continuation (BFC) at 6-weeks PP and factors a/w BFC. Bivariate statistics were used compare characteristics and logistic regression to estimate adjusted odds ratios (aOR). Results: Of 397 women with PPROM, 342 (86.1%) had BFI. Women who didn't initiate BF were more likely to use tobacco in pregnancy (Table 1 ). In contrast, women with private insurance (aOR 2.53; 95%CI 1.19,5.37) and PPROM latency >14 days (aOR 3.02; 95%CI 1.09,8.38) had increased odds of BFI (Table 1) .At 6 weeks PP, only 214 (73%) of 297 women had BFC. Age <20 (aOR 0.07; 95%CI 0.01,0.67) and multiparity (aOR 0.54; 95%CI 0.29,0.99) were associated with non-BFC. Women with private insurance were observed to have increased odds of BFC (Table 2) . Conclusion: Among women with PPROM, tobacco use was associated with non-initiation of BF prior to discharge, while age <20 and multiparity were associated with BF cessation. BF education and support should be offered to all women admitted for PPROM. Further research is needed how to best support these women in BF. Introduction: Antibiotics are one of the most commonly prescribed medication classes during pregnancy. Little is known regarding their impact on pregnancy. Our primary aim is to determine whether antibiotic use during pregnancy is associated with preterm birth (PTB) less than 37 weeks estimated gestational age (EGA). Secondary aims will assess the relationship of antibiotic use with cytokine levels, maternal outcomes, and neonatal outcomes. Methods: This is a secondary analysis of a multicenter, prospective cohort study to evaluate the impact of vaginal infections during pregnancy on PTB. Exposure was any antibiotic use during pregnancy. Primary outcome was PTB < 37 weeks EGA. Secondary outcomes were midtrimester cervical length (CL), vaginal bleeding (VB), inflammatory cytokine levels, and maternal and neonatal outcomes associated with infection. Descriptive statistics were generated. Univariate and multivariable logistic regression were performed to examine potential associations between antibiotic use and the primary outcome. Results were considered statistically significant if p<.05. Results: There were 3073 women included in the analysis: 1233 with antibiotic use during pregnancy, 1840 without. Women with antibiotic use were younger, had lower BMI, were more likely to have smoked during pregnancy, and were more likely to have less than high-school level education. When controlling for confounders, antibiotic use during pregnancy was not associated with PTB less than 37 weeks EGA (OR = 1.13; 95% CI 0.91-1.40; p=0.28). Women with antibiotic use had greater CL and were more likely to experience first or second trimester VB. Neonates from mothers with antibiotic use during pregnancy had lower birth weights and were more likely to experience necrotizing enterocolitis. Serum IL-10 levels at 24 weeks EGA and TNF receptor type 2 levels at 28 weeks EGA were higher for the antibiotic use group, while C-reactive protein levels at 24 weeks EGA were lower for the antibiotic use group. In this study, antibiotic use during pregnancy was not associated with PTB less than 37 weeks EGA. Introduction: Preterm syndrome (PTS) behaves a pre-labor premature rupture of membrane (pPROM) or a spontaneous premature labor (sPTL) with uterine contraction that may result in a rupture of fetal membrane as the course of parturition initiated. We have determined that intracellular long noncoding RNAs (lncRNAs) were involved in a ubiquitin-proteinasecollagen pathway that may result in down-regulation of collagens in pPROM. We hypothesize that lncRNA may involve in regulation of extracellular matrix (ECM) pathway in PTS. Methods: Two lncRNAs, the lnc-ADAM9 and lnc-PCDH10, and their epigenetic regulatory impact on ECM in the PTS, were studied. Gene expression profiles of these lncRNAs and their overlapped mRNA loci were assessed with a cohort of 120 prebanked fetal membrane tissues, among which 30 cases were in each pPROM, FTB (full-term birth), sPTL, and PROM (full-term premature rupture of membrane), respectively. Over-expression of lncADAM9 and lncPCDH10 followed by RNA-seq, qRT-PCR, and Western blot in cultured HTR8 cell models. Results: Differential expression genes that were enriched in both cell cultures of overexpressing lncADAM9 and lncPCDH10 were enriched in extracellular matrix structural constituent, biological adhesion, extracellular matrix organization, homotypic cell-cell adhesion, and cell-cell adhesion via plasma-membrane adhesion molecules (Figure 1) . A pathway, the cell adhesion molecules (CAM), was enriched in both over-expression cell cultures. RNAs and proteins in CAM pathway, in vivo analyzed with fetal membranes, showing that they presented significantly in distinguishing PTS from controls (Table 1) . Conclusion: Our results indicated that overexpressed lnc-ADAM9 and lnc-PCDH10 has a pathogenic impact on extracellular matrix and cell adhesion molecules, which lead a potential of applying these molecules as clinical biomarker for early prediction of PTS. Early Childhood Growth after Term NICU Admission by Admission Diagnosis. Joan Krickellas, 1,2 Sadia F Chowdhury †, 1,2,3 Adwoa Nantwi †, 4 Sylvia Dygulski, 1, 2 Introduction: Neonatal intensive care unit (NICU) admission marks potentially at-risk children for developmental programming. We explore patterns of early childhood growth after NICU admission in a low-risk community-based population with universal placental examination. A community hospital based sample with universal placental examination was searched for those births delivered at a gestation of at least 37 completed weeks and followed to at least age 2 years at our institution. Gross placental examination was performed according to a protocol that recorded trimmed placental weight (PW), major and minor disk axes, minimum and maximum disk thickness and cord eccentricity. NICU admission and admission diagnoses were extracted from the medical record. Infant sex and centiles for weight and length/height at birth, age 1, and age 2 were extracted from medical records. Gross measures and centiles of growth were both analyzed with nonparametric tests due to non-normal distributions. Results: 1054 infants met inclusion criteria, 101 of whom were admitted to the NICU. There were no associations of birth weight, length or head circumference centiles, or centiles of growth at ages 1 or 2 years in this term population. This lack of association held within the NICU population when indications for NICU admission were considered, including neonatal hypoglycemia, abnormal fetal heart rate, hyperbilirubinemia, or newborn complications related to meconium exposure. The data suggest that NICU admission of a term newborn does not correlate with longterm abnormalities of early childhood growth. Term infants admitted to our NICU show no evidence of significant reduction in birth weight or length centiles, which may reflect the nature of our community based hospital sample. Results: The SEC fractions with the highest protein content also showed positive signals for the sEV markers CD81 and CD63. No cellular contamination has been observed (no signals for GM130 or Grp94). These sEV fractions contained high amounts of miRNAs, such as miRNA 22-5p, miRNA 27b-3p or let7b-5p. Conclusion: The highly abundant miRNAs in the sEV fractions target specific apoptotic or inflammatory pathways and drive oligodendrocyte differentiation. Therefore, these miRNAs might have positive effects on WMI outcomes. For a better understanding of this hypothesis, the sEV fractions containing the most abundant miRNAs are currently tested for their functionality using dual luciferase assays. For this, the 3' UTR of the target mRNA is cloned into a luciferase reporter vector and transfected into HEK293-cells followed by incubation with sEV fractions containing highly expressed miRNAs. The inhibitory or excitatory effects of miRNAs on the gene expression in the transfected HEK293 cells are monitored by the amount of luciferase activity in the different experiments and deliver further knowledge about the functionality of WJ-MSC-derived sEV. Diabetic Methods: BeWo cells were used as a placental model. They were exposed to high glucose concentrations to mimic diabetic microenvironment. Control cells were exposed to 5 mM glucose, whereas 25 mM glucose was used to simulate high glucose. After 48 hours of treatment, the media and lysate were collected. Three different populations of EVs were isolated from the supernatant, based on centrifugation speed (2000 x g, 10000 x g and 100000 x g). Mass spectrometry analysis (IDA/SWATH) was performed in each population of EVs, as well as the lysate, to identify and quantify the proteins. Results: BeWo cells exhibited differential expression of proteins in response to high glucose treatment. 177 proteins significantly changed (p<0.05) as a result of high glucose treatment in the lysate. This change was also observed in 281 proteins identified in the 2000 x g EVs preparation, 238 proteins in the 10000 x g EVs preparation, and 179 proteins in the 100000 x g EVs preparation. Interestingly, there was no evidence of proteins with significant changes in expression that were shared among the four groups. However, a set of uniquely and significantly expressed proteins was identified in each group. Lysate expressed 107 unique proteins, with 195 proteins identified only in the 2000 x g population, 160 proteins in the 10000 x g, and 119 proteins in the 100000 x g. This IDA/SWATH method evidenced the role of placental cells as sensors of the extracellular microenvironment, and revealed that the placental microenvironment can significantly alter the proteomic profile under pathological conditions. The results also provide encouraging data from a biomarker perspective, due to the unique expression of proteins in specific populations of EVs. Introduction: Due to the worldwide burden of obesity in women of reproductive age, bariatric surgery is increasing. Excessive rapid weight loss and high dose vitamins lead to iatrogenic malnutrition or synthetic 'toxicity' infl uencing foetal growth, birthweight and pregnancy outcome. We will evaluate the infl uence of bariatric surgery and supplementation on maternal nutritional status, foetal growth and pregnancy outcome. Methods: A retrospective chart review was performed at a bariatric expertise center (Maasstad Hospital, Rotterdam) in pregnancies between 2009 and 2019. Nutritional status during all trimesters regarding blood samples, estimated foetal weight, 2nd and 3rd trimester ultrasonographic parameters and birth weight were collected. Results: Women had a median BMI>40kg/m 2 before bariatric surgery and 29.0 kg/m 2 at conception. Vitamin defi ciencies ( Here we demonstrate that bariatric surgery decreases the risk for pregnancy complications. However, despite supplementation, defi ciencies occurred mainly during the fi rst trimester and up to 40%. The reduced foetal growth and birth weight suggests that other nutrients and hormones regulated by the stomach are also infl uenced by bariatric surgery resulting in an iatrogenic malnutritional, metabolic and endocrine state. This data emphasises the urgent need for periconceptional lifestyle counselling of women after bariatric surgery contemplating pregnancy, extra ultrasounds examinations and regular vitamin level monitoring during pregnancy. Further research on the impact of bariatric surgery on metabolism and endocrinology and the consequences of high dose multivitamins is needed. Introduction: Maternal obesity is a rising complication affecting pregnancy. Maternal weight gain and diet practices are thought to contribute to increasing rates of gestational diabetes and increased maternal and fetal complications. Diet manipulation in pregnancy is limited by patient compliance and concern that inadequate nutrition will aff ect fetal growth. As in human's, old-world African green vervet nonhuman primates (vervet) are at increased risk for type II diabetes, obesity and metabolic syndrome. The traditional vervet diet is a soy based high fi ber diet that diff ers signifi cantly from the standard American diet (USA). We hypothesized that the introduction of a Western diet similar to an USA diet verse a soy based Standard Chow diet in pregnant vervet primates would increase insulin resistance and have a poor lipid profi le eff ect. Methods: 33 pregnant vervet primates were divided into three groups for diet exposure: Standard chow ad libitum (ad lib), Western diet ad lib or restricted Western diet. Each group was exposed to their assigned diet for a minimum of one trimester equivalent (55 of 165 days total in gestation). Maternal body weight was measured every 2 weeks. CBC, HbA1c and clinical chemistry analyses were performed at baseline and 4 wk after the diet change. Plasma lipid concentrations, total cholesterol, HDL cholesterol, LDL cholesterol, triglycerides, glucose, insulin, and were measured at baseline and at 4, 8, and 12 wk after the diet change. Fetal weight, head circumference and outcome were recorded. Univariate and multivariate analyses were used as appropriate. Results: 33 pregnant vervet primates had complete data and were analyzed by group as follows: Standard Chow ad lib (n=15), Western Diet ad lib (n=8), Western Diet Restricted (n=10); see Table 1 Diabetes Distress Scores and Perinatal Outcomes among Women with Gestational and Pregestational Diabetes. Jennifer Jacobson †, 1 Amy Godecker, 1 Jennifer Janik, 1 April Eddy, 2 Jacquelyn Adams * . 1 Introduction: Living with diabetes is associated with depression and anxiety in women. Little pregnancy data is available despite high prevalence of gestational diabetes (GDM) and pregestational diabetes (preDM). Several clinical assessments have sought to quantify diabetesrelated emotional distress and the abbreviated Diabetes Distress Scale (DDS) demonstrates high reliability. We hypothesize that women with high DDS will have higher HbA1c and EPDS scores in pregnancy. Methods: A retrospective cohort study of 295 women with preDM (prediabetes, type 2 DM, type 1 DM, n=121) or GDM (n= 174) between 1/1/2018 and 7/31/2020. Patients were identifi ed using the American Diabetes Association database. Demographic and pregnancy data were obtained from PeriData, a statewide quality improvement database, and the electronic medical record. Results: Demographics were similar between groups, but women with preDM delivered at earlier GA (37.4 vs. 38.5, p=0.000). High DDS was present in 27.5% with no diff erence between preDM and GDM (30.3% vs. 25.4%, p=0.387). We performed a logistic regression while controlling for DM type and GA at delivery. High DDS score was associated with higher mean 3 rd trimester A1c (6.0% vs. Conclusion: High DDS is equally prevalent among women with GDM and preDM. High DDS was associated with higher A1c values and EPDS scores in the 3 rd trimester but not at 6 weeks PP. High DDS alone was not associated with NICU admission, RDS or hypoglycemia. This study asserts that DDS may be a useful tool for risk stratifi cation of women with diabetes in pregnancy. The are important predictors of adverse maternal and offspring health outcomes. The Institute of Medicine recommends that all individuals, regardless of pre-pregnancy body mass index (BMI), gain weight during pregnancy. Individuals who receive appropriate GWG recommendations from providers have greater odds of gaining a healthy amount of weight during pregnancy. Underweight and overweight pre-pregnancy BMI are also risk factors for insuffi cient or excessive GWG, respectively. More research is needed to explore factors related to individuals' GWG and weight goals (WGs) for pregnancy, and factors that infl uence providers' WG recommendations to their patients. This study examines factors that contribute to pregnant individuals' own WGs for pregnancy, and factors that contribute to providers recommending appropriate WGs to patients. Methods: Participants are pregnant individuals (N = 149) enrolled in an ongoing longitudinal study examining the eff ects of Mindfulness-Based Cognitive Therapy on maternal functioning and off spring outcomes. The current study examined self-report measures collected at baseline (14-23 weeks gestation). Self-report measures included questionnaires about medical history and prenatal care, which assessed participants' WGs for pregnancy and their providers' WG recommendations. Provider WG recommendation and participant WG for pregnancy were defi ned as binary dependent variables: staying at pre-pregnancy weight or losing weight (an "inadequate" WG recommendation/participant WG) and gaining weight (an "adequate" WG recommendation/participant WG). Results: A logistic regression was conducted to test the relationship between the outcome variable, adequacy of provider WG recommendation, and predictor variable, BMI, adjusting for ethnicity. The model was statistically signifi cant, χ 2 (2) = 25.10, p < .001. To examine the relationship between provider WG recommendation and participant WG for pregnancy, a Pearson's chi-square analysis was conducted. There was a signifi cant association between provider WG recommendation and participant WG, χ 2 (2) = 39.71, p < .001. The fi ndings suggest that maternal BMI aff ects the adequacy of providers' WG recommendations for pregnancy, such that providers are more likely to recommend inadequate WGs for individuals with higher BMIs. Our results suggest that providers who recommend inadequate WGs to patients may increase the risk of insuffi cient (or excessive) GWG and subsequent adverse maternal and off spring outcomes, which will be further examined. Future studies should explore the relationship between patients' self-report of their providers' WG recommendation and providers' documented recommendation using medical record data. Villi with Gestational Diabetes Mellitus: Implication for Impaired Glucose Homeostasis. Anthony M Kendle †, Nihan Semerci, Asli Ozmen, Xiaofang Guo, Ali Wells †, Ozlem Guzeloglu-Kayisli * , Umit Kayisli * , Charles J Lockwood * . The University of South Florida, Tampa, FL, United States. Introduction: Gestational diabetes mellitus (GDM) affects 2-10% of pregnancies annually in the United States, and these mothers and their offspring are at increased risk for metabolic derangement later in life. Fatty acid binding protein 4 (FABP4) is a secreted adipokine that plays a major role in glucose homeostasis, progression of insulin resistance and inflammation. FABP4-deficient mice are highly resistant to developing various metabolic diseases, including diabetes, atherosclerosis, dietinduced obesity, genetic obesity, or hypercholesterolemia. Recent studies have demonstrated increased serum levels of FABP4 in both maternal and umbilical cord serum at time of delivery in pregnancies affected by GDM. We hypothesize that FABP4 expression is increased in placental villous tissues of pregnancies affected by GDM compared to non-GDM, and this differential expression may contribute to the pathogenesis of GDM. Methods: Placentas were collected prospectively from pregnancies with GDM (n=4) and from normal pregnancies (n=3), matching for age, gestational age at delivery, and body mass index. A piece of placental villous tissue was processed for RNA and protein extraction to detect in situ FABP4 levels, whereas another portion of placental villi was used for explant cultures for 24 h. Explant cultures and media were then collected for RNA and protein extraction. All samples were then analyzed by qPCR and immunoblotting. Results: Immunoblot analysis revealed that in situ FABP4 protein levels were significantly increased (Mean ±SEM; 2.34 ±0.24 vs. 0.25 ±0.05; p=0.001) in placentas from pregnancies with GDM vs. from normal pregnancies. FABP4 mRNA levels were 5.74-fold higher (p<0.05) in explant cultures of placental villi of pregnancies with GDM vs. normal pregnancies. Moreover, analysis of explant culture media by immunoblotting detected significantly higher FABP4 secretion (129.3 ± 24.8 vs. 11.8 ± 7.8; p=0.011) in placental villi of pregnancies with GDM vs. normal pregnancies. Conclusion: Placentas of patients with GDM display higher amounts of FABP4 protein compared to non-GDM placentas, suggesting placentalderived FABP4 involvement in the pathogenesis of GDM by impairing maternal glucose homeostasis or promoting insulin resistance. Higher levels of FABP4 mRNA expression and protein secretion in explant cultures of GDM placentas also support the hypothesis that increased FABP4 levels in GDM maternal blood may originate from placental FABP4 secretion to impair glucose homeostasis. Neonatal Outcomes in Preterm Trial of Labor in Women without a Prior Vaginal Delivery. Sunitha C Suresh †, Annie Dude * . University of Chicago, Chicago, IL, United States. Introduction: Trial of labor (TOL) after cesarean delivery is associated with a low absolute risk of neonatal morbidity. Few studies have examined the effect of TOL on neonatal morbidity in preterm infants, who account for the majority of neonatal morbidity in non-anomalous neonates. Over half of the women studied in a prior study on preterm TOL had a prior successful vaginal delivery, which increases the likelihood of success. The purpose of this study was to characterize neonatal morbidity following preterm TOL in comparison to elective repeat cesarean section (eRCS) specifically among women without a prior vaginal delivery who may have a lower success rate. Methods: This is a secondary analysis of the MFMU Cesarean Section Registry. Analysis was restricted to singleton pregnancies without a prior vaginal delivery who delivered an infant between 24 weeks and 36 weeks 6 days gestation. Patients with an antepartum stillbirth, major congenital malformations, or an indicated cesarean delivery were excluded. Neonatal outcomes were compared using chi squared analysis between those with a TOL and those undergoing eRCS. Logistic regression was used to control for potential confounders including gestational age. Results: 2120 patients were included in analysis. The TOL success rate was 62.7%. Trial of labor was related to gestational age at time of delivery with 83% of women having a trial of labor at < 30 weeks, and only 48.0% of women having a trial of labor at > 30 weeks. Women with a TOL were less likely to have pre-existing medical conditions, but more likely to have conditions such as abruption and chorioamnionitis (Table 1) . After adjustment for confounders, women with a TOL had no difference in neonatal outcomes with the exception of a decreased risk of proven/ suspected sepsis (adjusted OR 0.69 (0.54, 0.88), Table 1 ). Conclusion: TOL in women without a prior vaginal delivery delivering in the preterm period is not associated with increased neonatal morbidity, and is in fact associated with decrease risk of sepsis. TOL remains a safe option for this patient population. Introduction: A first trimester ultrasound finding of subchorionic hemorrhage (SCH) can be alarming to patients, as little data exists on their impact on pregnancy outcomes. As such, this study aims to evaluate the impact of subchorionic hematoma (SCH) on early pregnancy loss (EPL). Methods: A retrospective cohort study was conducted on 205 patients who received in vitro fertilization treatment and underwent embryo transfer between 2014 and 2018 at Texas Children's Hospital. The primary outcome was EPL and preterm delivery was studied as a secondary outcome. EPL was defined as ultrasound confirmed spontaneous abortion at less than 20 weeks gestation, where gestational age was determined based on date of embryo transfer. Ultrasound imaging completed in the first trimester was reviewed for each patient. Presence, date first noted, size, and largest dimensions of a SCH were recorded. Inclusion criteria were those patients undergoing embryo transfer between 2014-2018. Those without documented first trimester ultrasounds findings were excluded (n=14). Baseline characteristics were compared using chi square and t-test statistics. Multivariate logistic regression was utilized to adjust for baseline characteristics that were statistically significant in the univariate analysis. Adjusted RR were obtained from the regression analyses. The prevalence of SCH was 46.3% in our IVF population between 2014-2018. Of those with subchorionic hemorrhage, 10.5% had early pregnancy loss, compared to 7% in those without SCH (p=0.49, RR 1.38 (0.57-3.36)). Baseline characteristics did not statistically differ between those with and without SCH. No statistically significant relation was found between SCH and rates of EPL or preterm delivery both without and with adjustment for vaginal bleeding (Adjusted RR: 1.15 (0.39-3.50); 0.84 (0.29-2.39)). Largest diameter of SCH was not correlated with EPL (p=0.4). The presence of multiple SCHs, however, did correlate with EPL (p=0.01). Conclusion: Despite high rates of SCH identified in the IVF population, there was no evidence of increased rates of early pregnancy loss or preterm delivery. Further studies must be completed to understand the etiology of IVF and increased rates of SCH to assess for ways in which SCH could impact pregnancy outcomes outside of loss and preterm delivery. Respiratory Morbidity in Subsequent Pregnancy. Naima Ross †, Sunitha Suresh †, Ann Dude * . University of Chicago, Chicago, IL, United States. Introduction: Prior studies have demonstrated a potential genetic contribution to respiratory distress syndrome (RDS). Delivery in the late preterm period is a known risk factor for respiratory morbidity. It is not well established whether a history of an infant with respiratory problems at birth relates to respiratory morbidity in a subsequent pregnancy. Methods: This is a secondary analysis of a randomized control trial of antenatal corticosteroids (ACS) in the late preterm period (34+0 to 36+6 weeks gestation). Multiparous patients were included, and participants with a prior delivery at <34 weeks were excluded. Demographic characteristics were compared between those with a self-reported history of a neonate with respiratory problems and those without. The presence of respiratory morbidity (major respiratory morbidity (MRM), RDS, or transient tachypnea (TTN) of the newborn) was compared by history of a previous infant with respiratory problems. Logistic regression was performed to adjust for confounders, including gestational age and variables significantly different between groups at a p of 0.1. The analysis was repeated stratified by any betamethasone (BMZ) use. We included 1,412 multiparous patients. Those with a prior infant with respiratory problems were more likely to be non-Hispanic, have private insurance, and have infants with higher birth weight (Table 1) . MRM was more likely if mothers reported a history of a prior infant with respiratory morbidity (adjusted OR 1.90 95% CI [1.20, 3 .02]). Similar results were seen for RDS and a composite of RDS/ TTN/Apnea ( Figure 1 ). When stratified by administration of BMZ, respiratory morbidity was only more likely among those who did not receive BMZ (aOR for MRM in BMZ group 1.92 [.93, 3.96] ). Conclusion: A history of a late term/ term infant with respiratory problems at birth is associated with respiratory morbidity in a subsequent late preterm/ term infant. Future work is needed in both determining the underlying pathophysiology of respiratory morbidity in the late preterm/ term period, and the utility of ACS in patients with a history of respiratory morbidity in early term gestation. systems. An important regulator of developmental physiology is the gut microbiome. These infants often develop dysbiosis during their NICU stay, which could have potential eff ects on many developing systems. Apart from determining composition, predicting functional potential of the microbiome may provide important new insights into factors that shape later growth and development. Methods: Stool samples were collected weekly up to eight weeks from 83 preterm infants (mean gestational age 28 weeks). The V4 region of 16S rRNA gene was PCR amplifi ed and sequenced in a paired-end manner on the MiSeq platform (Illumina). The DADA2 pipeline was employed to predict Exact Sequence Variants (ESVs) and deduce bacterial taxonomy. To compare these preterm infants with appropriate controls, publicly available comparable 16S raw data from term infants were accessed from a previous study (Pannaraj et.al., 2017) and were analyzed with the preterms. Overall, a total of 375 and 112 specimens from preterm and term infants, respectively, were studied. Metagenomic assemblies and functional potential were achieved by piphillin using the KEGG database (Oct 2018 version). The preterms displayed marked Gammaproteobacteria abundances during this period and alpha diversity was low throughout the study in comparison to term infants. Pathway prediction identifi ed 317 bacterial metabolic pathways in the preterms and 325 in the term infants. There were fi fteen pathways predicted in term infants that were not found in preterms. Apart from these, a total of 228 metabolic pathways were signifi cantly diff erent in abundance between the groups. A few of them, which were most signifi cantly lower in preterms, are shown in Figure 1 and include alanine, aspartate and glutamate metabolism (KO00250), Vitamin B6 metabolism (KO00750), Sphingolipid metabolism (KO00600) and peroxisome (KO04146). The present study constitutes one of the fi rst attempts to correlate gut microbiome composition to predicted function, to ultimately predict relationships between early gut microbiome composition to later physical and mental growth and development. However, metagenomic and metatranscriptomic, along with metabolomic follow-up studies, will be essential to help validate these predictions. Introduction: Postpartum venous thromboembolism (VTE) is a signifi cant contributor to maternal morbidity and mortality. National guidelines have called for postpartum risk-stratification protocols to identify patients at elevated risk of VTE who would benefi t from chemical thromboprophylaxis. We aimed to evaluate modern trends in VTE incidence and use of chemical thromboprophylaxis in postpartum patients in a large, insurance-claims database. Secondarily, we aimed to evaluate VTE and thromboprophylaxis use by delivery mode and location. Methods: This was a retrospective cohort study of all females aged 16 to 50 years with at least one delivery (>20 weeks gestation) in the IBM MarketScan Research Database between 2008 and 2017. The fi rst delivery from 2009 through the fi rst half of 2017 was included. VTE events were identifi ed by International Classifi cation of Diseases 9 th and 10 th Revision codes. Administration of chemical prophylaxis (low molecular weight heparin or unfractionated heparin) was identifi ed using medication codes. Women with a VTE prior to delivery were excluded. The rate of VTE and chemical thromboprophylaxis in the fi rst 12 weeks postpartum was estimated over the full study period and by year. VTE and chemical thromboprophylaxis use rates were compared across years with a test of trend. Diff erences by mode of delivery and urban versus rural location were tested with a Cochran-Mantel-Haenszel statistic. Results: Of 3,145,105 individuals included for analysis, 4,480 (0.14%) had a VTE in the first 12 weeks postpartum, and 10,173 received postpartum chemical thromboprophylaxis (0.32%). The rate of VTE decreased over time from 0.19% in 2009 to 0.09% in 2017 (p<0.001 for test of trend), while the rate of chemical thromboprophylaxis increased from 0.37% to 0.53% over the same period (p<0.001 for test of trend). One-third (34%) of women delivered by cesarean and the majority (87%) delivered in an urban hospital. The rate of VTE decreased and the rate of thromboprophylaxis increased across all modes of delivery and delivery locations, but signifi cantly more among cesarean deliveries and urban deliveries (p<0.001 for test of trend). The incidence of VTE decreased while rates of chemical thromboprophylaxis increased over time in this U.S. cohort. It is unknown whether changes in prophylaxis, or other changes to obstetric care over this time period, reduced VTE events. Biological evidence indicates that smoking, excessive alcohol consumption and obesity may lead to sperm oxidative DNA damage, being a known risk factor for pregnancy loss. The aim of this systematic review and meta-analysis was to evaluate the association between paternal lifestyle factors in the preconception period and the risk of pregnancy loss. Methods: PubMed and Embase databases were searched in August 2020. Paternal factors examined were: cigarette smoking, alcohol consumption and Body Mass Index (BMI). A qualitative risk of bias assessment was performed for all included studies. Meta-analysis was performed if sufficient data were available from studies that controlled for maternal factors. PRISMA guidelines for systematic reviews were followed. Results: The systematic search included 3386 articles of which 11 articles met the inclusion criteria. In a meta-analysis ( Figure 1 ) of eight studies, paternal smoking of >10 cigarettes per day in the preconception period was found to be associated with an increased risk of pregnancy loss, after adjustment for maternal smoking status (1-10 cigarettes per day: 1.01, 95% CI 0.97-1.06; 11-20 cigarettes per day: 1.12, 95% CI 1.08-1.16; >20 cigarettes per day: 1.23, 95% CI 1.17-1.29). Based on five available studies, no clear association was found between paternal alcohol consumption and pregnancy loss. No studies were retrieved that evaluated the association between paternal BMI and pregnancy loss. Conclusion: Awareness of the association between paternal smoking in the preconception period and the risk of pregnancy loss should be raised. More well-designed studies are needed to further investigate the effects of paternal lifestyle factors, including obesity and alcohol consumption, on the risk of pregnancy loss. The The performance parameters of UA components to predict UTI on urine culture were calculated. Primary outcome was UTI. Secondary outcomes included preterm delivery, maternal and neonatal outcomes. Results: 92 were initially treated for UTI, and 59% were treated after an asymptomatic bacteriuria diagnosis. Of those treated based on UA, 33% were found to have a confi rmed UTI on urine culture. Among UA components, positive nitrite was the most specifi c (99.6%), however the most sensitive component was presence of blood (43.5%). Positive nitrites, 3+ blood, or any amount of all three components were also found to be very specifi c (99.6, 96.8, 99.9%). Changes in the Antepartum Population Over Time. Anna J Rujan †, Ashley Hesson * , Deborah R Berman * . University of Michigan, Ann Arbor, MI, United States. Introduction: The characteristics of the modern antepartum population are under researched. Existing data from the 1990s indicate that antepartum patients are more likely to be young, black, and without private insurance, but the modern population has not been studied. Furthermore, this population makeup may be quite dynamic as maternal interventions, neonatal resuscitative capabilities, and fetal therapies continue to progress, changing the limits of viability, interventional thresholds, and indications for long-term admissions. We characterize the antepartum hospitalizations of a large tertiary care center and report trends in the composition of the antepartum population over a nine-year retrospective period. Methods: All births occurring at a single center between the years 2011 and 2019 were identifi ed, as were patients admitted for at least 96 hours to the antepartum service. Chart review was conducted to obtain demographic, pregnancy, and neonatal outcome information. Descriptive statistics, Student T tests, Chi-squared tests, linear modeling, and Pearson product-moment correlations were used as appropriate to characterize underlying diff erences between the antepartum and general obstetric populations and changes in this relationship over time. Results: When evaluated comprehensively over the study period, the antepartum group was younger (29.5 vs 30.5 years, P<0.01), delivered earlier (269 vs 272 days, P<0.01), and had more prior deliveries (0.61 vs 0.50 gestations, P<0.01) than the general obstetric population. The distribution of patient race between the antepartum group and the general group was similar (P=0.18) and the proportion of non-white patients has not signifi cantly increased over the study period as a whole (P=0.28). Notably however, the proportion of non-white patients is increasing at a greater rate in the antepartum population than in the general population over the last three years (beta=0.046 vs 0.011). The antepartum population is an at-risk population at baseline. This analysis suggests they are becoming even more vulnerable as gestational age at delivery continues to decrease and race disparities (percent of non-white antepartum patients) are trending upwards. Racial We sought to examine whether racial and ethnic differences were associated with mode of delivery for women undergoing an induction of labor. We conducted a secondary analysis of a retrospective cohort study of all women for whom a labor induction was performed at Yale-New Haven Hospital from February 1, 2013 to August 1, 2014. Data including maternal age, race/ethnicity, body mass index (BMI), history of cesarean delivery, indication and length of induction, gestational age, and maternal morbidities such as diabetes and hypertension were abstracted from electronic medical records. The primary outcome was mode of delivery. Adjusted logistic regression analyses were performed to determine the association between the probability of cesarean delivery during an induction of labor and race/ethnicity. Results: 1002 patient records were reviewed and 176 patients were excluded since they only received cervical ripening. Among 826 patients, 24.4% underwent cesarean delivery. Cesarean delivery was significantly more common among Asian, Hispanic and non-Hispanic Black women than among non-Hispanic White women; this association persisted for all racial/ethnic groups even after adjustment for other sociodemographic variables and maternal characteristics, including BMI, parity, bishop score, use of epidural analgesia, use of maternal antibiotics, length of induction, prior vaginal delivery, any hypertensive or diabetes diagnosis, gestational age, and medical insurance status. Non-Hispanic black and Asian women have the highest increased odds of a cesarean delivery during induction of labor compared to non-Hispanic white women with adjusted OR 2.65 (95% CI 1.54-4.56) and aOR 2.69 (95% 1.32-5.48), respectively. Conclusion: All non-white racial/ethnic categories were found to have a 2-3 fold increased risk of cesarean delivery during induction of labor. The underlying reasons for this finding should be further examined in order to optimize maternal health by decreasing the morbidity associated with cesarean delivery and to eliminate the prevalent racial disparities in obstetric care. Introduction: Cardiovascular disease (CVD) is the number one cause of death among women and defining cardiovascular risk (CVR) factors is necessary to reduce its prevalence. A history of preeclampsia or preterm birth has been correlated with increased risk of maternal cardiovascular disease later in life. However, whether a history of spontaneous preterm birth (SPTB), about two thirds of all preterm births, also predisposes to higher CVR is unknown. Methods: We prospectively included 350 women with a history of SPTB between 22 and 37 weeks (cases) and matched them with 166 women with a history of a term birth (controls). In both groups women with pregnancy complications that are known to be associated with CVD, mainly hypertensive disorders of pregnancy and gestational diabetes in any of their pregnancies, were excluded. Both groups underwent cardiovascular risk assessment 9 to 16 years after pregnancy. We performed a subgroup analysis based upon the severity of SPTB defined as extreme preterm (GA 22+0 -27+6 weeks), very preterm (GA 28+0 -31+6 weeks) and moderate preterm (GA 32+0 -36+6 weeks) and compared spontaneous preterm delivery of a girl with spontaneous preterm delivery of a boy. Results: We found no significant differences in hypertension, blood and urine fasting lipids, Framingham Risk Score (FRS) and Systematic Coronary Risk Evaluation (SCORE). Women with a history of SPTB only had significantly higher diastolic pressure (74.6 ± 9.7 mmHg vs. 72.5 ± 9.7 mmHg, p=.023) and were significantly more often diagnosed with abdominal obesity (n=163, 46.6% vs. n=54, 32.5%, p=.003). Abdominal obesity was more pronounced with more severe preterm birth. The number of boys was higher in the cases. With cases preterm birth of a boy was associated with a lower CVR compared to women who had a preterm birth of a girl. Conclusion: Cardiovascular risk was comparable between women with a history of SPTB compared to women with a history of uncomplicated term birth 9 to 16 years after pregnancy, in this prospective study in which women with other complications of pregnancy were excluded. Transcriptomic Highly concordant DMC and DEG, based on an inverse correlation of transcripts vs. methylation levels, were used to identify markers of endothelial programming by multivariable logistic analysis. Results: Few DMC were found in females (164 CpG) and males (84 CpG), but comparison of top 1,000 sites (non-adjusted p < 0.01) resulted in FGR-and sex-specific clustering ( Figure 1A ). Top-1,000 DEG resulted in FGR-specific, but not sex-specific clustering ( Figure 1B ). FGR samples presented epigenetic (12 DMC) and transcriptional (8 DEG) biomarkers of aging compared to controls. Conversely, five DMC selected according to their inverse relation with DEG, allowed to discriminate between FGR and control (AUC, 0.93, Figure 1C ), and this model was improved when sex-specific DMC were selected. Conclusion: Vascular dysfunction related with FGR may result from accelerated aging, as shown at epigenomic and transcriptional level in the umbilical endothelium. Furthermore, this profile allows to discriminate between growth restricted or normal growth intrauterine conditions, in a sex-specific manner. Additional studies are required to address the applicability of these markers to diagnose postnatally when impaired fetal growth has been missed during pregnancy. Funded by Fondecyt 1181341. Introduction: Since the developing fetal heart beats directly against placental vascular bed resistance, optimal placental vascular function is likely vital for healthy fetal cardiovascular development. Fetal growth restriction (FGR) is strongly associated with diminished placental vasculature, but the exact mechanisms involved and specific implications for the fetal cardiovascular system are unknown. Here, we use a rat model of glucocorticoid excess to examine the feto-placental vasculature in FGR, using a novel, integrative approach encompassing structural and molecular analysis techniques. Methods: Pregnant Wistar rats were administered dexamethasone acetate (DEX) from embryonic day (E)13 to E21 (term is E22). 3D feto-placental vascular casts were obtained via perfusion of radiopaque contrast medium and assessed with μ-CT scans. Expression of angiogenic markers and mechanoreceptors involved in endothelial sensing of blood flow were quantified in the placenta and fetal heart by RT-qPCR. Results: DEX animals exhibited fetal (20%; P<0.001) and placental (34%; P<0.01) growth restriction by E21. 3D casts showed that the placental arterial network volume was 50% lower in DEX (P<0.01); attributed to decreased arterial length (45%; P<0.01) and branching (58%; P<0.05) (Fig 1A) . This was accompanied by a 40% reduction in Nos3 expression (P<0.05) and trends for increased expression of the mechanoreceptor Piezo1 (P=0.053) but reduced Itgb1 (P=0.055) in DEX placentas. DEX treatment increased fetal heart volume relative to body weight by 50% (P<0.01; Fig 1B) , and substantially increased the volume and diameter of the fetal aorta ( Fig 1C) . This corresponded to elevated fetal cardiac Vegfα (68%; P<0.05; Fig 1D) There is an overlap in mechanism of disease between PE and spontaneous preterm birth (SPTB) in terms of vascular disorders found in the histology in the placenta. Therefore, we aimed to determine whether SPTB, one of the most prevalent complications in pregnancy, also predisposes to HFpEF. Methods: Cases were women with a history of SPTB, who were matched to a control group consisting of women with uncomplicated term pregnancies. In both groups women with other pregnancy complications in any pregnancy, including hypertensive disorders and gestational diabetes, were excluded. Both groups underwent echocardiographic investigation 9 to 16 years after pregnancy. We performed a subgroup analysis for the echocardiographic findings based upon the severity of SPTB defined as extreme preterm (GA 22+0 -27+6 weeks), very preterm (GA 28+0 -31+6 weeks) and moderate preterm (GA 32+0 -36+6 weeks). Results: A total of 94 cases and 94 controls were included, on average 13 years after the index pregnancy. Echocardiographic measures of LV diastolic dysfunction did not differ between the groups. Diastolic dysfunction was diagnosed in 2.1% of the cases and 4.3% of the controls (p=.682). No differences in the subgroup analyses were found. Conclusion: This study is the first that investigated LV diastolic dysfunction in women with a SPTB as an early parameter of CVD. We conclude that women with a history of SPTB have no increased risk on LV diastolic dysfunction later in life. Therefore, the increased risk of CVD after SPTB may result from other mechanisms in vascular injury. ) exhibit potent antiinflammatory activity, while certain saturated fatty acids (SFA; e.g. 14:0, 16:0, 18:0) exhibit pro-inflammatory activity. However, in human pregnancy the relationships of FAs to maternal systemic inflammation and maternal and newborn body composition are not well characterized. Erythrocyte membrane FAs (eFA) provide a stable index of dietary FA intake over time. In the present study, we address relationships between eFAs, plasma cytokines, % maternal fat (%MF), and % neonatal body fat (%NF). Methods: Pregnant women (n=71), evenly distributed between body mass index classes, were recruited in the 1 st trimester. %MF was estimated using air displacement plethysmography (ADP) during the 1 st and 2 nd trimesters. Maternal plasma cytokines (ELISA) and eFA (GC-MS/MS and GC-FID) were determined during the 3 rd trimester. %NF was obtained by ADP for 44 of the infants within 24-72 hours post-delivery. Relationships between variables were examined using Pearson's r correlation. Results: The maternal n-6/n-3 ratio was significantly increased in women with higher %MF (p=0.01), but was not associated with maternal cytokines nor with %NF (Table) . ω-3 FAs were negatively associated with %MF (DHA p=0.008; DPA p=0.001) and IL-6 (DHA p=0.017; DPA p=0.006) and positively associated with adiponectin (DHA p=0.001; DPA p=0.002). The sum of 14, 16, 18:0 SFA (ΣSFA) positively correlated with IL-6, %MF, and %NF (p=0.007, 0.026, and 0.02, respectively) and negatively correlated with adiponectin (p=0.003). Conclusion: Specific pro-inflammatory maternal eSFAs were related to %MF and cytokines, suggesting that a Western-style diet is associated with increased maternal adiposity and inflammation. Since only ΣSFA correlated with %NF, maternal SFAs during gestation may play a role in mediating neonatal adiposity. Further investigation is warranted into mechanisms by which specific maternal SFAs may mediate neonatal adiposity. Maternal (NAFLD) . Hematopoietic stem and progenitor cells (HSPCs) develop in the fetal liver then migrate to the bone marrow (BM), seeding both tissues with hematopoietic cells that will last a lifetime. However, the impact of maternal WSD (mWSD) on fetal HSPC development and postnatal function of HSPCs and macrophage (Mφ) is unclear. Methods: We studied HSPC from the BM and liver of early third trimester non-human primate (NHP) fetuses exposed to mWSD, and BM HSPCs and BM derived Mφ (BMDM) from 3-year-old (3YO) NHP exposed to mWSD and weaned onto a chow diet (CD) at 7 months of age. We used fl uorescence lifetime imaging (FLIM) of NADH and FAD to measure glycolysis and oxidative phosphorylation (oxphos) in HSPCs, and metabolome profi ling in bone marrow and liver immune cells. Bulk RNA-sequencing was used to measure HSPC gene expression in fetal BM and a nanostring panel of immune response genes was used to assess BMDM gene expression in 3YO. Ingenuity pathway analysis was used to identify pathways and regulators in HSPCs and BMDM. Hepatic collagen content was measured using second harmonic generation imaging. Data were analyzed by t-test. Results: FLIM and metabolite profi ling demonstrated that BM and liver HSPCs from mWSD fetuses have increased glycolysis and decreased oxphos, and a similar signature was found in BM HSPCs from mWSD 3YO. Bulk RNA-sequencing of mWSD fetal BM HSPCs showed gene expression consistent with activation of infl ammatory pathways. The top predicted regulators were CEBPA and CD38, which both regulate hematopoiesis and response to infl ammatory signals. Gene expression in BMDM from mWSD 3YO demonstrated increased NFKB activation, increased glycolysis, decreased oxphos, impaired anti-infl ammatory response to IL4, and a pro-infl ammatory response to LPS. Finally, livers from fetal and 3YO mWSD off spring had increased collagen deposition, a feature of fi brosis and NAFLD. Conclusion: Our fi ndings demonstrate that mWSD drives fetal metabolic programming at the level of HSPCs and Mφ, which suggests that fetal rewiring of immunity may precede obesity and plays a formative role in the development of a pro-infl ammatory, pro-fi brotic disease pattern in the fetal liver that persists at 3YO. Sex-Specific Differences in Immune Dysregulation Following Exposure to Maternal Infl ammation. Jin Liu †, Yang Liu †, Anguo Liu †, Jun Lei * , Irina Burd * . Johns Hopkins University, Baltimore, MD, United States. Introduction: Infl ammation during pregnancy can disrupt regulatory/ effector immune response balance, which may result in long-term sequelae in the neonates such as allergy and other immune disorders. We have previously found a dysregulation in maternal adaptive immune following intrauterine infl ammation exposure. Here, we extend our studies to determine whether maternal infl ammation may contribute to fetal immune programming dysregulation and whether there are any sex-specifi c diff erences. Methods: At embryonic day (E)14, CD1 dams (n=16, 8/treatment group) were randomly allocated into two groups: intraperitoneal injection (IP) of 100uL phosphate-buff ered saline (PBS) or 0.5ug/100uL PBS of murine recombinant IL-1β (rIL-1β). The dams were injected for four consecutive days to simulate maternal sub-chronic infl ammation (MI). 26 pups (13 dams/2 pups per dam) were randomly selected to be euthanized by CO2 exposure at post-natal day (PND) 12. Furthermore, to investigate how MI contributed to the immune response when the pups encountered the challenges during their postnatal days, pups received IP rIL-1β treatment at PND12. 32 pups were randomly selected to receive 0.125ug/50uL rIL-1β or 50uL PBS. Splenic immune cells were characterized using fl ow cytometry after 24 hours (24hpi). Forkhead box P3(Foxp3) expression was evaluated by intranuclear staining and analyzed by fl ow cytometry. One-way-ANOVA and unpaired-t test were used for data analysis. Results: Splenic CD8+ T cells (Teff ) in MI pups decreased (p<0.05) with no changes in splenic Tregs. The ratio of Treg/Teff were higher (p<0.05) in MI pups than in control. Notably, Treg/Teff of MI female pups was 1.5 times higher than that in male pups (p<0.01). After pups received rIL-1β, we found that Teff cells in control pups decreased (p<0.001), Tregs in MI pups increased (p<0.001), and Treg/Teff increased in control pups. Male pups had a higher ratio of Treg/Teff than that in female pups in MI group (p<0.01). Conclusion: Perinatal exposure to maternal infl ammation exhibited sex-specifi c diff erences. Compared to female pups exposed to maternal infl ammation, male pups had decreased Treg/Teff , which indicated that male pups were more sensitive to infl ammation exposure. Furthermore, following maternal infl ammation exposure, males encountering post-natal infl ammation challenge, showed more immune dysregulation compared to females. Objective: To determine the relationship between fetal growth and HPA-A stress response to a psychosocial stressor in a large population of young adults. Methods: Participants: A total of 917 participants aged 18 were sourced from Gen 2 of the Raine Study. Measurements: Detailed obstetric and neonatal biometric data were collected. Plasma and salivary measures of cortisol and ACTH were measured before and after the Trier Social Stress Test (TSST). Results: An inverse linear relationship was observed between fetal growth and basal cortisol, peak cortisol, area under the curve above ground (C-AUCg) of plasma cortisol and adrenal sensitivity (C-AUCg/ACTH-AUCg). Similar results were demonstrated for salivary cortisol. Further, participants born in the upper tertile of birthweight had an attenuated and delayed cortisol response to the TSST compared to those in the middle and lower tertile. No quadratic relationships were identified. No associations were found between measures of fetal adiposity and HPA-A function at age 18. Removal of anticipatory responders from the models substantially attenuated the observed relationships. Conclusion: Using a gold standard HPA-A assessment, we confirmed an inverse linear relationship between fetal growth and HPA-A function at age 18. This differs from the inverse parabolic relationship (inverted J curve) reported in adults of advanced age. Our data suggest that decreased adrenal sensitivity may play a role in the relationship between birthweight and HPA-A function in later life. Methods: Based on our success of analyzing exosomal GEP of SVATs in peripheral plasmas of young children with autism spectrum disorder (ASD), from which a statistical significance of GEP for SVAT-associated lncRNAs at genetic loci of STX8, SYT9, SYT15, SV2C, SLC18A2, and SYP, and four of SVAT-associated mRNAs at SYT9, SYT15, SV2C, and SYP were differentially expressed, we developed a real-time assessment, on a weekly basis during pregnancy from the 11th to the 40th gestational week (GW), for longitudinal dynamic monitoring GEP of SVAT molecules within exosomes that are circulated in maternal plasmas. Our results showed that SVAT-associated lncRNAs/mRNAs were differentially expressed from the first trimester of pregnancy to the term of birth (Figure 1 ), suggesting that GEP of SVAT-mRNAs has been epigenetically regulated by SVAT-lncRNAs during the period of intrauterine development of fetal neural circuits. Comparing pathological pregnancies, including spontaneous preterm birth (sPTB), preeclampsia (PE), and gestational diabetes mellitus (GDM), to normal pregnancies, we established specific correlations of SVAT-lncRNA and SVAT-mRNA of STX8, SLC18A2, and SYPwith sPTB; SVAT-lncRNA and SVAT-mRNA of STX8 with PE; and SVAT-lncRNA and SVAT-mRNA of SV2C as well as SVAT-mRNA of SYP with GDM ( Figure 2 ). Conclusion: Our study concluded that variant complication in pathological pregnancies may alter GEP of the SVATs, which is likely to affect the intrauterine development of neural circuits and consequently influence the fetal brain development. Qiwei Yang, Ayman Al-Hendy. University of Chicago, Chicago, IL, United States. Introduction: The period during which tissue and organ development occurs is a time of exquisite sensitivity to environmental exposure. However, the mechanisms by which the epigenome is disrupted in response to developmental insult leading to an increased risk of hormonedependent diseases such as uterine fibroids remain unclear. In recent years, high-throughput sequencing technologies provide unprecedented opportunities to depict the development of diseases at multiple molecular levels. The integration and analysis of these multi-omics datasets allow us to yield a better understanding and a clearer picture of the system under study. Methods: Female newborn Eker rats (5 animals per group) were treated subcutaneously with vehicle (VEH) or 10 µg of diethylstilbestrol (DES, a tool compound for environmental EDCs) on postnatal days 10-12, a critical period of uterine development. Myometrial stem cells (MMSCs) were isolated from 5 month-old myometrium tissue (N=5 for each group) using Stro-1 and CD44 surface markers. The multiple high-throughput omics sequencing including RNA-seq, CHIP-seq, and Reduced Representation Bisulfite Sequencing (RRBS) was performed to determine the transcriptome and epigenome landscapes of DES-exposed MMSCs (high-risk) and VEH-exposed MMSCs (low-risk). Fisher's exact and Student's T-test were used for statistical analysis. Results: RNA-seq and ChIP-seq (H3K4me3) revealed 2922 and 6473 differentially expressed and H3K4me3 mark differentially enriched genes respectively. Integration analysis of RRBS, ChIP-seq, and RNA-seq demonstrated that among 1474 EDC-upregulated genes with expected direction, 47.1% of genes were correlated with H3K4me3 enrichment. 25.6% of genes with DNA hypomethylation were correlated with EDCinduced upregulation of RNA expression. Among 1448 EDC-down regulated genes, 33.5% of genes were correlated with H3K4me3 reduction and 10.2% of genes were correlated with DNA hypermethylation. The co-regulation analysis demonstrated that 23.1% and 11.5% of EDCupregulated and -downregulated genes exhibited overlap between H3K4me3 and DNA methylation. Considering expected direction analysis, the status of H3K4me3 (enrichment or reduction) plays a dominant role in regulating gene expression in MMSCs genome-widely in response to EDC exposure. There is a significant difference between the number of genes with H3K4me3 enrichment+ hypomethylation verse H3K4me3 reduction+ hypermethylation (p<0.001). Conclusion: Together, these data set the stage to study MMSCs as the myometrial stem/progenitor cells that are the target for environmental exposure. Moreover, these studies will be helpful to develop novel interventions to prevent and/or decrease morbidity associated with uterine fibroids. The Impact of Anticoagulation Use on Cell-Free DNA Metrics for Women without Autoimmune Disease. H MacKinnon †, T Kolarova †, J Hedge †, E Vinopal †, S Delaney * , C Lockwood * , R Shree * . University of Washington Medical Center, Seattle, WA, United States. Introduction: Previous studies showing an association between anticoagulation and indeterminate cell-free DNA (cfDNA) results have included women with autoimmune disease, which alone is associated with indeterminate results likely from low fetal fraction (FF). We sought to evaluate differences in cfDNA test metrics for women on anticoagulation without autoimmune disease compared to controls. Methods: Retrospective, single institution cohort study of singleton pregnancies with a previously validated cfDNA assay using whole genome sequencing. Women with autoimmune disease and pregnancies with suspected aneuploidy were excluded. Anticoagulation included unfractionated heparin (UFH) and low-molecular-weight heparin (LMWH). An indeterminate result was defined as FF<4%. We evaluated the association between maternal anticoagulation use and FF, indeterminate rate, and total cfDNA concentration using univariate and multivariate analyses, controlling for body mass index (BMI) and gestational age (GA) at sample collection. Results: Of 1, 283 patients, 22 were on anticoagulation (2 on UFH; 20 on LMWH). In those on anticoagulation, FF was signifi cantly lower (9% vs 12%, p=0.01), the indeterminate rate was signifi cantly higher (18% vs 4%, p<0.001), and the total cfDNA concentration was signifi cantly higher (371.1 pg/uL vs 101.9 pg/uL, p<0.001) compared to controls. After controlling for maternal BMI and GA at sample collection, anticoagulation was associated with a 6-fold increase in the likelihood of an indeterminate result (p<0.01) [ Table 1 ]. In linear regression, anticoagulation was signifi cantly associated with decreasing FF (p<0.01) and increasing total cfDNA concentration (p<0.001) [ Figure 1 ]. Conclusion: Women on anticoagulation without autoimmune disease have lower FF, higher rates of indeterminate cfDNA results, and higher total cfDNA concentration compared to controls. This suggests a possible dilutional eff ect of anticoagulation on cfDNA assays used for non-invasive prenatal screening and warrants further studies to elucidate precise mechanisms. Fetal Membrane Cells and Their Exosomes A Gateway for Drug Transportation during Pregnancy. Ananth Kumar Kammala, Lauren Richardson, Enkhtuya Radnaa. The University of Texas Medical Branch, Galveston, TX, United States. Introduction: During pregnancy, the drug transport mechanism has been well established in placental tissue utilizing several transporters proteins (TPs). Fetal membranes (FM) or amniochorionic membranes are one of the most intriguing tissues in the intrauterine cavity that is essential for the protection of the fetus, maintenance of pregnancy. However, its role in drug transport is not studied. We hypothesize that human fetal membranes and exosomes derived from the membrane cells express drug TPs and can function as a gateway for drug transport during pregnancy. This study determined the diff erential expression of TPs in fetal membrane cells and exosomes derived from them. Methods: Immortalized human amnion epithelial cells (AECs), amnion mesenchymal cells (AMCs), and chorion trophoblast cells (CTCs), were cultured in normal conditions. Exosomes were isolated from media from each cell type using diff erential ultracentrifugation followed by size exclusion chromatography. Cells and their respective exosomes were screened for the expression of four distinct TPs: P-glycoprotein (P-gp), breast cancer resistance protein (BCRP-1), organic anion/cation transporters (OAT), and Serotonin Transporter protein (SERT) by western blot, and immunofl uorescence staining. The human placental cell line (BeWo) was used as control. Results: The effl ux TP, P-gp expression was signifi cantly higher in amnion cells (both AECs and AMCs) compared to CTCs (both P<0.01). In contrast, the expression levels of BCRP-1, another effl ux TP, and OAT-1, an infl ux TP, were signifi cantly higher in CTCs compared to amnion cells. SERT, a serotonin uptake TP, was expressed in all FM cell types but its expression was signifi cantly lower in AECs compared to the other FM cells (all P<0.05). We further examined TPs in exosomes from membrane cells. Signifi cantly higher expression of P-gp was seen in CTC-derived exosomes compared to AEC and AMC-derived exosomes (p<0.001) whereas BCRP-1, OAT-1, and SERT were expressed in signifi cantly higher amounts in AMC-derived exosomes than in CTC-derived exosomes (p<0.05). The results were summarized in Introduction: Genetic and fetal structural abnormalities were identifi ed as the potential cause of death in 13.7% stillborn fetuses (SB), while chromosomal microarray (CMA) identified copy number changes (CNCs) in 44 (9.5%) SB. However, the relationship between specifi c CNCs, fetal malformations and SB remains uncertain. Thus, we evaluated the associations between specifi c CNCs and fetal structural anomalies among SB. Methods: We conducted a secondary analysis of the Stillbirth Collaborative Research Network study among SB (n=388) with CMA and postmortem examinations of the fetus and placenta. Major anomalies were grouped by anatomic system and specifi c anomaly type. To detect CNCs, we used single-nucleotide polymorphism array with ≥500 kb. We classifi ed CMA into two groups: normal defi ned as no CNCs or benign CNCs, and abnormal defi ned as pathogenic CNCs (including aneuploidy) or variants of unknown clinical signifi cance (VOUS). We compared proportions of abnormal and normal CNCs between SB with and without structural anomalies using the Wald Chi-squared test. The proportion of anomalous SB with pathogenic/VOUS CNCs (46.7%) was higher in comparison to those with benign CNCs (19.6%; p<0.001). Anatomic system malformations including cystic hygroma, hydrops, and gastrointestinal, cardiac, skeletal and cranial defects were significantly associated with pathogenic/VOUS CNCs. We identified a pathogenic deletion CNC associated with a skeletal defect involving fortysix genes and a pathogenic duplication CNC associated with a cardiac defect involving four genes. Conclusion: Findings reported herein provide evidence for specific CNCs associated with fetal malformations among SB and warrant further investigation of the identified genes. Knowledge of the specific pathogenic chromosomal abnormalities associated with fetal anomalies may improve fetal genotype-phenotype databases and assist practitioners in designing care plans for anomalous fetuses with increased risk for SB. Introduction: Per-and polyfluoralkyl substances (PFAS), a class of synthetic chemicals present in commercial products, have been detected in the blood of >95% of the United States population. Human exposure is associated with adverse health effects including endocrine disruption, liver and immune toxicity, and developmental effects. Increasing evidence raises concerns that maternal PFAS exposure is associated with adverse pregnancy and birth outcomes, including maternal hypertensive disorders, thyroid hormone disruption, and fetal growth restriction. We recently found that PFAS levels are two to four times higher in the blood of Pittsboro, NC residents than the U.S. population as a whole, likely due to highly contaminated drinking water drawn from the Haw River. Methods: To understand if maternal PFAS exposure to Pittsboro, NC residents during pregnancy may lead to adverse health outcomes, we evaluated relevant pregnancy endpoints using an in vivo rabbit model. Female New Zealand White rabbits were supplied control (no detectable PFAS levels) or PFAS-contaminated drinking water, which was formulated with PFAS to resemble levels measured in tap water collected from Pittsboro, NC (10 PFAS compounds; total PFAS load = 758.6 ng/L). Dams were bred one week after drinking water exposure began and sacrificed on gestational day 25. All data was analyzed with each dam representing a biological replicate (control, n=5; PFAS-mixture, n=6), with kits as repeated measures when applicable. Results: Maternal PFAS exposure led to increased body weight corrected for gravid uterus weight (p=0.002) and liver weight (p=0.001) and decreased fetus number (p=0.03). PFAS-exposed dams were anecdotally observed to have small lesions across the uterus and two dams had late fetal resorptions, which was not observed in controls. Placenta weight from exposed dams trended heavier than control placentas (p=0.06). There was no change in fetal body weight, crown rump length, and brain weight (absolute and adjusted; p>0.05). Maternal blood pressure, taken via indirect doppler arterial measurements at baseline and GD25, showed PFAS-exposed dams with increased mean arterial blood pressure as compared to control dams (p=0.01). Blood chemistry analyses showed PFAS-exposed dams had increased blood area nitrogen: creatinine ratio (p=0.0008), calcium (p=0.02), and glucose (p=0.04). Conclusion: Maternal PFAS exposure in an in vivo model leads to maternal health effects, including hypertension, increased maternal body and liver weight, poor kidney function, and adverse pregnancy outcomes like decreased kit number. Future work will investigate physiology and function of target organs (placenta, uterus, liver, kidney) through pathology, serum biomarker assays, hormone measurements, and related gene and protein expression. There is no ability to predict which Mo/Di twin pregnancy will progress to TTTS, thus current recommendations are to survey these pregnancies every two weeks via ultrasound. Preliminary data show differences in miRNAs between mild and severe TTTS stages. MicroRNAs (miRs) are small RNAs that regulate gene expression and are associated with many obstetric disease processes, including preeclampsia, fetal growth restriction, and pregnancy loss. To date no studies have evaluated the relationship between amniotic fluid (AF) miR and maternal serum (MS) miR in pregnancies complicated by TTTS. The primary objective of this study is to determine whether there is a correlation between the miRNA profiles in the AF and the maternal serum in TTTS cases undergoing laser treatment. Methods: This is a prospective cohort study. AF and MS were collected at the time of selective fetoscopic laser photocoagulation from monochorionic diamniotic twin pregnancies with TTTS at any stage and those samples were stored at -80° C. RNA was extracted from the AF and MS samples using the miRNeasy Mini Kit (Qiagen) and miR arrays were performed using the TaqMan Open Array miR panel (ThermoFisher). Several candidate miRs were identified from prior studies that differed between pregnancies affected by TTTS and singleton pregnancies (miR-19, miR-155, miR-548, and miR-483) . These miRs were then quantified in both MS and AF samples. A regression analysis was performed and a p-value of <0.05 was used to determine whether the candidate MS miRs were significantly correlated with AF miRs. Results: A total of 6 MS and AF sample pairs from pregnancies with TTTS were analyzed. There were 2 MS miR that were either positively or negative correlated with AF miR. MS miR-548 was positively correlated with AF miR with a cor of 0.99 and a p-value of 0.00017 (Fig 1) . MS miR-155 was negatively correlated with AF miR, with a cor of -0.89 and a p-value of 0.019 (Fig2). There was a trend towards negative correlation between MS and AF samples for miR-19a and miR-483. Conclusion: MS miR correlates with AF miR profi les in pregnancies complicated by TTTS. This presents a potentially useful and readilyavailable biomarker for pregnancies at risk of TTTS. Further studies are needed to confi rm this and to assess miR profi les across pregnancy. A Overexpression of the glucagon receptor in the mouse beta-cell results in increased insulin secretion and beta-cell mass, while glucagon receptor knockout impairs islet development. Fetal glucagon concentrations are elevated in response to stress, but little is known about the eff ects of glucagon on insulin secretion and islet development in the late gestation fetus. We hypothesized that hyperglucagonemia would enhance insulin secretion and beta-cell proliferation. Methods: Late gestation fetal sheep received an intravenous infusion of low-or high-dose glucagon (5 or 50ng/kg/min) or vehicle control. Fetal glucose-stimulated insulin secretion (GSIS) was measured in response to acute (3 hour) and chronic (8-10 days) hyperglucagonemia. After 8-10 days of infusion, fetal and organ weights were measured, in addition to islet structure and cell proliferation using immunofl uorescent staining. Statistical analysis was performed using one-or two-way repeated measures/mixed-models ANOVA with individual means comparisons. Results: Acute high-dose glucagon infusion increased basal insulin concentrations 3-fold (n=4) and enhanced GSIS with 2.5-fold higher insulin secretion compared to control (n=12) and 3.1-fold higher than acute low-dose glucagon infusion (n=10; p<0.01). In contrast, chronic high-dose glucagon infusion blunted GSIS (n=5), while chronic low-dose glucagon infusion enhanced GSIS (n=7) compared to control (n=7; p<0.05). Both low-and high-dose chronic glucagon exposure resulted in a 2-3-fold reduction in basal plasma insulin concentrations by study end (p<0.0001). In all hyperglucagonemic fetuses, pancreatic weight, alpha-cell mass, alpha-and beta-cell proliferation, and islet area were lower (p<0.05) There was a trend toward lower beta-cell mass (p=0.063). The relative proportion of alpha-and beta-cells within the islet remained the same. Conclusion: These findings demonstrate a differential beta-cell response to acute vs. chronic and low-vs. high-dose glucagon with regard to GSIS. Despite this difference in GSIS, chronic hyperglucagonemia reduced basal insulin concentrations, alpha-and beta-cell proliferation, islet area, and overall pancreas weight, regardless of dose. This implicates an inhibitory role for glucagon in the regulation of pancreatic growth. Introduction: IGF-1 is a critical fetal growth hormone; intrauterine growth restriction and fetal macrosomia are associated with low and high cord blood concentrations of IGF-1, respectively. Infusion of IGF-1 LR3, an analogue of IGF-1 designed to have low affinity for the IGF binding proteins, increases organ weight and myoblast proliferation in fetal sheep. We hypothesized that a sheep-specific recombinant IGF-1 (oIGF-1) in its native environment with accessibility to binding proteins will similarly demonstrate anabolic effects in fetal sheep. Methods: oIGF-1 was made using bacterial transformation, fermentation, inclusion body separation, chemical refolding, and purification by reverse phase and ion exchange chromatography. A three-pronged approach was used to test the anabolic effects of oIGF-1, including myoblast proliferation, downstream signaling, and organ growth. First, myoblasts (n=4) harvested from fetal sheep were exposed to oIGF-1 (1, 10, and 100 ng/ml). Cell proliferation was measured by MTT assay. Second, anesthetized and catheterized fetal sheep were infused with oIGF-1 (22 or 220 µg/hr; n=4) or saline (n=3) for 2 hr. Serial biceps femoris muscle biopsies were taken to measure signaling response to oIGF-1 by western blot, including phosphorylated Akt (Ser473), Erk 1/2 (Thr202/ Tyr204), and p70 S6 Kinase (S6K, Thr389 and Thr421/Ser424). Finally, in catheterized pregnant sheep carrying twins, one fetus received oIGF-1 infusion (n=6) and the other received saline (n=6) for 1 week. EdU was infused to measure myoblast proliferation in vivo using flow cytometry. Fetal and organ weights were obtained. Results: oIGF-1 (100 ng/ml) increased myoblast proliferation (P=0.03). The difference in phosphorylation of Akt, Erk 1/2, and S6K in muscle biopsies taken at multiple time points during infusion compared to baseline was similar in oIGF-1 and saline-infused fetuses. After a oneweek infusion of oIGF-1 compared to saline, fetal body and skeletal muscle weights were similar. Adrenal glands were larger (P<0.05), and heart, kidneys, and spleen tended to be larger (P≤0.06) in oIGF-1-infused fetuses. The percentage of EdU positive myoblasts tended to be higher in oIGF-1 (n=3/group, P=0.09). Conclusion: Similar to IGF-1 LR3, oIGF-1 increased fetal organ weights including the adrenal glands, heart, kidneys, and spleen. Anabolic effects were further demonstrated by increased myoblast proliferation in vitro and a trend towards increased myoblast proliferation in vivo. Infusion of oIGF-1 for a week did not increase skeletal muscle weight potentially due to lack of an increase in IGF-1 signaling. More research is needed to determine the specific role of IGF binding proteins in regulating the effects of IGF-1 on fetal growth. 1 1 Erasmus Medical Center, Rotterdam, Netherlands; 2 New York University School of Medicine, New York, NY, United States; 3 Dr. von Hauners Children's Hospital, LMU München, Munich, Germany; 4 Dr. von Hauners Children's Hospital, LMU München, Munich, Netherlands. Introduction: Fetal exposure to bisphenols is associated with altered fetal growth, adverse birth outcomes and childhood cardio-metabolic risk factors. Metabolomics may serve as a tool to identify the mechanisms underlying these associations. We examined the associations of maternal bisphenol urinary concentrations in pregnancy with neonatal metabolite profiles from cord blood. Methods: In a population-based prospective cohort study among 225 mother-child pairs, maternal urinary bisphenol A, S and F concentrations in first, second and third trimester were measured. LC-MS/MS was used to determine neonatal concentrations of amino acids, non-esterified fatty acids, phospholipids, and carnitines in cord blood. No associations of maternal total bisphenol concentrations with neonatal metabolite profiles were present. Higher maternal average BPA concentrations were associated with higher neonatal monounsaturated alkyl-lysophosphatidylcholine concentrations, whereas higher maternal average BPS was associated with lower neonatal overall and saturated alkyl-lysophosphatidylcholine (p-values<0.05). Trimester-specific analyses showed that higher maternal BPA, BPS and BPF were associated with alterations in neonatal non-esterified fatty acids, diacyl-phosphatidylcholines, acyl-alkyl-phosphatidylcholines, alkyl-lysophosphatidylcholine, sphingomyelines and acyl-carnitines, with the strongest effects for third trimester maternal bisphenol and neonatal diacyl-phosphatidylcholine, sphingomyeline and acyl-carnitine metabolites (p-values<0.05). Associations were not explained by maternal socio-demographic and lifestyle characteristics or birth characteristics. Conclusion: Higher maternal bisphenol A, F and S concentrations in pregnancy are associated with alterations in neonatal metabolite profile, mainly in non-esterified fatty acids, phospholipids and carnitines concentrations. These findings provide novel insight into potential mechanisms underlying associations of maternal bisphenol exposure during pregnancy with adverse offspring outcomes but need to be replicated among larger, diverse populations. who underwent ultrasound between 22weeks0days-29 weeks6days were included. Participants were divided into 3 groups according to ultrasound visit measurements:1)EFW<10% 2)AC<10% with EFW≥10% (isolated AC<10%) and 3)EFW≥10% and AC≥10% (normal growth). Primary outcome was a neonatal composite: perinatal death, small for GA (birthweight<10%) or NICU admission. Secondary outcomes included birthweight, gestational age at delivery, hypertensive disorder of pregnancy and Apgar scores. We excluded women with missing data, incomplete ascertainment of primary outcome, fetal anomalies or EFW>90%. We fit a logistic regression model to adjust for cofounders. Results: Of 10,038 women, 7,284 participants met inclusion criteria. 1.3% (n=100) had EFW<10%, 1.6% (n=120) had isolated AC<10% and 96.9% (n=7064) had normal growth. Baseline characteristics were similar except for maternal age, race/ethnicity, education, smoking and alcohol use. The primary outcome was significantly more common in women with EFW<10% (67%) compared to women with either normal growth(22%) or isolated AC<10%(42%), p<0.01. In adjusted analysis, women with EFW<10% had higher rates of primary outcome compared to isolated AC<10% (aOR 3.09, 95%CI 1.42,6.69), while women with isolated AC<10% had higher rates compared to those with normal growth (aOR 2.13, 95%CI 1.27, 3.57) . Other outcomes were similar between women with isolated AC<10% and women with EFW<10%. Conclusion: Compared to normal fetal growth, FGR defined by isolated AC<10% was associated with increased risk of adverse perinatal outcomes but not to the extent of women with EFW<10%. Hong Song, Loren P. Thompson * . Univ. of Maryland SOM, Baltimore, MD, United States. Introduction: Chronic intrauterine HPX is a major cause of fetal growth restriction and altered fetal heart maturation. Regulation of energy metabolism is important for both the metabolic switch and transition to cellular hypertrophy that occurs in the fetal heart prior to birth. We hypothesized that intrauterine HPX targets the fetal cardiac mitochondria in disrupting respiration, contributing to developmental programming of the offspring heart. We measured the effects of HPX on indices of mitochondrial respiratory function in fetal GP heart ventricles. Methods: Pregnant GPs were exposed to either normoxia (NMX, N=7) or early-(25d gestation, 40d duration, N=7) and late-onset (50d gestation, 14d duration, N=7) HPX (10.5%O 2 )(term =~65d) to determine the effects of timing of HPX exposure. Near-term (64d gestation) male and female fetuses (N=7 each group, 2 per litter) were obtained by cesarean section of anesthetized sows and fetal body, placenta, and organ weights measured. Left cardiac ventricles were excised and frozen in liquid N 2 and stored at -80C. Cardiac mitochondria were isolated and respiratory chain complex (CI-V) subunit protein levels were measured by Western blot and CI and CIV catalytic rates by colorimetric assays. Results: Chronic HPX slightly decreased fetal body weight and increased relative placenta weight. Olga V Patey †, 1 Fig.1A -C). LV shortening fraction and the LV moycardial performance index were greater for all H1-H3 groups (Fig.1D&E ). While myocardial deformation intensified in H2, these indices were lower in H3 relative to control fetuses (Fig.1F&G ). Hypoxic fetal sheep showed bi-ventricular diastolic dysfunction, with LV impairment preceding RV diastolic function (Fig.1H&I ). Human FGR pregnancy showed fetal LV preponderance and cardiac dysfunction similar to hypoxic fetal sheep. However, alterations in human FGR best corresponded to fetal sheep between H1 and H2 groups ( Fig.1J (6):399, 2012). However, the effects of maternal intermittent hypoxia (IH) on the fetal heart are completely unknown. This is important because IH is a much greater stimulus of oxidative stress, and it is known that chronic hypoxia (CH), secondary to oxidative stress, induces a fetal origin of heart disease (Giussani & Davidge, J DOHaD 4(5):328, 2013) . Here, we have used a chicken embryo model to isolate the direct effects of IH on the developing heart, independent of effect on the mother and/or placenta. The study tested the hypothesis that IH, compared with CH, has greater direct detrimental effects on the developing heart. Methods: Fertilised chicken eggs were incubated under normoxia (N; 21% O2), CH (13.5% O2) or IH (15 cycles/h between 21 and 13.5% O2 for 12h/day) from day 1 (term is 21 days). On day 19 , following biometry, embryonic hearts were isolated and mounted on a Langendorff preparation to determine cardiac function during baseline and following an ischaemia/reperfusion (I/R) challenge (30 min ischaemia, 120 min reperfusion). Coronary flow rate (CFR) was calculated gravimetrically. Hearts were then sectioned and stained (triphenyltetrazolium) for infarct size analysis. Statistical comparisons were made using one-or two-way RM ANOVA and correlations determined using the Pearson correlation. n numbers are shown in the Figure. Results: Relative to N, CH but not IH promoted asymmetric growth restriction ( Fig.1 A & B) . However, both CH and IH induced similar cardiac systolic and diastolic dysfunction ( Fig.1 C & D) . Only CH, but not IH, increased basal CFR and improved cardiac recovery to IR. However, no treatment affected infarct size ( Fig. 1 E, F, G) . Across groups, embryo weight was directly related to systolic function and inversely related to diastolic function ( Fig. 1 H & The mechanosensitive cation channel Piezo1, a shear stress sensor, has been implicated in eNOS activation and endothelial-dependent relaxation (Wang et al., J Clin Invest. 2016) . Placental vascular tone is tightly regulated by local cues, such as endothelial-derived factors released in response to changes in blood flow and shear stress. However, nothing is known about the role of Piezo1 in control pregnancy or development complicated by fetal growth restriction (FGR) or chronic hypoxia. Here, we tested the hypothesis that the expression of Piezo1 among other mechanosensing genes is decreased by FGR and hypoxia in the umbilical and placental endothelium in human pregnancy. Methods: Transcriptome datasets from placental endothelial cells (PLAEC) from healthy and FGR pregnancies, and from umbilical vein endothelial cells (HUVEC) exposed to hypoxia in vitro were analyzed using the Transcriptome Analysis Console 4.0. Additionally, in situ levels of Piezo1 protein were determined by immunohistochemistry of paraffin-embedded sections of human umbilical cords from healthy and FGR pregnancies. Results: Transcriptome analysis of FGR PLAEC showed downregulation of several genes [71 out of 78, p < 0.01, False discovery rate (FDR) < 0.05] related to mechanosensing pathways (i.e. focal adhesion-PI3K-Akt). This effect was also observed in HUVEC exposed to hypoxia in vitro 83 out of 146, p < 0.01, FDR < 0.05). Further analysis showed that both FGR (PLAEC) and hypoxia (HUVEC) were associated with decreased levels of Piezo1 and other key shear stress-related transcripts (Fig.1 A&B) . Analysis of Piezo1 protein in the endothelium of umbilical vessels showed decreased levels in FGR umbilical veins compared with control (Fig. 1C) . Introduction: Chronic fetal hypoxia is commonly associated with intrauterine growth restriction (IUGR), defi ned as a birth weight below the 10th percentile for gestational age. IUGR babies are at increased risk of premature delivery and thus also to antenatal exposure to dexamethasone, a synthetic glucocorticoid used clinically to promote lung maturation during late gestation. Though the use of glucocorticoids in premature birth has been well studied, their eff ect on fetal lungs that have experienced chronic hypoxia has not yet been fully explored. Methods: Under general anaesthesia, sheep bearing a singleton male fetus were surgically instrumented with femoral catheters at 100d gestation (term, 145d). Ewes were then randomly assigned to Normoxia Saline (21% O 2; 2ml vehicle), Hypoxia Saline (10-11% O 2 ), Normoxia Dexamethasone (2 i.m. injection containing 12mg of dexamethasone 24h apart at 115 and 116d gestation) or Hypoxia Dexamethasone groups. Chronic hypoxia for 1 month was induced in isobaric chambers (Brain et al. Physiol Rep 3(12): e12614, 2015) . At 138d gestation animals were humanely killed (sodium pentobarbitone). Fetal lungs were frozen in liquid N 2 for total protein extraction. Western blot was used to determine the expression of proteins involved in surfactant maturation and glucocorticoid regulation within the fetal lung. Data were analysed by Two-way ANOVA. Results: Hypoxia did not signifi cantly alter the expression of surfactant protein B involved in surfactant maturation in fetal lungs [SFTPB (Fig. 1A) ]. There was no eff ect of hypoxia or dexamethasone treatment on the expression of Glucocorticoid receptor [GR (Fig. 1B) ]. However, fetal lungs from dexamethasone treated pregnancy showed decreased expression of 11β-Hydroxysteroid dehydrogenase 1 [11βHSD1 ( Fig. 1C) ], the enzyme responsible for conversion of inactive cortisone to cortisol. We show that maternal hypoxia in the late gestation fetal lung did not aff ect fetal lung maturation regardless of dexamethasone treatment. Although there was no change in the expression of Glucocorticoid receptor, there was a reduction in the enzyme responsible for conversion of cortisone to cortisol in the lung due to dexamethasone treatment, likely due to reduced reliance on endogenous glucocorticoid. Introduction: Recently, neuroinfl ammation has been posited to be a major mechanism in the aetiology and progression of many neurodevelopmental disorders (such as epilepsy and autism), especially during the gestation and early development of newborns. However, investigating human neuroinfl ammatory pathways in newborns is very challenging in vivo. To better investigate the complex relationships behind neuroinfl ammation and neurodevelopment, human immortalised neural stem cells can be used as viable experimental models. Cytokines and prostaglandins are crucial components of infl ammation, but prostaglandins' roles in neuroinfl ammation are still ill-defi ned. Therefore, developing a valid in vitro model using neural stem cells can provide a way to better understand the interactions between prostaglandins, cytokines and neuroinfl ammation during gestation and early-stage development. Methods: ReNcells CX and VM (cortical and ventral mesencephalon fetal neural stem cell lines, respectively) were acquired from Merck. Cells were seeded in 24-well plates (70 000 cells per well) for 24 hours and treated with 10 ng/mL IL-1β for 24 hours, after which the media was collected from each treated well. PGE 2 , PGF 2α and IL-6 production (pg/mL/well) was calculated using measurements in medium by ELISA. A sigmoidal equation (4-parameter logistic and X is concentration) was used to interpolate the unknown from the standard curve, following the manufacturer's instructions. Results: ReNcell CX production of IL-6 (29.71 ± 0.01428 pg/well/24hr) was signifi cantly increased by 353.33 ± 1.023412 percent in response to 10 ng/mL IL-1β, compared to untreated control. In contrast, PGE 2 production (29.7 ± 4.4 pg/well/24hr) was decreased by 19.83 ± 26.98 percent and PGF 2α production (6.9 ± 4.76 pg/well/24hr) was decreased by 62.25 ± 31.14 percent in response to 10 ng/mL IL-1β, compared to untreated control. ReNcell VM production of IL-6 (92.58 ± 0.01428 pg/well/24hr) was increased by 1977.731 ± 6.76 percent in response to 10 ng/mL IL-1β, compared to untreated control. However, the same treatment showed that production of PGE 2 (62.45 ± 9.595pg/well/24hr) was decreased by 33.9168 ± 25.40 percent and PGF 2α (14.25 ± 5.34pg/well/24hr) production was increased by 88.43921 ± 47.10 percent in response to 10 ng/mL IL-1β, compared to untreated control. Data are represented as mean ± SEM, N=3. Conclusion: Our results show that 10 ng/mL IL-1β treatment for 24 h substantially increased production of IL-6 in ReNcell CX and VM. In contrast, PGE 2 shows decreased production by both ReNcell CX and VM in response to 10 ng/mL IL-1β treatment for 24 h. These results provide a basis for greater insights into inflammatory mediator regulation by neural stem cells. IFNg-Producing Gamma/Delta T Cells in the Fetal Brain Following Intrauterine Inflammation: Possible Mechanism of Fetal Neuronal Injury. Emma L Lewis †, Natalia Tulina, Michal A Elovitz * . University of Pennsylvania, Philadelphia, PA, United States. Introduction: Intrauterine inflammation is associated with adverse neurobehavioral outcomes from schizophrenia to autism spectrum disorder. However, the mechanisms remain largely unknown. To address this gap in knowledge, this study sought to assess how inflammation transverses across multiple anatomic compartments in the maternal-fetal dyad and what specific immune cell types in the fetal brain may mediate long-term neuronal injury. We utilized a well-established mouse model of intrauterine inflammation causing fetal brain injury. Timed-pregnant CD-1 mice received intrauterine injections of 50μg LPS or saline at E15. At 48 and 72 hours post-injections, dams were sacrificed and maternal spleen, uterus, placentae, fetal liver and fetal brain were analyzed for broad immune cell composition by flow cytometry (N=8-9 dams/treatment/time point). In follow-up experiments at 72 hours post-LPS injection, CD3+ cells were isolated from the maternal spleen, decidua, and fetal brain, stimulated in vitro, and stained for intracellular cytokine production (N=10). 3.3 x10 3 , p=0.004) in the fetal brain. γ/δ T cells were more activated and differentiated to produce IFNγ, in the fetal brain compared to maternal tissues, both in terms of the frequency of T cells making IFNγ (Fig. A, p<0 .0001) and the amount of IFNγ produced (Fig. B, p<0 .0001). The presence of IFNγ producing γ/δ T cells, followed by an increase in activated microglia in the fetal brains of mice exposed to intrauterine inflammation, is a potential mechanism of fetal neuronal injury. Microglia exposure to IFNγ is known to activate a neurotoxic microglial state, and prenatal exposure can create lasting alterations to microglial epigenetic states, which explain the long-term neurobehavioral outcomes associated with intrauterine inflammation. Introduction: Increase in the incidence of gynaecological cancers has resulted in increased operative procedures, specifically in patients with multiple comorbidities including obesity and frailty. This is often associated with prolonged admission and higher rates of postoperative mortality and morbidity and presents a challenge with an unmet need for an accurate, personalised risk prediction. DASI is a 12 item scale in the form of self-reported questionnaire based around commonly performed activities of daily living. Currently, DASI is used to evaluate patients with cardiovascular diseases, however there is growing interest in utilising it in preoperative setting in different specialities. This study investigates the accuracy of DASI in preoperative prediction of postoperative outcomes in gynaeoncology. A retrospective cohort study of 330 patients who had undergone an operative treatment at a tertiary oncology centre. Data collection undertaken through dedicated gynaeoncology database and missing data collected through patients' records. All patients had completed the DASI questionnaire prior to their consultation. Actual postoperative 30 day complications and the length of stay also recorded. DASI was then compared with the occurrence of postoperative complications. Results: 181 patients had a Da Vinci robot-assisted procedure, 37laparoscopic and 112 -open surgery. 76/330 were classifi ed as having any type of complications within 30 days of the operation. Our results have shown that the higher DASI score the less likely patients were to have postoperative complications. This result was statistically signifi cant with odds ratio of 0.974 and confi dence interval between 0.958 and 0.991. We were also able to demonstrate that for every 10 points further up the DASI score a patient was 0.768 times less likely to have a postoperative complication. Hence general morbidity prediction of DASI score has been found to statistically signifi cantly predict postoperative complications (AUC-0.700). Our study has shown that DASI self-reported score is a useful predictive tool of perioperative estimation of postoperative complications in the gynaeoncology setting. Further analysis with a larger sample size and a multicentre prospective study is currently underway to validate the fi ndings. Uterus 163 Ovary 108 Tube 23 Cervix 26 Other 10 Placental Endocrine Function and Insulin-Like Growth Factor-2 Maternal Aging Impacts Vascular Adaptations to Pregnancy. Mazhar Pasha, Raven Kirschenman, Amy Wooldridge, Floor Spaans, Sandra Davidge, Christy-Lynn Cooke. University of Alberta, Edmonton, AB, Canada. Introduction: Advanced maternal age (≥35 years) increases the risk of pregnancy complications, which may be due to vascular maladaptations to pregnancy. Aging is associated with vascular stiff ness and endothelial dysfunction, potentially via oxidative stress, reduced nitric oxide (NO) and increased endothelin-1 (ET-1) levels. However, whether these vascular changes aff ect vascular adaptations during aged pregnancies and contribute to endothelial dysfunction remains unknown. We hypothesize that maternal aging impairs vascular adaptations, due to altered NO and ET-1-dependent mechanisms. Methods: Pregnant young (4 months) and aged (9.5 months of age; ~35 year in humans) rats (n=6-10/group) were studied on gestational day 20 (term=22 days) and compared to age-matched non-pregnant rats. Blood pressure was measured with the CODA tail-cuff system and rats were euthanized for ex vivo vascular studies. Mesenteric artery endothelium-dependent relaxation to methylcholine (MCh) was assessed in the presence/absence of pan nitric oxide [NO] synthase inhibitor (L-NAME), or NADPH oxidase inhibitor (Apocynin Methods: This is a retrospective sub-analysis of a prospective study that had three study visits (follicular phase (V1), late first trimester at 12-14 wks (V2), mid third trimester at 29-34 wks (V3) in nulliparous women achieving a stable pregnancy (N=15). We examined plasma levels of placental alkaline phosphatase (PLAP) activity as a surrogate for circulating SDMVs at all visits and examined their relationship to changes in cardiovascular function. Cardiac output was measured using echocardiographic techniques. Continuous arterial blood pressures were measured non-invasively and mean arterial pressure (MAP) determined. Uterine blood flow was measured by uterine artery color Doppler ultrasound examinations at V1 and V2. All measurements and samples were collected prior to clinical diagnosis of any hypertensive disorder (late onset preeclampsia (PE) subsequently diagnosed in n=4 women). Correlation analyses were made for single visits and in comparison to the change of a measurement across two visits as indicated. Results: PLAP activity levels at V3 ranged from 13.3-82.9 μg/mL (44.2 ± 18.3 μg/mL); levels of PLAP at V1 and V2 ranged from 0-5.3 μg/mL and 0-4.7 μg/mL, respectively. V3 levels of PLAP and MAP had a correlation of r = 0.479 (p = 0.07), but PLAP showed no correlation with cardiac output at V3 (r = 0.013) or with V2 measurements of uterine blood flow (r = 0.107). Levels of PLAP at V3 were not different between normotensive pregnancies (44.3 ± 21.3 μg/mL) and pregnancies that were subsequently diagnosed with PE (44.0 ± 7.4 μg/mL). The changes in MAP and cardiac output between V2 and V3 were then examined relative to V3 levels of PLAP. A correlation was observed between PLAP and 1) the change in MAP (r = 0.602 p = 0.0502 in normotensive pregnancies, r=0.569 p = 0.03 all pregnancies ) and 2) the change in cardiac output (r = 0.597 p = 0.053 in normotensive pregnancies, r=0.308 p = 0.26 all pregnancies). Conclusion: These findings indicate that changes in systemic maternal cardiovascular function, but not early uterine perfusion, correlate with changes in SDMV abundance as measured using PLAP activity as a surrogate. The correlation between systemic PLAP levels and changes in MAP in all pregnancies indicates that the subsequent development of PE in nulliparous women did not present as independent influences on systemic PLAP levels earlier in the third trimester. Progesterone Withdrawal Induces Eosinophilic Inflammation in the Process of Mouse Cervical Ripening. Yosuke Sugita, Yoshimitsu Kuwabara * , Shigeru Matsuda, Yumiko Oishi, Toshiyuki Takeshita. Nippon Medical School, Tokyo, Japan. Introduction: Cervical ripening is a sterile process that induces an inflammatory response characterized by immune cell infiltration into the cervical stroma, and has been speculated to be triggered by functional progesterone (P4)withdrawal. In this study, we newly identified and analyzed the inflammatory markers associated with the cervical histological changes in a mouse model of preterm birth triggered by the anti-P4 drug. Methods: C57BL/6J mice on day 15 of pregnancy were injected subcutaneously with a progesterone receptor antagonist (500 µg mifepristone) or a solvent containing 200 µL ethanol (n=5 vs. n=5), and each uterine cervix was collected 12 h later. RNA was extracted from the tissue and a polymerase chain reaction (PCR) array targeting inflammatory cytokines and their receptors was performed. Molecules upregulated by mifepristone administration were subjected to comparative analysis by real-time PCR, western blotting (WB) of extracted proteins, and immunohistochemistry (IH) of tissue sections. Mice treated with mifepristone showed cervical ripening changes characterized by swelling of the cervical stroma (Figure1). PCR array and real-time PCR identified the chemokine CCL11 (eotaxin-1), a major chemotactic factor of eosinophils, as a molecule whose expression was markedly increased by mifepristone treatment (Student's t-test P<0.05) (Figure2 A). In WB, a 9 kDa band corresponding to CCL11 was clearly seen after mifepristone treatment (Figure2 B). Based on IH results, CCL11 expression was enhanced throughout the cervical epithelium and stroma. Furthermore, the eosinophil cell surface marker CCR3, a specific receptor for CCL11, was widely detected, suggesting that eosinophil infiltration of the cervical tissue had occurred (Figure2 C). is suggested to be involved in the molecular mechanisms of cervical ripening triggered by P4 withdrawal. Introduction: Obesity and liver disease are increasing. Metabolic alterations and mitochondrial dysfunction are hallmarks of those conditions. Pregnancy represents a critical challenge to metabolism due to greater energy and nutrient requirements. In a compromised obese liver, the additional metabolic challenge imposed by pregnancy might exacerbate hepatic dysfunction's progression. We investigated effects of maternal obesity (MO) during gestation on maternal hepatic mitochondrial function. Methods: Nonpregnant ewes were fed 150% (MO, n=8) or 100% (Control, C, n=10) recommended global nutrient intake 60 days before conception and throughout gestation. At 90% gestation, we euthanized ewes under general anesthesia and collected maternal livers. We measured mitochondrial protein expression and enzymatic activities (Western blot and spectrophotometric assays), glutathione (HPLC) and NAD + /NADH (luminescent assay). Data were compared using unpaired t-test: p<0.05 considered significant Results: In MO we observed decreased protein kinase A activity (40%), a hepatic metabolism master regulator. MO induced changes in mitochondrial oxidative phosphorylation: complex II (C-II) activity and its subunits SDHA and SDHB, and C-IV subunit mtCO1 protein expression decreased while C-I and C-IV activities increased. Consistently, NAD + /NADH was higher in MO due to reduced NADH (19.9%). Mitochondrial mass indicators, mtDNA copy number, citrate synthase activity, and TOM20 protein were similar. MO increased Fis1 (34.3%) hepatic expression and reduced OPA-1 (51%), proteins involved in mitochondrial fission and fusion. Concomitantly, MO induced 81% increase in lipid peroxidation and 55% decrease in GSSG/GSH and altered antioxidant enzymatic activities: +35% SOD, -30% catalase and +32.3% mitochondrial catalase. Macroautophagy (LC3-II/LC3-I) was also increased (380%) Conclusion: While the emphasis on programming by MO has been on fetal changes, few data are available in maternal organs. We showed that MO results in altered maternal hepatic mitochondrial function and redox state, likely predisposing to hepatic dysfunction. Monitoring maternal liver function during MO pregnancy provides new insights to understand and prevent problems in the mother and offspring. Introduction: Nowadays, an increasing number of pregnancies occur at advanced maternal age (>35 years), which is associated with pregnancy complications. This may be due to impaired adaptations to uteroplacental blood flow during pregnancy. In a rat model of maternal aging, we previously showed that constriction responses to increasing intraluminal pressures (i.e. myogenic tone) were greater in uterine arteries from aged compared to young pregnant dams. We hypothesized that age-related differences in vascular function develop as the result of poor adaptations during pregnancy. Methods: Pregnant young (~4 months) and aged (~9 months; equivalent to ~35 years in humans) rats were studied on gestational day 20 (term=22 days) and compared to age-matched non-pregnant rats. Pregnancy outcomes from dams (n=16-23 dams/group) were recorded. Myogenic tone (%, n=3-9/group) and mechanical properties (measures of elasticity and deformation across increasing pressure; n=10-24/group) were assessed in isolated main uterine arteries using pressure myography. Myography data were analyzed as area under the curve [AUC] . Data were analyzed by two-way ANOVA with Sidak post-hoc comparisons, or by unpaired t-test; mean ± SEM. Results: Pregnancies in aged dams resulted in more reabsorptions (young: 0.7±0.2 vs aged: 3.3±0.7; p=0.001), fewer fetuses (young: 15±1 vs aged: 9±1; p<0.0001), greater placental weight (young: 0.48±0.01 g vs aged: 0.63±0.05 g; p<0.0001) and lower fetal weight (young: 3.8±0.1 g vs aged: 3.1±0.1 g; p<0.0001) than young dams. Myogenic tone was reduced in young pregnant compared to nonpregnant rats (AUC pregnant 11±3: vs non-pregnant: 44±6; p=0.027). However, this pregnancy adaptation did not occur in aged dams (AUC pregnant 37±2 vs non-pregnant: 30±3; NS). As a result, myogenic tone was lower in arteries from young dams than in arteries from aged dams (AUC young: 11±3 vs aged: 37±2; p=0.017). In arteries from non-pregnant rats, age did not affect myogenic tone. Circumferential stress and strain increased with pregnancy (p<0.0001 for both). The circumferential stress was not affected by age, however, the circumferential strain was lower in arteries from aged pregnant dams than arteries from young pregnant dams (AUC young: 139±6 vs aged: 120±4; p=0.029). Conclusion: Maternal aging compromised pregnancy outcomes and was associated with impaired uterine artery adaptations to pregnancy. Of the arteries from pregnant rats, those from aged dams were less compliant, and more constrictive with increasing pressure, compared to those from young dams. These impairments due to aging were not shown in the non-pregnant state, suggesting that they developed during pregnancy, possibly due to pregnancy being a 'secondary hit'. These poor pregnancy adaptations may contribute to the increased risk of pregnancy complications with advanced maternal age. Introduction: Preeclampsia is a pregnancy-specific syndrome characterized by new onset hypertension and proteinuria. This disorder affects 3-5% of pregnancies worldwide, contributing to maternal morbidity, mortality and risk of future cardiovascular disease. Despite its prevalence, there is no cure for preeclampsia other than inducing delivery. Therefore, identifying therapeutic strategies to alleviate preeclampsia and associated vascular dysfunction is critical for maternal and fetal health. The nutraceutical L-citrulline promotes nitric oxide (NO) bioavailability and contributes to improved vascular function. The aim of this study was to investigate the effect of L-citrulline supplementation on vascular health during pregnancy in a preeclampsia-like mouse model. Methods: Healthy wildtype C57BL/6 female mice were bred to male complement component C1q knockout (C1q -/-) mice. The C57BL/6xC1q-/breeding scheme is documented to result in a preeclampsia-like pregnancy (PE) evidenced by pregnancy-specific hypertension, altered kidney and placental morphology, and vascular dysfunction. A subset of PE dams received L-citrulline (PE+CIT, 0.25%) in drinking water from gestation day (GD) 0.5-17.5. At the end of pregnancy, blood pressure and vascular function were assessed. Results: Female preeclampsia-like mice supplemented with citrulline (PE+CIT) exhibited reduced systolic blood pressure (p<0.01), diastolic blood pressure (p=0.04), and mean arterial pressure (p=0.02) when compared to untreated PE mice. Wire myography data indicate that PE+CIT dams have improved vascular function compared to PE mice evidenced by reduced sensitivity to phenylephrine (p<0.03). Further, PE+CIT mice displayed improved endothelial-dependent (p<0.01) and -independent relaxation (p<0.01) compared to untreated PE mice, supporting improved vascular function in PE mice supplemented with L-citrulline. Conclusion: L-citrulline supplementation during pregnancy improves blood pressure and vascular function in a mouse model of preeclampsia. The current work points to a potential novel therapeutic which may improve vascular health during pregnancy and may contribute to improved maternal health throughout the lifespan.This project was supported by the American Heart Association Go Red for Women 16SFRN27810001. Alterations in Inorganic Phosphate and Calcium Maternal Excretion Associated with Gestational Age and Parity. Ana Correia-Branco †, 1 Monica Rincon, 2 Leonardo Pereira, 2 Mary C Wallingford. 1 1 Tufts Medical Center, Boston, MA, United States; 2 Oregon Health Science Center, Oregon, OR, United States. Introduction: Inorganic phosphate (P i ) and calcium (Ca) are essential minerals that enable skeletal ossifi cation, support cellular structure and organellar function, and serve key biochemical roles in energetics and molecular signaling. Disrupted P i and Ca homeostasis are associated with phosphate wasting, mineral and bone disorders, and vascular calcifi cation. Homeostasis is also signifi cantly altered during pregnancy, as bone resorption and deposition creates are uncoupled. P i and Ca homeostasis are regulated in part by fi broblast growth factor-23 (FGF-23), an endocrine hormone that is produced in osteocytes. FGF23 signaling downregulates P i transporters and has been described to decrease with parity. We hypothesize that parity regulates maternal P i and Cahomeostasis by reducing P i pools and accretion, and increasing vascular calcifi cation. Methods: In order to address these unknowns, we examined biological fl uid characteristics of P i and Ca during pregnancy in accordance with parity. Amniotic fl uid and maternal urinary P i levels were assessed with the P i Assay Kit (Sigma-Aldrich, MAK308) and Ca levels were determined with Calcium Reagent Set (Teco Diagnostics, C503-480). QuantiPro BCA Assay Kit (Sigma-Aldrich, QPBCA) was used to normalize to protein content. Correlations with gestational age at delivery (GAD), parity, preterm birth, preeclampsia, diabetes mellitus, and ectopic calcifi cation were evaluated. Results: During third trimester of pregnancy, we observed an uncoupling of maternal urinary P i and Ca levels. P i excretion increased with GAD (1.92 mmol/L at 28.7 weeks and 9.47 mmol/L at 33.0 weeks), whereas and Ca excretion decreased with GAD (3.03 mg/L at 28.7 weeks and 0.13 mg/L at 33.0 weeks). Amniotic fl uid P i levels decreased with gestation, ranging from 1.28 to 0.15 mmol/L, while low second trimester levels associated with preterm birth. Maternal phosphaturia was reduced with parity (14.92 ± 2.57 vs. 4.72 ± 1.59 mmol/L; p = 0.0045), whereas calciuria excretion increased (0.21 ± 0.09 vs. 1.20 ± 0.40 mg/L; p = 0.031052). Conclusion: Together, this data supports that prior pregnancy (multigravida) associates with an uncoupling of P i and Ca excretion compared to primigravida (fi rst pregnancies). No correlations were observed between urinary P i or Ca levels and preeclampsia or diabetes. In conclusion, P i and Ca levels provide clinical information regarding the temporal fl uctuation of maternal-fetal phosphate homeostasis, in relation to parity, supporting that gestational P i homeostasis should be examined more closely and in larger populations. We performed a retrospective cohort study using data from two hospitals in an academic health system from 2016 through 2020. A population to screen for cardiac disease was identifi ed by international classifi cation of disease diagnosis codes from the electronic medical records (EMR), and data were assembled using both automated extracts and chart review. The primary outcome was cesarean delivery (CD), with patients with obstetric contraindication to vaginal delivery excluded. Unadjusted associations between mode of delivery and clinical characteristics were assessed using t-tests and chi-squared tests as appropriate, with multiply-imputed logistic regression employed for adjusted associations. Results: A total of 231 patients were included, including 78 (35%) with congenital heart disease (CHD), 36 (16.4%) with a cardiomyopathy, 58 (26.2%) with history of cardiac surgery, 69 (31.1%) with an arrhythmia, and 25 (12.2%) with aortic disease. CD was utilized for 86 (37%) percent of deliveries. The most common reasons for CD included history of prior CD, and non-reassuring fetal tracing (Table 1 ). In unadjusted comparisons of patients undergoing cesarean and vaginal delivery, increasing age, preeclampsia with severe features, and history of prior cesarean section were associated with increased risk of cesarean section. In adjusted analyses, preeclampsia with severe features and history of prior cesarean section remained statistically signifi cant (Table 2) . Conclusion: In this study, risk of cesarean delivery was not increased, and was near the national average of 32%. In this cohort, no specifi c category of cardiac disease was associated with an increased risk of CD. Eff ect of Long-Term Storage and Pre-Pregnancy BMI on Lipid Parameters in Stored Maternal Plasma Samples. Theresa Boyer, Nada Elsayed, Kimberly Jones-Beatty, Irina Burd * . Johns Hopkins University, Baltimore, MD, United States. Introduction: Maternal lipid levels may serve as a marker for maternal infl ammation and a predictor of adverse pregnancy outcomes. We sought to determine the eff ect of pre-pregnancy BMI on maternal lipid profi le, and to assess the eff ect of long-term storage on the integrity of maternal lipoprotein level measurements. Methods: Pregnant women were enrolled in a prospective, longitudinal cohort study. Women were categorized as normal (BMI < 24.9), overweight (25.030.0) based on prepregnancy BMI. Plasma samples were analyzed for levels of LDL, HDL, and total cholesterol (TC). Samples were stored at -80°C. Standard statistical methods were employed and storage eff ect on lipoproteins was assessed using linear regression. Results: EDTA-extracted plasma samples from normal (n=18), overweight (n=8), and obese women (n=13) were collected at study enrollment and at delivery. Among all women, LDL, HDL, and total cholesterol increased during pregnancy (p < 0.001, p = 0.028, p < 0.001, respectively). There was no signifi cant diff erence in LDL, HDL, or TC at the time of enrollment or delivery between groups. Enrollment and delivery samples were stored at -80°C for an average of 433 and 263 days, respectively. A signifi cant decay eff ect of storage time was noted. LDL degradation occurred at a signifi cantly faster rate in enrollment samples from normal weight women (β = -0.294, p < 0.001) compared to both overweight (β = 0.060, p=0.012) and obese (β = -0.102, p=0.029) women. Conclusion: While we did not fi nd a signifi cant diff erence in maternal lipid profi les among BMI categories, we established that long-term storage of plasma from women with diff erent BMIs may interfere with lipid level measurements in a non-linear fashion. Plasma lipid analysis should be conducted as soon as possible following collection to avoid potential degradation. Furthermore, consideration should be made for diff erent lipid degradation rates or mechanisms in women with diff erent BMIs. (MB) is an anatomic variant where a segment of a major coronary artery courses through the myocardium and is susceptible to fl ow impairment and malignant arrhythmias. Physiologic changes of pregnancy cause cardiac stress and elevated heart rates. Our hypothesis was that during pregnancy MB patients are at increased risk compared with a healthy population and may be more comparable to those with other known cardiac conditions. Methods: We conducted a matched cohort study of 10 cases of MB in pregnancy between 2014 to 2020 at a single quaternary care institution. The cases were compared to two control groups matched by parity and gestational age at delivery (weeks). The two control groups were (1) healthy pregnant patients and (2) pregnant patients with known cardiac disease cared for by a multidisciplinary team; both with no underlying chronic medical or obstetric conditions. We collected data via medical chart review and did statistical analysis via Fisher exact and chi-squared tests for comparison of MB cases and cardiac controls. Results: MB cases were similar to the cardiac control group regarding NYHA classifi cation, CARPREG II risk score, prior cardiac surgery, and ejection fraction (Table 1) . MB cases were more likely than healthy controls to experience angina (60% vs 0%) or peripartum cardiac symptoms (80% vs 0%) ( Few studies examine the phenotype of immune cells relative to nursing. Studies in rodent models have linked altered immunity and lack of nursing to impaired postpartum (PP) vascular remodeling. We compared immune cells in non-nursing(NN) and nursing (N) PP mice. Methods: Adult (~4 months) C57BL/6 females were mated to samestrain males and allowed to litter. At 48 hours after delivery, pups were either removed or allowed to stay and nurse. Mothers (n=4/group) were euthanized 2 weeks PP, and mesenteric and uterine nodes, spleen and thymus were removed for examination. Additionally, tissues from late gestation mice (LG, 17 days of 19 total, n= 3) were studied. Tissues were examined by flow cytometry using antibodies (BD Biosciences) to the T cell receptor beta chain, T cell delta chain, CD4, CD8, a B cell marker (B220), and to the NK cell marker (NK1.1) which was also used, along with anti T cell beta chain, to delineate NK T cells. Studies also used antibodies to the activation/memory marker CD44 and to the receptor for the homeostatic cytokine, IL-7. After gating for single lymphocytes, the % of each cell population was determined using FlowJo (Ashland OR). Population numbers (millions) in the spleen and thymus were also calculated. Differences were compared by ANOVA with GraphPad Prism (San Diego CA The glycocalyx is a network of proteoglycans and glycoproteins projecting from the endothelial cell (EC) surface that plays a key role in maintaining endothelial integrity. Proteolytic release of components of the glycocalyx (i.e. shedding) has been shown to occur in response to a number of physiologic challenges. Syndecan-1 is a component of the endothelial glycocalyx and is substituted with heparan sulfate chains which promote its interactions with key anticoagulants such as tissue factor pathway inhibitor (TFPI) and antithrombin. Thrombomodulin (TM), another EC transmembrane protein, and TFPI are key components of the primary dynamic anticoagulant mechanism limiting thrombus growth and are also subject to proteolytic release. In this longitudinal study of the peripartum period, we evaluate the circulating plasma levels of these proteins in healthy women. Methods: Healthy women (N=10) were prospectively enrolled in a longitudinal study at the University of Vermont Medical Center in a protocol approved by the Institutional Review Board. Two blood collections were obtained, Visit 1 was up to 1 week before a vaginal delivery (n = 5) or scheduled Cesarean-section (n = 5) and Visit 2 was within 18-36 hours after delivery. Blood was collected into citrate and platelet poor plasma aliquots were prepared. Syndecan-1, soluble TM (sTM), Total TFPI and Free TFPI were measured on all samples by ELISA. Comparisons were made across Visits using a paired Student's t-test. Data are shown as mean ± SD. Results: Pre-and post-delivery levels of syndecan-1, sTM, Free TFPI and Total TFPI are reported in the Table. A comparison of the four analytes at each Visit segregated by route of delivery did not reveal any differences (data not shown). Syndecan-1 levels fell to 21±5% of the pre-delivery level. sTM, Free TFPI, and Total TFPI fell on average to 87% of predelivery levels (86±11%, 87±11%, and 89±7%, respectively). Conclusion: After delivery women show significant decreases in plasma levels of four endothelial cell markers. The greater impact on syndecan-1 levels suggest differential regulation of the proteolytic enzymes targeting syndecan-1 than sTM. A potential inference from these data is that after delivery the endothelial cell surface expresses or retains higher levels of these potent anticoagulants thus restoring the non-thrombogenic character of the endothelial surface. Results: Among 6,875 deliveries meeting inclusion criteria, fetal position was OA in 6,600 (96.0%), OP in 222 (3.2%), and OT in 53 (0.8%). We found OP to be associated with increased risk of 3 rd -degree laceration (p=0.002) and 4 th -degree laceration (p=0.014). Multivariate analysis was performed to adjust for demographic and labor differences between the groups, and fetal position remained significantly associated with severe perineal laceration. In the multivariate analysis, other significant factors associated with severe perineal laceration included race, BMI ≥35, second stage duration, and birth weight. OP was also associated with increased risk of sulcal laceration (p=0.011), but fetal position was not significant in the multivariate regression. There was no association between fetal position and anterior vulvar (p=0.154), cervical (p=0.593), 2 nd -degree (p=0.397), or perineal (p=0.765) lacerations. The most notable association between fetal position and obstetric laceration was the increased risk of severe perineal laceration in OP position. Recent studies consistently demonstrate that ILCs are present at the maternal-fetal interface (MFI) during pregnancy, however, the distribution of ILC subsets throughout the MFI is currently unclear. We evaluated total ILCs and ILC subset distribution throughout the MFI in term pregnancy. Methods: Maternal blood, cord blood, placenta (n=7 each), and uterine decidua (n=4) specimens were obtained from women with uncomplicated pregnancies at the time of scheduled Cesarean delivery at term (37-40 weeks). Mononuclear cells were isolated from blood samples, and placenta and decidua samples were digested with collagenase to isolate immune cells. High-parameter fl ow cytometry was performed using a panel of 20 cell surface markers to identify total ILC (CD127+, lineage negative), ILC1 (CD117/CRTH2 neg), ILC2 (CD117neg/CRTH2+), and ILC3 (CD117+/CRTH2neg) subsets ( Figure 1A ). Kruskal Wallis testing was performed to determine signifi cant diff erences in ILCs between tissues. Results: Among the tissues at the MFI, we found that cord blood contained a signifi cantly greater concentration of ILCs (0.42% of total lymphocytes) compared to decidua (0.24%), placenta (0.17%), and maternal blood (0.12%), p=0.013 ( Figure 1B ). There was a signifi cant diff erence between ILC2 (p=0.038) and ILC3 (p=0.004) but not ILC1 subsets between the tissues of the MFI. Maternal blood contained the highest percentage of ILC2 and the lowest percentage of ILC3, while decidua contained the highest percentage of ILC3 and the lowest percentage of ILC2. Conclusion: There are signifi cant diff erences in the distribution of ILCs and ILC subsets between the tissues of the MFI. These diff erences may refl ect functional requirements as ILC2 are thought to have primarily anti-infl ammatory properties, while ILC3 can have both pro-or antiinfl ammatory functions. Further studies are necessary to demonstrate the activation status and stimuli of ILCs at the MFI, which are currently unknown. Migraine Introduction: Migraine aff ects more than 1 in 4 women of childbearing age and is associated with endothelial dysfunction and infl ammation. Migraine history has been associated with adverse pregnancy outcomes (APOs) including hypertensive disorders of pregnancy, preterm delivery, and low birth weight, but few prospective studies have investigated this association, and most studies were done in non-US populations. Mothers-to-be (nuMoM2b) study enrolled 10,038 nulliparous US women with singleton gestation in early pregnancy and followed them through delivery. Medical histories, including history of migraine, were collected from participants by self-report at each study visit. We defi ned APO as 1 or more of the following: gestational hypertension, preeclampsia/eclampsia, preterm delivery, gestational diabetes, small for gestational age (SGA), or stillbirth. All APOs and self-reported medical comorbidities including migraine were adjudicated by study investigators. We calculated odds ratios (OR) and 95% confi dence intervals (95%CI) for the association of migraine with APOs, adjusting for self-reported race/ethnicity, recent smoking, and APO-associated comorbidities including chronic hypertension, obesity, chronic kidney disease, pre-gestational diabetes and autoimmune disorders. We tested for interactions between migraine and obesity, and migraine and chronic hypertension. Results: Of the 10,038 women in the sample, 1,181 (11.8%) had a migraine diagnosis. A higher proportion of women who self-identifi ed as White reported migraine. Adjusting for covariates, migraineurs had higher odds of any APO (adjusted OR 1.3, 95%CI 1.2-1.5). For individual APOs, migraineurs had higher odds of gestational hypertension, preeclampsia, and preterm birth, but not gestational diabetes, SGA, or stillbirth (Table) . There were no signifi cant interactions between migraine and obesity or chronic hypertension. Bold type indicates confi dence interval does not cross 1.0. .14), albeit not significantly. No associations were found between aldosterone or aldosterone/renin ratio and maternal TL and also not after adjustment. After stratification by mode of conception, no association between RAAS determinants and maternal TL was found in pregnancies conceived spontaneously or after in in-vitro fertilization treatment. Conclusion: Negative associations independent from maternal age were found between renin and maternal TL. This finding supports the hypothesis that increased renin detrimentally impacts maternal TL due to chronic exposure to excessive oxidative stress and inflammation. No role for aldosterone, as an oxidative stressor, was found. Additional studies are needed to investigate whether TL is also a marker of cardiovascular hemodynamic adaptation to pregnancy. In the Virtual Placenta study, embedded in the Rotterdam Periconception cohort, 201 women with 0 (n=8), 1 (n=143), or >1 (n=51) CL were selected. Renin, prorenin and aldosterone levels were determined at 11 weeks gestational age (GA). Placenta Volume (PV) and utero-Placental Vascular Volume (uPVV) were measured from transvaginal 3D ultrasound scans at 7, 9 and 11 weeks GA. Pulsatility (PI) and resistance indices (RI) of the uterine arteries (UtA) were assessed by pulsed wave Doppler ultrasounds at 7, 9, 11, 13, 22 and 32 weeks GA. At birth placental weight was obtained using standardized procedures. Associations between CL number and RAAS components (prorenin and the aldosterone/renin ratio, indicative for angiotensin-and aldosteronemediated effects, respectively) with PV, uPVV and UtA indices were studied using linear mixed models and adjusted for patient and fertility treatment characteristics. Introduction: Pregnancy loss is the most common complication of pregnancy. About 60% of first trimester miscarriages are due to genetic abnormalities such as aneuploidy. In a genetically normal pregnancy, epigenetics could have a role in pregnancy loss. The mammalian placental epigenome has two distinct features: 1) Genomic imprinting; 2) Global DNA hypomethylation. Imprinted genes are expressed from one parental allele only and are epigenetically regulated. Species-specific differences between mouse and human placenta occur, for example, some genes are imprinted in human placenta and not in mouse; large contiguous genomic regions (>100kb) of hypomethylation called partial methylated domains (PMD) are found in human placenta and not in mouse. The PMDs are interspersed between highly methylated domains (HMD) and are stable across the three trimesters of pregnancy. The genes in the PMDs are tissue-specifi c and repressed. Genes in PMDs have hypomethylated gene bodies and hypermethylated promoter regions. The function of PMD/ HMD regions in human placenta is unknown. Several studies show that miscarriages are associated with abnormal methylation in a subset of imprinted genes. However, it is unknown if changes in PMDs occur in chorionic villi in euploid miscarriages. Our study shows preliminary evidence that there are diff erences in the DNA methylation levels in PMDs in chorionic villi of euploid miscarriages compared to control villi. Methods: The Illumina Human Methylation450K bead chip array was performed on eight fi rst trimester euploid chorionic villi from miscarriages and eight fi rst trimester chorionic villi obtained from elective terminations. Array data was processed and normalized using minfi R package. Distributions of methylation ratios of CpG that are within PMD were compared between euploid miscarriages and terminations using Mann-Whitney test. The diff erentially methylated regions (DMR) (beta value>20%) in euploid miscarriages were not more frequently overlapping with PMD in contrast to prior studies which found that most DMR were in PMDs in normal human placenta. Furthermore, we found that imprinted genes (7.5%) were more likely to have signifi cantly diff erentially methylated CpGs than non-imprinted genes (1.4-1.9%) in euploid miscarriages consistent with prior studies. Interestingly, we found an overall signifi cant increase of 2.5% in the DNA methylation of CpGs in PMDs in euploid miscarriages compared to elective terminations (p<0.001). These methylation diff erences are primarily found in the protein-coding regions and not at the transcription start sites of the PMD genes. Conclusion: Our study shows preliminary evidence that changes in DNA methylation occur in the PMD regions of placenta from fi rst trimester human pregnancy loss. Our fi ndings contribute to our knowledge regarding the placental epigenome of human pregnancy loss. Mapping Enhancer -Transcription Factor Interactions in Human Placenta Development and Trophoblast Diff erentiation. David Owen, Xuan Huang, Anusha Nagari, Tulip Nandu, W. Lee Kraus * . UT Southwestern Medical Center, Dallas, TX, United States. Introduction: The architecture of placenta villi changes over gestation from immature forms with a low syncytiotrophoblast/volume ratio in early pregnancy to highly branched mature villi with much greater syncytiotrophoblast surface area at term. These changes facilitate increased nutrient and gas exchange to support fetal growth. The transcription factors responsible for this process, and their genomic targets, particularly within enhancer elements, are not well understood. The objective of this study is to identify changes in active enhancer elements and their associated transcription factors in immature and mature human placenta tissue, and to correlate these fi ndings with a human trophoblast stem cell model of sycytiotrophoblast diff erentiation. The transcription factors identifi ed could serve as targets to modulate placenta development, while the genomic loci where they act could facilitate genetic risk assessment for placenta pathologies such as delayed villous maturation, associated with stillbirth. We identifi ed ~ 20,000 enhancer sites in human placenta tissue across gestation by enhancer RNA transcription (PRO-seq) and characteristic histone marks (ChIP-seq). We then implemented the Total Functional Score of Enhancer Elements (TF-SEE) methodology, which integrates enhancer activity, transcription factor binding site motif analysis, and transcription factor expression levels (RNA-seq) to predict the most active transcription factors at enhancers in a given set of samples. We in SB. These diff erences were small and given the frequency of these abnormalities in normal pregnancies and women without IT, the fi ndings are unlikely to be discriminatory or consequential. Conclusion: Among LB and SB, most placental abnormalities are not associated with maternal IT. Introduction: Despite the critical importance of invasive extravillous trophoblast (EVT) to events such as uterine spiral artery remodeling, a mechanistic framework controlling EVT differentiation from cytotrophoblast (CTB) has not been developed. We have suggested previously that this process is mediated by the epithelial-mesenchymal transition (EMT), which transforms anchorage-dependent, epithelial cells such as CTB into invasive, mesenchymal-like EVT. As gestation advances, we have shown that the EVT lose their invasiveness, but appear to maintain mesenchymal characteristics. We hypothesized that diff erentiation and the later reversion to non-invasive status, is refl ected in unique, 3rd trimester, trophoblast-specifi c gene expression profi les. Methods: In this study we compared global patterns of gene expression between third trimester CTB and EVT using RNA-sequencing. CTB and EVT (n=8,7) were prepared from normal placentae by immunomagnetic affi nity separation, using anti-integrin ß4 and anti-HLA-G antibodies. Cellular RNA was ribo-depleted (Ribo-Zero kit, Illumina) and cDNA libraries were constructed (NEBNext Ultra II RNA kit and Multiplex oligos) for RNA sequencing, which was performed on an Illumina NextSeq 500. Results: Out of ~23K genes assessed, 4206 genes were diff erentially expressed (FDR < 0.05; >2-fold increase/decrease). Cellular phenotypic diff erences were highlighted by up-regulation of mesenchymal markers (HLA-G, ITGA5) and down-regulation of epithelial markers (EGFR, ITGA6) in the EVT. Compared to a library of 486 genes associated with EMT in other tissues, 215 genes were observed in common, including many seen in multiple EMT types (e.g. FN1, ERBB2, KRT19, VIM, CDH1, BMP7). There were a number of other notable trophoblast-specifi c changes, including down-regulation of genes involved in syncytialization (ERVFRD-1, ERVW-1), alterations in extracellular signaling (CSH1, CSH2, CGA) and in genes related to placental steroid synthesis (ESRRG, CYP11A1, CYP19A1). Conclusion: Despite the fact that they are no longer invasive, third trimester EVT display clear signs of having undergone the EMT process when compared to CTB. With these results, EMT is clearly defi ned as the mechanistic framework for CTB diff erentiation. The novel, placental EMT profi le derived from this data encompasses placenta-specifi c elements including genes involved in placental hormonal signaling, syncytialization and steroid synthesis. These data now provide the essential baseline necessary for assessment of EMT-related gene expression changes in pregnancy pathologies. This is crucial for those pathologies associated with aberrant invasion, such as preeclampsia and placenta accreta, disorders often not apparent until the late second or early third trimester. Our aim was to explore gene expression in the preterm placenta to understand the underlying pathomechanism of PTB. Methods: Total RNA was extracted from villous tissue of 12 term and 12 preterm human placentas. Next Generation Sequencing of RNA (RNAseq) was conducted for diff erential gene expression analysis and targeted qRT-PCR was done for further mechanistic exploration. Results: RNAseq analysis identified 803 upregulated and 273 downregulated genes (FDR 0.05). Pathway analysis revealed an involvement of upregulated genes in immunity-related pathways and downregulated genes in cell cycling-related pathways along with apoptosis and autophagy. qRT-PCR on the same samples detected a 50% downregulation of master autophagy gene BECN1 in preterm placenta (p = 0.002). Pro-apoptotic gene Bax and anti-apoptotic gene Bcl-2 were downregulated in preterm placenta by 30% (p = 0.006) and 70% (p = 0.005) respectively. The balance between Bax/Bcl-2 is crucial for normal tissue function. We found a strong correlation between Bax/Bcl-2 expression in term placenta (r = 0.70, p = 0.02), which was perturbed in preterm placenta (r = 0.31, p = 0.32). Ratio calculation revealed a signifi cant relative loss of Bcl-2 compared to Bax in preterm placenta (term = 1.05 vs preterm = 0.81, p = 0.002). Bcl-2 is a negative regulator of BECN1. The Ct value of BECN1/Bcl-2 ratio was signifi cantly reduced in preterm placenta (p = 0.006), whereas, BECN1/Bax ratio was unaltered. Conclusion: Together, we postulate that relative loss of Bcl-2 may augment trophoblast apoptosis and potentiate autophagy within villous tissue which may lead to early labour and preterm birth. crosstalk has yet to be described. We hypothesized that hypoxia activates NOTCH1 to promote TB migration and invasion in the physiologic microenvironment of early pregnancy. Methods: HTR-8 cells were exposed to normoxia (21% O 2 ) or hypoxia (2.5% O 2 ), which mimics early placentation, for 6hrs and 24hrs. mRNA sequencing (mRNA-seq) was performed to identify differentially expressed genes and upregulated cellular pathways. Changes in gene and protein expression were determined by qPCR and western blot, respectively. Transwell assays were performed to assess HTR-8 cell migration and invasion after exposure to DAPT in hypoxic vs normoxic conditions for 24hrs. For transwell migration assays (n=6 per condition), the number of migrated cells through culture inserts were counted. For invasion assays (n=6 per condition), the number of cells that invaded into Matrigel and collagen I matrices were counted. Means were compared using unpaired t-tests and statistical significance was defined as p<0.05. Introduction: Epigenetic regulation via DNA methylation is recognized as a means of regulating gene expression at the level of transcription, usually associated with suppression of gene expression but which can also lead to activation. Human placental cytotrophoblast (CTB) to extravillous trophoblast (EVT) differentiation is accompanied by a broad array of gene expression changes as epithelial CTB are transformed into invasive, mesenchymal-like EVT. As gestation advances, we have shown that the EVT lose their invasiveness, an apparently irreversible event. Previous research has shown significant changes in methylation during differentiation and thus we wondered whether methylation might be associated with the non-invasive EVT phenotype. We hypothesized that reversion of EVT to a non-invasive status, might involve both global and gene-specific changes in DNA methylation. In this study we compared methylation changes between paired, third trimester CTB and EVT. Methods: CTB and EVT were prepared from normal placentae by immunomagnetic affinity separation, using anti-integrin ß4 and anti-HLA-G antibodies. Genomic DNA was extracted, and CpG methylation patterns were assessed genome-wide using Illumina EPIC (800K) Methylation Beadchips (n=3,3). The EPIC data showed a widespread loss of DNA methylation in EVT (affecting ~12K genes) compared to the paired CTB. By contrast, a much smaller group of ~100 genes showed a gain of methylation of more than 20%, at more than one CpG site in the EVT. Of these genes, half also showed differential mRNA expression. When tabulated against known EMT-associated genes, a small group of common genes was identified. Several of these genes were substantially down regulated (>10-fold) including ALDH1A3, BMP7, FGFR2, MSX2, SEMA3F and SLC27A2. Interestingly, several genes showed up-regulation associated with methylation; FSCN1, RUNX1 and COL5A1. Some of the top biological processes associated with these genes, as assessed by gene ontology (apart from epithelial-mesenchymal transition), include embryonic morphogenesis and mesenchymal cell differentiation. Conclusion: It is widely accepted that the placenta, like certain cancers, displays a degree of hypomethylation relative to other somatic tissues. Examining specific placental cell types, we find that there is extensive hypomethylation in EVT compared to CTB, further defining the epigenetic status of this tissue. There are however specific genes that show gains in methylation, several of which are associated with the EMT mechanism. The altered gene expression associated with these gains of methylation may serve to regulate the non-invasive EVT phenotype. Moreover, decidual over-production of DCN was associated PE, and a rise in DCN levels in maternal blood during the second trimester was a predictive biomarker for PE. The anti-proliferative, anti-migratory and ant-invasive functions of DCN resulted from binding to multiple tyrosine kinase receptors on the EVT. We wish to identify additional epigenetic mechanisms. Objectives: MicroRNAs are 15-20 nucleotide long small RNAs which block gene transcription by binding to mRNAs. Many miRNAs were reported to be dysregulated in PE. Since DCN overproduction is associated with PE, we wish to identify miRNAs that may compromise DCN mediated EVT functions known to be altered in PE. Methods: Since EVT cells do not express DCN, we conducted a miRNA micro-array using ectopically DCN-over-expressing EVT (HTR-8/SVneo) and control EVT cells. Of multiple DCN-regulated miRNAs, we selected some which were reported to be upregulated in PE and validated them by qPCR using exogenous DCN (250nM)-treated EVT cells. Selected miRNAs were were then manipulated in EVT cells by transfection with either miRNA inhibitor (for knockdown) or mimic (for over-expression), and validated with qPCR. Then we measured proliferation (24hr EdU uptake), migration (24hr across 8μM pore membranes inserted in transwells) and endovascular differentiation (tube formation on matrigel in the presence of VEGF) with the miRNA-manipulated and control (mock-transfected) EVT cells. We validated two miRNAs hsa-miR-512-3p and hsa-miRlet-7c-5p to be significantly upregulated by DCN. We decided to knockdown hsa-miR-let-7c-5p and overexpress hsa-miR-512-3p in EVT cells for functional assays. Suppression of miR-let-7c-5p did not affect proliferation, but increased migration and endovascular differentiation of EVT cells. Conversely, overexpression of miR-512-3p inhibited EVT cell proliferation and migration and totally blocked endovascular differentiation. Finally qRT-PCR analysis showed significantly increased expression of both miRNAs in PE-associated placentas relative to those in healthy normotensive pregnancies (control) (n=5 each). N=3, *p < 0.05. Introduction: pICln is one of chloride channel-forming proteins which mediates chloride intercellular transportation. It is also known that it is involved in the vascular endothelial production of soluble vascular endothelial growth factor (VEGF) receptor (fms-like tyrosine kinase 1: sFlt-1) which can inhibit neovascularization. It is reported that sFlt-1 is a main cause of the pathogenesis of preeclampsia (PE). Therefore, pICln could be also involved in the pathogenesis of PE through the modulation of sFlt-1 production. In this study, we investigated the effect of pICln on the production of sFlt-1 in trophoblasts. Methods: Expression of pICln of placental tissues derived from normal pregnant women and PE patients were evaluated using immunohistochemistry. mRNA of pICln and sFlt-1 was extracted from placenta and analyzed using real-time RT-PCR. sFlt-1 production was evaluated by pICln DNA and siRNA transfection in TBT (rat syncytiotrophoblast) and HTR-8 (human extravillous trophoblast) cells. Results: pICln and Flt-1 was strongly expressed in PE placenta. mRNA of pICln was significantly decreased in PE placenta; however, sFlt-1 mRNA was significantly increased in TBT. pICln DNA transfection did not change sFlt-1 production in TBT; however, the production was reduced in HTR-8. On the other hand, pICln siRNA transfection significantly increased sFlt-1 production in TBT; however, the production was not changed in HTR-8. Conclusion: pICln-mediated sFlt-1 production is different between in syncytiotrophoblast and extravillous trophoblast. It is thought that pICln plays an important role in the pathogenesis of PE through sFlt-1 production in trophoblast. Sustained Hypoxemia Activates Nutrient Shuttles between the Placenta and Fetus. Introduction: Gestational hypoxemia can reduce birth weight, yet how hypoxemia affects placental metabolism and nutrient supply to the fetus is unclear. Hypoxemia has been proposed to increase placental glucose utilization and lactate production, thus decreasing glucose and increasing lactate supply to the fetus. However, other reports indicate no change in placental glucose or amino acid transport capacity. This study aimed to test the hypothesis that sustained hypoxemia will activate placental-fetal nutrient shuttles that allow the fetus to maintain its metabolic rate. Methods: We produced hypoxemia in pregnant sheep (HOX, n = 11) via maternal intratracheal nitrogen gas insufflation for 10 days, between 0.8 to 0.9 gestation, compared to ewes receiving air (CON, n = 7). Studies were performed to measure blood flow and net oxygen and nutrient uptake rates across the uterine, placental, and umbilical circulation. Gene expression, protein expression, and enzyme activities were measured in placental cotyledon tissue. Data were analyzed by t-test (P<0.05). Results: Uterine blood flow and uterine and placental oxygen and glucose uptake rates were similar in CON and HOX groups. Placental lactate production was increased, and glutamate uptake was decreased in the HOX group. Fetal glucose, lactate, and oxygen uptake rates were not different, yet fetal pyruvate output was increased in HOX fetuses and lower glucose oxidation rates were associated with severity of hypoxemia. HOX fetuses also had decreased alanine (Ala) uptake and trends for decreased glutamate (Glu) and serine (Ser) output. Concentrations of oxygen, Ser, Glu, and aspartate were decreased, and lactate, pyruvate, and Ala concentrations were increased in HOX fetuses. There was no difference in fetal glucose concentrations or weight. In HOX placenta tissue, expression of glycolytic genes (PFK1, PKM2) was decreased, and lactate production (LDH protein) was increased. Conclusion: Our results support increased fetal pyruvate output during hypoxemia and a shuttle between the fetus and placenta whereby pyruvate from the fetus, rather from increased placental glucose uptake and glycolysis, is used by the placenta for lactate production. HOX fetuses had increased Ala concentrations yet decreased Ala uptake without a decrease in placental Ala output, suggesting increased Ala synthesis by the fetus. Decreased fetal release of Ser and Glu and increased pyruvate output, as result of limited glucose oxidation, may reflect liver metabolism as it normally releases pyruvate and these amino acids to the placenta, in exchange for lactate, glycine, and glutamine. Together, these data support activation of placental-fetal nutrient shuttles that alter substrate milieu and enable maintained growth and oxidative metabolism in the HOX fetus. Interaction Introduction: Maternal-fetal inorganic phosphate (P i ) performs numerous critical functions during embryonic development, but chronic exposure to P i is detrimental to vascular health. Our previous work has shown that the sodium-dependent placental P i transporter Slc20a2 is a critical P i transporter in mouse placenta, and loss of Slc20a2 results in ectopic placental calcification. Clinically, expression of Slc20a2 is decreased in early preeclampsia, while the homeostatic endoplasmic stress unfolded protein response (UPR ER ) is activated. UPR ER activation increases X-box binding protein 1 (XBP1) splicing, and activates protein disulfide isomerase (PDI), a molecular chaperone. Methods: In this study, we hypothesized that Slc20a2 loss contributes to cellular stress in the placenta, and evaluated the role of Pi in placental vascular health at the molecular level by analyzing placental proteomes from control and Slc20a2 knockout (KO) mice. Results: Proteomics of WT and Slc20a2 KO placental tissue identified 3,050 unique proteins. Differences in protein abundance between WT and KO models and at two gestational time pointes (13.5 days and 17.5 days) were calculated using an independent t-test (p<0.05). Those with significant changes were analyzed on the STRING database which confirmed that 23 endoplasmic reticulum and Golgi-associated proteins were significantly altered (7 decreased, 9 increased, 7 discordant). In support of failed UPR ER activation, XBP1 mRNA splicing was decreased in in E17.5 Slc20a2 KO placenta. To determine whether UPR ER is influenced by Pi, we examined XBP1 splicing in placental Jeg3 cells in response to high extracellular P i (1-4 mM). Splicing was further attenuated with increasing extracellular fluid Pi levels. Ongoing work investigates UPR ER activation in mouse placenta with PDI immunofluorescence and immunoblotting. Conclusion: We conclude that P i and Slc20a2 both interact with placental UPR ER . We now propose that Slc20a2 protects the placenta from ectopic calcification by maintaining homeostatic P i levels in balance with UPR ER . In our future work, we will test the hypothesis that Slc20a2 loss upregulates extracellular P i and UPR ER in placenta to advance our understanding of the link between maternal P i homeostasis and placental calcification, a condition leading to preterm birth. Localization and Kinetics of the Transferrin-Dependent Iron Transport Machinery in the Mouse Placenta. Chang Cao †, Mark D Fleming. Boston Children's Hospital, Boston, MA, United States. Introduction: All the iron needed for fetal growth is transferred from the maternal circulation by the placenta. Mice are commonly used to study placental iron transport. However, it is unclear where the major iron transporters including transferrin receptor (Tfrc) and ferroportin (Fpn) are located within the multiple placental cell layers involved in iron delivery to the fetus. Similarly, how maternal transferrin iron is trafficked across the syncytiotrophoblasts and fetal endothelium before reaching fetal circulation is unknown. Answers to these fundamental questions are critical for future research on the mechanism of placental iron transport. Methods: Using high resolution immunogold electron microscopy, we determined the subcellular locations of the iron importer protein Tfrc and the iron exporter protein Fpn in the mouse placenta at embryonic day 15.5. Fluorescently labeled transferrin iron was injected in the mother and placental uptake of maternal transferrin was studied at different time points (1, 2, 5, 30 , 120 minutes, and 2 days) post-injection by immunofluorescence. In the mature mouse placenta, Tfrc was localized to the intracellular vesicles in the syncytiotrophoblast layer 1. Fpn was localized to syncytiotrophoblast layer 2 and is absent from fetal endothelium ( Figure 1 ). Maternally injected transferrin iron was taken up by the placenta within 120 minutes and colocalized with Tfrc in syncytiotrophoblast layer 1 (Figure 2 ). Conclusion: We show for the first time the precise locations of Tfrc and Fpn in the mouse placenta. We provide evidence that transferrincycle is confined in syncytiotrophoblast layer 1 and that iron transfer in syncytiotrophoblast layer 2 and fetal endothelium may be independent of transferrin. Taken together, these data strongly suggest that iron transport mechanism is distinct in different placental cells involved in iron delivery to the fetus. This study also demonstrates the usefulness of modern imaging techniques to study the cellular mechanism and kinetics of nutrient transport in the placenta. Placental biopsy from fetal side were genotyped for gender. In male (M-PL) and female placenta (F-PL), glycogen (Gly) was measured by an ELISA assay, while placental proteins involved in glucose uptake (GLUT4 and IR-β), glycogen synthesis (Akt, pAkt T-308 ) and ATP production (pPDH) were measured by Western blot. 1-way or 2-way ANOVA were used for statistical analysis. Results: Gly storage was higher in M-PL and F-PL of HF group dams vs. CTR and was signifi cantly reduced by INO supplementation in both genders (Fig. 1A) . Active pAkt T-308 was higher in M-PL of HF group dams vs. CTR and was increased by INO supplementation in F-PL (Fig. 1B) . No diff erences were seen in GLUT4, IR-β, total AkT and pPDH expression between groups (Table 1) . The time and duration of maternal obesity play a role in the degree of placental metabolic abnormalities predisposing to altered fetal programming. Maternal INO supplementation seems to have a benefi cial metabolic eff ect that is gender dependent. Dynamic Wistar rat dams at 10-12 weeks of age were randomly divided into control (21%) and hypoxic (13%) pregnancy from E6 to 20 (n=10 per group). On day 20, animals were euthanized and weighed, and the placentas from male fetuses were processed for molecular studies. The expression of ER stress and UPR markers BiP, CHOP and apoptotic markers were analyzed (WB, IHC and TUNEL). Results: BIP and CHOP were actively upregulated from E13 and increased over 20 fold towards term. In contrast, CASP3 declined to undetectable levels as term approached (Fig. 1A) . Hypoxic pregnancy led to a further 2 fold upregulation of the UPR without modifi cation to birth or placental weight (Fig.1B) . TM-induced ER stress actively modifi ed the UPR in a gestational, spatial, dose and time-dependent manner (Fig.1C, D) . Conclusion: We show the dynamic capacity of the placental UPR to mediate cellular adaptation to advancing gestation in healthy pregnancy and in pregnancy complicated by physiological and chemical stress. We suggest that the placenta utilizes the ER and UPR to avoid apoptotic endpoints in response endogenous and exogenous stimuli, allowing for successful placentation and normal embryo development and viability. Results: DAGLα/β isoforms were in situ detectable with varying expression in different cell types of CTRL and PE term placentas. We identified DAGLβ as the predominant DAGL isoform (p<0.001) which is mainly located to trophoblasts (54%). DAGLβ transcripts and protein expression were significantly increased (p=0.009, p=0.018, respectively) in PE. Activity of DAGLβ in placental tissue was detected and ex vivo perfusion underlined the physiological role of this enzyme by decreased 2-AG (p=0.036) tissue levels upon pharmacological inhibition. Conclusion: Our results suggest DAGLβ dependent induction of 2-AG signaling events in the human term placenta. Pharmaceutical inhibition of DAGLβ activity directly impacts the lipid profile in the tissue. Exaggerated chronic inflammation during pregnancy as observed in PE, increases placental DAGLβ expression and activity. We conclude that placental DAGLβ synthesizes bioactive lipids cell type specifically upon metabolic demand and thereby triggers inflammatory processes in PE. We aim to identify the role of DAGLβ in placental physiology and disease, to test the enzyme as a potential target for pharmaceutical intervention. Circulating However, no evidence exists of the potential use of c-miRNAs as biomarkers for different gestation processes. In this study, we aimed to characterize c-miRNA profiles at different periods of gestation, following the pregnancy of healthy women from CDMX's perinatal cohort with the purpose of identifying potential c-miRNA signatures associated to specific events of gestation, and performing computational genomic approaches. Methods: 32 plasma samples collected during pregnancy (1T, 2T, and 3T trimesters) and after birth (AB) of eight clinically healthy pregnant women (PW) were used for small RNA (sRNA) profiling by next generation sequencing. sRNA profiles in plasma of ten healthy age-matched nonpregnant women (NPW) were employed as controls. c-miRNA expression levels were quantified carrying out the optimal discovery procedure and generalized likelihood ratio tests. Chromosome 14 microRNA cluster (C14MC) and C19MC were identified in our c-miRNA expression dataset, as well as the top 25% of miRNAs expressed in placenta, umbilical cord plasma, amniotic fluid were obtained from: GSE112343, GSE112343, GSE107524. Wilcoxon signed-rank tests were used to assess significant collective changes of these datasets, between each pregnancy stage, and NPW. Data handling and statistical analyses were carried out in R. Results: 1,449 c-miRNAs were identified in the plasma of PW and NPW. A moderate subset of 46 c-miRNAs were differentially expressed in association to progressive stages of pregnancy, and AB were significantly down regulated (FDRs <0.05). Members of C14CM were down regulated (p<4x10 -6 ) and C19CM were up regulated (p<4x10 -4 ) throughout pregnancy. Comparing the profiling of our dataset with available GEO expression data, we found that c-miRNAs most prominently expressed in reproductive tissues are also collectively down regulated throughout pregnancy (p<0.02 in placenta and umbilical cord plasma, p<0.009 in amniotic fluid, and umbilical cord plasma, p<0.05 in breast milk) and many of those returned to a basal expression AB (p<0.4). Temporal changes of c-miRNA signatures and subpopulations associated to distinct aspects of gestation, including correlates of reproductive tissues supports a wider potential of peripheral miRNAs as biomarkers of normal pregnancy. Using The placenta is the interface between mother and fetus and plays a crucial role throughout pregnancy by performing critical physiological and endocrinological functions. Alterations in the exchange of metabolites between the placenta and fetus may impact fetal development, perinatal outcomes, and long-term health. Methods: We analyzed transcriptome data from 112 term non-pathological placentas, collected at Magee Womens Research Institute, using paired-end RNA sequencing. We leveraged this data to generate the first genome-scale metabolic network of human placenta, iHumanPlacenta, using mCADRE algorithm and Recon3D as the template model. We used an aggregated publicly available placental villous microarray dataset that consisted of 55 preterm and 78 term samples. We also prospectively collected urine samples twice weekly from 100 pregnant women with a previous history of preterm birth beginning at 24 weeks of gestation through the end of pregnancy. We have extracted the untargeted metabolome of urine from 58 pregnant women across multiple timepoints and identified metabolites that are significantly associated with preterm delivery, as determined by linear regression with gestational age. The placenta specific metabolic network, iHumanPlacenta has 7104 reactions, 1896 metabolic genes and 3643 metabolites. We integrated gene expression dataset with the metabolic network and identified reactions associated with RRM2B and FADS2 having significant flux differences between term and preterm samples. Our dense sampling of 2256 urine samples identified 26 unique metabolites that were consistent with the effect size and significant across multiple time points. Among those that decreased included N-methylnicotinamide and creatine and succinate and lactate increased with gestational age. We also developed a workflow to integrate tissue-specific transcriptional regulatory network with iHumanPlacenta network to identify transcription factors that regulate the metabolic landscape in placenta. The clinical impact of this work lies in the identification of metabolic signatures for normal placental development and pregnancy complications. The iHumanPlacenta metabolic reconstruction provides insights into normal placental development and identifying metabolic signatures associated with pregnancy complications. Early Gestation T2*-Based BOLD Effect in Human Placenta. Conclusion: Our analysis shows median T2* values alone were not signifi cantly diff erent between subjects with and without adverse events or between non-obese and obese subjects, which could suggest low inter-subject variation in global oxygenation at early gestation. However, the diff erences in the shape of T2* histograms between pregnancies of diff erent complication groups could suggest potential diff erences in local T2* heterogeneities. Results: Viremia was observed in 6/7 dams between 4-7 dpi, resolving <14 dpi. Fetal death occurred at 5 dpi in 1/4 early G dams. ZIKV RNA was detected in uterus (3/4 early; 0/3 mid-G), lymph nodes (2/4 early; 3/3 mid-G) but not placenta (0/7) and in fetal tissues. Preliminary analysis showed gross structural fetal brain defects (abnormal gyri, sulci) and smaller frontal lobe. H&E staining of fetal frontal cortex showed disrupted formation of the ordered six-layered cortex, decreased pyramidal neurons in the cortical plate and significant cerebellar neuropathology in 3 fetuses (2 early and 1 mid-G). Conversely, progesterone treatment in the lung cell line (Calu-3) was associated with a significant increase in cytotoxicity (51.8% vs. 65.2% untreated, p<0.05) and upregulation of il6 expression (7.6 vs. 6.4 untreated log2fold, p<0.05). Caspase-1 activity was significantly decreased in both cell lines after treatment with P4 (p<0.05, both). Conclusion: Pre-treatment with P4 was associated with divergent innate immune and inflammatory responses in placental and lung cell lines marked by less viral cytotoxicity and innate immune activation in ACH-3P, but greater cytotoxicity and il6 expression in Calu-3. In both ACH-3P and Calu-3, caspase-1 activity was significantly decreased indicating NLRP3 inflammasome activation was not involved in innate immune activation. These data provide evidence that progesterone has a dual role in mediating an antiviral response in the placenta, but may exacerbate influenza A virus-associated injury in the lung. We have previously determined that placental CD8+T cells play a crucial role in neonatal outcomes following maternal inflammation. However, specific subsets of CD8+ T cell and their functional properties in placenta following inflammation exposure require further investigation. Methods: At embryonic day (E)14, timed-pregnant CD1 dams (n=14) were randomly allocated into two groups: intraperitoneal injection (IP) of 100uL phosphate-buffered saline (PBS) (n=4) or 0.5ug/100uL PBS of mouse recombinant IL-1β (rIL-1β) (n=10). The dams were injected for four consecutive days to simulate maternal sub-chronic inflammation (MI). After 24 hours (24hpi), placenta tissue was harvested and digested into cells. Flow cytometry was used to analyze immune cell infiltrates and their phenotype in placenta at 24hpi. Intracellular staining for flow cytometry was performed to analyze the cytokines produced by CD8+ T cells, including IL4, IL13, IFN-γ and TNF-α. Results: Effector CD8+ T cells and exhausted CD8+ T cells increased in placenta under maternal sub-chronic inflammatory condition (p<0.01). The production of IFN-γ and TNF-α in placental CD8+ T cells increased (p<0.05) but there was no significance for IL4 and IL13. The heterogeneity and functional properties of placental CD8+ T cells changed following maternal sub-chronic inflammation exposure. Following maternal sub-chronic inflammation, CD8+ T cells functioned via production of IFN-γ and TNF-α, cytokines implicated in hypoxia. Protective Effect of IL-1Ra on GBS-Induced Chorioamnionitis and Neurobehavioural Impairment of the Progeny. Taghreed A. Ayash †. McGill University Health Center, Montréal, QC, Canada. Introduction: Group B Streptococcus (GBS) is one of the most common bacteria isolated in human chorioamnionitis, which is a major risk factor for preterm birth, fetal brain injuries, and neurodevelopmental disorders such as cerebral palsy and autism spectrum disorder. Despite the risk of placental inflammation induced by GBS in human, still little known about it. Previous preclinical work from our lab, showed that placental inflammation triggered by GBS induces placental chemokine (CXCL-1), which triggers massive infiltration of the placenta by PMN -which is the hallmark of human chorioamnionitis. In addition, GBS-induced chorioamnionitis triggers an upregulation of interleukin-1Β (IL-1Β) in the placenta and maternal/fetal blood, which associated to a higher risk of having autism spectrum disease (ASD) and attention-deficit hyperactivity disorder (ADHD) in human. Based on this previous finding we hypothesized that counteracting live GBS-induced placental inflammation using IL-1 Receptor antagonist (IL-1Ra) will prevent chorioamnionitis and subsequent neurobehavioral impairments in the offspring. Methods: We used preclinical Lewis rat model of live GBS-induced chorioamnionitis to study the protective effect of IL-1 Receptor antagonist (IL-1Ra). Dams were treated with 10 mg/kg/12 h, i.p of IL-1Ra. ELISA was used to titrate the protein expression level of proinflammatory cytokines including IL-1β, IL-6 and TNF-α. In addition, in situ immunohistochemical (IHC) experiments were used to measure the PMNs infiltration density in the placenta tissue. We showed that administration of 10 mg/kg of IL-1Ra treatment improved the weight gain of the GBS+IL-1Ra dams. Most of the pro-inflammatory cytokines including IL-6, TNF-α and IL-1Β were decreased in the placenta, as well as in maternal and fetal blood circulation of GBS+IL-1Ra compared to GBS treated group. Moreover, IL-1Ra treatment, showed a protective effect on the placental infiltration of PMNs in GBS+IL-1Ra compared to GBS-exposed dams. (2015) 1 . Patients are seen in the first trimester and followed monthly. Results: Since 2015, 6 women were diagnosed with this condition. They had 8 pregnancies afterward. They all had suffered at least 1 intrauterine death (median 1.5). All patients received low dose aspirin, dalteparin and low dose prednisone (median 10 mg/d). Half the patients also received hydroxychloroquine. Patients delivered, at a median term of 37 weeks, babies with a median weight above the 10 th percentile. Five of eight pregnancies were complicated by gestational diabetes. Two women suffered from a recurrence of chronic intervillositis. Both started their preventive treatment before 8 weeks of pregnancy. The first one presented preterm preeclampsia but delivered at 37 weeks a girl of 1870 grams. The second one presented with an intrauterine growth restriction (IUGR) at 16 weeks. The fetal weight of the second woman was less than the 3 rd percentile at 20 weeks with an increase in alkaline phosphatase (ALKP) levels to 302 U/L (N<126 for the 2nd trimester). The ALKP was used as a marker of placental inflammation. We considered a recurrence of placental chronic intervillositis as the most probable diagnosis and administered IVIG 1g/kg/wk. We observed a decrease in ALKP and improvement in fetal growth along pregnancy. At 30 weeks, as ALKP was increasing, the dose of IVIG was increased to 1.5g/kg/wk. At 32 weeks, the fetal middle cerebral artery doppler showed some vasodilatation and she had a c-section at 33 weeks after betamethasone administration. A healthy boy of 1775 g (10 th percentile) was born. No intrauterine death occurred. Conclusion: Discussion In our series, the recurrence rate was 25% and all babies were born alive at a median term of 37 weeks (32-40). We present, to our knowledge, the first report of rescue treatment for recurrent chronic intervillositis in the 2nd trimester. Presence of IUGR and increased levels of ALKP suggested recurrence. Monitoring ALKP levels allowed us to adjust therapy and the addition of IVIG helped avoid extreme prematurity and favored fetal growth. Introduction: Pregnancy complications with a basis of placental dysfunction such as preeclampsia and intra-uterine growth restriction constitute a major cause of mortality and morbidity for mother and child. Their etiology is not fully understood in part because placental disorders are detected at late stages of pregnancy, when early placental progenitors are no longer available for isolation and study. It is therefore of paramount importance to develop a platform that allows the production of the earliest placental progenitors from differentiated cells. Our research aims to generate stable and fully functional human induced trophoblast stem cells (hiTSCs), from skin cells (fibroblasts), by the transient expression of a small number of master regulatory genes. Methods: By using somatic cell nuclear reprogramming technology utilizing lentiviral vectors with a Tet-on system, we transiently overexpressed in fibroblasts transcription factors which are important in establishment of TSC identity. The resultant colonies were analyzed using qPCR, immunostaining, RNAseq and RRBS in order to assess their gene expression and methylome profiles and confirm TSC identity, while functional experiments, such as differentiation into trophoblast cell subtypes, were also performed. Results: Based on evidence we have collected thus far, our hiTSCs undergo a stable conversion process and are generally indistinguishable from their human blastocyst-derived TSC counterparts. Gene expression and methylomic analyses as well as functional assays such as the formation of trophoblastic lesions in NOD-SCID mice and differentiation into trophoblastic cell types and the formation of organoids indicate fully reprogrammed functional TSCs. Conclusion: These results suggest that stable and functional human TSCs can be produced from differentiated cells and propose a new platform to model placental dysfunction diseases. The removal of all the CpGs influenced by gestational age, cell composition, ethnicity, experiment, age of the mother, parity and birthweight leads to a final total of only 6 CpGs that are correlated to the disease status. These 6 CpGs were found in the three different analyses performed with different samples subsets, improving the significance of these CpGs to a p-value= 1e-13. Gene ontology analysis shows that hypertension is the predominant disease associated with these CpGs (P-value < 0.00075). Moreover, according to the Single Cell Type Atlas (The Human Protein Atlas), these genes are highly expressed in placental cell types, specially Hofbauer cells and fibroblast cells. Conclusion: This strategy allows, despite the limited size of the cohort, to identify in pathological placentas differential methylated CpGs located in genes highly relevant to the placenta pathophysiology. Future studies on meQTL analysis will be developed to determine the role of genetic variants in methylation level. in presence or absence of sFLT-1 for 24 hours and harvested for mRNA extraction using QIAGEN RNA extraction kit. Expression of mRNA for mitochondrial enzyme complexes was assessed by qRT-PCR using gene specific primers and analyzed relative to the expression of GAPDH and 18s. Data was analyzed with Prism GraphPad Software using 1-way ANOVA or unpaired t test. P ≤ 0.05 was considered statistically significant. Results: 1)CGRP dose-dependently increases: a) ND1 and ND2 mRNA encoding proteins in mitochondrial complex 1, b) Cytochrome b (CYTB) in complex 3,c) Cytochrome c oxidase subunit I (CO1) mRNA in complex 4, and d) ATPase V mRNA in complex 5 (P<0.05); 2) sFLT-1 decreases the expression of ND1 and these decreases are inhibited in presence of CGRP; 3) sFLT-1 shows a tendency to decrease the expression of ND2 in HUVEC which becomes significant in presence of CGRP (P<0.05) and 4) sFLT-1 has no effect on the expression of CYTB, CO1and ATPase5 in HUVEC cells in presence or absence of CGRP. Conclusion: CGRP mediated increase in mitochondrial enzyme complexes in endothelial cell and rescue of sFLT-1-mediated decreases in ND1, suggest a potential role for CGRP in regulating oxidative stress and ameliorating sFLT-1 induced endothelial dysfunction. Introduction: Low-dose aspirin has been shown to have variable antiplatelet activity in individual patients and discussion remains on the effectiveness of aspirin 80 mg. The objective of this study is to compare the effect of aspirin 80 mg and placebo on platelet function tests in second and third trimester of pregnancy. Methods: We performed platelet function tests in a subpopulation of the APRIL trial: a randomised double-blinded trial comparing aspirin 80 mg once daily to placebo for the prevention of recurrent preterm birth. Aspirin resistance was measured at 18-22 and 28-32 weeks of gestation with three platelet function tests: VerifyNow®, Chronolog light transmission aggregometry (Chronolog LTA) and serum thromboxane B 2 (TxB 2 ). The technician performing the tests was also blinded. The Wilcoxon test was performed to compare the measurements at two time points, and the Mann Whitney U test to compare the means of the groups. Compliance to medication was evaluated by a structured interview on each occasion and by a participant-reported medication diary. Results: In total, 11 women participated in the present study: 6 in the aspirin group and 5 in the placebo group. Treatment groups were comparable with respect to maternal age and body mass index. Platelet function measurements of all participants are shown in Figure 1 . The measurements at 18-22 and 28-32 weeks gestation were similar for VerifyNow® (p=0.17), Chronolog LTA (p=0.83), and TxB 2 (p=0.78). Two platelet function tests in the aspirin group showed a markedly reduced platelet activity compared to the placebo group: VerifyNow® (p=0.02) and Chronolog LTA (p=0.01). The discriminative effect of TxB 2 was less clear (p=0.33). There was one participant in the aspirin group without an effect on platelet function, who reported not to be compliant to medication. Conclusion: Aspirin 80 mg has a clear inhibitory effect on platelet function during pregnancy compared to placebo, which is similar in second and third trimester. where vasodilator production needs to be improved but the monolayer has yet to be damaged; and CLA Mix will do no additional harm. However, it is unlikely to be effective when the endothelial damage has progressed and is in need of repair. With the exception of bFGF, U0126 was injurious to the monolayer. PP2 broadly offered support to the monolayer, buffering bFGF and boosting IL-6 and IL-8. Both IL-1b and TNFa led to reductions in monolayer resistance. In the case of TNFa this was prevented with PP2. This is notable, showing potential for Src inhibition to prevent the greatest insult. Src inhibition therefore offers a potential strategy for stabilization of the endothelium, and could serve as part of a therapeutic strategy for treating endothelial dysfunction in PE. Hydroxychloroquine Effect on Healthy and Activated Fetoplacental Endothelial Cells In Vitro. Maja Gajic †, Christian Wadsack * , Mila Cervar-Zivkovic * , Karoline Mayer-Pickel * . Medical University of Graz, Graz, Austria. Introduction: Preeclampsia (PE) is characterized by insufficient placental perfusion, followed by the production of pro-inflammatory cytokines and anti-angiogenic factors. PE can increase maternal and/or fetal morbidity and mortality. Moreover, it has been shown that PE has a long-term negative effect on offspring. The only currently available treatment for PE is delivery. We suggest hydroxychloroquine (HCQ) as a potential drug for PE. HCQ is an anti-inflammatory drug improving endothelial homeostasis in lupus. However, the effect of the drug on placental vasculature is still unknown. We aim to investigate the effect of HCQ on health fetal endothelial cells as well as in a model of inflammatory-induced endothelial activation at the fetal side of the human placenta. Methods: Primary fetoplacental arterial endothelial cells (fpECAs) isolated from healthy placentas (N=7) were exposed to a pro-inflammatory environment (TNF-α, IL-6 and IL-1β). Pharmacological (10 ng/ml, 10 ng/ml, 1 ng/ml) concentrations of cytokines in the presence or absence of HCQ (1 µg/ml) were used. Subsequently, gene expression of cytokines (IL-8 and IL-6), leukocyte adhesion molecules (ICAM-1, VCAM-1 and selectin E) and angiogenic mediators (placenta growing factor (PlGF) and endoglin (ENG)) were quantified by qPCR. Moreover, protein concentrations of secreted IL-8 and PlGF were evaluated by ELISA, while cell abundance of ICAM-1 and VCAM-1, as well as phosphorylation of nuclear factor κB (NFκB), was determined by Western Blot analysis. -9) . Previous studies suggested that CFCmtDNA may be a potential pathogenic trigger or a contributor to the maintenance of preeclampsia. The main objectives of this study were 1) to determine absolute concentrations of CFCmtDNA, in membrane-bound and -unbound states, independent of nuclear DNA (nDNA) changes, in cases with preeclampsia and healthy controls and 2) to implement a penalized regression analysis to establish the contribution of CFCmtDNA to preeclampsia diagnosis and its interaction with commonly collected patient characteristics. Methods: Plasma CFCmtDNA (MT-ND5 gene) concentrations were quantified using an absolute quantification protocol. DNase I concentrations in maternal plasma were measured using an enzyme-linked immunosorbent assay and TLR-9 activity was monitored using SEAP reporter 293 cells expressing the human TLR-9 gene. Results: Concentrations of CFCmtDNA were reduced in preeclampsia compared to healthy controls both in lysis buffer-treated samples (P=0.02) and in samples not treated with lysis buffer (P<0.0001). Even though CFCmtDNA concentrations were reduced, plasma from women with preeclampsia induced greater TLR-9 activation than plasma from gestational age matched controls (P<0.01). Multivariate analysis showed that high concentrations of nDNA and DNase I, a prior history of preeclampsia, and a lower concentration of CFCmtDNA are predictors of preeclampsia diagnosis. In conclusion, our data demonstrate an increased immunostimulatory potential of CFCmtDNA and upregulation of DNA degradation mechanisms in women with preeclampsia at the third trimester. This may suggest differential transfer of cells at the maternal fetal interface in PE. Studies in larger cohorts are needed to uncover underlying mechanisms for differential cellular exchange between mother and fetus in PE. The .001) was identified as a risk factor for acute liver rejection. Elevated liver enzymes (AST, ALT) was universal for rejection but occurred in a minority of those with preeclampsia (18%), who were mainly diagnosed based on elevated blood pressures. Although there were no significant differences in maternal outcomes, there was more graft loss after peripartum acute rejection (41% vs 16%, p= 0.017). Acute liver rejection was associated with a higher rate of preterm delivery at <32 weeks (41% vs. 16%, p = 0.04) and was independently associated with neonatal composite morbidity (aOR 5.02 [CI 1.06, 24 .8], p = 0.04) when compared with pregnancies affected by preeclampsia. Conclusion: Though both rejection and preeclampsia can cause liver damage, liver transplant recipients with preeclampsia presented with hypertension without transaminitis and had better obstetric and graft outcomes. These data highlight the importance of preconception counseling and graft optimization prior to pregnancy to reduce the risks of graft loss, preterm delivery, and neonatal morbidity associated with liver transplant rejection during pregnancy. . Expected frequency of distribution of genotypes for HWE in the main group: G / G = 36.6; G / A = 9.7; A / A = 0.6. The observed frequency of distribution of genotypes for RHV in the main group: G / G = 37; G / A = 9; A / A = 1. When comparing the frequencies of genotypes and alleles of the ESR1 gene polymorphism in the studied groups of patients and controls, we did not find statistically significant differences. In the main group, the frequency of the G allele of polymorphism 2014G> A of the ESR1 gene was 88.3%, in the control group -85.7%, which also indicated an insignificant association with an increased risk of predisposition to preeclampsia (χ2 = 0.31; P = 0, 28; OR = 1.26; 95% CI: 0.56-2.89). Conclusion: Thus, according to preliminary data, the presence of the G allele and the hetero-and homozygous G / A and GG genotypes increases, and the identification of the A allele and the AA genotype decreases the risk of preeclampsia. It is recommended to conduct further studies of the association of ESR 1 gene polymorphism with the development of preeclampsia using a larger sample. . We adopted the process of cfDNA extraction and performed wholegenome cfDNA methylation sequencing in our first trimester samples. We assessed unbiased determination of tissue origins of cfDNA using deconvolution, and identified differentially methylated regions (DMRs) and annotated genes. We used Student's t tests and one-way analysis of variance and Holm-Sidak test for analysis. We considered p < 0.05 to be statistically signifi cant. Results: Clinical characteristics differed only in PE and chronic hypertension incidence. Birth weight was signifi cantly lower in the PE group. Global cfDNA methylation changes and potential cfDNA methylation origin point towards a homogenous PE/HT group (Fig. 1A+B) . We detected 86 DMRs in PE/HT (75 genes) compared to PE/ Ctr (DMRs: 139; 75 genes) and HT/Ctr (DMRs: 140; 74 genes) groups (Fig. 2C ). Analysis of specifi c genes point towards an association with cardiovascular disorders (Fig. 2C -red highlighted genes) . The cfDNA methylation profi le in the fi rst trimester supports the pivotal role of the cardiovascular system in the pathogenesis of HDP. Early identification of embryos with high implantation potential is required for avoiding clinical complications to the newborn and to the mother that are associated with multiple pregnancy and for shortening time to pregnancy. We hypothesize that non-invasive in situ measurement of the viscoelastic properties of oocytes during in vitro maturation (IVM) can accurately and robustly predict maturation, fertilization and implantation potential. We developed the MechanoPLATE -a multiplate-based glass device for performing continuous viscoelastic characterization of oocytes and embryos under optimal culture conditions. Stress-strain relationships are obtained via in situ aspiration creep test measurements that are performed in each well of the MehcanoPLATE seperately. Accurate mechanical characterization of oocytes and embryos is calculated by fitting the measured compliance to a linear viscoelastic model. In this manner, we measure the mechanical dynamic response of the intact oocyte or embryo to applied forces and independently probe ooplasm mechanics. Applied forces are maintained below a threshold to avoid structural damage and to maintain biological functions. The developmental potential of oocytes and embryos is scored based on the capacity to complete second metaphase (MII) and to reach blastulation. Results: Using a bovine model, we demonstrate a non-invasive rheological characterization, which does not compromise the developmental potential of oocytes and embryos. Surprisingly, we find that the viscoelastic properties of the oocytes change drastically such that GV oocytes behave like a purely elastic solid material that transforms into a fluid-like viscoelastic material after 22 hours of IVM. Moreover, only high quality GV oocytes that complete first meiosis and reach MII soften during IVM whereas poor quality arrested oocytes remain stiff. These mechanical differences that mark a decrease in the developmental potential of oocytes are consistent with a decrease in the reproductive potential as exhibited by aged versus young cows and by oocytes collected from antral follicles during the hot versus the cold season. Conclusion: In situ rheological profiling offers a real-time, non-invasive, and standardized method for evaluating the developmental potential of oocytes and embryos. In addition, viscoelastic measurement inside the MechanoPLATE can be combined with time-lapse imaging for improving the selection of high quality embryos for transfer. Collectively, our work introduces a mechanical assisted reproductive technology that we believe will improve implantation and live birth rates in human IVF. (age>35), and NOR. In addition, viability of GC was consistently above 95%. Both TOP5300 and rh-FSH stimulated estradiol production and steroidogenic gene expression from human GC. The fold increase in estradiol production (48hr) with TOP5300 was often greater than rh-FSH among PCOS and ARA patients, but was heterogeneous within each patient population. TOP5300 induced statistically greater expression of both STAR and CYP19A1 in GC after 6hr of treatment compared to rh-FSH in both ARA and PCOS patients, but not for GC from NOR patients. The intensity of membrane FSHR staining for TOP5300 relative to rh-FSH was greater in ARA and PCOS patients, and similar for TOP5300 and rh-FSH in GC obtained from NOR patients. Conclusion: TOP5300 leads to greater induction of ovarian steroidogenic gene expression and extended presence of the FSHR at the plasma membrane in GC from PCOS and ARA patient populations. One possible explanation for the superior steroidogenic response of TOP5300 relative to rh-FSH in GC from PCOS and ARA may reflect extended presence of FSHR at the plasma membrane of GC. Our results provide the first evidence that an oral FSHR allosteric agonist performs differently in specified infertile patient populations, addressing a therapeutic gap in personalized medicine available for infertility treatments. Of those who recommended complete cessation, 40/68 (58.8%) identified specific concerns about stimulating while on testosterone; most common were oocyte quality (40%) or stimulation success (37.5%). There were no significant relationships between formal training, comfort with counseling and/or stimulation, and cessation of testosterone. The mean comfort levels for providing ART counseling and performing stimulation were each 7.1 on a 0-10 scale, and 35.0% of respondents received some form of formal training. In the absence of relevant data or formal guidelines, most REIs stop testosterone completely prior to ovarian stimulation. Because cessation of hormones and return of menses can significantly increase dysphoria, consideration could be given to maintaining testosterone therapy during stimulation after appropriate counseling. Other areas of variable practice include recommended duration of cessation, mental health consults, or requiring a menses before stimulation. This suggests an opportunity for additional research to determine the optimal approach to ART for transgender men, and subsequent standardization of education in this area. Is Conception with Assisted Reproductive Technology Associated with Increased Maternal Psychological Stress in Nulliparous Women? Amir Lueth * , Nathan Blue, Robert Silver. University of Utah, Salt Lake City, UT, United States. Introduction: Pregnancy achieved through assisted reproductive technology (ART) has been associated with obstetric morbidity, but results are mixed. One potential confounder is the potential stress associated with ART. Thus, we aimed to examine the relationship between maternal stress during pregnancy and ART in a well characterized cohort with prospectively and objectively assessed emotional health. Study Monitoring Mothers-to-be (nuMoM2b), a prospective observational cohort study. Participants were recruited in their first trimester of pregnancy from 8 institutions and had 4 study visits, including at delivery. ART was defined as IVF or intrauterine insemination. For the primary analysis, psychological stress was assessed using the Perceived Stress Scale questionnaire and compared between women who underwent ART and women who conceived naturally. Secondary analyses included comparisons of Edinburgh Postnatal Depression Scale (EPDS) and the State-Trait Anxiety Inventory (STAI-T) scores. Comparisons were made using univariable and multivariable analyses as appropriate. Results: 10,038 women were included in the analysis. 3.9% (n=391) women conceived with ART. Several factors were associated with ART, including maternal age, first trimester bleeding, hyperthyroidism, and inherited bleeding disorders (Table 1) . In unadjusted analysis, women who underwent ART were less likely to have high (OR 0.18, 0.06-0.55) or moderate stress scores (OR 0.59, 0.47-0.74). After adjusting for maternal age, education, race, parity, smoking, prior abdominal surgery, 1 st trimester bleeding and medical diagnoses, differences in stress were no longer different between groups. Analyzing by type of ART did not change the results. In secondary analysis, women who conceived through ART were less likely to have a high STAI-T score (OR 0.65, 0.47-0.89) in the first trimester (Table 2) . Conclusion: In this large prospective cohort of nulliparous women, conception with ART was not independently associated with differences in perceived stress scale, STAI-T, or EPDS scores. Introduction: Hashimoto thyroiditis is the most common autoimmune disease in women of childbearing age. This disease decreases thyroid gland function and negatively affects female fertility, impairing fertilization, embryo quality, and live birth rates. However, the mechanism of this association is still unknown. The autoantibodies, characteristic of this disease, are present in the ovarian follicular fluid. Thus, the ovarian follicle microenvironment may be the answer to how the disease could impact fertility. This study aimed to investigate the follicular fluid metabolic components from women with Hashimoto thyroiditis undergoing in vitro fertilization and compare it to data from euthyroid patients. Methods: In this study, we collected patients' follicular fluid from two reproductive medicine centers for two years. In total 61 patients were screened, including 38 euthyroid women who were positive for thyroid autoantibodies and 23 negative controls. 210 metabolites were analyzed in the follicular fluid was carried out by the liquid chromatography method coupled to an electrospray ionization mass spectrometer. Multivariate analysis was performed by partial least squares discriminant analysis (PLS-DA). The metabolomic profile of each group was identified using the Metaboanalyst 4.0 software. Results: As a result, we got 15 potential biomarkers, of which 9 were increased and 6 were decreased in the Hashimoto thyroiditis patients' follicular fluid compared with the control group. Among the biomarkers identified, Hashimoto thyroiditis patients showed an increased abundance of amino acids (serine, threonine, histidine, and leucine), carnitines (stearoylcarnitine, propionylcarnitine, palmitoylcarnitine, and butyrylcarnitine), and phosphatidylcholine, PC(16:0/14:0) compared to control follicular fluids. Our results showed different metabolite concentrations between women with Hashimoto thyroiditis and controls, thus suggesting that the disease changes the follicular fluid metabolic profile and the ovarian follicle microenvironment. Our finds suggest biological pathways that may help explain how Hashimoto's disease affects female fertility. Introduction: Despite the increased prevalence of marijuana use in women of reproductive age, there is limited data on its impact on female reproductive health. Results from existing human studies are conflicting and often reflect marijuana use through smoking and not the direct effect of delta-9-tetrahydrocannabinol (THC), the main psychoactive ingredient of marijuana. Our study's objective is to determine the dose-dependent effect of contemporary marijuana exposure on female menstrual cyclicity in a nonhuman primate model. Methods: Adult female rhesus macaques (n=8) with regular menstrual cycle lengths (MCL) were maintained on a standard chow diet with a daily THC edible. All animals were titrated to the maximum dose (2.5mg/7kg/ day, equivalent to a heavy medical dose in humans) of THC over 4 months. THC dosing was increased every month to replicate established medical marijuana acclimation guidelines. MCL for up to 4 cycles was recorded before and during THC induction. Serum collected on menstrual cycle days 1, 3, and 5 was analyzed for estradiol (E2) and progesterone (P4). Anti-Müllerian hormone (AMH) and prolactin (PRL) assays were performed on day 3 samples. Results: All rhesus macaques in this study were of reproductive age and the majority (7 of 8) of proven prior fertility. No animals had prior exposure to THC or other environmental perturbations. The average MCL was 28-29 [standard deviation (SD) 2.8] days pre-THC and during THCinduction; but, the average MCL was 37.8 [SD 15.8 ] days at highest THC dosing (Fig 1) . There was no significant THC effect on average basal E2, P4, or PRL levels. Average AMH concentrations increased with higher THC dosing. Mean AMH at baseline (pre-THC) was 10.7ng/ml [SD 8.4 ] compared to 13.2ng/ml [SD 5 .5] at 0.5mg/7kg/day, 14.6ng/ml [SD 6 .4] at 1mg/7kg/day) and 14.0ng/ml [SD 8 .0] at 2.5mg/7kg/day of THC. Conclusion: A dose-dependent trend towards increased MCL and AMH levels with increasing THC doses was observed in reproductive-aged rhesus macaques. Unlike smoking marijuana, THC edibles allows the study of the direct effects of THC and avoids the chemicals in smoke that may compound the effect of THC on reproductive characteristics. Further studies are needed to determine whether the increase in AMH is indicative of other reproductive abnormalities and reduced fecundity, as well as the effect of a longer duration of exposure. The live birth rates of IVF-ET treatments have steadily declined worldwide during the past decade concomitantly with increasing patient's maternal age. Classification algorithms that assess the potential to implant of cleavage-stage embryos based on time-lapse real-time imaging of preimplantation development support extended incubation towards blastocyst transfer. However, optimizing the day-of-transfer with respect to the developmental properties of individual embryos is lacking. Methods: To assess the individual treatment effect of blastocyst transfer with respect to implantation, we trained a causal inference model using a retrospective dataset of time-lapse imaging of freshly transferred Day-3 (2,167 embryos) and Day-5 (778 blastocysts) embryos obtained from four medical centers. Cleavage-stage embryos were characterized by the Transfer Lift, which is a novel developmental property that quantifies the increase (positive Transfer Lift) or decrease (negative Transfer Lift) in the estimated implantation rate of blastocyst-stage versus cleavagestage transfers. Results: While extended incubation towards blastocyst transfer of most embryos was estimated to increase their implantation rate by up to 30%, it decreases the implantation rate of 8% of the embryos by up to 10%. Complementary to the Transfer Lift, we provide a classifier that predicts blastulation outcome of cleavage stage embryos (66 hours post fertilization) with AUC 0.92, which can be used for de-selecting embryos for blastocyst transfer. Conclusion: Retrospective evaluation of a test-set of 338 cleavage-stage and 150 blastocyst-stage transferred embryos reveals that adjusting the individual day-of-transfer according to the Transfer Lift can improve implantation rate by >30%. Our decision-support tool marks the first utilization of counterfactual inference in reproductive medicine. Novel Compound Heterozygous Variants in PATL2 Associate with Oocyte Meiotic Arrest. Beatriz Rodríguez-Alonso †, Hakan Cakmak * , Aleksandar Rajkovic * . UCSF, San Francisco, CA, United States. Introduction: Oocyte maturation defect is characterized by oocyte meiotic arrest that can occur at different stages of oocyte development, thus impairing fertilization and embryo development. Studies over the past few years have begun to elucidate genetic heterogeneity of this condition. Methods: We report the case of a 38-year-old G0 healthy woman with primary infertility who presented for infertility work up with unremarkable pelvic ultrasound, hormone testing and semen analysis. She underwent 3 antagonist IVF cycles with excellent ovarian response. The patient had a total of 64 dominant follicles (between sizes of 13-20 mm) on the day of trigger shot. The patient received Lupron 4 mg and/or hCG up to 5000 IU to induce oocyte maturation. Although the oocyte yield was excellent (total of 89 eggs retrieved), the mature (MII) oocyte rate was very low (2 MII, 6 MI, and remaining was GV or abnormal looking). ICSI was performed to all MII and MI oocysts, and no fertilization was observed. The diagnosis of oocyte meiotic arrest was entertained and whole exome sequencing of the patient revealed two novel compound heterozygous missense variants in the PATL2 gene, c.1418C>T at chromosomal position ch15:44959349 (hg19) and c.16G>A at chromosomal position ch15:44968673. Both variants were confirmed by Sanger sequencing. Results: These variants were not reported previously, and were not present in ClinVar or HGMD databases. The population allele frequency for the c.1418C>T (p.Ser473Leu) heterozygous variant was very low (3 alleles out of >180,000 alleles) in gnomAD, while the c.16G>A (p.Gly6Arg) variant was not reported in the 1000 Genomes, ExAC, or gnomAD population sequencing projects. Given the strong gene-disease but absent variant-disease associations, the variants were both classified as "variant of uncertain significance". The PATL2 gene encodes protein PAT1 homolog 2, a protein highly expressed in immature human oocytes. PATL2 acts as a translational repressor, and when there is a loss-of-function, a downstream protein synthesis is activated leading to oocyte maturation arrest. Variants in this gene are associated with oocyte maturation defect 4, an autosomal recessive disorder characterized by some oocytes exhibiting maturation arrest at GV or MI stage. Conclusion: In women diagnosed with oocyte maturation arrest, genetic testing can avoid subsequent IVF cycles with anticipated lack of fertilization, saving the patients from the financial and emotional hardship of repeated failed cycles. The knowledge of the full spectrum of PATL2 mutations leading to female infertility is necessary for better counseling of women affected with this condition. Oh Boy! Exploring the Effect of Microfluidic Sperm Separation on Embryonic Sex. Safina Usmani †, Caroline Peschansky †, Sarah Dynia †, Sonia Patel †, Jawaria Amir †, Royi Lynn †, Kayla Vitale †, Lauren Grimm †, Lizabeth Dulle †, Erica Louden * , Roohi Jeelani * , Angeline Beltsos * . Vios Fertility Institute, Chicago, IL, United States. Introduction: Increased interest in the effects of male factor fertility on embryo development between days 3-5, when paternal gene activation takes place, has led to innovative sperm sorting techniques that are thought to result in higher quality sperm selection for use in in-vitro fertilization (IVF), including microfluidics sperm separation. Previous independent studies have shown inconclusive data on whether or not different sperm preparation techniques truly result in better quality embryos, either morphologically or chromosomally. As new sperm preparation protocols become more widely used, understanding their clinical utility is paramount prior to laboratory use. The purpose of our study is to understand whether or not different sperm preparation techniques result in bias of sex differentiation in developing embryos Methods: Retrospective chart review at a private fertility clinic. All IVF cycles between June 2018 to January 2021 were analyzed and split into two groups: those that had received sperm processing using microfluidics sperm sorting and those that used density gradient centrifugation. Only cycles resulting in utilizable embryos that underwent preimplantation genetic testing (PGT) were used. Quantitative semen parameters, including concentration and motility, as well as the results of embryonic chromosomal analysis were evaluated. T-tests and chi square analysis were used to analyze the data using SPSS (SPSS Inc., Chicago, IL, USA). Results: A total of 2,390 embryos were analyzed, with 720 embryos included in the microfluidics group and 1670 embryos included in the density gradient control group. The average age of the egg and sperm sources in the microfluidics group was 39.98 and 39.5 years respectively, compared to 39.99 (p>0.05) and 37.95 years (p<0.05) in the control group. The microfluidics group had an average concentration and total motility of 70.9M and 66% respectively, compared to 72M (p>0.05) and 65% (p>0.05) in the control group. PGT results showed a euploid rate of 58.05% in the microfluidics group, compared to 52.6% (p<0.05). Of the embryos that received a chromosomal sex designation, we found that the microfluidics sperm sorting device resulted in 52.5% of embryos being male, 39.6% female (p<0.05), compared to a near even split of 50.2% males and 49.8% females in the density gradient group. Conclusion: Our data suggests that use of microfluidic sperm separation yields more male embryos than female embryos. Interestingly, while not a primary endpoint of our study, we did also find that the microfluidic technique resulted in increased rate of euploidy compared to the traditional density gradient centrifugation. Further studies are warranted to validate these chromosomal sex differences seen in embryos created via different sperm preparation techniques. Identifying the Optimal, Multistep and Adaptive Embryo Transfer Strategy for Improving IVF Outcome. Yoav Kan Tor †, Deborah Wolhandler †, Buxboim Amnon. Hebrew University of Jerusalem, Jerusalem, Israel. Introduction: Human IVF technology may require a sequence of fresh and frozen embryo transfer cycles to achieve conception and live birth. Given the finite, often limiting number of high-quality fertilized oocytes retrieved from patients, the multistep decision of how many and which embryos to transfer on each cycle becomes crucial for shortening time to pregnancy while avoiding clinical complications associated with multiple pregnancy. We hypothesize that a multistep, look-ahead approach can identify the optimal embryo transfer strategy and improve IVF outcome. Methods: Using dynamic programming, we developed an online decisionsupport tool that surveys all possible embryo transfer combinations at each step as defined by the given cohort of a patient's embryos, and scores the expected action outcome (EAO). For each possible action (transfer one, two or three embryos), the EAO scores the potential to conceive combined with penalties due to multiple pregnancy and time to pregnancy by integrating the future actions allowed by all possible strategies. The potential to conceive depends on the assessments of embryo quality and endometrial receptivity -the latter is computationally adjusted in real time based on the outcome of previous transfers. Embryo quality can be assessed using various methods chosen by the user. Here we present machine learning and automated deep learning algorithms that predict the potential to reach important developmental milestones: blastulation, implantation, avoiding 1st trimester miscarriage and live birth. Finally, EAO scoring also allows a physician evaluation of embryo freezing effects and related patient-specific medical risks. The medical utility of our decision-support tool is demonstrated retrospectively using an expansive database of IVF treatments collected from five medical centers. It includes time-lapse videos, maternal information, embryo transfer statistics, chemical and clinical pregnancy measurements, miscarriage and live birth outcome for more 20,000 embryos and 5,400 transfer cycles. For each medical center we identify a distinctive embryo-transfer policy applied to all patients, rather than a patient-specific strategy. We retrospectively quantify the distances between the transfer decisions made by the physicians and the optimal actions defined by the decision-support tool. A negative correlation between these distances and implantation outcome will support accuracy and clinical utility. The multistep embryo transfer decision-making process can be projected onto a graph and solved analytically using dynamic programming. Clinical adoption of established computational tools has the potential to implement a personalized-care approach, shorten time to pregnancy, minimize health risks and improve live-birth rates. Does More Really Mean More? Comparing Pregnancy Rates and Number of Gestational Sacs Visible on Ultrasound Following Transfer of 1 vs. 2 PGT-Normal Embryos. Anisa Hussain †, Abeer Salhia * , Lauren Grimm †, Jacqueline Sehring †, Jody Esguerra †, Angeline Beltsos * , Roohi Jeelani * . Vios Fertility Institute, Chicago, IL, United States. Introduction: We investigated whether transferring 2 embryos determined to be euploid by preimplantation genetic testing for aneuploidy (PGT-A) truly resulted in improved clinical pregnancy rate without putting patient health and wellbeing at risk due to multiple pregnancy; would the benefits outweigh the risks? Methods: Patients undergoing day 5 frozen embryo transfer (FET) of 1 or 2 euploid (PGT-normal) embryos were included. All embryos were biopsied and tested with Next Generation DNA Sequencing, frozen, then thawed for transfer. 10-12 days post-transfer serum beta-hCG level was tested, with a level of 5 mIU/mL or greater indicating pregnancy. Following positive pregnancy test, serum beta-hCG level was monitored every other day for 4 days, as the level should double every two days with a clinical pregnancy. 10-14 days after the initial positive test, when accompanied by appropriately-rising serum beta-hCG, an ultrasound was performed to confirm intrauterine pregnancy. Clinical pregnancies were managed at the fertility clinic for approximately 8 weeks, after which care was transferred to an OB/GYN. Results: 173 total cycles were included. In 163 cycles, a single PGTnormal embryo was transferred (single embryo transfer = sET). In the remaining 10 cycles, two PGT-normal embryos were transferred (double embryo transfer = dET). 79% of sETs and 90% dETs resulted in positive serum beta hCG level. Overall clinical pregnancy rate was 60% for sET and 90% for dET. Chi square test determined no significant difference between positive pregnancy test and clinical pregnancy rates in both groups (p=.41 and p=.059, respectively). For those patients that achieved pregnancy after transfer of 1 or 2 PGT-normal embryos, dET resulted in a significantly higher average number of gestational sacs visible on ultrasound, with an average of .946 gestational sacs for sETs and 1.444 for dETs (p<.05). Conclusion: Previous studies suggest that PGT-A significantly increases pregnancy and live birth rates in patients with recurrent pregnancy loss, implantation failure, and advanced maternal age. However, current guidelines do not address whether or not increasing the number of embryos transferred increases the chance of clinical pregnancy. While clinical pregnancy rates and transfer of care to an OB/GYN did not differ between sET and dET, the number of intrauterine pregnancies did increase significantly with dET. When counseling patients about multiple embryo transfer, physicians must bear in mind the risks that come with multiple pregnancy, including preterm delivery, low birth weight, and fetal loss. One must consider if the risks associated with multiple pregnancy are truly warranted when the chance of clinical pregnancy is the same with single and double embryo transfer. The Introduction: Polycystic ovarian syndrome (PCOS) is a multifactorial condition that affects 5-10% of reproductive aged women and is a common cause of anovulatory infertility. Anti-Müllerian hormone (AMH), a marker for ovarian reserve, is produced by growing ovarian antral follicles. AMH levels are elevated in women with PCOS in comparison to normo-ovulatory women, consistent with the increased number of antral follicles in PCOS. Evidence suggests that AMH concentrations are correlated with the degree of ovulatory dysfunction in PCOS patients. PCOS is also associated with obesity where approximately 50% of patients are overweight or obese. While the association between obesity and PCOS is complex, obesity exacerbates many aspects of the phenotype. The relationship between obesity and AMH levels has been studied with conflicting results. While most studies have demonstrated a negative correlation or no correlation, a 2018 study demonstrated a positive correlation between AMH and BMI in non-PCOS patients. We sought to investigate a correlation between AMH and BMI in PCOS patients and whether worsening BMI and elevated AMH levels resulted in poorer embryo quality as seen in embryo grade and preimplantation genetic testing outcomes in this cohort. Methods: A retrospective chart review was performed on a total of 465 patients with a diagnosis of PCOS who underwent IVF at a private infertility center from 2018 to 2020. All cycles from this group were analyzed for blast quality score and preimplantation genetic testing. Logistic regressions to calculate Pearson coefficient correlation were utilized to analyze the data using SPSS 21.0 (SPSS Inc., Chicago, IL, USA). Results: A total of 465 cases were identified, out of which 352 patients made blastocysts for grading and 167 had genetic testing done. Our results indicate there is no significant correlation between BMI and serum AMH levels in women with PCOS (r squared = 0.00). Similarly, there was no significant correlation when AMH and BMI were used to assess a correlation with Blastocyst Quality (morphology) or euploid embryo rate (r squared = 0.00). As was expected, there was a slight positive correlation between serum AMH level and euploidy rate (r squared = 0.02). Conclusion: While previous research has shown discrepancies in whether or not a relationship exists between BMI and serum AMH levels in non-PCOS women, our study shows that among women with PCOS, there is no correlation between BMI, AMH, or embryo quality, both chromosomally or morphologically. While this new information may help to alleviate any concerns in embryo utility for women with PCOS, especially severe PCOS, further research is needed to better understand the clinical outcomes in women with various presentations of PCOS. Prevalence The prevalence of PCOS is estimated to be between 6% and 9% in the United States but variations by region and race/ethnicity are not well understood. Although previous literature has demonstrated higher BMI and insulin resistance in Mexican Americans, which may potentiate increased risk for PCOS, the prevalence of hirsutism and PCOS in Latinx women (LX) in the United States remains poorly characterized. The objective of this study is to explore the prevalence of diagnosed PCOS and of PCOS-related clinical findings. Methods: A cross-sectional analysis was performed from a prospective longitudinal cohort study of LX between the ages of 21 and 50 years. All study members were participants in ELLAS, a NIH funded community engaged study. Participants were administered questionnaires collecting demographic information, medical, and reproductive health history including questions pertaining to hirsutism and menstrual cycles. Additionally, fasting blood samples were collected to assess for glucose dysregulation. Statistical analysis was performed using Chi-squared and Wilcoxon rank sum tests. Results: 652 LX have enrolled in ELLAS and 574 completed the first study visit. The average age of the cohort is 37.5 years ± 6.99 years. 6.2% of women reported a prior diagnosis of PCOS, but only 4.4% reported any prior medical treatment for PCOS. 86 women (15.0%) reported hirsutism of which 15.1% had a known diagnosis of PCOS. Women with hirsutism were more likely to be born in the United States (16.3 vs 8.1%; p = 0.015) and have a higher BMI (30.6 vs 28.8; p = 0.03). They also had longer menses (5.0 vs 4.0 days; p = 0.004) and cycles that were more likely to be irregular in the past three months (36.0% vs 23.1%, p = 0.026). Based on hemoglobin A1C values, 96 (20.1%) were prediabetic and 30 (6.3%) were diabetic. Women with previously diagnosed PCOS or both hirsutism and irregular cycles were more likely to be obese (56.7% vs 38.8%; p = 0.014) and to report a history of infertility (43.3% vs 26.6%; p = 0.007). Conclusion: While the prevalence of diagnosed PCOS among this cohort of LX was only 6.2%, PCOS-related clinical findings of hirsutism (15.0%) and irregular menstrual cycles (33.7%) were commonly reported. The high prevalence of obesity, glucose dysregulation and infertility in this cohort of largely first generation LX highlights a need for improved preventative and reproductive health care for this group and suggests potential underdiagnosis of PCOS. Further research is needed to better characterize the prevalence and treatment of PCOS and associated comorbidities in LX. Introduction: Polycystic ovarian syndrome (PCOS) is a common endocrine metabolic disorder affecting up to 20% of women in reproductive age. The PCOS patients may have a range of reproductive, metabolic, and endocrine dysfunction with medical comorbidities, including type II diabetes, cardiovascular diseases and psychiatric disorders. While the etiology and pathophysiology of PCOS remains to be elucidated, the androgen excess seen in up to 90% of affected women leads to several, often combined symptoms such as hirsutism, acne, ovarian cysts, infertility and metabolic syndrome. Methods: In this study, we used two rat experimental models of PCOS. High androgen levels were either induced by treatment with dihydrotestosterone (DHT) or the aromatase inhibitor letrozole, to explore the molecular mechanisms of PCOS pathogenesis. Results: RNA-seq based transcriptomic analysis of various tissues in the rat PCOS models revealed changes in important molecular pathways, e.g., ATP metabolic process, energy expenditure. In addition, the dysregulated genes in disease models are shown to be regulated by inflammatory pathways, glucose homeostasis, response to insulin, and regulation of angiogenesis, suggesting a variety of pathway involved in developing PCOS phenotypes. Furthermore, several potential master regulators were identified (which may have tissue specific functions) by combining our data set with publicly available data on tissue specific expression (e.g. GTEx). Conclusion: In summary, by generating transcriptomic maps of two rat models we have improved the molecular understanding of PCOS pathogenesis in these models. This study investigated cytokine expression profiles in seminal plasma of male partners of couples with unexplained recurrent pregnancy loss (RPL) and the association with clinical and lifestyle characteristics, including smoking, alcohol consumption and Body Mass Index (BMI). In the seminal plasma of 52 men who visited a specialized RPL clinic the levels of 25 pre-selected cytokines, chemokines and growth factors were measured by Bio-Plex assay or ELISA. Two-way hierarchical cluster analysis was performed. Identified patient clusters were compared on clinical and lifestyle characteristics. Results: Two distinct cytokine expression profiles in the seminal plasma were revealed by cluster analysis (Figure 1 ). Patient cluster I showed relatively higher levels of pro-inflammatory cytokines, including IL-1α, IL-1β, IL-6, IL-8, IL-12, IL-18 and TNF-α, compared to Patient cluster II. Men belonging to Patient cluster I were significantly older and had significantly more lifestyle risk factors compared to men in Patient cluster II. Conclusion: Cluster analysis suggested the existence of a less favorable pro-inflammatory cytokine expression profile, being present in part of men affected by RPL and associated with advanced male age and lifestyle risk factors. These findings may serve as a starting point for further research into underlying mechanisms and ultimately lead to novel diagnostic and therapeutic approaches for couples with RPL. Membrane Lipid Rich Freezing Medium Improves Pre-Pubertal Testicular Tissue Cryosurvival. Guruprasad Kalthur * , Reyon Dcunha, Ananda Hanumappa, Satish K Adiga. Kasturba Medical College, Manipal, Manipal, India. Introduction: Cryopreservation of testicular tissue has proven to have potential benefits in artificial reproductive technology (ART), especially in pre-pubertal boys diagnosed with cancer. During the freeze-thaw process, testicular cells are highly prone to undergo damage due to loss of membrane lipids, lipid peroxidation and high oxidative stress. Since preventing damage to the germ cells is very essential for successful generation of spermatozoa, either by in-vitro spermatogenesis or by auto-transplantation techniques, an efficient cryopreservation protocol is very critical. However, an optimum protocol for cryopreservation of testicular tissue is still lacking. In this direction, in the present study we aimed at exploring the beneficial effects of few major membrane lipids on prepubertal testicular tissue cryopreservation. Methods: Pre-pubertal male Swiss albino mice were sacrificed and testicular tissue was cut into 3 mm 2 pieces and segregated into 3 groups. The fresh tissue was not subjected to any cryopreservation. Part of tissue was frozen with control freezing medium (5% DMSO, 30% FCS in DMEM/F12 media) and freezing medium with membrane lipids (soy lecithin, phosphatidylethanolamine, phosphatidyl serine and cholesterol). The tissues were placed in the cryovials containing different freezing medium, transferred to an isopropanol chamber and placed in -80°C freezer for 24h. Samples were later stored in liquid nitrogen until further assessment. The samples were thawed rapidly in a water bath maintained at 37 o C for 5 min and subjected to enzymatic digestion (trypsin collagenase: 1 mg/mL). Following digestion, the contents were passed through a 70 μm and 40 μm cell strainer, and centrifuged at 1100 rpm for 10 min. The cell pellet formed was resuspended in Hanks balanced salt solution (HBSS) containing 10% FCS and different parameters were assessed. Results: Significant increase in viability of germ cells (p< 0.05), reduction in γ-H2AX (p<0.001) positive cells and Caspase-3 expression (p<0.05) was observed in the tissue cryopreserved in the membrane lipid rich medium. Freeze-thaw process resulted in a significant increase in malondialdehyde (MDA) level, protein carbonyl content (p<0.0001) and a significant decrease (p<0.001) in the reduced glutathione (GSH) compared to that of fresh tissue. Pre-pubertal tissue cryopreserved in the membrane lipid rich medium showed reduced oxidative stress and significant increase (p<0.05) in the Gpx4 expression in tissue cryopreserved using membrane lipid rich medium, suggesting the mitigation of oxidative stress generated during freeze-thaw process. Conclusion: Membrane lipid rich medium can enhance the survival of pre-pubertal testicular tissue during cryopreservation and hence has a high translational value in fertility preservation for prepubertal boys undergoing chemotherapy. Elucidating the Role of SYCP2L in Oocyte Quality and Fecundity in Humans. Caterina Clementi, Karen Hunter Cohn, Genevieve Galarneau, Piraye Yurttas Beim * . Celmatix Inc., New York, NY, United States. Introduction: Synaptonemal complex protein 2-like (SYCP2L) has been shown in mice to be an oocyte-specific protein that localizes to centromeres of primordial oocytes at the dictyate stage and regulates their survival. Common genetic variants in SYCP2L have previously been associated with age of menopause in women by multiple GWAS, however, its role in human reproductive biology remains to be further elucidated. Methods: Our Personalized Reproductive Medicine (PReM) Initiative cohort consists of a centralized repository of biological samples derived from patients undergoing treatment at multiple fertility centers in the United States, linked to detailed reproductive phenotype data. Samples underwent whole genome or exome sequencing. We used Ensembl Variant Effect Predictor to perform the functional annotation of variants with a minor allele frequency < 1% in gnomAD located within gene boundaries. For a subset of genes known to regulate ovarian function, we evaluated variants predicted to have high impact effects on protein function. Results: Within our PReM cohort, we identified 9 patients who had rare genetic variants predicted to have a significant functional impact on SYCP2L. We found that, although relatively young (ranging from 26-36 years of age), patients with these rare variants experienced some of the poorest reproductive outcomes within our cohort. All necessitated in vitro fertilization (IVF) treatment and most experienced multiple failed IVF cycles. Three patients were never able to conceive with their own oocytes, but were able to achieve a live birth with donated oocytes. For patients who did have successful IVF cycles with their own eggs, the majority of ongoing pregnancies were only achieved with preimplantation genetic testing to screen for euploid embryos. Conclusion: Rare functional variants in SYCP2L are associated with reduced fecundity and poor IVF outcomes in women, most likely due to poor oocyte quality. This is consistent with observations that SYCP2L is an oocyte-specific protein known to localize to centromeres during preovulatory meiosis in mice. Notably, several patients with rare functional variants in SYCP2L were able to achieve ongoing pregnancies after preimplantation genetic screening of their embryos. can be attributed to several advancements, such improved culture conditions. Culture media are of special interest as supplier of essential nutrients and growth factors, which have previously been shown to impact birthweight. IVF pregnancies are associated with an increased male:female ratio. However, it is unknown if culture media also impact prenatal growth. Therefore, our aim is to study the (sex-specific) impact of two different culture media (SAGE 1-Step and Vitrolife G-1 PLUS) used in IVF treatment on first trimester embryonic growth and development, and fetal outcomes. Methods: In the Rotterdam Periconception Cohort, 879 pregnancies were included; 153 after culture in Vitrolife, 251 after culture in SAGE, and 475 naturally conceived. Serial measurements of crow-rump length (CRL), embryonic volume (EV) and Carnegie stage at 7, 9 and 11 weeks gestational age (GA) were performed offline by using 3D ultrasound and virtual reality techniques. Second-trimester estimated fetal weight (EFW) and birth outcomes, such as weight and gestational age, were retrieved from medical records. Linear mixed models were used to study associations between culture in Vitrolife or SAGE, or natural conception, and first-trimester embryonic growth and development with stratification for fetal sex and adjusted for GA and maternal characteristics. Differences in EFW and birth outcomes were assessed by Kruskall-Wallis tests. Results: Embryos cultured in SAGE grow faster than those cultured in Vitrolife (β EV 0.030 (95%CI 0.008-0.052), p=0.007). No significant differences were observed regarding CRL and Carnegie stages. After stratification for fetal sex, similar results were observed for male embryos (β EV 0.048 (95%CI 0.015-0.081), p=0.005). When compared to naturally conceived embryos, embryos cultured in SAGE grow faster (β EV 0.033 (95%CI 0.006-0.060), p=0.018). This association was most pronounced in male embryos (β EV 0.066 (95%CI 0.024-0.108), p=0.002). EFW and birth outcomes were comparable between the three groups, except for gestational age, which was shorter in naturally conceived pregnancies than after IVF treatment with culture in either Vitrolife or SAGE (272, 276 and 276 days respectively, p=0.001). Conclusion: SAGE culture medium used for IVF treatment accelerates embryonic growth trajectories compared to Vitrolife and natural conceived pregnancies, especially in male embryos. Further research should focus on the scientific and clinical impact of faster embryonic growth as well as on optimising culture medium composition for optimal embryogenesis, fetal development and offspring health during the life course. Using Introduction: Around 10% of all intrauterine pregnancies are lost in the first trimester. A further 1-2% of pregnancies are located outside the endometrial cavity; these ectopic pregnancies are the leading cause of maternal mortality in the first trimester of gestation. Early miscarriages may also cause significant morbidity when bleeding or infection occurs. The symptoms of miscarriages and ectopic pregnancy are often similar (pain and bleeding), however, such symptoms are also common in viable intrauterine pregnancies (VIUPs). To date, no biomarkers have been identified to differentiate VIUPs from non-viable and ectopic pregnancies. Methods: This is a prospective cohort study that included 332 pregnant women at less than ten weeks of gestation, who attended the early pregnancy assessment unit (EPAU) at Liverpool Women's Hospital with pain and/or bleeding. Blood samples were collected from the 332 pregnant women prior to final clinical diagnosis of pregnancy outcome. Serum samples were subjected to NMR metabolomics profiling. 1D 1 H-NMR spectra were acquired at 37 °C on a 700 MHz spectrometer. Relative metabolite abundances underwent statistical analysis using MetaboAnalyst 5.0 (p-value FDR adjusted). Results: Final pregnancy outcomes were as follows: one hydatidiform mole (0.3%), 48 ectopic pregnancies (14.4%), three pregnancies of unknown location (PULs, 0.9%), 78 failed pregnancies of unknown location (FPULs, 23.4%), 47 miscarriages (14.1%), two vanishing twin pregnancies (0.6%) and 153 VIUPs (45.8%). Due to small sample numbers, the hydatidiform mole, PULs and vanishing twin pregnancies were excluded from further analysis. To compare VIUPs to other pregnancy outcomes, ectopic pregnancies, FPULs and miscarriages were grouped together. Univariate analysis of serum metabolite concentrations identified four metabolites (phenylalanine, alanine, glutamate and glutamine) as significantly different in VIUPs compared to other pregnancy outcomes. Multivariate partial least squared discriminant analysis provided only weak correlation between the serum metabolome and pregnancy outcome. Conclusion: This study identifies some serum metabolites associated with VIUPs. The 'metabolite profile' that we have identified could be clinically useful to developed into a diagnostic test that could confirm VIUPs and thus exclude potentially life-threatening pregnancy outcomes in emergency gynaecology. Introduction: Maternal-embryo communication during preconception is key for pregnancy success and offspring health. We revealed a cellcell communication mechanism in which miR-30d delivered from the endometrium to the pre-implantation embryo via extracellular vesicles (EVs) modifies the embryo transcriptome. Here, we investigated endometrial EV mitochondrial DNA (mtDNA) cargo internalization by the embryo as a potential mechanism by which the maternal endometrium modulates embryo bioenergetics. Methods: Secreted EVs [apoptotic bodies (ABs), microvesicles (MVs) and exosomes (EXOs)] were isolated from endometrial fluid (EF) of fertile donors (n = 10) in their receptive phase. mtDNA copy number was quantified in receptive-phase human endometrial biopsies by qPCR ratio of β-ACTIN (nuclear) to ATP8 (mitochondrial) genes, and changes in metabolic gene set were studied using targeted RNAseq (Ion AmpliSeq Transcriptome Human Gene Expression Core Panel). EV DNA cargo tagged with 5-ethynyl-2'-deoxyuridine was followed by confocal imaging after co-incubation of EVs with murine embryos (n = 600). ATP levels were assessed by FLASC luciferase reporter system, and mitochondrial membrane potential was evaluated by JC-1 confocal visualization (n = 250 embryos). Results: Receptive-phase endometria had lower mtDNA content together with an upregulation of genes that promote mitophagy in vesicular compartments. Yet, in human EF-derived EVs, MVs were 11.12 ± 0.53fold enriched in the 13 mtDNA-encoded genes for electron transport chain complexes, and 7.1-26.7-fold enriched in transcription factor binding sites (TFBSs). Most TFBSs mapped to the mitochondrial genome; some were associated with transcription factors (SRF, GABP, E2F4, TR4, FOXA2, FOXA1, CTCF, GATA2, PAX5) with roles in early embryo development, mitochondrial function and biogenesis. EV DNA transfer and internalization were detected in murine embryos in the cytoplasm and nuclei of trophectoderm cells. Murine embryos incubated with ABs or MVs from human EF maintained their ATP levels, but co-incubation with EXOs reduced the ATP content (p < 0.001). Mitochondrial membrane potential did not differ among conditions, but JC-1 patterning indicated EXO co-incubation promoted a reduction in total mitochondrial mass. During the preconception period, endometrial mtDNA content is reduced through mitophagy. Processed mtDNA, both coding and regulatory, is secreted through EVs to the EF and taken up by the embryo, where it modulates embryo energetics to support embryo ATP status. These findings require further investigation. CS & FV contributed equally. Treatments are an important source of stress, the impact of chronic stress on fertility and endometrial function is still controversial. This study evaluates the molecular relationship between both stress-related biomarker metabolites and reproductive hormones measured in endometrium and reproductive outcomes. Methods: Functions in common between receptivity and chronic stress response were consulted in GeneCards, KEGG and Gene Ontology databases for understanding the molecules involved in both processes. The concentrations of prioritized metabolites in common were measured by LC/MS-MS in endometrial biopsies collected at the window of implantation of 76 IVF patients in a hormone replacement therapy cycle and with no uterine pathologies. Correlations between metabolites' concentrations were calculated using Pearson's r; and three concentration cut-offs (first and third quartile and relative maximum) were stablished to evaluate their relationship with receptivity (defined by the ERA test) and reproductive outcomes using Barnard's test. Results: We identified 118 genes potentially involved in stress and receptivity that were enriched in the steroid hormone biosynthesis pathway (FDR<0.05), concretely in the deviation from progesterone (P4) to estrogens but also in the cortisol to cortisone conversion. Patients with cortisol < 2.18 ng/ml (n=19) and P4 > 40.07 μg/mL (n=9) gave a significantly higher proportion of receptive endometria (78.9% vs 50.9% and 77.8% vs 34.8% respectively; p<0.05); and testosterone > 0.52 ng/ ml (n=19) and cortisone > 98.91 ng/ml (n=19) rose the proportion of patients with non-receptive endometria (63.2% vs 35.2% p<0.05 and 78.9% vs 54.4% p=0.06, respectively). Patients with estrone > 21.27 ng/ ml (n=4) favored pregnancy (100% pregnancy success vs 40%, p<0.05) and potentially implantation (100% vs 46.7%, p=0.07). P4 and 17OHP4 positively correlated with cortisol (r=0.29 and 0.25, respectively) and androstenedione (r=0.71 and 0.81, respectively), which is a precursor of estrogens; and 17OHP4 also correlated with estrone (r=0.29) (all p<0.05). Conclusion: High endometrial cortisol and cortisone levels potentially reduce endometrial receptivity, giving clues of how chronic stress metabolites could compromise endometrial function. Independently, high estrone levels could promote pregnancy. A reason for caution is the preliminary nature of the study with modest sample sizes. . So far it has been described that exposure to Hg induces oxidative stress and perturbs the structure of the cytoskeleton in Ishikawa cells (Guyot et al., 2015, Plos One) . However, the effect of Hg on primary endometrial stromal cells (ESC) has not been tested yet. This study aims to analyze the effects of in vitro exposure to Hg on ESC viability, ROS production and decidualization capacity. Methods: Primary ESC were isolated by gravity sedimentation from endometrial biopsies collected from healthy oocyte donors, the day of ovarian puncture (n=12). Cell viability of ESC (n=4) exposed to Hg (0-500 nM) up to 72h was measured each 24h using colorimetric MTS assay (Promega). The acute production of cellular Reactive Oxygen Species (ROS) was detected by dichlorofluorescin diacetate (DCFDA) a fluorogenic dye that measures hydroxyl, peroxyl and other reactive oxygen species ROS activity within the cell (DCFDA Cellular ROS Detection Assay Kit, Abcam) and then measured with a fluorescence microscopy in ESC (n=4) exposed to Hg (0-500nM) for 24h. For the in vitro decidualization study, ESC (n=4) were pre-treated with Hg (0-500 nM) for 24 h. Then, decidualization was induced with P4+E2 for 8 days in the presence of their respective doses of Hg. Decidualization was checked by prolactin (PRL) secretion in culture media by ELISA (Abnova). Cell integrity was assessed by F-actin immunostaining with Rhodamine-Phalloidin (Abcam), and their proliferative status was checked using Ki67 immunostaining (Merk Millipore). Results: In ESC exposed to Hg (500 nM), cell viability was significantly reduced (p<0.05) at 48 h and 72 h. ROS production was significantly increased (p<0.01) in ESCs exposed to Hg (500nM) for 24h. After 8 days of decidualization, PRL secretion was significantly decreased (p<0.05) at 250nM and 500nM. Accordingly, altered actin cytoskeleton was observed at 250nM and 500nM in a dose dependent manner. There was also a decrease in Ki67 positive cells, indicating a decrease in cell proliferation at 500nM (p<0.01) which reflect alterations in the correct differentiation of these cells. Conclusion: High doses of Hg acutely affect the physiology of endometrial cells by decreasing cell viability, possibly related to an increase of ROS production. At low-medium doses, Hg can act as an endocrine disruptor, inhibiting ESC decidualization and disturbing actin cytoskeleton. Funded by APOTIP/2018/010, PFIS (PI/00009), Miguel Servet Contract (CPII18/00002) and ISCIII FIS project (PI17/00931). In Vitro. Introduction: Human embryonic implantation is regulated by neuroendocrine hormones, ovarian steroids, growth factors and cytokines. Sympathetic innervation of the uterus also may play a role. We tested the hypothesis that cabergoline (Cb), an agonist of type 2 dopamine receptors (DRD2), could influence endometrial decidualization in vitro. Methods: Immunohistochemistry confirmed the presence of catecholaminergic neurons in human uterine tissue. DRD2 mRNA and protein expression in endometrial tissue and cells were validated by quantitative RT-PCR, cDNA microarrays, RNA sequencing and Western blotting. Isolated human endometrial stromal cells (ESC) were subjected to dose-response and time-course experiments in the absence or presence of decidualizing hormones (10 nM estradiol, 100 nM progesterone and 0,5 mM dibutyryl cAMP). In some cases, interleukin (IL)-1β (0.1 nM) was used as an inflammatory stimulus. Well-characterized in vitro biomarkers were quantified. Results: DRD2 were maximally expressed in vivo in the midsecretory phase of the cycle and upregulated in ESC in response to decidualizing hormones, as were classical (eg, prolactin) and emerging (eg, VEGF and connexin 43) differentiation biomarkers. Cabergoline augmented biomarker expression, whereas risperidone, a dopamine receptor antagonist, inhibited ESC differentiation. Cabergoline induced characteristic decidual morphology changes and blocked detrimental effects of IL-1β on decidual cytology. Conclusion: Our results support the hypothesis that dopaminergic neurons modulate decidualization in situ. We postulate that dopamine agonists, like Cb, could be developed as therapeutic agents to enhance implantation in couples with inflammation-associated infertility. Entosis Occurs in Human Embryo Implantation. Andrea Palomar †, 1 Roberto Gonzalez-Martin †, 2 Stefania Salsano, 2 Silvia Pérez-Debén, 2 Alicia Quiñonero, 2 Francisco Domínguez * . Valencia, Spain; Valencia, Spain. Introduction: The incapability of the embryo to clear the luminal epithelial cells to reach the stroma could lead to implantation failures. Although apoptosis is the proposed mechanism for the removal of endometrial epithelial cells (EEC), recent research points out that a non-apoptotic cell-in-cell invasion mechanism named entosis would lead to the clearance of the EEC lining. Emerging evidences in murine models strongly suggest that entosis could drive the first stages of human implantation. Thus, it is proposed that trophoblast cells of human blastocysts could internalize EEC, throughout the activation of Rho-ROCK pathway in EEC. The main objective of this research was to confirm the occurrence of entosis in human embryo implantation and the implication of Rho-ROCK pathway in this mechanism. Methods: Primary human EEC obtained from endometrial biopsies of egg donors attending our clinic were cocultured in vitro with human trophoblastic spheroids (JAR) and human aneuploid blastocysts (in suspension and adherent conditions) to asses internalization of EEC inside trophoblastic cells. EEC and trophoblast cells were differentially stained using Cell-Tracker fluorescent probes. Internalization phenomena was evaluated by confocal microscopy analysis and 3D reconstruction models. To study the role of Rho-ROCK pathway on internalization, EEC were treated with 10uM of ROCK inhibitor (Y-27632). Inhibited and control stained EEC were cocultured with JAR spheroids. After 24 hours, JAR spheroids were isolated. Effect of ROCK inhibition was assessed by counting fluorescent signal of EEC and checking gene expression of ROCK1, Vimentin and hCG by qPCR on isolated JAR spheroids. Results: Confocal microscopy analysis and 3D reconstruction models confirmed entosis of EEC by trophoblast cells, meaning that EEC were internalized by JAR spheroids and trophoblast cells of human blastocysts. After the analysis of fluorescent signals associated to EEC in isolated JAR spheroids from cocultures in suspension, we found that inhibition of ROCK in EEC lead to a decrease in EEC internalization. Expression of vimentin in isolated JAR spheroids was also decreased, indicating lower number of EEC internalized. Conclusion: Our data support that entosis occurs in human embryo implantation and Rho-ROCK pathway may be implicated in this process. Up to our knowledge, our study is the first to confirm the occurrence of entosis in human embryo implantation. Support: PFIS (PI/00009), APOTIP/2018/010, Miguel Servet Contract (CPII18/00002) and ISCIII FIS project (PI17/00931). In In pregnancy, the decidualization of uterine endometrial cells has a pivotal role in the implantation of a fertilized embryo. Decidualization of endometrium includes drastic functional and morphological changes of endometrial stromal cells and can lead to the establishment of a successful pregnancy. Endometrial decidualization is caused by a complex combination of transcription factors, morphogens, cytokines, cell cycle regulators, and signaling pathways. However, the deeper knowledge of molecular characteristics and mechanisms of reception of embryo by decidualized endometrial cells were not sufficiently elucidated. Methods: Uterine horns of 6 weeks old female C57BL/6 mice were isolated and the endometrial stromal cells were extracted using collagenase type I (1 mg/ml). Collected cells were expanded and treated under each condition, 1) P4, 2) P4+E2, 3) P4+ cAMP, 4) cAMP, for 14 days. The expression of specific genes and proteins were analyzed using RT-qPCR and immunoblotting. Results: Here, we were focusing on finding the best condition of inducing decidualization in mouse endometrial stromal cells. We found that three important molecules are mainly involved in the induction of decidualization, such as cyclic adenosine monophosphate (cAMP), estradiol (E2), and progesterone (P4). We confirmed that the groups of treatment with P4 and P4+E2 for 14 days show morphological change like decidualization, which are representatively contracted cytosol. Also, we found that forkhead box O1 (FOXO1), which is a well-known transcription factor in the decidualization process, and desmin, which is an intermediate filament expressed for decidualization, are highly expressed in decidualized cells. Most importantly, the expression of a decidual marker, such as decidual prolactin (PRL), was confirmed by western blot analysis. These results indicate that P4 and P4+E2 treatment can stimulate endometrial stromal cells to transform into a decidualization state. These results indicate that our experimental system generates in vitro decidualized mouse endometrial cells and can reveal signals or factors increasing proper communications between the embryo and decidualized endometrial cells, even we address the potential methods to cure infertility because of abnormality of endometrial reception and communication network between them (2020R1A2C1010293 and 2020R1F1A1076286). (FKBP51) is an immunophilin that acts as a co-chaperone with heat shock protein 90 that negatively regulates transcriptional activity of glucocorticoid receptor (GR) and progesterone receptor (PR). FKBP51 levels are increased by stress condition and with advancing age. Our previous studies demonstrate that Fkbp5 gene depletion was protective against maternal restrained stress-induced preterm birth (PTB) and fetal growth restriction (FGR). The current study investigated whether Fkbp5 deficiency also affected litter size in maternal age and stress-dependent manners. Methods: Timed-pregnant Fkbp5 +/+ wild type or Fkbp5 -/knockout mice were randomly grouped as placebo (Control; n=86) or maternal restrained stress-administration (1h x3/day, n=54) from embryonic days 8 to 18. Litter size was counted upon delivery and compared on age groups of 1-3 months, 4-6 months, and 7-10 months with a t-test with P< 0.05 accepted as statistically significant. As an initial study, ovaries from Fkbp5 +/+ and Fkbp5 -/control mice were harvested at 8 weeks of age and serially sectioned and stained with Periodic acid-Schiff (PAS). Follicles were counted according to developmental stage and means were compared for primordial, primary, secondary, antral, and atretic follicles with a One-Way ANOVA test with P<0.05 accepted as statistically significant. Results: Litter size was similar in Fkbp5 +/+ and Fkbp5 -/mice in all age groups, and follicle numbers were similar in Fkbp5 +/+ and Fkbp5 -/control mice at 8 weeks. Conclusion: Significant reduction in live births in stress-induced Fkbp5 +/+ mice with advanced age and the concurrent absence of this reduction in Fkbp5 -/mice suggest that critical role of FKBP51 in mediating combined action of stress and advancing maternal age, which require further studies to explain the FKBP51 mediated mechanism(s). Introduction: Women are born with a limited number of primordial follicles which constitute their ovarian reserve. The activation of a primordial follicle is an irreversible process that leads to either ovulation or atresia. Mullerian inhibiting substance (MIS/AMH), produced by granulosa cells of growing follicles, is an important regulator of ovarian reserve maintenance by providing negative feedback to primordial follicle. We hypothesized that MIS inhibits folliculogenesis by imposing a quiescent state on granulosa cells. Methods: Mice were injected with AAV9-MIS, or empty vector control at postnatal day 1 and euthanized at day 6, and the ovaries were dissociated to perform single-cell RNA sequencing (inDROP). We catalogued a cell atlas of the neonatal ovary along with gene expression signatures uniquely associated with MIS treatment and confirmed these cell-specific signatures by qPCR and in situ hybridization Results: We first confirmed expression of the MIS receptor (MISR2) in pregranulosa and granulosa cells in mouse ovaries by RNAish. In these cells, we identified a unique cell-specific signature induced by MIS. By comparing gene expression in quiescent and activated follicles in the control to that of granulosa cells treated by MIS we defined a quiescent gene signature involving important pathways of stemness, immediate-early genes, and cytokine signaling. Interestingly, treatment with MIS resulted in a preantral follicle maturation defect in which oocyte development occurred without concomitant expansion and differentiation of granulosa cells. This observation was supported by the modest transcriptional perturbation associated with MIS in Oocytes, suggesting the inhibition of folliculogenesis is primarily driven by inhibition of granulosa cell differentiation. Conclusion: Treatment with MIS imposed a quiescent cell state in granulosa cells of primordial follicles that led to a profound suppression of ovarian activity independently of oocytes maturation. Introduction: An increasing population of women suffer from ovarian dysfunction. Better understanding of mechanisms underlying the ovarian dysfunction pathogenesis using newer animal models is imperative for better therapies, ovarian longevity and reproductive success. A mouse model previously generated in our laboratory, with a 162 nt AU-rich element (ARE) replaced with random nucleotides in the 3' untranslated region (3'UTR) of the interferon gamma (IFNg) gene, displays chronic circulating serum IFNg levels. Homozygous ARE-deletion mice (ARE -/-) exhibit varied autoimmune diseases and fail to reproduce. We hypothesized that the persistent IFNg levels result in autoimmune ovarian dysfunction. As a first step, we sought to identify the prevailing female reproductive pathology which we present as a novel mouse model of IFNg-induced ovarian dysfunction. Methods: Estrous synchronization was done before experiments and cycle stages determined. Histopathological and immunohistochemistry evaluation were performed with flow cytometric analysis. ELISA assays for hormone analysis was also done. A minimum of 5 mice per genotype was utilized. Data were analyzed using either one-way ANOVA/Dunnett post-hoc or unpaired Student t-test. The ARE -/mice had decreased estrous cycles (P < 0.0001; 0-24h) and ovulation rates evidenced by few corpora lutea (P = 0.06). Elevated serum progesterone with decreased follicle stimulating and luteinizing hormone (P = 0.036 and 0.043 respectively) contributed to the reduced ovulatory rate with elevated primary follicles. CD8a+ cells were concentrated in ovarian stroma, theca and corpus luteum indicating increased ovarian cell cytotoxicity. This was supported by high phenotypic expression of CD8+ (P = 0.033) and CD4+ T cells with increased effector and cytolytic phenotypes. Reduced NK1.1+ cells (P = 0.026) with increased effector functions were seen. Double negative T cells (DNT) were decreased (P = 0.035) suggesting DNTreg suppression. Taken together, the evidence shows that chronic IFNg expression drives ovarian dysfunction causing infertility/sub-fertility. We also present a novel mouse model of IFNg-induced ovarian dysfunction. MMc cellular subsets include mainly T, B and myeloid cells and can be detected in fetal immune organs. It has been proposed that MMc enhance neonatal immunity, but insights into the underlying mechanisms are still unknown. To address this gap in knowledge, we developed a mouse model in which offspring are significantly devoid of MMc. Using this model, we investigated functional pathways through which MMc affect fetal immune development. Methods: Since MMc are comprised of T and B cells, we used reciprocal allogeneic mating strategies between Rag2 -/γc -/and wild type male and female mice. Rag2 +/γc +/offspring from Rag2 -/γc -/females were termed MMc low and reciprocally MMc + when born to wild type mothers..Tissue clearing and lightsheet microscopy (LSM) was perfomed to localize MMc in fetal bone marrow. Additionally, MMc, fetal bone marrow and thymic cells were characterized upon magnetic activated cell separation, followed by flow cytometry. Bone-marrow derived hematopoietic stem cells (HSC) were assessed for differentially methylated promoter regions. MMc low and MMc + offspring did not differ with regard to reproductive fitness (implantation, fetal losses, placental function, weight gain), gene imprinting or neonatal microbiome. MMc could be localized in fetal bone marrow using LSM. Significant differentially methylated promoter regions could be identified among HSC between MMc pos vs MMc low offspring. Moreover, MMc low offspring exhibited significantly higher frequencies of myeloid precursor cells, however, lymphoid precursors were decreased. These findings are accompanied by significantly decreased frequency of monocytes and CD8 Tcells. Adoptive immune cell transfer into knockout dams significantly restored levels of MMc and the frequency of monocytes in MMc low offspring. Conclusion: We here provide evidence for the functional impact of MMc on neonatal immunity. MMc favour the differentiation of HSC towards monocytes in fetal bone marrow via epigenetic pathways, which yields to an enhanced immunity towards early life pathogen challenges. The embryo of an oocyte donation (OD) pregnancy is completely allogeneic to the mother, which may lead to a bigger challenge for the maternal immune system to tolerize the fetus compared to autologous pregnancies. Decidual macrophages may be essential in maintaining a healthy pregnancy. In addition, macrophages can be classified into different categories based on phenotype and characteristics, in which type 2 macrophages are thought to exhibit immune suppressive activity. We hypothesized that the quantity and composition of decidual macrophages are different between uncomplicated OD pregnancies and non-OD in vitro fertilization (IVF) pregnancies, and that these differences in macrophages are related to fetal-maternal incompatibility. Methods: This retrospective case-control study included patients who delivered at the Leiden University Medical Center between January 1st 2006 and July 1st 2016. A total of 42 pregnancies were enrolled in this study, conceived by uncomplicated singleton OD pregnancies (n=25) or non-OD IVF pregnancies (n=17). Placentas were collected and immunohistochemically stained for CD14 (pan-macrophage marker) and CD163 (type 2 macrophage marker). The extent of staining in both the decidua basalis and the decidua parietalis was quantitated by digital image analysis software. To assess HLA mismatching, maternal and fetal DNA was typed for HLA-A, -B, C, -DRB1, and -DQB1. Results: A significantly lower percentage of CD14 positive staining was observed in the decidua basalis of OD pregnancies compared to non-OD IVF pregnancies (p=0.030). In the parietalis, OD pregnancies demonstrated a higher percentage of CD163+ staining (p=0.040) and higher CD163/CD14 ratio (p=0.032) compared to non-OD IVF. The OD group was separated into a syngeneic group (number of mismatches lower than half of the antigens per HLA locus) and an allogeneic group (number of mismatches higher than half of the antigens per HLA locus). Significant differences of CD163+ and CD163/CD14 ratio were found in the decidua parietalis when comparing the HLA-class-II-allogeneic OD group with the non-OD IVF group (p<0.05). This difference was not found for the HLA-class-II-syngeneic OD group. Conclusion: Healthy OD pregnancies show a higher CD163 positive cell fraction within the total macrophage population in the decidua compared to non-OD IVF pregnancies, which may suggest that a local type 2 macrophage-related mechanism is needed to compensate for the higher fetal-maternal HLA mismatch load in OD pregnancies. syndromes; yet, the molecular mechanisms underlying these fetal inflammatory responses are not well understood. Herein, we investigated the cord blood transcriptome of preterm neonates diagnosed with FIRS Type I or Type II. Methods: Cord blood was obtained from preterm neonates with i) FIRS Type I (n = 11), diagnosed by cord blood interleukin (IL)-6 levels > 11 pg/ mL and acute funisitis; ii) FIRS Type II (n = 6), diagnosed by cord blood CXCL10 levels > 82.34 pg/mL, IL-6 < 11 pg/mL, and chronic placental inflammation; and iii) controls (n = 22) without inflammation. Cytokine concentrations were evaluated in fetal plasma. Cord blood transcriptomes were obtained using RNA sequencing. Differentially expressed genes between groups were identified and used to infer perturbed upstream regulators, KEGG pathways, and gene ontology categories. The contribution of immune cell subsets was assessed by integrating cord blood mRNA changes with single-cell signatures. Perturbations of celland tissue-specific signatures derived from the Human Gene Atlas were also quantified. Results: Neonates with FIRS Type I had elevated systemic concentrations of inflammatory cytokines (IL-6, IL-8, IL-1β, TNF), whereas those with FIRS Type II showed elevated levels of CXCL10 alone. The FIRS Type I transcriptome was characterized by the upregulation of innate immune pathways and downregulation of adaptive immune responses compared to controls. In contrast, the FIRS Type II transcriptome showed differential expression of HLA genes, yet was largely indistinguishable from controls. PCA analysis using single-cell RNA sequencing-derived signatures revealed that FIRS Type I samples form a cluster distinct from those of FIRS Type II or controls, most strongly driven by monocyte and T-cell signatures. Consistently, using Human Gene Atlas-derived signatures, FIRS Type I was characterized by elevated bone marrow/myeloid/ monocyte signatures together with a decreased dendritic cell signature compared to controls. Conclusion: The FIRS Type I cord blood transcriptome is associated with significant alterations indicative of a severe acute inflammatory response, whereas that of FIRS Type II shows only mild differential expression of chronic inflammatory genes. These findings indicate that FIRS Type I and FIRS Type II are driven by distinct immune mechanisms. Introduction: Chronic histiocytic intervillositis (CHI) is a rare placental disorder characterised by histiocyte accumulation in the intervillous space. CHI is associated with severe fetal growth restriction, prematurity, intrauterine death and a high recurrence rate (up to 80%). The pathogenesis is unknown, but coexistence with autoimmune disease, complement C4d deposition in affected placental tissues and modest clinical benefit from maternal immunosuppression suggest an alloimmune "placental rejection" aetiology. The diagnosis can only be made through postpartum histology. There are currently no clinical biomarkers or treatments proven to consistently predict or prevent recurrence of CHI in a subsequent pregnancy. Methods: This was a case-control study designed to investigate whether women with recurrent CHI had altered antibody reactivity to placental antigen, compared with women who had uncomplicated pregnancies. Following ethical approval (London, 19/LO/0105), 22 women affected by CHI were recruited through a Facebook support group and via a Patient Engagement Day held at UCL. Serum samples were collected from a subset of women with ≥2 stillbirths due to histologically-proven CHI (n=6) and controls with ≥2 healthy pregnancies (n=6). Western blots were performed using lysed human syncytiotrophoblast cell lines (JAR and JEG-3), probed with affinity-purified IgG from participants and exposed using chemiluminescence. Immunoprecipitation with patient-derived whole IgG and mass spectrometry analysis were used to elute and identify the putative antigen from trophoblast cell lysate. Results: Chemiluminescence revealed bands corresponding to a 55-60kDa protein in both JAR and JEG-3 cell lysate in all six cases of CHI. No bands were identified in the control participants. Mass spectrometry (MALDI-QTOF) analysis of immunoprecipitation eluate generated credible candidates with high sequence coverage, including the complement inhibitor C4-binding protein. Initial Western blot experiments using membranes containing recombinant C4BP showed reactivity to C4BP in a subset of participants (n=3) with a particularly aggressive disease phenotype. These results demonstrate that women with recurrent stillbirth due to CHI have circulating antibodies against proteins in trophoblast cell lines. This provides a biologically plausible mechanism for immune complex formation and complement dysregulation at the feto-placental unit, leading to compromised fetal growth and adverse perinatal outcomes. Further characterisation of this antibody in affected women could lead to identification of a novel biomarker for CHI and translate into discovery of targeted maternal immunosuppressive therapy to prevent recurrence. Utilizing Primary HLA-G+ EVT and EVT-Like Cell Lines to Study Maternal Fetal Interactions. Introduction: During pregnancy invading extravillous trophoblasts (EVT) play a key role in placental development, uterine spiral artery remodeling and prevention of a detrimental maternal immune responses to foreign placental and fetal antigens. Failure of these processes are suggested to play a role in development of pregnancy complications, but very little is known about the underlying mechanisms. EVT express human leukocyte antigen-C (HLA-C), a highly polymorphic antigen that can elicit maternal immune responses, and HLA-G which has been associated with immune tolerance. Thus far, EVT have been difficult to study due to the low EVT numbers that can be obtained, the lack of proliferative capacity, and limited survival in vitro. Moreover, HLA-G and HLA-C orthologues are only present in humans, chimpanzees, and gorillas. Thus further studies on human HLA-G+/C+ EVT are essential to understand their role in placental tolerance and inflammation. Methods: Here we present validated methods to purify and culture primary HLA-G+/C+ EVT from 1 st trimester placental villi as well as the placental disk and chorionic membrane at healthy term pregnancy. In addition, we established highly proliferative HLA-G and HLA-C expressing EVT-like cell lines using a modified protocol first published by Okae et al., 2018. Results: Characterization of HLA-G+/C+ EVT from term pregnancy compared to 1st trimester, revealed their unique phenotypes, gene expression profiles and capacity induce regulatory T cells during coculture assays. Furthermore, essential clinical variables such as gestational age and fetal sex significantly influenced EVT biology and function. The newly established HLA-G+/C+ EVT-like cell lines expressed a large number of EVT specific proteins (HLA-G, HLA-C, PDL1, B7H3) and gene transcripts (CD9, PDL2, HIF1A, TGFβ) while some other EVT-specific markers were not expressed (EGFR1, ITGA5, EBi3). This suggests the EVT-like cell lines resemble EVT but may require additional signaling to fully differentiate into EVT. Indeed switching the EVT-like cell lines from a collagen IV matrix to a fibronectin matrix significantly increased their EGFR1 and ITGA5 protein expression levels. This demonstrates that the EVT-like lines are responsive to their environment and have the capacity to further differentiate. Conclusion: These methods and approaches form a solid basis for further investigation of the role of HLA-G+/C+ EVT in the development of detrimental placental inflammatory responses associated with pregnancy complications including spontaneous preterm delivery and preeclampsia. Ozone cycle have limited treatment options with a large majority of patients resorting to using donor oocytes and gestational carrier. Data in animal studies suggest that Ozone Therapy (OT) and PEMF are emerging as potential therapeutic adjuncts for female reproduction. The objective of this study was to determine whether OT+PEMF in vivo administration via the HOCATT machine, that uses the CO2/Carbonic Acid modality, improves the outcome in women undergoing IVF/FET and to assess the effect of OT in vitro on human granulosa cell (GC) function. The study was approved by IRB and participants were consented. Experiments: #1) Women (n=15) with severe DOR underwent: 1 st IVF cycle (Cycle 1), followed by OT (transdermally and vaginally) +PEMF administration for 3 weeks, followed by a 2 nd IVF cycle (Cycle 2) using the same protocol as Cycle 1. #2) Participants (n=3) had a persistently thin EMT (<5 mm) despite the intake of most medical agents known to improve EMT, making them unable to have an FET. They underwent OT+PEMF for 3 weeks after which EMT was compared. #3) Participants (n=6) who underwent oocyte retrieval had their GCs split equally and cultured with OT or placed on room temperature (control); after which PCR was performed for genes involved in steroidogenesis: aromatase (CYP19A1), Side-Chain Cleavage (SCC), StAR, and 3 Beta-hydroxysteroid dehydrogenase (HSD). Data were presented as mean±SEM. Paired t-test was used to compare data. Results: #1) Cycles 1 and 2 had no significant difference in the # of days of stimulation (p>0.05), dose of medications used (p>0.05), # of oocytes retrieved (1.1 ± 0.4 vs. 1.5 ± 0.3, respectively; p=0.3) or peak E2 levels (539.5 ± 96.1 vs. 591.5 ± 102.6 pg/mL, respectively; p=0.6). The # of embryos formed in Cycle 2 was significantly higher than the # of embryos formed in Cycle 1 (1.2 ± 0.3 vs. 0.4 ± 0.4, respectively; p=0.02). #2) All participants reached an EMT of approximately 7 mm. Following FET, participant A is currently in the 2 nd trimester of pregnancy; participant B became pregnant and had a missed abortion; and participant C did not get pregnant. #3) OT caused a significant 5 times increase in CYP19A1 and 50% significant decrease in SCC (p<0.05 for both). Conclusion: OT+PEMF, both of which have vasodilatatory, antiinflammatory, and anti-oxidant actions, could improve EMT and could improve the # of formed embryos without increasing the # of oocytes retrieved, suggesting improvement in oocyte quality. OT alters genes involved in steroidognesis in particular aromatase. , 2018] . These hTSCs can be differentiated into the major trophoblast subpopulations of the placenta including cytotrophoblast cells (CTB), extravillous cytotrophoblast cells (EVT) and syncytiotrophoblast (STB). The development of 3D trophoblast organoids to model early maternalfetal interactions during human pregnancy [Turco, 2018] have been hindered by the inside-out (STB on the inside, undifferentiated cells and CTB on the outside) morphology of the generated structures. Methods: 5X10 5 hTSCs (C27) cells were incubated with collagen IV pretreated polystyrene beads in supplemented medium at 37°C for 4 hours, then were transferred to low attachment cell culture plates and cultured for an additional 20 days in a series of differentiation-inducing media. Media was changed every 48 hours for the first 6 days then every 3-4 days after that. Organoids were fixed on day 20 for standard immunohistochemistry. The collagen-coated beads were covered with cells within 24 hours of incubation and organoids grew continuously throughout culture to an average size of 400µM (Fig. 1A) . On day 20 of culture, the surface cells of the organoids express cytokertain-7 (KRT7, a pan-trophoblast marker) and hCGα (a syncytiotrophoblast cell maker) while the central cells of the organoids expressed the cytotrophoblast markers GATA3 and TP63 (Fig. 1B, 1C) . Conclusion: Using collagen-coated beads, we have successfully established human trophoblast organoids characterized by inner undifferentiated and CTB The finding of an effective therapy for endometrial injury such as Asherman's syndrome and endometrial atrophy remains as an outstanding issue in reproductive medicine. Extracellular matrix (ECM) hydrogels made from decellularized tissues are promising biocompatible materials for tissue regeneration. We previously reported the development of a porcine endometrial ECM hydrogel (EndoECM) (López-Martínez et al., 2021) . Here, we investigated its potential alone or supplemented as a treatment for endometrial repair in a murine model of endometrial damage. Methods: Endometrial injury was induced by injection of ethanol in uterine horns of C57BL/6 mice (n=33). After four days, three therapies were injected: (a) saline (negative control), (b) biotin-labelled EndoECM or (c) biotin-labelled EndoECM plus basic fibroblast growth factor, insulin-like growth factor I and platelet-derived growth factor (EndoECM+GF). Endometrial regeneration and fertility were evaluated after two weeks. Trichrome staining was performed to assess endometrial area, collagen and number of glands using ImageJ/QuPath software (n=3 saline, n=4 EndoECM, n=4 EndoECM+GF mice with a damaged/treated horn and a non-injured horn). Number of fetuses 10 days after natural mating was counted (n=4 saline, n=9 EndoECM, n=9 EndoECM+GF, one or both damaged/treated horns). The estrous cycle was monitored and considered in the analyses. Kruskal-Wallis with Dunn's multiple comparisons test was applied for statistics. Results: All mice presented cyclicity confirming a normal ovarian function not disrupted by ethanol. Both treatments showed an increased number of glands compared to saline solution (31.7±6.26, 58.2±16.53 and 53.5±10.92 glands/mm 2 in saline, EndoECM (P=0.07) and EndoECM+GF (P=0.08)), and a non-significant increase in endometrial thickness. All groups showed a low incidence of fibrosis, yet collagen deposition was significantly higher in EndoECM compared to EndoECM+GF (90.7±3.21 and 82.7±4.86%, P<0.05). Ethanol caused a significant disruption of fertility in saline group (no pregnancy) compared to non-injured horns (80% pregnancy rate, 3.8±2.60 fetuses/horn), which was not significantly improved by EndoECM ( Previous studies suggest that bone marrow derived stem cells (BMDSC) have regenerative properties in both human and mouse impaired ovaries. Moreover, BMDSC autologous ovarian transplantation improved ovarian reserve biomarkers in patients with poor ovarian response (POR) allowing pregnancies. Thus, we aimed to identify proteins and pathways that may be involved in the regenerative effects of BMDSC in ovaries to inform future experiments aimed at optimizing clinical application of BMDSC therapy. Methods: Eight ovarian cortex biopsies from POR women were xenografted into NOD/SCID ovariectomized females (n=4). A week later, after xenograft vascularization, animals were allocated into two experimental groups, receiving an intravenous injection of saline (control group) or 1x10 6 human BMDSC (BMDSC group). Two weeks after, ovarian xenografts (control n=3; BMDSC n=4) were recovered to establish their proteomic profiles by SWATH. A penalized linear regression model using elastic net was used to identify differently expressed proteins (DEP) among control and BMDSC xenografts. Results: Of the 1,224 proteins quantified by SWATH, 22 were differentially expressed in the BMDSC grafts compared to controls. Discriminant analysis and heatmap considering these DEP showed a clear separation between groups ( Figure 1A-B) . These proteins were involved in KEGG pathways related to ovarian function, such as as FoxO signaling pathway, regulation of actin cytoskeleton, protein processing in endoplasmic reticulum and apoptosis ( Figure 1C ). Moreover, 8 of the DEP (such as TIPS and CATS) were previously described as proteins whose levels change in plasma with aging. Conclusion: This study shows proteomic changes induced by BMDSC in human ovarian tissue and proposes specific pathways and molecules that may be involved in ovarian rescue induced by these adult stem cells. Of them, TIPS and CATS could be interesting targets to address in at our institution. Billing codes were searched for diagnoses related to autism spectrum disorder (ASD) among the patient population of the Department of Pediatrics Developmental Pediatrics group. At least 2 diagnoses related to ASD as per Newschaffer et al were required to be considered an ASD case. Controls were selected from the next infant born of same gender, gestational age +/-2 weeks, and season of birth +/-2 weeks. Maternal uteroplacental vascular pathology (UVP) considered both acceleration of villous maturation and lesions such as infarct and thrombosis; fetal vascular pathology (FVP) was coded to distinguish terminal villous lesions (avascular villi, stromal karyorrhexis and erythrocyte fragmentation) and mural thrombi embedded in the walls of muscular placental vessels. Contingency tables considered p<0.05 significant. Results: There was no association of maternal UVP lesions and ASD (p=0.17). 27 (21%) of ASD had villous fibrosis, hypovascularity and increased syncytial knotting compared to 14% of controls (p=0.09). There was no association of ASD with presence, number, size or location of placental infarcts (p=0.45). Chorionic or fetal stem mural thrombi were seen 18 (13.7 %) ASD and 50 (12%) of controls. However, fetal vascular pathology confined to terminal villi was seen in 12 (9%) of ASD cases and 19 (4.5%) of controls. Conclusion: Gross placental destructive lesions of uteroplacental vascular thrombosis and infarct were not associated with ASD in the population based cohort. Among lesions of the fetal placental vasculature, mural thrombi have been linked to neurodevelopmenthal impairment. However, this study finds no link to ASD, but rather lesions of the finer terminal villous capillary network. We have elsewhere reported a significant increase in terminal villous hemosiderin in placentas of newborns with an older sibling with ASD. These findings in a population of sporadic ASD provide additional evidence for capillary level vascular fragility to be a significant pathology in both genetic and sporadic ASD. The Introduction: Preterm birth is one of the most persistent health disparities in medicine. Preterm birth is more prevalent in Black versus White American women and contributes to 3.4 times more Black American infant deaths. Multiple lines of evidence indicate that social inequities play a significant role in racial health disparities, including preterm birth. Differential access/exposure to social and environmental determinants of health (SEDHs) is known to correlate broadly with self-identified race (Race), yet little is known about how these exposures contribute to racial disparities in preterm birth risk. The aim of this research was to investigate whether and to what extent SEDHs in five broad domains mediated the relationship between Race and gestational age at birth (GA). Methods: Data on SEDHs and birth outcomes was obtained from the Pregnancy, Race, Environment, Genes (PREG) study (PI: York), a prospective cohort of 177 women (50.3% Black American) in Richmond, Virginia. At up to four study visits, extensive measures were collected by questionnaire on pre-pregnancy SEDH, pregnancy-specific environmental exposures and medical history. Variables reflecting five empirically supported domains of SEDH were extracted, each with racially disparate links to preterm birth, including economic stability, education, social and community context, health and health care, and neighborhood/built environment. The internal consistency of instruments were assessed by Cronbach's alpha and factor analyses, both exploratory and confirmatory approaches, were performed to validate instruments by each self-identified racial group. A mediation model approach (mediation R package v. 4.5) was used to test the hypothesis that the direct association of Race on GA can be indirectly accounted for, at least in part, by variables from the five SEDH domains. The screened variable list consisted of 31 variables representing the five SEDH domains. The variable set considered for mediation analysis was identified from those estimated by linear regression to have a direct effect on GA at a Pval < 0.10 (N = 12). Race was estimated to explain 6.91% of the inter-individual variability in GA (Pval < 0.001). Mediation model results identified three variables with an indirect effect including: 'education level' (Pval = 0.022), 'someone close in trouble with the police' (Pval = 0.022), and 'length of time at current job' (Pval = 0.036). Conclusion: Current research on racial disparities in birth outcomes is limited by the availability of information obtainable by medical records abstraction. This study identified specific variables that mediated the influence of Race on GA. Further studies in larger samples should seek to identify other variables that account for race-specific preterm birth risk. Introduction: Exposure to consumer product chemicals during pregnancy may increase susceptibility to pregnancy disorders by influencing maternal inflammation. However, effects on specific inflammatory pathways have not been well characterized. Recently, we observed that oxylipins, an important class of lipid mediators of inflammation, are associated with adverse fetal growth outcomes. In this study, we aimed to determine the association between plasma oxylipins and urinary biomarkers of three classes of consumer product chemicals among pregnant women. Methods: Data come from a pilot study of 90 pregnant women nested within the LIFECODES cohort. Maternal plasma and urine were collected at three prenatal visits. Plasma was analyzed for 61 oxylipins, which were grouped into biosynthetic pathways defined by upstream: 1) fatty acid precursor: linoleic, arachidonic, docosahexaenoic, or eicosapentaenoic acid; and 2) enzyme pathway: cyclooxygenase (COX), lipoxygenase (LOX), or cytochrome P450 (CYP). Urine was analyzed for 12 phthalate, 12 phenols, and 9 organophosphate ester (OPEs). Linear mixed effect models were used for single-pollutant analyses, while the novel quantile g-computation was used to examine the joint effect of class-specific chemical mixtures. Results: Single-pollutant and mixture analyses showed urinary biomarkers of consumer product chemicals were most consistently associated with oxylipins produced from arachidonic acid by LOX or COX enzymes. The LOX-derived oxylipins, including a variety of hydroxyeicosatetraenoic acids (HETEs), were most strongly and positively associated with phenol biomarkers. Mixture analyses showed that at mid-pregnancy a quartile increase in all 7 phenols was associated with a 72% increase (95% confidence interval [CI]: 7%,178%) in 5-HETE, an important pro-inflammatory oxylipin. The HETE oxylipins were also positively associated with monoethyl phthalate, but not associated with other phthalate or OPE metabolites. In addition, the COX-derived oxylipin prostaglandin E2 (PGE2) was inversely associated with several chemicals from each class. Single-pollutant models showed a doubling of the OPEs diphenyl phosphate and bis(1,3-dichloro-2-propyl) phosphate was associated with 28% lower (95%CI: -42%,-12%) and 24% lower (95%CI: -38%,-6%) in PGE2, respectively. Conclusion: We estimate that elevated phenol, phthalate, and OPE exposures are associated with changes in inflammation-related oxylipins, but that the direction of association varies between oxylipins based upon the biosynthetic pathway of production. These findings provide insight into impacts of environmental chemicals on specific pathways of maternal inflammation in pregnancy. ever menstruated, installing the Apple Research app on iPhone with iOS version 13.2 or later, living in USA, age of 18 years or older in most states (19 years old in Alabama and Nebraska, 21 years old in Puerto Rico), profi ciency in written and spoken English, sole user of an iCloud account or iPhone, and providing informed consent to participate in the study. Results: We collected data from the 10,000 participants who responded to the demographics survey upon enrollment between November 14, 2019 and May 15, 2020. Participants were asked to complete a monthly follow-up through November 2020. Mean age at enrollment was 34 years old (+/-standard deviation 10.3). Race/ethnicity was representative of the U.S. population (69% White), while education was above average (51% had graduated college or beyond). Participant geographic distribution included all U.S. states and Puerto Rico. Seventy percent reported use of an Apple Watch, and 26% consented to sensor-based data collection. The majority of participants (54%) did not continue after enrollment. Non-White participants were slightly more likely to drop out than White participants; those remaining at 6 months were otherwise similar in demographic characteristics to the original enrollment group. Conclusion: Because the AWHS can capture time-varying demographic, lifestyle, and behavioral data that is built into Research app that can interface with multiple data sources, it has strong potential to contribute to much new knowledge about long overlooked and understudied women's health issues. years. Similar lack of association was found in males compared to females. However, there was a significant association of fetal placental weight ratio with both birth and Year 1 growth centiles that was unique to Caucasian infants (p's =0.04-0.015 v. p>0.20 in other race/ethnicities). This effect was found to be due to associations of fetal placental weight ratio with growth centiles in female Caucasian infants. We have previously demonstrated significant differences between associations of fetal placental weight ratio in males as compared to females. We speculated that males are less responsive than females to prenatal "cues" signaled by the placenta to modulate fetal growth. Our data suggest that this female-specific "responsiveness" to intrauterine environmental cues has effects on childhood growth that persist to at least age 2 years. This may carry implications for sensitivity of female children to environmental cue in early life that contribute to developmental programming. Introduction: Early growth in children subsequently diagnosed with autism spectrum disorders (ASD) is infrequently studied in low risk community based samples. We here compare change in centiles for weight and length to age 2 years in ASD versus gestational age, sex, and season of birth matched controls. Methods: A community hospital based sample with universal placental examination was searched for those births followed to at least age 2 years at our institution.Billing codes were searched for diagnoses related to autism spectrum disorder (ASD) among the patient population of the Department of Pediatrics Developmental Pediatrics group. At least 2 diagnoses related to ASD as per Newschaffer et al were required to be considered an ASD case. Controls were selected from the next infant born of same gender, gestational age +/-2 weeks, and season of birth +/-2 weeks. 165 ASD and 617 controls were included in the current analysis. Due to nonnormal distribution of growth variables, non-parametric tests were used. Results: At birth, a trend to increased head circumference centile (p=0.06) was observed but no other differences between cases and controls. While mean weight centile at Year 1 decreased 5% from birth in ASD (compared to an increase of 5% in controls), there was a broad range of weight centile changes that precluded statistical significance. No differences in growth centiles at ages 1 or 2 years were observed between ASD cases and controls. No sex differences in birth or age 1 or 2-year growth centiles were found in controls. but ASD males tended to reduced head cirumference and length centile (each p=0.08). In this large population sample of ASD with matched controls, little difference in childhood growth measures, either as absolute values or as rates of change, are seen in ASD cases. Our data suggest reduced growth in ASD males, but further studies are required to confirm and examine the implications of reduced growth in ASD males. Periconceptional Maternal Obesity and Underweight Have a Negative Impact on Post-Implantation Embryonic Growth and Developmental Trajectories: The Rotterdam Periconception Cohort. Linette van Duijn †, Melek Rousian * , Joop SE Laven * , Régine PM Steegers-Theunissen * . Erasmus University Medical Centre, Rotterdam, Netherlands. Introduction: Globally, the prevalence of extremes in body mass index (BMI) have risen rapidly over the past few decades. Besides numerous non-communicable diseases, these extremes are also associated with severe pregnancy complications. Although complications are generally detected in the second and third trimester of pregnancy, most of them originate in the periconception period, during which embryogenesis takes place. Moreover, fetal sex also impacts pregnancy course and outcome. Therefore, our aim is to study (sex-specific) associations between periconceptional maternal BMI and embryonic growth and morphological development. Methods: A total of 884 women with singleton pregnancies were selected from the Rotterdam Periconception Cohort, comprising 15 women with underweight, 483 with normal weight, 231 with overweight and 155 with obesity. Longitudinal three-dimensional ultrasound examinations were performed at 7, 9 and 11 weeks of gestation for offline measurements to estimate embryonic growth, i.e., crown-rump length (CRL), embryonic volume (EV), and morphological development, i.e., Carnegie stages, using virtual reality techniques. Linear mixed models were used to study associations between maternal periconceptional BMI and first-trimester growth and developmental trajectories, and stratified for fetal sex. Adjustments were made for gestational age and maternal characteristics. Results: Compared with pregnancies of normal weight women, a negative trend in embryonic growth was observed in pregnancies of obese women (β EV -0.03 (95%CI -0.06, 0.00, p=0.086), whereas embryonic growth and morphological developmental in overweight women were comparable. Maternal underweight was associated with faster morphological development (β Carnegie 0.78 (95%CI 0.25, 1.31), p=0.004). Moreover, after stratification for fetal sex, female embryos of underweight women grow and morphologically develop faster than those of normal weight women (β EV 0.13 (95%CI 0.03, 0.23), p=0.008; β Carnegie 1.39, p<0.001), whereas female embryos of obese women grow slower (β EV -0.05 (95%CI -0.09, -0.01), p=0.027). Conclusion: Periconceptional maternal underweight is associated with faster morphological development and embryonic growth, especially in females. In contrast, female embryos of obese women grow slower than thoseof women with normal weight. These results may be explained by sex specific adaptation to the prenatal environment. Future research should focus on strategies for personalisation of optimal preconceptional maternal weight in order to reduce BMI-related pregnancy complications and improve the health of future generations. Knowledge May Not Be the Barrier to Care for Pregnant Women response rate was 71% (range 42% to 91%) pre-presentation and increased by 12% (range -7% to 41%) to 83% (range 65% to 95%) post-presentation. The greatest improvement was in knowledge of recommended OUD screening methods. Only minimal (<10%) improvement was observed in 5 of 8 items (63%). Most respondents (67% to 77%) were either unsure or stated no specific protocols exist for screening and referral to treatment for OUD in pregnancy at their hospital. 90% were motivated by the presentation to educate themselves about current hospital screening policies. Conclusion: Basic knowledge of OUD was generally good with only modest improvement (12%) post-presentation but, we are optimistic that 90% of those individuals are motivated to educate themselves. Awareness, and/or lack, of policies appears to be the biggest challenge to caring for pregnant women with OUD. Optimal care of these patients must address complexities not common to other chronic medical conditions; efforts should be targeted toward ensuring readiness for every patient in every clinical setting focusing on best practices such as SBIRT, access to medication-assisted treatment, and CAPTA legislation requirements to name a few. The most common primary diagnoses for non-OBGYN related visits were: Abdominal pain (1,985,523 visits in 2018) , acute upper respiratory tract infection (1, 508, 558) , urinary tract infection (1, 249, 307) , chest pain (1, 200, 426) , and headache (710,478). The most frequent OBGYN diagnoses were: Unspecified pregnancy related conditions (773,682 of visits in 2018), hemorrhage in early pregnancy (558,425), disorders of menstruation and other abnormal bleeding (414,551), pelvic and perineal pain (314,124), and excessive vomiting of pregnancy (298,117). The number of visits for the most common OBGYN diagnoses also increased during this 13-year period (2,110,889 vs 2,358,899; P<.01) and in 2018 only 23,951 (1%) of these visits resulted in inpatient admission. Conclusion: Reproductive age women currently comprise 23.5% of all ED visits, with an 11.6% increase volume over the past 13 years. While these visits are most commonly for non-OBGYN related diagnoses, a significant percentage are for OBGYN complaints. The five most common OBGYN-related diagnoses represented 7% of all visits, though this may be an underestimate since abdominal pain diagnoses often have OBGYN etiologies. These diagnoses include common complications of the first trimester of pregnancy and general gynecologic issues typically managed in the outpatient setting. High ED utilization for these conditions, coupled with low rates of admission, suggest an opportunity to optimize outpatient management for common OBGYN conditions to prevent further overburdening of the ED system. Hannah Anvari †, Kara Goldman * , Mary Ellen G. Pavone * , Jian-Jun Wei * , Melissa Simon * , Francesca Duncan * . Northwestern University, Chicago, IL, United States. Introduction: The weathering hypothesis is a framework positing that non-Hispanic Black (NHB) women experience decreased health outcomes due to cumulative social and economic disadvantage. Higher allostatic loads -or wear and tear -from lifetime exposure to stress in a raceconscious society can also accelerate aging. Whether racial disparities exist with respect to ovarian aging has not been systematically evaluated. Methods: Ovarian aging is associated with decreased numbers of follicles, increased stromal inflammation and fibrosis. To determine if an association between race and ovarian aging exists, we used fixed human ovarian cortex tissue from a research archive established by the Oncofertility Consortium. Samples were from age-matched NHB and non-Hispanic white (NHW) women (2, 4, 5, 6, 7, 9, 10, 11, 12, 13, 15, 16, 18, 20, 22, 28, 29, 34 years, N=23 NHB and N=52 NHW) undergoing ovarian tissue cryopreservation (OTC) for hematologic malignancies, solid tumors, or hematologic, gynecologic and rheumatologic disorders. We counted follicles (primordial, primary, secondary, early antral) on H&E stained sections, and reported average follicle number per ovarian area. We further constructed an ovarian tissue microarray (TMA) with tissues from these participants to evaluate differences in stromal markers by histochemical analysis and immunohistochemistry (collagen, vimentin, alpha-smooth muscle actin, desmin, CD68, CD163, and CD34). Picrosirius Red (PSR), specific for collagen I and III fibers, was used to evaluate ovarian fibrosis. We quantified the area positive for PSR staining and reported percent fibrotic area relative to area of ovarian core. We then compared the profiles of 80 fibroinflammatory cytokines in follicular fluid (FF) from the Northwestern University Reproductive Tissue Library (RTL) using cytokine antibody arrays. FF samples were collected from agematched NHB and NHW women (22, 23, 30, 32, 35, 36, 37, 38, 40, 41, 43, 44 years, N=9 NHB and N=8 NHW) undergoing oocyte retrieval for infertility diagnoses (unexplained, social, diminished ovarian reserve, or polycystic ovarian syndrome). We observed no significant differences in average follicle number in any class by race, but there was a tendency for follicle counts to be higher in NHW females aged 6-9, 10-14, 15-18, 19-22, and 23-34 years. PSR staining for collagen was highest among NHB and NHW females aged 2-11 years relative to 11-16 or 17-34 years, but levels did not vary by race. Analysis of other stromal markers is ongoing. Levels of fibroinflammatory cytokine profiles of FF did not differ among agematched NHB and NHW females. Conclusion: Our results do not reveal obvious racial disparities in ovarian aging markers, however our population included females with oncologic diagnoses that may not be representative of the general population, therefore future studies are warranted. Characterization of Human Uterine Leiomyoma-Derived Exosomes and Its Impact on Endometrium. Antonia Navarro, Maria Victoria Bariani †, Hang-Soo Park †, Ayman Al-Hendy * . University of Chicago, Chicago, IL, United States. Introduction: Uterine fibroids (UF) are the most common benign pelvic tumors in women of reproductive age, they cause heavy menstrual bleeding (HMB), leading to severe anemia and subsequent major negative effects on quality of life. The aim of this study is to investigate the effects of human uterine leiomyoma smooth muscle cells (HULM) and human uterine smooth muscle cells (UTSM)-derived exosomes on growth and angiogenesis of the human endometrium-related endothelial cells. In addition, to characterize the miRNA profiling of HULM-and UTSMderived exosomes using NGS. Methods: We isolated and characterized HULM-and UTSM-derived exosomes. Then, we performed in vitro studies treating human endometrial microvascular endothelial cells (HEMEC) with HULM-and UTSMderived exosomes to understand the molecular mechanisms by which uterine fibroids mediates their proliferative and angiogenic properties that ultimately cause HMB. We also performed RNA-seq to obtain the miRNA signature of HULM-and UTSM-derived exosomes. We treated HEMEC cells with HULM-and UTSM-derived exosomes at several time points and different exosome concentrations. Then, we measured cell proliferation via BrdU incorporation assay; we checked mRNA expression of proliferation and angiogenic markers such as PCNA, C-Myc and VEGFA by real-time PCR. Additionally, we performed tube formation assay and RNA-seq of HULM-and UTSM-derived exosomes. Results: We observed that HULM-derived exosomes cocultured with HEMEC increased cell proliferation by 60% (P <0.01), and this increase is more significant culturing it for 48 hrs. We confirmed that this effect is associated with the upregulation of specific markers for proliferation (PCNA and C-Myc) and angiogenesis (VEGFA). HEMEC cells treated with HULM-derived exosomes showed increased in tube formation length by tube formation assay. MiRNA profiles of HULM-and UTSM-derived exosomes demonstrated that 84 miRNA were significantly downregulated and 71 significantly upregulated in HULM-derived exosomes compared to UTSM-derived exosomes. Interestingly, some of the upregulated miRNAs are associated with endometrial receptivity and implantation. Our study suggests that HULM-derived exosomes have strong paracrine effects on human endometrial microvascular endothelial cells, likely containing bioactive factors that enhance endometrial proliferation and angiogenesis, which eventually cause HMB. Further characterization of these factors can lead to novel druggable therapeutic targets to improve health care for women with uterine fibroids associated heavy menstrual bleeding. Keywords (3) Introduction: Rotterdam, the second largest city of the Netherlands, with many deprived neighborhoods and considerable inequalities in perinatal health. Socioeconomic disadvantage (low SES) is associated with ill health and exposure to chronic stress. Stress on its own also affects ill health. These factors make people with low SES more vulnerable for adverse outcomes. In case of pregnancy, both the health of the mother and the child is affected by the circumstances, making these women highly vulnerable. Objective: To examine perinatal outcomes in highly vulnerable pregnant women within the Mothers of Rotterdam (MoR) study compared to the Netherlands in general. The MoR-study is a pragmatic prospective cohort study evaluating social care and health outcomes for highly vulnerable pregnant women and their offspring. Vulnerability was assessed by filling out a checklist, and eligibility was defined as: at least 3 problems from a total of 47 problems divided over at least 2 problem domains (i.e. pregnancy, residence, administration and finance, work and education, parenting, health, social functioning, safety and crime). Records on maternal and neonatal outcomes were obtained from obstetric care professionals. Outcome measures were prevalence rates of preterm birth, small for gestational age (SGA) and perinatal mortality. Crude prevalence rates (per 1000) and 95% confidence intervals (95%CI) were calculated for the MoR-group and the Netherlands. Data from the national birth registry (2015-2018) was used to calculate prevalence rates for the Netherlands. Subsequently, all prevalence rates were standardized for maternal age, parity, and living in a deprived neighbourhood, using direct standardization. (table 1) . The prevalence rates for preterm birth and perinatal mortality were lower in the MoR-group, but with overlapping 95%CI (table 1) . Direct standardization did not change the comparison between the MoRgroup and the Netherlands. Conclusion: SGA was more often found in the group of highly vulnerable pregnant women compared to the Netherlands. Although preterm birth and perinatal mortality was not more prevalent in the MoR-group, awareness of social risk factors in pregnancies is important to anticipate on adverse outcomes. To examine the association between SARS-CoV-2 infection during pregnancy and adverse pre-and postnatal outcomes by severity of illness. Methods: A retrospective cohort study using data on 29,323 pregnant women extracted from the KPSC electronic health records between 04/6/2020-12/31/2020. SARS-CoV-2 infection was ascertained by PCR-based test that was universally offered to all women. Outcomes were ascertained from the EHRs. Diagnosis of acute respiratory disease (ARD) at the time of, or soon after COVID-19 diagnosis was used as a proxy for disease severity. Multivariable logistic regression was used to estimate the odds ratios (OR). Results: Women with ARD related to COVID-19 were at significantly increased risk for preeclampsia (adj Conclusion: Most adverse pregnancy outcomes associated with SARS-CoV-2 are associated with the respiratory disease caused by the virus. However, even in the absence of maternal ARD, SARS-CoV-2 infection still increased the risk of a low Apgar score. This suggests that there are clinical as well as subclinical associations of SARS-CoV-2 infection with risks of adverse pregnancy outcomes. Sonam Verma †, Ebony B Carter, Indira U Mysorekar * . Washington University SOM, St. Louis, MO, United States. Introduction: The pandemic caused by the Beta-coronavirus SARS-CoV-2 has wreaked havoc in people of all ages. The rate of severe COVID-19 infection appears to increase the risk of adverse pregnancy outcomes in pregnant women such as preeclampsia, but the mechanism by which this difference occurs remains unclear. Here, we explored the pathophysiology of SARS-CoV-2 at the human maternal-fetal interface in pregnant women who tested positive for the virus. Methods: Placental tissues were acquired at delivery from pregnant women who tested positive for SARS COV2 as well as sera pre-and post delivery. RNA In situ hybridization and Immunohistochemistry was used to localize the viral RNA or Spike protein in placental tissue as well as ACE receptor to determine impact of viral infection. The choriocarcinoma cell line, JEG3, was treated with recombinant Spike protein or a chimeric virus, VSV-SARSCoV2-S and viral impact on ACE2 was measured via Western Blotting. Finally, sera from COVID19+ and -women was analyzed for markers associated with preeclampsia. Results: We show that SARS-CoV-2 colonizes multiple compartments at the human maternal-fetal interface. Viral colonization was highest in the maternal decidua, fetal villous and extravillous trophoblasts, Hofbauer cells, and in placentas delivered prematurely. We localized SARS-CoV-2 to cells expressing Angiotensin-converting enzyme 2 (ACE2), the cellular receptor for the SARS-CoV-2 Spike (S) protein and demonstrate that infected placentas had significantly reduced ACE2. ACE2 is a key enzyme in the circulating renin-angiotensin system (RAS), promoting Angiotensin-II binding to its receptor AT 1 R. To uncover whether viral infection alters the RAS in placenta, we infected human trophoblasts with either recombinant S protein or a live modified virus with a vesicular stomatitis viral backbone expressing S protein. In both cases, cellular ACE2 decreased while AT 1 R increased with concomitant increase in the soluble variant of VEGFR1 (soluble fms-like tyrosine kinase-1, sFlt1), an antagonist of angiogenesis. Furthermore, viral infection decreased proangiogenic factors, AT 2 R and Placental growth factor, which competitively binds to sFlt1. Finally, we demonstrate that sera from SARS-CoV-2 infected pregnant women had elevated levels of sFlt1 and Angiotensin II type 1-Receptor Autoantibody (AT 1 -AA) prior to delivery, both signatory markers of preeclampsia. In sum, we demonstrate that SARS-CoV-2 colonizes ACE2expressing fetal trophoblasts, stromal cells, and macrophages in the placenta and that SARS-CoV-2 infection in pregnant women correlates with dysregulation of the normal placental RAS. As RAS regulates blood pressure, SARS-CoV-2 may thus increase adverse hemodynamic outcomes such as preeclampsia in pregnant women. We also compared the placental pathology findings in cases of COVID-19 diagnosed on admission to the hospital for delivery with findings in cases of COVID-19 diagnosed earlier in the pregnancy. Results: There were a total of 141 cases of COVID-19 in pregnancy with 106 deliveries having occurred at the time of the study. Placental tissue was submitted for histopathologic evaluation after delivery in 59 (55.7%) subjects. COVID-19 diagnosis occurred at admission for delivery in 33 (55.9%) cases, and 30 (50.8%) subjects were symptomatic at diagnosis. Of the 59 placentas evaluated, 31 (52.5%) were found to have evidence of acute infection, either acute subchorionitis or acute chorioamnionitis. Those with COVID-19 infection diagnosed on admission for delivery were 3.8 times more likely to have evidence of acute placental infection as compared to those diagnosed earlier in the pregnancy (95% CI 1.3, 11). The average gestational age at COVID-19 diagnosis was 35 weeks in those with acute placental infection compared to 31.5 weeks in those without acute placental infection (P=.01). Notably, no subjects with evidence of acute infection on histopathology had clinical evidence of chorioamnionitis. Conclusion: Despite lack of clinical symptoms of chorioamnionitis, placental histopathology demonstrates evidence of acute infection in patients with COVID-19 in pregnancy. Placental infection is more common in subjects with a recent COVID-19 diagnosis. Histopathologic evaluation in cases of COVID-19 should be encouraged to further characterize markers of inflammation and infection and to better understand the potential impact of such placental pathology on fetal and neonatal well-being. -19) , has been confirmed in over 16 million people within the United States with a 1.8% mortality rate as of December 2020. Over 47,000 of said cases have been confirmed among pregnant women, emphasizing the importance of studying the effects of COVID-19 in this population. The aim of this study is to describe the demographics, risk factors, and outcomes of pregnant and postpartum patients (i.e., delivery within 6 weeks from initial positive SARS-CoV2 nasopharyngeal PCR test) with a history of SARS-CoV-2 infection/COVID-19 disease. Methods: We performed a retrospective chart review of electronic health records for pregnant and postpartum patients with positive SARS-CoV2 nasopharyngeal PCR testing at Woman's Hospital in Baton Rouge, Louisiana between March 11, 2020 to December 3, 2020. Demographic, pre-existing medical and obstetrics characteristics along with both obstetrical and neonatal outcomes were assessed. Patients were grouped according to severity of disease course (asymptomatic-mild versus severecritical). Chi-square tests and ANOVA were used to compare categorical and numerical demographic, medical, and obstetrical characteristics as well as obstetrical and neonatal outcomes between groups. Results: A total of 131 pregnant (n=124) and postpartum (n=7) patients with positive SARS-CoV2 testing were included, of which 96 (73.2%) were asymptomatic or experienced mild COVID-19 disease and 35 (26.7%) experienced severe or critical COVID-19 disease. Patients with severe-critical COVID-19 disease were more likely to be African American (p = 0.03), have obesity (p < 0.01), use Medicaid insurance (p < 0.01), be multiparous (p=0.01), have the diagnosis of gestational diabetes in a previous and/or current pregnancy (p=0.02 and 0.04, respectively). Patients with severe-critical disease were more likely to deliver at an earlier gestational age (p < 0.01) and have positive SARS-CoV2 testing at the time of delivery (p < 0.01). Ninety-nine percent of pregnancies studied resulted in live births. Neonates born to mothers with severe-critical COVID-19 were more likely to be admitted to the neonatal intensive care unit (NICU; p=0.05). Overall maternal mortality, attributable to COVID-19 disease, was 2.3% (n=3). Conclusion: Consistent with previous studies, we found that COVID-19 disease in pregnancy is associated with earlier gestational ages at delivery and, presumably, neonates requiring admission to the NICU. Differences in COVID-19 disease among various races and insurance statuses emphasize the importance in addressing underlying disparities in healthcare nationwide. Introduction: SARS-CoV-2 is known to induce systemic coagulation and immune-inflammatory reactions, which can result in exaggerated host response. At the placental level, this can lead to a higher rate of ischemic, thrombotic, or inflammatory changes that are associated with adverse pregnancy outcomes. We aimed to evaluate the rate of histopathologic findings in the placentas of patients with COVID-19. Methods: Maryland Study Group is a collaboration of major medical systems (University of Maryland Medical System and Johns Hopkins Health System) in the State of Maryland. We reviewed all patients with COVID-19 from March 2020 until January 2021. Data were recorded in a research electronic data capture registry. Pregnancy outcomes and placental histopathologic reports were analyzed. Pregnancy outcomes included live birth rate, pregnancy losses (<20 weeks), fetal demise (>20 weeks), and fetal growth restriction (estimated fetal weight <10th percentile). Placental histopathologic reports were categorized as no diagnostic abnormalities (NDA), ischemic/thrombotic (I/T) changes, inflammatory/ infectious (I/I) changes, and non-specific changes. The rate of I/T and I/I changes were compared with the published historical data (PHD) (12% I/T and I/I in normal live births). Patients with an unknown delivery outcome, early pregnancy losses, terminations, or no pathology report were excluded. Results: Out of 347 cases reviewed, pregnancy outcomes were known in 296 patients (Flowchart). Placental reports were available in 139/275 live birth (51%). I/T changes were seen in 40 (29%) placentas, at a significantly higher rate than PHD (p=0.001). I/I changes were seen in 32 (23%) placentas, which was similar to PHD (p=0.06). NDA was reported in 68 cases (43%). There were 14 cases of FGR. Of those, 4 (6%) were in the NDA group and 10 (17%) in placentas with I/T and I/I changes (p=0.049). Conclusion: Patients with COVID-19 had higher rates of I/T changes that are associated with adverse pregnancy outcomes. Further research is needed to compare the rates of FGR and other pregnancy complications in pregnant women with and without COVID-19. Increased surveillance of pregnant women with COVID-19 should be considered. Introduction: ACE2 enzyme serves as SARS-CoV-2 human receptor through binding of the viral S protein and subsequent trimming of S protein between S1 and S2 units by host serine proteases as TMPRSS2, CTSB or CTSL. Here, we aim to investigate the expression of the diff erent cell entry proteins involved in SARS-CoV-2 infection in the diff erent cell types of the human endometrium throughout the menstrual cycle with specifi c focus on the preconceptional endometrium using single-cell RNAseq (scRNAseq). Methods: Human endometrial cells isolated from endometrial biopsies obtained from 27 donors across the menstrual cycle. After tissue dissociation, single cell capture was performed on Fluidigm C1 system (n= 2,149 cells) or Chromium 10x system (Chromium Next GEM Chip G, 10x Genomics) (n= 71,032 cells) followed by reverse-transcription, cDNA generation and library construction. Barcoded libraries were sequenced in pair-end reads on Nextseq (Illumina) for the C1 dataset or Novaseq (Illumina) for the 10x dataset . Data pre-processing, quality fi ltering, and statistical analyses were performed using custom Python, R, and Java scripts Results: ScRNAseq analysis showed no signifi cant expression of ACE2 in stromal or unciliated epithelial cells in any phase of the menstrual cycle. TMPRSS2 was expressed in epithelial cells during the early proliferative and mid-secretory phases. Interestingly, expression of NRP1, CTSB and CTSL was observed in both stromal and epithelial cells across all phases of the menstrual cycle, and CTSB was the most abundant of these genes. In the mid-secretory phase, we detectedcoexpression of ACE2 and TMPRSS2 in 0.07% of luminal epithelial cells and coexpresssion of ACE2 and NRP1 in 0.10% of stromal cells and 0.08% of luminal epithelial cells. No cells simultaneously expressed ACE2, NRP1 and TMPRSS2 at the time of embryo implantation. Our fi ndings at the single-cell level imply low effi ciency of SARS-CoV-2 infection in the endometrium, especially in the preconceptional period. However, NRP1 is high in stromal and decidual cells independent of the cycle phase, suggesting an infectivity potential during pregnancy. These fi ndings will facilitate preconception risk assessment in asymptomatic carriers. , and with stemness-maintaining growth factor removed to enable normal diff erentiation (ND). Alternately, ESC were cultured with doses of positive control hyper-osmotic sorbitol in NS media to test for changes in viral susceptibility. RNA lysates were tested using Illumina NovaSeq6000 RNAseq for changes in gene expression for genes mediating virus uptake (susceptibility). Gene ontology (GO) groups mediating host viral resistance were assessed for stress eff ects. Thirty-three loading control genes assured correct assignment of cellular gene expression. qRT-PCR was used to confi rm expression changes of key genes. Results: Coronavirus receptors TMPRSS2, DPP4, Enpep and Vim increased during stressed ESC culture compared with normal stemness and/or diff erentiation. The Covid-19 receptor ACE2 was not detected in ESC culture, but ACE2 arises in some human or mouse ESC lines after diff erentiation to 1st lineage in the early implanting embryo, yolk sac endoderm. TMPRSS2, DPP4, Enpep and VIM are expressed in yolk sac endoderm which arises in stressed ESC. Also, most genes in 4 GO groups mediating host negative regulatory virus interaction -resistance -increase with normal diff erentiation but decrease during stress. The increase in viral susceptibility gene expression and decrease in viral resistance gene expression in stressed ESC here may also be caused by environmental stresses. Stress may aff ect viral susceptibility and pathogenesis of ESC and early embryos. It remains to be tested if stress aff ects human ESC in similar ways. Does Covid-19 infect or kill environmentally stressed ESC and their yolk sac progeny more than unstressed ESC? Oral T-145, T-146, T-147, T-148, T-149, T-150, T-151, T-152, T-153, T-154, T-155, T-156, T-157, T-158, T- T-078, T-079, T-080, T-081, T-082, T-083, T-084, T-085, T-086, T-087, T-088, T-089, T-090, T- of Maternal and Fetal Vascular Pathology in a Case-Control Study of Autism Introduction: Oxidative stress pathways have been identified as abnormal in children with autism specttrum disorder (ASD); placental evidence of maternal and or fetal vascular pathology (MVP, FVP) such as infarcts and vascular thromboses have not been studied in ASD in a low risk community based population. Methods: A community hospital based sample with universal placental examination was searched for those births followed to at least age 2 years Recent Trends in Gestational Diabetes Based on Maternal Age Methods: This population study used electronic health records of pregnancies delivered at the Kaiser Permanente Southern California healthcare system between 2009-2018 (n=379,866). GDM diagnosis was made using Carpenter-Coustan thresholds. We fi rst examined the annual rate of GDM, followed by the adjusted trends by comparing rates in 8% in 2017-2018, an adjusted relative decrease (ARD) of 9%. The prevalence was highest in Asian/Pacifi c Islanders (17.2%), followed by Latinas (11.8%), Blacks (7.6%), and Whites (7.1%). Among Whites, GDM prevalence decreased from 7.5% ARD:25% (95%CI:18-31%), and this was driven by a decrease in the 30-34 age group Association between SARS-CoV-2 Infection and Adverse Pre-and Postnatal Outcomes by the Trimester of Diagnosis United States; 4 Kaiser Permanente Southern California Methods: A retrospective cohort study was conducted using data from 29,323 pregnant women extracted from the Kaiser Permanente Southern California electronic health records (04/06/2020-12/31/2020). SARS-CoV-2 infection was ascertained from PCR-based test results that was universally offered to all women All neonates born to Covid-19 positive mothers were at increased risk for Apgar score <7 (adj.OR:1.96, 95%CI:1.09-3.55) and to test positive for SARS-CoV-2 infection (adj.OR: 10.59, 95%CI:5.84-19.18) after the first day of life, compared to neonates born to women without Covid-19 diagnosis. Conclusion: Women who tested positive for SARS-CoV-2 infection during the 1 st /2 nd trimester are at increased risk for PTB and stillbirth. The higher risk of GDM associated with SARS-CoV-2 infection Increased Fetal Demise/Stillbirth within a USA COVID-19 Epicenter (2020) did not differ. Likely cause of death was identified in ~65% of cases for each year. Placental pathology contributory to mortality was identified in >50% of all cases (p=NS between years). However no specific diagnosis or category of placental pathology differed between years. Only 3/79 of the 2020 cases had SARS-CoV-2 infection as a preceding or concurrent diagnosis. Conclusion: Our tertiary care Institution, averaging 6000 births/yr O-128 W-005, O-027 O-053 O-044, O-096, T-119, T-120, T-122 O-053, O-094 O-053, O-059, O-094 O-008, O-097 O-091, W-099, T-105 O-056, O-091 O-008, O-097 O-006, O-030 O-131, T-204 O-096, T-119 O-008, W-096, W-103, O-134 Publication Number Prefix Key Oral Presentations Poster Presentations O-001 -O-004 = Tuesday Oral Presentations W-001 -W-263 = Wednesday Presentations O-005 -O-086 = Wednesday Oral Presentations T-001 -T-256 = Thursday Presentations O-087 -O-151 = Thursday Oral Presentations T-002, O-021, O-132 W-099, T-105 W-021, T-025, W-065, W-169 T-019, W-021, W-065 T-103, W-115 W-114 W Women's Health Disparities and Inequities O-127, O-128, W-252, W-253 Women's Health Inequities in Maternal Health W-145 Women's Health Inequities in Gynecologic Disorders O-073 Women's Health Inequities in Gynecologic Malignancies O-162 Women's Health Inequities in Infertility Care O-113 Women's Health Inequities in Perinatal Outcomes W-094 Women's Health Inequities in Preeclampsia & Related Disorders O-143 Fetal Growth Restriction: Isolated Abdominal Circumference and Perinatal Outcomes. Maria Andrikopoulou †, 1 Natalie Bello, 1 Shai Bejerano, 1 Karin Fuchs, 1 Russell Miller, 1 Eliza Miller, 1 David M Haas, 2 William Grobman, 3 Brian M Mercer, 4 Samuel Parry, 5 Robert M Silver, 6 Ronald Wapner, 1 Deborah Wing, 7 George R Saade, 8 Uma Reddy, 9 Hyagriv Simhan, 10 Corette Parker, 11 Cynthia Gyamfi-Bannerman * . 1 1 Columbia University Irving Medical Center, New York, NY, United States; 2 Indiana University School of Medicine, Indianapolis, IN, United States; 3 Northwestern University Feinberg School of Medicine, Chicago, IL, United States; 4 MetroHealth Medical Cent Case Western Reserve University, Cleveland, OH, United States; 5 University of Pennsylvania, Philadelphia, PA, United States; 6 University of Utah, Salt Lake City, UT, United States; 7 University of California, Irvine, CA, United States; 8 University of Texas Medical Branch, Galveston, TX, United States; 9 Yale School of Medicine, New Haven, CT, United States; 10 University of Pittsburgh, Pittsburgh, PA, United States; 11 RTI International, Research Triangle Park, NC, United States. Introduction: Objective: To examine the frequency of isolated fetal abdominal circumference (AC<10% with estimated fetal weight EFW>10%) and to compare perinatal outcomes in those with isolated AC<10% to those with EFW<10% (regardless of AC%) Methods: This was a secondary analysis of a prospective longitudinal cohort of nulliparous women. Women with singleton pregnancies Placental DAGLbeta Regulates 2-arachidonoylglycerol Levels and Is Involved in Pregnancy Induced Infl ammation. Natascha Berger †, 1 Thomas Bärnthaler * , 2 Jürgen Gindlhuber †, 1 Nermeen Girgis * , 2 Tom van der Wel * , 3 Birgit Hirschmugl * , 1 Ruth Birner-Gruenberger * , 1 Mario van der Stelt * , 3 Robert Zimmermann * , 2 Christian Wadsack * . 1 1 Medical University of Graz, Graz, Austria; 2 University of Graz, Graz, Austria; 3 Leiden University, Leiden, Netherlands. Introduction: Diacylglycerollipase α/β (DAGLα/β) possess hydrolytic activity for arachidonic acid (AA)-esterified diacylglycerols to generate 2-arachidonoylglycerol (2-AG) which is one of the main endocannabinoids (EC). 2-AG is the precursor of AA and both lipid species serve as substrates for pro-infl ammatory cellular pathways. Given the emerging evidence for an enhanced infl ammatory status and altered lipid metabolism in compromised pregnancies like preeclampsia (PE), we aim to identify the specifi c function and regulation of DAGLα/β in healthy and PE placentas. Methods: In situ hybridization complemented with immunohistochemical staining was used to determine the cellular localization and distribution of DAGLα/β in CTRL (n= 4) and PE (n=6) placental tissue (2-way ANOVA). The expression was quantifi ed by RT-qPCR of CTRL (n=12) and PE (n =10) placentas (unpaired two tailed T-test). Immunoblot analysis (n=5, unpaired two tailed T-test) and activity-based protein profi ling (ABPP) served to identify protein expression and active sites of isoforms. Placentas were perfused with DAGL inhibitor (DH376 [1µM]) and changes in lipid profi les were determined by LC-MS. The Apple Women's Health Study (AWHS) Cohort was designed to gain a deeper understanding of the relationship between menstrual cycles, health, and behaviors. This abstract describes the design and methods of the ongoing AWHS and provides demographic characteristics of the fi rst 10,000 participants who meet inclusion criteria and the subset who responded to the 6-month follow-up. Methods: This is a mobile-application-based longitudinal cohort study with survey and sensor-based data. Eligibility criteria include having Jennifer S Feng †, 1,2,3 Joan Krickellas, 1,2 Sadia F Chowdhury †, 1,2,3 Adwoa Nantwi †, 4 Sylvia Dygulski, 1,2 Hannah Bromberg, 1,2 Ruchit Shah, 5 Michael Joyce, 1 Mehrin Jan, 1,2 Serena Chen, 1,2 Christine Chen, 1,2 Jillamika Pongsachai, 1,2 Beata Dygulska, 2 Carolyn Salafi a * . 1, 2,6 1 Placental Analytics, New Rochelle, NY, United States; 2 NYPBMH, Brooklyn, NY, United States; 3 CUNY Hunter College, New York, NY, United States; 4 NYU CGPH, New Rochelle, NY, United States; 5 Institute of Basic Research, Staten Island, NY, United States; 6 Institute for Basic Research, Staten Island, NY, United States. Introduction: In a cohort based in the mid-last century, fetal placental weight ratio impacted childhood growth and blood pressure at age 7 years. We explore in a community based low risk modern cohort whether the fetal placental weight ratio varies with childhood growth centiles at 1 and 2 yrs of life. Methods: Fetal placental weight ratio was calculated for 899 term singleton liveborns delivered between January 2010 and March 2015, and compared using Spearman's correlation to weight and length centiles calculated for measures at birth and ages 1 and 2 years. Results: There were no correlations between the fetal placental weight ratio and weight and length centiles calculated at birth, or at ages 1 or 2 with Opioid Use Disorder: The ACOG District II Education Bundle. Neil Seligman, 1 Kathleen Dermady, 2 David Garry, 3 Leah Kaufman, 2 Darcy Dreyer, 4 Marilyn Kacica, 5 Cassie Leonard, 6 Kelly Gilchrist, 7 Christa Christakis. 7 1 Univ. of Rochester, Rochester, NY, United States; 2 Upstate Medical Center, Syracuse, NY, United States; 3 Stony Brook Medicine, Stony Brook, NY, United States; 4 March of Dimes, Rochester, NY, United States; 5 NYS DOH, Albany, NY, United States; 6 Hudson Headwaters Health Network, Queensbury, NY, United States; 7 ACOG District II, Albany, NY, United States. Introduction: Opioid use disorder (OUD) is one of the most important public health issues affecting pregnant women in the 21st century yet 62% of Ob/Gyns in New York State feel there is not adequate training and resources in their area/region to manage pregnant women with OUD. In 2017, ACOG District II (DII) convened a multidisciplinary task force to create a comprehensive education "Bundle" to increase awareness of evidence-based guidelines. The objective was to assess the effectiveness of the ACOG DII OUD in Pregnancy Bundle to improve provider knowledge. Methods: From 5/2018-9/2019, the Bundle was presented on request by a task force member. A pre-and post-presentation test containing 8 items assessing basic knowledge of OUD management and 2 items assessing knowledge about local hospital policies was administered using Mentimeter (Stockholm, Sweden). Baseline site characteristics were described. Test performance was assessed pre-and post-presentation. Results: The bundle was presented at 8 hospitals. Most (88%) were community hospitals and only 2 had an Ob/Gyn residency. Delivery volume ranged from 454-8,389 births/yr with most (63%) having >1,000 births/yr. 101 and 66 respondents answered the pre-and post-presentation questions respectively. Of the 8 basic knowledge items, the average correct Novel Mechanisms of Disrupted Placental Development: Lipid Mediators and Inflammatory Signaling. Yuliya Fakhr †, 1,2 Kirsten Webster †, 1, 2 Denise G Hemmings * . 1,2,3 1 Department of Obstetrics and Gynecology, University of Alberta, Edmonton, AB, Canada; 2 Women and Children's Health Research Institute, Edmonton, AB, Canada; 3 Department of Medical Microbiology and Immunology, Univeristy of Alberta, Edmonton, AB, Canada. Introduction: The pathophysiology of preeclampsia, an inflammatory pregnancy disorder, is rooted in poor trophoblast fusion that forms the multinucleated syncytium, the site of maternal-fetal exchange. In preeclampsia, elevated pro-inflammatory tumor necrosis factor-α (TNF-α) hinders trophoblast fusion into the syncytium. However, the mechanism of this response remains unclear. In endothelial cells, TNF-α exerts its disruptive effects by modulating the levels of sphingosine 1-phosphate (S1P), a signaling lipid, and its receptors (S1PRs). Similarly to TNF-α, S1P hinders trophoblast fusion. We hypothesize that TNF-ɑ disrupts syncytium fusion by modulating S1P regulatory enzymes and S1PRs in the human placenta, similar to effects in endothelial cells. Methods: Chorionic villous explants from term placentas were treated after syncytial sloughing (day 4) with or without 1ng/mL TNF-ɑ. Syncytium re-formation and cell death were examined up to 48hrs later. The role of S1P was assessed using 1μM PF-543, which inhibits S1P main synthesizing enzyme, sphingosine kinase 1 (SK1). Cell fusion (n=4) was assessed by E-cadherin staining, demarcating cell membranes that are lost during syncytialization. Cell death and syncytium function were measured with lactate dehydrogenase (LDH) and chorionic gonadotropin (CG) assays (n=8). S1P regulatory enzymes and S1PR1-3 mRNA expressions were measured by qRT-PCR (n=5-7). Results were analyzed by 2-way ANOVA for combined treatments and mixed effects model for time courses. Results: TNF-ɑ treatment decreased formation of multinucleated units by 37.2±0.09% (p=0.008). Inhibiting S1P formation with PF-543 in the absence of TNF-ɑ also decreased fusion by 30.9±0.09% (p=0.04). Combined treatment led to a 41.3±0.09 % decrease (p=0.04) with a TNF-ɑ and PF-543 interaction (p=0.06), indicating that SK1 inhibition is part of TNF-ɑ signalling. LDH and CG were unaltered in response to TNF-ɑ. S1PR2, SK1, and S1P lyase (irreversibly degrades S1P) levels were unchanged throughout syncytialization with or without TNF-ɑ. S1P phosphatase-1 (reversibly degrades S1P) increased after 48hrs of re-syncytialization with and without TNF-ɑ (7.0±1.72 fold, p=0.04 and 5.8±1.37-fold, p=0.02, respectively). Under normal culture conditions, only S1PR1 (17.5±3.82 fold, p=0.01) mRNA expression was upregulated after 48hrs. TNF-ɑ treatment blocked this normal S1PR1 surge and increased S1PR3 expression (5.4±1.47 fold, p=0.03). Conclusion: SK1-induced S1P synthesis is crucial for trophoblast fusion. TNF-ɑ disrupts fusion by decreasing SK1 activity. Fusion hindered by TNF-ɑ is associated with a decrease in S1PR1 and increase in S1PR3 levels and potentially signalling. Washington, DC, United States; 3 Rocket Pharmaceuticals, Inc., Cranbury, NJ, United States. Introduction: Our previous study and others indicated that mitophagy, a subtype of autophagy targeting dysfunctional mitochondria, was impaired in GDM placentas, which was coincident with reduced AMPK signaling. However, to date, mitophagy pathways have not been characterized in human trophoblast cells. To fill this gap in knowledge, we hypothesized that AMPK signaling stimulates mitophagy in human trophoblast cells via classical mitophagy pathways. Methods: In Study One, to determine whether AICAR (AMPK activator) can stimulate AMPK signaling in human trophoblast cells, BeWo cell line was treated with AICAR (0.5mM) for 12 or 24 hours, and the phosphorylated AMPK at Thr 172 (p-AMPK; AMPK activity indicator) and ACC at Ser 79 (p-ACC; phosphorylated by AMPK) were analyzed by Western blotting. In Study Two, to determine whether and how AICAR induces mitophagy, BeWo cells were treated with AICAR (0.5mM), chloroquine (CLQ; 40µM; blocking the degradation of mitochondria) and their combination for 24 hours. The abundance of LC3II proteins (mitochondria receptor in mitophagy) in both whole cell lysates and mitochondrial fractions, and PINK1, PARKIN, BNIP3 and BNIP3L (mediators of mitophagy) in mitochondrial fractions was analyzed by Western blotting. The abundance of proteins was normalized to ACTB or total proteins in blots after MemCode staining. The effects of AICAR, CLQ and/or their combination were analyzed by one or two way ANOVA (n=3). Results: The main findings include: 1) The p-AMPK levels were increased (P<0.05) by 1.59-and 1.54-fold by AICAR after 12 and 24 hours' treatment, respectively, compared to the control group, while total AMPK protein levels were unchanged; coincidently, changes in p-ACC levels followed the same pattern to p-AMPK; 2) The abundance of LC3II in whole cell lysates was increased (P<0.001) by 3.10-fold by AICAR and further elevated (P<0.001) by 9.69-fold by the combination of AICAR and CLQ; similarly, the abundance of LC3II in mitochondrial fractions was increased (P<0.05) by 1.92-fold by AICAR and further elevated (P<0.05) by 1.95-fold by the combination of AICAR and CLQ; 3) In mitochondrial fractions, the abundance of PINK1, PARKIN, and FUNDC1 was increased (P<0.05) by 1.21-, 1.24-,1.58-fold, respectively, by AICAR, while the abundance of BNIP3 and BNIP3L was reduced (P<0.05) by 1.66-and 1.29-fold by AICAR, respectively. Conclusion: Taken together, we report for the first time that AICAR induced AMPK signaling can stimulate mitophagy in human trophoblast cells via pathways mediated by PINK1/PARKIN and FUNDC1, but not by BNIP3/BNIP3L, suggesting that mitophagy in the human placenta may be finely tuned by involvement of multiple pathways. Placental Pathology Associated with Liveborn and Stillbirth Infants in Women with and without an Inherited Thrombophilia. Jhenette Lauder †, 1,2 Jessica Page * , 1,2 Amanda Allshouse * , 1 Robert Goldenberg * , 3 Carol Hogue * , 4 Halit Pinar * , 5 Ware Branch * , 1,2 Robert Silver * . 1 Introduction: Inherited Thrombophilia's (IT) have been linked to adverse perinatal outcomes via placental thrombosis and infarction. However, data are mixed, and the association is controversial. Thus, we sought to characterize placental pathology among women with and without IT, who experienced either livebirths (LB) or stillbirths (SB). Methods: This is a secondary analysis of data from the Stillbirth Collaborative Research Network (SCRN), a case-control study that enrolled LB and SB at the time of delivery. Standardized evaluation of placentas was performed by perinatal pathologists with centralized training. We included all enrollees who had a non-anomalous, singleton pregnancy with placental pathology and completion of IT testing (Factor V Leiden (FV), Prothrombin G20210A (PT), Plasminogen Activator Inhibitor-1 (PAI-1), and MTHFR A1298C and C677T). Primary outcomes included placental lesions adopted from Amsterdam Criteria and included five categories previously associated with SB: maternal vascular lesions (MVL), fetal vascular lesions (FVL), maternal inflammation, fetal inflammation, and immune/idiopathic lesions. Placental lesions were compared between IT groups and stratified by LB and SB. Statistical analysis incorporated analytical weights using Wald chi-square and ANOVA where appropriate, reflecting the SCRN sampling design. Placental-analysis-specific analytical weights were used for analysis of placental lesions. Results: Of the 2,595 women enrolled in SCRN, 1,085 were included for analysis. Placental abnormalities were extremely common in both LB and SB (Table 1) . For most lesions, there were no differences in their incidence in placentas with and without maternal IT. When all thrombophilia's are considered, the IT group had more immune lesions in LB, but fewer FVL in SB. For FV and PT alone, there were more FVL in LB but fewer MVL future studies because their expression significantly change in the wave of aging that occurs at the age of 34, when ovarian aging starts. Support: PROMETEO/2018/137 Stillbirth Rates Are Falling Faster Than Perceived. Roshan Selvaratnam †, 1,2 Daniel Rolnik * , 1 Mary-Ann Davey * , 1,2 Euan M Wallace * . 1,2 1 The Ritchie Centre, Monash University, Melbourne, Australia; 2 Safer Care Victoria, Melbourne, Australia. Introduction: Rates of stillbirth are falling across high-income countries despite significant changes in maternal characteristics over time. However, in view of the increasing number of women with risk factors for stillbirth, it might have been expected that the rate of stillbirth would have increased over time. We sought to quantify how the changing stillbirth risk profile of women is affecting the interpretation of the stillbirth rate. Methods: A retrospective, population-based cohort study in Victoria, Australia on all births ≥28 weeks' gestation from 1983 to 2018. Changes in maternal characteristics over time were assessed. A multivariable logistic regression model was designed for stillbirth based on maternal characteristics in 1983-87 and used to calculate individual predictive probabilities of stillbirth from the regression equation. The number of expected stillbirths per year as a result of the change in maternal demographics was then calculated, assuming no changes in care and in the associations between maternal characteristics and stillbirth over time. Results: There were 2,419,923 births at ≥28 weeks' gestation between 1983 and 2018 in Victoria, Australia. Compared to 1983-87, there were more women of older age groups giving birth, more nulliparous women, more Indigenous women and women born in Oceania, Asia, and Africa, more multiple pregnancies, and more women with pre-existing diabetes in 2014-18. Despite this, the rate of stillbirth fell from 5.42 per 1,000 births in 1983 to 1.72 per 1,000 births in 2018 (p-value < 0.001). Applying the multivariable logistic regression equation derived from 1983-87 to each year, had there been no changes in care or in the associations between maternal characteristics and stillbirth, the rate of stillbirth would have increased by 12%, from 4.94 per 1,000 in 1983 to 5.54 per 1,000 in 2018 as a result of the change in maternal characteristics. Conclusion: There has been a substantial reduction in late pregnancy stillbirth in Victoria over the last 35 years. This reduction has been achieved despite a demographic shift toward greater numbers and proportions of childbearing women with a higher stillbirth risk profile than previously. Had the risk associated with maternal characteristics not changed and care not improved, the rate of stillbirth would be expected to have increased by 12%. This suggests that the impact of long-term efforts to reduce stillbirth has been underestimated and that the contributions improved care have made to outcomes are larger than recognised. Introduction: Women are more susceptible to posttraumatic stress disorder. Mitigating stress in pregnant women is important for their own well-being, and to protect the unborn child from the effects of prenatal stress. Disaster stress can be measured as objective hardship (degree of disaster exposure), subjective distress (emotional response intensity) and cognitive appraisal of the event. We postulate that resilience, positive coping styles and cognitive appraisal would moderate effects of objective hardship on posttraumatic stress (PTS) symptoms in mothers 10 and 24 months after the 2016 Fort McMurray Wood Buffalo wildfire in Alberta, Canada. Methods: 200 women who were pregnant or within 6 months of conception during the fire were recruited 10.3 ± 4.0 months after the disaster. They completed the Impact of Event Scale-Revised (IES-R) for PTS symptoms, Connor-Davidson Resilience Scale for resilience and Brief COPE for coping strategies at recruitment. At 24 months post-fire (24MPF), 109 women (54.5%) completed the McMurray Objective Maternal Stress Scale and indicated their cognitive appraisal of the disaster (very negative to very positive). Of these, 75 (37.5%) also returned the 24MPF IES-R. Repeated measures, correlation and multiple linear regressions with interaction terms to test moderation of the relationship between objective hardship and PTS symptoms were performed, with p<0.05 considered significant. Results: PTS symptoms did not significantly decrease between recruitment and 24MPF (p=0.26). High levels of objective hardship, dysfunctional coping, and negative cognitive appraisal correlated with higher PTS symptoms at recruitment and 24MPF (p<0.001). High dysfunctional coping at recruitment (n=75, p=0.03) and high emotion-focused coping at 24MPF (p=0.02) associated with more severe PTS symptoms. High levels of resilience protected against PTS symptoms at low, but not high, degrees of hardship at recruitment but not 24MPF (p=0.01). While a negative cognitive appraisal was associated with more PTS symptoms at increasing levels of hardship, neutral or positive cognitive appraisal protected women against PTS symptoms at 24MPF (p=0.001) with increasing magnitude of effects the more severe the objective hardship. Conclusion: The persistence of PTS symptoms two years after a natural disaster is concerning. Attitudes and personality play an important role in the development of enduring post-disaster PTS symptoms. The ability to positively reframe a tragedy is protective towards the continuation of symptoms, even at high levels of objective hardship. Supporting resilience, reframing and positive coping styles may be beneficial for maternal mental health and child development. Hackensack University Medical Center Hackensack, NJ United States Hadassah -Hebrew Univ. MC Jerusalem IsraelIrwin, Juan C. Bunkyo-ku Japan Chiba University, Graduate SOM Chiba Japan Tokai University SOM Isehara Japan Hamamatsu University SOM Hamamatsu Japan Oral Poster T-061 Oral